Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ABAT GABAT ENSG00000183044 "4-aminobutyrate aminotransferase" P80404 16 8674565-8784575 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Neurotransmitter degradation" "Aminotransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 53.3;liver: 136.5;pancreas: 54.2" "Cell type enhanced" "Detected in many" 19 "Hepatocytes: 234.8;Proximal tubular cells: 72.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 45.3;MCF7: 29.1;RH-30: 25.6;T-47d: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041528, HPA041690" Enhanced Supported Supported Mitochondria No No 1500000 Mitochondria "HPA041528: AB_10795690, HPA041690: AB_10794674" "unprognostic (1.77e-2)" "unprognostic (3.27e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-1)" "unprognostic (2.90e-1)" "unprognostic (2.05e-1)" "prognostic favorable (5.36e-5)" "prognostic favorable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "prognostic favorable (5.44e-8)" "unprognostic (2.10e-1)" "unprognostic (2.48e-2)" "unprognostic (3.80e-1)" "unprognostic (1.50e-2)" 2.1 12.6 26.1 2.7 39.3 1.7 3.2 19.9 43.3 2.2 5.2 10.9 0.1 17.5 2.1 5.0 3.0 2.8 2.7 6.2 20.4 30.9 53.3 136.5 2.8 2.8 24.5 26.1 5.3 54.2 4.0 22.1 2.3 14.3 9.9 4.2 2.6 2.6 2.5 1.4 2.1 8.4 2.1 14.1 2.5 3.9 6.3 11.8 1.0 12.7 0.4 3.3 6.4 1.1 2.2 1.9 8.8 5.8 1.6 2.5 1.8 0.2 0.0 12.1 6.9 1.9 0.7 0.5 1.4 0.8 0.7 0.2 4.5 0.3 1.4 0.5 0.8 0.4 3.1 0.8 2.8 0.9 0.8 0.6 2.0 0.0 45.3 3.1 0.4 3.1 2.5 1.3 1.2 0.5 0.3 0.2 3.9 0.3 1.0 0.2 29.1 0.7 0.2 1.0 8.5 0.1 3.5 25.6 0.6 0.4 7.2 1.9 5.8 0.7 0.4 0.0 2.5 15.9 1.2 0.2 0.2 2.0 0.9 0.0 1.1 0.1 0.3 0.3 2.1 1.4 1.1 3.1 4.1 2.5 3.6 1.1 0.8 1.7 1.7 1.9 2.2 1.1 1.8 8.8 1.6 5.8 0.3 1.6 1.8 26.1 39.3 19.9 35.1 20.4 30.9 24.5 26.1 14.3 11.8 0.0 5.8 12.2 3.3 1.3 16.6 8.9 15.3 2.7 7.9 1.8 3.9 1.2 19.9 1.2 8.3 1.4 10.3 0.0 5.5 1.2 2.1 9.6 1.1 234.8 4.3 33.4 15.0 5.5 9.1 6.0 3.4 5.4 1.7 0.0 4.9 48.7 6.3 6.5 4.2 72.0 6.0 0.0 2.5 1.5 0.9 0.5 1.1 7.2 6.8 4.2 ABCB6 "EST45597, MTABC3, umat" ENSG00000115657 "ATP binding cassette subfamily B member 6 (Langereis blood group)" Q9NP58 2 219209766-219219017 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dyskeratosis congenita, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 4.0;Club cells: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046723, HPA058011" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol" NA NA 22000 "Golgi apparatus" "Nucleoplasm, Plasma membrane, Mitochondria, Cytosol" "HPA046723: AB_10960288, HPA058011: AB_2683578" "unprognostic (8.04e-2)" "unprognostic (3.22e-2)" "unprognostic (4.53e-3)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (9.45e-7)" "unprognostic (2.26e-1)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" "unprognostic (1.18e-4)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.51e-1)" "unprognostic (9.55e-2)" "unprognostic (7.75e-2)" "unprognostic (2.30e-1)" 10.1 8.4 8.2 3.9 13.5 10.2 9.2 7.6 9.1 6.9 7.6 5.4 8.3 8.1 7.1 10.1 9.0 8.4 8.5 9.5 5.6 8.2 6.9 16.2 7.2 4.9 9.8 7.6 13.1 7.1 8.0 6.0 3.7 9.2 9.2 4.2 6.0 5.6 11.3 24.0 5.5 8.0 9.5 9.2 3.2 6.8 19.5 7.7 0.8 9.9 11.3 4.7 14.8 6.0 2.8 5.6 1.3 1.1 1.2 3.2 2.4 0.1 9.9 2.0 12.5 14.0 5.0 12.3 3.7 3.4 4.1 4.1 15.2 2.1 0.1 19.1 3.6 2.2 21.4 0.2 1.5 1.3 6.3 2.2 15.5 10.9 27.9 16.9 0.0 5.2 7.3 1.8 2.7 0.0 6.1 7.1 2.1 13.1 1.9 2.7 5.1 1.0 0.1 3.1 23.0 4.1 5.2 6.3 0.6 2.2 0.2 7.4 7.9 7.7 18.3 8.1 8.0 5.5 0.3 3.2 5.5 0.2 7.4 4.3 5.0 4.0 0.0 6.2 0.1 7.3 1.3 1.1 0.0 1.7 0.9 0.5 2.8 1.3 0.7 0.9 2.3 3.2 2.1 0.0 1.2 0.8 5.6 1.1 2.4 8.2 13.5 7.6 9.1 5.6 8.2 9.8 7.6 9.2 7.7 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 4.0 2.3 0.0 0.0 0.2 0.0 0.6 1.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.7 0.0 0.2 0.9 0.2 0.3 0.2 0.0 0.0 0.0 ABCB8 "EST328128, M-ABC1, MABC1" ENSG00000197150 "ATP binding cassette subfamily B member 8" Q9NUT2 7 151028422-151047782 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045187 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA045187: AB_10964281" "unprognostic (5.29e-2)" "unprognostic (9.17e-3)" "unprognostic (8.28e-2)" "unprognostic (8.32e-2)" "unprognostic (8.63e-3)" "prognostic favorable (5.91e-4)" "unprognostic (4.76e-2)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "prognostic favorable (3.34e-4)" "unprognostic (2.26e-1)" "prognostic favorable (5.88e-4)" "unprognostic (7.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.64e-2)" "unprognostic (1.23e-1)" 12.6 22.8 14.4 13.8 22.0 12.2 8.5 24.9 24.8 16.3 12.3 22.2 10.4 19.3 16.5 14.9 17.6 12.9 11.5 13.0 14.5 12.8 14.5 33.5 11.7 13.3 19.1 17.9 13.3 12.6 15.4 20.1 23.6 15.9 12.3 9.5 12.5 11.1 12.8 11.2 13.7 14.7 12.7 13.3 11.5 13.1 13.6 19.5 14.0 18.4 11.7 10.6 9.6 10.4 4.4 10.4 10.3 6.7 4.0 7.5 3.6 12.5 19.8 5.1 16.1 8.1 4.7 10.2 6.6 6.9 10.6 11.2 7.9 21.1 6.6 8.9 7.0 12.8 13.3 7.4 13.8 4.7 8.2 8.1 5.2 7.9 9.4 5.3 4.0 13.1 8.1 10.5 12.6 5.2 3.9 10.6 14.7 27.4 9.1 7.9 28.1 15.3 7.6 3.4 9.5 22.6 7.3 3.2 23.5 7.1 5.4 4.9 9.9 7.1 20.2 6.4 4.1 8.0 5.3 6.5 9.9 2.6 7.1 9.9 9.2 4.6 4.7 14.0 9.7 10.1 10.3 4.5 3.4 7.5 6.7 5.2 4.4 5.3 6.1 6.3 3.5 4.9 6.9 1.1 4.0 4.7 10.4 5.6 3.6 14.4 22.0 24.9 24.8 14.5 12.8 19.1 17.9 15.9 19.5 11.9 0.6 11.7 5.2 3.3 22.7 6.7 12.7 1.4 1.2 10.4 35.3 32.5 3.3 13.7 1.8 3.4 24.1 0.0 17.6 18.5 6.5 7.1 50.6 21.2 25.1 28.6 0.0 5.5 8.1 1.9 6.1 5.9 8.5 11.8 8.7 11.2 17.7 7.8 11.7 12.8 32.9 25.8 5.9 8.8 15.4 6.5 68.4 7.5 10.6 5.1 ABHD11 "PP1226, WBSCR21" ENSG00000106077 "Abhydrolase domain containing 11" Q8NFV4 7 73736094-73738867 "Disease related genes, Predicted intracellular proteins" Hydrolase "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 161.7;Urothelial cells: 241.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.7;SK-BR-3: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024042, HPA049641" Approved Supported Mitochondria NA NA 450000 Mitochondria "HPA024042: AB_1844445, HPA049641: AB_2680838" "unprognostic (4.74e-2)" "unprognostic (8.62e-3)" "unprognostic (1.42e-1)" "unprognostic (2.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-3)" "unprognostic (1.91e-2)" "unprognostic (9.32e-2)" "unprognostic (7.79e-2)" "unprognostic (1.74e-1)" "prognostic favorable (3.66e-7)" "unprognostic (3.61e-3)" "unprognostic (4.44e-2)" "unprognostic (1.02e-1)" "unprognostic (7.29e-2)" 5.6 8.9 7.7 11.5 8.7 4.2 12.2 8.8 9.2 8.1 28.5 8.3 14.8 15.7 6.0 12.7 8.3 14.0 17.0 20.1 7.1 8.1 21.6 6.6 8.4 6.9 8.6 5.6 5.0 18.9 7.3 10.8 40.2 10.0 14.7 17.5 7.8 23.9 22.2 9.8 7.9 28.1 5.6 5.9 5.2 8.3 6.1 5.6 6.9 20.1 8.4 12.6 5.8 5.4 8.3 12.9 12.2 21.0 9.7 6.7 8.0 17.5 4.1 2.8 6.4 1.4 2.0 15.6 8.1 3.4 5.0 5.9 5.0 19.8 8.3 2.4 3.4 6.8 7.8 1.2 4.6 3.4 3.1 6.0 4.1 2.7 3.1 2.6 4.4 4.5 1.8 1.9 6.4 3.0 1.8 3.5 2.9 5.5 4.8 4.7 34.7 3.3 5.6 3.2 11.1 15.1 1.9 4.5 15.4 11.5 8.3 7.2 3.0 6.6 44.2 2.7 2.1 14.3 2.9 3.4 4.3 4.0 18.2 8.4 2.9 1.5 5.6 6.8 4.2 7.9 6.1 13.1 12.2 6.0 21.0 4.8 6.3 6.7 6.2 12.9 8.3 6.3 4.4 10.5 9.7 20.7 6.3 4.4 8.0 7.7 8.7 8.8 9.2 7.1 8.1 8.6 5.6 10.0 5.6 41.7 11.2 11.1 58.4 4.8 14.7 15.3 40.8 83.0 36.4 54.1 3.9 68.1 61.3 45.0 1.0 8.4 161.7 0.0 35.7 109.7 8.7 56.7 15.0 7.8 24.5 4.8 60.0 6.2 8.9 2.1 8.3 14.8 13.5 9.0 63.5 26.4 35.6 108.7 3.2 34.8 14.2 0.0 12.0 5.4 8.0 5.5 106.8 13.1 94.5 241.0 AC004556.1 ENSG00000276345 Unmapped 2585-11802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.0" "Cell type enhanced" "Detected in many" 17 "Distal tubular cells: 26.6;Hofbauer cells: 22.3;Kupffer cells: 73.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 25.6;K-562: 21.5;MOLT-4: 24.1;NB-4: 46.5;PC-3: 43.4;WM-115: 31.2" HPA050406 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA050406: AB_2681116" 0.9 0.0 0.9 0.0 8.3 3.7 0.0 3.8 0.0 1.3 5.9 0.0 1.5 1.7 9.3 1.6 3.0 0.0 0.0 2.4 2.0 0.0 0.0 1.5 0.0 2.2 0.0 6.1 1.4 3.6 0.0 0.9 1.2 0.0 0.3 0.0 1.4 2.8 4.7 13.0 9.6 3.2 6.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 8.4 12.0 13.0 9.4 25.6 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 14.4 0.0 8.7 13.4 21.5 11.8 0.1 0.1 24.1 46.5 0.0 0.0 43.4 0.1 7.6 0.0 12.1 7.3 0.0 0.1 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 31.2 13.0 5.6 3.1 2.8 9.6 2.4 2.5 4.5 6.0 4.1 2.8 4.5 5.2 1.0 3.2 4.0 4.7 5.9 4.0 0.0 0.0 8.7 0.1 0.0 0.0 0.0 2.5 4.0 2.3 17.4 0.0 2.8 26.6 0.0 0.9 0.0 0.0 0.0 0.3 10.9 0.0 0.0 0.0 1.1 22.3 0.0 0.0 17.2 73.1 2.8 3.7 0.2 0.0 0.0 1.1 0.0 0.1 0.2 0.4 6.9 0.0 0.0 0.0 3.5 5.9 0.0 3.3 3.8 0.4 0.1 AC139530.2 ENSG00000262660 17 81703371-81720539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6;MOLT-4: 18.5;SK-BR-3: 7.0" "HPA022853, HPA023043, HPA023048" Approved Supported Mitochondria NA NA Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950" "unprognostic (2.36e-3)" "unprognostic (1.17e-1)" "unprognostic (2.87e-1)" "unprognostic (3.83e-1)" 2.4 3.6 2.3 2.3 3.0 1.5 6.3 2.7 5.7 2.3 4.6 0.8 2.7 13.8 3.4 1.5 4.6 2.3 2.7 16.3 2.4 2.3 4.9 16.6 3.0 4.2 2.5 1.5 2.3 9.9 3.6 2.3 3.4 2.2 2.4 1.5 1.1 3.1 2.4 15.5 2.4 5.9 1.6 2.3 3.3 2.6 2.6 0.6 3.0 2.4 12.6 3.0 2.3 2.3 0.0 0.4 0.0 0.1 0.8 0.6 0.1 1.3 0.6 1.8 4.7 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.3 0.3 0.9 0.3 0.0 1.7 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.2 0.0 0.6 0.7 0.3 0.1 0.0 6.6 0.0 0.8 18.5 0.8 1.0 0.7 0.0 3.3 0.3 1.2 0.0 0.0 3.2 1.6 0.0 7.0 1.8 0.4 3.0 1.6 0.0 0.5 1.1 1.0 1.7 0.6 0.0 0.7 1.2 0.5 2.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 2.3 3.0 2.7 3.7 2.4 2.3 2.5 1.5 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACAA2 DSAEC ENSG00000167315 "Acetyl-CoA acyltransferase 2" P42765 18 49782167-49813960 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 245.7" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 686.3;Proximal tubular cells: 536.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042303 Approved Supported Mitochondria NA NA 3200000 Mitochondria "HPA042303: AB_10794046" "unprognostic (7.94e-2)" "unprognostic (3.14e-2)" "unprognostic (2.20e-3)" "prognostic unfavorable (8.53e-4)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (7.63e-2)" "unprognostic (1.70e-1)" "unprognostic (7.97e-2)" "unprognostic (8.03e-3)" "unprognostic (1.72e-1)" "unprognostic (3.84e-1)" "prognostic favorable (1.36e-10)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (8.26e-3)" "unprognostic (3.41e-1)" 22.7 12.9 9.4 6.9 10.7 4.4 13.0 3.6 7.0 4.1 27.2 8.0 7.8 25.9 5.1 5.1 7.1 4.1 9.2 38.9 6.8 7.0 60.3 245.7 7.9 7.5 10.7 6.1 6.4 13.6 6.3 7.1 7.5 6.7 7.9 18.4 9.5 3.3 6.2 22.9 4.2 37.0 11.3 9.7 6.9 6.0 6.5 7.5 8.4 15.7 8.8 5.0 8.1 4.9 13.0 31.8 27.5 33.0 35.5 40.9 28.6 0.8 14.1 23.6 21.6 31.3 16.6 12.0 7.2 11.8 12.2 9.5 30.0 12.3 12.6 15.5 26.6 12.6 0.9 39.3 4.6 12.1 38.6 9.2 8.9 18.5 35.6 14.8 0.1 16.9 21.9 1.5 19.7 6.2 9.9 20.0 18.3 7.7 11.9 33.9 16.3 0.5 19.5 21.4 5.3 5.7 31.0 50.5 46.2 41.3 0.6 33.9 26.9 0.5 16.6 1.1 19.5 9.4 13.1 9.5 10.4 13.1 15.7 7.9 24.2 27.9 32.2 7.4 18.2 9.5 13.1 25.9 27.5 32.1 33.0 40.9 13.0 19.2 28.6 31.8 9.7 16.4 24.3 2.5 35.5 31.1 14.9 22.6 28.6 9.4 10.7 3.6 7.0 6.8 7.0 10.7 6.1 6.7 7.5 35.7 38.9 45.7 10.9 3.2 5.9 161.7 229.3 29.4 30.7 52.4 3.9 30.0 250.4 111.1 56.2 32.3 191.9 0.0 40.7 49.6 32.6 10.2 44.9 686.3 101.9 1.6 38.5 46.6 63.1 122.0 44.5 46.6 18.6 61.3 59.2 53.2 84.8 76.3 35.0 536.1 27.2 19.4 17.6 27.7 39.6 4.3 22.5 68.2 98.9 4.5 ACADSB "ACAD7, SBCAD" ENSG00000196177 "Acyl-CoA dehydrogenase short/branched chain" P45954 10 123008979-123058311 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 28.9;liver: 114.2" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 481.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041458, HPA063555" Enhanced Supported Mitochondria NA NA 63000 Mitochondria "HPA041458: AB_2677491, HPA063555: " "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.91e-3)" "unprognostic (2.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.87e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-3)" "unprognostic (1.30e-1)" "unprognostic (3.67e-1)" "prognostic favorable (3.40e-4)" "unprognostic (9.37e-3)" "prognostic favorable (6.37e-12)" "unprognostic (2.69e-1)" "unprognostic (7.20e-2)" "unprognostic (1.60e-3)" "unprognostic (7.14e-2)" 4.6 9.4 6.7 2.4 9.0 1.4 8.3 10.3 8.3 3.9 5.3 5.5 6.4 16.8 4.1 3.3 4.4 4.1 3.1 13.7 8.5 4.8 28.9 114.2 4.3 2.7 5.1 8.2 5.0 5.3 8.0 4.9 1.9 7.5 7.9 5.8 4.9 5.6 6.0 12.7 4.7 5.5 5.2 4.8 2.7 4.8 2.9 5.4 3.6 4.3 7.9 3.9 5.0 4.1 6.3 6.8 13.5 5.0 9.0 11.7 6.0 9.7 7.0 5.2 9.5 7.1 8.9 4.6 6.0 12.2 6.1 6.1 6.1 3.2 10.2 4.2 5.1 3.7 4.1 8.1 4.2 10.1 6.6 8.4 5.3 2.1 35.3 5.0 7.5 5.1 6.5 4.3 3.8 3.5 9.0 5.8 8.6 5.1 7.5 7.5 4.5 7.1 6.2 3.2 5.4 4.4 8.5 10.9 3.2 8.6 10.8 1.0 6.0 9.2 2.8 9.5 5.2 8.4 3.7 6.1 3.3 3.0 7.5 7.3 8.5 9.6 5.4 5.1 7.1 2.5 13.5 5.0 12.3 10.0 5.0 11.7 5.9 9.4 8.6 6.8 6.3 8.9 9.9 3.2 9.0 3.0 4.1 7.6 6.0 6.7 9.0 10.3 8.3 8.5 4.8 5.1 8.2 7.5 5.4 26.8 40.3 7.3 7.2 8.2 17.2 64.9 43.3 17.4 29.6 10.4 9.8 17.9 39.7 6.4 6.0 7.4 6.8 0.0 4.2 2.5 7.5 26.5 3.5 481.6 6.3 20.6 11.6 15.4 11.8 7.8 12.4 7.6 6.8 8.2 13.3 12.2 4.3 5.8 10.3 116.2 7.3 19.4 11.3 9.7 2.5 12.0 25.2 13.8 15.7 10.7 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria NA NA 19000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 32.7 69.2 22.8 18.2 21.1 15.1 24.1 19.8 18.4 21.1 44.0 16.5 26.7 51.7 17.4 19.7 31.5 14.2 24.4 118.2 20.2 12.2 35.2 90.0 17.3 9.8 18.5 16.8 15.5 67.8 31.5 32.3 40.2 20.9 22.1 24.2 20.0 27.4 29.0 132.3 20.3 51.2 25.0 15.7 21.9 28.7 11.5 18.6 14.6 29.6 36.9 21.2 22.4 31.8 8.3 32.0 37.9 29.0 11.6 14.9 20.0 33.5 32.1 13.2 18.1 57.0 21.0 25.0 24.7 34.4 28.1 17.5 12.9 30.3 18.0 20.6 51.7 10.1 25.9 8.8 27.0 24.9 56.9 9.1 9.6 22.8 19.7 27.4 9.1 25.0 23.3 24.7 23.5 37.1 43.6 25.3 22.1 12.3 21.9 45.1 12.7 9.4 11.0 6.2 35.2 12.7 13.2 14.6 42.6 62.6 30.6 3.5 8.7 34.8 44.3 20.2 12.9 20.3 14.0 25.1 24.9 18.7 12.6 24.1 20.6 9.6 0.9 45.9 16.1 18.1 6.8 29.0 37.9 13.5 18.0 12.4 8.3 10.9 14.9 32.0 7.6 8.3 10.2 6.3 11.6 12.0 26.0 9.7 20.0 22.8 21.1 19.8 18.4 20.2 12.2 18.5 16.8 20.9 18.6 56.6 73.4 64.0 249.7 77.5 39.6 397.7 150.3 17.4 43.3 191.9 58.9 369.3 157.5 241.9 107.0 71.4 453.8 23.3 66.5 164.5 100.7 311.9 89.7 297.9 171.6 31.8 172.2 51.5 68.0 184.1 115.3 93.1 77.6 423.8 144.6 37.1 129.2 196.4 124.8 276.8 38.8 103.5 102.3 100.5 34.7 76.5 554.7 68.2 215.2 275.4 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 278.7" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 266.6;Paneth cells: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria NA NA 22000 Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 10.0 1.4 3.1 12.7 3.5 2.2 6.4 1.2 3.1 9.3 84.6 1.6 3.8 64.5 8.7 41.8 4.2 8.0 11.2 3.1 3.3 3.1 3.2 56.5 10.8 7.1 4.0 1.2 5.0 1.6 0.1 1.2 2.1 3.9 7.0 21.5 8.4 2.4 4.0 2.6 1.3 278.7 2.6 3.8 12.4 7.7 2.3 2.5 6.3 3.1 2.7 7.2 17.4 6.7 10.8 19.4 16.3 17.0 16.2 25.1 11.7 11.6 0.3 0.2 0.0 0.8 0.1 1.0 0.3 2.3 0.0 0.2 10.6 43.3 14.2 2.6 0.6 2.1 0.1 0.0 0.0 0.2 11.9 0.0 11.1 0.4 18.5 2.8 17.2 18.8 1.9 0.0 0.2 0.0 0.8 0.8 0.0 0.0 6.5 0.0 0.0 0.0 7.9 0.0 9.8 0.4 3.9 0.0 8.7 1.2 44.2 0.0 0.3 17.3 6.6 0.0 0.0 0.0 9.7 12.5 0.1 0.1 0.7 0.7 4.7 0.0 6.9 0.4 21.6 0.0 14.5 9.3 16.3 16.7 17.0 16.6 10.8 13.7 18.4 19.4 8.2 9.5 14.5 2.5 16.2 15.9 6.2 25.1 11.7 3.1 3.5 1.2 3.1 3.3 3.1 4.0 1.2 3.9 2.5 11.9 43.5 21.6 7.4 3.4 0.0 1.4 12.7 5.3 33.0 0.0 3.9 1.6 0.0 12.0 65.8 24.5 266.6 0.0 5.6 1.9 1.7 5.7 17.3 79.9 16.7 0.0 39.2 16.0 19.2 29.7 14.7 23.5 3.3 4.6 84.3 0.0 29.0 93.1 11.3 0.0 1.2 0.0 1.4 1.7 1.4 1.5 0.6 14.9 90.6 41.4 ACSS3 FLJ21963 ENSG00000111058 "Acyl-CoA synthetase short chain family member 3" Q9H6R3 12 80936414-81261205 "Enzymes, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 42.8;Hepatocytes: 47.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "basophil: 8.3;neutrophil: 6.0" "Lineage enriched" "Detected in single" 71 "granulocytes: 8.3" "Cell line enhanced" "Detected in many" "ASC diff: 9.4;ASC TERT1: 10.7;Hep G2: 26.5;hTERT-RPE1: 9.1;RH-30: 12.3;SK-BR-3: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039353, HPA047956, HPA061517" Approved Supported Mitochondria NA NA Mitochondria "HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549" "unprognostic (8.59e-2)" "unprognostic (9.29e-4)" "unprognostic (1.47e-1)" "unprognostic (9.37e-3)" "unprognostic (2.46e-2)" "unprognostic (2.21e-1)" "unprognostic (9.25e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (7.18e-3)" "unprognostic (1.68e-1)" "unprognostic (7.79e-2)" "prognostic favorable (0.00e+0)" "unprognostic (6.16e-4)" "unprognostic (1.63e-1)" "unprognostic (2.00e-1)" "unprognostic (2.00e-4)" 19.6 18.3 7.4 1.9 8.3 1.0 8.1 2.7 7.7 13.2 2.6 5.5 10.8 1.2 18.2 14.4 2.0 8.3 8.1 10.9 6.4 3.9 24.4 37.1 8.8 1.7 7.4 6.5 16.7 2.6 21.3 11.0 4.1 6.5 7.1 1.6 10.3 20.4 11.4 9.8 2.1 1.9 6.6 5.5 2.8 1.9 4.0 4.1 0.0 9.2 2.9 1.6 3.5 6.3 0.0 0.0 8.3 0.0 0.0 0.1 0.0 0.0 0.1 2.2 0.0 9.4 10.7 0.0 1.5 7.0 1.1 1.2 0.3 0.0 0.1 0.0 3.1 3.3 0.1 0.0 0.0 0.7 0.0 1.7 0.0 0.1 26.5 3.2 0.3 0.0 7.2 0.0 0.3 0.0 9.1 0.2 0.0 0.0 0.0 5.0 0.6 0.0 0.1 3.2 0.0 0.0 0.0 12.3 1.7 0.0 0.0 2.1 0.0 0.0 11.6 0.0 4.8 5.2 0.3 0.0 1.9 1.8 0.2 0.7 0.1 0.1 0.0 2.3 0.0 2.1 8.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 7.4 8.3 2.7 7.7 6.4 3.9 7.4 6.5 6.5 4.1 20.8 42.8 0.0 7.0 0.8 31.6 19.3 15.3 6.7 5.7 12.2 3.9 1.3 5.0 4.0 33.3 1.0 0.0 0.0 2.6 0.6 4.3 4.4 0.0 47.4 0.6 27.0 0.0 3.1 2.4 6.4 22.2 0.4 0.0 0.0 0.0 19.7 0.2 0.0 22.3 26.7 4.5 6.5 5.7 4.2 0.5 0.1 0.5 0.0 0.0 2.0 AFG3L2 "SCA28, SPAX5" ENSG00000141385 "AFG3 like matrix AAA peptidase subunit 2" Q9Y4W6 18 12328944-12377314 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004479, HPA004480" Enhanced Supported Mitochondria NA NA Mitochondria "HPA004479: AB_1078109, HPA004480: AB_1078108" "unprognostic (1.11e-1)" "unprognostic (7.49e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (1.31e-1)" "unprognostic (5.06e-3)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (5.35e-2)" "unprognostic (1.54e-2)" "unprognostic (4.05e-2)" "unprognostic (3.00e-2)" "prognostic favorable (6.05e-14)" "unprognostic (5.90e-2)" "unprognostic (9.41e-2)" "unprognostic (5.74e-3)" "unprognostic (2.22e-1)" 11.5 15.8 11.8 14.3 14.0 11.7 19.9 17.2 30.3 11.2 25.7 9.5 12.7 33.1 11.4 10.1 18.3 10.4 11.2 77.4 13.2 13.1 27.2 22.9 16.3 23.7 12.0 13.2 12.0 23.1 34.3 12.6 9.9 16.9 10.8 23.5 12.2 14.9 14.8 61.0 17.5 35.0 15.1 14.0 9.9 16.0 8.9 7.1 10.7 16.9 22.4 13.2 14.0 11.6 10.1 15.8 8.5 12.3 19.9 15.2 8.4 15.0 15.4 11.0 12.4 12.7 14.0 14.7 16.9 16.8 24.2 17.8 23.8 9.3 43.4 18.6 15.3 21.5 15.2 27.8 19.4 19.8 10.1 11.9 13.0 16.9 22.3 17.4 48.9 19.5 15.4 21.3 22.9 30.3 13.4 17.6 15.6 29.2 25.7 11.8 23.9 17.5 15.0 15.3 74.6 11.4 19.7 34.8 36.2 20.8 33.5 20.6 14.4 26.5 28.8 23.7 14.8 13.2 22.1 13.3 28.9 24.8 27.4 22.0 18.1 20.8 27.8 15.8 19.3 13.2 2.6 11.5 8.5 8.7 12.3 10.7 10.1 10.4 13.7 15.8 7.7 13.3 15.2 0.8 19.9 10.8 8.1 6.4 8.4 11.8 14.0 17.2 30.3 13.2 13.1 12.0 13.2 16.9 7.1 38.7 35.6 27.6 31.2 19.7 46.8 69.2 40.8 28.1 33.0 33.2 47.1 50.2 61.3 33.0 4.2 23.3 78.3 46.7 32.4 29.6 23.8 24.6 13.9 71.5 32.6 28.6 37.6 18.4 22.3 2.7 30.5 25.6 21.9 20.8 71.9 29.1 36.4 31.7 28.3 54.2 55.2 25.8 20.6 47.7 72.0 27.4 77.6 17.5 75.2 29.8 AGK "FLJ10842, MULK" ENSG00000006530 "Acylglycerol kinase" Q53H12 7 141551189-141655244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 37.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020959, HPA053471" Supported Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA Mitochondria Vesicles "HPA020959: AB_1854206, HPA053471: AB_2682164" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (9.47e-3)" "unprognostic (5.43e-2)" "unprognostic (2.15e-2)" "unprognostic (3.68e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (1.14e-1)" "unprognostic (6.24e-3)" "unprognostic (7.90e-2)" "unprognostic (9.29e-2)" "unprognostic (9.65e-2)" "unprognostic (3.30e-1)" "unprognostic (1.18e-1)" 8.7 12.0 11.9 8.0 19.0 5.9 10.6 21.3 23.7 8.8 8.9 10.2 8.8 6.4 16.8 17.1 9.5 11.9 6.8 24.5 16.1 12.3 16.0 10.5 8.4 10.0 11.8 18.8 10.8 8.0 15.7 13.3 9.9 14.2 10.1 13.4 10.6 13.5 10.7 8.4 6.8 8.8 15.0 13.9 12.2 9.0 12.9 9.0 7.8 9.8 8.4 15.6 8.4 8.5 4.6 6.4 0.4 5.5 37.9 10.3 5.7 12.4 13.5 13.4 11.0 10.6 13.2 9.1 13.2 12.9 21.2 21.2 10.5 9.6 14.0 11.8 12.6 20.0 9.3 18.7 15.4 22.9 16.5 16.6 13.0 6.4 10.4 15.8 9.0 7.0 14.7 13.6 18.6 18.2 9.9 16.2 16.1 19.3 20.0 10.2 12.5 24.3 4.1 14.2 9.6 15.2 15.7 2.3 41.9 13.6 10.6 11.7 16.1 13.7 16.6 13.6 14.1 8.9 9.9 9.1 9.8 7.7 13.1 19.0 15.2 15.0 6.7 16.2 4.2 27.0 0.0 2.6 0.4 9.1 5.5 6.5 4.6 7.4 10.3 6.4 2.5 5.5 9.6 0.2 37.9 3.2 2.5 7.2 5.7 11.9 19.0 21.3 23.7 16.1 12.3 11.8 18.8 14.2 9.0 0.0 5.9 3.7 5.1 2.7 10.7 16.8 5.1 6.7 5.7 12.2 7.9 13.4 8.3 6.3 10.0 5.8 2.0 0.0 6.1 6.7 5.4 2.6 8.1 4.5 6.1 14.3 0.0 3.1 4.7 8.5 6.4 4.7 6.8 18.0 2.9 9.8 4.6 0.0 9.9 6.1 16.4 0.0 6.2 4.6 4.9 2.4 7.7 11.4 5.6 2.7 AGPAT5 "FLJ11210, LPAAT-e, LPAAT-epsilon" ENSG00000155189 "1-acylglycerol-3-phosphate O-acyltransferase 5" Q9NUQ2 8 6708357-6759666 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010644, HPA010950, HPA011646" Approved Supported Mitochondria NA NA Mitochondria "HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: " "unprognostic (1.05e-3)" "unprognostic (4.69e-1)" "prognostic favorable (8.82e-4)" "unprognostic (2.05e-2)" "unprognostic (2.99e-1)" "unprognostic (1.44e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (4.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.98e-2)" "unprognostic (6.33e-2)" "unprognostic (2.91e-1)" "unprognostic (6.62e-2)" "unprognostic (2.83e-1)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (5.09e-3)" 5.9 12.5 20.0 8.5 20.7 5.1 9.8 10.0 21.2 6.0 12.2 16.5 6.8 9.3 9.3 19.1 8.4 9.7 5.9 4.0 19.3 16.9 14.2 14.3 5.1 16.8 18.7 9.5 6.4 16.2 11.4 18.5 16.3 14.2 11.0 12.3 3.3 5.4 16.0 10.2 5.1 8.4 8.6 30.6 8.6 11.0 30.8 12.7 14.3 7.3 6.8 10.4 7.3 5.7 11.0 8.4 3.0 4.8 5.3 3.9 2.9 9.4 7.6 11.9 7.0 3.1 5.1 10.6 5.0 5.2 7.5 7.3 4.7 7.5 20.7 3.3 3.3 10.5 11.2 9.1 10.1 13.2 4.5 6.2 25.4 5.9 10.6 7.9 10.6 11.1 6.8 8.6 7.3 9.8 6.9 13.1 8.7 18.7 11.1 12.3 6.1 19.2 13.1 20.8 12.7 5.9 13.9 14.3 8.1 6.8 13.3 24.4 12.8 4.8 8.8 9.5 7.3 4.0 14.0 5.4 12.3 5.8 4.7 13.9 4.2 12.8 11.3 7.2 12.8 14.6 3.0 4.1 2.6 1.9 4.8 3.9 8.7 3.0 3.3 2.7 11.0 2.3 2.7 0.4 5.3 4.2 8.4 2.7 2.9 20.0 20.7 10.0 14.6 19.3 16.9 18.7 9.5 14.2 12.7 3.0 4.1 16.6 10.5 8.0 7.7 5.3 12.7 10.7 7.9 7.0 2.0 7.7 3.3 8.4 29.8 15.8 11.4 0.0 8.5 10.7 5.7 13.4 17.4 29.2 11.0 6.4 21.2 8.6 14.0 22.9 14.7 6.4 6.8 1.0 7.9 37.9 8.0 8.6 14.5 17.4 8.8 6.5 13.2 20.9 8.6 9.2 15.4 4.4 20.0 10.6 AIFM1 "AIF, CMTX4, NAMSD, PDCD8" ENSG00000156709 "Apoptosis inducing factor mitochondria associated 1" O95831 X 130129362-130165887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "DNA-binding, Oxidoreductase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 66.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 148.9;Proximal tubular cells: 209.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003764, HPA030611" Enhanced Supported Mitochondria NA NA 160000 Mitochondria "CAB003764: AB_289587, HPA030611: AB_2673549" "unprognostic (3.00e-3)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (2.10e-2)" "unprognostic (3.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.43e-1)" "unprognostic (3.11e-2)" "unprognostic (2.54e-3)" "unprognostic (2.81e-3)" "prognostic favorable (4.42e-10)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.11e-2)" 9.9 28.9 7.1 11.3 8.6 5.3 7.1 7.5 8.9 10.4 14.2 8.4 10.0 19.6 9.9 11.7 8.6 13.0 11.4 34.2 7.2 7.0 66.8 50.5 5.8 9.8 8.2 7.1 7.3 14.6 16.8 7.7 6.1 8.8 6.9 14.2 12.3 13.1 9.4 35.7 5.8 23.2 8.9 6.4 8.7 14.9 14.9 7.2 19.5 7.9 16.1 9.7 8.4 6.0 10.8 22.0 9.8 18.3 15.8 12.8 8.0 16.8 31.2 12.8 32.0 14.6 10.4 16.9 10.7 9.3 16.5 13.3 22.1 12.5 36.4 37.3 9.8 19.6 16.3 39.4 13.9 17.6 13.9 24.0 23.1 23.5 30.0 18.6 20.2 24.3 12.9 13.7 17.5 15.0 9.2 13.9 27.5 19.8 16.9 11.6 40.6 20.5 31.7 9.2 34.0 24.2 18.6 14.3 42.1 37.3 17.1 16.5 9.6 12.5 28.9 27.8 15.2 14.9 18.3 10.1 7.9 7.6 21.4 20.3 9.0 14.6 17.0 10.1 33.9 11.8 2.9 14.8 9.8 9.1 18.3 9.6 10.8 9.7 11.2 22.0 8.1 9.6 9.7 2.1 15.8 15.5 10.6 12.8 8.0 7.1 8.6 7.5 8.9 7.2 7.0 8.2 7.1 8.8 7.2 14.9 15.3 20.1 8.0 7.7 17.8 148.9 20.4 21.4 15.9 38.4 21.6 48.7 77.9 21.8 1.3 10.2 33.3 0.0 18.1 22.0 13.9 6.9 10.4 83.4 33.5 14.3 9.2 14.7 15.5 3.9 16.1 14.0 10.1 17.2 17.6 12.2 17.3 17.3 16.3 209.8 36.6 6.5 9.0 3.9 32.1 5.9 33.2 13.1 32.6 8.9 AIFM3 "AIFL, FLJ30473" ENSG00000183773 "Apoptosis inducing factor, mitochondria associated 3" Q96NN9 22 20965108-20981360 "Predicted intracellular proteins" "Apoptosis, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.7;intestine: 28.0" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 42.3;Mucus-secreting cells: 33.7;Paneth cells: 29.1;Undifferentiated cells: 39.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 7.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 2.2;intermediate monocyte: 5.7;myeloid DC: 3.8;non-classical monocyte: 3.4" "Group enriched" "Detected in many" 22 "dendritic cells: 3.8;monocytes: 5.7" "Cell line enhanced" "Detected in some" "Hep G2: 8.8;HMC-1: 13.1;T-47d: 6.4;THP-1: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001271 Supported Mitochondria NA NA Mitochondria "HPA001271: AB_1078114" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (7.49e-2)" "unprognostic (9.99e-2)" "unprognostic (6.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.47e-1)" "unprognostic (2.73e-3)" "unprognostic (3.28e-1)" "unprognostic (1.56e-1)" "unprognostic (4.13e-3)" "unprognostic (5.13e-2)" "unprognostic (7.99e-2)" "unprognostic (6.78e-2)" "unprognostic (1.47e-1)" "unprognostic (3.37e-1)" "prognostic favorable (7.13e-5)" 1.3 1.3 20.3 4.6 19.0 5.4 0.8 14.4 18.4 1.2 28.0 9.7 0.0 4.3 0.9 0.8 0.9 1.2 1.6 0.9 14.6 9.9 0.9 0.8 1.5 1.4 14.8 12.4 1.0 0.9 0.9 1.9 1.3 21.7 1.2 13.0 5.0 2.2 1.9 0.7 0.9 3.4 1.9 9.6 2.7 1.6 1.1 7.6 0.0 1.0 0.0 0.8 1.9 0.1 0.2 3.8 0.0 5.7 0.0 0.0 0.9 1.2 2.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.3 0.0 2.2 0.0 8.8 0.2 0.0 13.1 0.6 0.7 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.6 0.0 0.1 0.0 0.4 0.0 0.1 0.0 1.4 0.0 1.5 1.8 1.1 1.0 0.1 0.0 0.1 6.4 9.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 5.7 0.0 0.2 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.9 20.3 19.0 14.4 18.4 14.6 9.9 14.8 12.4 21.7 7.6 0.0 1.0 1.7 1.6 0.6 10.9 2.4 0.0 0.0 0.0 1.8 5.9 0.9 10.0 0.7 0.0 0.7 42.3 0.0 0.6 0.6 0.4 2.9 1.1 1.8 2.9 0.0 9.9 1.3 3.7 0.0 0.0 2.2 0.0 0.0 33.7 18.1 0.6 29.1 0.0 6.0 2.9 0.0 0.8 0.0 0.7 0.6 0.7 0.0 39.2 2.2 AIM2 PYHIN4 ENSG00000163568 "Absent in melanoma 2" O14862 1 159062484-159147096 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 44.7;lymphoid tissue: 43.8" "Group enriched" "Detected in some" 6 "B-cells: 18.9;Early spermatids: 19.7;Late spermatids: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "memory B-cell: 44.7;naive B-cell: 14.3" "Lineage enriched" "Detected in many" 9 "B-cells: 44.7" "Cell line enhanced" "Detected in some" "Daudi: 31.8;HDLM-2: 44.3;Karpas-707: 17.6;U-266/70: 14.8;U-266/84: 11.1;U-87 MG: 13.7" "Low region specificity" "Detected in all" "HPA031365, HPA040309" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA031365: AB_10601332, HPA040309: AB_2676925" "unprognostic (6.05e-2)" "unprognostic (7.68e-2)" "unprognostic (4.24e-3)" "unprognostic (2.08e-2)" "unprognostic (6.94e-2)" "unprognostic (3.44e-1)" "unprognostic (3.20e-1)" "unprognostic (1.35e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-3)" "unprognostic (7.10e-3)" "unprognostic (1.13e-1)" "unprognostic (1.23e-12)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-3)" 0.7 0.3 1.3 28.2 0.9 0.4 0.6 0.5 0.6 0.4 1.9 0.1 0.0 0.7 0.2 0.2 4.1 0.5 1.1 0.5 1.2 0.6 0.9 0.8 2.0 24.1 0.5 0.2 0.6 0.3 0.0 8.8 0.4 0.5 0.7 1.0 0.5 1.9 0.0 0.2 0.3 12.8 0.2 2.6 43.8 1.3 1.4 1.4 1.4 0.7 0.6 25.9 4.0 0.5 44.7 1.2 4.7 2.4 0.0 3.3 1.4 5.3 0.0 0.3 0.0 0.0 4.4 0.0 0.0 0.5 0.4 0.3 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 44.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 2.9 0.0 2.8 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.1 14.8 11.1 0.3 13.7 1.2 2.3 4.2 2.4 0.0 0.6 2.1 1.7 44.7 1.6 1.1 1.2 14.3 0.1 0.4 4.7 0.0 2.2 0.0 3.3 1.4 1.3 0.9 0.5 0.6 1.2 0.6 0.5 0.2 0.5 1.4 0.0 0.0 18.9 0.1 0.0 0.7 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.9 24.1 0.3 1.0 3.3 1.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.1 0.0 0.4 AK3 "AK3L1, AK6, AKL3L1" ENSG00000147853 "Adenylate kinase 3" Q9UIJ7 9 4709559-4742043 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 86.8;HEL: 55.6" "Low region specificity" "Detected in all" HPA063324 Enhanced Supported Mitochondria NA NA 68000 Mitochondria "HPA063324: AB_2684985" "unprognostic (1.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-3)" "unprognostic (6.44e-2)" "unprognostic (2.81e-2)" "unprognostic (9.81e-3)" "unprognostic (1.90e-1)" "unprognostic (2.76e-2)" "prognostic favorable (6.07e-9)" "unprognostic (1.24e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.55e-3)" 24.6 25.1 20.9 9.8 22.4 6.8 24.0 14.6 17.5 17.7 23.7 15.3 16.0 24.4 18.9 17.5 28.3 14.0 16.1 90.0 22.4 16.4 37.7 75.1 16.4 13.1 25.2 15.2 22.4 15.7 16.9 14.1 13.0 22.9 19.0 23.0 17.4 14.5 19.1 72.0 18.1 22.0 21.2 24.1 12.1 22.5 9.3 24.9 15.2 20.8 32.8 14.9 20.1 17.1 7.0 14.4 17.0 5.6 14.7 17.1 10.2 8.8 7.5 12.8 5.2 17.9 13.2 0.9 11.3 26.5 7.1 10.6 1.3 9.9 8.3 3.8 14.3 3.9 5.8 9.3 10.8 12.0 86.8 7.0 55.6 13.3 22.5 14.1 5.8 2.9 20.8 9.7 6.0 8.4 16.5 20.8 8.5 4.2 11.3 21.1 5.3 5.6 16.9 11.4 17.4 2.8 7.6 4.6 4.1 20.6 12.5 21.1 13.3 13.2 4.3 7.5 13.0 6.0 11.7 12.8 5.9 6.0 15.5 8.8 2.9 1.8 10.2 10.9 4.4 4.2 6.8 5.6 17.0 16.2 4.4 14.7 7.0 12.5 14.8 10.5 6.9 16.6 17.1 1.9 14.7 3.4 14.4 16.7 10.2 20.9 22.4 14.6 17.5 22.4 16.4 25.2 15.2 22.9 24.9 53.6 88.6 32.0 59.7 65.9 11.9 155.8 66.2 45.5 68.2 62.8 21.6 83.2 218.8 74.1 2.6 56.6 104.3 0.0 61.0 10.9 79.1 116.1 44.0 282.7 40.3 14.3 105.2 74.3 36.8 1.9 100.7 36.7 70.9 53.3 103.3 22.3 61.2 57.5 140.7 148.4 8.8 103.5 59.8 6.6 15.3 91.2 179.0 38.5 135.0 92.5 AK4 "AK3, AK3L1" ENSG00000162433 "Adenylate kinase 4" P27144 1 65147549-65232145 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 89.7;liver: 50.7" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 223.0;Proximal tubular cells: 422.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;myeloid DC: 5.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1" "Cell line enhanced" "Detected in many" "Hep G2: 59.4" "Low region specificity" "Detected in all" "HPA042753, HPA049461" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 18000 Mitochondria "HPA042753: AB_2678146, HPA049461: AB_2680776" "unprognostic (3.73e-2)" "prognostic unfavorable (4.17e-4)" "unprognostic (2.25e-1)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (1.16e-3)" "unprognostic (3.89e-2)" "unprognostic (4.03e-1)" "unprognostic (5.39e-2)" "prognostic unfavorable (4.34e-5)" "unprognostic (6.71e-2)" "prognostic unfavorable (4.36e-4)" "prognostic unfavorable (4.87e-4)" "unprognostic (2.69e-1)" "unprognostic (7.07e-2)" "unprognostic (7.57e-2)" 12.4 1.6 11.7 3.7 11.2 2.7 13.4 12.0 9.9 4.0 9.5 4.0 4.7 2.7 3.9 4.4 12.3 4.2 8.6 26.0 9.3 7.1 89.7 50.7 1.6 1.4 6.3 9.1 5.8 1.8 8.2 2.6 4.5 7.2 8.9 7.7 4.4 9.4 7.3 2.2 14.0 3.5 13.6 8.1 1.2 7.8 6.0 5.0 0.4 1.9 5.7 3.2 12.4 7.4 0.5 5.3 1.6 6.1 0.6 0.5 1.4 20.6 1.4 1.6 7.0 15.6 14.9 3.5 3.5 4.4 7.6 21.2 31.0 2.5 11.1 9.2 5.4 9.5 13.4 5.5 26.1 30.6 9.3 6.3 10.8 7.0 59.4 0.7 8.3 1.3 8.2 14.7 7.4 21.9 12.6 0.2 3.5 13.4 0.2 11.6 8.8 0.3 0.3 7.2 0.3 12.4 0.0 12.1 2.0 11.2 0.9 6.1 4.5 6.2 0.4 4.9 8.0 8.7 3.7 1.2 12.7 10.9 0.9 5.9 11.7 5.2 0.6 20.5 3.1 0.7 1.6 6.1 0.0 0.2 1.4 0.4 0.5 0.2 0.5 5.3 0.4 0.2 0.2 1.0 0.6 0.2 0.8 0.1 1.4 11.7 11.2 12.0 9.9 9.3 7.1 6.3 9.1 7.2 5.0 0.0 0.3 4.9 19.8 44.2 14.7 91.5 61.1 5.3 6.8 29.6 2.0 1.2 48.0 16.1 1.6 17.5 13.5 0.0 11.0 13.9 10.3 33.2 0.0 223.0 3.3 15.9 5.2 5.5 5.6 4.2 3.7 2.7 23.6 7.2 6.7 27.4 22.8 3.5 8.9 422.4 6.2 6.5 27.4 2.1 5.1 65.0 4.1 1.0 22.9 16.6 AKAP1 "AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17" ENSG00000121057 "A-kinase anchoring protein 1" Q92667 17 57085092-57121349 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 80.1;testis: 75.4" "Group enriched" "Detected in many" 9 "Early spermatids: 596.3;Late spermatids: 1760.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008620, HPA008691, CAB019286" Supported Supported Mitochondria NA NA Mitochondria "CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119" "unprognostic (5.52e-2)" "unprognostic (1.83e-1)" "unprognostic (6.96e-3)" "unprognostic (1.78e-1)" "unprognostic (1.79e-2)" "unprognostic (6.38e-2)" "unprognostic (7.19e-2)" "unprognostic (1.48e-2)" "unprognostic (8.14e-2)" "unprognostic (2.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.00e-1)" "prognostic favorable (7.86e-9)" "unprognostic (6.82e-2)" "unprognostic (2.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.38e-1)" 16.4 6.1 13.5 9.2 16.3 2.8 14.7 13.4 12.5 10.3 28.1 8.7 9.3 22.6 10.2 14.3 18.1 12.5 19.2 35.0 10.0 6.6 11.9 26.4 8.3 4.4 13.6 9.9 9.0 16.4 18.8 7.1 3.3 7.9 15.5 20.6 9.3 13.6 13.9 80.1 10.2 25.2 23.5 8.4 4.9 22.2 75.4 10.1 4.7 14.9 19.7 7.4 20.5 9.8 3.3 6.5 2.8 3.3 6.0 7.4 2.1 16.2 20.4 28.3 9.3 7.3 4.8 17.0 6.8 6.6 9.0 6.4 21.8 14.6 26.1 19.4 5.2 9.5 25.9 15.8 14.9 9.0 14.3 23.0 22.2 18.0 41.3 6.9 20.8 8.6 4.2 14.9 9.9 13.9 5.1 9.1 8.0 14.8 10.1 5.2 13.9 26.3 7.9 10.4 34.4 21.9 20.2 12.0 21.3 6.0 19.3 21.7 14.3 5.4 15.8 8.8 6.4 10.9 21.5 6.7 7.9 8.8 10.2 15.3 10.0 12.5 19.7 5.0 16.3 7.0 2.8 1.7 0.6 4.7 3.3 4.1 3.3 3.8 3.8 4.0 2.4 7.4 4.0 0.2 6.0 0.9 6.5 2.8 2.1 13.5 16.3 13.4 12.5 10.0 6.6 13.6 9.9 7.9 10.1 32.8 37.5 15.1 21.0 20.0 35.4 133.6 33.1 6.7 45.5 5.2 45.2 18.0 1.7 15.3 596.3 10.7 60.0 0.0 14.4 10.0 9.5 23.9 3.5 54.6 8.4 35.0 44.1 10.4 8.5 1760.2 18.1 7.7 6.8 6.4 85.1 6.8 10.7 43.2 13.1 5.8 71.0 45.3 45.3 13.9 10.0 17.2 5.7 6.4 92.8 11.8 ALAS1 "ALAS, ALAS3" ENSG00000023330 "5'-aminolevulinate synthase 1" P13196 3 52198086-52214327 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 167.6;liver: 136.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 210.5;Syncytiotrophoblasts: 258.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 55.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 55.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017498, HPA035860" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB017498: AB_2225629, HPA035860: AB_10672992" "unprognostic (1.17e-1)" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (7.09e-2)" "unprognostic (2.33e-1)" "unprognostic (6.21e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.98e-2)" "unprognostic (1.26e-1)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (5.64e-2)" "prognostic favorable (6.06e-7)" "unprognostic (8.45e-2)" "unprognostic (3.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" 9.2 167.6 7.8 6.7 10.6 39.1 8.9 17.0 15.4 6.0 11.0 12.0 15.3 11.4 6.3 11.8 10.5 4.7 8.7 24.8 8.8 7.0 14.1 136.4 13.5 10.0 7.6 9.9 5.8 6.1 8.5 5.8 13.4 12.2 7.3 11.1 8.3 15.7 16.9 24.6 6.8 17.4 6.5 7.3 6.3 12.2 9.7 5.0 7.5 7.4 11.4 9.6 12.1 7.6 6.8 8.4 55.0 12.2 8.8 11.3 6.3 10.3 16.1 11.4 10.5 17.8 13.3 31.0 15.2 14.1 20.4 19.8 21.4 19.6 9.7 3.8 10.6 41.4 6.1 16.3 12.5 16.7 18.8 6.4 12.4 12.7 16.2 25.2 20.1 25.0 16.5 11.7 32.4 10.8 7.5 18.6 17.0 7.3 8.0 18.5 8.4 9.5 30.7 9.8 11.9 27.9 5.7 7.1 15.3 17.9 62.7 6.0 4.0 24.6 12.1 13.7 9.6 6.9 28.7 13.3 11.4 11.3 23.5 21.9 11.9 20.5 14.6 12.7 21.9 18.1 55.0 9.2 27.8 6.9 12.2 11.3 6.8 7.2 7.7 8.4 6.0 6.5 7.0 14.2 8.8 10.2 4.8 9.7 6.3 7.8 10.6 17.0 15.4 8.8 7.0 7.6 9.9 12.2 5.0 32.8 47.6 4.5 16.4 15.3 15.1 88.4 35.7 38.8 27.3 22.7 3.9 67.2 48.0 28.5 9.7 25.9 35.4 0.0 27.6 21.7 19.9 18.1 89.4 210.5 62.6 11.1 33.3 25.2 14.6 3.1 12.4 23.3 5.0 73.9 18.6 9.1 33.4 18.7 15.6 25.9 6.8 12.9 27.3 23.7 19.0 14.2 258.6 17.3 16.1 24.3 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392664-38398661 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 113.9" "Group enriched" "Detected in many" 5 "Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 55.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021037, HPA077080" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA 210000 Mitochondria "Nucleoplasm, Vesicles, Cytosol" "HPA021037: AB_1844724, HPA077080: " "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.89e-2)" 7.4 4.9 2.1 16.8 2.1 0.6 5.4 1.1 5.4 5.8 25.4 1.7 6.1 7.0 27.3 10.7 21.6 16.7 30.8 11.6 3.1 2.0 18.0 55.2 3.5 5.9 2.4 2.0 12.2 14.6 1.4 1.4 1.6 3.0 22.7 11.5 5.2 5.9 18.2 19.4 3.0 11.2 113.9 2.7 2.8 15.8 7.8 1.7 1.6 6.3 7.0 2.0 54.5 8.3 5.9 9.4 1.2 10.5 7.5 10.2 5.1 21.5 20.1 6.2 9.9 8.8 10.5 5.0 10.3 5.2 8.7 9.0 13.4 4.2 13.6 6.2 14.5 13.2 3.0 20.4 21.9 8.7 15.2 8.8 6.7 14.8 39.8 6.4 10.7 7.6 12.5 4.8 7.1 6.2 17.9 8.3 3.3 19.4 13.4 13.2 8.2 0.0 4.3 18.4 55.5 9.0 4.4 37.6 10.4 7.8 9.7 13.6 6.3 7.9 5.2 6.0 6.8 4.9 8.4 5.6 10.1 16.7 8.4 12.9 2.0 3.9 5.4 5.2 11.0 6.8 0.2 4.2 0.2 7.3 9.1 10.2 5.9 7.0 6.6 9.4 3.1 5.8 6.8 1.2 7.5 10.5 1.3 4.8 5.1 2.1 2.1 1.1 5.4 3.1 2.0 2.4 2.0 3.0 1.7 8.9 1.7 3.6 3.8 0.9 1.3 5.6 117.2 0.0 3.4 15.7 2.0 1.3 14.9 60.1 0.5 3.8 7.0 0.0 5.9 40.0 6.2 2.9 9.2 113.4 6.5 0.0 15.0 9.8 3.8 1.3 6.1 4.0 0.0 7.2 16.9 1.3 14.2 3.5 6.3 118.8 0.3 0.0 9.5 0.3 0.6 0.9 1.5 2.9 68.9 2.6 ALDH4A1 "ALDH4, P5CDh" ENSG00000159423 "Aldehyde dehydrogenase 4 family member A1" P30038 1 18871430-18902781 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 73.7;liver: 92.6" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 313.9;Proximal tubular cells: 167.5" "Cancer enhanced" "Detected in all" "liver cancer: 72.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Hep G2: 34.6;SK-BR-3: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004645, HPA006401, HPA072759" Enhanced Supported Mitochondria NA NA 40000 Mitochondria "CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: " "unprognostic (1.17e-1)" "prognostic favorable (5.06e-4)" "unprognostic (1.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.15e-1)" "unprognostic (7.67e-2)" "unprognostic (1.28e-1)" "unprognostic (6.18e-2)" "unprognostic (1.92e-1)" "unprognostic (1.09e-2)" "unprognostic (1.02e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-3)" "unprognostic (9.41e-3)" "unprognostic (3.83e-1)" "unprognostic (2.69e-3)" "unprognostic (9.34e-2)" 22.9 4.1 14.4 2.0 18.0 4.6 6.6 3.1 16.8 3.8 2.4 8.6 18.9 1.3 2.5 5.2 11.4 2.7 3.0 12.6 8.6 7.1 73.7 92.6 2.4 1.7 15.9 11.2 2.9 2.2 9.4 2.4 8.3 8.5 12.1 1.6 9.7 2.4 12.1 25.6 8.0 1.3 3.3 2.7 2.1 3.4 1.4 6.6 2.8 3.0 8.9 2.9 8.3 3.6 1.5 7.2 2.6 5.6 0.3 1.4 2.2 5.1 8.0 4.1 12.1 17.4 2.6 10.0 4.9 3.0 5.1 4.1 5.8 3.8 3.4 6.6 6.4 2.4 13.8 6.9 14.7 1.9 1.9 6.1 1.9 1.9 34.6 5.5 1.7 6.2 6.7 8.2 2.8 2.8 3.8 5.7 5.8 7.7 2.5 3.4 13.2 1.7 8.3 2.0 10.6 4.1 10.7 3.4 4.0 5.3 13.0 8.1 3.1 8.7 35.8 6.4 6.5 16.3 2.6 4.7 4.4 5.8 5.3 1.7 2.8 6.6 1.0 1.6 13.5 5.8 0.0 4.1 2.6 1.1 5.6 0.9 1.5 0.7 1.4 7.2 1.1 0.3 0.9 0.6 0.3 3.1 2.4 1.0 2.2 14.4 18.0 3.1 16.8 8.6 7.1 15.9 11.2 8.5 6.6 0.0 3.2 7.2 14.0 6.6 3.1 18.5 38.2 1.4 0.0 43.6 9.8 61.1 39.7 5.6 0.4 2.7 0.4 0.0 0.8 7.2 2.3 9.5 4.6 313.9 11.9 19.1 2.4 16.5 14.0 0.4 1.1 1.4 3.3 17.2 2.9 10.8 2.9 1.5 2.5 167.5 4.2 6.5 4.3 2.1 3.6 4.6 72.4 2.2 3.3 9.7 ALDH5A1 "SSADH, SSDH" ENSG00000112294 "Aldehyde dehydrogenase 5 family member A1" P51649 6 24494852-24537207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.6" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 41.1;U-698: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029715, HPA029716" Enhanced Supported Mitochondria NA NA 44000 Mitochondria "HPA029715: AB_10599994, HPA029716: AB_10601876" "unprognostic (7.43e-2)" "unprognostic (1.12e-3)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "prognostic favorable (7.61e-6)" "unprognostic (2.38e-2)" "unprognostic (2.17e-2)" "prognostic favorable (6.20e-4)" "unprognostic (1.43e-2)" "unprognostic (1.21e-1)" "prognostic favorable (3.68e-4)" "unprognostic (1.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.00e-2)" "unprognostic (1.08e-2)" 5.8 4.8 23.7 8.3 27.4 3.1 4.1 13.5 21.5 4.1 6.0 9.5 1.2 7.7 3.9 3.1 5.6 13.5 4.4 9.8 17.3 21.0 18.4 62.6 5.0 8.9 16.0 14.7 5.8 6.6 11.4 4.5 2.2 13.0 6.2 5.7 4.1 3.9 4.3 31.1 6.9 5.4 2.8 10.9 4.8 5.2 3.7 8.8 21.4 12.1 4.9 8.8 6.3 5.5 3.9 3.8 0.4 0.2 1.6 6.8 1.2 3.2 3.0 2.1 3.2 0.0 0.0 3.5 0.3 0.6 0.8 0.5 11.7 0.8 41.1 6.2 0.3 0.7 0.0 3.4 0.4 0.5 4.2 5.7 6.4 1.9 13.4 0.5 9.9 0.8 0.3 1.6 0.1 0.0 2.3 0.0 11.3 3.2 0.0 0.6 7.6 12.0 5.9 0.8 5.8 1.5 13.9 0.6 0.4 2.5 6.6 3.7 3.3 3.8 0.4 4.0 0.9 5.9 5.4 0.0 0.4 2.1 0.1 2.1 5.8 8.6 51.4 0.0 3.1 0.4 0.4 0.1 0.2 1.7 0.0 3.3 3.7 2.4 2.8 0.2 3.9 6.8 5.7 0.4 1.6 0.2 3.8 1.6 1.2 23.7 27.4 13.5 21.5 17.3 21.0 16.0 14.7 13.0 8.8 14.9 22.3 8.8 4.6 1.4 10.6 29.9 5.1 13.4 9.1 7.0 15.7 5.0 1.7 1.8 0.5 3.1 8.4 23.3 0.8 4.3 2.1 5.1 6.9 85.5 3.2 15.9 8.1 6.7 3.8 0.0 3.1 2.0 1.7 0.0 10.5 10.4 1.3 3.5 4.2 24.0 6.5 0.0 1.6 1.4 6.1 2.6 1.6 5.4 16.7 11.5 ALDH7A1 "ATQ1, EPD, PDE" ENSG00000164904 "Aldehyde dehydrogenase 7 family member A1" P49419 5 126531200-126595418 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 64.4" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023296, HPA053675" Enhanced Supported Mitochondria,Cytosol Yes No 140000 Mitochondria Cytosol "HPA023296: AB_1844738, HPA053675: " "unprognostic (1.37e-1)" "unprognostic (9.67e-2)" "unprognostic (2.07e-2)" "unprognostic (2.20e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.58e-3)" "unprognostic (9.49e-3)" "unprognostic (7.61e-2)" "unprognostic (7.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.33e-1)" "prognostic favorable (3.08e-4)" "unprognostic (1.51e-1)" "unprognostic (3.70e-1)" "unprognostic (3.10e-3)" "unprognostic (4.93e-2)" 9.0 14.2 46.0 3.4 39.1 0.8 18.8 11.0 22.5 14.0 11.5 23.1 7.2 9.5 10.5 7.5 13.5 11.9 7.8 10.8 35.0 17.3 46.5 64.4 6.4 3.1 28.7 18.5 27.6 10.8 17.7 5.9 17.7 16.9 17.6 11.2 13.7 15.0 12.2 4.5 11.9 8.1 9.8 20.2 2.8 9.0 4.9 28.4 4.0 19.4 10.1 7.4 7.2 7.1 1.3 9.7 0.7 0.3 0.1 1.8 0.6 15.0 10.0 28.3 46.8 23.5 14.0 36.1 18.1 22.4 21.1 27.2 28.0 14.5 0.0 18.5 14.1 8.8 11.3 8.8 61.1 19.4 0.0 10.6 2.9 14.9 23.8 11.5 0.0 0.0 17.1 14.4 16.4 11.8 15.6 16.8 0.0 0.0 0.0 18.5 9.9 0.6 0.0 19.1 11.1 8.5 9.0 32.1 0.0 20.0 11.5 9.6 11.5 0.0 10.0 10.5 22.7 18.0 0.6 20.4 6.1 18.9 7.0 12.4 0.0 0.0 0.0 3.3 0.0 9.8 0.7 0.3 0.1 0.2 0.0 0.3 1.3 0.3 0.2 2.7 1.1 1.8 1.0 0.3 0.1 0.0 9.7 0.1 0.6 46.0 39.1 11.0 22.5 35.0 17.3 28.7 18.5 16.9 28.4 14.9 24.0 11.8 48.6 23.0 22.4 35.5 25.5 20.1 33.0 40.1 21.6 364.8 64.6 31.9 24.9 14.7 17.8 0.0 12.1 88.6 30.8 28.6 6.9 69.5 42.5 23.8 20.8 20.9 9.4 29.5 23.6 7.4 52.3 12.6 22.1 96.8 15.1 8.6 35.0 241.4 12.2 19.4 17.3 1.0 3.1 14.1 185.9 2.5 43.7 34.8 ALKBH7 "MGC10974, SPATA11" ENSG00000125652 "AlkB homolog 7" Q9BT30 19 6372433-6375251 "Predicted intracellular proteins" Necrosis "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 2375.8;Late spermatids: 5313.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008539, HPA039571, HPA039872" Approved Supported Mitochondria NA NA Mitochondria "HPA008539: , HPA039571: AB_2676577, HPA039872: AB_10697710" "unprognostic (5.38e-2)" "unprognostic (3.58e-2)" "unprognostic (2.20e-1)" "unprognostic (1.15e-2)" "unprognostic (7.79e-2)" "unprognostic (3.56e-3)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (3.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.72e-3)" "unprognostic (1.54e-1)" "prognostic favorable (7.83e-6)" "unprognostic (7.07e-2)" "unprognostic (2.00e-1)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" 10.8 14.7 13.7 14.1 15.2 12.7 13.6 16.3 15.8 12.3 25.0 11.1 28.4 30.9 12.4 18.8 17.2 15.4 18.7 49.3 12.6 11.9 17.1 32.7 20.2 26.3 14.2 11.9 19.0 65.0 10.2 14.0 7.9 15.8 15.5 9.8 16.0 29.7 21.5 62.9 11.9 29.6 15.8 15.9 9.9 14.2 96.5 7.3 29.9 19.4 29.5 16.2 12.6 13.6 34.3 43.8 19.7 32.8 18.4 45.9 28.4 9.8 8.6 7.6 13.2 4.3 12.1 9.4 5.9 6.4 6.5 6.9 15.1 6.4 12.7 22.3 9.1 4.6 7.6 3.4 6.0 1.3 12.9 12.0 6.8 6.3 14.0 12.6 4.1 10.3 13.8 12.1 5.6 4.4 6.3 8.0 14.4 7.7 28.6 4.9 20.0 20.1 14.1 10.5 11.7 35.9 14.2 3.9 26.8 7.2 7.8 10.1 15.0 4.0 12.9 24.8 3.8 14.6 15.5 5.3 6.5 8.4 23.8 6.8 41.2 29.8 8.4 12.2 13.4 5.6 9.9 32.8 4.9 17.1 26.5 23.5 34.3 29.8 23.3 38.8 31.6 45.9 36.0 19.7 18.4 20.4 43.8 25.3 28.4 13.7 15.2 16.3 15.8 12.6 11.9 14.2 11.9 15.8 7.3 56.6 70.3 108.8 116.9 74.4 87.5 95.6 99.3 38.8 48.9 62.8 62.8 75.6 265.2 90.7 2375.8 82.3 579.2 0.0 213.1 109.8 89.1 123.5 65.7 258.2 170.0 39.7 211.6 89.6 138.9 5313.3 95.5 116.1 126.5 202.0 317.0 99.5 112.2 399.8 83.4 312.4 107.3 90.5 100.1 945.7 49.4 88.0 91.1 82.2 334.4 200.6 AMT "GCST, NKH" ENSG00000145020 Aminomethyltransferase P48728 3 49416775-49422753 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 10.4;Hep G2: 29.9;NTERA-2: 5.4;SH-SY5Y: 7.9;SuSa: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005566 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA005566: AB_1844811" "unprognostic (2.10e-2)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (9.14e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (2.17e-3)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.88e-1)" "prognostic favorable (3.90e-8)" "unprognostic (4.40e-1)" "unprognostic (1.91e-1)" "unprognostic (3.60e-1)" "unprognostic (1.98e-3)" 4.7 10.9 6.6 8.0 8.8 6.0 6.6 16.7 10.4 8.4 10.0 7.4 21.3 10.9 9.2 11.1 3.4 9.7 13.0 16.6 7.4 2.0 21.4 41.2 5.6 2.3 7.6 8.3 14.5 18.5 16.3 10.4 2.5 10.7 9.1 10.1 12.2 9.8 20.0 3.8 5.4 11.0 7.1 5.8 7.9 8.1 2.6 7.4 1.7 8.7 0.4 1.8 6.2 8.1 0.7 5.4 4.7 3.2 8.9 1.6 2.3 0.1 0.5 0.7 0.1 0.4 0.0 10.4 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.2 0.1 0.4 0.1 0.2 0.2 0.0 0.3 29.9 1.1 0.0 0.1 0.3 0.7 0.0 0.4 1.1 0.1 0.2 0.0 0.0 0.1 0.3 0.2 0.2 5.4 0.0 0.1 0.0 0.1 0.2 0.7 0.2 0.0 7.9 0.1 0.0 0.6 7.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 3.2 4.7 0.0 1.9 0.1 0.6 0.0 0.0 5.4 0.7 1.6 1.5 0.3 8.9 0.7 0.5 0.0 2.3 6.6 8.8 16.7 10.4 7.4 2.0 7.6 8.3 10.7 7.4 3.0 11.6 3.7 11.4 2.5 17.2 18.3 17.8 6.7 7.9 0.0 19.6 22.7 0.0 0.7 1.7 2.7 19.7 0.0 0.6 6.5 4.7 10.1 7.0 37.3 4.4 7.9 12.2 3.1 2.7 1.6 9.8 3.5 5.0 0.0 16.2 21.5 0.5 14.0 6.0 0.7 17.7 6.5 4.3 1.4 0.4 2.4 8.6 5.7 31.1 8.6 ARG2 ENSG00000081181 "Arginase 2" P78540 14 67619798-67651720 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 53.7;thyroid gland: 75.4" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 140.3;Collecting duct cells: 157.1;Syncytiotrophoblasts: 502.9;Urothelial cells: 134.9" "Cancer enhanced" "Detected in all" "prostate cancer: 49.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 24.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000663, CAB009435" Enhanced Supported Mitochondria NA NA Mitochondria "CAB009435: AB_2059089, HPA000663: AB_1078192" "unprognostic (8.74e-3)" "unprognostic (3.06e-2)" "unprognostic (1.35e-2)" "unprognostic (2.29e-1)" "unprognostic (2.30e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-3)" "unprognostic (4.62e-3)" "unprognostic (5.37e-2)" "unprognostic (4.66e-3)" "unprognostic (1.72e-1)" "unprognostic (9.39e-2)" "unprognostic (4.26e-1)" "unprognostic (2.31e-1)" "unprognostic (4.34e-1)" "unprognostic (1.26e-1)" 1.5 3.9 2.4 1.7 6.4 0.6 2.7 8.3 5.3 9.3 5.4 0.5 2.0 2.1 3.7 2.3 7.3 0.8 4.9 2.1 3.3 5.5 41.4 2.0 1.7 0.6 3.2 1.7 8.8 2.6 32.1 22.5 4.4 4.6 53.7 1.1 3.4 26.6 3.8 17.2 0.8 10.4 2.2 3.9 0.7 1.4 1.9 2.1 0.1 75.4 13.6 2.2 5.3 4.1 2.5 1.7 2.0 1.4 0.3 2.9 3.4 3.5 0.5 6.2 4.0 0.9 0.0 8.4 2.7 7.5 9.0 15.3 15.3 1.8 6.0 0.7 1.8 4.1 0.8 24.9 11.3 11.0 0.2 6.2 2.7 1.1 17.4 2.7 0.6 16.3 0.4 14.7 4.4 21.5 0.7 15.3 16.1 7.9 0.0 0.6 1.7 0.9 0.6 11.8 1.5 0.2 0.2 0.8 6.8 7.3 5.9 13.8 5.2 1.7 1.7 2.6 15.0 6.4 0.2 3.1 2.7 6.9 0.2 2.0 0.5 0.9 2.0 5.5 3.1 4.6 0.3 1.4 2.0 1.1 0.5 0.5 0.7 0.3 0.9 1.7 2.5 0.6 0.6 1.7 0.3 1.2 0.1 2.9 3.4 2.4 6.4 8.3 5.3 3.3 5.5 3.2 1.7 4.6 2.1 0.0 4.3 3.7 140.3 7.8 5.0 5.0 2.5 2.7 27.3 157.1 9.8 82.0 31.5 9.2 12.3 3.0 14.8 23.3 2.8 5.2 3.7 84.0 6.9 1.5 12.3 9.5 35.3 1.8 0.3 1.0 0.3 3.9 10.1 1.0 4.3 40.7 4.5 3.5 0.4 75.6 16.0 6.5 4.1 7.2 2.6 4.6 502.9 5.0 3.3 134.9 ARMCX1 "ALEX1, GASP7" ENSG00000126947 "Armadillo repeat containing, X-linked 1" Q9P291 X 101550531-101554700 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 26.9;ASC TERT1: 24.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;LHCN-M2: 24.4;RH-30: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000268, HPA005685, CAB020695" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "CAB020695: , HPA000268: , HPA005685: AB_10600781" "unprognostic (2.31e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-1)" "unprognostic (2.18e-3)" "unprognostic (2.13e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.32e-5)" "unprognostic (1.02e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-3)" "unprognostic (8.77e-2)" "unprognostic (2.12e-2)" "unprognostic (1.09e-2)" 17.5 29.8 13.6 7.4 16.5 2.7 18.9 13.4 21.5 24.4 18.7 9.6 15.9 6.2 27.3 19.0 12.3 16.3 14.8 26.6 13.3 18.4 12.1 3.8 11.6 4.4 13.7 14.6 42.6 10.2 20.1 18.0 12.5 16.4 25.8 7.0 13.0 12.0 21.1 22.7 8.1 7.6 26.3 9.1 11.4 10.0 8.1 10.5 3.5 14.0 11.6 3.3 26.8 29.7 0.2 9.9 0.5 4.3 2.1 3.7 2.1 0.7 0.2 5.6 0.0 26.9 24.2 0.0 8.7 17.2 11.0 27.8 0.0 0.1 0.0 7.5 13.4 12.1 0.7 0.0 1.2 6.2 0.0 0.0 5.0 1.7 0.0 14.2 0.0 0.0 20.2 1.7 8.3 0.0 9.1 6.6 0.0 0.1 0.1 24.4 0.3 0.0 0.0 8.0 0.0 0.0 0.0 30.8 0.0 7.5 0.0 5.5 4.6 0.0 0.1 15.0 1.6 0.9 3.7 8.7 6.7 3.5 19.4 0.1 0.0 0.1 0.0 6.5 0.0 4.1 0.0 4.3 0.5 0.0 3.9 0.7 0.0 0.6 0.3 9.9 0.2 1.5 3.7 0.1 2.1 1.1 5.1 0.9 2.1 13.6 16.5 13.4 19.9 13.3 18.4 13.7 14.6 16.4 10.5 23.8 6.1 0.0 23.8 29.5 26.3 54.8 7.6 5.3 5.7 22.7 5.9 1.4 11.6 14.6 0.3 23.2 0.5 0.0 6.0 2.1 52.1 21.0 24.2 0.4 23.6 20.6 5.2 17.8 9.4 0.9 43.7 11.0 55.6 6.4 1.0 31.1 7.5 0.0 41.8 11.4 13.3 45.3 48.4 1.7 0.7 19.1 2.2 1.0 0.6 7.4 ATG4D "APG4-D, APG4D, AUTL4" ENSG00000130734 "Autophagy related 4D cysteine peptidase" Q86TL0 19 10543895-10553418 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067683 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA067683: AB_2685886" "unprognostic (2.85e-1)" "prognostic favorable (3.18e-5)" "unprognostic (2.73e-1)" "unprognostic (3.67e-1)" "unprognostic (2.18e-1)" "unprognostic (1.15e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (4.28e-2)" "unprognostic (7.30e-2)" "prognostic favorable (9.95e-4)" "unprognostic (1.52e-1)" "prognostic favorable (2.39e-7)" "prognostic favorable (5.03e-4)" "unprognostic (3.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.18e-3)" 6.4 10.8 5.1 9.2 7.8 35.0 6.3 15.6 14.9 6.2 18.4 9.8 8.1 26.0 6.1 7.2 18.4 5.5 7.6 15.4 4.6 4.9 14.5 8.8 7.3 9.8 9.6 6.4 7.0 16.1 8.2 12.1 6.9 7.3 9.7 7.3 7.8 11.5 8.5 31.5 17.7 27.3 4.0 4.5 12.0 10.5 29.0 8.8 19.9 9.8 16.4 10.5 7.5 9.6 2.0 7.6 5.7 1.6 2.2 3.6 1.4 7.0 4.7 6.6 8.9 1.2 1.0 5.1 4.3 4.3 6.2 6.8 7.9 2.3 4.5 8.2 0.5 4.7 11.1 4.1 3.7 0.8 4.4 10.7 12.0 11.5 4.4 4.1 4.8 12.3 1.0 7.7 5.3 1.9 1.6 1.8 9.9 8.9 11.0 1.9 11.3 14.1 29.3 10.0 3.2 12.9 10.4 4.1 8.0 3.5 9.5 24.8 9.6 6.4 12.5 4.9 1.2 7.7 11.8 3.4 9.5 6.0 19.0 9.6 9.8 6.6 5.3 8.1 9.3 10.7 3.0 1.6 5.7 2.1 1.5 3.1 2.0 2.5 2.3 1.1 1.0 2.5 3.4 0.5 2.2 0.7 7.6 3.6 1.4 5.1 7.8 15.6 14.9 4.6 4.9 9.6 6.4 7.3 8.8 8.9 10.0 8.8 18.9 27.1 15.0 0.4 17.8 2.7 1.2 1.8 13.7 23.7 11.6 14.3 51.1 4.1 90.5 23.3 14.4 5.4 10.1 17.3 6.9 9.7 11.7 27.0 21.4 5.5 12.0 6.8 8.1 8.7 11.8 19.0 28.4 10.6 16.6 38.2 4.2 16.8 17.6 12.9 16.0 63.1 19.6 27.4 30.6 21.3 23.3 29.3 ATP5F1A "ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM" ENSG00000152234 "ATP synthase F1 subunit alpha" P25705 18 46080248-46104334 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 678.0;Distal tubular cells: 994.7;Proximal tubular cells: 716.2;Syncytiotrophoblasts: 483.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013067, HPA040622, HPA044202" Enhanced Supported Mitochondria NA NA 51000000 Mitochondria "CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855" "unprognostic (3.08e-2)" "unprognostic (9.13e-2)" "unprognostic (1.84e-2)" "unprognostic (3.54e-1)" "unprognostic (6.36e-2)" "unprognostic (2.61e-1)" "unprognostic (1.89e-2)" "unprognostic (6.79e-2)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "unprognostic (7.30e-3)" "unprognostic (1.50e-2)" "prognostic favorable (1.22e-15)" "unprognostic (4.60e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-1)" "unprognostic (4.87e-3)" 30.1 60.0 34.7 30.3 45.8 22.4 33.9 52.6 65.0 27.0 52.1 20.5 39.3 55.6 25.2 30.5 44.4 30.0 27.9 196.2 31.4 36.1 94.0 64.8 25.2 40.2 42.3 31.8 28.6 49.0 73.2 35.9 25.7 41.5 28.3 54.9 37.6 42.6 42.8 182.2 34.0 50.4 36.6 22.6 32.1 46.7 24.0 19.9 45.6 35.1 99.7 41.1 31.5 26.4 58.7 110.9 17.9 64.5 44.2 63.6 124.8 43.2 44.1 58.7 55.1 71.5 79.5 65.1 50.1 71.1 77.2 67.7 66.0 34.2 102.6 30.7 60.6 41.4 80.7 101.1 76.9 72.1 45.6 56.8 67.8 56.9 81.7 46.9 143.4 64.4 73.2 54.0 55.6 58.0 62.1 79.6 55.7 54.7 60.7 66.0 45.0 73.7 70.6 55.0 42.4 46.6 73.0 68.3 138.6 104.7 105.9 59.8 55.8 36.7 45.9 61.5 57.6 59.1 83.8 46.3 42.5 36.8 22.3 43.6 69.7 59.6 66.1 42.4 86.3 45.2 11.8 64.5 17.9 43.5 58.2 55.8 58.7 52.4 47.5 110.9 44.0 63.6 52.8 6.7 44.2 52.2 54.0 58.9 124.8 34.7 45.8 52.6 65.0 31.4 36.1 42.3 31.8 41.5 19.9 157.8 126.7 0.0 0.0 0.0 0.0 0.0 0.0 175.3 184.2 162.3 0.0 678.0 994.7 285.1 0.0 0.0 0.0 0.0 236.7 359.7 0.0 0.0 82.5 0.0 363.9 0.0 0.0 0.0 0.0 0.0 0.0 64.5 0.0 313.8 0.0 0.0 195.3 0.0 0.0 716.2 0.0 0.0 0.0 0.0 0.0 0.0 483.5 0.0 0.0 0.0 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396466 "Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1135.7;Ductal cells: 625.1;Exocrine glandular cells: 623.7;monocytes: 754.8;Pancreatic endocrine cells: 789.0;Proximal tubular cells: 951.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria NA NA Mitochondria "HPA044798: AB_2679091" "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 48.0 46.2 91.7 26.2 67.0 26.6 56.1 33.5 71.7 38.4 77.9 21.2 29.2 43.8 22.1 72.3 56.3 28.8 31.0 131.5 67.8 57.4 79.3 92.5 24.6 27.7 65.2 44.4 19.7 58.1 21.1 38.2 25.9 46.0 30.0 75.8 23.4 52.7 43.3 146.9 22.4 57.3 39.1 41.4 26.1 40.9 20.2 30.7 22.9 31.3 125.5 39.8 41.2 28.9 71.3 109.1 101.2 85.2 50.7 76.6 66.4 60.6 64.4 61.0 72.7 68.2 85.7 39.9 58.4 73.7 59.7 66.8 103.7 67.7 34.9 33.9 66.0 47.2 62.2 57.1 59.5 82.4 45.8 102.5 36.2 83.0 115.9 66.3 73.8 56.2 69.1 93.4 53.6 84.8 102.3 76.9 56.6 47.4 58.3 99.7 94.1 59.9 127.2 45.3 93.2 109.2 38.9 37.2 54.3 141.9 98.9 23.1 53.5 30.8 47.3 84.0 89.1 42.0 68.6 43.5 29.6 45.3 44.8 76.4 61.5 100.4 58.2 62.5 75.8 22.3 101.2 65.9 88.7 55.9 85.2 63.3 71.3 76.6 65.7 73.3 51.5 65.9 65.6 55.8 50.7 80.6 109.1 71.7 66.4 91.7 67.0 33.5 71.7 67.8 57.4 65.2 44.4 46.0 30.7 196.5 169.5 0.0 0.0 0.0 0.0 0.0 0.0 222.1 167.2 368.2 0.0 256.1 1135.7 625.1 0.0 0.0 0.0 0.0 623.7 361.7 0.0 0.0 109.3 0.0 478.9 0.0 0.0 0.0 0.0 0.0 0.0 129.1 0.0 754.8 0.0 0.0 789.0 0.0 0.0 951.7 0.0 0.0 0.0 0.0 0.0 0.0 255.7 0.0 0.0 0.0 ATP5ME ATP5I ENSG00000169020 "ATP synthase membrane subunit e" P56385 4 672436-674338 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.8" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 840.9;Distal tubular cells: 1465.6;Proximal tubular cells: 1359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035010 Enhanced Supported Mitochondria NA NA 220000 Mitochondria "HPA035010: AB_10669853" "unprognostic (1.42e-1)" "unprognostic (4.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.32e-1)" "unprognostic (1.35e-3)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (2.46e-3)" "unprognostic (6.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.48e-1)" "unprognostic (6.45e-3)" 41.2 48.1 69.3 30.8 69.0 34.4 34.2 27.7 67.6 29.3 66.6 28.2 44.4 60.0 20.5 34.1 40.1 23.1 31.6 95.8 62.0 49.2 47.5 68.9 25.8 25.2 68.6 48.7 26.2 57.9 24.5 26.6 19.6 62.2 23.9 43.9 17.8 40.7 37.2 221.8 22.3 55.6 45.8 67.2 23.3 40.7 14.1 47.7 10.9 22.1 98.7 28.1 18.9 31.1 166.1 148.1 142.2 135.7 107.4 127.6 158.4 49.9 47.3 68.2 55.5 57.4 53.4 38.0 48.7 39.0 37.0 32.9 45.4 49.5 25.9 46.9 51.5 60.1 32.0 54.9 76.8 20.3 22.9 101.4 76.2 87.7 113.3 59.7 97.0 33.6 66.2 45.1 42.4 43.0 57.8 45.2 51.7 63.0 28.4 41.9 72.0 83.6 127.1 80.1 88.1 123.8 51.0 49.8 56.4 70.7 87.2 66.2 52.0 35.4 47.7 54.0 44.7 54.5 66.9 52.4 33.3 31.6 29.3 67.9 66.4 109.5 81.9 48.9 66.9 36.4 103.7 135.7 142.2 98.5 112.1 101.0 166.1 121.1 109.2 135.4 123.2 110.3 110.3 122.3 107.4 97.7 148.1 127.6 158.4 69.3 69.0 27.7 67.6 62.0 49.2 68.6 48.7 62.2 47.7 142.9 207.3 0.0 0.0 0.0 0.0 0.0 0.0 337.3 224.1 840.9 0.0 343.2 1465.6 413.4 0.0 0.0 0.0 0.0 598.1 265.5 0.0 0.0 112.8 0.0 580.0 0.0 0.0 0.0 0.0 0.0 0.0 109.4 0.0 485.1 0.0 0.0 478.0 0.0 0.0 1359.9 0.0 0.0 0.0 0.0 0.0 0.0 229.9 0.0 0.0 0.0 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466331 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 700.3;Distal tubular cells: 1212.0;Hofbauer cells: 681.7;monocytes: 591.5;Proximal tubular cells: 993.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 1400000 Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 42.4 49.0 68.0 36.6 52.0 46.4 42.8 37.3 58.8 30.7 62.7 19.0 39.9 62.9 21.2 41.2 57.4 24.8 36.6 94.5 53.9 49.8 59.6 93.5 30.0 35.5 54.6 43.6 20.7 63.6 16.3 36.7 33.4 36.3 35.0 47.3 30.9 57.1 45.2 178.8 27.8 61.5 24.6 33.0 35.6 43.4 58.3 25.5 52.9 37.9 98.0 37.6 27.8 30.2 68.3 129.7 117.2 104.1 58.3 84.0 140.0 86.7 76.6 64.6 104.3 50.9 51.7 40.9 57.6 44.9 61.9 67.1 81.3 80.2 81.4 60.8 35.7 105.4 53.5 71.4 66.0 66.2 58.6 91.7 55.1 122.5 104.8 38.4 93.9 63.1 58.9 63.7 53.8 57.0 54.2 58.9 70.6 111.7 89.7 64.8 203.9 140.4 163.0 91.9 174.2 90.2 62.9 53.9 139.1 130.5 96.5 62.1 68.5 75.4 186.6 54.5 100.7 47.0 121.9 49.9 54.5 87.2 90.0 84.0 51.4 118.1 169.8 63.1 91.9 83.7 90.0 104.0 117.2 54.2 104.1 51.7 68.3 63.5 61.0 129.7 56.9 55.8 59.5 49.7 58.3 79.2 102.7 84.0 140.0 68.0 52.0 37.3 58.8 53.9 49.8 54.6 43.6 36.3 25.5 20.8 44.7 0.0 0.0 0.0 0.0 0.0 0.0 93.7 67.1 366.4 0.0 700.3 1212.0 418.8 0.0 0.0 0.0 0.0 501.7 525.7 0.0 0.0 59.3 0.0 681.7 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 591.5 0.0 0.0 502.5 0.0 0.0 993.9 0.0 0.0 0.0 0.0 0.0 0.0 364.9 0.0 0.0 0.0 ATP5MG "ATP5JG, ATP5L" ENSG00000167283 "ATP synthase membrane subunit g" O75964 11 118401154-118431496 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 1200.8;Distal tubular cells: 2463.7;Hofbauer cells: 1173.9;monocytes: 1183.1;Proximal tubular cells: 1669.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044629 Approved Supported Mitochondria NA NA 590000 Mitochondria "HPA044629: AB_2679028" "unprognostic (1.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (1.61e-1)" "unprognostic (3.27e-2)" "unprognostic (3.90e-2)" "unprognostic (8.19e-2)" "unprognostic (5.13e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (7.41e-2)" "prognostic favorable (4.09e-5)" "unprognostic (6.26e-2)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (3.05e-2)" 32.3 42.4 45.3 31.8 46.7 36.0 39.6 38.1 40.4 25.6 39.0 21.1 30.3 33.8 33.9 40.4 27.9 26.5 30.1 85.8 37.5 38.4 55.6 42.6 29.1 41.9 39.2 23.6 31.3 70.1 25.8 31.1 23.6 28.3 26.3 41.5 39.0 71.9 29.5 68.4 20.9 39.5 47.3 27.8 30.7 29.5 17.9 15.7 53.2 33.7 60.2 43.7 30.0 23.6 42.7 54.6 30.8 48.0 32.5 53.5 98.1 21.4 11.1 29.3 28.4 25.4 28.4 23.5 22.0 25.0 20.2 21.5 28.1 34.8 42.6 46.0 23.9 31.7 27.4 29.5 30.8 22.5 34.0 19.4 67.3 10.5 16.9 26.0 38.2 32.3 30.2 29.2 24.9 23.7 23.8 27.1 32.3 30.7 35.7 28.1 38.4 53.4 47.7 18.6 60.6 31.0 36.7 24.6 46.8 52.5 18.5 23.3 17.6 33.2 53.8 16.2 33.9 39.1 35.7 26.6 16.7 18.7 14.3 25.1 16.3 22.3 43.3 12.4 44.6 20.8 28.8 48.0 30.8 27.1 33.3 39.3 42.7 42.9 35.5 49.9 34.6 53.5 40.2 24.0 32.5 31.5 54.6 45.8 98.1 45.3 46.7 38.1 40.4 37.5 38.4 39.2 23.6 28.3 15.7 336.5 314.3 0.0 0.0 0.0 0.0 0.0 0.0 345.3 306.0 579.3 0.0 1200.8 2463.7 680.9 0.0 0.0 0.0 0.0 858.6 734.2 0.0 0.0 238.3 0.0 1173.9 0.0 0.0 0.0 0.0 0.0 0.0 317.5 0.0 1183.1 0.0 0.0 798.2 0.0 0.0 1669.9 0.0 0.0 0.0 0.0 0.0 0.0 837.4 0.0 0.0 0.0 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1357.9;Hofbauer cells: 793.2;Proximal tubular cells: 1064.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA058978: AB_2683867, HPA060520: AB_2684302" "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favorable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 23.1 34.5 69.4 19.3 64.3 40.2 34.9 31.0 91.7 21.0 43.0 16.0 26.8 44.1 16.5 39.1 27.3 21.3 20.5 87.5 57.5 44.7 43.0 45.2 15.7 28.6 54.0 41.4 22.1 38.2 17.2 29.2 20.5 30.4 22.1 45.6 20.1 28.9 30.3 117.3 17.3 33.6 24.6 28.5 19.5 25.8 17.5 24.4 18.9 23.6 58.9 30.9 18.4 17.2 51.8 63.1 91.6 91.0 32.8 54.6 98.1 37.9 43.8 38.0 36.1 45.5 47.3 37.5 29.7 33.7 37.3 32.7 37.8 27.0 39.8 31.4 30.4 30.1 32.4 48.9 35.8 50.6 32.9 49.3 44.4 37.1 58.1 30.1 53.6 30.9 49.6 48.8 25.3 27.1 42.9 41.9 53.7 26.9 42.7 41.0 112.7 51.8 76.6 29.7 88.5 83.8 33.3 33.2 36.1 56.8 54.0 32.9 39.3 24.9 46.7 56.0 43.9 57.8 63.8 22.5 14.7 23.0 39.6 24.3 32.8 55.7 55.7 34.4 30.6 24.7 54.8 91.0 55.0 37.5 68.0 41.7 51.8 47.8 42.3 63.1 43.6 54.6 48.4 91.6 32.8 65.0 61.2 46.5 98.1 69.4 64.3 31.0 91.7 57.5 44.7 54.0 41.4 30.4 24.4 205.4 192.2 0.0 0.0 0.0 0.0 0.0 0.0 269.0 169.5 392.6 0.0 537.4 1357.9 448.4 0.0 0.0 0.0 0.0 495.8 570.0 0.0 0.0 86.0 0.0 793.2 0.0 0.0 0.0 0.0 0.0 0.0 158.5 0.0 585.3 0.0 0.0 512.8 0.0 0.0 1064.7 0.0 0.0 0.0 0.0 0.0 0.0 593.8 0.0 0.0 0.0 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 297.5;Distal tubular cells: 391.3;Extravillous trophoblasts: 335.0;Hofbauer cells: 328.7;Proximal tubular cells: 348.8;Syncytiotrophoblasts: 290.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 640000 Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.26e-9)" "prognostic favorable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 11.6 16.0 16.8 11.4 22.6 8.0 10.4 30.7 28.8 10.7 30.0 10.4 11.3 16.1 14.4 10.7 21.1 13.7 9.7 57.1 16.4 15.4 30.5 26.2 10.2 14.2 16.1 15.5 12.6 15.3 18.0 13.3 16.3 22.8 13.4 17.8 9.8 20.4 12.4 83.6 9.7 25.4 13.7 13.9 13.7 13.1 11.4 10.1 18.7 18.6 34.0 15.4 15.5 11.5 8.3 10.8 4.3 10.0 5.9 11.9 22.9 15.3 3.5 13.0 10.1 8.4 7.6 8.4 17.0 18.8 17.7 14.7 6.2 7.8 20.9 15.8 11.1 3.8 16.0 18.9 21.0 15.8 16.6 7.4 20.9 4.9 4.1 6.1 26.3 21.1 6.6 9.0 19.4 18.2 4.1 14.1 2.9 18.4 9.2 10.1 7.1 44.9 6.1 9.9 4.0 24.0 11.6 40.6 8.2 14.0 5.2 9.5 3.0 13.2 18.9 13.9 3.1 15.2 9.5 13.6 8.3 14.7 16.2 16.8 12.7 12.1 49.8 20.1 20.0 15.5 1.9 10.0 4.3 9.7 6.4 8.6 7.5 10.8 9.2 10.8 8.3 11.9 7.3 2.9 5.9 5.0 5.9 9.0 22.9 16.8 22.6 30.7 28.8 16.4 15.4 16.1 15.5 22.8 10.1 62.5 73.9 0.0 0.0 0.0 0.0 0.0 0.0 136.5 105.8 118.7 0.0 297.5 391.3 205.2 0.0 0.0 0.0 0.0 172.3 335.0 0.0 0.0 82.5 0.0 328.7 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.0 172.3 0.0 0.0 151.6 0.0 0.0 348.8 0.0 0.0 0.0 0.0 0.0 0.0 290.7 0.0 0.0 0.0 ATP5PD "ATP5H, ATP5JD, ATPQ" ENSG00000167863 "ATP synthase peripheral stalk subunit d" O75947 17 75038863-75046985 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 968.2;Proximal tubular cells: 714.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042777, HPA048459" Enhanced Supported Mitochondria NA NA 1600000 Mitochondria "HPA042777: AB_2678160, HPA048459: AB_2680402" "unprognostic (1.37e-1)" "unprognostic (4.41e-2)" "unprognostic (1.70e-3)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "unprognostic (4.81e-2)" "unprognostic (7.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (2.72e-1)" "unprognostic (8.72e-2)" "unprognostic (2.56e-2)" "unprognostic (1.42e-1)" "unprognostic (3.26e-1)" "unprognostic (1.73e-1)" "unprognostic (4.29e-2)" 38.8 38.5 54.3 28.6 48.6 25.6 37.8 34.5 50.4 30.0 52.9 19.6 33.2 46.6 25.8 47.4 58.9 25.7 31.0 143.6 47.7 44.8 78.8 86.2 24.8 29.2 45.7 39.2 28.5 43.3 38.5 29.8 35.4 40.3 33.1 53.1 35.4 56.8 36.3 184.2 35.5 59.9 39.1 32.8 32.7 40.4 15.7 21.3 30.3 48.7 88.5 33.7 45.8 29.0 72.5 100.7 90.9 103.8 54.9 100.0 86.2 63.5 55.8 42.8 55.7 69.8 85.4 57.5 54.7 72.2 61.4 58.6 43.6 50.0 43.1 36.4 68.4 57.9 58.0 51.5 71.7 82.4 20.9 43.7 44.0 46.5 85.9 68.7 56.0 28.9 72.5 57.1 49.9 71.4 49.1 81.7 33.7 45.8 58.8 75.4 61.7 55.4 63.0 32.6 146.1 79.4 39.4 124.0 79.9 126.9 62.2 43.1 47.4 64.6 103.0 87.1 66.8 102.1 57.2 42.1 76.5 53.5 66.4 63.8 47.3 37.3 44.1 68.5 56.3 49.2 67.2 90.5 90.9 58.3 103.8 67.4 72.5 100.0 71.6 100.7 57.6 90.9 83.5 50.7 54.9 83.1 89.8 94.6 86.2 54.3 48.6 34.5 50.4 47.7 44.8 45.7 39.2 40.3 21.3 160.8 115.9 0.0 0.0 0.0 0.0 0.0 0.0 186.0 188.8 246.0 0.0 327.6 968.2 259.9 0.0 0.0 0.0 0.0 330.1 269.2 0.0 0.0 81.4 0.0 401.2 0.0 0.0 0.0 0.0 0.0 0.0 121.7 0.0 364.3 0.0 0.0 268.3 0.0 0.0 714.6 0.0 0.0 0.0 0.0 0.0 0.0 281.2 0.0 0.0 0.0 ATP5PF "ATP5, ATP5A, ATP5J, ATPM, CF6" ENSG00000154723 "ATP synthase peripheral stalk subunit F6" P18859 21 25716503-25735673 "Plasma proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Distal tubular cells: 2012.7;Proximal tubular cells: 1143.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031069 Supported Supported Mitochondria NA NA 720000 Mitochondria "HPA031069: AB_10603676" "unprognostic (3.52e-2)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (4.87e-2)" "unprognostic (1.77e-1)" "unprognostic (8.83e-2)" "prognostic favorable (2.37e-5)" "unprognostic (1.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.56e-1)" "unprognostic (2.15e-2)" 39.8 46.8 49.0 20.3 43.6 23.0 32.6 30.8 46.6 25.9 48.6 26.1 22.4 43.0 24.0 57.4 45.2 21.6 19.2 148.9 41.1 37.1 72.8 111.0 18.7 22.2 47.0 27.0 23.9 37.4 31.2 37.5 33.9 45.7 32.6 47.9 33.9 47.1 37.5 164.7 18.7 57.9 46.9 32.8 25.0 37.6 21.0 25.8 31.4 32.1 69.9 29.9 42.0 23.1 87.8 102.4 80.9 91.5 69.1 95.2 112.2 41.8 30.1 38.4 43.1 41.4 38.1 47.7 37.0 43.1 36.2 35.4 69.1 33.0 51.5 24.5 36.5 57.9 22.9 51.4 44.4 39.9 45.0 54.6 107.4 61.2 68.6 46.8 78.4 35.2 37.2 54.8 34.6 31.1 49.3 42.0 49.8 67.0 63.4 52.8 46.7 54.3 79.4 69.0 94.8 54.7 42.5 74.7 97.3 77.2 57.2 43.9 48.8 62.2 62.9 57.0 56.8 45.5 70.7 31.7 27.7 33.2 25.8 31.8 63.3 103.5 65.2 42.5 82.1 34.7 69.2 88.8 80.9 60.3 91.5 64.0 87.8 80.2 74.6 102.4 71.6 79.6 78.0 56.9 69.1 89.7 96.4 95.2 112.2 49.0 43.6 30.8 46.6 41.1 37.1 47.0 27.0 45.7 25.8 157.8 157.2 0.0 0.0 0.0 0.0 0.0 0.0 261.0 194.5 397.8 0.0 553.9 2012.7 380.3 0.0 0.0 0.0 0.0 410.7 419.1 0.0 0.0 101.1 0.0 458.5 0.0 0.0 0.0 0.0 0.0 0.0 101.3 0.0 395.0 0.0 0.0 402.6 0.0 0.0 1143.7 0.0 0.0 0.0 0.0 0.0 0.0 592.2 0.0 0.0 0.0 AURKAIP1 "AIP, AKIP, FLJ20608" ENSG00000175756 "Aurora kinase A interacting protein 1" Q9NWT8 1 1373730-1375495 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Late spermatids: 2457.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031821 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA031821: AB_10601458" "unprognostic (9.54e-2)" "unprognostic (1.86e-2)" "unprognostic (2.77e-1)" "unprognostic (4.77e-2)" "unprognostic (2.68e-1)" "unprognostic (2.98e-2)" "unprognostic (3.31e-1)" "unprognostic (9.52e-2)" "unprognostic (2.76e-1)" "unprognostic (9.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.34e-1)" "prognostic favorable (8.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (7.18e-2)" "unprognostic (1.84e-1)" 26.6 29.3 30.3 19.6 30.5 20.9 16.3 17.8 40.5 14.1 27.9 18.7 18.3 33.5 14.3 18.3 25.0 14.5 22.9 55.2 25.3 23.4 35.0 59.1 14.4 17.6 29.0 23.0 14.8 41.2 16.8 18.7 23.6 21.9 17.2 13.6 20.0 35.8 20.4 115.9 20.2 29.5 15.9 18.5 16.9 24.7 73.8 12.6 16.0 27.1 41.4 20.7 18.2 15.2 53.4 81.9 82.5 67.5 36.1 61.6 59.2 38.9 23.7 13.0 23.3 11.5 14.6 24.0 23.7 15.8 37.6 26.8 41.5 36.2 20.6 35.4 16.0 18.9 28.9 17.8 31.4 10.9 24.7 50.3 16.6 31.0 38.3 22.7 21.4 22.6 19.1 14.2 26.3 10.7 11.0 20.4 19.7 32.7 28.5 21.8 29.7 26.2 76.5 24.6 24.6 67.5 30.7 16.0 44.2 29.7 10.4 41.8 31.3 17.0 59.4 56.3 8.3 25.7 50.1 15.2 23.3 29.9 27.7 34.9 37.3 34.0 43.2 32.5 31.7 15.7 60.8 67.5 70.6 51.1 53.6 48.4 53.1 53.9 53.7 58.0 53.4 50.7 49.3 82.5 36.1 46.0 81.9 61.6 59.2 30.3 30.5 17.8 40.5 25.3 23.4 29.0 23.0 21.9 12.6 44.7 60.9 130.3 137.2 144.1 107.1 195.9 180.9 89.7 56.9 157.1 60.9 351.3 573.6 261.8 1001.4 114.7 553.0 116.8 362.4 394.1 140.0 198.9 86.5 355.2 260.5 98.5 195.6 106.2 140.4 2457.2 126.0 155.3 205.8 225.4 267.9 199.3 331.2 287.5 111.4 527.2 88.0 155.2 136.5 419.6 143.7 172.8 366.4 100.2 314.0 225.6 BCAT2 "BCAM, BCT2" ENSG00000105552 "Branched chain amino acid transaminase 2" O15382 19 48795062-48811029 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Branched-chain amino acid biosynthesis" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 72.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054091 Enhanced Supported Mitochondria NA NA 3400000 Mitochondria "HPA054091: AB_2682374" "unprognostic (2.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.16e-1)" "unprognostic (2.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.97e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-2)" "unprognostic (2.98e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.68e-5)" "unprognostic (1.87e-3)" "unprognostic (1.35e-1)" "unprognostic (2.42e-1)" "unprognostic (7.50e-3)" 11.8 34.1 6.7 10.9 7.7 3.8 15.0 15.0 10.7 11.9 16.7 11.3 15.8 10.2 12.9 9.8 24.6 11.9 15.2 25.1 6.8 6.9 22.6 8.0 19.9 16.3 9.8 7.8 22.3 42.6 9.0 12.3 27.5 22.0 16.8 12.1 6.3 24.7 17.2 23.3 9.8 10.3 17.5 7.6 10.9 22.8 15.9 10.7 12.5 19.1 23.3 16.7 29.2 12.2 15.0 18.2 1.8 9.8 8.8 15.4 7.1 17.5 21.1 5.6 11.9 23.4 7.9 10.0 7.8 4.0 9.6 9.4 21.2 10.8 20.7 8.9 6.9 3.0 8.3 8.6 13.6 4.8 12.8 21.9 7.6 9.5 1.4 22.7 10.2 7.1 11.5 8.7 7.1 10.3 9.4 13.3 16.0 9.6 12.7 3.5 21.0 13.9 10.8 4.9 27.9 10.3 21.2 9.7 22.8 9.1 72.7 30.3 8.6 11.8 19.5 5.7 4.1 12.4 5.0 7.4 9.4 9.0 11.0 9.7 12.0 15.9 9.9 5.1 16.0 6.1 0.0 8.7 1.8 9.7 9.8 13.6 15.0 11.7 12.4 16.1 12.8 10.8 9.6 0.4 8.8 3.7 18.2 15.4 7.1 6.7 7.7 15.0 10.7 6.8 6.9 9.8 7.8 22.0 10.7 26.8 34.4 9.0 26.7 5.4 8.2 22.1 20.4 6.7 13.6 12.2 19.6 54.6 61.3 34.2 5.8 13.5 15.6 0.0 18.6 15.8 11.7 16.4 23.1 8.3 23.4 1.6 19.1 12.3 4.7 6.2 16.1 8.6 23.6 33.3 25.8 5.6 19.8 14.0 28.3 28.2 11.2 19.4 16.1 7.0 17.1 6.1 38.3 7.0 30.3 40.4 BCKDHB ENSG00000083123 "Branched chain keto acid dehydrogenase E1 subunit beta" P21953 6 80106647-80346270 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 56.4;Hepatocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031580, HPA031956" Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" Yes No Mitochondria Nucleoli "HPA031580: AB_10696054, HPA031956: " "unprognostic (4.23e-1)" "unprognostic (1.61e-1)" "unprognostic (9.50e-3)" "unprognostic (9.37e-3)" "unprognostic (1.66e-1)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (2.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.32e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "prognostic favorable (5.54e-9)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (1.49e-2)" 13.9 12.0 9.9 9.0 12.2 5.8 18.1 9.5 14.3 10.2 17.3 22.7 9.4 9.1 11.6 7.7 10.2 10.9 7.4 14.7 11.9 7.6 24.7 58.6 6.4 8.1 11.3 11.2 13.9 12.1 13.7 15.5 5.5 14.1 13.1 16.5 11.7 30.5 10.3 8.2 8.6 11.8 11.5 16.7 5.3 15.0 10.0 12.4 11.2 12.5 7.9 7.7 14.0 8.2 9.1 10.3 2.6 4.3 13.4 15.7 5.2 7.0 2.6 10.0 13.4 10.2 8.9 8.0 5.0 10.4 8.3 11.4 4.3 9.7 20.0 5.4 12.0 9.7 7.1 5.5 6.6 11.6 24.8 8.2 9.9 6.9 5.8 11.3 14.0 4.5 8.5 6.8 5.7 7.1 7.4 9.8 15.6 8.3 17.9 18.5 3.9 5.1 8.2 7.4 15.4 3.4 13.0 31.1 17.1 22.9 10.8 6.7 9.5 8.5 7.1 5.0 11.5 9.1 10.8 4.2 5.0 3.4 4.5 6.7 12.8 12.5 6.6 6.1 10.5 7.4 2.6 3.4 0.8 8.5 4.0 11.1 9.1 7.2 7.2 6.6 9.1 9.6 10.0 0.7 13.4 4.3 10.3 15.7 5.2 9.9 12.2 9.5 14.3 11.9 7.6 11.3 11.2 14.1 12.4 8.9 15.2 6.7 10.1 7.6 7.0 26.0 10.2 16.0 14.8 5.2 2.0 15.7 23.2 6.8 56.4 9.0 12.4 0.0 9.0 6.6 13.0 8.6 16.1 55.0 10.2 3.2 11.5 11.1 9.8 4.1 8.1 6.1 15.1 10.0 28.8 14.6 4.5 11.5 8.1 25.2 8.2 6.5 8.9 7.7 4.8 10.8 8.7 8.9 15.3 9.8 BCKDK ENSG00000103507 "Branched chain ketoacid dehydrogenase kinase" O14874 16 31106107-31112791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 26.8;granulocytes: 26.6;monocytes: 33.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017995, HPA056067" Supported Supported Mitochondria NA NA Mitochondria "HPA017995: AB_1845309, HPA056067: AB_2683024" "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (6.94e-2)" "unprognostic (5.20e-2)" "unprognostic (5.39e-2)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (5.47e-2)" "unprognostic (1.60e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.24e-2)" "unprognostic (2.66e-3)" "unprognostic (4.85e-2)" "unprognostic (3.93e-2)" "unprognostic (1.00e-1)" "unprognostic (4.97e-2)" 15.4 29.7 11.9 13.1 15.0 9.4 18.3 18.8 21.3 11.7 14.1 9.6 19.9 11.2 14.8 14.9 14.9 13.8 15.1 39.2 14.2 10.3 21.3 46.5 18.2 32.5 10.7 17.3 15.1 52.4 17.4 8.9 11.4 13.2 14.9 9.9 10.4 33.9 25.7 67.7 21.5 12.2 19.9 15.6 16.0 19.9 11.2 9.3 8.0 11.7 25.9 10.6 15.3 12.0 6.9 26.8 26.6 33.0 6.3 6.8 13.6 18.2 20.5 11.6 17.4 14.3 14.4 12.6 15.9 19.6 24.8 24.3 13.4 12.2 17.1 23.1 19.8 12.1 12.7 8.2 27.7 16.0 13.8 25.4 18.5 13.9 24.3 25.2 9.6 17.0 21.1 11.2 21.2 17.7 22.8 26.4 13.1 9.3 16.2 37.1 31.1 8.8 12.7 9.8 8.5 16.6 17.9 16.9 31.5 18.9 12.6 17.9 16.4 12.3 30.5 9.9 10.4 18.4 9.2 16.9 18.9 10.9 19.4 13.2 16.9 6.0 6.1 21.5 13.9 17.7 12.2 33.0 23.1 5.7 27.4 5.6 6.9 5.2 4.2 26.8 5.4 4.4 5.0 26.6 6.3 19.3 5.8 6.8 13.6 11.9 15.0 18.8 21.3 14.2 10.3 10.7 17.3 13.2 9.3 17.9 17.8 27.4 21.2 16.5 11.0 32.1 25.5 13.4 9.1 19.2 0.0 47.3 68.0 57.7 2.2 20.9 39.3 0.0 68.3 54.7 20.7 26.1 33.4 34.7 83.9 11.1 19.1 27.0 41.9 3.6 19.2 56.7 11.8 95.6 20.5 22.1 49.3 40.3 24.1 65.3 7.2 45.3 28.9 16.7 15.2 24.0 58.0 14.4 26.7 19.3 BCL2L11 "BIM, BimEL, BimL, BimS, BOD" ENSG00000153094 "BCL2 like 11" O43521 2 111119378-111168447 "Predicted intracellular proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026332, CAB079899" Approved Supported Mitochondria NA NA Mitochondria "CAB026332: AB_566386, CAB079899: AB_10981505" "unprognostic (1.43e-1)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-3)" "unprognostic (8.15e-3)" "unprognostic (7.86e-2)" 10.0 7.9 4.9 18.9 5.6 24.8 17.9 1.6 4.7 6.9 15.7 5.1 17.7 5.3 7.9 6.6 10.8 7.8 10.3 7.0 3.8 3.0 14.6 16.3 9.7 46.7 5.5 4.1 12.2 15.1 12.2 21.3 13.3 4.6 8.6 8.8 7.8 11.4 21.8 13.9 6.2 13.7 3.8 4.2 31.5 7.2 19.1 5.5 40.4 32.3 8.6 16.0 10.3 11.8 4.9 3.4 8.3 8.2 2.4 9.5 2.2 3.5 1.4 5.1 4.6 4.0 2.1 13.7 0.6 1.0 1.4 1.4 3.7 11.0 13.8 3.4 0.5 8.9 4.1 4.3 1.6 1.0 10.6 8.7 16.6 3.5 4.5 2.1 6.1 4.3 2.1 4.6 1.9 1.7 3.3 2.0 6.7 8.7 21.2 0.3 2.8 7.3 6.2 5.9 3.3 3.5 8.7 4.5 18.2 1.9 6.0 4.7 11.8 4.9 6.3 3.8 3.3 2.7 13.7 0.9 0.9 6.0 1.8 1.8 41.9 8.1 19.6 1.3 4.4 0.7 6.1 5.6 3.3 2.6 3.8 3.0 4.9 3.9 3.1 3.4 3.2 2.7 2.1 8.3 2.4 8.2 0.7 9.5 2.2 4.9 5.6 1.6 4.7 3.8 3.0 5.5 4.1 4.6 5.5 3.0 6.9 40.9 14.7 15.5 4.7 16.1 7.6 14.7 6.8 8.7 9.8 3.6 11.6 9.8 85.7 10.8 16.8 46.7 5.8 6.7 8.7 12.8 10.5 10.5 9.4 0.0 20.6 12.3 29.4 27.6 5.5 17.5 21.9 36.9 17.7 15.1 7.7 14.4 3.5 4.6 20.2 0.0 11.3 5.7 17.0 9.5 4.8 23.5 9.8 13.6 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;smooth muscle: 10.5" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 35.7;Cardiomyocytes: 9.6;Smooth muscle cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 22.7;BJ hTERT+ SV40 Large T+: 17.4;BJ hTERT+ SV40 Large T+ RasG12V: 13.2;HBF TERT88: 16.7;U-138 MG: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" NA NA 16000000 "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038" "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.9 1.3 5.0 0.6 4.5 0.5 0.6 9.4 14.5 1.6 0.8 0.6 0.7 0.8 0.7 8.2 1.4 0.5 2.1 5.8 8.5 5.7 0.9 0.5 4.1 0.4 2.5 4.7 1.2 1.0 0.2 2.3 3.7 12.7 4.9 0.4 3.0 0.9 4.2 1.3 2.1 0.5 10.5 1.0 0.6 0.9 1.3 0.0 0.0 2.3 0.0 0.4 3.2 1.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 1.6 6.7 0.2 0.0 2.4 1.9 0.0 22.7 4.4 17.4 13.2 0.0 2.6 0.0 2.1 8.2 0.3 1.0 0.1 0.2 16.7 0.1 0.1 0.0 2.2 0.0 10.1 0.1 0.1 5.9 2.2 3.8 2.2 10.6 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 2.1 0.0 1.8 0.0 1.3 0.0 2.5 0.0 0.1 0.6 4.3 0.0 0.0 1.0 0.1 0.0 7.5 24.4 4.1 9.4 5.0 0.3 0.0 0.0 9.4 0.6 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.1 0.7 0.4 0.0 0.1 0.0 0.4 1.0 0.1 5.0 4.5 9.4 9.4 8.5 5.7 2.5 4.7 12.7 0.0 35.7 0.3 0.0 0.2 0.6 4.7 9.6 0.0 0.0 0.0 1.8 3.9 0.2 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.3 4.1 0.4 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 1.7 0.0 0.0 0.1 0.2 0.0 0.0 0.3 1.5 0.0 6.6 0.4 0.7 0.0 0.6 0.0 0.0 0.0 BOLA3 ENSG00000163170 "BolA family member 3" Q53S33 2 74135398-74147994 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 267.6;Distal tubular cells: 298.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046393, HPA053162" Uncertain Supported "Nuclear bodies,Mitochondria,Cytosol" NA NA "Nuclear bodies, Mitochondria" Cytosol "HPA046393: , HPA053162: AB_2682063" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.83e-2)" "unprognostic (4.23e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.86e-3)" "unprognostic (8.03e-2)" "unprognostic (1.60e-2)" "unprognostic (4.03e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (9.90e-5)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (4.40e-1)" 18.5 16.1 23.2 11.7 26.0 18.0 20.4 15.6 29.8 11.0 24.0 7.5 12.1 18.4 10.0 13.8 12.6 11.2 12.5 56.8 18.9 21.0 22.0 15.7 14.1 14.7 24.1 18.1 6.9 27.8 12.8 12.3 7.7 17.6 11.5 19.7 11.9 21.5 14.2 57.2 5.9 15.3 14.4 15.8 8.8 16.8 8.2 10.6 7.7 12.1 27.9 11.1 8.9 9.1 14.3 20.7 3.4 9.7 15.2 32.0 13.9 23.4 30.5 11.1 10.9 20.5 19.5 27.5 21.9 12.9 24.4 16.7 39.6 10.9 15.5 20.0 18.9 24.6 12.4 25.5 31.2 21.9 30.4 42.0 19.7 21.2 60.4 18.4 38.6 9.7 15.5 23.9 23.6 29.4 11.2 18.0 34.7 41.2 18.4 26.3 36.1 32.2 28.8 16.3 45.3 46.9 21.2 28.9 31.8 32.2 23.7 16.8 10.0 15.5 25.6 27.0 15.4 14.6 24.5 9.9 20.2 34.5 22.5 43.4 16.9 29.7 21.2 21.3 31.0 18.1 3.4 4.8 1.1 23.2 9.1 25.3 14.3 32.0 24.5 12.1 12.4 28.0 24.1 0.9 15.2 9.7 20.7 27.8 13.9 23.2 26.0 15.6 29.8 18.9 21.0 24.1 18.1 17.6 10.6 8.9 28.0 16.4 39.3 20.1 27.8 267.6 56.0 46.8 30.7 80.3 15.7 50.8 298.4 83.8 13.0 34.9 78.6 186.9 96.3 140.3 38.4 51.5 25.3 87.3 98.4 25.4 73.1 36.2 31.6 5.4 30.5 28.8 94.5 91.0 107.7 29.9 82.6 51.8 43.5 165.7 37.6 19.4 43.8 63.5 96.7 14.8 18.7 29.9 160.6 37.4 C14orf119 FLJ20671 ENSG00000179933 "Chromosome 14 open reading frame 119" Q9NWQ9 14 23094765-23100462 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003638 Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA003638: AB_2243669" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (2.91e-1)" "unprognostic (2.33e-2)" "unprognostic (5.26e-3)" "prognostic unfavorable (5.42e-5)" "unprognostic (1.23e-1)" "unprognostic (3.36e-2)" "unprognostic (1.65e-2)" "unprognostic (4.08e-3)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-2)" "unprognostic (3.61e-2)" "prognostic favorable (3.30e-5)" "unprognostic (1.63e-1)" 28.2 35.0 16.3 22.0 18.5 9.2 38.9 11.6 17.3 30.4 28.4 17.0 23.9 22.6 29.9 30.3 32.0 23.5 22.4 29.6 16.3 19.9 36.3 24.6 30.4 37.3 22.4 15.1 25.2 39.4 16.7 28.1 32.2 23.1 27.9 35.8 27.1 28.0 28.1 21.2 20.7 27.4 33.5 20.1 33.8 28.2 33.0 16.7 27.2 40.0 26.3 33.1 25.8 24.0 34.6 37.4 72.7 40.2 30.2 45.0 43.7 13.8 13.7 20.7 12.5 45.7 39.8 16.7 23.2 34.4 30.7 36.6 10.8 21.5 10.5 12.1 37.6 37.3 23.7 19.6 30.8 42.7 16.7 9.6 15.9 11.4 46.2 36.0 23.7 24.8 48.5 27.9 25.8 19.1 28.1 33.5 19.2 10.5 11.8 33.6 19.8 11.1 18.4 13.0 32.2 21.0 9.9 15.4 12.1 34.8 22.3 10.0 9.1 19.4 18.3 20.1 24.1 12.3 13.8 26.9 14.6 12.8 21.9 10.4 11.1 13.0 12.9 13.4 15.1 13.0 63.7 40.2 72.7 32.6 25.7 37.1 34.6 37.2 36.2 37.4 28.5 39.1 38.3 23.8 30.2 17.3 25.2 45.0 43.7 16.3 18.5 11.6 17.3 16.3 19.9 22.4 15.1 23.1 16.7 44.7 41.3 39.3 73.7 23.6 28.7 21.4 30.6 38.8 46.6 29.6 7.9 76.0 109.5 81.1 13.7 45.7 39.3 23.3 74.5 84.3 43.6 40.4 52.1 27.7 93.8 19.1 27.2 43.6 42.9 11.4 59.2 57.9 45.5 111.0 43.7 31.3 81.5 43.2 45.6 76.4 15.4 32.3 37.6 25.0 24.6 29.6 119.7 48.4 45.4 67.4 C19orf70 "MIC13, P117, QIL1" ENSG00000174917 "Chromosome 19 open reading frame 70" Q5XKP0 19 5678421-5680896 "Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 13 "Late spermatids: 2933.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042672 Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA042672: AB_10794531" "unprognostic (9.54e-2)" "unprognostic (4.90e-3)" "unprognostic (3.04e-1)" "unprognostic (3.21e-3)" "unprognostic (1.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.65e-1)" "unprognostic (2.53e-3)" "unprognostic (2.14e-2)" "unprognostic (9.32e-2)" "unprognostic (2.50e-2)" "unprognostic (1.57e-1)" "prognostic favorable (7.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.94e-2)" "unprognostic (2.27e-1)" "unprognostic (5.47e-2)" 20.2 23.6 32.9 14.5 28.4 13.2 16.0 11.0 29.8 13.0 22.2 13.5 17.8 25.4 12.2 26.8 22.7 16.7 24.0 70.2 27.2 26.5 30.5 38.4 12.7 21.1 32.1 21.1 13.5 24.2 13.2 15.6 12.4 16.9 16.6 11.7 13.6 28.7 22.7 79.1 17.6 20.7 14.7 20.9 14.1 18.2 33.4 12.3 11.6 20.3 45.0 12.6 15.4 11.8 43.6 48.2 11.6 42.2 27.4 39.5 40.7 24.2 20.1 7.0 13.4 16.5 17.1 9.1 16.1 15.3 18.6 15.4 16.0 12.7 10.6 26.2 14.0 9.9 18.1 3.6 22.8 5.3 17.4 38.4 10.3 14.0 17.8 23.3 14.1 13.0 20.0 20.6 10.0 13.9 11.7 13.3 16.3 15.9 33.1 14.0 21.9 21.3 16.8 7.4 17.8 64.4 11.7 8.5 38.7 20.3 15.3 16.4 20.9 4.9 31.8 22.5 4.7 19.4 17.4 13.5 18.3 7.8 33.4 22.7 50.0 33.1 8.4 27.3 22.6 18.5 8.9 35.5 11.6 33.6 42.2 39.5 43.6 38.6 37.2 41.2 35.6 38.1 35.9 5.6 27.4 35.6 48.2 30.9 40.7 32.9 28.4 11.0 29.8 27.2 26.5 32.1 21.1 16.9 12.3 65.5 61.7 101.3 135.8 87.3 47.7 288.5 122.3 167.3 76.2 150.1 25.5 132.2 623.4 178.9 798.0 106.8 325.2 46.7 265.1 165.3 137.3 120.3 92.3 251.0 214.9 17.5 154.8 98.8 146.2 2933.3 115.3 157.0 163.6 263.3 176.9 49.5 211.4 214.0 112.8 383.4 42.2 109.9 170.0 106.7 73.5 109.3 105.3 94.8 219.4 109.5 C21orf2 "A2, LRRC76, YF5" ENSG00000160226 "Chromosome 21 open reading frame 2" O43822 21 44328944-44339402 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA damage" "Ciliopathy, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030283, HPA030284, CAB034126, CAB034128" Supported Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700" "unprognostic (1.84e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (9.73e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.49e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.98e-1)" "unprognostic (2.79e-1)" "unprognostic (1.32e-2)" "unprognostic (1.06e-1)" 18.8 13.4 19.8 11.3 21.6 19.7 9.2 10.3 23.4 13.8 14.7 18.2 14.3 13.4 12.6 19.1 6.9 14.7 13.2 11.3 19.5 16.6 18.0 11.6 12.8 12.4 16.4 19.1 15.2 14.5 7.4 17.6 12.4 13.2 12.3 3.9 14.3 16.1 17.2 21.0 22.3 15.4 5.8 12.6 16.1 21.1 16.7 11.2 10.9 16.4 8.1 13.0 8.1 7.0 10.8 21.7 1.2 8.5 12.1 9.7 4.9 8.0 3.4 3.2 4.2 2.1 1.4 12.9 4.2 2.5 1.7 0.9 6.1 2.4 5.8 8.4 1.4 3.4 3.8 0.6 0.8 0.4 8.8 8.4 6.0 2.7 7.1 2.8 6.5 6.5 2.0 1.5 0.7 1.5 2.9 1.0 4.4 7.3 10.0 1.0 9.9 7.1 15.9 8.1 4.1 5.2 18.1 4.2 12.9 1.9 11.8 8.6 7.9 5.8 1.4 6.9 2.0 6.2 14.3 4.7 3.6 4.7 3.9 3.1 16.3 8.6 4.0 8.9 13.1 6.5 1.2 7.1 1.0 7.1 8.5 8.5 10.8 7.3 9.7 7.3 8.6 8.5 8.2 0.9 12.1 6.2 21.7 4.0 4.9 19.8 21.6 10.3 22.4 19.5 16.6 16.4 19.1 13.2 11.2 3.0 16.5 25.0 18.4 14.4 43.7 2.2 35.7 32.1 9.1 12.2 35.3 25.4 66.3 24.9 73.3 10.0 27.6 0.0 51.4 12.3 38.1 21.2 19.5 18.1 31.3 35.0 31.6 9.2 14.5 196.9 24.5 17.6 40.5 31.5 29.6 34.1 20.6 31.1 29.7 36.0 24.8 12.9 18.9 40.3 10.9 13.6 27.3 20.8 31.8 18.6 CA5B ENSG00000169239 "Carbonic anhydrase 5B" Q9Y2D0 X 15688830-15788409 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 15.7;fHDF/TERT166: 17.9;hTERT-HME1: 23.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012618 Uncertain Supported Mitochondria NA NA Mitochondria "HPA012618: AB_1846000" "unprognostic (1.62e-2)" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (1.55e-3)" "unprognostic (1.16e-2)" "unprognostic (4.59e-5)" "unprognostic (2.50e-1)" "unprognostic (6.89e-4)" "unprognostic (4.11e-1)" "unprognostic (3.89e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favorable (6.66e-6)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (8.94e-2)" "unprognostic (3.08e-1)" 9.3 4.6 10.6 4.9 11.1 4.1 10.2 3.1 7.8 28.7 3.6 11.5 1.4 2.2 9.8 3.7 8.1 9.5 9.1 6.5 9.9 8.2 10.3 7.8 7.3 8.8 12.2 6.7 15.2 4.4 16.8 4.4 3.9 13.1 6.2 4.7 29.5 8.3 6.2 2.0 7.5 4.1 9.4 7.1 5.3 5.4 23.0 8.1 2.3 8.9 10.9 11.6 6.3 9.4 4.3 3.5 2.7 3.6 7.9 13.3 7.0 2.7 1.7 2.0 3.2 5.9 15.7 1.1 2.9 3.7 2.2 3.2 0.8 1.9 0.8 3.1 17.9 4.2 3.0 6.9 3.3 3.9 0.7 3.3 1.5 2.1 0.7 5.8 1.9 3.4 3.6 3.6 2.9 23.5 3.9 3.2 2.3 0.8 2.1 10.3 1.5 1.6 1.5 0.8 0.5 12.5 0.9 1.4 1.4 3.3 2.0 1.7 3.7 4.1 1.5 2.6 2.4 2.1 1.9 4.3 2.6 1.7 13.9 1.6 1.5 1.5 0.9 2.9 3.9 4.8 2.7 3.0 0.3 13.1 3.6 11.4 3.6 13.3 12.3 3.5 4.3 9.8 8.3 1.7 7.9 2.3 0.5 10.0 7.0 10.6 11.1 3.1 7.8 9.9 8.2 12.2 6.7 13.1 8.1 0.0 9.3 7.2 5.3 3.8 8.9 1.6 0.0 17.4 10.3 1.8 15.7 1.4 1.7 3.6 0.9 10.7 0.5 23.3 3.5 1.2 7.2 9.7 2.3 2.4 1.7 1.6 2.9 3.7 7.8 1.3 7.2 9.6 3.3 1.0 2.4 37.2 3.8 0.9 4.9 2.2 8.0 6.5 7.2 3.3 5.9 4.0 1.6 15.9 1.7 6.3 CARD19 "bA370F5.1, BinCARD, C9orf89, MGC11115" ENSG00000165233 "Caspase recruitment domain family member 19" Q96LW7 9 93096218-93113283 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010921, HPA010990, HPA038297" Approved Supported Mitochondria NA NA Mitochondria "HPA010921: AB_10670295, HPA010990: AB_2668400, HPA038297: AB_2675938" "unprognostic (7.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (2.22e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.21e-1)" "unprognostic (1.36e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (9.13e-2)" "unprognostic (6.82e-2)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" 15.1 17.8 9.9 8.1 10.6 6.8 19.6 19.8 15.0 13.5 18.1 13.9 6.4 13.7 13.8 14.2 12.9 12.3 13.0 14.5 9.7 7.5 18.1 12.2 12.0 7.8 14.8 10.7 9.6 9.1 6.1 8.1 7.6 13.7 10.2 7.6 9.9 12.1 10.7 15.5 14.6 12.2 12.5 12.5 12.5 15.7 19.9 10.3 5.3 10.0 13.4 7.1 15.5 12.6 5.6 17.3 23.0 21.7 9.2 11.5 12.3 12.1 11.9 1.4 3.5 1.9 3.7 5.0 10.1 5.0 7.1 3.2 2.9 4.1 2.6 7.1 3.6 5.1 21.2 1.2 8.1 0.6 50.0 4.7 4.6 2.5 6.7 8.1 4.1 4.4 9.3 2.6 5.1 2.0 7.0 8.2 2.3 2.0 4.9 4.8 24.1 4.4 11.1 1.4 7.7 27.1 2.9 8.0 10.6 8.7 4.5 3.7 6.7 5.4 2.6 11.0 0.0 6.0 4.3 8.1 3.6 7.3 6.8 3.1 3.9 3.6 0.5 14.9 4.2 12.4 14.1 21.7 12.8 6.1 16.0 6.2 5.6 6.0 6.5 17.3 3.3 5.5 5.5 23.0 9.2 9.1 6.2 11.5 12.3 9.9 10.6 19.8 15.0 9.7 7.5 14.8 10.7 13.7 10.3 20.8 18.1 6.7 38.6 0.0 10.2 0.0 25.5 4.0 10.3 15.7 15.7 18.5 53.0 70.5 28.5 24.8 23.6 0.0 51.8 27.7 20.8 42.0 27.9 12.4 72.1 4.8 15.2 34.4 46.4 9.3 42.3 64.9 0.0 71.3 25.5 15.1 83.4 7.0 41.1 43.9 21.6 58.2 0.0 75.2 29.6 0.0 18.1 22.4 21.0 66.8 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria NA NA "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 9.9 14.9 10.1 7.1 12.7 4.5 9.6 10.4 15.9 8.9 12.8 7.5 12.4 11.6 8.2 11.4 15.9 9.7 8.4 12.3 9.2 8.2 15.2 17.8 7.1 9.0 9.9 15.4 8.7 8.5 9.4 7.4 8.5 10.6 7.7 15.1 9.9 11.0 11.2 16.3 10.9 8.8 11.6 8.8 14.7 7.9 10.7 8.9 10.4 11.3 16.1 12.0 8.8 9.7 19.2 18.2 4.8 10.4 10.6 14.8 9.7 9.7 11.9 7.2 8.4 10.6 11.3 19.7 6.5 6.0 13.1 10.7 18.8 16.4 21.2 9.3 5.1 9.8 14.3 17.6 21.2 8.0 9.9 11.6 18.1 18.9 14.1 16.4 8.8 8.3 8.5 48.2 16.1 17.7 7.1 7.4 12.5 10.0 6.2 12.3 9.3 10.2 11.4 15.7 21.0 19.3 7.1 8.4 16.3 17.7 12.2 5.9 12.5 10.7 11.7 17.4 7.0 12.6 13.7 5.6 7.6 10.3 18.8 12.4 10.0 14.6 11.1 10.1 19.1 7.1 2.0 10.4 4.8 12.0 10.2 12.1 19.2 11.2 14.8 18.2 15.4 11.7 13.4 4.5 10.6 6.1 15.2 13.4 9.7 10.1 12.7 10.4 15.9 9.2 8.2 9.9 15.4 10.6 8.9 11.9 1.6 8.9 3.0 4.1 6.8 7.3 22.9 5.3 5.7 8.7 0.0 35.3 19.9 13.2 2.5 5.3 12.6 0.0 10.8 15.3 10.7 3.7 3.5 11.9 14.1 7.9 5.2 3.1 3.8 2.2 11.2 4.1 13.5 13.6 6.3 10.1 12.4 5.8 12.4 27.0 9.5 6.5 3.1 4.8 17.3 4.1 5.6 4.3 12.4 3.1 CHCHD1 "C10orf34, FLJ25854" ENSG00000172586 "Coiled-coil-helix-coiled-coil-helix domain containing 1" Q96BP2 10 73782047-73783652 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 114.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039046 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Mitochondria" "Nucleoli fibrillar center" "HPA039046: AB_10673234" "unprognostic (4.97e-2)" "unprognostic (1.90e-3)" "unprognostic (2.96e-1)" "unprognostic (1.31e-3)" "unprognostic (1.80e-1)" "unprognostic (9.85e-2)" "unprognostic (1.75e-2)" "unprognostic (3.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.24e-2)" "unprognostic (4.53e-1)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (5.58e-2)" "prognostic favorable (5.42e-4)" 16.4 33.6 22.6 21.7 21.5 16.5 32.0 21.3 29.4 16.4 24.7 9.2 25.9 28.0 16.8 38.6 29.5 17.8 25.3 36.1 19.3 18.4 32.9 37.8 28.9 23.8 19.4 20.9 15.6 47.2 16.3 19.7 25.3 21.2 21.5 20.8 12.7 31.9 28.7 45.1 16.6 24.3 22.0 15.3 24.8 23.4 24.8 15.6 21.0 29.5 31.6 20.6 17.0 18.1 30.7 38.2 22.2 27.3 17.9 32.1 18.2 22.5 17.2 14.5 20.5 12.0 11.7 14.6 11.8 13.8 11.9 16.1 15.4 20.6 11.2 13.1 10.4 12.2 16.0 14.1 15.3 9.9 17.1 26.9 8.6 14.4 23.7 14.1 13.1 13.8 10.9 19.1 10.1 6.9 18.1 16.5 15.6 13.0 12.8 15.7 22.8 16.1 29.0 13.8 21.5 114.1 15.4 11.2 14.6 19.4 12.7 7.2 14.1 7.3 51.5 24.1 12.4 28.8 18.3 9.7 7.6 16.6 12.5 20.2 12.8 13.3 17.7 17.7 26.6 5.9 22.2 27.0 15.9 19.7 27.3 23.7 30.7 24.2 23.5 26.6 26.1 20.3 20.5 11.1 17.9 21.5 38.2 32.1 18.2 22.6 21.5 21.3 29.4 19.3 18.4 19.4 20.9 21.2 15.6 38.7 36.6 58.1 32.1 31.1 26.0 66.9 33.1 77.6 54.6 57.6 21.6 127.4 169.1 72.5 37.4 31.2 94.4 46.7 76.3 142.6 26.2 45.5 28.9 109.7 118.2 19.1 59.4 50.3 55.3 7.6 52.3 50.1 38.8 82.0 88.4 53.2 83.5 89.6 51.9 145.7 27.7 51.8 26.8 44.5 49.1 38.0 107.1 39.9 89.5 42.2 CHCHD10 "C22orf16, N27C7-4" ENSG00000250479 "Coiled-coil-helix-coiled-coil-helix domain containing 10" Q8WYQ3 22 23765834-23768443 "Disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 127.0;skeletal muscle: 226.6" "Cell type enhanced" "Detected in all" 8 "Distal tubular cells: 2117.1;Enterocytes: 1174.4;Hepatocytes: 1666.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003440 Enhanced Supported Mitochondria NA NA Mitochondria "HPA003440: AB_1078348" "unprognostic (3.88e-2)" "unprognostic (2.36e-3)" "unprognostic (8.90e-2)" "unprognostic (9.80e-2)" "unprognostic (7.68e-2)" "unprognostic (5.97e-3)" "unprognostic (1.59e-1)" "unprognostic (1.85e-1)" "unprognostic (2.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" "prognostic favorable (2.15e-7)" "unprognostic (5.19e-3)" "unprognostic (2.06e-1)" "unprognostic (5.68e-3)" "unprognostic (2.62e-3)" 23.1 14.9 25.8 16.4 33.9 5.7 20.0 11.8 31.0 17.3 39.4 9.6 18.3 30.6 6.1 15.5 20.2 7.6 11.3 127.0 23.7 23.5 40.4 86.1 8.3 16.9 25.8 18.4 4.8 24.3 36.4 12.7 11.7 14.5 11.7 31.6 24.3 33.7 22.2 226.6 7.2 30.2 12.8 12.2 13.0 17.3 4.1 9.6 3.0 27.8 73.1 15.8 13.8 9.3 9.4 7.3 7.6 7.8 0.8 5.0 1.0 5.8 16.0 4.9 20.7 10.9 6.9 8.0 2.1 5.6 5.9 6.8 29.8 8.0 18.0 5.5 10.1 3.2 18.9 27.0 8.5 5.3 5.8 29.4 4.6 12.6 28.1 18.5 13.3 21.4 13.4 22.5 8.9 2.4 1.2 7.1 3.9 8.2 11.6 5.2 29.7 4.1 8.4 3.6 47.6 40.5 15.6 0.8 41.5 27.6 13.3 8.7 4.6 2.8 35.5 27.2 9.7 12.7 10.4 3.1 0.2 0.1 3.6 0.0 4.5 2.0 12.4 4.8 11.1 2.6 0.2 3.9 7.6 2.8 7.8 1.9 9.4 3.2 4.0 1.7 7.8 5.0 3.6 0.1 0.8 6.9 7.3 3.7 1.0 25.8 33.9 11.8 31.0 23.7 23.5 25.8 18.4 14.5 9.6 11.9 8.0 277.6 303.6 42.7 134.9 422.5 295.5 4.0 11.4 397.8 108.0 25.5 2117.1 75.8 24.6 33.8 1174.4 46.7 46.5 229.6 58.5 151.0 86.1 1666.3 550.7 93.8 298.3 76.1 204.5 13.0 45.1 214.4 354.3 26.2 653.9 94.8 45.8 623.8 27.6 877.4 179.8 122.9 200.9 26.5 44.5 38.3 88.0 85.8 692.8 383.5 CHCHD3 "FLJ20420, Mic19, MINOS3, PPP1R22" ENSG00000106554 "Coiled-coil-helix-coiled-coil-helix domain containing 3" Q9NX63 7 132784868-133082088 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 109.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042935 Enhanced Supported Mitochondria NA NA 110000 Mitochondria "HPA042935: AB_10794538" "unprognostic (1.53e-1)" "unprognostic (2.50e-1)" "unprognostic (4.15e-2)" "unprognostic (3.00e-3)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.39e-2)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "prognostic favorable (1.15e-4)" "unprognostic (4.98e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-1)" "unprognostic (8.03e-2)" 15.2 15.8 9.9 13.4 11.6 15.4 13.7 10.1 14.2 10.5 17.3 9.8 7.9 19.9 13.2 9.7 10.5 9.7 10.4 42.6 9.5 8.9 23.2 17.9 11.7 10.6 10.4 8.0 11.6 9.8 13.9 17.0 10.7 10.9 10.5 18.3 11.5 10.6 11.1 109.1 9.0 20.5 13.9 9.7 12.2 13.9 6.4 10.8 19.7 14.6 30.1 13.2 12.9 13.6 19.0 28.2 15.4 29.9 21.2 19.9 15.3 23.4 24.1 24.5 33.8 17.7 16.3 14.5 23.0 21.9 26.3 29.2 28.3 26.1 19.5 9.2 14.6 58.5 16.5 28.3 19.8 37.2 25.5 26.8 20.1 24.9 16.4 35.2 45.1 15.0 14.7 13.7 36.0 37.7 13.2 18.3 25.8 42.8 17.9 24.3 30.9 65.6 39.6 40.2 37.9 27.9 32.7 35.9 27.9 25.6 19.5 31.3 39.1 19.1 15.1 43.5 17.5 12.6 27.1 15.1 25.2 10.8 39.4 41.2 17.3 22.1 49.2 39.7 38.7 35.3 14.9 21.8 15.4 16.1 29.9 15.3 19.0 14.7 15.5 28.2 11.7 13.0 14.5 3.1 21.2 24.1 24.6 19.9 15.3 9.9 11.6 10.1 14.2 9.5 8.9 10.4 8.0 10.9 10.8 23.8 19.2 25.3 26.1 31.0 23.1 116.2 40.8 29.4 28.4 14.0 21.6 64.7 106.1 46.3 76.6 29.3 40.2 0.0 53.2 67.5 37.3 25.3 33.5 19.2 67.5 14.3 34.4 16.0 24.0 74.9 29.1 38.1 35.4 59.5 46.7 22.9 42.8 21.0 33.2 67.4 23.8 32.3 50.9 12.7 24.7 35.3 57.2 35.5 71.7 35.4 CHCHD4 "FLJ31709, MIA40, TIMM40" ENSG00000163528 "Coiled-coil-helix-coiled-coil-helix domain containing 4" Q8N4Q1 3 14112077-14124870 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 71.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA034688, HPA063727" Uncertain Supported Mitochondria NA NA Mitochondria "HPA034688: AB_10696361, HPA063727: AB_2685103" "unprognostic (3.89e-3)" "unprognostic (8.82e-2)" "unprognostic (1.50e-2)" "unprognostic (7.34e-2)" "unprognostic (1.11e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-3)" "unprognostic (1.02e-1)" "unprognostic (1.82e-1)" "unprognostic (5.55e-2)" "unprognostic (3.59e-2)" "unprognostic (1.43e-1)" "prognostic favorable (8.63e-5)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (9.65e-2)" "unprognostic (7.85e-3)" 11.4 13.3 15.0 8.8 16.4 3.3 12.8 11.6 17.7 9.2 15.8 12.6 9.5 15.7 8.7 11.7 12.1 10.9 9.8 27.3 13.7 13.5 22.3 20.1 7.8 8.9 17.0 10.7 11.5 18.8 21.7 9.3 9.2 13.5 12.7 17.2 9.6 10.7 13.8 32.2 8.9 12.7 15.3 11.1 9.6 11.9 9.4 14.3 7.2 13.4 12.4 13.2 14.0 16.4 14.1 19.8 7.9 18.1 16.6 14.3 8.6 8.0 16.8 8.8 8.6 7.6 8.6 25.5 8.7 8.2 10.8 9.6 9.9 6.6 17.5 8.6 6.6 11.0 6.6 18.1 18.1 13.4 10.9 18.1 20.4 12.5 13.0 12.8 13.7 8.8 7.5 19.3 17.7 28.4 7.7 12.1 14.1 21.1 15.7 11.5 17.1 17.1 8.3 13.5 25.3 22.7 12.4 8.8 37.2 12.2 8.9 7.3 8.9 9.8 31.7 12.7 7.9 15.2 14.0 4.3 9.9 7.2 12.3 15.9 8.8 23.1 17.4 9.8 21.2 7.2 5.7 12.5 7.9 6.6 18.1 11.4 11.2 11.0 9.9 19.8 14.1 14.3 9.7 5.4 16.6 17.5 8.1 12.2 8.6 15.0 16.4 11.6 17.7 13.7 13.5 17.0 10.7 13.5 14.3 14.9 7.5 18.2 10.7 8.4 7.6 21.8 12.7 5.3 6.8 8.7 0.0 20.2 71.3 16.6 1.9 8.1 15.9 0.0 11.7 16.8 9.9 11.4 10.4 16.3 18.5 4.8 4.7 3.7 6.9 4.0 10.6 8.2 8.5 7.2 12.1 7.4 10.7 13.5 9.6 37.8 5.6 6.5 7.8 16.6 36.8 10.3 10.9 7.5 17.9 10.9 CHCHD6 "CHCM1, MGC13016, Mic25, PPP1R23" ENSG00000159685 "Coiled-coil-helix-coiled-coil-helix domain containing 6" Q9BRQ6 3 126704220-126960406 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 136.0;Melanocytes: 163.6" "Cancer enhanced" "Detected in all" "melanoma: 34.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047673, HPA051975" Approved Supported Mitochondria NA NA Mitochondria "HPA047673: AB_10961761, HPA051975: AB_2681679" "unprognostic (3.94e-2)" "prognostic favorable (7.46e-4)" "unprognostic (6.20e-2)" "unprognostic (1.91e-2)" "unprognostic (2.60e-1)" "unprognostic (1.16e-1)" "unprognostic (6.83e-3)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (6.79e-2)" "unprognostic (2.08e-1)" "prognostic favorable (6.76e-4)" "unprognostic (6.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.11e-3)" 5.5 13.8 23.2 5.8 20.8 3.8 8.7 8.9 27.0 7.4 5.3 8.7 4.9 4.1 6.7 5.6 7.2 14.6 5.6 11.6 31.1 17.0 7.5 6.1 8.3 3.7 15.3 18.8 14.5 15.1 6.7 7.7 4.4 11.4 7.0 3.4 7.6 14.2 8.9 4.0 8.1 4.6 5.8 9.9 4.8 7.4 34.0 7.6 3.3 12.3 5.9 4.3 5.0 7.4 10.5 6.3 1.8 3.5 6.3 11.1 4.3 18.9 11.1 9.8 23.8 3.5 5.4 5.6 7.3 5.0 8.6 8.4 15.2 8.3 8.3 17.1 4.3 9.4 11.1 7.3 20.1 4.2 2.3 20.0 6.8 8.1 14.8 10.4 14.9 4.6 5.4 12.3 4.1 8.8 7.0 5.6 15.0 6.2 5.0 7.5 14.2 21.7 14.9 11.8 10.8 12.6 11.7 15.0 20.0 7.5 8.3 18.1 11.2 7.5 12.9 23.4 5.0 7.5 5.6 5.0 9.7 12.1 13.0 7.5 6.4 3.0 10.3 10.9 4.9 9.0 0.0 2.3 1.8 6.9 3.5 8.7 7.8 9.8 8.1 6.3 10.5 9.5 11.1 0.0 6.3 3.3 4.4 8.9 4.3 23.2 20.8 8.9 25.6 31.1 17.0 15.3 18.8 11.4 7.6 17.9 8.4 6.5 16.7 26.3 12.6 12.6 5.1 37.5 21.6 14.0 17.7 27.5 49.7 22.8 69.0 6.8 2.6 0.0 21.3 9.3 13.9 13.7 13.9 5.9 136.0 19.1 7.5 6.2 6.6 82.1 14.7 9.4 163.6 3.6 9.1 14.0 15.3 7.0 20.8 22.3 13.5 0.0 18.8 64.1 46.7 26.3 12.9 5.3 12.0 17.3 CIAPIN1 Anamorsin ENSG00000005194 "Cytokine induced apoptosis inhibitor 1" Q6FI81 16 57428169-57447528 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 158.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041350, HPA042182" Enhanced Supported Mitochondria No No 6400 Mitochondria "HPA041350: AB_10796665, HPA042182: AB_10794646" "unprognostic (1.78e-2)" "unprognostic (9.62e-2)" "unprognostic (6.44e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.41e-3)" "unprognostic (8.15e-3)" "unprognostic (1.99e-1)" "unprognostic (2.48e-2)" "unprognostic (4.70e-3)" "unprognostic (1.62e-1)" "prognostic favorable (4.42e-4)" "unprognostic (5.61e-2)" "unprognostic (3.86e-2)" "unprognostic (8.90e-3)" "unprognostic (1.16e-1)" 13.5 21.0 12.8 12.6 19.1 11.5 12.2 18.3 29.3 10.6 19.3 14.8 8.7 14.5 11.9 10.7 18.9 10.8 15.9 23.9 12.8 16.5 20.7 19.7 13.1 14.1 15.6 17.6 10.5 17.2 18.9 11.9 21.8 21.0 11.7 17.3 14.2 15.0 11.3 35.3 17.5 15.0 14.2 10.6 14.4 13.7 44.0 10.7 19.2 15.8 18.0 20.9 13.1 12.1 22.7 32.4 17.3 27.5 27.5 48.8 45.5 16.0 24.0 25.8 19.9 14.8 10.2 22.3 18.9 16.0 32.8 15.4 26.9 13.1 17.3 27.3 14.2 10.5 31.0 34.5 25.2 28.4 10.0 21.1 22.2 21.0 28.2 24.3 26.9 23.1 16.1 27.8 23.6 30.2 12.9 31.9 21.8 31.0 10.6 18.8 15.9 26.6 21.6 35.0 18.6 35.3 49.7 31.1 36.1 21.9 18.3 22.7 28.5 40.4 28.9 18.2 21.9 21.1 23.6 20.4 14.5 18.8 14.5 21.0 28.5 36.1 57.8 17.5 25.8 22.7 13.9 27.5 17.3 26.9 25.7 24.8 22.7 22.7 28.3 32.4 22.3 48.8 43.0 6.7 27.5 20.8 27.7 24.3 45.5 12.8 19.1 18.3 29.3 12.8 16.5 15.6 17.6 21.0 10.7 14.9 22.4 13.4 13.2 12.7 27.8 33.0 22.9 12.0 17.0 21.0 9.8 78.3 33.2 50.4 14.5 20.3 15.4 0.0 45.2 38.8 14.3 13.0 10.4 15.7 34.7 22.3 17.9 19.6 10.5 25.4 13.0 17.7 23.6 57.7 17.2 26.1 42.5 24.6 19.4 28.0 14.6 38.8 12.2 158.4 51.5 13.9 88.8 14.6 23.8 13.2 CISD1 "C10orf70, MDS029, mitoNEET, ZCD1" ENSG00000122873 "CDGSH iron sulfur domain 1" Q9NZ45 10 58269058-58289586 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 63.1" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 606.8;Proximal tubular cells: 437.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074383 Supported Supported Mitochondria NA NA Mitochondria "HPA074383: AB_2686684" "prognostic unfavorable (1.11e-4)" "unprognostic (8.60e-3)" "unprognostic (1.07e-1)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.87e-2)" "unprognostic (2.35e-1)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "unprognostic (7.23e-2)" "unprognostic (1.34e-3)" "unprognostic (4.19e-2)" "unprognostic (7.20e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (6.69e-4)" 4.7 8.9 14.0 5.4 21.6 1.4 5.4 14.8 24.9 6.2 10.3 3.7 3.6 17.8 5.2 3.9 9.5 5.7 6.4 32.1 16.2 17.6 20.8 13.2 4.1 4.9 14.7 19.5 6.4 4.8 63.1 10.5 5.0 16.6 6.9 7.7 5.8 8.0 6.7 43.9 7.2 16.7 8.9 9.0 4.2 6.4 3.0 6.0 3.5 8.7 20.4 5.1 8.3 4.4 7.6 9.5 3.0 5.8 6.1 8.3 5.1 12.1 6.2 4.9 9.0 6.7 7.5 2.9 10.3 11.9 10.3 14.2 14.5 11.5 21.7 8.7 10.6 6.0 8.0 13.4 9.2 9.3 9.7 18.2 5.7 10.3 11.7 7.6 10.0 4.5 9.3 7.6 9.8 15.1 8.8 12.0 11.0 12.5 10.2 7.1 4.1 8.5 10.8 5.3 9.3 19.5 6.6 18.3 11.4 13.9 4.3 15.7 5.6 7.9 21.2 7.3 4.5 14.1 5.4 11.8 4.4 8.0 12.8 12.2 10.4 16.9 16.3 11.9 10.0 4.3 0.0 5.8 0.3 5.7 4.2 6.7 7.6 6.6 6.6 9.5 6.0 7.7 7.5 3.0 6.1 2.6 6.2 8.3 5.1 14.0 21.6 14.8 24.9 16.2 17.6 14.7 19.5 16.6 6.0 56.6 40.8 43.2 69.2 114.4 85.6 290.3 127.4 66.9 55.7 127.4 41.2 139.3 606.8 85.2 163.9 59.9 102.8 23.3 70.7 53.7 53.8 54.1 34.5 218.9 59.2 39.7 216.5 78.0 41.4 266.7 39.1 30.5 173.7 19.8 105.2 33.6 75.5 104.0 37.8 437.6 44.2 32.3 59.0 46.8 59.2 99.9 60.8 26.6 102.8 57.1 CLPP ENSG00000125656 "Caseinolytic mitochondrial matrix peptidase proteolytic subunit" Q16740 19 6361452-6368910 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010649 Supported Supported Mitochondria NA NA Mitochondria "HPA010649: AB_1078538" "unprognostic (2.28e-1)" "unprognostic (7.14e-2)" "unprognostic (2.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.17e-2)" "unprognostic (1.15e-2)" "unprognostic (6.17e-3)" "unprognostic (7.43e-2)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "prognostic favorable (6.50e-4)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (6.97e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.86e-3)" 22.1 27.3 18.4 22.5 18.8 20.1 19.9 16.6 20.9 16.1 23.2 17.9 22.2 25.4 16.9 15.1 26.6 15.3 19.2 28.9 17.4 16.7 28.5 64.7 15.5 35.5 19.0 15.2 23.7 32.7 11.6 18.5 18.4 13.6 19.1 14.1 18.6 26.3 23.4 73.1 17.8 26.0 14.8 16.7 21.2 21.3 21.1 11.4 54.8 27.0 25.1 25.3 20.7 23.2 29.7 37.5 14.9 20.0 27.6 46.3 32.9 31.6 21.1 15.4 28.1 9.7 13.5 16.0 18.8 13.8 26.8 24.1 16.9 11.6 31.9 29.3 15.0 15.3 19.8 15.3 23.7 10.2 33.1 47.9 23.5 18.6 25.0 26.3 21.2 31.1 17.1 17.4 18.6 20.8 18.4 26.0 42.3 23.3 43.3 17.5 37.0 36.3 22.2 22.2 24.5 49.5 25.6 18.6 48.4 19.9 17.7 25.5 24.5 11.9 29.2 27.6 10.0 15.0 30.4 18.2 17.8 16.5 41.6 35.4 55.6 46.4 30.7 24.3 30.0 28.2 5.5 20.0 10.5 28.0 17.7 33.2 28.3 39.9 34.5 24.1 29.7 35.2 34.1 14.9 27.6 12.1 37.5 46.3 32.9 18.4 18.8 16.6 20.9 17.4 16.7 19.0 15.2 13.6 11.4 20.8 35.7 37.2 49.7 40.0 30.7 40.3 58.6 36.1 17.0 41.8 11.8 60.5 122.7 78.4 82.6 46.3 64.7 23.3 84.4 102.0 37.0 67.2 25.4 81.5 71.6 20.6 33.9 49.1 31.4 188.9 39.4 35.5 52.3 93.8 43.9 34.4 88.0 56.1 40.7 126.3 20.5 12.9 36.0 68.8 45.8 32.4 48.3 53.2 60.6 56.1 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit" O76031 15 65148219-65185342 "Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.9" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 189.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: AB_2680312" "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favorable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 10.4 12.8 11.3 8.9 12.7 7.7 10.2 10.9 10.7 11.7 13.4 11.2 4.7 9.3 9.8 10.3 15.5 8.9 9.6 15.9 10.7 9.2 16.8 50.9 9.4 8.8 12.8 8.1 10.8 10.6 11.0 6.3 10.6 9.8 9.7 8.9 7.4 8.9 7.1 25.8 15.6 12.6 10.8 9.7 9.7 9.9 9.3 12.6 17.8 12.9 14.7 10.2 12.5 9.5 7.7 9.8 11.4 7.1 8.2 9.2 4.4 5.3 9.1 8.0 10.1 8.5 11.0 8.6 6.1 6.9 6.8 7.1 9.1 7.5 16.6 5.2 8.2 5.0 11.5 29.3 8.1 7.3 6.5 5.3 12.5 8.9 11.5 12.2 15.9 7.3 13.1 11.2 6.2 11.9 7.8 8.6 9.0 11.4 5.9 7.9 6.8 7.5 14.1 9.0 10.6 4.1 14.8 9.5 17.1 12.7 12.4 7.0 5.7 8.3 13.3 9.0 11.0 6.1 13.5 7.5 6.9 6.0 5.5 5.7 6.3 9.6 8.7 6.7 20.2 5.3 3.5 7.1 10.3 7.6 5.7 7.0 7.7 6.7 5.6 6.4 7.2 9.2 7.3 11.4 8.2 5.1 9.8 5.7 4.4 11.3 12.7 10.9 10.7 10.7 9.2 12.8 8.1 9.8 12.6 32.8 28.6 14.9 17.9 17.1 27.3 62.7 28.1 33.5 33.0 31.4 13.7 35.1 18.3 32.5 87.1 17.9 15.6 0.0 27.4 27.2 19.7 20.0 15.1 79.9 19.8 30.2 9.9 22.1 23.9 189.0 26.7 16.0 16.9 26.2 22.4 24.3 27.3 17.5 28.0 28.4 24.1 25.8 16.0 33.9 29.6 26.3 74.6 19.1 23.3 18.4 CMC2 "C16orf61, DC13, MGC45036" ENSG00000103121 "C-X9-C motif containing 2" Q9NRP2 16 80966448-81020270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 265.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006871, CAB026396" Approved Supported Mitochondria NA NA Mitochondria "CAB026396: , HPA006871: AB_1845581" "unprognostic (2.43e-1)" "unprognostic (3.63e-2)" "unprognostic (1.70e-1)" "unprognostic (3.52e-2)" "unprognostic (1.50e-1)" "unprognostic (3.01e-3)" "unprognostic (2.48e-2)" "unprognostic (6.36e-2)" "unprognostic (9.20e-2)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (4.57e-3)" "prognostic favorable (2.64e-5)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (2.68e-1)" 8.2 17.0 31.5 8.9 30.9 25.5 15.0 18.7 28.7 7.2 11.8 22.2 8.7 12.8 6.4 11.9 12.5 5.5 11.5 42.3 28.3 27.9 24.7 29.1 9.5 13.3 30.7 16.0 5.7 19.7 19.2 11.1 11.0 23.9 15.2 11.8 7.0 10.3 9.3 32.0 6.2 13.5 10.6 27.8 9.5 13.5 28.1 20.3 9.8 10.3 13.0 11.0 11.8 7.0 21.9 25.3 20.1 17.9 24.7 34.6 10.3 22.1 31.7 23.8 14.2 7.9 8.0 14.0 22.6 10.3 20.1 10.4 21.6 15.3 10.3 16.9 10.8 19.8 16.0 16.1 13.1 26.8 15.1 19.4 15.7 22.6 23.1 13.1 12.8 26.8 7.0 7.4 24.3 13.7 9.2 17.8 25.4 37.0 13.8 19.5 42.4 20.0 41.6 14.0 18.0 19.1 25.2 12.9 13.1 15.6 11.2 20.0 11.6 34.3 12.2 25.8 12.9 24.3 11.9 10.2 18.3 25.7 17.6 22.6 14.2 30.9 57.1 14.0 16.6 21.3 14.9 16.6 20.1 17.4 16.0 16.3 21.9 22.1 17.9 17.8 18.9 15.7 17.8 7.1 24.7 17.9 25.3 34.6 10.3 31.5 30.9 18.7 28.7 28.3 27.9 30.7 16.0 23.9 20.3 32.8 44.6 52.4 56.6 86.7 30.0 177.4 35.7 33.5 28.4 45.4 51.1 35.1 134.3 31.7 74.7 35.1 25.7 46.7 32.9 52.1 47.6 68.0 91.4 80.0 46.5 28.6 36.8 28.3 51.5 128.4 22.7 64.0 62.4 25.2 36.6 25.0 35.2 31.6 27.6 119.0 15.4 58.2 55.6 265.1 102.6 89.3 31.8 58.9 37.9 64.1 CMC4 "MTCP1, MTCP1NB, p8, P8MTCP1" ENSG00000182712 "C-X9-C motif containing 4" P56277 X 155061622-155071362 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 8.1;Club cells: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 36.5" "Low region specificity" "Detected in all" HPA045866 Approved Supported Mitochondria NA NA Mitochondria "HPA045866: AB_10964642" "unprognostic (4.54e-3)" "unprognostic (7.31e-2)" 11.5 9.2 13.4 9.2 12.6 6.2 26.7 7.1 8.9 11.0 11.3 6.7 13.2 9.7 9.9 13.6 12.5 8.9 8.3 49.6 10.9 10.0 12.0 21.8 15.0 26.2 13.7 5.7 11.9 34.6 7.1 11.4 6.8 11.6 10.5 6.0 7.6 14.5 12.6 21.2 8.2 11.4 15.2 15.8 8.3 8.5 7.3 7.4 5.4 14.5 10.0 7.7 12.4 8.7 11.3 10.8 11.8 7.5 12.0 9.0 4.6 19.9 5.1 3.0 6.7 8.5 8.2 4.7 4.0 5.7 5.7 9.7 3.8 3.8 13.7 10.5 4.4 16.0 6.6 4.0 5.2 4.0 14.5 10.3 2.3 3.5 4.5 8.7 4.2 3.1 7.8 8.6 5.9 7.6 5.3 4.7 8.3 2.3 5.0 5.9 7.5 5.7 8.0 1.8 7.9 14.5 4.4 7.1 8.9 6.4 1.2 6.2 5.1 5.3 5.9 6.8 3.9 4.4 2.5 5.6 8.7 5.4 5.6 5.3 20.6 20.6 36.5 8.2 9.9 5.7 1.1 7.5 11.8 9.0 4.2 8.7 11.0 7.1 8.3 10.8 11.3 2.2 5.9 0.8 12.0 1.5 2.1 8.2 4.6 13.4 12.6 7.1 8.9 10.9 10.0 13.7 5.7 11.6 7.4 0.0 2.6 0.0 0.9 0.7 1.0 0.0 2.5 8.1 10.3 0.0 0.0 0.9 3.3 0.8 0.0 0.0 1.1 0.0 0.4 0.8 1.5 0.4 4.7 3.6 0.9 0.0 1.7 2.5 1.0 1.3 3.4 1.2 1.7 1.0 0.9 1.8 0.9 0.3 1.8 2.8 0.3 0.0 0.3 1.5 0.4 2.0 1.0 2.5 1.7 0.6 CMPK2 "NDK, TYKi, UMP-CMPK2" ENSG00000134326 "Cytidine/uridine monophosphate kinase 2" Q5EBM0 2 6840570-6866635 "Enzymes, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.9;HEL: 20.1;MOLT-4: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041430 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA041430: AB_10796674" "unprognostic (2.37e-1)" "unprognostic (6.07e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.82e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-2)" "unprognostic (8.93e-2)" "unprognostic (6.63e-2)" "unprognostic (4.54e-3)" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (1.09e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (7.69e-2)" "unprognostic (4.32e-2)" 8.8 3.8 3.0 6.8 8.1 14.5 4.2 0.9 5.0 2.7 4.2 4.0 1.3 5.0 2.5 6.4 1.8 2.3 3.4 3.7 3.3 3.9 4.0 3.1 17.9 13.4 3.2 5.7 1.3 3.7 2.9 3.0 4.7 3.6 2.1 2.2 4.7 20.8 4.3 3.0 1.2 6.1 3.1 3.8 7.9 7.4 9.2 0.4 8.8 3.1 1.6 2.6 2.7 1.6 1.4 1.9 7.8 6.4 0.9 0.7 1.2 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.2 14.2 12.9 0.0 1.4 3.1 0.8 0.0 3.7 0.2 0.0 0.0 0.0 0.3 0.2 20.1 0.0 0.0 0.0 0.7 1.4 0.0 0.0 0.1 0.0 0.0 0.0 2.0 4.9 0.1 0.0 0.1 11.0 3.7 0.3 0.0 1.1 3.5 0.0 0.0 0.0 0.4 0.3 0.5 0.2 0.0 1.7 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 3.3 0.4 0.0 0.0 3.7 0.9 5.5 2.8 7.8 0.7 6.4 0.4 1.4 0.5 0.4 1.9 0.2 0.5 0.5 1.8 0.9 3.2 0.1 0.6 1.2 3.0 8.1 0.9 5.0 3.3 3.9 3.2 5.7 3.6 0.4 3.0 6.9 2.7 0.8 0.3 1.6 1.4 0.0 4.0 0.0 1.8 0.0 2.0 1.7 2.4 2.5 4.7 5.3 70.0 5.8 2.4 1.9 0.7 2.3 1.3 15.9 0.0 6.9 7.4 6.7 1.1 1.4 5.1 0.0 5.4 1.7 4.6 4.1 1.9 5.3 0.6 0.2 0.0 2.0 0.1 4.1 0.4 0.7 4.3 0.9 1.6 COA1 "C7orf44, FLJ10803, MITRAC15" ENSG00000106603 "Cytochrome c oxidase assembly factor 1 homolog" Q9GZY4 7 43608456-43729717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA011944 Approved Supported Mitochondria NA NA Mitochondria "HPA011944: AB_1848671" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (2.22e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.21e-1)" "unprognostic (4.42e-2)" "unprognostic (2.22e-2)" "unprognostic (5.22e-2)" "unprognostic (6.74e-2)" "unprognostic (1.52e-1)" "unprognostic (3.52e-1)" "unprognostic (1.02e-2)" "unprognostic (2.56e-2)" "unprognostic (5.39e-2)" 13.8 16.2 22.4 14.4 21.7 17.6 14.5 13.8 24.0 11.8 10.9 14.4 17.4 11.4 14.8 14.3 15.1 9.6 10.9 47.8 19.7 18.5 23.4 14.4 11.9 24.2 23.0 13.2 11.1 23.9 9.4 22.1 11.3 17.4 10.9 14.7 17.9 17.5 17.7 55.5 7.0 12.6 9.7 19.9 16.2 14.5 11.8 14.3 16.2 15.8 22.4 28.3 14.8 8.8 21.0 17.9 24.2 17.2 18.6 21.0 14.4 10.5 28.5 23.6 23.2 6.9 7.8 15.8 14.8 25.4 20.2 21.0 21.7 24.2 20.1 25.1 9.0 42.6 15.4 27.2 22.8 25.6 18.0 25.0 25.0 16.8 19.9 11.4 19.4 11.1 6.4 14.6 14.6 21.8 21.7 18.3 24.4 42.3 17.5 16.4 14.4 28.5 48.8 14.8 22.1 20.6 17.3 21.6 37.1 24.6 11.9 14.5 26.0 14.9 27.7 9.6 35.6 20.7 13.1 13.6 10.0 21.9 9.8 20.9 42.2 34.1 36.1 28.5 25.0 26.6 1.3 15.3 16.0 12.9 17.2 9.5 19.7 12.0 13.2 17.9 21.0 16.9 21.0 24.2 18.6 14.6 16.0 11.5 14.4 22.4 21.7 13.8 24.0 19.7 18.5 23.0 13.2 17.4 14.3 26.8 35.0 59.1 58.9 11.6 42.6 55.7 17.8 29.4 23.9 33.2 43.2 28.3 99.5 49.1 4.8 25.8 16.9 46.7 37.1 43.0 26.0 44.0 25.4 19.2 50.1 31.8 26.6 18.4 33.8 6.6 27.3 34.8 35.4 48.7 20.9 22.3 38.8 10.5 18.4 100.4 53.4 12.9 22.7 54.2 85.2 14.6 15.0 52.2 24.9 37.6 COA5 "C2orf64, FLJ27524, MGC52110, Pet191" ENSG00000183513 "Cytochrome c oxidase assembly factor 5" Q86WW8 2 98599310-98608515 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 152.5;Proximal tubular cells: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057768 Uncertain Supported Mitochondria No No Mitochondria "HPA057768: AB_2683521" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (1.67e-3)" "unprognostic (2.61e-2)" "unprognostic (7.11e-2)" "unprognostic (4.69e-2)" "prognostic favorable (2.65e-4)" "unprognostic (1.32e-3)" "unprognostic (3.71e-3)" "unprognostic (8.00e-3)" "unprognostic (3.08e-2)" "unprognostic (1.40e-1)" "unprognostic (1.29e-1)" "unprognostic (4.93e-2)" "unprognostic (2.50e-1)" "prognostic favorable (1.00e-5)" 13.7 21.4 30.9 12.2 29.3 9.1 20.6 31.3 28.2 18.6 15.0 20.3 18.5 15.4 20.2 33.5 11.1 20.5 13.4 19.3 28.3 26.5 28.1 23.4 13.9 15.8 30.7 29.0 23.6 16.8 21.0 19.1 14.2 23.4 19.8 15.9 13.7 16.2 20.3 30.7 18.0 13.5 14.7 32.7 15.6 16.0 15.6 21.5 15.3 24.5 10.1 16.1 13.9 15.0 24.7 30.3 28.1 25.5 18.1 30.0 22.0 12.6 5.4 16.8 12.2 19.7 16.4 14.0 7.3 5.8 7.9 8.4 10.9 10.9 6.4 13.4 5.8 14.9 9.0 14.6 7.8 9.7 16.7 13.6 8.9 11.0 17.8 14.4 8.5 8.3 15.8 16.8 5.6 7.3 14.0 8.6 18.1 12.6 7.5 8.7 10.6 11.3 15.1 11.6 13.0 11.9 6.9 12.5 14.1 17.4 6.9 12.8 16.2 6.2 7.8 18.4 20.1 9.6 17.9 7.5 12.2 11.0 7.2 6.0 12.4 17.3 8.1 14.7 18.9 9.9 18.2 25.5 28.0 25.2 22.7 21.9 23.5 23.0 24.1 24.1 24.7 28.1 27.9 28.1 18.1 23.7 30.3 30.0 22.0 30.9 29.3 31.3 25.9 28.3 26.5 30.7 29.0 23.4 21.5 14.9 23.7 29.0 25.9 9.3 26.2 56.8 43.3 42.8 15.9 45.4 5.9 31.9 152.5 31.4 11.8 26.0 22.5 0.0 21.6 31.2 23.0 26.9 26.5 53.8 45.3 20.6 25.9 27.0 33.2 9.0 30.2 29.1 27.0 31.5 39.0 31.3 29.2 21.0 32.9 133.1 22.2 12.9 25.2 75.6 33.2 10.2 27.3 20.8 36.0 29.5 COA6 C1orf31 ENSG00000168275 "Cytochrome c oxidase assembly factor 6" Q5JTJ3 1 234373456-234384049 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028588 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA028588: AB_10601123" "unprognostic (6.26e-2)" "unprognostic (1.92e-1)" "unprognostic (3.05e-1)" "unprognostic (1.01e-1)" "unprognostic (7.87e-2)" "unprognostic (1.20e-3)" "unprognostic (4.04e-3)" "unprognostic (4.89e-2)" "unprognostic (2.79e-2)" "unprognostic (6.25e-3)" "unprognostic (9.24e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (2.19e-1)" "prognostic favorable (7.12e-4)" 11.0 17.8 26.4 14.4 33.9 9.4 16.6 14.3 27.5 9.7 17.7 5.7 12.9 26.4 8.4 20.3 15.5 9.4 14.2 19.1 19.3 15.7 21.4 21.4 13.6 16.2 16.3 16.1 9.1 16.7 7.6 9.5 8.7 13.4 13.3 15.6 6.0 13.6 11.6 52.7 8.7 19.7 10.6 11.4 12.5 14.4 5.8 13.3 13.1 13.6 20.2 12.0 11.6 14.6 27.5 33.3 19.7 31.3 18.3 36.6 20.2 17.8 22.9 8.3 9.4 8.7 17.3 26.4 13.1 8.0 13.8 13.0 17.6 23.9 17.8 24.4 7.5 25.9 22.8 12.9 16.2 11.0 22.1 55.1 8.0 26.0 46.6 33.6 19.6 15.6 11.4 21.8 18.1 14.0 12.1 17.0 19.8 38.8 16.1 14.9 9.5 18.6 38.1 20.4 40.3 10.9 11.1 10.0 35.0 17.2 16.9 14.8 10.8 12.7 22.6 40.4 5.5 20.0 33.9 12.8 16.4 13.6 21.9 39.2 19.2 37.2 21.8 12.5 31.2 29.2 19.7 31.3 9.7 18.5 28.5 18.2 27.5 29.9 23.0 33.3 18.0 31.3 23.1 8.1 18.3 23.8 22.5 36.6 20.2 26.4 33.9 14.3 27.5 19.3 15.7 16.3 16.1 13.4 13.3 8.9 20.0 38.5 39.3 50.8 13.8 71.2 22.9 53.5 26.1 45.4 3.9 44.1 87.9 47.5 2.9 23.3 63.5 23.3 59.9 71.2 34.2 56.7 21.9 46.9 75.0 11.1 21.4 22.1 35.3 3.4 24.2 49.2 28.7 43.3 52.3 20.6 56.3 40.3 26.5 86.4 13.3 19.4 24.5 17.2 25.3 51.3 36.5 30.0 65.5 64.8 COQ4 CGI-92 ENSG00000167113 "Coenzyme Q4" Q9Y3A0 9 128322536-128334072 "Disease related genes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021406, HPA042945" Supported Supported Mitochondria NA NA Mitochondria "HPA021406: AB_2670691, HPA042945: AB_10961047" "unprognostic (9.15e-2)" "prognostic favorable (2.97e-5)" "unprognostic (2.29e-1)" "prognostic favorable (4.93e-6)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (2.11e-1)" "unprognostic (1.31e-3)" "unprognostic (2.89e-2)" "prognostic favorable (5.76e-6)" "unprognostic (6.21e-3)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.14e-3)" 15.5 29.4 22.6 21.4 29.9 12.2 25.4 20.7 33.8 19.8 23.0 15.7 34.8 53.8 14.8 30.5 32.8 37.7 24.0 23.9 22.6 21.7 31.8 33.4 28.9 28.6 18.9 31.4 18.1 43.8 24.7 30.7 13.1 27.7 22.2 18.0 15.2 32.9 50.7 29.6 31.6 37.3 20.1 25.7 15.9 23.1 17.5 14.3 13.6 34.5 25.0 16.7 18.5 17.9 18.3 28.2 8.0 15.5 14.1 21.1 13.2 11.1 16.8 10.2 11.1 7.5 10.6 18.4 9.8 6.4 12.9 9.2 14.3 14.0 15.0 8.8 7.5 9.4 31.9 8.7 11.7 4.8 7.2 17.3 5.5 36.3 16.0 12.3 15.6 8.4 12.3 13.7 10.7 11.7 7.5 10.1 12.8 36.4 10.2 8.1 30.9 19.0 12.0 11.3 22.6 19.8 18.6 14.1 28.5 15.8 11.0 19.0 13.6 19.2 22.9 11.9 4.8 29.5 5.3 13.9 12.3 11.5 17.8 13.1 17.5 14.4 12.3 15.6 7.6 8.5 7.8 14.2 8.0 21.1 15.5 19.1 18.3 19.2 20.9 17.7 16.0 15.5 18.9 1.8 14.1 15.2 28.2 15.2 13.2 22.6 29.9 20.7 33.8 22.6 21.7 18.9 31.4 27.7 14.3 20.8 25.3 41.0 43.1 25.5 29.2 33.9 33.1 141.8 30.7 54.1 25.5 75.4 121.0 46.8 11.0 23.3 99.8 23.3 55.3 39.9 29.9 34.1 36.8 66.0 44.1 28.6 30.5 26.4 24.0 19.1 27.9 22.1 38.8 27.1 55.4 23.8 40.3 56.2 29.0 133.2 46.9 25.8 26.7 41.4 31.6 43.7 39.5 30.2 71.7 40.9 COQ5 MGC4767 ENSG00000110871 "Coenzyme Q5, methyltransferase" Q5HYK3 12 120503274-120534434 "Enzymes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049487 Approved Uncertain Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "HPA049487: AB_2680789" "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-1)" "unprognostic (6.30e-3)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (1.60e-1)" "unprognostic (2.01e-2)" "unprognostic (6.20e-2)" "unprognostic (1.62e-1)" "unprognostic (8.37e-2)" "unprognostic (3.79e-2)" "unprognostic (2.02e-1)" "unprognostic (7.73e-2)" "unprognostic (2.00e-2)" "unprognostic (3.88e-2)" 14.6 21.7 15.8 16.1 16.7 7.0 29.5 15.6 21.3 12.5 16.4 13.5 21.8 15.7 12.6 16.4 14.0 15.5 13.5 31.9 14.8 13.1 26.0 39.8 17.6 19.1 17.5 15.4 15.1 28.6 14.2 13.4 18.6 19.4 12.7 17.1 11.6 17.9 17.8 58.4 11.1 13.2 14.0 18.5 14.6 12.4 16.9 15.0 17.2 17.7 30.4 15.2 10.1 17.0 21.3 27.4 9.7 19.6 25.1 28.2 22.4 15.9 25.6 23.1 6.6 30.5 23.5 15.9 19.5 12.8 20.0 12.7 10.2 13.5 16.1 23.1 20.4 14.2 17.3 20.5 21.7 20.6 20.1 12.1 21.4 15.7 16.9 24.9 23.3 13.5 22.5 23.5 18.6 22.0 31.3 17.5 31.1 21.0 11.8 23.1 20.9 13.4 26.8 20.3 11.5 19.9 25.0 23.4 23.3 25.7 12.2 17.5 14.1 14.1 7.2 26.5 25.2 36.3 19.3 17.5 13.9 15.9 10.2 12.9 25.5 21.5 18.3 15.8 22.2 16.6 9.4 19.6 9.7 18.8 19.2 18.2 21.1 20.4 19.9 27.4 21.3 28.2 22.3 2.1 25.1 17.9 18.0 24.4 22.4 15.8 16.7 15.6 21.3 14.8 13.1 17.5 15.4 19.4 15.0 11.9 10.9 16.3 10.7 6.9 11.5 26.2 15.3 16.0 7.9 14.0 13.7 60.9 39.7 25.5 42.0 11.7 17.2 23.3 17.3 38.3 14.1 8.4 17.3 37.2 40.3 4.8 14.5 16.0 15.6 14.5 15.3 13.1 21.9 36.1 14.6 11.8 12.3 23.2 17.7 52.6 14.4 6.5 10.3 13.7 15.4 7.9 48.7 17.5 29.2 7.5 COQ8A "ADCK3, CABC1, COQ8, SCAR9" ENSG00000163050 "Coenzyme Q8A" Q8NI60 1 226897536-226987545 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Kinase, Transferase" "Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 216.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 18.7;Collecting duct cells: 31.4;Exocrine glandular cells: 28.2;monocytes: 19.8;Proximal tubular cells: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 32.8;RPMI-8226: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061662 Supported Mitochondria NA NA Mitochondria "HPA061662: AB_2684578" "unprognostic (6.37e-3)" "unprognostic (2.09e-2)" "unprognostic (2.29e-1)" "unprognostic (9.06e-2)" "unprognostic (8.94e-2)" "unprognostic (2.49e-1)" "unprognostic (4.42e-2)" "unprognostic (3.50e-3)" "unprognostic (1.81e-1)" "unprognostic (4.02e-1)" "unprognostic (4.15e-3)" "unprognostic (8.67e-2)" "unprognostic (2.40e-2)" "unprognostic (9.24e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (2.62e-1)" 13.3 25.4 2.8 2.7 4.5 5.3 8.5 14.5 3.9 3.2 7.3 4.1 4.2 6.9 3.6 5.5 7.3 5.0 6.1 41.0 2.7 1.8 3.8 17.7 2.7 4.1 5.0 2.4 7.2 20.3 1.6 1.6 2.0 3.8 6.5 2.0 1.9 7.2 5.0 216.5 4.4 4.4 7.8 2.9 3.5 8.8 3.0 4.7 2.7 4.6 50.2 5.8 10.2 3.5 15.2 9.3 32.3 11.5 9.9 11.8 11.6 3.1 5.8 1.5 4.4 4.7 3.0 23.4 1.5 1.3 2.1 2.8 9.1 5.1 9.4 7.2 1.0 1.2 3.7 2.9 3.3 0.5 9.9 32.8 6.6 4.8 15.0 1.0 9.9 4.0 5.9 5.0 1.7 2.3 2.1 1.0 9.7 11.3 7.8 0.3 4.3 5.7 14.6 6.4 24.3 11.9 5.7 7.0 29.9 0.7 2.4 24.1 9.9 2.9 11.7 8.5 1.7 6.2 13.5 1.2 2.5 2.3 3.4 5.4 17.5 15.3 4.9 2.3 11.3 2.4 19.7 11.5 32.3 8.7 8.6 8.3 12.1 8.5 7.7 9.3 15.2 11.8 9.0 21.9 9.9 6.5 4.1 10.6 11.6 2.8 4.5 14.5 3.9 2.7 1.8 5.0 2.4 3.8 4.7 3.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 7.9 31.4 0.0 10.4 13.3 14.2 0.0 0.0 0.0 0.0 28.2 7.8 0.0 0.0 12.8 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 19.8 0.0 0.0 14.5 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 CORO7-PAM16 ENSG00000103426 "CORO7-PAM16 readthrough" 16 4340251-4420494 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Ciliated cells: 1.4;Club cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;HDLM-2: 2.4;THP-1: 1.9;TIME: 1.5" "HPA041657, HPA053586, HPA062721" Uncertain Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849" "unprognostic (2.95e-2)" "unprognostic (2.46e-1)" "unprognostic (1.44e-1)" "unprognostic (2.46e-1)" "unprognostic (2.11e-1)" "unprognostic (1.24e-2)" "unprognostic (2.11e-4)" "unprognostic (4.39e-2)" "unprognostic (9.83e-3)" "unprognostic (1.20e-1)" "unprognostic (8.75e-3)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.59e-2)" "unprognostic (2.19e-1)" "unprognostic (3.85e-1)" 2.4 3.4 5.4 5.2 7.4 6.7 2.0 3.0 6.0 2.0 2.5 10.0 0.6 3.2 2.2 2.4 2.2 2.9 3.1 2.2 4.8 4.1 2.0 2.9 3.4 11.2 10.9 3.2 2.0 2.0 2.0 1.7 2.4 4.1 2.2 2.0 1.1 2.0 3.0 2.4 3.1 2.5 2.2 10.1 4.5 2.5 4.3 9.9 4.7 2.0 1.2 4.1 2.8 1.8 0.4 0.6 2.7 1.3 0.5 0.8 1.3 0.0 0.0 0.0 0.4 0.0 0.3 0.8 0.2 0.4 0.0 0.0 1.7 0.3 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.7 0.0 0.5 0.0 0.2 1.4 0.2 0.7 0.7 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.2 0.0 1.9 1.5 0.0 0.0 0.6 0.1 0.6 1.2 0.1 0.0 0.1 0.0 0.0 1.3 0.9 0.8 0.7 0.7 0.3 0.4 0.3 0.6 0.4 0.3 0.3 2.7 0.5 0.4 0.3 0.3 1.3 5.4 7.4 3.0 6.0 4.8 4.1 10.9 3.2 4.1 9.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 89.2;Late spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.32e-6)" "prognostic favorable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 7.3 14.1 5.9 8.4 5.9 5.4 13.3 8.9 6.2 16.3 11.3 12.3 5.4 17.3 7.1 9.0 5.6 14.1 11.9 11.5 13.1 9.3 12.0 10.3 11.3 13.6 10.3 10.6 9.7 7.7 14.5 10.2 13.0 6.5 8.6 12.3 13.9 5.9 7.2 9.1 9.0 7.0 8.9 27.6 7.3 7.6 19.9 12.2 10.2 13.8 4.4 7.4 9.2 12.3 11.0 29.1 6.9 6.0 7.0 7.1 6.0 7.2 11.2 7.2 10.1 7.8 10.7 11.0 8.8 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 0.0 14.3 5.2 7.2 8.7 8.0 89.2 7.6 5.3 4.5 10.4 9.8 16.5 34.9 8.0 33.1 4.9 19.0 0.0 7.5 14.8 5.1 7.4 4.7 8.9 9.4 0.0 12.1 4.9 3.8 61.2 2.0 5.4 5.0 4.6 14.2 2.8 8.6 11.0 6.3 11.4 11.6 0.0 5.1 14.6 15.9 9.2 13.5 5.3 15.1 11.8 COX14 "C12orf62, MGC14288" ENSG00000178449 "COX14, cytochrome c oxidase assembly factor" Q96I36 12 50111979-50120457 "Disease related genes, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Proximal tubular cells: 571.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044618, HPA062014" Approved Supported Mitochondria NA NA Mitochondria "HPA044618: AB_10960419, HPA062014: AB_2684657" "unprognostic (5.71e-2)" "unprognostic (1.86e-2)" "unprognostic (1.43e-1)" "unprognostic (4.04e-1)" "unprognostic (1.87e-2)" "unprognostic (3.66e-2)" "unprognostic (2.20e-2)" "unprognostic (4.20e-3)" "prognostic unfavorable (7.90e-4)" "unprognostic (7.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.09e-3)" "unprognostic (3.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-3)" 33.1 30.2 25.9 16.7 33.7 17.5 27.8 46.4 28.9 18.5 24.0 16.7 29.7 28.1 13.9 34.0 17.6 17.1 22.1 60.1 23.4 24.9 39.5 40.4 18.2 18.6 29.6 28.7 16.6 19.6 19.5 26.1 15.0 27.8 18.5 22.0 25.1 26.4 30.5 75.4 13.1 27.1 20.5 24.8 19.0 20.9 8.4 26.6 8.7 25.4 38.5 16.7 19.3 21.8 56.8 65.7 56.4 52.2 38.7 58.6 52.5 16.7 32.2 7.1 16.2 31.7 19.4 14.3 12.9 16.7 19.1 16.5 30.7 21.8 15.8 37.3 15.7 17.1 16.3 12.1 18.3 16.5 17.3 45.4 31.0 28.6 24.7 13.2 24.2 27.6 24.5 25.3 14.3 16.6 19.8 17.4 16.8 15.0 30.8 19.4 36.7 19.5 34.4 11.7 23.7 43.4 16.1 12.5 36.2 27.6 27.9 19.0 11.4 19.8 35.8 37.6 15.2 23.8 20.5 15.2 11.9 12.9 19.3 11.3 22.6 32.2 19.2 17.3 21.0 6.4 56.4 52.2 46.0 43.2 48.9 45.4 56.8 54.5 47.6 49.5 47.1 52.0 50.9 18.8 38.7 44.3 65.7 58.6 52.5 25.9 33.7 46.4 28.9 23.4 24.9 29.6 28.7 27.8 26.6 56.6 95.2 111.2 77.0 110.9 65.4 464.4 165.6 93.7 63.7 211.1 21.6 164.5 479.1 104.3 5.5 95.2 364.2 46.7 148.2 95.7 85.9 119.9 65.6 322.2 191.9 44.5 149.9 73.6 123.3 17.9 119.7 114.8 141.7 202.0 184.1 64.2 118.9 228.0 102.9 571.4 49.0 103.5 154.3 38.4 50.3 139.3 106.6 109.0 191.6 86.0 COX15 CEMCOX2 ENSG00000014919 "COX15, cytochrome c oxidase assembly homolog" Q7KZN9 10 99711844-99732100 "Disease related genes, Predicted membrane proteins" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037727, HPA037728, HPA066096" Uncertain Supported Mitochondria NA NA Mitochondria "HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: AB_2685616" "unprognostic (9.74e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (6.55e-3)" "unprognostic (1.50e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.96e-1)" "unprognostic (6.84e-2)" "unprognostic (1.76e-1)" "unprognostic (3.40e-2)" "unprognostic (8.34e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-2)" "unprognostic (3.40e-2)" 14.0 31.6 15.5 13.5 23.8 7.8 15.3 15.2 25.6 13.8 17.9 23.0 14.2 15.5 18.2 15.5 17.3 16.4 16.8 19.3 14.4 15.5 25.3 27.1 11.0 15.4 15.2 16.2 20.7 15.3 17.0 26.7 17.1 22.7 15.9 20.1 21.9 13.5 14.0 28.8 14.4 14.1 16.0 14.6 17.0 15.1 14.2 14.0 21.0 18.9 12.0 23.0 19.4 13.6 17.4 18.0 21.7 23.1 11.7 13.0 12.9 14.6 31.6 13.4 29.3 19.4 15.1 11.0 11.2 14.4 17.0 16.1 23.6 21.0 27.3 18.5 9.8 11.1 21.6 28.7 15.8 18.4 12.6 14.1 15.7 16.1 24.4 20.4 21.1 15.0 16.5 14.7 17.9 29.0 25.9 17.7 24.6 17.7 21.2 15.5 15.4 15.1 15.5 14.9 14.7 15.0 18.8 19.6 17.6 15.7 10.6 11.0 18.2 20.2 11.1 19.0 11.4 42.3 8.8 13.9 8.9 12.6 13.2 16.7 17.3 22.4 18.4 15.6 34.2 7.5 21.7 17.4 16.4 10.7 20.1 12.4 17.4 12.2 12.3 18.0 16.5 12.6 12.9 13.3 11.7 23.1 8.3 13.0 12.9 15.5 23.8 15.2 25.6 14.4 15.5 15.2 16.2 22.7 14.0 20.8 6.7 13.3 8.0 5.5 13.2 21.4 15.3 34.8 14.8 14.0 9.8 20.0 24.9 14.4 1.6 10.6 13.4 0.0 13.8 18.5 7.1 8.1 2.3 22.2 15.6 12.7 16.8 4.9 25.1 1.4 9.8 10.9 11.8 13.6 10.9 12.4 13.3 10.5 9.6 20.3 14.9 0.0 8.2 8.4 9.8 8.2 19.0 8.7 16.6 6.8 COX16 "C14orf112, HSPC203" ENSG00000133983 "COX16, cytochrome c oxidase assembly homolog" Q9P0S2 14 70325081-70359731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062659 Uncertain Supported Mitochondria NA NA Mitochondria "HPA062659: AB_2684823" "unprognostic (5.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (6.37e-3)" "unprognostic (1.80e-2)" "unprognostic (8.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-2)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "prognostic favorable (1.03e-12)" "unprognostic (4.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.97e-1)" "unprognostic (1.72e-1)" 19.3 25.2 23.6 15.4 20.4 10.9 23.5 14.8 23.3 16.2 19.6 16.8 16.8 21.8 12.4 29.6 19.9 18.3 18.5 24.0 19.4 20.1 30.6 40.6 15.3 16.0 20.9 16.2 16.9 32.3 12.3 18.3 19.1 20.3 19.7 21.2 13.4 28.9 16.7 39.7 17.0 24.6 11.3 20.6 23.5 24.4 11.7 15.3 19.9 25.9 29.2 18.4 14.2 14.2 22.3 22.9 11.1 17.2 20.4 19.4 18.0 30.8 14.6 18.5 17.7 11.7 18.0 14.3 16.0 14.1 14.9 15.6 10.5 28.9 10.3 11.9 14.8 9.5 12.7 13.5 16.8 19.5 9.1 14.5 11.6 11.7 10.5 6.8 13.4 14.4 16.0 12.5 9.3 9.2 12.7 16.1 19.6 8.2 16.3 18.3 24.7 20.1 13.9 18.5 32.1 22.0 14.7 18.4 16.9 19.8 14.4 20.3 17.8 15.2 30.1 10.8 13.9 22.6 19.8 15.2 13.8 25.2 14.4 15.2 14.5 12.3 9.4 24.4 5.0 16.3 11.1 16.7 3.9 13.3 17.1 15.5 22.3 17.2 15.2 17.6 17.9 17.3 17.6 1.3 20.4 17.2 22.9 19.4 18.0 23.6 20.4 14.8 23.3 19.4 20.1 20.9 16.2 20.3 15.3 47.6 45.1 20.6 6.7 75.0 8.5 6.1 50.9 77.6 44.3 22.7 2.0 13.2 44.7 40.3 1.6 19.1 23.8 0.0 56.0 16.1 13.5 10.6 31.3 50.0 16.2 1.6 30.0 28.8 37.5 2.5 17.0 50.6 91.1 28.9 36.9 14.6 53.1 24.6 14.9 32.9 8.0 6.5 33.3 15.8 21.3 88.1 9.2 27.4 37.4 11.9 COX17 ENSG00000138495 "COX17, cytochrome c oxidase copper chaperone" Q14061 3 119654513-119677454 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042226, HPA048158" Supported Supported Mitochondria NA NA 1000000 Mitochondria "HPA042226: AB_2677911, HPA048158: AB_2680292" "unprognostic (1.98e-2)" "unprognostic (3.49e-2)" "unprognostic (1.96e-2)" "unprognostic (8.29e-2)" "unprognostic (2.88e-2)" "unprognostic (6.63e-3)" "unprognostic (3.49e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-1)" "unprognostic (7.11e-3)" "unprognostic (2.12e-1)" "unprognostic (4.45e-2)" "unprognostic (1.33e-2)" "unprognostic (2.15e-2)" "unprognostic (1.65e-1)" "unprognostic (9.19e-2)" "unprognostic (2.64e-2)" 16.6 42.9 20.0 18.2 19.4 21.2 30.4 21.1 20.4 10.2 16.8 9.2 43.5 22.0 11.9 22.9 11.7 11.0 13.6 53.5 17.2 23.0 27.6 37.0 17.8 20.3 23.2 15.2 7.9 39.9 21.1 45.7 18.2 33.7 17.2 16.2 19.4 25.6 33.3 80.4 8.7 21.0 15.4 20.8 15.3 22.3 13.4 16.7 11.1 16.6 37.1 17.2 13.7 20.1 35.6 53.5 52.8 46.9 19.8 33.9 22.0 27.7 28.9 15.8 3.9 6.1 5.7 5.7 15.5 9.3 14.3 14.9 25.5 20.1 20.1 18.8 7.4 22.1 10.5 15.7 15.8 8.6 25.2 18.8 17.4 22.9 20.1 7.0 25.3 32.5 6.5 15.2 8.9 12.3 9.8 9.2 25.2 14.1 48.2 16.6 45.1 25.4 36.5 17.8 25.2 48.4 11.2 10.7 33.1 22.2 16.3 26.4 11.6 19.1 18.4 23.2 10.4 23.1 40.3 7.3 12.3 19.3 7.7 21.3 34.4 34.3 42.5 17.5 19.4 21.2 50.1 22.4 52.8 21.8 33.2 23.0 35.6 27.2 24.7 22.9 27.2 21.7 22.6 17.7 19.8 46.9 53.5 33.9 22.0 20.0 19.4 21.1 20.4 17.2 23.0 23.2 15.2 33.7 16.7 145.9 163.6 145.9 99.6 83.6 101.3 592.3 244.5 194.1 118.3 472.8 41.2 125.7 606.8 206.9 59.6 165.4 386.9 210.2 359.2 147.4 95.8 189.0 295.2 628.7 191.0 71.5 205.8 109.2 171.8 19.7 84.3 254.2 263.2 453.6 223.0 88.7 397.0 333.1 128.7 464.7 118.6 181.1 142.8 266.2 132.2 109.7 176.4 137.1 121.4 191.1 COX4I1 "COX4, COX4-1" ENSG00000131143 "Cytochrome c oxidase subunit 4I1" P13073 16 85798633-85807044 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002485, CAB004080" Supported Supported Mitochondria NA NA 970000 Mitochondria "CAB004080: AB_2085427, HPA002485: AB_1078559" "unprognostic (4.73e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-1)" "unprognostic (6.18e-3)" "unprognostic (2.47e-1)" "unprognostic (4.52e-2)" "unprognostic (2.65e-1)" "unprognostic (1.46e-1)" "unprognostic (5.97e-2)" "unprognostic (7.82e-3)" "unprognostic (3.32e-2)" "unprognostic (2.29e-1)" "prognostic favorable (2.56e-8)" "unprognostic (4.23e-2)" "unprognostic (4.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.38e-2)" 41.6 38.6 101.1 54.0 100.2 66.5 60.6 51.6 86.9 38.1 87.1 38.9 43.9 77.6 33.9 69.3 54.7 50.4 59.8 218.6 82.3 73.0 59.7 69.5 29.6 49.1 100.1 65.9 45.4 71.2 55.7 36.3 36.8 57.0 37.6 98.4 40.6 65.9 53.1 172.3 48.0 76.5 51.2 58.4 40.1 56.5 21.8 38.7 46.6 49.1 112.6 70.2 47.1 52.4 123.0 144.1 74.8 130.8 74.7 121.9 222.6 44.7 73.0 49.7 66.3 92.0 86.3 85.7 40.9 83.7 77.5 38.8 123.5 67.9 73.5 50.3 65.1 42.4 90.2 70.6 82.2 69.1 24.9 73.0 41.0 61.8 119.9 83.0 37.2 30.6 100.0 127.6 63.4 86.6 81.2 80.9 60.5 68.9 30.2 65.7 161.5 74.4 115.3 66.6 99.8 86.1 84.6 31.2 64.3 114.9 88.9 59.1 48.0 86.6 55.1 66.2 55.7 80.8 103.9 56.8 38.9 45.1 35.7 43.7 60.9 57.8 168.9 59.4 73.8 43.6 50.9 130.8 74.8 72.5 112.8 88.4 123.0 96.3 85.0 144.1 116.1 121.9 100.0 50.7 74.7 98.6 107.7 102.7 222.6 101.1 100.2 51.6 86.9 82.3 73.0 100.1 65.9 57.0 38.7 256.1 363.9 981.6 971.7 1003.2 230.7 3140.6 1197.4 362.7 382.2 600.2 123.7 1081.3 2332.7 965.7 464.1 701.9 2320.1 280.4 1145.7 924.4 671.8 956.9 507.1 1060.0 1395.9 200.2 970.5 596.0 1378.7 820.3 462.0 1118.7 1086.5 1424.7 1513.6 283.9 1228.5 1740.3 336.3 1959.5 260.3 349.3 760.4 345.7 304.0 1190.3 1239.3 852.8 1984.7 1551.2 COX6A1 COX6A ENSG00000111775 "Cytochrome c oxidase subunit 6A1" P12074 12 120438090-120440742 "Disease related genes, Predicted membrane proteins" Oxidoreductase "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062394 Approved Supported Mitochondria NA NA Mitochondria "HPA062394: AB_2684749" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (5.10e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-1)" "unprognostic (8.78e-2)" "unprognostic (3.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (3.22e-2)" "unprognostic (2.82e-1)" "prognostic favorable (6.50e-7)" "unprognostic (2.53e-1)" "unprognostic (1.31e-1)" "unprognostic (5.48e-2)" "unprognostic (2.63e-2)" 49.2 48.0 171.0 32.1 103.0 52.6 43.8 44.4 107.5 37.3 96.8 38.5 32.4 102.8 28.0 47.0 59.3 41.8 37.6 41.5 121.5 92.0 85.8 102.6 32.4 39.6 140.0 57.9 27.7 62.7 43.8 38.3 44.4 86.9 43.1 74.3 31.3 63.8 44.2 10.6 37.7 85.7 38.1 67.2 32.1 60.8 28.1 61.2 33.7 48.2 36.0 40.1 42.1 35.0 74.5 102.2 60.5 69.8 47.8 87.4 83.0 47.2 101.2 57.6 60.1 44.4 37.9 70.6 30.1 40.3 53.5 45.7 122.3 48.3 99.6 90.1 42.5 41.4 79.1 56.1 66.1 34.7 59.7 121.0 53.4 57.9 89.5 41.1 58.5 38.4 45.5 81.6 48.8 57.9 44.2 45.0 72.6 52.3 31.2 44.4 132.3 84.4 148.2 52.5 92.1 148.4 57.7 38.6 93.3 84.4 114.0 76.0 66.1 55.2 54.2 70.7 33.5 97.2 66.9 33.9 33.4 41.3 34.4 41.8 48.5 66.6 77.1 52.4 57.4 44.4 38.5 65.5 58.3 54.4 69.5 58.5 74.5 64.3 59.5 95.1 59.2 59.1 59.3 60.5 47.8 69.8 102.2 87.4 83.0 171.0 103.0 44.4 107.5 121.5 92.0 140.0 57.9 86.9 61.2 369.2 267.5 329.6 423.0 340.5 204.2 104.8 682.8 548.7 311.7 734.5 543.9 662.2 1255.0 574.2 113.2 290.2 1336.6 93.5 578.7 601.6 281.6 433.2 262.5 840.8 680.4 138.2 495.4 264.6 384.0 100.3 279.6 388.0 497.7 739.4 694.0 232.4 574.7 1129.3 249.6 1194.5 252.8 336.3 428.1 355.7 331.5 339.1 775.3 316.6 860.7 644.8 COX6B1 "COX6B, COXG" ENSG00000126267 "Cytochrome c oxidase subunit 6B1" P14854 19 35648223-35658861 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 2503.3;Distal tubular cells: 2530.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004192 Supported Supported Mitochondria NA NA 1200000 Mitochondria "HPA004192: AB_1847180" "unprognostic (5.12e-2)" "unprognostic (1.86e-2)" "unprognostic (3.81e-2)" "unprognostic (1.22e-1)" "unprognostic (1.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.18e-1)" "unprognostic (6.16e-2)" "unprognostic (3.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" "prognostic favorable (5.42e-4)" "unprognostic (2.10e-2)" "unprognostic (6.98e-2)" "unprognostic (5.74e-2)" "unprognostic (5.48e-3)" 37.2 32.2 62.1 32.1 58.7 46.2 42.8 31.1 57.6 34.1 65.0 25.2 41.2 52.7 27.1 70.2 52.4 36.3 39.8 132.5 51.5 52.2 61.1 68.9 24.7 40.4 57.4 60.2 29.2 41.1 41.4 28.8 30.2 39.2 30.2 77.1 31.8 54.9 44.2 168.4 35.1 63.2 37.6 38.7 30.7 42.0 21.0 29.0 42.7 37.6 110.6 52.7 33.8 31.6 110.6 115.5 111.1 116.1 61.2 107.9 167.5 36.4 87.1 37.8 50.4 49.7 50.9 35.1 29.7 45.1 49.1 49.7 71.1 36.7 41.1 52.6 46.7 32.9 26.8 60.7 50.4 48.3 47.8 41.5 70.4 46.6 69.6 39.3 63.2 36.7 59.8 63.3 45.8 26.6 47.1 47.6 44.7 43.9 61.6 49.3 70.5 44.4 46.6 28.1 184.2 58.8 38.5 41.6 68.0 111.9 72.9 33.2 38.0 47.8 82.4 29.3 46.1 32.7 68.7 28.4 28.4 32.5 30.1 46.2 37.0 44.4 55.8 37.5 49.0 36.5 87.7 108.6 94.7 65.5 116.1 62.4 110.6 90.5 76.1 111.8 92.7 89.6 79.4 111.1 61.2 107.8 115.5 107.9 167.5 62.1 58.7 31.1 57.6 51.5 52.2 57.4 60.2 39.2 29.0 226.3 220.0 458.4 406.9 379.4 129.5 2503.3 772.0 354.7 217.2 663.0 60.9 533.3 2530.0 637.7 277.5 330.3 1579.1 210.2 701.4 649.3 430.6 454.9 274.7 1065.5 910.2 84.2 601.2 320.4 754.1 587.8 303.5 609.7 710.3 822.4 1028.9 175.1 735.8 1153.8 256.7 1262.3 137.8 258.7 388.3 116.9 177.2 494.3 560.9 394.4 1027.2 623.0 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99894062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Supported Mitochondria NA NA 53000 Mitochondria "CAB016244: AB_2085703, HPA014295: AB_2668966" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 20.5 43.1 66.1 21.6 56.2 44.4 23.3 28.5 63.8 18.7 46.0 14.3 29.4 113.7 38.8 64.1 31.6 27.4 23.5 113.0 54.8 46.9 38.7 66.8 18.2 23.2 58.8 36.7 32.7 26.5 12.1 24.0 30.7 38.8 23.3 38.1 20.6 32.4 30.1 232.1 31.2 55.8 38.7 40.4 23.7 35.1 29.6 23.5 17.9 19.5 80.6 17.8 31.0 21.3 45.9 62.3 55.7 50.6 37.2 73.5 48.0 17.0 6.9 8.0 32.8 18.3 13.3 13.4 5.6 5.3 3.8 4.3 6.9 36.5 41.4 42.4 8.7 6.1 22.7 4.5 46.4 6.4 7.5 11.6 85.9 8.2 20.1 11.9 39.6 26.6 12.3 61.8 3.2 7.1 17.0 5.7 13.0 6.0 74.4 6.4 16.3 41.1 36.5 15.4 25.7 15.9 47.8 2.6 40.5 58.2 90.8 24.9 15.2 3.9 85.1 41.6 8.6 60.0 25.4 4.9 29.1 37.9 30.7 7.9 18.5 14.9 24.6 40.9 16.1 25.7 55.7 29.3 22.1 40.1 42.3 41.8 45.9 61.0 42.5 43.8 41.7 73.5 65.7 3.5 37.2 50.6 62.3 56.9 48.0 66.1 56.2 28.5 63.8 54.8 46.9 58.8 36.7 38.8 23.5 375.2 414.8 374.3 402.8 435.9 194.1 2063.7 626.8 575.5 377.6 574.0 96.2 831.0 1886.7 571.0 645.5 416.6 1532.5 303.7 739.7 730.3 697.7 423.0 347.2 1528.6 904.1 147.8 776.1 376.3 443.5 180.9 615.6 499.6 695.0 943.2 982.6 392.7 687.3 1094.2 552.3 1121.0 205.6 485.0 628.5 756.0 487.0 560.0 1492.7 393.7 1121.0 582.7 CPT1A "CPT1, CPT1-L, L-CPT1" ENSG00000110090 "Carnitine palmitoyltransferase 1A" P50416 11 68754620-68844410 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008835 Supported Supported Mitochondria NA NA 790000 Mitochondria "HPA008835: AB_1078563" "prognostic unfavorable (3.84e-4)" "unprognostic (1.38e-3)" "unprognostic (3.04e-3)" "unprognostic (2.46e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (2.17e-1)" "unprognostic (4.99e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-1)" "prognostic favorable (2.67e-7)" "unprognostic (9.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" 18.0 18.3 9.9 9.9 12.1 15.8 24.4 7.0 10.3 12.8 31.9 8.2 14.1 33.7 17.0 7.2 11.2 12.8 14.7 14.6 12.0 6.6 30.6 62.0 13.1 10.1 10.5 8.6 17.0 24.4 16.9 13.8 8.7 10.8 15.6 22.0 19.7 12.9 11.4 6.9 10.3 33.4 16.9 8.7 18.9 16.8 10.4 9.0 17.9 13.2 7.5 7.6 11.3 30.2 2.5 11.9 10.6 8.6 5.7 8.8 2.5 8.1 14.5 2.1 14.2 9.3 8.4 0.6 6.5 5.4 5.2 1.0 0.5 27.6 0.0 24.2 17.2 18.2 26.9 18.4 3.9 1.5 13.0 1.8 20.1 15.8 6.7 13.9 11.6 24.3 8.7 1.9 10.4 6.3 7.1 18.3 8.1 2.1 16.5 4.7 23.4 9.4 20.6 0.2 42.2 15.4 26.5 0.3 35.6 12.2 20.4 0.2 9.3 18.0 34.9 5.7 1.4 31.1 11.3 18.4 11.3 0.2 22.6 9.4 12.9 16.4 8.3 11.9 8.6 12.3 9.2 7.8 10.6 8.8 8.6 5.1 2.3 5.5 5.3 5.0 2.5 3.4 7.0 3.8 5.7 7.2 11.9 2.9 2.5 9.9 12.1 7.0 10.3 12.0 6.6 10.5 8.6 10.8 9.0 35.7 36.9 11.5 7.7 8.4 4.9 22.1 28.1 32.1 22.7 22.7 60.9 12.9 16.6 11.2 9.2 25.4 82.1 0.0 8.1 4.1 13.9 7.4 27.8 79.0 14.6 1.6 15.5 37.4 42.3 15.7 8.9 13.5 0.0 11.8 44.9 12.9 9.7 40.3 30.1 9.4 41.0 38.8 16.0 12.1 8.8 6.8 6.5 16.6 59.0 6.4 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 64.6;Hepatocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoplasm, Mitochondria" Nucleoli "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favorable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.7 3.2 7.5 7.3 6.5 3.8 8.5 4.8 4.9 6.9 6.4 1.6 6.5 13.2 7.3 2.2 7.8 7.7 14.0 11.0 5.9 7.3 8.2 7.5 4.3 1.3 9.5 7.1 7.3 8.2 9.4 5.0 4.2 7.7 4.7 11.7 9.6 4.7 4.2 4.5 5.5 5.8 14.0 14.4 8.6 6.4 7.2 13.9 8.6 7.2 11.2 7.6 9.6 12.2 18.1 18.1 14.2 15.2 4.5 3.9 3.1 6.8 3.9 14.5 8.9 8.1 5.0 8.2 5.7 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 11.9 20.8 8.9 5.1 1.5 3.1 12.4 15.3 4.0 3.4 10.4 13.7 64.6 21.6 10.7 1.1 3.6 39.8 0.0 9.3 16.0 2.8 4.8 2.3 80.0 23.6 14.3 13.9 6.7 13.5 2.1 6.4 8.2 6.8 26.2 26.9 10.5 9.8 21.0 4.9 28.3 9.9 6.5 3.2 29.8 16.3 2.3 45.7 7.1 25.3 4.6 CTU2 "C16orf84, NCS2" ENSG00000174177 "Cytosolic thiouridylase subunit 2" Q2VPK5 16 88706463-88715386 "Predicted intracellular proteins" "tRNA processing" "Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041135, HPA041894" Uncertain Supported Mitochondria NA NA Mitochondria "HPA041135: AB_10794543, HPA041894: AB_10796463" "unprognostic (4.19e-1)" "unprognostic (3.62e-2)" "unprognostic (5.19e-2)" "unprognostic (5.77e-2)" "unprognostic (3.00e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (5.68e-4)" "unprognostic (4.83e-2)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (1.19e-3)" "unprognostic (2.90e-2)" "unprognostic (1.25e-2)" "unprognostic (3.03e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" 10.9 10.5 13.0 10.9 12.8 12.0 7.8 11.6 17.4 9.0 8.8 11.7 4.6 9.5 11.4 6.7 8.1 8.8 8.5 11.0 12.8 10.2 6.5 11.4 7.7 12.2 12.9 15.3 12.5 15.7 7.0 10.9 7.5 9.9 8.3 4.4 5.8 15.6 9.6 25.4 11.5 7.8 14.7 8.7 9.1 9.5 22.8 11.2 9.3 9.7 11.1 7.9 8.3 7.2 7.5 7.7 1.4 8.0 8.1 9.3 4.6 6.9 11.0 4.3 9.3 3.7 3.8 10.7 7.4 5.6 8.2 4.0 12.9 6.6 10.4 9.9 4.7 3.8 7.0 7.2 7.2 2.2 3.1 21.6 7.2 4.6 12.9 6.3 7.0 5.4 4.2 5.3 6.5 6.9 3.0 6.9 6.4 26.4 3.0 3.1 18.8 19.1 15.9 6.5 6.1 17.9 15.5 3.4 10.9 2.9 2.7 14.4 7.0 12.0 2.2 4.6 2.7 6.5 7.7 7.7 8.6 11.0 9.8 8.0 9.7 4.8 29.3 7.2 15.2 9.3 1.4 6.4 0.0 9.3 8.0 7.8 6.9 8.4 9.0 7.7 7.5 8.9 7.1 0.5 8.1 6.5 7.6 4.7 4.6 13.0 12.8 11.6 17.4 12.8 10.2 12.9 15.3 9.9 11.2 0.0 4.1 8.9 7.8 12.2 12.7 2.2 10.2 4.0 5.7 1.8 5.9 9.5 10.0 5.8 9.8 4.5 5.8 0.0 11.6 13.2 8.0 6.1 0.0 5.9 8.8 12.7 5.2 3.1 2.2 5.5 7.5 4.6 5.0 4.6 5.0 5.7 7.9 6.0 9.2 5.8 8.2 0.0 9.9 17.9 23.5 9.4 6.8 5.7 8.9 7.1 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Group enriched" "Detected in some" 16 "A549: 95.1;Hep G2: 27.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 95.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.7 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.6 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 0.0 0.0 1.5 21.1 20.3 0.0 0.3 0.0 8.1 29.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 39.9 D2HGDH "D2HGD, FLJ42195, MGC25181" ENSG00000180902 "D-2-hydroxyglutarate dehydrogenase" Q8N465 2 241734579-241768816 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 5.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056216, HPA060548" Uncertain Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA056216: AB_2683070, HPA060548: AB_2732650" "unprognostic (2.85e-1)" "unprognostic (3.35e-2)" "unprognostic (6.98e-3)" "unprognostic (7.88e-2)" "unprognostic (2.42e-1)" "prognostic favorable (9.11e-4)" "unprognostic (2.49e-3)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (7.82e-3)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (9.60e-2)" "unprognostic (3.05e-2)" 7.3 17.0 10.9 13.3 10.7 11.5 7.7 9.8 9.5 12.2 15.9 11.7 32.4 7.8 14.6 30.6 12.0 11.7 22.6 8.7 11.3 7.9 13.8 18.7 8.7 7.7 12.2 8.5 10.6 17.1 18.7 26.4 7.4 13.0 12.3 10.1 13.1 13.8 22.2 24.3 27.1 10.5 11.8 7.0 10.0 9.9 4.3 11.3 6.1 15.2 14.0 12.5 11.3 9.5 5.0 1.1 0.0 0.6 0.0 2.8 0.3 6.6 7.1 4.2 6.7 10.1 5.4 14.6 6.1 8.1 6.5 5.2 7.7 14.6 5.5 3.0 6.3 7.4 15.3 3.9 5.1 2.9 6.0 3.9 10.2 6.4 13.2 5.6 12.0 8.1 9.7 9.2 5.1 5.1 12.5 6.3 8.6 13.0 3.5 5.7 11.2 10.1 12.4 2.0 8.9 13.7 12.6 4.7 10.3 11.8 24.0 13.7 4.5 6.2 16.0 4.2 2.9 9.8 4.3 2.5 10.1 3.8 5.2 3.7 6.5 1.2 8.4 7.0 13.4 6.6 0.0 0.5 0.0 0.8 0.6 1.2 5.0 0.3 2.8 1.1 0.6 1.6 0.6 0.0 0.0 0.6 0.3 1.9 0.3 10.9 10.7 9.8 9.5 11.3 7.9 12.2 8.5 13.0 11.3 8.9 14.7 13.7 22.9 17.5 12.5 7.8 30.6 9.4 11.4 17.4 13.7 36.9 19.9 8.4 2.3 8.4 24.4 0.0 7.5 13.6 12.0 16.9 5.7 34.6 15.1 11.1 30.5 13.5 9.2 1.6 15.5 7.8 3.3 1.8 55.3 46.4 7.6 21.0 17.0 25.8 11.2 6.5 10.3 1.7 6.1 12.9 18.9 10.7 47.9 17.3 DARS2 FLJ10514 ENSG00000117593 "Aspartyl-tRNA synthetase 2, mitochondrial" Q6PI48 1 173824503-173858546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026506, HPA026528" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA026506: AB_1847482, HPA026528: AB_1847483" "unprognostic (3.14e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-3)" "unprognostic (4.10e-3)" "unprognostic (2.20e-1)" "unprognostic (1.42e-1)" "unprognostic (6.17e-2)" "unprognostic (1.15e-1)" "prognostic favorable (1.74e-4)" "unprognostic (3.30e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (4.73e-3)" 17.0 22.2 6.3 10.1 8.1 5.4 9.0 7.5 8.6 7.8 15.1 6.7 8.3 11.7 10.4 6.1 13.4 6.4 5.9 11.2 5.5 6.0 21.9 14.8 8.2 11.0 6.4 4.2 9.5 14.9 18.1 15.3 10.9 10.0 8.5 16.6 10.2 10.2 6.2 10.6 6.0 16.1 6.2 9.0 11.4 11.3 8.4 6.9 26.1 12.2 6.3 12.5 9.7 8.1 9.3 9.0 4.8 10.7 5.0 9.3 5.2 29.0 19.4 12.1 7.5 9.2 13.1 15.5 12.8 10.6 18.5 14.2 18.2 26.1 15.7 17.5 10.2 12.2 29.8 33.4 21.6 25.3 17.9 16.4 13.6 9.7 12.6 9.0 11.5 12.4 9.5 9.9 18.7 19.1 5.9 18.4 11.9 27.5 12.4 15.4 8.0 14.6 6.5 23.4 32.5 17.4 17.2 15.4 28.9 16.8 9.7 15.9 14.5 14.0 31.3 20.2 19.0 32.8 15.2 8.1 9.5 15.0 13.1 20.4 9.7 24.5 18.2 5.5 12.7 20.5 4.4 7.0 4.8 6.6 10.7 9.3 9.3 7.2 5.8 9.0 7.3 7.7 4.8 0.7 5.0 7.4 3.7 5.1 5.2 6.3 8.1 7.5 8.6 5.5 6.0 6.4 4.2 10.0 6.9 3.0 1.9 4.3 3.6 1.5 2.2 10.5 7.6 1.4 3.4 5.2 0.0 7.3 6.6 3.9 1.9 3.2 4.5 23.3 2.3 13.0 3.4 2.3 5.7 4.3 8.9 3.2 4.1 1.3 3.5 1.0 2.8 5.0 1.7 6.4 5.0 2.4 3.6 0.0 1.4 6.4 2.7 0.0 2.3 5.7 6.4 1.4 3.5 2.9 6.0 2.5 DBT ENSG00000137992 "Dihydrolipoamide branched chain transacylase E2" P11182 1 100186919-100249834 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026481, HPA026485, HPA026533" Enhanced Supported Mitochondria NA NA Mitochondria "HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506" "unprognostic (1.23e-1)" "unprognostic (1.23e-1)" "unprognostic (3.67e-2)" "unprognostic (5.29e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "unprognostic (3.88e-2)" "unprognostic (1.65e-2)" "unprognostic (6.01e-2)" "unprognostic (1.21e-1)" "unprognostic (2.37e-2)" "unprognostic (2.90e-1)" "prognostic favorable (8.79e-12)" "unprognostic (1.63e-1)" "unprognostic (3.77e-1)" "unprognostic (9.67e-2)" "unprognostic (9.92e-2)" 8.6 14.1 8.3 5.0 13.6 3.9 8.7 8.0 11.8 8.5 7.8 7.9 13.6 6.6 9.8 6.6 13.6 8.6 5.2 18.1 8.6 7.3 22.2 29.1 8.0 5.3 10.2 8.2 9.1 13.7 10.2 12.3 7.3 9.4 12.0 7.6 5.2 11.3 8.3 15.7 8.1 5.8 11.2 8.6 6.0 12.6 5.7 8.2 9.6 13.0 8.7 6.3 12.8 7.7 4.4 2.6 3.3 3.1 4.0 5.0 2.1 11.7 5.8 5.3 10.8 11.7 10.3 12.4 8.0 6.5 7.2 8.7 12.0 4.5 10.7 11.7 4.8 4.6 10.5 11.8 8.5 9.0 11.2 6.8 7.7 11.1 5.9 10.1 10.1 3.7 10.0 9.4 5.9 9.3 6.5 6.7 10.0 12.4 11.7 5.7 2.7 8.4 3.3 11.2 7.8 11.5 8.2 19.4 8.0 7.9 10.6 9.4 5.8 17.8 15.9 13.4 9.8 12.5 6.3 7.7 7.1 4.7 9.1 7.2 8.2 8.3 5.5 8.4 6.2 3.1 3.3 2.2 1.8 4.9 3.1 5.0 4.4 4.4 4.2 2.2 4.1 4.5 4.2 2.1 4.0 2.7 2.6 3.4 2.1 8.3 13.6 8.0 11.8 8.6 7.3 10.2 8.2 9.4 8.2 20.8 28.4 16.7 5.9 6.1 21.3 62.5 20.4 16.0 9.1 12.2 37.3 16.0 43.1 8.1 0.6 6.7 8.1 0.0 7.2 10.3 7.5 7.4 2.3 43.1 7.4 14.3 8.7 10.4 7.5 0.9 14.1 7.8 3.3 6.4 12.5 15.6 6.7 3.5 19.8 26.5 20.8 6.5 8.1 2.4 5.5 6.4 6.9 10.0 12.7 4.6 DDAH2 G6A ENSG00000213722 "Dimethylarginine dimethylaminohydrolase 2" O95865 6 31727038-31730617 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 10.7;ASC TERT1: 13.4;EFO-21: 17.1;fHDF/TERT166: 10.6;SK-MEL-30: 10.7;U-2 OS: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012389, HPA012509" Uncertain Supported Mitochondria NA NA 1800000 Mitochondria "HPA012389: , HPA012509: AB_1847533" "unprognostic (2.29e-2)" "unprognostic (1.38e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-1)" "unprognostic (7.67e-2)" "unprognostic (1.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.62e-1)" "unprognostic (8.78e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (1.02e-1)" "unprognostic (9.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.24e-2)" "unprognostic (2.72e-2)" 24.3 7.8 12.5 11.1 10.3 5.5 22.7 3.1 7.8 32.1 17.0 7.9 12.9 2.6 34.6 22.0 18.4 18.1 26.7 20.7 11.8 10.8 16.9 12.9 37.4 16.5 10.6 6.6 22.5 4.3 3.0 6.2 13.7 13.1 19.8 5.4 13.0 18.1 13.2 6.8 15.1 22.3 27.1 18.9 21.4 11.4 7.3 9.9 14.1 35.4 17.1 8.9 16.3 23.4 2.9 5.5 8.0 2.7 2.3 0.5 0.3 0.4 6.6 0.2 1.4 10.7 13.4 0.7 0.6 0.3 0.4 0.1 4.4 0.7 0.2 17.1 10.6 0.0 0.8 0.0 6.2 0.0 0.1 9.0 0.5 0.5 0.1 0.3 0.9 0.0 8.6 0.1 0.8 0.1 0.7 0.1 9.7 0.2 2.3 0.0 3.6 0.5 2.5 0.1 1.4 0.2 0.3 0.5 0.0 7.6 0.7 0.4 1.0 0.3 0.0 10.7 0.7 0.7 0.9 1.2 0.8 12.7 0.2 0.1 2.7 9.3 2.5 7.4 1.5 0.2 8.0 0.8 7.7 0.5 2.6 0.3 2.9 0.2 0.3 1.5 2.5 0.1 0.1 1.3 2.3 2.7 5.5 0.4 0.3 12.5 10.3 3.1 7.8 11.8 10.8 10.6 6.6 13.1 9.9 26.8 17.1 39.8 83.5 59.4 4.0 32.5 38.2 33.5 17.0 78.5 27.5 13.7 150.9 113.3 87.7 94.4 114.4 0.0 28.5 24.3 96.9 77.4 109.8 27.2 186.9 0.0 143.9 57.7 101.8 14.7 167.1 97.2 97.8 79.4 47.6 79.4 71.2 98.2 143.9 116.9 22.9 103.5 127.7 2.6 12.4 51.8 15.1 33.1 63.1 53.8 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68021274-68023442 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Syncytiotrophoblasts: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol No No "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: AB_2682200" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favorable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 9.8 12.7 6.2 6.7 8.3 19.7 7.1 6.0 12.9 8.3 7.2 6.4 6.8 5.2 7.5 7.3 9.7 7.1 7.0 9.2 5.2 5.9 8.9 12.4 5.8 18.4 6.4 5.1 8.6 13.3 6.8 4.6 17.1 6.6 6.1 6.0 7.8 6.3 5.2 16.2 9.9 7.9 5.3 3.0 11.1 7.0 11.5 2.7 14.6 10.2 7.3 10.6 8.0 4.8 17.8 18.0 22.9 19.1 17.0 22.9 16.6 6.1 9.2 4.5 5.4 6.3 3.5 10.6 4.2 6.3 10.7 7.6 8.9 9.8 23.2 6.5 5.2 5.8 11.2 6.4 10.2 6.3 3.1 10.6 8.4 4.8 9.2 8.5 13.1 9.0 6.9 11.2 8.8 8.1 3.7 5.9 15.7 14.9 3.6 4.7 13.8 13.7 18.5 11.1 6.3 6.8 13.5 4.2 24.8 7.5 7.2 9.5 6.4 17.2 4.9 9.3 5.4 9.5 14.4 4.2 4.7 4.0 6.7 6.9 8.2 9.9 22.3 5.8 10.1 6.4 17.7 19.1 22.9 15.7 18.8 17.3 12.6 14.6 16.9 18.0 17.8 22.9 16.9 6.3 17.0 18.5 9.0 13.8 16.6 6.2 8.3 6.0 12.9 5.2 5.9 6.4 5.1 6.6 2.7 6.0 5.0 7.5 13.5 8.1 4.8 3.1 2.5 2.7 5.7 3.5 0.0 24.0 11.6 9.5 5.9 6.0 1.7 0.0 8.5 9.4 4.2 3.1 3.5 9.7 15.4 3.2 4.6 4.3 10.3 3.1 4.6 6.6 6.8 11.8 2.8 7.2 7.2 4.5 3.2 14.6 3.4 12.9 4.1 20.6 15.1 9.4 83.5 10.1 5.8 10.3 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90052092 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 120.2" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 338.2;Proximal tubular cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 132.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol No No 740000 Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavorable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favorable (6.06e-4)" 26.9 45.7 13.2 18.1 17.6 9.2 15.6 10.3 14.5 13.0 29.0 10.4 11.8 32.4 11.9 13.7 16.2 8.5 12.6 70.0 15.4 9.0 44.8 120.2 12.9 14.0 12.5 12.8 12.7 14.4 22.2 16.8 5.8 13.6 11.0 22.9 9.5 15.7 9.9 37.9 12.5 42.7 11.5 11.9 20.1 12.7 17.0 14.5 20.3 15.0 32.1 15.3 11.6 10.6 23.4 52.3 37.2 42.8 19.8 31.3 27.8 10.5 6.0 17.8 20.1 12.5 20.3 3.8 9.3 16.1 6.1 9.5 2.4 10.5 8.1 7.4 11.1 5.5 8.0 6.6 9.4 10.2 12.2 0.7 19.3 5.4 9.6 15.6 4.2 4.0 16.0 7.3 4.8 8.1 15.1 18.0 12.9 20.1 16.0 29.0 12.1 12.0 6.2 1.1 22.4 18.2 10.2 4.7 14.4 29.8 26.6 0.8 6.7 14.0 132.5 11.1 0.5 17.0 10.9 16.3 10.3 4.9 13.5 5.5 8.1 6.1 9.5 9.8 9.6 13.1 15.0 31.5 10.2 21.4 42.8 22.6 23.4 20.1 21.8 52.3 19.2 21.3 21.0 37.2 19.8 37.2 20.4 31.3 27.8 13.2 17.6 10.3 14.5 15.4 9.0 12.5 12.8 13.6 14.5 71.5 50.7 52.5 52.8 36.7 12.7 229.8 79.0 71.0 51.2 68.0 2.0 44.0 338.2 106.7 118.9 49.7 161.9 0.0 82.2 42.9 47.8 37.6 48.5 196.2 104.2 30.2 100.6 52.2 85.9 33.7 79.1 96.9 81.0 80.2 84.9 41.0 80.5 101.7 48.4 333.3 6.5 71.1 40.1 118.4 23.4 35.9 34.3 71.9 118.0 55.4 DEGS1 "DEGS-1, Des-1, DES1, FADS7, MLD" ENSG00000143753 "Delta 4-desaturase, sphingolipid 1" O15121 1 224175756-224193441 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 164.4" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 218.5;Cytotrophoblasts: 229.8;Suprabasal keratinocytes: 280.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076422 Supported Mitochondria NA NA Mitochondria "HPA076422: AB_2686799" "unprognostic (2.34e-2)" "unprognostic (6.91e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (7.74e-5)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.29e-5)" "unprognostic (7.70e-2)" "unprognostic (2.31e-1)" "unprognostic (3.20e-1)" "unprognostic (3.63e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.83e-7)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (2.53e-4)" 19.2 10.7 14.7 14.1 15.7 20.0 28.6 11.9 17.8 17.8 17.0 19.9 15.8 15.0 17.2 13.4 16.1 13.1 13.5 16.6 15.1 16.4 12.8 17.3 16.1 24.5 22.0 17.4 14.4 9.3 11.8 15.1 40.1 17.9 27.6 9.4 15.9 14.8 20.1 7.6 164.4 12.1 23.3 22.1 13.0 14.6 9.2 19.3 7.7 19.7 12.3 15.7 15.5 24.9 31.7 39.5 43.6 25.7 16.1 24.4 16.8 14.9 10.6 14.0 10.4 61.0 39.4 10.9 42.0 47.3 29.5 35.5 9.8 11.5 11.9 54.6 38.0 17.9 15.9 16.3 14.3 32.8 17.4 29.1 8.6 11.7 5.9 37.1 17.2 18.7 39.2 32.0 27.1 15.3 30.9 29.1 6.6 12.6 13.2 37.8 5.5 8.7 9.3 17.4 8.2 15.7 8.0 19.8 7.7 37.5 4.1 9.1 14.7 22.3 35.2 22.2 26.8 11.9 25.1 26.5 28.4 9.0 32.6 40.9 9.4 11.1 11.0 30.6 8.6 31.8 32.3 22.3 43.6 12.7 25.7 24.4 23.9 21.5 17.5 39.5 31.7 17.1 15.0 26.1 16.1 17.4 13.2 22.0 16.8 14.7 15.7 11.9 17.8 15.1 16.4 22.0 17.4 17.9 19.3 77.4 27.7 37.9 37.6 218.5 30.5 15.7 12.7 22.7 20.5 10.4 13.7 229.8 11.6 30.3 15.3 49.6 4.2 23.3 38.8 36.5 83.9 44.4 103.9 18.1 85.9 17.5 14.3 60.2 49.3 8.5 58.4 80.4 65.8 75.7 5.0 21.7 25.8 5.8 74.6 25.8 15.9 103.5 85.6 67.0 42.8 280.0 166.4 61.0 5.6 12.9 DEPP1 "C10orf10, DEPP, FIG, Fseg" ENSG00000165507 "DEPP1, autophagy regulator" Q9NTK1 10 44970981-44978810 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 204.9;breast: 227.9" "Cell type enhanced" "Detected in some" 17 "Ductal cells: 96.0;Exocrine glandular cells: 99.5;Pancreatic endocrine cells: 71.2;Syncytiotrophoblasts: 251.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 35.2;HDLM-2: 24.4;HHSteC: 63.6;HSkMC: 49.5;HUVEC TERT2: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013687, HPA037818, HPA037819" Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA Mitochondria Vesicles "CAB013687: , HPA037818: , HPA037819: AB_2675685" "unprognostic (3.99e-2)" "unprognostic (4.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-3)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (4.25e-1)" "unprognostic (5.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.89e-2)" "prognostic unfavorable (2.29e-6)" "unprognostic (2.30e-3)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.74e-1)" 204.9 14.6 8.7 14.1 16.8 2.4 227.9 10.8 19.7 14.1 36.5 2.9 10.0 7.4 25.0 14.9 23.5 25.5 28.0 37.0 8.5 6.0 13.0 48.2 70.7 20.6 9.4 3.3 51.2 107.1 4.7 12.2 33.4 21.6 25.8 5.7 12.1 16.2 13.0 81.0 19.6 9.9 30.2 39.0 9.5 12.7 31.9 11.0 0.8 33.3 13.4 19.1 52.1 27.6 0.0 3.7 1.2 0.3 0.0 0.7 1.4 6.9 0.0 0.1 0.0 35.2 17.2 1.7 0.0 2.4 0.1 0.4 0.2 2.6 0.0 0.4 3.1 1.7 0.3 0.3 2.1 0.1 24.4 0.9 0.0 0.0 2.5 63.6 0.0 0.0 49.5 0.1 0.0 0.3 6.0 39.2 0.0 0.0 15.1 0.1 0.0 0.0 0.3 0.0 0.1 0.2 1.1 0.4 5.8 0.1 2.5 1.3 0.0 0.0 0.3 1.3 4.2 0.0 1.6 0.3 1.9 1.3 0.1 1.6 0.4 0.6 0.0 10.7 0.6 1.0 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.5 0.0 0.1 3.7 0.0 1.4 8.7 16.8 10.8 19.7 8.5 6.0 9.4 3.3 21.6 11.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 10.7 11.4 29.6 0.0 39.6 31.5 96.0 0.0 0.0 0.0 0.0 99.5 11.6 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 71.2 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 251.0 0.0 0.0 0.0 DHRS2 "HEP27, SDR25C1" ENSG00000100867 "Dehydrogenase/reductase 2" Q13268 14 23630115-23645639 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 141.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8" "Region enriched" "Detected in single" 4 "cerebellum: 2.7" "HPA053915, HPA069551" Enhanced Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA053915: AB_2682307, HPA069551: AB_2686150" "unprognostic (3.07e-1)" "unprognostic (4.91e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (9.97e-2)" "unprognostic (5.03e-3)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-1)" "unprognostic (6.91e-2)" "unprognostic (6.66e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (1.83e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "prognostic favorable (6.45e-4)" 0.1 0.3 0.3 0.0 0.2 0.0 79.9 0.1 0.2 0.5 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.8 1.8 5.0 0.2 0.0 0.2 0.0 9.0 5.9 0.3 0.5 5.0 0.1 40.2 0.0 0.1 20.1 0.6 0.1 0.7 0.1 23.1 0.3 3.7 0.8 0.9 0.0 0.0 0.1 0.0 0.0 120.7 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.4 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.1 20.1 1.5 0.1 0.0 49.9 0.0 0.2 1.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.4 2.2 0.1 0.4 0.1 0.0 59.8 0.2 0.3 0.4 292.6 0.3 0.0 0.2 0.0 0.0 0.1 95.8 0.5 0.3 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.3 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 5.9 6.6 0.0 3.4 0.0 0.0 0.0 0.2 10.3 0.3 0.2 0.0 0.8 1.6 0.0 3.4 0.0 0.8 3.0 0.0 0.0 0.0 1.0 0.0 0.0 6.7 0.0 1.1 0.1 1.0 6.5 0.0 0.0 8.5 0.1 20.7 0.0 0.5 11.9 DHTKD1 "CMT2Q, DKFZP762M115, KIAA1630, MGC3090" ENSG00000181192 "Dehydrogenase E1 and transketolase domain containing 1" Q96HY7 10 12068972-12123225 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Oxidoreductase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.5" "Group enriched" "Detected in many" 4 "Hepatocytes: 213.4;Proximal tubular cells: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037949, HPA037950, HPA066098" Enhanced Supported Mitochondria NA NA Mitochondria "HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617" "unprognostic (3.76e-2)" "unprognostic (8.08e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (3.04e-3)" "unprognostic (3.83e-3)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (3.02e-3)" "unprognostic (3.46e-1)" "unprognostic (1.56e-1)" "prognostic favorable (3.43e-4)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-2)" "unprognostic (2.88e-3)" 5.7 6.3 6.5 4.7 6.6 2.2 5.0 5.7 7.2 5.5 5.7 9.8 5.0 4.5 4.7 5.0 5.1 4.2 4.5 7.7 5.3 4.8 23.8 69.5 4.2 6.9 7.5 5.2 7.1 16.6 5.4 4.1 4.7 6.2 7.6 6.3 7.2 9.7 7.1 10.5 3.6 4.3 3.5 6.1 5.1 6.1 4.4 6.6 10.1 6.8 6.7 8.0 5.2 4.1 9.5 12.5 16.8 11.0 10.2 4.1 3.3 11.4 8.8 13.2 10.5 8.2 4.9 16.0 5.8 3.7 10.4 9.2 5.6 6.9 8.3 1.9 3.6 4.8 16.3 13.8 4.5 11.9 4.6 6.2 4.5 3.5 4.3 8.1 1.8 1.7 6.0 3.5 6.0 2.4 4.1 5.6 10.1 7.0 6.7 2.8 22.2 6.0 3.2 7.3 10.6 2.1 10.3 4.3 7.0 6.7 2.7 3.4 15.5 11.4 20.4 6.8 14.8 45.0 6.5 2.5 3.4 2.5 7.0 4.2 6.0 4.2 5.3 4.3 3.2 5.6 16.8 4.8 10.7 3.2 6.8 3.4 9.5 2.5 2.1 8.6 7.8 2.5 3.3 14.0 10.2 11.0 12.5 4.1 3.3 6.5 6.6 5.7 7.2 5.3 4.8 7.5 5.2 6.2 6.6 11.9 32.1 21.6 5.5 4.6 11.5 26.6 25.5 5.3 6.8 15.7 9.8 22.3 16.6 9.3 2.6 7.4 10.3 0.0 9.7 18.5 6.6 11.2 8.1 213.4 8.4 25.4 10.9 11.6 11.9 3.1 11.5 11.3 5.0 13.6 19.6 10.8 9.7 10.5 11.3 55.4 18.7 12.9 5.0 5.6 3.6 5.3 11.3 7.1 15.0 6.2 DHX30 "DDX30, FLJ11214, KIAA0890" ENSG00000132153 "DExH-box helicase 30" Q7L2E3 3 47802909-47850195 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034806 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA034806: AB_10601364" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "prognostic favorable (1.37e-6)" "unprognostic (4.12e-2)" "unprognostic (1.43e-1)" "unprognostic (2.81e-1)" "unprognostic (2.22e-1)" 18.4 18.7 22.1 18.5 31.1 23.6 18.3 31.2 43.5 22.3 17.8 26.9 15.5 17.3 23.3 14.8 21.0 24.8 17.9 21.3 19.1 19.8 18.6 19.3 16.7 22.0 20.4 28.0 27.1 21.2 37.3 24.8 20.6 23.6 20.4 13.0 22.0 20.4 23.6 27.1 26.2 16.1 18.8 15.3 21.2 18.7 54.4 18.4 23.8 20.1 15.2 16.9 18.6 17.6 9.9 13.0 9.8 10.5 8.2 16.1 11.6 8.1 20.7 20.5 21.1 9.5 7.9 14.0 15.4 13.2 26.6 19.2 23.8 17.4 26.5 12.1 15.0 18.5 12.5 30.3 21.5 9.5 18.0 36.3 23.1 30.5 23.2 16.5 21.5 24.0 13.8 13.7 28.1 19.8 10.5 17.3 24.5 32.5 17.1 12.4 22.0 27.3 23.6 22.8 10.8 35.4 18.2 11.0 23.5 13.3 20.7 16.9 22.5 15.0 21.4 11.1 10.3 15.0 22.6 12.0 16.1 20.9 18.1 28.2 20.7 25.8 24.0 16.7 18.8 19.9 9.8 10.1 7.2 15.0 10.3 13.0 9.9 12.7 16.1 13.0 9.3 12.1 13.0 1.5 8.2 10.5 7.8 14.3 11.6 22.1 31.1 31.2 43.5 19.1 19.8 20.4 28.0 23.6 18.4 35.7 44.3 33.3 22.5 16.1 46.6 31.3 35.7 42.8 28.4 48.8 41.2 35.6 56.3 33.4 93.4 33.1 32.4 23.3 31.3 18.8 20.4 23.6 23.1 43.3 30.5 55.6 38.5 23.4 27.7 89.2 23.0 28.0 18.6 25.2 23.6 39.2 38.5 29.6 28.3 56.9 46.8 32.3 19.4 136.8 41.1 17.3 24.7 23.5 30.9 22.7 DLAT "DLTA, PDC-E2" ENSG00000150768 "Dihydrolipoamide S-acetyltransferase" P10515 11 112024814-112064390 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 55.4" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 95.8;Distal tubular cells: 63.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003782, HPA040786, HPA062766" Supported Supported Mitochondria NA NA Mitochondria "CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864" "unprognostic (4.57e-3)" "unprognostic (1.75e-1)" "prognostic favorable (6.19e-6)" "unprognostic (7.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-2)" "prognostic unfavorable (7.49e-5)" "unprognostic (8.68e-2)" "unprognostic (5.36e-2)" "unprognostic (2.93e-1)" "unprognostic (2.23e-3)" "unprognostic (6.25e-2)" "prognostic favorable (1.95e-14)" "unprognostic (5.82e-2)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (6.15e-2)" 14.1 10.7 10.6 8.8 11.9 4.8 10.9 10.5 14.2 6.7 13.3 6.3 7.8 12.4 6.3 8.1 12.2 7.2 6.4 55.4 10.4 13.5 19.1 12.0 6.6 8.7 11.2 9.7 7.9 6.0 15.8 7.8 8.3 13.0 8.3 13.5 7.6 10.4 9.9 41.0 7.2 13.0 6.6 7.3 6.9 8.1 7.3 4.2 12.7 10.7 22.1 8.8 7.5 6.7 9.2 9.1 7.9 8.9 7.2 10.3 8.0 6.1 6.2 8.3 11.0 11.6 8.7 9.9 8.5 4.9 9.4 10.7 19.7 18.2 25.3 16.7 7.7 12.8 13.3 17.2 9.1 10.7 9.1 10.8 16.1 6.6 12.1 8.3 20.3 9.2 10.5 10.0 9.4 9.5 7.2 8.5 12.5 26.2 12.1 11.0 4.8 9.2 24.3 9.7 15.8 12.1 14.3 11.2 28.5 17.2 6.5 15.9 9.7 10.2 28.9 6.4 9.9 21.4 12.6 5.7 9.4 10.2 9.4 10.9 4.0 6.3 38.4 2.6 22.2 7.3 7.9 6.6 4.7 8.3 8.9 9.5 9.2 8.2 8.9 9.1 7.5 10.3 8.3 0.5 7.2 8.9 7.4 8.8 8.0 10.6 11.9 10.5 14.2 10.4 13.5 11.2 9.7 13.0 4.2 11.9 12.6 16.4 7.1 10.0 7.6 95.8 12.7 32.1 7.9 10.4 0.0 17.8 63.0 16.0 3.0 8.3 19.1 0.0 10.1 34.1 8.5 6.3 3.5 14.3 16.4 7.9 16.6 5.5 12.3 2.3 5.8 7.9 16.9 18.0 18.5 8.6 12.5 3.5 10.3 29.2 10.5 0.0 11.3 21.6 15.8 8.5 14.5 8.6 24.8 9.1 DMGDH ENSG00000132837 "Dimethylglycine dehydrogenase" Q9UI17 5 78997606-79236038 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "kidney: 50.2;liver: 81.8" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 25.2;Hepatocytes: 84.9;Late spermatids: 27.1;Proximal tubular cells: 59.0" "Group enriched" "Detected in some" 12 "liver cancer: 15.6;renal cancer: 12.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.7;Hep G2: 11.5;hTEC/SVTERT24-B: 3.6;Karpas-707: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036441, HPA036442, HPA077849" Enhanced Supported Mitochondria NA NA 440000 Mitochondria "HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859" "unprognostic (3.11e-2)" "unprognostic (3.36e-1)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (3.15e-1)" "unprognostic (2.52e-3)" "prognostic favorable (5.32e-5)" "unprognostic (2.21e-1)" "unprognostic (3.05e-2)" "unprognostic (3.19e-2)" "unprognostic (1.07e-4)" "unprognostic (1.89e-1)" "prognostic favorable (1.17e-5)" "unprognostic (2.03e-2)" "unprognostic (9.75e-4)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" 2.8 2.2 0.8 0.8 1.3 0.0 1.5 0.4 0.6 0.5 0.5 0.7 1.9 0.1 0.9 5.9 0.4 0.4 0.6 1.3 0.8 0.8 50.2 81.8 0.1 0.1 0.8 0.3 1.0 0.5 0.3 2.1 0.0 1.1 0.9 0.1 2.7 0.4 1.1 0.6 0.2 0.3 2.0 1.7 0.0 0.4 1.2 0.2 0.0 1.5 0.8 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.5 0.5 1.4 0.4 0.3 5.7 1.3 2.3 0.0 0.1 0.0 0.4 1.8 0.0 0.0 0.1 0.0 1.9 0.3 0.0 0.0 0.0 11.5 3.2 0.0 0.0 2.7 3.3 3.6 2.6 2.5 0.0 1.3 0.0 3.6 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 3.3 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 1.3 0.4 0.6 0.8 0.8 0.8 0.3 1.1 0.2 0.0 0.6 1.4 0.4 0.1 1.5 0.8 2.5 2.7 0.0 8.7 2.0 0.2 16.6 0.4 25.2 0.6 0.5 0.0 0.6 0.1 0.8 0.9 0.0 84.9 0.1 0.0 1.2 1.3 2.4 27.1 2.3 0.4 0.0 0.0 1.1 3.5 0.7 0.6 2.5 59.0 4.1 0.0 0.1 3.4 5.2 0.3 0.2 0.5 0.6 0.7 DNA2 "DNA2L, KIAA0083" ENSG00000138346 "DNA replication helicase/nuclease 2" P51530 10 68414064-68472121 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 49.1" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.5" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037487, HPA057526" Approved Supported Mitochondria No No Mitochondria "HPA037487: AB_10672493, HPA057526: AB_2683456" "unprognostic (1.79e-1)" "unprognostic (1.35e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (4.50e-5)" "unprognostic (3.36e-2)" "unprognostic (4.70e-2)" "unprognostic (3.72e-2)" "unprognostic (1.30e-2)" "unprognostic (3.29e-4)" "unprognostic (1.09e-10)" "unprognostic (3.43e-2)" "unprognostic (1.98e-1)" "unprognostic (9.36e-2)" "unprognostic (1.23e-2)" 1.6 1.2 2.0 13.7 2.4 7.0 3.0 6.2 3.8 1.6 4.5 1.1 0.8 3.5 3.0 1.8 3.2 1.0 2.4 2.0 2.5 2.2 3.4 6.2 3.3 8.4 2.9 5.0 1.9 2.4 1.1 2.3 4.0 1.7 3.0 5.0 0.9 2.3 0.8 2.3 2.9 5.2 1.9 3.0 5.2 2.6 7.0 1.4 49.1 1.5 5.1 10.8 2.3 2.0 0.4 0.1 0.9 0.1 5.5 0.6 0.1 13.9 7.2 16.5 11.6 1.9 1.3 11.6 6.9 5.8 9.9 12.2 17.2 9.1 14.3 2.6 2.1 3.8 8.6 9.4 3.6 12.0 8.8 7.1 8.7 4.5 6.6 0.5 14.9 9.4 1.0 1.5 7.0 2.1 2.5 4.4 9.5 12.7 13.0 5.7 4.9 23.0 10.8 11.6 5.9 13.6 18.0 11.4 4.6 4.2 6.5 7.5 9.0 9.5 12.1 2.3 12.2 9.3 6.3 1.8 3.8 11.9 4.8 13.1 6.6 7.4 21.4 3.2 14.3 5.0 0.0 0.0 0.9 0.2 0.0 0.2 0.4 0.2 0.6 0.1 0.4 0.3 0.3 0.1 5.5 0.1 0.0 0.4 0.1 2.0 2.4 6.2 3.8 2.5 2.2 2.9 5.0 1.7 1.4 6.0 0.6 0.0 0.7 2.1 2.2 7.3 2.5 0.0 1.2 1.8 5.9 2.0 0.0 0.5 1.6 0.7 1.3 70.0 0.8 3.8 1.9 3.2 0.0 4.4 1.8 0.0 1.2 1.3 2.2 3.1 0.6 0.0 0.0 0.0 1.3 0.2 0.7 0.0 0.7 0.4 3.6 0.0 1.0 5.0 14.2 1.5 1.0 1.5 2.3 0.9 DNAJA3 "hTid-1, TID1" ENSG00000103423 "DnaJ heat shock protein family (Hsp40) member A3" Q96EY1 16 4425805-4456775 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016095, HPA040875, HPA044229" Approved Supported Vesicles,Mitochondria NA NA Mitochondria Vesicles "CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (2.86e-3)" "unprognostic (2.91e-2)" "unprognostic (4.17e-1)" "unprognostic (5.18e-2)" "unprognostic (1.60e-1)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (3.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.27e-2)" "prognostic favorable (1.79e-4)" "unprognostic (4.17e-2)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.92e-1)" 10.8 26.6 10.7 11.3 15.5 6.2 13.0 15.3 20.8 10.0 14.0 13.9 11.1 17.3 11.3 8.7 15.6 12.6 12.5 28.8 13.9 12.6 19.0 44.8 9.1 13.4 13.0 13.0 13.2 18.1 21.6 12.1 13.7 14.2 11.5 13.4 10.6 14.4 13.4 46.7 12.8 13.2 11.4 12.6 11.4 12.8 15.1 11.1 13.6 16.1 16.2 13.3 13.4 11.2 10.4 6.5 2.2 7.0 7.8 11.9 7.9 9.0 18.1 6.3 12.0 7.9 7.0 11.8 11.9 9.0 16.6 13.7 15.0 12.8 17.8 11.1 7.7 11.8 13.7 20.6 14.1 9.7 12.2 17.8 9.0 15.6 14.5 19.7 15.8 8.7 8.5 16.9 14.7 24.5 8.4 8.0 14.0 23.4 14.7 9.4 20.7 14.7 11.4 13.8 16.8 16.7 18.4 10.1 33.3 12.4 9.7 15.6 6.7 13.0 29.9 19.7 5.7 17.1 13.3 7.4 12.4 8.4 29.9 14.9 15.2 20.4 24.3 6.6 15.3 14.6 0.7 4.6 2.2 9.5 7.0 11.0 10.4 9.1 8.9 6.5 8.9 11.9 9.2 0.5 7.8 5.2 4.6 7.4 7.9 10.7 15.5 15.3 20.8 13.9 12.6 13.0 13.0 14.2 11.1 11.9 7.2 17.9 16.3 14.0 22.0 30.7 10.2 8.1 12.5 24.4 9.8 35.8 38.1 17.3 52.4 10.5 15.3 0.0 10.6 24.7 13.3 14.9 12.7 36.1 14.4 22.3 16.8 6.7 10.1 12.7 17.8 10.0 20.3 14.4 15.8 19.5 13.0 14.0 20.8 21.4 20.5 12.9 11.8 35.4 34.5 14.8 23.8 15.2 28.5 13.5 DNAJC11 FLJ10737 ENSG00000007923 "DnaJ heat shock protein family (Hsp40) member C11" Q9NVH1 1 6634168-6701924 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023707, HPA028705" Uncertain Supported Mitochondria No No Mitochondria "HPA023707: , HPA028705: AB_10603662" "unprognostic (3.74e-2)" "unprognostic (3.19e-2)" "unprognostic (4.06e-2)" "unprognostic (6.05e-3)" "unprognostic (9.55e-2)" "unprognostic (6.65e-2)" "unprognostic (4.38e-3)" "unprognostic (6.10e-2)" "unprognostic (6.34e-2)" "unprognostic (2.89e-1)" "unprognostic (1.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.30e-2)" "unprognostic (1.76e-1)" "unprognostic (9.77e-2)" "unprognostic (1.04e-1)" 13.8 24.0 20.5 16.1 25.2 10.2 12.7 19.1 31.3 13.0 23.4 17.3 10.5 22.4 14.6 11.2 19.5 12.7 11.9 26.9 15.7 13.0 33.5 25.8 11.2 14.4 13.9 19.6 16.5 15.3 21.4 13.4 15.5 25.0 12.6 27.4 15.4 13.8 12.4 44.2 16.6 19.5 15.1 14.6 19.6 16.2 12.4 14.2 12.6 12.3 17.2 18.4 14.0 12.6 8.1 12.2 7.2 13.4 10.0 10.1 8.6 16.6 16.3 19.3 17.5 16.9 11.9 17.8 16.7 14.4 33.3 23.6 19.6 24.2 26.8 16.3 19.2 14.2 22.6 33.0 27.0 29.5 15.1 22.7 27.3 31.0 19.7 16.4 32.8 15.0 17.2 7.5 30.0 19.8 11.9 15.6 20.5 34.4 12.0 16.7 13.5 20.3 16.9 19.6 23.4 28.1 22.7 16.7 19.4 21.3 14.6 25.8 18.3 19.1 39.2 20.9 17.0 15.4 17.0 15.3 19.8 10.6 16.3 19.5 13.9 15.1 35.6 19.2 35.7 9.8 7.2 9.6 3.4 9.4 12.5 9.4 8.1 6.9 10.1 12.2 8.1 7.4 5.9 0.3 10.0 13.4 5.3 7.2 8.6 20.5 25.2 19.1 31.3 15.7 13.0 13.9 19.6 25.0 14.2 8.9 10.2 8.3 3.9 17.4 16.6 8.1 2.5 14.7 7.9 12.2 27.5 18.0 29.9 12.1 11.3 7.5 24.2 0.0 11.9 18.8 12.3 3.0 4.7 10.6 14.8 19.1 14.0 5.5 7.6 7.4 7.5 11.1 27.0 8.2 26.0 12.1 9.7 21.0 4.2 25.9 17.5 6.5 14.4 13.3 12.2 15.9 19.9 4.8 33.7 4.8 DNLZ "bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17" ENSG00000213221 "DNL-type zinc finger" Q5SXM8 9 136359480-136363789 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 7.4;Collecting duct cells: 5.2;Spermatogonia: 4.8;Suprabasal keratinocytes: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 40.2;MCF7: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062738 Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA062738: AB_2684857" "unprognostic (2.81e-1)" "unprognostic (2.93e-1)" "unprognostic (8.73e-3)" "unprognostic (2.05e-2)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (7.61e-2)" "unprognostic (2.30e-1)" "unprognostic (9.51e-3)" "unprognostic (4.50e-2)" "unprognostic (2.56e-2)" "unprognostic (9.07e-2)" "unprognostic (1.17e-1)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 12.6 11.3 13.8 13.0 11.9 13.4 10.4 8.1 13.9 9.7 8.9 9.2 4.0 12.8 10.0 6.2 13.4 7.4 7.1 29.9 11.2 9.1 13.7 14.0 8.0 14.9 11.4 3.5 13.6 25.3 5.0 6.5 7.1 8.5 11.2 2.8 6.2 9.2 7.0 29.6 7.0 7.2 9.9 8.0 13.7 8.3 6.3 6.8 11.6 11.2 7.4 8.9 8.0 9.2 8.6 4.2 8.0 3.1 0.9 6.9 1.2 4.1 7.6 2.6 7.7 1.3 2.8 6.8 6.9 3.8 5.6 2.5 9.1 4.5 9.9 25.3 5.0 4.1 9.2 1.6 4.0 0.6 40.2 10.0 3.5 3.8 3.8 5.2 8.0 6.7 3.5 4.1 4.1 2.5 1.4 2.9 4.3 5.7 7.1 3.6 31.6 9.4 13.1 11.5 6.1 20.1 28.7 3.8 11.4 6.8 4.4 11.7 16.9 7.0 6.5 6.2 1.1 8.1 7.3 6.4 9.4 8.5 6.5 10.5 6.2 8.9 8.7 6.9 3.9 8.6 8.0 1.8 0.3 3.8 3.1 4.8 8.6 5.3 5.6 2.4 5.7 5.4 4.5 1.4 0.9 1.7 4.2 6.9 1.2 13.8 11.9 8.1 11.7 11.2 9.1 11.4 3.5 8.5 6.8 0.0 0.0 1.7 0.9 7.4 0.4 0.8 0.0 0.0 1.2 5.2 0.0 0.8 1.7 0.4 0.1 0.5 0.8 0.0 1.0 0.8 1.0 0.5 0.0 0.9 0.9 0.0 0.0 0.6 0.3 0.0 1.1 1.0 1.7 0.0 1.1 0.5 0.5 0.0 1.1 2.4 0.4 0.0 3.3 0.9 4.8 8.0 0.9 0.0 1.1 1.0 DOK7 "C4orf25, Dok-7, FLJ33718, FLJ39137" ENSG00000175920 "Docking protein 7" Q18PE1 4 3463311-3501473 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 19.1;skeletal muscle: 17.0" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 11.9;Collecting duct cells: 5.2;Early spermatids: 5.5;Intestinal endocrine cells: 5.8;Late spermatids: 4.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.0" "Group enriched" "Detected in some" 8 "cerebellum: 8.7;pons and medulla: 2.5" "Group enriched" "Detected in some" 14 "memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2" "Group enriched" "Detected in many" 15 "B-cells: 6.3;NK-cells: 3.2" "Cell line enriched" "Detected in some" 4 "MCF7: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059449, HPA062780" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA059449: AB_2684023, HPA062780: AB_2732688" "prognostic favorable (8.45e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-2)" "prognostic favorable (2.19e-4)" "unprognostic (5.96e-2)" "unprognostic (6.80e-3)" "unprognostic (1.05e-2)" "unprognostic (9.54e-2)" "unprognostic (1.12e-2)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-4)" "unprognostic (4.61e-3)" "unprognostic (5.09e-1)" "unprognostic (3.16e-2)" "prognostic favorable (1.28e-4)" 1.2 0.5 0.1 0.2 0.2 0.2 0.5 8.7 0.7 1.5 0.3 1.4 0.1 0.1 1.3 4.7 1.1 5.0 3.7 19.1 0.4 0.6 1.4 0.4 1.7 0.7 0.1 0.1 1.3 4.3 0.0 9.7 0.1 2.5 0.7 0.1 2.4 2.0 6.4 17.0 0.3 0.1 0.7 0.1 0.6 2.2 5.3 0.4 0.1 0.6 1.8 0.6 0.6 0.1 6.3 0.0 0.0 0.0 3.2 0.3 0.2 2.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.9 0.0 0.1 1.0 0.0 3.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 27.8 0.0 1.1 0.2 1.2 0.1 0.0 5.4 0.2 1.8 2.4 0.5 0.1 2.3 0.0 0.0 0.0 6.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.3 0.0 3.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.2 0.1 0.2 8.7 0.7 0.4 0.6 0.1 0.1 2.5 0.4 0.0 1.0 0.0 3.2 0.0 0.2 11.9 0.0 1.4 4.5 5.2 0.0 0.0 0.0 1.9 5.5 0.0 0.0 0.0 3.8 0.0 0.3 1.8 0.0 0.0 0.1 0.0 5.8 0.0 0.0 4.8 0.9 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.0 0.4 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 ECH1 HPXEL ENSG00000104823 "Enoyl-CoA hydratase 1" Q13011 19 38815422-38832005 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002907, HPA005835" Supported Supported Supported Mitochondria No No 5700000 Mitochondria "HPA002907: AB_1847964, HPA005835: AB_1847965" "unprognostic (1.91e-1)" "unprognostic (3.03e-2)" "unprognostic (3.64e-2)" "unprognostic (6.43e-2)" "unprognostic (5.73e-3)" "unprognostic (6.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (5.86e-2)" "unprognostic (2.24e-1)" "unprognostic (3.37e-1)" "unprognostic (7.01e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (3.54e-1)" "unprognostic (3.52e-1)" "unprognostic (1.74e-2)" 33.0 52.0 17.6 21.7 20.9 14.7 29.6 11.4 19.8 14.8 34.1 19.5 19.8 25.8 16.8 15.4 30.2 18.9 30.6 130.6 18.6 15.5 40.0 105.8 16.9 19.6 22.2 17.2 16.0 36.5 11.5 11.3 32.8 17.5 20.9 27.1 20.8 27.4 15.2 130.9 18.7 24.4 27.0 13.3 28.1 24.8 26.2 20.6 15.9 24.5 43.5 21.5 21.3 19.3 68.7 60.7 49.9 61.1 61.4 72.6 83.3 12.6 55.6 8.6 14.3 33.7 17.5 12.7 6.2 10.9 5.5 5.6 35.7 25.1 19.8 24.5 14.7 5.0 6.0 14.4 14.9 4.3 68.5 8.0 24.0 16.9 28.8 34.3 25.4 24.3 23.2 38.6 7.2 12.5 10.9 13.0 26.2 11.3 33.1 12.1 23.7 17.7 14.6 5.7 55.9 13.4 20.1 26.0 39.4 34.8 28.8 10.8 13.9 32.7 16.2 17.2 5.8 21.8 57.1 10.9 9.7 8.3 9.6 5.8 25.1 29.1 18.9 14.8 32.8 18.6 49.1 61.1 49.9 51.9 46.8 48.9 68.7 50.9 51.2 60.7 62.2 45.7 51.4 8.1 61.4 38.3 41.4 72.6 83.3 17.6 20.9 11.4 19.8 18.6 15.5 22.2 17.2 17.5 20.6 80.4 82.4 123.2 165.8 73.0 19.3 280.9 234.4 97.7 73.9 137.9 15.7 632.1 432.7 146.8 45.4 83.1 264.9 46.7 80.0 307.0 84.6 125.8 115.7 460.6 245.2 35.0 181.6 92.7 111.3 42.2 121.1 102.2 138.3 289.5 227.3 54.7 110.4 235.9 134.4 659.8 17.5 77.6 99.9 79.1 47.7 79.4 485.8 139.5 278.3 180.2 EXD2 "C14orf114, EXDL2, FLJ10738" ENSG00000081177 "Exonuclease 3'-5' domain containing 2" Q9NVH0 14 69191511-69244020 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002906, HPA005848" Uncertain Approved "Intermediate filaments,Mitochondria" NA NA Mitochondria "Intermediate filaments" "HPA002906: AB_1078767, HPA005848: AB_1078768" "unprognostic (3.36e-2)" "unprognostic (1.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (9.91e-2)" "unprognostic (8.03e-2)" "unprognostic (2.46e-1)" "unprognostic (4.64e-2)" "unprognostic (8.97e-2)" "prognostic favorable (2.08e-9)" "unprognostic (1.16e-1)" "unprognostic (3.06e-2)" "unprognostic (8.75e-2)" "unprognostic (2.14e-2)" 8.1 7.7 14.3 5.0 19.0 2.3 10.6 20.4 20.1 15.8 8.8 21.7 10.2 7.2 14.4 13.6 10.7 14.5 8.6 8.9 13.8 12.0 11.5 6.0 9.0 4.0 13.7 13.3 12.4 24.9 21.9 13.2 8.0 13.9 11.4 10.0 9.6 17.0 12.1 10.3 7.0 6.8 11.0 20.7 5.8 8.7 20.0 12.6 5.0 12.4 5.2 5.9 10.5 7.9 4.1 7.4 10.9 3.4 3.6 6.0 3.1 19.1 9.0 7.0 10.3 4.3 5.2 8.9 9.6 8.1 9.0 11.9 7.6 13.6 0.0 7.1 10.0 5.5 10.9 7.7 9.7 10.2 4.8 9.2 5.6 3.4 4.5 16.9 4.1 5.4 10.5 16.1 9.1 6.0 5.5 12.6 4.9 3.5 7.4 8.5 9.7 2.3 6.3 7.6 10.3 9.1 0.0 6.7 6.7 13.2 7.1 13.7 12.2 7.2 15.0 7.0 7.9 20.1 3.6 10.0 8.4 6.0 6.7 4.9 5.7 7.6 0.0 0.0 4.5 6.2 10.9 3.4 2.9 3.3 1.9 6.0 4.1 3.5 3.3 7.4 2.4 4.2 6.0 0.4 3.6 1.7 5.8 2.4 3.1 14.3 19.0 20.4 20.1 13.8 12.0 13.7 13.3 13.9 12.6 11.9 7.5 3.2 4.2 2.9 9.4 10.3 5.1 9.4 9.1 0.0 7.9 7.1 5.0 10.0 2.4 4.4 3.2 0.0 7.6 3.8 4.6 4.8 1.1 4.7 5.6 9.5 5.8 10.4 5.9 1.8 5.8 1.8 3.3 9.0 8.7 6.8 9.0 7.0 11.3 4.8 8.7 0.0 3.9 31.0 8.7 3.8 2.4 0.5 6.9 3.0 EXOG "ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b" ENSG00000157036 "Exo/endonuclease G" Q9Y2C4 3 38496127-38542161 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 52.2;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 77.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012531, HPA071050" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA012531: AB_2732403, HPA071050: " "unprognostic (2.88e-1)" "unprognostic (5.81e-3)" "unprognostic (3.55e-3)" "unprognostic (2.77e-1)" "unprognostic (8.32e-3)" "unprognostic (8.90e-3)" "unprognostic (4.78e-4)" "unprognostic (3.59e-2)" "unprognostic (3.99e-2)" "unprognostic (3.10e-2)" "prognostic favorable (1.92e-5)" "prognostic unfavorable (4.90e-4)" "unprognostic (6.51e-2)" "unprognostic (1.64e-2)" "unprognostic (4.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" 7.4 9.9 14.1 12.8 14.2 8.1 6.6 18.5 14.1 8.2 8.0 10.5 6.6 5.4 9.7 8.9 5.2 7.4 9.0 22.8 11.7 9.1 7.2 5.8 7.2 12.9 11.1 11.0 8.0 7.4 7.6 16.8 7.3 8.7 9.4 8.2 6.8 5.9 9.3 9.5 4.8 8.1 11.2 8.0 10.8 6.6 9.7 11.2 11.5 8.7 4.0 11.0 9.0 6.4 24.5 6.8 2.1 5.2 12.0 13.6 2.6 3.7 6.7 7.7 6.7 5.2 7.7 3.1 12.0 7.7 10.5 11.8 6.1 3.7 13.0 3.2 4.9 2.9 3.8 9.7 4.2 8.9 14.5 8.7 9.8 10.1 6.3 6.3 10.6 8.2 5.9 4.6 9.3 4.9 4.9 14.1 7.3 4.5 8.6 16.6 2.5 7.4 3.5 7.4 3.2 8.5 4.8 4.3 5.8 5.5 5.1 3.5 1.8 7.4 1.8 3.2 3.6 2.6 5.0 11.7 8.7 6.2 9.3 9.7 4.8 8.2 11.9 6.6 9.1 6.3 0.4 5.0 2.1 13.6 4.4 11.9 24.5 13.0 13.0 3.4 22.4 13.1 13.0 0.2 12.0 5.2 6.8 5.8 2.6 14.1 14.2 18.5 14.1 11.7 9.1 11.1 11.0 8.7 11.2 6.0 5.0 24.1 5.1 2.6 52.2 29.9 12.7 8.1 1.2 10.4 53.0 9.3 0.0 7.6 3.0 9.0 3.9 0.0 4.6 1.1 10.8 4.4 1.1 5.4 5.9 38.1 16.3 8.6 7.0 2.9 25.0 5.6 11.8 8.2 6.9 18.4 5.5 10.1 16.6 2.8 77.1 12.9 11.2 37.0 22.8 0.9 1.6 25.4 9.0 5.0 FAM110B "C8orf72, MGC39325" ENSG00000169122 "Family with sequence similarity 110 member B" Q8TC76 8 57994509-58204279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 13.1;intermediate monocyte: 3.6;non-classical monocyte: 6.4" "Group enriched" "Detected in many" 11 "granulocytes: 13.1;monocytes: 6.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008318, HPA011781" Uncertain Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA008318: AB_1853892, HPA011781: AB_1853891" "unprognostic (2.07e-1)" "unprognostic (6.91e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.88e-8)" "unprognostic (4.09e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (2.02e-1)" "unprognostic (8.72e-2)" "prognostic favorable (1.44e-4)" "unprognostic (1.06e-2)" "prognostic favorable (4.31e-8)" "unprognostic (2.23e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.15e-4)" 6.5 3.1 15.7 4.1 12.2 4.1 9.9 23.7 18.4 8.8 6.1 5.0 24.3 2.3 8.9 6.8 3.0 9.1 7.9 21.7 10.3 14.4 6.6 6.0 4.1 2.0 8.0 5.9 8.2 3.0 16.7 4.1 5.0 7.9 10.0 3.2 9.5 8.5 19.8 17.1 3.0 3.3 10.4 11.5 30.8 5.5 14.7 4.9 0.0 8.6 3.4 2.1 7.9 9.4 0.3 0.9 13.1 6.4 0.0 0.2 0.5 0.0 1.1 4.1 0.1 1.8 0.7 1.6 7.8 9.1 5.5 2.5 0.0 0.1 0.0 1.5 5.5 4.9 0.0 3.7 0.0 4.2 0.0 3.8 0.7 1.2 4.5 6.3 1.0 0.2 6.6 1.5 0.2 3.4 0.7 0.0 1.8 0.0 0.1 4.1 0.1 0.0 2.7 3.9 5.4 1.7 0.0 4.6 0.0 13.5 0.8 4.0 4.4 0.0 0.5 0.2 5.0 3.6 0.4 0.0 3.9 2.5 0.0 2.7 1.7 0.0 0.0 1.8 0.0 4.5 0.0 1.4 13.1 0.0 3.6 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.2 0.5 0.0 6.4 0.0 0.1 0.5 15.7 12.2 23.7 11.8 10.3 14.4 8.0 5.9 7.9 4.9 0.0 5.6 0.0 14.2 8.8 8.8 21.8 2.5 1.4 1.2 22.7 2.0 1.5 6.6 5.9 2.2 4.7 0.0 0.0 2.5 15.0 22.7 10.6 4.6 5.7 4.3 6.4 6.9 15.4 8.1 1.4 9.2 6.3 15.1 0.0 0.0 25.5 2.6 0.0 13.8 6.1 5.4 32.3 22.3 1.7 1.5 3.6 1.3 0.5 0.0 6.7 FASTK FAST ENSG00000164896 "Fas activated serine/threonine kinase" Q14296 7 151076593-151080866 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031621, CAB032539" Approved Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "CAB032539: AB_2101115, HPA031621: AB_10611966" "unprognostic (7.67e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (4.73e-4)" "unprognostic (2.60e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-3)" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-2)" "prognostic favorable (3.99e-4)" "unprognostic (3.49e-2)" "unprognostic (2.79e-2)" "unprognostic (4.12e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.17e-2)" 13.8 16.8 18.8 15.7 19.0 6.4 10.2 19.0 26.4 18.0 20.6 13.4 20.3 21.2 12.4 14.6 20.3 16.7 16.8 35.7 17.6 12.9 17.7 25.6 9.5 10.4 12.0 15.0 14.4 20.7 20.2 21.8 18.5 12.0 16.8 10.6 14.0 21.7 17.9 89.5 14.4 25.8 11.3 9.2 14.9 14.8 10.6 10.9 11.2 16.8 28.1 16.9 17.4 11.8 15.4 26.0 19.7 22.3 13.1 19.0 14.5 15.9 18.6 5.9 14.2 22.1 10.0 9.9 12.8 17.4 10.9 13.1 12.8 13.7 3.8 17.5 17.3 20.1 10.3 5.7 15.3 2.9 10.9 10.2 4.6 4.6 10.8 28.1 3.2 10.5 13.0 22.5 12.6 9.3 8.9 12.8 9.5 6.8 8.0 12.6 31.9 7.8 9.2 9.9 19.8 21.8 5.2 7.1 11.8 14.8 10.9 7.1 7.4 16.9 26.2 17.0 5.3 14.1 12.7 10.4 13.9 3.0 13.0 11.3 21.4 13.0 2.4 27.7 7.2 15.9 10.5 22.3 19.7 16.4 21.7 17.1 13.7 17.3 16.9 19.4 15.4 19.0 16.3 4.8 13.1 20.8 26.0 18.7 14.5 18.8 19.0 19.0 26.4 17.6 12.9 12.0 15.0 12.0 10.9 0.0 6.5 32.8 35.2 21.9 39.2 16.5 28.1 2.7 12.5 24.4 23.6 42.5 72.9 43.5 7.1 22.2 63.6 0.0 41.8 23.0 34.8 27.1 39.1 31.6 38.4 35.0 43.1 22.7 26.6 11.6 33.6 25.5 89.4 34.3 42.5 51.0 35.5 39.6 32.2 50.2 48.9 12.9 27.8 47.1 68.2 22.1 50.6 38.4 50.8 26.7 FASTKD2 KIAA0971 ENSG00000118246 "FAST kinase domains 2" Q9NYY8 2 206765357-206792509 "Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067191 Supported Mitochondria NA NA Mitochondria "HPA067191: AB_2685801" "unprognostic (1.19e-1)" "unprognostic (2.45e-1)" "unprognostic (3.50e-3)" "unprognostic (1.36e-3)" "unprognostic (7.40e-2)" "unprognostic (2.69e-3)" "prognostic unfavorable (8.29e-4)" "unprognostic (1.69e-2)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.38e-3)" "unprognostic (1.48e-1)" "unprognostic (6.32e-2)" "unprognostic (4.87e-2)" "unprognostic (7.18e-2)" "unprognostic (1.03e-3)" "unprognostic (3.57e-2)" 17.2 20.0 12.8 11.2 24.2 9.4 17.1 18.7 23.9 15.5 15.0 9.0 13.1 14.1 19.7 12.7 20.9 15.5 11.2 23.9 12.1 8.4 19.0 27.4 12.8 12.4 10.4 18.1 16.9 15.1 16.6 29.4 12.3 21.2 13.5 17.0 10.3 15.5 11.5 42.0 17.1 14.5 15.6 11.0 14.0 16.3 10.8 11.8 14.2 17.7 19.4 16.0 16.7 14.2 13.4 19.6 5.1 13.9 19.2 19.5 12.8 14.7 13.5 12.6 14.3 14.4 17.3 23.6 17.2 14.6 29.6 16.9 23.9 16.2 18.6 19.4 18.0 34.2 20.2 15.7 24.3 26.3 5.7 10.2 14.5 13.9 23.0 17.5 31.3 13.6 18.5 24.9 22.5 24.7 15.0 19.9 13.7 27.3 9.4 21.7 12.6 13.2 13.3 22.5 13.9 25.9 11.6 19.6 19.0 20.5 24.7 18.4 11.8 13.3 22.6 20.5 19.7 10.6 16.4 15.4 18.1 16.2 12.4 17.9 9.5 15.7 24.0 21.0 14.6 14.9 5.1 13.9 3.2 13.1 13.5 14.4 13.4 14.6 13.7 19.6 10.8 19.5 17.5 0.8 19.2 9.8 9.4 11.3 12.8 12.8 24.2 18.7 23.9 12.1 8.4 10.4 18.1 21.2 11.8 26.8 10.7 17.1 24.7 21.1 17.4 21.4 7.6 14.7 13.6 12.2 21.6 24.0 8.3 16.4 17.3 14.1 7.3 0.0 13.1 18.5 14.3 10.5 4.7 16.6 13.2 6.4 7.0 11.1 4.7 5.1 8.9 8.9 5.0 11.8 9.0 10.9 11.2 10.4 13.1 10.2 21.6 12.9 15.6 18.9 11.9 18.7 21.5 15.0 11.0 21.3 FASTKD3 "FLJ23274, MGC5297" ENSG00000124279 "FAST kinase domains 3" Q14CZ7 5 7859159-7869037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068525, HPA074462" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA068525: AB_2685999, HPA074462: AB_2686692" "unprognostic (5.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.87e-5)" "unprognostic (6.66e-3)" "unprognostic (4.56e-3)" "unprognostic (3.19e-2)" "unprognostic (1.61e-2)" "unprognostic (5.82e-3)" "unprognostic (5.68e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "prognostic favorable (8.53e-4)" 7.1 15.5 8.6 9.7 13.3 7.6 12.3 9.1 15.0 8.3 10.7 8.6 7.9 10.4 8.8 10.2 8.9 7.5 6.5 7.2 8.7 7.3 17.8 14.5 8.3 10.0 9.2 13.7 9.3 8.4 13.0 10.8 6.4 8.0 8.6 13.5 8.1 11.1 15.8 10.2 9.0 12.1 7.8 8.8 12.0 9.1 6.0 7.4 12.2 8.9 7.4 12.2 9.1 7.0 9.6 6.7 7.4 7.3 4.8 10.3 4.7 7.1 6.3 6.2 8.0 3.9 4.9 12.1 6.0 5.2 9.5 7.3 9.4 7.7 24.9 12.2 6.3 12.1 7.6 15.1 8.4 13.5 6.8 7.8 8.6 20.6 7.4 5.3 14.2 7.2 5.6 3.6 8.8 5.5 4.3 5.2 10.2 11.8 4.4 7.1 5.1 9.5 8.3 5.6 7.5 9.0 11.1 7.6 5.7 7.7 7.7 4.3 4.1 18.1 8.0 8.8 5.8 7.2 6.6 3.5 9.4 9.6 9.7 9.9 5.1 4.8 15.9 6.2 13.2 7.6 3.8 5.4 7.4 6.1 7.3 8.2 9.6 9.4 6.5 6.7 6.8 10.3 9.7 0.2 4.8 5.7 3.8 10.2 4.7 8.6 13.3 9.1 15.0 8.7 7.3 9.2 13.7 8.0 7.4 14.9 5.1 5.2 1.9 2.3 2.9 3.6 7.6 5.3 0.0 0.0 0.0 6.3 5.0 7.2 0.4 4.3 8.0 0.0 10.3 7.0 4.6 2.3 3.5 9.9 7.3 4.8 6.9 4.9 7.0 0.4 4.9 5.8 1.7 14.4 6.2 3.5 9.3 3.5 4.2 14.9 5.1 0.0 5.1 3.4 5.4 4.8 3.5 6.9 6.6 1.6 FIS1 "CGI-135, Fis1, H_NH0132A01.6, TTC11" ENSG00000214253 "Fission, mitochondrial 1" Q9Y3D6 7 101239458-101252316 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017430 Approved Supported Mitochondria NA NA 590000 Mitochondria "HPA017430: AB_1848608" "unprognostic (1.45e-2)" "unprognostic (8.20e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.48e-2)" "unprognostic (1.63e-1)" "unprognostic (7.73e-2)" "unprognostic (6.54e-2)" "unprognostic (5.33e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-3)" "unprognostic (3.47e-2)" "prognostic favorable (1.08e-7)" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" 35.1 46.8 53.4 22.3 49.9 32.7 35.8 26.0 60.0 30.3 34.4 57.9 38.0 30.0 31.1 42.7 35.6 47.0 39.4 78.6 52.6 44.8 39.6 58.3 27.8 23.6 65.3 37.8 41.2 56.6 39.5 37.1 34.0 45.1 29.3 26.3 28.8 45.2 43.8 120.5 29.7 29.2 32.4 87.9 28.1 31.1 30.4 44.1 21.3 47.1 48.8 22.6 30.5 29.3 73.0 73.4 63.6 67.4 55.6 72.8 87.9 25.0 29.5 22.1 31.7 25.6 34.2 15.1 27.2 33.1 24.9 21.5 20.3 41.2 24.5 36.3 37.3 22.8 14.8 15.4 43.9 13.9 19.0 22.4 11.1 42.9 26.9 30.5 20.7 17.3 32.6 41.4 17.3 26.7 28.0 44.9 13.6 23.3 33.7 37.4 115.0 32.2 37.4 24.5 50.6 28.7 15.8 12.4 53.8 37.6 29.0 28.7 33.6 13.0 62.5 18.4 20.3 20.8 23.5 36.8 29.2 18.8 30.2 28.9 28.6 21.8 14.1 27.1 23.6 38.1 58.9 67.4 63.6 63.2 65.5 65.1 72.2 61.0 59.7 73.4 73.0 60.7 63.5 51.4 55.6 59.0 61.4 72.8 87.9 53.4 49.9 26.0 60.0 52.6 44.8 65.3 37.8 45.1 44.1 95.3 100.9 113.2 110.6 93.2 42.7 311.2 216.6 109.7 67.1 218.1 15.7 209.3 475.9 225.3 158.1 164.5 399.5 537.3 254.1 253.9 149.0 192.6 133.9 365.3 254.4 33.4 210.7 152.2 158.6 575.1 179.5 136.4 207.5 212.0 223.3 159.0 210.6 475.1 168.3 613.6 43.3 97.0 162.7 157.3 182.7 118.6 271.1 129.8 226.8 173.1 FKBP8 "FKBP38, FKBPr38" ENSG00000105701 "FK506 binding protein 8" Q14318 19 18531751-18544077 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 972.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 32.5;neutrophil: 31.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 32.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025346, HPA045177" Supported Supported "Endoplasmic reticulum,Mitochondria,Cytosol" NA NA Mitochondria "Endoplasmic reticulum, Cytosol" "CAB025346: , HPA045177: AB_2679244" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (9.22e-2)" "unprognostic (2.54e-2)" "unprognostic (2.26e-1)" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "prognostic favorable (7.76e-4)" "unprognostic (8.51e-2)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (2.32e-1)" 44.3 38.1 75.9 27.5 82.1 82.5 26.5 43.4 113.7 35.2 31.9 41.2 34.6 31.1 31.4 27.2 48.7 39.3 34.5 43.4 69.6 62.1 28.9 42.7 34.3 31.1 55.3 54.3 56.1 60.4 28.8 42.2 36.6 51.2 36.5 12.9 31.9 73.1 46.1 56.7 35.1 31.6 34.6 46.3 36.7 31.9 49.5 26.9 32.1 38.8 24.2 30.7 36.3 45.8 4.3 4.3 32.5 6.9 3.1 6.6 9.1 36.9 26.5 20.8 39.5 21.5 33.8 52.2 29.9 31.9 22.9 31.8 25.1 50.5 21.2 48.7 36.7 15.4 20.1 12.8 41.7 6.5 25.8 60.9 19.8 34.6 30.2 37.0 19.6 43.6 44.1 40.2 20.6 13.1 44.1 23.5 41.3 41.4 50.5 19.9 61.6 35.6 58.7 42.5 33.2 38.5 37.4 17.3 72.4 30.8 24.2 23.1 42.1 21.0 17.3 37.3 16.5 20.4 57.2 27.4 28.7 26.2 55.9 22.7 38.6 22.2 24.6 64.8 31.5 25.4 6.3 5.6 32.5 6.0 5.8 5.5 4.1 6.1 6.6 4.3 4.3 4.7 5.3 31.0 3.1 6.9 4.3 6.0 9.1 75.9 82.1 43.4 113.7 69.6 62.1 55.3 54.3 51.2 26.9 8.9 1.4 107.1 128.1 84.6 57.2 2.0 71.4 2.7 5.7 96.0 13.7 219.4 210.5 151.9 314.6 76.6 289.8 233.6 111.8 173.9 174.8 132.3 54.0 55.9 208.7 93.8 197.7 79.8 159.9 972.7 188.7 127.3 192.3 254.3 108.6 104.6 130.6 224.5 155.6 222.1 41.3 97.0 149.9 203.6 97.7 103.1 261.7 163.0 127.0 126.6 FOXRED1 H17 ENSG00000110074 "FAD dependent oxidoreductase domain containing 1" Q96CU9 11 126269055-126278131 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039620, HPA046192" Uncertain Supported Mitochondria NA NA Mitochondria "HPA039620: AB_2676602, HPA046192: AB_2679580" "prognostic unfavorable (7.36e-4)" "unprognostic (4.62e-2)" "unprognostic (2.71e-1)" "unprognostic (3.47e-3)" "unprognostic (1.76e-1)" "unprognostic (1.84e-1)" "unprognostic (9.59e-2)" "unprognostic (1.43e-1)" "unprognostic (8.14e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.01e-6)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (2.00e-1)" "unprognostic (1.94e-1)" 7.2 12.3 14.6 8.5 14.9 10.4 7.8 12.6 19.2 6.1 11.7 9.2 6.4 10.3 6.8 6.9 7.7 7.7 7.5 20.1 11.1 11.7 14.6 36.2 5.1 9.2 12.9 18.2 4.3 7.5 9.2 7.7 7.1 13.6 5.8 13.0 8.0 7.5 11.9 15.0 6.1 8.2 8.0 8.7 9.5 8.8 6.8 11.7 8.3 6.2 9.8 10.0 8.0 4.9 7.5 16.5 5.3 12.4 8.5 8.9 7.7 9.5 10.9 8.0 10.0 6.1 2.8 11.1 4.9 6.2 9.3 9.3 16.2 9.8 15.5 13.8 4.0 12.2 15.9 21.4 12.9 5.8 8.3 5.8 32.3 7.1 19.1 8.0 7.9 6.9 2.6 5.0 6.1 11.2 2.5 10.2 16.7 18.5 8.5 7.8 13.1 9.0 13.9 6.6 25.0 18.9 14.8 14.3 18.3 8.5 4.9 10.5 9.0 9.9 14.9 5.3 5.3 36.0 13.4 3.7 5.6 4.6 10.0 7.9 5.2 7.4 12.7 6.8 27.1 7.6 1.6 9.7 5.3 6.9 12.4 7.1 7.5 5.5 8.9 11.8 6.2 7.9 6.9 1.9 8.5 8.9 16.5 7.6 7.7 14.6 14.9 12.6 19.2 11.1 11.7 12.9 18.2 13.6 11.7 8.9 8.6 13.7 6.7 3.2 24.4 19.1 5.1 2.7 6.8 3.5 25.5 25.0 6.6 9.7 2.5 6.2 9.7 0.0 12.1 19.1 8.9 3.9 9.2 25.2 17.5 12.7 12.6 13.5 5.4 6.0 5.2 8.3 8.5 6.4 8.7 17.9 8.9 3.5 10.6 15.8 29.3 6.5 9.2 13.6 23.0 5.0 17.6 7.9 13.3 2.7 FXN "CyaY, FA, FARR, FRDA, X25" ENSG00000165060 Frataxin Q16595 9 69035259-69120427 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022164, HPA068304" Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "CAB022164: , HPA068304: AB_2685970" "unprognostic (3.38e-2)" "unprognostic (1.54e-1)" "unprognostic (7.47e-2)" "unprognostic (2.37e-3)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (2.53e-1)" "unprognostic (2.71e-3)" "unprognostic (1.10e-1)" "unprognostic (9.06e-2)" "unprognostic (1.67e-1)" "unprognostic (4.74e-2)" 8.7 19.9 10.8 9.1 9.8 21.9 11.8 13.9 11.0 8.3 9.3 12.3 11.6 6.6 12.4 11.7 9.2 9.6 7.2 20.2 8.7 10.1 10.2 40.2 9.5 12.8 11.7 8.5 16.8 25.9 18.8 8.6 8.4 10.5 9.9 11.6 12.1 11.9 13.6 25.1 5.2 7.2 16.6 8.9 12.9 9.2 13.3 9.7 3.7 11.1 9.5 9.6 10.5 7.9 15.8 17.7 2.0 18.5 24.2 28.3 19.1 11.3 9.6 15.8 7.6 7.2 10.7 15.3 8.2 7.3 12.6 9.7 5.1 7.4 20.4 6.4 8.5 13.0 12.4 18.6 18.8 15.9 23.8 21.3 28.6 6.3 37.8 12.4 20.9 12.5 11.9 15.2 12.6 13.7 4.5 16.8 12.6 21.5 20.0 11.6 11.1 5.9 9.2 21.3 23.1 19.2 14.1 10.8 13.9 14.5 9.4 12.2 5.5 8.4 5.5 8.6 11.6 6.2 6.5 10.0 8.3 14.4 10.8 11.9 5.6 4.8 12.1 3.9 17.3 8.2 2.0 16.7 0.1 21.5 18.5 16.3 15.8 22.0 21.2 17.7 10.3 28.3 27.1 0.8 24.2 14.1 15.0 17.0 19.1 10.8 9.8 13.9 11.0 8.7 10.1 11.7 8.5 10.5 9.7 3.0 11.5 20.6 17.3 8.7 6.2 39.9 7.6 5.3 3.4 14.0 3.9 35.6 18.3 16.1 2.0 11.7 3.1 0.0 12.7 16.7 14.6 12.0 6.9 60.1 30.0 0.0 6.9 8.0 14.6 4.6 14.7 15.5 16.9 14.4 11.5 8.3 15.0 0.0 12.4 20.7 1.0 12.9 17.6 3.8 31.7 7.0 12.2 13.1 15.6 11.9 GADD45GIP1 "CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6" ENSG00000179271 "GADD45G interacting protein 1" Q8TAE8 19 12953119-12957236 "Predicted intracellular proteins, Ribosomal proteins" "Cell cycle, Host-virus interaction" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055205, HPA065048, HPA071910" Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA055205: AB_2682736, HPA065048: AB_2685412, HPA071910: " "unprognostic (5.82e-2)" "unprognostic (2.62e-2)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (8.14e-3)" "unprognostic (2.49e-1)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (9.67e-2)" "unprognostic (7.73e-3)" "unprognostic (1.06e-1)" "unprognostic (7.09e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-2)" "unprognostic (1.73e-1)" 23.9 31.8 32.7 22.3 29.1 28.1 19.3 17.2 31.4 16.9 18.9 11.2 17.9 21.1 19.2 20.0 22.3 17.5 25.0 41.9 26.4 27.6 24.3 31.5 15.3 21.0 26.0 23.6 20.7 29.6 10.1 18.5 21.3 17.7 18.7 9.7 13.1 36.2 21.7 85.5 18.4 19.2 19.5 19.3 19.8 20.0 17.2 17.1 14.8 27.0 37.9 14.8 17.5 21.5 34.2 17.7 4.8 14.1 16.1 23.6 10.6 20.1 17.2 7.2 10.1 5.1 6.6 10.1 14.9 7.5 14.9 12.3 23.7 8.2 14.6 24.9 8.9 10.7 14.1 8.8 14.5 3.9 9.5 43.2 10.3 23.2 26.6 12.4 17.1 15.8 7.8 11.8 10.3 8.5 7.9 8.6 14.1 15.6 5.7 9.2 29.6 27.0 36.0 19.9 13.1 54.3 20.1 7.3 23.3 11.4 11.9 22.2 20.3 11.1 15.0 16.8 3.7 11.7 16.2 13.9 28.9 10.1 25.1 27.3 22.7 15.8 15.1 20.1 21.5 16.6 4.1 14.1 4.8 14.4 13.4 14.5 34.2 22.1 22.8 17.7 28.0 23.6 17.4 0.9 16.1 11.3 16.9 17.5 10.6 32.7 29.1 17.2 29.1 26.4 27.6 26.0 23.6 17.7 17.1 38.7 48.8 182.3 139.8 129.1 56.0 138.4 114.7 85.6 58.0 130.9 21.6 278.6 339.8 261.6 30.0 159.5 164.2 116.8 326.4 297.6 155.1 145.6 72.7 225.1 217.4 35.0 133.6 149.8 133.3 39.7 177.2 143.5 170.4 318.4 137.1 65.9 279.8 125.8 160.1 483.6 62.7 187.5 150.4 81.2 152.0 140.6 170.8 107.6 173.2 145.0 GATB "PET112, PET112L" ENSG00000059691 "Glutamyl-tRNA amidotransferase subunit B" O75879 4 151670504-151761023 "Predicted intracellular proteins" "Protein biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 317.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042610 Uncertain Supported Mitochondria NA NA Mitochondria "HPA042610: AB_10797502" "unprognostic (2.52e-1)" "unprognostic (3.33e-1)" "unprognostic (1.01e-3)" "unprognostic (5.08e-2)" "unprognostic (2.31e-1)" "unprognostic (6.91e-2)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (2.06e-1)" "unprognostic (6.76e-2)" "unprognostic (1.37e-1)" "unprognostic (8.17e-2)" "prognostic favorable (1.20e-10)" "unprognostic (1.91e-1)" "unprognostic (8.39e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-1)" 11.2 17.0 12.3 10.5 13.6 8.2 9.2 10.7 19.8 7.3 9.7 11.2 6.4 5.8 5.9 8.9 10.1 9.1 7.0 31.3 10.7 10.8 21.4 21.8 5.3 6.8 15.8 11.1 12.1 6.8 14.6 8.4 9.9 10.6 5.9 9.9 7.8 7.7 7.1 22.7 8.5 6.3 8.1 22.6 6.9 7.4 7.8 10.4 10.5 7.7 18.9 9.3 8.0 5.8 9.1 17.0 1.5 13.2 6.8 6.8 8.3 8.8 6.9 9.9 9.5 14.5 14.0 8.6 11.7 15.3 20.8 16.3 11.6 14.5 12.0 3.1 12.1 12.7 8.3 21.2 22.4 22.3 6.7 13.0 5.5 9.6 23.9 14.2 11.3 5.5 14.4 14.4 20.0 7.0 12.0 15.4 17.1 21.4 10.5 15.9 9.7 14.1 12.2 10.1 7.4 13.0 12.0 9.5 9.5 18.8 7.4 10.3 11.4 9.4 13.0 13.7 10.0 11.0 8.2 8.4 10.5 5.7 7.2 8.0 12.6 16.3 10.0 14.7 10.0 7.6 0.7 9.4 1.5 4.0 13.2 6.3 9.1 5.3 5.6 17.0 8.2 6.8 6.4 0.9 6.8 9.4 6.7 5.4 8.3 12.3 13.6 10.7 19.8 10.7 10.8 15.8 11.1 10.6 10.4 8.9 3.7 2.2 5.5 0.0 8.7 58.8 0.0 2.7 6.8 10.4 7.9 19.7 23.2 8.8 5.7 2.9 2.6 0.0 6.4 13.2 7.4 2.9 1.1 13.6 15.4 9.5 2.4 2.5 6.5 6.0 4.9 5.8 0.0 13.6 5.9 317.1 6.9 6.5 4.2 14.9 13.6 6.5 3.6 12.2 12.0 0.0 11.2 1.5 8.8 2.6 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 186.3;liver: 252.2;pancreas: 286.1" "Group enriched" "Detected in many" 8 "Hepatocytes: 1105.8;Proximal tubular cells: 2889.0" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 6 "B-cells: 12.8;dendritic cells: 6.9" "Group enriched" "Detected in some" 4 "RH-30: 57.1;RT4: 15.0;U-266/70: 35.3;U-266/84: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria Yes NA 620000 Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favorable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 1.8 2.5 18.5 1.6 14.7 0.6 2.9 11.4 16.2 1.5 3.1 24.9 0.3 17.8 1.3 2.2 3.0 1.7 5.0 5.5 15.2 10.3 186.3 252.2 1.2 2.1 20.6 14.3 17.6 286.1 0.7 1.2 7.8 14.5 1.7 1.7 1.5 5.5 2.1 13.5 13.9 10.8 2.7 26.1 3.5 10.0 8.0 18.4 0.7 6.6 2.5 3.1 2.2 2.0 12.8 6.9 0.3 1.5 0.1 1.5 0.8 3.4 1.7 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 5.8 9.0 0.3 0.0 1.5 0.6 4.5 0.1 0.1 0.4 0.0 0.7 0.1 0.0 0.2 5.2 0.7 0.2 0.2 0.0 0.1 0.0 0.1 2.1 0.1 0.2 0.0 0.1 0.6 0.1 3.2 7.9 0.0 0.1 57.1 0.4 0.9 15.0 6.6 1.1 1.8 0.1 0.3 0.6 0.8 5.9 0.0 0.0 0.1 0.0 1.7 35.3 44.6 0.2 0.5 0.1 0.4 0.0 1.1 0.3 0.3 1.5 0.0 12.8 0.0 0.3 6.9 5.9 0.0 1.5 0.0 0.1 0.6 6.8 0.0 0.8 18.5 14.7 11.4 16.2 15.2 10.3 20.6 14.3 14.5 18.4 3.0 0.6 33.0 12.7 48.2 8.6 29.5 191.1 2.7 5.7 68.0 0.0 1.0 250.4 36.2 7.4 7.8 4.2 23.3 255.7 0.9 9.9 3.9 3.5 1105.8 69.7 7.9 0.0 20.9 55.8 11.0 4.0 39.6 21.9 5.4 0.2 18.7 151.7 0.3 3.2 2889.0 4.0 6.5 11.3 22.9 7.4 116.9 1.5 6.9 0.4 15.5 GCAT KBL ENSG00000100116 "Glycine C-acetyltransferase" O75600 22 37807905-37817176 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 81.6" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 68.0;Hepatocytes: 55.7;Proximal tubular cells: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020460, HPA063924" Approved Supported "Nucleoplasm,Nuclear speckles,Mitochondria" Yes No Nucleoplasm "Nuclear speckles, Mitochondria" "HPA020460: AB_1849548, HPA063924: " "unprognostic (1.61e-1)" "unprognostic (1.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-2)" "unprognostic (4.17e-2)" "unprognostic (2.40e-1)" "unprognostic (1.37e-2)" "unprognostic (3.56e-2)" "unprognostic (2.76e-3)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.36e-3)" "unprognostic (8.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.73e-3)" "unprognostic (3.99e-1)" 2.9 6.0 8.9 2.4 8.8 8.1 4.2 8.3 12.3 4.5 4.7 5.2 8.0 3.5 3.0 4.0 6.3 3.9 6.0 21.5 8.6 8.4 8.1 19.1 2.3 2.1 10.1 7.4 4.0 81.6 3.5 3.7 2.2 7.4 12.2 3.5 4.3 12.0 5.0 10.3 3.2 3.2 3.1 6.3 1.1 4.4 5.9 4.3 2.8 10.7 9.3 4.3 3.3 2.2 0.3 2.5 0.8 1.3 2.3 7.1 2.8 8.8 2.3 5.9 33.9 12.3 10.0 4.2 12.7 13.4 9.7 8.2 5.1 1.0 2.8 6.0 5.7 5.7 5.2 5.9 9.0 2.2 1.2 10.8 6.2 7.4 20.3 20.1 10.9 8.1 11.7 5.5 6.4 14.1 3.1 7.9 11.4 15.7 3.3 4.5 7.8 11.4 20.2 2.5 13.9 9.4 12.0 1.3 16.2 12.2 7.0 12.3 8.4 9.9 16.1 6.8 2.2 12.9 5.3 5.9 9.8 5.3 6.5 4.4 10.8 5.3 5.8 6.7 10.2 10.2 0.2 1.3 0.8 1.5 1.2 0.6 0.3 3.4 1.0 2.4 0.1 7.1 2.9 0.6 2.3 0.8 2.5 3.3 2.8 8.9 8.8 8.3 12.3 8.6 8.4 10.1 7.4 7.4 4.3 6.0 12.5 2.9 15.2 6.9 9.8 43.3 7.6 4.0 6.8 10.4 3.9 12.8 68.0 6.1 3.6 5.6 6.3 0.0 8.8 17.8 7.5 19.5 9.2 55.7 4.0 7.9 2.4 3.1 2.2 4.3 3.4 1.6 20.3 1.8 23.9 17.3 6.8 3.5 9.2 62.4 1.9 6.5 10.8 13.4 27.1 5.3 23.2 4.9 25.5 11.2 GCDH ACAD5 ENSG00000105607 "Glutaryl-CoA dehydrogenase" Q92947 19 12891026-12914207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.6" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 102.5;Proximal tubular cells: 94.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043252, HPA048492" Enhanced Supported Mitochondria NA NA Mitochondria "HPA043252: AB_2678390, HPA048492: AB_2680418" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" "unprognostic (6.79e-3)" "unprognostic (8.07e-3)" "unprognostic (8.20e-3)" "unprognostic (3.14e-2)" "prognostic favorable (7.28e-5)" "prognostic favorable (3.35e-4)" "unprognostic (1.62e-1)" "unprognostic (3.03e-2)" "unprognostic (7.50e-3)" "unprognostic (7.46e-2)" "prognostic favorable (6.79e-8)" "unprognostic (7.09e-3)" "unprognostic (3.42e-1)" "unprognostic (5.32e-2)" "unprognostic (1.59e-1)" 12.5 12.1 11.4 8.6 13.3 8.2 9.5 11.5 14.0 9.5 10.5 15.5 8.6 9.1 11.7 7.3 9.1 10.5 7.5 19.8 9.3 8.0 20.2 62.6 6.3 12.1 15.5 14.1 13.7 12.3 7.9 8.7 4.9 9.7 10.4 6.9 9.6 14.7 9.7 17.5 6.6 8.1 8.2 8.7 8.6 11.3 4.9 11.8 13.0 10.9 13.7 9.0 12.0 6.6 10.9 14.5 7.2 8.1 21.7 20.6 12.3 11.2 6.3 6.8 12.5 9.9 5.0 6.3 8.4 5.0 9.8 7.5 11.5 4.8 16.3 15.9 4.6 4.9 7.1 9.3 7.2 4.9 14.0 9.9 10.5 10.9 14.1 11.4 19.7 8.4 6.3 9.0 6.9 7.5 4.0 8.4 19.3 25.4 5.1 4.9 12.3 23.1 17.3 7.7 9.8 16.2 22.1 6.9 31.7 5.7 5.2 15.0 9.0 11.8 10.4 7.2 4.5 8.0 13.1 6.0 8.0 6.0 14.9 8.1 27.5 13.9 17.2 5.6 22.6 6.9 7.2 8.1 4.6 11.7 7.1 11.6 10.7 15.0 13.7 14.5 10.9 20.6 15.5 2.0 21.7 5.3 8.6 12.5 12.3 11.4 13.3 11.5 14.0 9.3 8.0 15.5 14.1 9.7 11.8 3.0 4.0 29.5 12.5 7.0 13.8 9.2 20.4 6.7 1.2 10.4 23.6 13.5 44.7 12.0 2.2 4.9 11.4 23.3 9.8 18.6 8.7 10.2 6.9 102.5 18.9 7.9 15.0 13.5 13.0 1.2 12.0 6.9 16.9 27.1 10.8 16.7 9.8 8.6 12.0 94.5 12.2 0.0 7.8 7.2 6.4 4.5 13.6 15.0 19.3 11.8 GDAP1 "CMT2K, CMT4, CMT4A" ENSG00000104381 "Ganglioside induced differentiation associated protein 1" Q8TB36 8 74321130-74488872 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 42.1;Cone photoreceptor cells: 45.2;Horizontal cells: 44.5;Rod photoreceptor cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014266, HPA024334" Enhanced Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA014266: AB_1849581, HPA024334: AB_1849583" "unprognostic (3.19e-2)" "unprognostic (1.52e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (3.31e-1)" "unprognostic (4.36e-2)" "unprognostic (1.72e-2)" "prognostic favorable (2.68e-4)" "unprognostic (3.88e-1)" "unprognostic (4.17e-1)" "unprognostic (9.44e-3)" "unprognostic (2.44e-1)" "unprognostic (5.40e-2)" "unprognostic (3.29e-1)" "unprognostic (6.99e-2)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.73e-1)" 2.8 11.2 19.2 3.8 25.9 2.1 5.6 24.9 48.3 3.2 2.9 7.6 1.1 3.2 5.4 5.7 5.3 3.7 3.4 2.8 17.6 21.4 5.3 2.0 3.2 3.7 16.5 19.2 8.2 10.8 12.3 16.4 2.3 23.3 5.6 3.6 3.7 2.9 5.4 2.6 2.1 3.0 3.9 14.6 2.9 3.2 5.4 9.6 0.7 7.5 0.5 3.4 3.8 1.8 2.7 1.7 2.8 7.2 1.9 4.6 1.4 2.3 7.7 12.0 2.7 1.0 0.9 1.2 1.0 5.7 6.1 7.0 4.1 2.7 9.2 1.4 1.3 6.4 4.0 6.4 3.9 11.9 7.9 2.0 4.8 4.3 7.9 1.3 3.9 9.9 2.9 1.3 2.9 6.2 0.7 0.7 3.9 2.3 0.1 3.6 2.9 8.0 0.6 13.9 12.5 10.6 4.1 5.7 1.7 2.0 7.2 11.8 28.9 7.1 2.7 6.0 3.6 11.9 1.3 0.1 8.9 4.1 2.0 2.8 6.1 5.7 4.5 4.0 0.2 9.3 0.0 1.7 2.8 1.5 4.3 1.8 2.7 1.6 1.9 1.7 1.9 1.3 1.6 0.0 1.9 7.2 0.0 4.6 1.4 19.2 25.9 24.9 25.8 17.6 21.4 16.5 19.2 23.3 9.6 6.0 3.2 3.5 6.4 1.5 42.1 4.8 5.1 4.0 3.4 3.5 45.2 0.4 8.3 4.1 4.4 6.4 2.4 0.0 5.2 0.3 2.9 3.7 17.3 1.6 4.1 44.5 19.5 5.5 4.0 0.5 3.7 4.9 1.7 1.0 2.0 18.0 3.6 0.3 5.3 5.0 45.4 0.0 6.6 14.2 11.7 1.1 0.0 1.5 1.4 3.3 GHITM "DERP2, HSPC282, My021, PTD010, TMBIM5" ENSG00000165678 "Growth hormone inducible transmembrane protein" Q9H3K2 10 84139440-84153245 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 1967.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016464, HPA061664" Approved Supported Mitochondria NA NA Mitochondria "HPA016464: AB_1849656, HPA061664: AB_2684579" "unprognostic (6.26e-3)" "unprognostic (1.85e-1)" "unprognostic (2.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (5.71e-2)" "unprognostic (4.56e-2)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (8.14e-2)" "unprognostic (5.71e-2)" "prognostic favorable (2.32e-10)" "unprognostic (2.46e-2)" "unprognostic (2.09e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" 28.7 50.7 46.0 21.9 53.3 25.3 26.0 30.9 62.7 21.4 45.5 20.2 23.9 43.3 21.2 24.5 30.0 19.9 21.8 94.9 40.8 42.8 80.5 71.6 19.2 23.2 45.2 42.4 20.7 25.1 29.9 24.0 20.9 62.8 22.6 46.0 24.3 26.0 24.5 87.6 19.9 35.6 28.9 24.6 20.1 30.1 41.7 17.5 21.5 29.3 47.6 26.6 26.1 19.1 46.8 63.7 60.6 67.5 44.4 51.6 106.0 42.0 43.7 18.7 42.8 32.2 28.7 33.3 29.0 51.3 37.7 35.4 53.1 35.0 33.3 32.7 38.3 33.2 38.0 39.7 38.0 36.5 33.2 30.1 23.6 45.7 52.3 61.0 73.5 38.8 32.3 74.7 38.9 113.5 39.3 32.5 28.6 54.7 62.3 34.6 36.7 26.0 58.8 18.9 34.4 39.0 23.7 17.2 50.0 52.3 33.9 15.3 17.9 29.3 25.7 58.6 22.6 52.5 47.3 27.5 18.4 24.7 26.7 46.7 44.1 48.0 37.4 48.3 68.2 12.7 52.6 64.3 60.6 42.2 67.5 47.1 46.8 44.2 44.9 63.7 37.2 41.5 44.4 51.3 44.4 59.6 33.0 51.6 106.0 46.0 53.3 30.9 62.7 40.8 42.8 45.2 42.4 62.8 17.5 89.3 83.5 136.2 153.4 151.3 140.5 659.4 145.2 87.0 79.6 150.1 66.8 215.6 490.7 245.2 963.4 127.2 319.8 303.7 203.3 204.3 113.7 156.4 99.3 296.0 241.3 95.3 120.5 81.0 150.4 1967.2 102.1 154.3 155.3 237.2 171.1 217.8 200.8 261.9 128.7 653.0 105.3 142.3 188.3 222.7 145.0 148.9 322.8 152.2 238.2 177.5 GLDC "GCSP, NKH" ENSG00000178445 "Glycine decarboxylase" P23378 9 6532464-6645783 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 22.3;liver: 40.3;placenta: 10.6" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4" "Cancer enhanced" "Detected in many" "testis cancer: 41.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002318, HPA052887" Enhanced Supported Nucleoplasm,Mitochondria NA NA 570000 Mitochondria Nucleoplasm "HPA002318: AB_1849700, HPA052887: AB_2681980" "unprognostic (6.73e-2)" "unprognostic (1.19e-1)" "unprognostic (6.50e-2)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (1.74e-1)" "unprognostic (2.47e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.65e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-3)" "unprognostic (1.17e-2)" 0.2 0.3 3.9 1.0 3.4 0.4 0.4 3.1 5.6 0.3 0.8 1.6 0.0 0.7 0.4 4.2 1.4 0.6 0.6 0.1 2.9 2.2 22.3 40.3 0.8 1.1 1.9 2.9 0.3 0.1 0.0 1.7 10.6 2.1 0.4 0.3 3.2 0.9 0.8 0.9 1.5 0.6 0.1 1.9 0.8 0.8 1.1 1.8 0.0 2.6 0.0 1.9 0.8 0.0 2.9 0.7 2.3 0.5 0.8 0.6 1.1 0.1 1.3 0.6 7.2 0.0 0.1 66.8 0.0 0.0 0.0 0.0 15.9 0.1 0.1 1.6 0.0 0.2 0.1 0.0 0.1 0.0 0.3 3.8 0.0 0.0 10.6 0.0 0.0 14.5 0.0 0.0 0.5 0.0 0.2 2.7 1.2 0.0 0.1 0.3 0.3 0.2 0.0 7.8 1.2 1.2 0.3 0.0 0.1 27.7 0.3 6.4 3.3 0.0 6.2 0.0 4.1 1.4 0.0 0.9 0.1 0.2 0.8 0.3 0.3 9.2 0.0 0.2 0.7 1.5 1.5 0.5 0.5 0.5 0.3 0.5 2.9 0.6 0.4 0.1 0.9 0.4 0.5 2.3 0.8 0.5 0.7 0.2 1.1 3.9 3.4 3.1 5.6 2.9 2.2 1.9 2.9 2.1 1.8 0.0 0.0 4.3 0.0 0.0 0.3 0.6 7.6 0.0 0.0 29.6 0.0 59.4 5.0 0.0 8.8 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.0 126.2 6.1 0.0 0.0 3.1 2.1 9.0 0.3 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 29.3 0.2 0.0 0.3 4.4 5.0 0.0 38.4 0.5 0.0 0.0 GLRX5 "C14orf87, GRX5, PR01238" ENSG00000182512 "Glutaredoxin 5" Q86SX6 14 95533503-95544724 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 439.3;Erythroid cells: 490.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042465, HPA063716" Approved Supported Mitochondria NA NA Mitochondria "HPA042465: AB_10794048, HPA063716: AB_2685102" "unprognostic (2.57e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-2)" "unprognostic (2.69e-2)" "unprognostic (3.72e-2)" "unprognostic (2.43e-3)" "unprognostic (1.29e-1)" "unprognostic (5.41e-2)" "unprognostic (8.28e-2)" "prognostic favorable (1.08e-5)" "unprognostic (1.85e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.83e-10)" "unprognostic (1.44e-1)" "unprognostic (3.81e-2)" "unprognostic (2.66e-2)" "unprognostic (8.91e-2)" 13.7 24.1 19.3 11.2 16.9 54.8 9.7 10.5 17.3 7.4 16.6 7.7 8.1 17.6 9.1 10.8 10.7 8.4 12.6 45.3 16.1 14.5 22.5 43.3 7.7 8.4 15.5 9.5 15.8 19.1 8.3 9.4 27.3 10.4 9.9 9.9 13.3 11.6 11.0 68.8 7.9 15.7 12.6 8.3 9.1 12.8 24.2 7.1 19.9 14.8 25.6 9.7 10.0 10.8 6.0 9.9 5.5 4.5 4.8 8.7 3.0 14.0 18.9 8.7 11.5 8.5 6.3 39.3 10.4 6.8 9.0 8.6 24.7 15.4 20.3 15.4 5.2 5.5 14.2 12.9 10.4 7.5 13.3 19.5 17.4 12.1 36.8 9.7 27.7 18.6 7.7 8.6 6.4 9.0 4.1 9.0 15.0 20.6 16.0 6.3 39.5 21.8 28.2 14.8 11.1 21.1 39.8 30.9 12.1 9.9 17.0 23.1 14.4 9.9 12.6 14.2 7.7 19.4 11.9 10.7 5.7 12.7 13.9 14.6 8.7 10.3 15.4 12.5 16.8 13.2 1.0 3.5 5.5 5.2 4.5 6.1 6.0 6.4 7.7 5.4 5.8 5.9 5.8 2.2 4.8 2.7 9.9 8.7 3.0 19.3 16.9 10.5 17.3 16.1 14.5 15.5 9.5 10.4 7.1 26.8 28.8 35.7 48.6 96.4 37.5 144.4 68.8 8.1 12.5 90.7 31.4 78.3 439.3 9.8 246.8 42.7 50.7 490.6 13.4 138.0 62.7 73.1 14.9 132.8 51.0 47.7 51.9 30.7 26.9 69.9 50.3 48.4 82.7 7.2 63.3 72.3 13.6 31.6 69.3 215.3 32.2 58.2 72.1 35.6 88.2 109.2 45.0 39.2 74.7 69.4 GLS "GLS1, KIAA0838" ENSG00000115419 Glutaminase O94925 2 190880827-190965552 "Enzymes, Predicted intracellular proteins" Hydrolase "Cataract, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 127.9" "Cell type enhanced" "Detected in all" 6 "Collecting duct cells: 371.6;Proximal tubular cells: 372.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 141.8;RPTEC TERT1: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036223 Enhanced Supported Mitochondria "Intracellular and membrane" No No 25000 Mitochondria "HPA036223: AB_10669984" "unprognostic (7.45e-2)" "unprognostic (3.42e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.17e-1)" "unprognostic (2.08e-3)" "unprognostic (2.51e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-1)" "unprognostic (2.40e-1)" "unprognostic (8.01e-2)" "unprognostic (9.06e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (5.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.12e-1)" 16.5 37.3 37.8 20.4 24.7 10.7 34.3 43.8 47.3 11.9 13.1 5.8 8.9 36.9 14.6 11.9 7.6 11.0 17.7 15.7 23.3 22.8 127.9 5.3 22.6 25.4 20.6 36.8 14.1 17.0 26.4 10.1 14.8 35.1 9.4 13.1 10.8 9.0 13.9 7.4 13.0 40.9 15.5 11.7 19.3 8.7 6.9 12.1 15.0 17.7 8.0 22.9 14.1 16.1 5.2 5.0 6.0 2.1 3.9 9.4 1.5 6.4 7.1 5.0 6.6 15.7 11.0 13.0 19.2 14.6 14.0 16.1 8.7 6.4 13.2 141.8 40.5 7.1 8.4 8.8 7.5 20.6 32.5 5.7 21.9 10.5 10.7 14.4 12.7 10.3 9.9 7.9 11.0 7.5 14.0 18.1 5.5 10.1 26.9 31.1 3.4 8.6 12.3 13.4 3.8 11.7 11.0 12.9 11.4 65.2 11.8 6.9 7.2 26.2 5.8 24.4 18.7 2.3 7.9 12.9 20.3 14.9 10.1 23.2 8.7 19.8 18.1 7.3 10.5 16.1 6.0 1.5 2.5 5.5 2.1 9.4 4.8 6.5 7.0 2.2 5.2 6.8 8.1 3.0 3.9 1.4 5.0 5.6 1.5 37.8 24.7 43.8 47.3 23.3 22.8 20.6 36.8 35.1 12.1 175.7 95.7 52.1 47.3 155.0 91.0 32.2 30.6 16.0 40.9 371.6 198.3 3.3 43.1 22.6 4.4 51.8 120.5 23.3 20.9 10.2 63.7 42.0 35.8 4.9 25.8 25.4 56.7 57.7 27.2 3.6 26.4 55.5 84.4 88.4 25.7 10.0 29.5 31.6 40.7 372.1 117.6 19.4 70.9 10.7 11.0 142.3 3.3 62.3 28.1 52.1 GLUD1 "GDH, GLUD" ENSG00000148672 "Glutamate dehydrogenase 1" P00367 10 87050486-87094866 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 182.4" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 357.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 108.1" "HPA042492, HPA044839, HPA061369" Approved Supported Mitochondria "Intracellular and membrane" NA NA 26000000 Mitochondria "HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494" "unprognostic (1.48e-1)" "unprognostic (1.26e-2)" "unprognostic (3.55e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.81e-4)" "unprognostic (1.31e-1)" "unprognostic (1.91e-2)" "unprognostic (5.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.57e-3)" "prognostic unfavorable (1.76e-5)" "unprognostic (1.13e-1)" "prognostic favorable (1.44e-6)" "unprognostic (2.29e-1)" "unprognostic (4.23e-2)" "unprognostic (7.19e-2)" "unprognostic (4.27e-2)" 15.5 21.5 57.8 9.9 54.5 5.9 23.2 13.4 37.9 12.1 14.5 19.9 5.5 18.4 10.9 7.5 17.0 11.5 12.6 16.7 44.1 35.3 56.2 182.4 13.1 11.5 40.6 30.8 17.5 15.2 8.7 6.6 13.5 31.1 26.5 14.6 8.1 10.0 13.3 9.2 15.3 19.8 14.0 22.7 10.2 12.2 6.4 33.2 12.6 16.1 8.7 13.1 14.0 9.5 9.2 15.8 9.2 14.6 13.7 11.9 5.9 24.5 19.8 15.6 26.4 29.7 36.6 17.1 19.4 33.6 18.8 20.7 45.8 24.1 27.6 15.9 28.3 10.8 38.7 20.3 19.5 20.2 19.9 16.0 13.4 11.9 108.1 66.3 31.3 19.4 25.2 36.9 20.9 62.6 28.7 22.4 21.8 13.5 25.0 20.3 17.8 28.2 28.1 17.8 26.7 16.0 21.4 19.9 18.0 54.1 20.1 8.0 15.0 17.4 13.8 24.7 15.7 19.0 22.1 22.2 9.8 8.7 19.8 19.7 15.0 15.4 33.0 23.6 35.9 5.8 5.5 13.8 9.2 8.7 11.1 10.9 9.2 11.8 10.6 15.8 8.8 10.6 8.5 1.3 13.7 14.6 5.9 11.9 5.9 57.8 54.5 13.4 37.9 44.1 35.3 40.6 30.8 31.1 33.2 20.8 19.2 40.4 53.0 94.2 20.7 49.8 53.5 17.4 45.5 57.6 35.3 77.3 132.6 27.7 11.2 45.6 54.7 46.7 29.4 52.4 55.2 96.0 43.7 357.2 63.1 14.3 37.8 50.3 67.1 18.7 81.4 68.2 99.5 30.7 44.6 133.3 37.2 42.1 85.2 119.8 60.1 64.7 76.2 9.6 6.4 107.0 39.8 55.4 40.7 75.9 GLUL GLNS ENSG00000135821 "Glutamate-ammonia ligase" P15104 1 182381704-182392206 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Angiogenesis "Ligase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Late spermatids: 6809.8;Muller glia cells: 5699.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 92.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 92.2" "Cell line enhanced" "Detected in many" "ASC diff: 141.5;ASC TERT1: 100.1;HSkMC: 86.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007316, HPA007571, CAB008636" Approved Supported "Plasma membrane,Mitochondria,Cytosol" NA NA 28000 "Mitochondria, Cytosol" "Plasma membrane" "CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980" "prognostic favorable (4.81e-4)" "unprognostic (1.52e-3)" "unprognostic (3.89e-1)" "unprognostic (3.32e-1)" "unprognostic (1.25e-1)" "unprognostic (9.52e-2)" "unprognostic (7.58e-2)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (8.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" "unprognostic (1.38e-2)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" "unprognostic (5.55e-2)" "unprognostic (4.53e-3)" 173.3 19.2 83.7 37.2 91.0 47.6 63.1 48.5 80.7 41.9 20.4 49.9 9.4 6.2 20.5 29.7 54.0 31.6 26.2 23.5 74.0 48.7 15.6 64.9 39.5 36.9 71.0 48.8 66.2 49.0 7.4 8.9 41.8 70.6 17.4 23.3 39.3 30.4 25.5 159.8 27.9 16.4 30.5 51.3 36.1 71.4 24.0 55.2 8.6 63.9 15.5 24.2 34.7 32.2 2.5 11.0 92.2 21.1 3.4 6.3 18.6 3.0 1.2 14.0 0.0 141.5 100.1 10.3 5.1 16.6 3.1 2.8 7.4 3.1 2.6 5.6 9.9 2.8 7.0 6.1 36.4 2.6 7.0 17.0 34.3 5.8 14.3 7.5 15.1 27.4 86.5 43.7 3.9 46.4 4.7 6.2 8.4 28.8 1.5 11.0 1.7 23.5 14.5 10.4 4.2 6.5 8.5 3.7 4.4 5.4 13.3 9.6 6.3 1.4 18.7 2.0 11.7 18.2 19.1 4.6 0.1 0.2 0.0 1.1 0.5 0.3 0.0 2.7 8.6 0.5 43.6 21.1 54.9 6.3 20.5 2.6 1.6 4.5 5.2 11.0 2.5 2.3 3.9 92.2 3.4 17.1 6.1 1.7 18.6 83.7 91.0 48.5 80.7 74.0 48.7 71.0 48.8 70.6 55.2 116.1 193.4 39.3 480.1 119.7 83.9 198.1 163.1 242.2 133.1 78.5 49.1 126.6 63.0 92.2 1437.2 175.0 45.7 210.2 99.7 54.7 230.2 354.1 758.5 179.4 734.4 41.3 312.5 129.5 692.2 6809.8 451.3 662.6 129.9 48.7 226.1 5699.1 116.5 83.4 352.5 40.4 128.3 90.5 209.3 38.8 52.4 112.0 196.8 96.9 130.8 1061.5 GPD2 ENSG00000115159 "Glycerol-3-phosphate dehydrogenase 2" P43304 2 156435290-156613735 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 81.5;Late spermatids: 75.7;Urothelial cells: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.5;eosinophil: 3.1;intermediate monocyte: 3.3;myeloid DC: 5.1;neutrophil: 2.3;non-classical monocyte: 4.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.1;granulocytes: 3.1;monocytes: 6.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008012, HPA045506" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 7600000 Mitochondria "HPA008012: AB_1079013, HPA045506: AB_2679355" "unprognostic (1.30e-1)" "unprognostic (2.50e-1)" "unprognostic (1.08e-1)" "unprognostic (4.79e-3)" "unprognostic (3.25e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.75e-1)" "unprognostic (1.57e-1)" "unprognostic (1.86e-1)" "unprognostic (2.60e-3)" "unprognostic (6.67e-2)" "unprognostic (6.02e-3)" "unprognostic (1.73e-1)" "unprognostic (1.89e-1)" "unprognostic (2.41e-1)" "unprognostic (1.01e-2)" 12.7 5.5 19.6 12.4 21.4 11.4 15.2 23.1 16.3 10.9 17.6 8.8 8.1 13.7 9.1 5.0 23.1 18.4 8.6 6.2 18.7 12.7 7.7 3.4 11.4 9.0 11.3 11.8 9.0 7.4 26.6 11.0 7.9 10.3 10.8 17.8 6.8 21.5 7.5 21.2 12.0 24.9 5.9 9.4 10.6 17.1 9.5 8.3 6.7 11.8 17.6 14.0 10.1 10.5 0.5 5.1 3.1 6.5 0.7 0.9 2.7 17.5 11.3 7.1 10.7 14.9 19.0 0.0 22.5 13.8 14.4 17.3 22.2 16.1 3.1 14.6 11.7 5.9 20.2 13.0 20.1 18.4 10.8 4.6 2.6 20.6 0.0 5.2 4.8 5.9 9.0 6.4 24.8 12.4 9.1 10.9 1.6 5.5 0.8 18.0 10.3 0.1 0.4 12.7 6.6 15.0 5.5 4.5 4.1 16.9 22.0 12.6 4.5 20.0 15.1 13.1 11.9 5.1 12.6 10.6 2.8 12.0 12.2 15.8 0.6 0.1 0.1 15.5 1.3 21.5 0.6 6.5 3.1 0.5 3.3 0.9 0.3 0.3 0.9 5.1 0.5 0.7 0.5 2.3 0.7 4.3 0.5 0.9 2.7 19.6 21.4 23.1 16.3 18.7 12.7 11.3 11.8 10.3 8.3 17.9 10.5 5.1 17.9 17.7 4.3 11.3 10.2 10.7 10.3 21.0 5.9 7.0 1.7 8.3 81.5 8.4 22.3 0.0 11.6 12.6 7.8 44.4 12.7 1.8 19.2 4.8 16.7 11.6 14.5 75.7 11.2 13.3 23.6 6.4 14.3 4.3 13.0 20.4 6.7 3.4 9.5 0.0 5.7 1.6 2.0 18.7 9.3 6.9 16.6 62.5 GRPEL1 "FLJ25609, GrpE, hMGE" ENSG00000109519 "GrpE like 1, mitochondrial" Q9HAV7 4 7058906-7068197 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036647 Supported Supported Mitochondria NA NA 1900000 Mitochondria "HPA036647: AB_10672359" "unprognostic (6.13e-3)" "unprognostic (3.66e-2)" "unprognostic (1.92e-2)" "unprognostic (6.31e-2)" "unprognostic (9.77e-2)" "unprognostic (2.12e-3)" "unprognostic (2.17e-1)" "unprognostic (2.21e-3)" "unprognostic (1.51e-1)" "unprognostic (5.53e-2)" "unprognostic (4.99e-2)" "unprognostic (3.86e-2)" "prognostic favorable (2.00e-6)" "unprognostic (9.61e-2)" "unprognostic (7.18e-2)" "unprognostic (2.81e-1)" "unprognostic (7.30e-2)" 14.7 35.8 11.5 7.3 10.8 20.7 11.4 10.6 15.2 7.9 9.9 9.3 8.5 8.9 7.8 8.8 11.4 8.7 7.6 22.8 10.9 11.6 22.6 46.8 8.1 9.0 12.5 10.9 10.9 12.9 9.6 7.7 11.0 14.8 8.3 9.9 7.2 9.1 8.5 38.0 10.2 10.4 8.4 11.4 17.2 10.7 14.2 11.7 8.1 9.4 15.8 10.7 11.2 8.3 17.6 22.9 24.8 16.8 15.8 21.5 15.8 9.9 9.4 5.4 10.6 10.5 8.9 6.7 13.2 10.5 14.9 11.0 16.5 13.1 21.6 8.9 10.0 23.2 10.2 21.4 15.1 17.6 5.1 13.4 23.0 8.5 17.8 12.3 23.2 11.7 8.8 20.0 13.2 16.0 7.6 13.0 14.6 13.5 9.1 17.5 10.1 18.3 28.8 8.1 18.1 31.4 12.3 20.3 9.0 14.9 10.5 15.3 7.4 10.3 10.3 11.1 5.7 9.2 13.6 11.2 10.0 6.2 14.2 22.8 9.8 14.0 14.5 13.6 15.1 7.9 6.3 16.0 24.8 15.3 16.8 21.5 17.6 16.7 17.3 22.9 12.8 21.4 16.4 5.5 15.8 13.4 13.9 16.3 15.8 11.5 10.8 10.6 15.2 10.9 11.6 12.5 10.9 14.8 11.7 23.8 27.2 41.9 79.6 118.5 28.6 86.2 40.8 37.5 30.7 36.6 9.8 62.7 112.7 73.0 41.6 39.6 43.9 0.0 41.4 65.1 35.6 36.7 55.6 100.8 54.6 27.0 17.7 21.5 28.9 58.0 25.9 42.5 60.8 70.3 20.9 23.6 69.6 25.2 27.3 143.8 22.5 0.0 77.8 36.3 49.8 109.4 72.0 46.5 36.2 76.0 GSTP1 "FAEES3, GST3, GSTP" ENSG00000084207 "Glutathione S-transferase pi 1" P09211 11 67583595-67586656 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 252.4;OE19: 379.4" "Low region specificity" "Detected in all" "HPA019779, HPA019869" Enhanced Supported Mitochondria,Cytosol No No 120000000 "Mitochondria, Cytosol" "HPA019779: AB_1849799, HPA019869: AB_1849801" "unprognostic (9.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.24e-2)" "unprognostic (2.72e-2)" "unprognostic (1.06e-2)" "unprognostic (1.30e-3)" "unprognostic (3.27e-1)" "unprognostic (4.98e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-3)" "unprognostic (2.14e-3)" "unprognostic (9.37e-2)" "unprognostic (5.72e-2)" "unprognostic (7.78e-2)" "unprognostic (2.23e-1)" "unprognostic (6.72e-3)" "unprognostic (1.48e-1)" 24.2 25.3 20.2 23.8 21.7 46.2 39.5 15.5 19.8 51.8 51.9 23.5 125.4 35.2 43.5 41.9 181.6 60.8 51.1 45.3 18.3 23.5 44.2 5.9 61.0 39.4 25.5 19.9 33.4 60.7 44.1 33.8 57.9 46.0 37.0 17.9 59.9 50.2 110.8 33.7 58.5 34.0 30.1 22.8 25.1 48.5 15.4 15.4 29.8 91.6 131.5 75.6 40.8 79.5 25.3 191.4 12.4 168.2 70.1 40.7 167.2 57.6 78.7 38.4 59.6 29.7 33.5 35.4 25.2 33.9 38.5 30.0 144.5 60.6 0.1 57.9 39.9 34.5 84.4 103.5 111.0 10.9 40.2 37.6 2.8 57.2 0.0 44.0 18.9 33.7 41.5 252.4 30.7 29.7 28.5 57.8 41.6 62.5 16.1 30.1 0.2 43.4 52.9 73.4 379.4 33.8 40.5 6.4 0.1 61.4 0.1 13.0 37.2 35.3 11.5 114.2 31.7 0.1 31.9 31.1 17.8 45.2 37.2 18.2 10.0 62.4 21.1 20.2 31.4 36.9 2.3 168.2 12.4 40.7 125.7 15.0 25.3 18.4 33.3 191.4 24.3 15.3 27.3 7.0 70.1 79.4 76.2 18.3 167.2 20.2 21.7 15.5 19.8 18.3 23.5 25.5 19.9 46.0 15.4 1072.0 720.7 317.1 1402.4 769.0 173.6 263.2 1108.3 2518.8 1170.4 1167.2 31.4 2000.9 1530.2 1548.4 3.0 432.0 610.1 46.7 1274.3 1522.1 711.2 802.7 262.2 7.2 793.1 66.7 353.7 365.8 595.7 9.3 529.8 867.5 1452.6 2663.7 867.8 370.2 1415.0 772.2 376.2 1617.9 188.6 355.7 676.5 3.2 63.0 928.1 1376.1 396.6 983.6 3031.0 GTPBP3 "FLJ14700, GTPBG3, MSS1, MTGP1, THDF1" ENSG00000130299 "GTP binding protein 3, mitochondrial" Q969Y2 19 17334920-17342735 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042158 Approved Supported Mitochondria NA NA Mitochondria "HPA042158: AB_10964400" "unprognostic (1.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (3.08e-3)" "unprognostic (1.34e-1)" "unprognostic (2.18e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (6.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (2.81e-4)" "prognostic unfavorable (1.64e-4)" "unprognostic (4.94e-3)" "unprognostic (1.21e-1)" "unprognostic (2.56e-1)" "unprognostic (1.79e-1)" 8.0 13.8 8.1 12.0 14.7 10.0 9.3 11.7 12.6 9.6 8.2 7.4 9.8 12.5 10.2 6.9 13.0 9.8 12.4 7.9 11.3 10.7 9.2 13.7 7.5 13.4 7.8 11.6 11.3 12.3 14.8 11.0 8.0 11.4 10.6 7.2 10.3 13.2 15.6 14.3 22.9 10.6 8.6 6.7 13.2 11.0 3.5 6.3 16.7 9.2 10.9 16.2 8.5 10.0 6.6 9.3 1.3 4.4 6.3 7.3 3.7 9.2 5.6 5.2 6.7 1.8 1.6 25.4 4.4 1.8 4.0 4.0 7.7 7.5 14.1 11.3 1.6 2.9 8.3 6.6 3.7 3.3 11.7 30.6 8.5 8.1 10.0 2.3 9.0 5.5 1.7 5.5 3.7 4.8 2.8 3.2 10.1 16.1 6.4 2.0 7.3 10.8 8.0 11.0 5.7 25.2 12.9 4.1 13.3 3.7 4.2 12.2 10.9 4.7 7.3 6.0 3.6 6.4 3.7 3.5 6.3 5.6 13.8 7.7 10.9 16.9 17.0 4.9 11.9 4.7 0.5 3.1 0.6 7.1 4.4 5.8 4.5 6.5 6.1 4.8 6.6 7.3 6.8 1.3 6.3 2.4 9.3 4.4 3.7 8.1 14.7 11.7 12.6 11.3 10.7 7.8 11.6 11.4 6.3 3.0 4.0 2.2 7.8 15.1 16.9 6.5 5.1 2.7 1.2 5.2 29.5 16.2 6.6 10.3 0.3 8.2 7.1 0.0 9.3 20.5 8.6 5.5 2.3 8.9 8.8 11.1 2.9 9.2 3.3 0.0 10.9 5.8 10.1 8.2 8.8 8.4 8.6 8.0 12.7 6.2 19.1 6.5 7.2 2.1 5.3 15.3 7.0 10.2 12.4 4.6 HADH "HADH1, HADHSC, SCHAD" ENSG00000138796 "Hydroxyacyl-CoA dehydrogenase" Q16836 4 107989714-108035175 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 98.3" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 244.0;Hepatocytes: 229.1;Proximal tubular cells: 241.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039588, HPA043888" Supported Supported Mitochondria No No 8700000 Mitochondria "HPA039588: AB_10673425, HPA043888: AB_2678716" "unprognostic (1.73e-1)" "unprognostic (3.32e-3)" "unprognostic (3.05e-3)" "unprognostic (8.86e-3)" "unprognostic (1.83e-1)" "unprognostic (6.83e-2)" "unprognostic (9.26e-3)" "unprognostic (1.55e-2)" "unprognostic (9.22e-2)" "unprognostic (3.24e-2)" "unprognostic (2.96e-1)" "unprognostic (1.18e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.67e-1)" "unprognostic (4.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.88e-2)" 36.6 19.5 8.5 15.6 9.2 6.1 41.7 5.4 9.7 15.2 29.7 10.6 9.4 23.3 18.3 13.3 20.5 15.7 12.4 98.3 7.8 8.1 37.2 60.3 10.6 8.8 10.0 7.0 17.1 17.8 9.8 6.8 5.1 9.2 15.6 25.0 11.6 20.4 12.5 64.6 9.0 37.1 19.6 10.2 8.0 19.1 12.6 7.2 40.9 16.1 38.0 13.1 14.2 10.6 18.6 22.6 5.6 10.7 20.2 13.0 8.9 8.7 8.2 17.7 12.9 42.7 13.8 8.6 12.9 19.2 14.0 13.8 5.9 16.5 49.8 6.9 10.5 9.1 11.8 23.6 17.8 15.5 15.2 12.3 11.6 15.6 13.0 6.8 24.4 5.4 14.3 9.5 9.9 9.1 11.5 9.4 35.0 14.3 26.5 15.8 15.9 41.4 9.7 8.4 38.7 10.9 31.6 24.9 24.9 15.1 35.6 21.5 12.3 12.4 44.5 12.7 10.8 21.2 19.3 5.2 9.9 5.6 13.9 7.0 15.0 17.3 21.6 13.5 16.6 7.6 0.0 6.1 5.6 10.1 7.8 12.5 18.6 11.4 12.1 19.7 15.5 13.0 13.0 0.7 20.2 10.7 22.6 10.0 8.9 8.5 9.2 5.4 9.7 7.8 8.1 10.0 7.0 9.2 7.2 26.8 26.0 29.0 45.8 13.9 7.3 194.2 61.1 81.7 36.4 33.2 3.9 27.5 135.9 37.9 159.1 14.3 244.0 46.7 28.1 33.2 15.5 29.6 10.4 229.1 96.2 6.4 31.2 19.0 32.4 78.4 42.8 17.2 20.3 6.4 71.1 24.6 30.7 84.2 33.2 241.4 5.7 38.8 30.8 25.1 20.1 15.8 14.2 16.2 172.2 38.7 HADHB MTPB ENSG00000138029 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta" P55084 2 26243170-26290468 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.0;skeletal muscle: 155.6" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 922.0;Distal tubular cells: 441.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037539, HPA037540, HPA066099" Enhanced Supported Mitochondria No No 1100000 Mitochondria "HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618" "unprognostic (5.15e-2)" "unprognostic (8.72e-2)" "unprognostic (8.21e-2)" "unprognostic (8.67e-2)" "unprognostic (7.70e-2)" "unprognostic (2.59e-2)" "unprognostic (7.29e-2)" "unprognostic (9.70e-2)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (2.03e-1)" "unprognostic (8.94e-2)" "prognostic favorable (1.37e-9)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (2.88e-1)" "unprognostic (9.68e-2)" 23.3 45.5 24.8 11.0 24.7 9.9 16.6 16.6 17.4 13.8 21.4 31.1 19.3 43.6 17.1 16.2 20.6 13.9 12.6 126.0 18.0 20.0 45.8 62.4 12.8 16.1 34.8 18.3 16.2 23.7 19.9 13.1 12.6 27.8 15.8 22.8 19.9 27.2 15.9 155.6 13.2 35.0 20.3 29.5 15.3 19.5 15.8 23.8 10.6 22.4 44.9 14.5 18.5 12.8 20.2 45.2 21.5 49.1 23.8 26.8 33.9 23.1 18.3 12.8 22.9 79.0 43.7 13.0 19.5 29.9 20.1 19.7 21.8 22.6 11.6 13.7 31.9 22.6 18.3 21.2 27.6 24.7 26.1 18.5 26.6 10.9 42.7 33.9 21.5 20.4 42.3 45.5 20.9 34.0 34.3 37.2 18.0 22.3 18.8 41.9 17.0 12.0 41.5 8.9 34.8 19.9 13.3 42.2 22.0 41.3 32.9 6.1 21.1 33.4 38.1 51.2 16.0 23.6 38.4 25.7 19.0 19.9 17.8 14.0 14.1 21.2 20.4 21.8 34.3 18.8 21.0 49.1 18.9 14.2 43.4 18.1 20.2 19.3 17.6 45.2 14.8 18.0 16.3 21.5 23.8 33.2 15.3 26.8 33.9 24.8 24.7 16.6 17.4 18.0 20.0 34.8 18.3 27.8 23.8 44.7 32.2 48.9 103.6 55.2 29.0 922.0 127.4 46.8 42.1 92.5 53.0 177.3 441.0 96.4 60.4 68.1 196.9 116.8 50.2 61.8 59.6 61.5 62.2 218.5 127.1 12.7 71.9 67.5 100.7 74.5 52.3 80.0 84.4 77.5 85.7 52.4 56.5 91.7 59.1 244.7 72.5 71.1 92.4 75.6 46.1 47.8 156.1 48.0 100.9 85.2 HAX1 "HCLSBP1, HS1BP1" ENSG00000143575 "HCLS1 associated protein X-1" O00165 1 154272511-154275875 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055141, HPA075289" Approved Supported Mitochondria NA NA Mitochondria "HPA055141: AB_2682714, HPA075289: AB_2686742" "unprognostic (1.32e-1)" "unprognostic (2.68e-1)" "unprognostic (9.50e-2)" "unprognostic (6.93e-2)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (2.20e-1)" "unprognostic (9.09e-3)" "unprognostic (3.09e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (3.96e-1)" 24.0 25.4 28.6 16.0 33.9 12.2 29.2 15.1 36.6 24.9 24.8 21.9 22.9 18.6 20.2 42.7 27.7 24.5 20.2 59.5 24.7 26.3 32.1 61.7 17.3 20.3 25.8 20.3 29.3 47.8 21.0 35.2 18.4 23.5 26.1 25.0 26.6 52.0 26.3 90.4 17.8 27.8 25.1 22.6 23.2 23.9 31.3 17.0 23.8 32.4 45.8 27.7 27.0 18.6 39.1 34.9 59.1 39.6 30.9 51.8 42.8 20.5 17.6 14.9 32.7 18.5 20.7 24.2 19.6 32.2 41.6 38.7 23.3 23.2 30.0 28.5 33.2 19.5 17.8 34.2 27.1 32.2 30.7 25.6 14.6 14.5 20.1 41.3 30.3 31.7 19.2 50.2 31.2 37.5 14.6 23.1 44.0 28.4 44.8 26.7 49.6 30.4 25.1 16.5 49.0 38.6 21.6 11.0 57.6 21.9 11.5 23.0 22.9 17.5 42.5 59.3 25.7 35.1 83.9 11.5 17.3 23.3 18.1 27.0 52.3 54.5 56.2 26.4 28.0 28.5 58.3 28.4 59.1 34.2 33.5 39.1 39.1 43.1 38.7 34.0 38.2 51.8 41.2 17.2 30.9 39.6 34.9 50.8 42.8 28.6 33.9 15.1 36.6 24.7 26.3 25.8 20.3 23.5 17.0 26.8 32.8 105.0 105.1 66.2 57.5 96.8 56.0 32.1 31.8 43.6 45.2 70.2 154.2 76.6 107.7 63.1 62.2 46.7 92.7 108.3 57.2 80.6 98.1 74.9 86.5 38.1 55.3 44.8 55.3 88.4 56.7 70.8 82.7 180.3 58.5 75.4 79.5 58.8 58.4 123.1 86.4 58.2 76.2 186.3 97.5 66.9 74.3 99.1 65.0 89.4 HIGD1A "DKFZP564K247, HIG1, RCF1A" ENSG00000181061 "HIG1 hypoxia inducible domain family member 1A" Q9Y241 3 42784298-42804531 "Predicted membrane proteins" "Electron transport, Respiratory chain, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 535.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 89.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043336 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA043336: AB_10795039" "unprognostic (6.46e-2)" "unprognostic (3.72e-3)" "prognostic favorable (2.12e-4)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (3.53e-1)" "unprognostic (3.70e-1)" "unprognostic (8.45e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-1)" "unprognostic (1.24e-1)" "unprognostic (8.94e-2)" "prognostic favorable (3.99e-8)" "unprognostic (7.37e-2)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" 27.7 30.4 50.1 15.5 43.4 9.6 20.4 20.3 56.4 18.3 63.8 25.2 10.8 35.2 15.7 24.8 36.7 13.5 18.8 68.6 43.2 43.3 45.9 78.4 15.3 16.0 54.4 35.9 12.8 12.8 14.7 29.2 17.2 50.9 24.4 67.3 21.8 16.6 26.8 34.9 15.0 28.4 22.8 58.8 13.0 31.6 14.7 20.7 8.9 28.1 30.6 16.9 20.1 25.0 11.9 89.9 25.9 26.6 12.3 18.8 30.1 27.4 15.4 34.3 28.1 87.8 52.5 33.4 37.1 30.5 36.4 33.4 27.2 28.0 16.8 22.3 32.4 22.6 16.6 27.5 40.9 45.5 24.1 30.4 51.9 27.7 50.3 40.1 29.8 24.5 54.4 45.0 27.8 38.8 18.1 31.9 25.6 51.2 18.0 50.7 11.2 16.4 10.9 28.8 23.3 37.6 13.4 24.3 11.9 89.7 68.2 14.5 18.9 32.5 24.7 35.0 35.7 24.7 22.5 27.9 21.5 19.5 60.1 38.3 16.8 34.7 34.7 28.3 31.7 16.6 16.9 14.7 25.9 15.4 22.7 13.7 11.9 15.1 15.1 16.3 8.5 12.9 15.3 14.9 12.3 26.6 89.9 18.8 30.1 50.1 43.4 20.3 56.4 43.2 43.3 54.4 35.9 50.9 20.7 50.6 73.8 43.3 134.0 116.5 33.4 319.5 79.0 48.2 60.3 130.9 9.8 99.0 535.5 105.9 6.7 57.3 183.7 93.5 127.6 162.8 82.5 160.2 92.2 169.5 69.4 27.0 78.7 55.3 46.3 9.1 28.4 70.1 167.0 114.6 120.5 121.0 198.7 300.1 49.1 213.1 25.1 77.6 125.8 135.9 72.8 178.8 250.8 45.7 135.9 173.3 HIGD2A "MGC2198, RCF1B" ENSG00000146066 "HIG1 hypoxia inducible domain family member 2A" Q9BW72 5 176388747-176389771 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA042715 Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA042715: AB_2678127" "unprognostic (9.24e-2)" "unprognostic (6.31e-3)" "unprognostic (7.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.94e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (2.39e-1)" "unprognostic (3.19e-1)" "unprognostic (1.98e-2)" "unprognostic (3.11e-3)" "unprognostic (9.56e-2)" "unprognostic (2.39e-2)" "unprognostic (1.45e-1)" "unprognostic (8.09e-2)" "unprognostic (1.78e-1)" "unprognostic (9.65e-2)" 37.2 38.5 31.4 33.5 36.0 34.9 37.5 21.4 33.2 26.8 43.8 22.5 29.7 36.7 25.7 31.1 47.0 31.5 39.4 80.0 28.5 26.6 46.3 56.1 30.1 54.1 30.3 20.0 33.2 42.6 36.6 28.8 26.4 21.0 41.2 30.9 31.2 64.0 32.6 115.9 27.8 38.1 43.3 25.9 37.3 31.6 28.8 15.0 63.1 42.3 53.8 34.3 42.1 28.7 70.4 104.6 25.5 107.7 31.1 67.6 88.9 17.9 31.7 19.0 32.1 19.9 38.1 49.8 11.3 21.6 33.0 41.6 33.1 38.0 32.7 27.6 20.6 40.3 23.2 28.7 50.7 13.2 76.6 45.1 16.1 32.7 45.3 28.0 25.1 43.9 48.3 42.2 18.6 22.6 24.3 27.7 27.5 17.8 65.9 24.2 59.3 28.5 31.9 22.4 34.6 34.9 27.7 14.1 59.1 51.6 29.9 20.0 26.7 12.9 54.6 55.5 20.3 32.6 42.3 17.3 22.5 23.3 20.6 23.5 30.7 36.6 26.6 29.1 45.1 14.1 25.5 84.5 23.8 46.3 106.5 45.8 70.4 64.9 53.5 104.6 52.2 59.6 55.6 14.4 31.1 107.7 68.6 67.6 88.9 31.4 36.0 21.4 33.2 28.5 26.6 30.3 20.0 21.0 15.0 68.5 61.2 245.0 289.8 206.3 55.1 130.4 180.9 116.4 104.6 172.7 11.8 187.5 452.6 160.5 55.4 114.7 272.4 23.3 206.0 150.2 154.5 216.1 128.0 198.8 329.3 62.0 256.0 111.7 344.3 44.7 129.8 304.5 244.6 408.4 365.8 77.7 132.6 412.7 79.9 405.0 38.4 116.4 130.6 108.0 81.6 196.7 234.3 221.4 328.6 443.0 HIGD2B HIGD2BP ENSG00000175202 "HIG1 hypoxia inducible domain family member 2B" Q4VC39 15 72675783-72686149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 11.6" "Group enriched" "Detected in some" 13 "Early spermatids: 11.0;Late spermatids: 7.1;Spermatocytes: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0" "HPA019016, HPA042715" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA019016: AB_1850711, HPA042715: AB_2678127" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.24e-3)" "unprognostic (5.09e-2)" "unprognostic (3.34e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (6.98e-2)" "unprognostic (3.90e-1)" "unprognostic (8.80e-2)" "unprognostic (6.11e-4)" "unprognostic (6.95e-2)" "unprognostic (2.97e-1)" "unprognostic (1.11e-2)" "unprognostic (3.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.6 0.2 0.0 0.7 0.0 1.3 0.7 1.1 0.0 0.0 0.4 0.0 0.6 0.6 0.8 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.2 0.0 0.6 0.0 1.0 0.0 0.5 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.9 0.9 0.7 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 15.1 0.9 0.1 0.1 0.0 0.0 0.1 HK1 ENSG00000156515 "Hexokinase 1" P19367 10 69269984-69401884 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycolysis, Immunity, Inflammatory response, Innate immunity" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 307.9;Horizontal cells: 287.6;Late spermatids: 870.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007043, HPA007044, CAB010052" Supported Supported Mitochondria NA NA 16000000 Mitochondria "CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049" "unprognostic (8.80e-2)" "unprognostic (1.78e-1)" "unprognostic (2.03e-1)" "unprognostic (2.00e-3)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (4.29e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-3)" "unprognostic (1.12e-1)" "unprognostic (1.37e-3)" "unprognostic (7.25e-2)" "unprognostic (1.40e-2)" "unprognostic (2.00e-3)" "unprognostic (3.86e-2)" 17.5 10.5 21.1 19.9 30.4 23.5 15.8 40.0 48.6 16.6 16.9 10.1 7.6 6.3 13.5 9.4 44.8 15.2 12.6 61.6 19.8 23.3 10.8 4.4 17.2 14.3 19.8 31.3 9.0 4.6 12.5 14.7 22.6 31.3 25.5 15.4 21.2 21.5 26.8 62.1 30.7 8.6 25.6 9.7 13.3 20.3 28.9 10.6 18.9 33.6 32.6 23.0 25.8 23.1 11.4 25.5 17.8 39.3 8.9 23.0 29.6 17.7 10.1 13.6 12.9 15.2 11.4 8.6 17.7 46.6 23.7 25.7 2.9 2.0 1.3 14.0 29.7 17.2 15.6 12.7 39.6 22.7 11.8 9.9 44.2 10.8 0.2 17.3 0.8 33.5 17.2 23.1 33.9 75.8 29.8 24.6 6.6 73.7 9.3 32.4 29.5 5.1 2.2 20.8 9.1 45.1 7.8 8.3 0.1 16.4 21.0 13.9 16.4 20.2 39.4 11.7 20.1 21.5 2.9 25.2 35.5 16.2 19.5 24.7 11.3 7.4 3.1 46.0 23.3 10.2 17.8 27.3 13.4 14.0 39.3 23.0 11.4 16.2 15.8 25.5 6.8 14.5 11.5 6.6 8.9 39.3 2.9 17.8 29.6 21.1 30.4 40.0 48.6 19.8 23.3 19.8 31.3 31.3 10.6 23.8 29.6 15.8 44.3 42.8 67.3 110.0 7.6 32.1 31.8 26.2 51.1 51.0 11.6 26.4 307.9 34.4 10.3 23.3 26.9 78.8 26.0 25.9 22.0 0.8 45.7 287.6 18.0 25.8 31.3 870.1 14.1 40.6 35.4 24.4 21.8 29.7 36.4 11.5 17.3 0.7 85.2 19.4 42.8 4.3 4.4 45.2 99.4 25.4 12.6 42.9 HK2 ENSG00000159399 "Hexokinase 2" P52789 2 74833981-74893359 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 87.9;Enterocytes: 116.3;Paneth cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 26.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 54.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028587, HPA061711" Enhanced Supported Vesicles,Centrosome,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "Vesicles, Centrosome" "HPA028587: AB_10602605, HPA061711: " "unprognostic (1.28e-1)" "unprognostic (1.52e-3)" "unprognostic (3.02e-1)" "unprognostic (3.63e-2)" "unprognostic (1.69e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (2.85e-2)" "unprognostic (2.57e-1)" "unprognostic (2.17e-1)" "unprognostic (4.43e-3)" "unprognostic (2.24e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.20e-1)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (7.67e-2)" 27.0 2.2 4.4 9.5 5.0 20.4 10.8 0.7 4.5 5.3 23.2 7.3 5.7 1.3 2.6 40.1 13.6 4.8 9.1 8.3 2.8 2.3 2.1 1.4 16.5 5.0 8.5 1.1 14.9 3.5 1.1 1.7 13.2 5.4 4.0 19.2 9.6 10.3 0.5 29.3 9.7 8.9 1.7 10.9 7.4 8.7 24.8 7.4 4.3 7.1 22.3 9.2 29.0 8.3 0.8 6.2 26.2 7.1 0.0 0.8 2.0 16.5 0.1 3.8 14.0 32.9 3.4 14.3 6.4 9.4 7.3 10.5 13.2 3.0 12.0 6.2 3.0 9.4 5.7 17.5 13.6 21.2 3.4 3.7 16.3 3.8 18.2 10.4 23.8 26.9 5.8 14.8 13.8 24.3 8.2 3.4 6.9 14.2 0.0 2.1 11.8 5.7 24.4 13.9 15.7 11.5 9.3 8.1 9.3 4.4 23.4 2.8 13.7 4.1 20.9 8.2 5.8 1.1 3.8 2.8 23.3 4.1 9.6 11.7 8.3 2.3 6.0 54.3 17.5 6.0 6.6 7.1 26.2 0.1 5.7 0.3 0.6 0.4 0.1 6.2 0.8 0.7 0.7 5.9 0.0 3.7 0.1 0.8 2.0 4.4 5.0 0.7 4.5 2.8 2.3 8.5 1.1 5.4 7.4 14.9 37.6 2.9 5.5 45.8 6.2 6.0 7.6 0.0 6.8 5.2 78.5 0.7 0.0 4.4 87.9 3.6 116.3 0.0 3.8 12.3 8.5 17.2 21.9 0.0 15.7 20.6 37.5 1.3 14.6 32.5 13.6 18.9 21.9 1.0 32.2 4.3 18.4 86.0 7.4 0.0 43.3 12.9 2.3 3.1 4.5 49.8 6.9 2.2 19.9 69.9 HMGCS2 ENSG00000134240 "3-hydroxy-3-methylglutaryl-CoA synthase 2" P54868 1 119747996-119768905 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 257.0" "Cell type enhanced" "Detected in many" 24 "Hepatocytes: 901.4;Mucus-secreting cells: 249.3;Undifferentiated cells: 248.3" "Cancer enhanced" "Detected in many" "liver cancer: 441.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "OE19: 35.4;RT4: 63.6" "Low region specificity" "Detected in all" "HPA027423, HPA027442, CAB032906" Enhanced Supported Mitochondria NA NA 820000 Mitochondria "CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277" "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "unprognostic (7.62e-2)" "unprognostic (1.49e-2)" "prognostic favorable (2.43e-7)" "unprognostic (9.68e-2)" "unprognostic (3.21e-2)" "prognostic favorable (2.17e-4)" "unprognostic (1.20e-1)" "unprognostic (6.42e-2)" "prognostic favorable (3.43e-5)" "unprognostic (9.57e-2)" "unprognostic (2.31e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" 0.3 0.1 0.3 8.7 0.3 0.0 20.6 0.3 0.3 0.3 30.8 0.4 0.3 13.8 0.3 0.3 0.7 0.1 4.4 42.0 0.4 0.0 7.4 257.0 0.8 0.3 0.3 0.3 0.3 1.4 0.0 0.3 0.8 0.7 3.8 19.8 18.9 5.1 0.3 1.4 1.8 12.2 1.9 0.3 0.3 8.1 6.1 0.3 0.4 0.3 0.6 2.1 7.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 35.4 0.0 0.0 0.2 0.2 0.0 63.6 0.0 0.2 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.3 0.7 0.3 3.0 6.7 7.5 3.6 0.1 0.0 4.5 68.8 0.0 0.0 29.6 0.0 0.2 0.0 0.0 1.5 0.0 76.1 0.0 0.0 0.1 0.0 10.3 4.6 901.4 0.2 0.0 70.2 16.0 17.8 2.7 1.4 0.0 5.0 0.0 249.3 0.0 0.1 126.7 0.0 0.3 0.0 6.5 0.0 0.5 0.4 0.3 7.9 0.0 248.3 15.4 HPDL "4-HPPD-L, GLOXD1, MGC15668" ENSG00000186603 "4-hydroxyphenylpyruvate dioxygenase like" Q96IR7 1 45326905-45328533 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 38.4" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 24.6;Undifferentiated cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 47.2;HL-60: 13.3;NB-4: 16.6;SK-BR-3: 29.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 35 "hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8" "HPA031997, HPA057346" Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA031997: AB_10602909, HPA057346: AB_2683415" "prognostic favorable (1.81e-4)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (1.02e-2)" "unprognostic (6.71e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-1)" "unprognostic (1.63e-1)" "prognostic favorable (1.03e-4)" "unprognostic (1.08e-3)" "unprognostic (2.52e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" "unprognostic (1.43e-1)" 0.9 0.7 2.7 3.1 4.2 3.6 1.0 7.6 3.4 2.0 8.4 2.4 0.0 5.4 1.0 1.3 3.6 1.0 1.8 3.0 2.7 2.4 0.7 0.2 0.8 2.6 2.5 1.8 1.0 0.3 0.2 0.4 5.1 3.1 1.7 7.1 38.4 1.3 0.6 3.3 1.1 4.7 0.9 2.2 2.8 7.8 1.4 0.6 6.4 1.0 4.2 2.3 0.8 1.6 3.1 0.7 0.0 0.3 2.1 1.5 0.8 0.0 0.4 0.1 0.0 0.0 0.1 47.2 0.6 0.0 0.8 0.2 11.7 3.1 2.4 0.1 0.6 0.0 2.8 0.0 0.1 0.2 0.0 0.1 0.2 5.1 0.0 0.3 13.3 0.3 0.5 0.1 0.5 0.0 0.0 0.9 0.0 0.0 2.2 0.1 5.8 8.6 16.6 0.2 9.1 0.0 2.6 0.0 7.7 0.1 0.1 9.3 0.6 6.0 29.8 4.6 0.6 0.0 2.5 0.4 0.0 0.1 0.4 0.0 0.3 0.1 8.3 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 1.5 3.1 0.7 1.2 0.7 0.3 0.9 0.8 0.0 2.1 0.0 0.0 0.4 0.8 2.7 4.2 7.6 3.4 2.7 2.4 2.5 1.8 3.1 0.6 0.0 0.0 1.9 1.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 24.6 3.3 0.5 0.1 0.3 0.7 0.0 0.0 1.7 0.4 0.9 0.0 0.0 2.1 0.0 1.2 0.6 0.0 0.0 0.3 0.0 0.0 0.0 3.0 0.0 1.1 0.0 0.0 0.3 0.3 0.0 0.4 0.0 2.1 1.0 4.2 0.0 6.6 1.0 HSCB "DNAJC20, HSC20, Jac1" ENSG00000100209 "HscB mitochondrial iron-sulfur cluster cochaperone" Q8IWL3 22 28742031-28757515 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018447, HPA031518" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA018447: AB_1853867, HPA031518: AB_2673919" "unprognostic (8.19e-3)" "unprognostic (6.48e-2)" "unprognostic (9.62e-3)" "prognostic favorable (3.78e-4)" "unprognostic (3.30e-1)" "unprognostic (7.02e-2)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "unprognostic (5.83e-2)" "unprognostic (7.38e-3)" "unprognostic (4.44e-1)" "unprognostic (2.81e-1)" "unprognostic (1.54e-3)" "unprognostic (2.19e-1)" "unprognostic (3.39e-1)" "unprognostic (2.12e-1)" "prognostic favorable (8.38e-4)" 9.6 18.8 13.1 9.2 13.9 4.9 12.4 13.7 12.9 14.1 11.6 9.1 20.3 13.7 11.5 8.8 11.8 10.4 11.4 9.6 12.3 8.3 12.9 29.5 7.3 15.5 15.8 9.0 16.5 15.2 6.2 16.1 8.7 10.6 15.9 7.7 8.2 28.2 17.5 14.6 9.2 10.0 8.9 12.2 10.9 12.8 6.0 13.2 6.9 14.4 8.1 10.3 15.0 10.5 12.9 11.3 7.7 14.4 9.7 8.5 5.8 9.3 6.0 2.5 3.8 4.6 11.8 4.8 6.9 9.7 10.3 6.3 2.6 3.4 10.6 3.3 3.8 2.5 6.6 4.8 4.5 4.9 10.0 19.5 3.6 4.7 7.4 9.8 6.6 5.4 7.9 9.9 5.7 9.0 5.3 7.8 3.2 5.6 9.3 4.1 13.5 3.0 6.1 6.0 10.3 14.8 6.0 7.8 11.9 11.1 2.7 8.5 7.7 3.8 14.6 18.4 2.1 6.0 4.1 4.1 14.1 7.4 13.3 6.2 13.1 10.7 9.1 9.9 4.9 9.3 7.7 7.9 3.6 6.3 14.4 7.6 12.9 6.4 7.4 11.3 9.9 7.0 8.5 0.4 9.7 11.0 5.9 4.8 5.8 13.1 13.9 13.7 12.9 12.3 8.3 15.8 9.0 10.6 13.2 20.8 15.8 20.1 22.7 10.3 4.8 6.0 22.9 32.1 26.1 19.2 5.9 13.2 24.9 21.9 3.3 15.8 10.3 0.0 24.7 12.0 16.6 18.9 22.0 33.0 23.7 4.8 19.0 17.2 14.9 2.6 17.3 18.5 13.5 19.8 13.1 9.7 21.0 7.0 11.0 37.1 8.1 6.5 15.6 12.2 16.1 13.7 11.1 17.8 19.7 12.8 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122146-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 42.9;Rod photoreceptor cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Supported "Vesicles,Intermediate filaments,Mitochondria" No No Mitochondria "Vesicles, Intermediate filaments" "HPA045745: AB_2679440" "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favorable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 6.0 13.4 16.9 5.6 22.1 3.1 10.2 16.5 18.7 9.7 5.8 9.0 6.7 5.1 11.3 9.4 6.7 11.1 6.0 13.1 14.5 19.5 9.1 4.1 7.6 6.8 11.5 13.2 19.6 4.3 12.6 16.7 7.6 20.8 8.6 6.1 10.5 6.3 10.0 15.2 6.5 4.9 9.4 7.4 7.0 5.3 13.5 8.7 8.6 23.2 5.0 7.5 6.6 6.2 7.4 3.1 14.5 6.6 4.2 6.5 4.4 5.6 6.6 30.5 10.4 11.1 8.0 7.7 7.3 6.9 9.2 4.9 7.3 9.8 11.7 13.1 6.5 10.1 4.0 16.4 6.3 14.6 2.5 10.0 5.6 4.4 16.7 11.6 8.7 10.2 6.1 10.7 12.9 8.3 11.7 10.9 16.0 11.6 14.8 18.1 14.0 18.9 8.7 15.5 3.3 6.9 18.6 10.7 4.3 8.8 6.2 14.4 10.9 18.2 2.9 19.9 16.0 18.2 5.1 9.3 10.4 12.6 7.4 5.8 23.5 18.6 19.1 12.2 6.3 9.4 14.5 5.2 11.7 4.4 3.8 5.6 5.4 4.7 5.2 3.1 7.4 6.1 6.5 6.2 4.2 6.6 0.0 5.6 4.4 16.9 22.1 16.5 18.7 14.5 19.5 11.5 13.2 20.8 8.7 11.9 13.1 5.1 4.6 4.2 18.8 14.1 2.5 10.7 7.9 3.5 13.7 5.9 5.0 6.5 24.6 5.7 2.9 0.0 6.0 4.8 5.4 4.7 1.1 2.9 10.4 42.9 9.1 7.4 6.3 8.8 5.5 5.3 5.0 2.8 3.0 22.6 5.7 2.9 9.6 6.2 38.1 0.0 5.2 27.0 27.0 6.0 7.3 6.7 4.1 3.3 HSPA9 "GRP75, HSPA9B, mot-2, mthsp75, PBP74" ENSG00000113013 "Heat shock protein family A (Hsp70) member 9" P38646 5 138554882-138575444 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000898, CAB005219" Supported Supported Mitochondria NA NA 3100000 Mitochondria "CAB005219: AB_647720, HPA000898: AB_1079032" "prognostic unfavorable (2.93e-4)" "unprognostic (1.86e-1)" "prognostic favorable (4.53e-4)" "unprognostic (3.73e-2)" "unprognostic (2.33e-1)" "unprognostic (9.06e-2)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (9.85e-2)" "unprognostic (2.53e-1)" "unprognostic (2.74e-1)" "unprognostic (1.31e-1)" "unprognostic (8.78e-3)" "unprognostic (1.02e-1)" "unprognostic (2.15e-1)" "unprognostic (3.27e-2)" "unprognostic (2.29e-1)" 26.4 76.4 30.9 22.1 33.2 39.8 27.7 24.3 39.5 20.0 28.7 30.4 24.0 27.8 23.1 29.7 28.5 19.1 19.3 55.0 28.2 32.5 59.9 117.7 20.5 22.8 35.5 31.3 28.9 31.9 56.7 25.5 24.6 43.7 25.3 32.7 20.6 26.0 26.4 84.2 24.0 25.7 24.0 29.3 24.6 27.7 18.6 32.0 21.1 41.0 32.8 29.1 23.7 33.1 19.3 24.1 6.6 20.9 20.5 28.3 23.3 32.8 41.5 23.7 45.5 24.9 16.3 48.8 34.8 30.9 39.1 42.6 79.1 35.0 62.9 47.8 25.9 81.7 27.9 63.1 46.7 54.3 31.5 30.9 34.7 37.4 52.7 67.3 34.8 38.5 27.7 70.9 43.2 97.5 18.6 18.5 34.9 43.2 54.2 30.8 40.3 36.5 30.0 34.8 41.2 34.5 41.0 34.3 48.6 43.9 47.3 28.5 21.8 40.3 64.2 131.8 54.2 36.9 40.9 17.7 38.4 24.3 32.0 55.1 66.8 47.8 63.2 47.3 61.5 38.3 6.6 16.9 6.5 24.0 20.9 28.3 19.3 20.6 23.0 24.1 14.1 23.0 22.8 3.9 20.5 20.6 14.1 18.2 23.3 30.9 33.2 24.3 39.5 28.2 32.5 35.5 31.3 43.7 32.0 92.3 107.5 91.5 189.1 78.1 88.6 317.9 48.4 133.8 137.6 94.2 78.5 173.0 189.0 95.9 8.0 72.1 76.6 0.0 92.2 101.6 79.5 116.1 162.9 146.7 117.6 93.8 70.0 42.4 46.7 9.5 62.5 101.4 79.2 92.0 66.7 103.5 85.4 66.6 68.2 159.6 83.0 45.3 128.1 52.3 83.5 64.5 146.8 88.6 107.5 141.4 HTD2 ENSG00000255154 "Hydroxyacyl-thioester dehydratase type 2" P86397 3 58306262-58318574 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Club cells: 2.3;granulocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066812, HPA077228" Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA066812: AB_2685727, HPA077228: " "unprognostic (1.95e-1)" "unprognostic (3.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.56e-1)" "unprognostic (2.05e-1)" "unprognostic (9.19e-3)" "unprognostic (1.11e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "unprognostic (7.50e-2)" "unprognostic (3.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" 7.9 8.9 9.0 6.6 13.9 6.9 9.4 17.0 11.5 7.4 9.2 6.4 7.1 11.3 8.6 8.5 9.4 7.8 7.1 15.9 7.9 9.3 12.1 16.2 6.9 8.2 8.5 10.7 11.0 12.9 8.8 14.2 6.7 7.8 9.6 10.1 9.7 9.2 9.4 35.2 7.2 9.7 12.6 6.0 9.7 8.6 9.8 6.4 6.8 10.7 19.8 9.2 7.8 8.1 23.9 21.6 23.7 20.4 21.3 26.5 13.5 8.2 6.3 9.6 6.8 8.2 9.2 12.3 11.7 8.9 14.6 12.9 13.7 6.2 16.3 3.5 8.4 11.7 7.2 16.0 10.6 15.0 9.1 11.2 9.8 13.9 11.5 8.9 12.8 9.3 11.3 10.9 15.5 9.4 7.8 12.7 12.1 9.6 15.5 9.1 4.8 8.3 6.5 12.4 8.4 14.2 5.8 6.1 11.7 9.8 12.1 6.0 9.0 7.2 6.8 13.3 10.6 9.1 11.4 7.4 12.4 8.8 11.2 14.3 11.9 21.3 12.7 10.0 9.5 7.5 13.5 17.3 23.7 18.7 20.4 20.1 23.9 18.7 23.5 17.5 23.8 26.5 20.2 18.4 21.3 16.7 21.6 13.4 13.5 9.0 13.9 17.0 11.5 7.9 9.3 8.5 10.7 7.8 6.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTRA2 "OMI, PARK13, PRSS25" ENSG00000115317 "HtrA serine peptidase 2" O43464 2 74529377-74533348 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Apoptosis "Hydrolase, Protease, Serine protease" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004004, HPA006602, HPA027366" Uncertain Supported Mitochondria NA NA Mitochondria "CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301" "unprognostic (3.09e-1)" "unprognostic (4.06e-2)" "unprognostic (2.82e-1)" "unprognostic (2.58e-2)" "unprognostic (1.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (7.77e-8)" "unprognostic (2.12e-3)" "unprognostic (4.18e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-2)" "unprognostic (8.15e-2)" "unprognostic (7.23e-3)" "unprognostic (4.03e-1)" "unprognostic (1.73e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-2)" 16.4 12.7 10.6 14.9 11.3 18.9 12.9 10.7 17.7 12.3 12.8 12.6 9.7 12.6 12.9 6.9 10.7 10.6 9.0 12.9 11.6 8.7 13.1 11.4 11.3 13.2 10.8 11.9 18.7 12.9 10.5 9.0 10.4 13.5 11.6 5.5 10.2 13.1 9.2 17.6 9.0 12.6 11.8 9.1 17.3 11.8 13.9 12.6 12.2 16.8 12.6 9.3 10.4 15.2 12.9 9.4 5.9 8.1 5.5 7.8 7.0 8.0 5.0 5.7 5.0 7.9 3.2 15.4 7.0 3.7 4.2 2.5 9.2 3.6 7.3 5.5 4.0 11.8 9.1 6.8 8.0 1.1 16.4 13.6 14.6 4.8 8.1 7.4 6.8 10.7 3.8 5.4 8.0 6.8 6.8 5.3 12.3 19.1 10.8 3.2 5.3 12.6 14.4 4.8 9.6 14.3 8.6 16.3 8.0 3.5 3.3 6.7 8.0 3.8 8.6 13.3 3.4 3.9 6.6 3.7 7.4 9.1 14.9 15.6 13.3 4.4 4.7 6.4 10.8 5.9 5.9 8.1 4.8 7.3 6.2 7.8 12.9 7.3 6.2 9.4 11.6 6.3 6.4 3.2 5.5 4.7 6.6 7.4 7.0 10.6 11.3 10.7 17.7 11.6 8.7 10.8 11.9 13.5 12.6 0.0 3.7 23.9 16.6 18.3 12.1 0.8 17.8 9.4 9.1 10.4 0.0 20.6 29.9 26.3 24.4 29.4 13.6 116.8 15.4 31.8 26.6 15.0 26.5 10.6 27.5 9.5 8.6 16.5 9.5 32.5 23.0 17.8 28.7 36.1 10.3 19.0 22.8 14.2 19.4 29.1 11.9 25.8 26.4 55.8 34.3 19.3 16.9 25.4 19.8 12.9 IBA57 "C1orf69, FLJ12734" ENSG00000181873 "IBA57, iron-sulfur cluster assembly" Q5T440 1 228165815-228182257 "Disease related genes, Predicted intracellular proteins" "Heme biosynthesis" Transferase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030555, HPA030556, HPA030557" Approved Supported Mitochondria NA NA Mitochondria "HPA030555: AB_2673522, HPA030556: AB_2673523, HPA030557: AB_10670433" "unprognostic (3.00e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-1)" "unprognostic (1.29e-2)" "unprognostic (1.34e-1)" "unprognostic (8.16e-3)" "unprognostic (1.03e-1)" "unprognostic (6.11e-2)" "unprognostic (7.01e-2)" "unprognostic (8.00e-3)" "unprognostic (2.87e-2)" "unprognostic (1.61e-1)" "prognostic favorable (1.71e-9)" "unprognostic (4.94e-2)" "unprognostic (5.02e-1)" "unprognostic (5.04e-3)" "unprognostic (7.14e-2)" 5.2 7.5 4.7 5.3 5.5 8.2 6.1 7.8 5.1 4.7 4.5 4.1 3.8 4.5 5.3 4.2 4.7 3.8 6.8 7.9 4.9 3.2 5.8 9.5 6.3 12.7 3.5 4.5 5.9 18.3 7.4 2.9 6.4 5.2 4.5 3.9 4.9 5.3 3.1 22.9 8.0 5.7 4.9 3.5 4.9 5.3 3.1 3.2 5.0 5.2 6.4 4.7 3.6 3.7 2.8 3.4 4.7 1.7 2.8 3.5 0.9 3.3 3.5 3.8 1.7 2.0 2.3 4.6 2.0 1.0 1.6 0.9 7.3 2.9 7.2 4.5 2.2 0.9 6.2 2.9 4.4 1.4 1.5 6.3 4.3 4.3 3.5 1.7 4.8 4.8 3.1 2.7 1.8 2.2 1.5 2.2 4.6 7.1 3.4 1.5 2.6 4.8 2.9 2.8 4.6 4.0 6.0 4.3 1.2 2.3 6.9 5.8 4.0 3.4 10.5 2.6 0.7 8.3 6.6 5.1 4.3 4.0 2.9 5.1 2.5 1.2 3.7 1.9 2.0 3.2 4.7 1.7 0.8 2.3 1.4 3.5 1.5 1.9 1.8 1.2 2.8 2.8 2.6 2.7 2.8 1.5 3.4 1.7 0.9 4.7 5.5 7.8 4.6 4.9 3.2 3.5 4.5 5.2 3.2 8.9 14.1 9.1 7.6 7.2 5.4 13.5 5.1 4.0 13.6 0.0 11.8 9.6 6.6 4.4 17.2 6.7 9.9 23.3 5.8 7.0 4.2 5.1 15.0 7.3 4.8 3.2 6.9 5.5 4.3 24.4 3.4 4.4 6.8 2.8 5.6 5.4 7.1 5.3 6.7 5.4 19.9 6.5 4.1 11.9 11.2 5.3 13.6 5.4 9.5 7.4 IDH2 ENSG00000182054 "Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial" P48735 15 90083045-90102504 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.2;skeletal muscle: 190.7" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 682.3;Distal tubular cells: 989.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007831 Enhanced Supported Mitochondria NA NA 53000000 Mitochondria "HPA007831: AB_1851397" "unprognostic (2.45e-2)" "prognostic favorable (5.15e-5)" "unprognostic (2.92e-1)" "unprognostic (1.53e-1)" "unprognostic (3.53e-1)" "unprognostic (8.46e-2)" "unprognostic (3.83e-2)" "unprognostic (2.55e-3)" "unprognostic (1.86e-2)" "unprognostic (1.89e-2)" "unprognostic (2.76e-1)" "unprognostic (4.90e-2)" "unprognostic (2.19e-3)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" 5.4 2.0 14.9 10.1 16.6 22.6 8.8 4.9 19.1 6.4 16.2 13.8 12.4 16.1 5.9 15.3 23.7 6.0 9.4 126.2 10.2 9.3 25.0 93.2 6.9 15.8 14.4 12.0 3.0 25.1 8.4 3.3 15.1 11.9 13.3 14.5 6.0 28.0 21.9 190.7 11.0 13.9 15.8 11.0 7.5 27.9 1.2 7.6 28.2 3.4 69.0 13.6 11.0 8.6 16.8 32.8 17.2 56.3 22.2 29.5 31.2 10.3 5.9 30.6 30.3 4.3 5.2 26.0 13.0 19.8 12.3 13.2 2.8 9.0 12.3 3.7 10.7 11.7 3.6 4.4 3.9 5.8 24.2 2.9 21.0 2.2 20.6 5.2 14.4 21.3 11.0 2.2 2.9 2.3 14.9 25.1 43.6 3.1 10.6 9.4 30.2 69.1 22.4 9.1 14.2 2.4 58.6 21.9 36.7 18.9 12.5 44.1 22.4 16.1 64.4 5.2 17.8 51.9 44.5 6.0 21.9 3.2 2.8 6.0 17.5 3.2 1.4 7.0 30.3 12.6 9.0 26.4 17.2 26.1 48.0 12.4 16.8 18.7 29.5 32.8 9.8 10.2 18.2 5.1 22.2 56.3 17.8 15.9 31.2 14.9 16.6 4.9 19.1 10.2 9.3 14.4 12.0 11.9 7.6 6.0 21.8 67.0 66.5 35.4 5.3 402.1 104.4 56.2 21.6 71.5 9.8 682.3 989.8 188.2 4.7 25.3 53.5 23.3 255.6 386.0 36.6 189.5 30.1 240.4 229.9 9.5 59.3 41.1 60.4 2.5 13.0 70.5 55.6 96.4 122.1 17.5 127.7 132.1 33.2 128.5 5.1 12.9 38.3 0.5 4.5 58.6 479.2 123.2 268.2 90.1 IDH3G ENSG00000067829 "Isocitrate dehydrogenase 3 (NAD(+)) gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favorable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 24.5 34.0 27.7 26.8 47.2 37.1 24.1 37.2 61.5 25.0 28.8 25.7 24.6 34.7 26.6 21.3 31.8 29.4 25.6 50.8 35.0 25.2 40.6 29.5 20.9 25.6 27.3 35.6 31.8 40.5 29.1 24.9 22.5 40.5 21.4 25.2 26.0 34.5 29.8 54.9 36.3 34.9 24.8 20.1 26.9 24.8 16.0 23.3 31.2 24.3 37.1 28.2 24.4 21.1 20.6 45.5 43.7 44.4 23.7 28.8 33.6 29.1 26.9 15.9 22.3 24.9 20.7 19.5 15.2 21.4 27.0 28.7 22.2 22.2 37.1 26.3 24.4 22.1 21.8 24.0 20.7 9.9 12.2 30.7 13.9 36.5 17.8 28.3 19.4 29.4 23.2 15.0 20.8 22.7 17.4 20.6 15.5 7.7 20.4 21.7 40.8 22.0 22.8 7.1 27.1 35.6 19.4 13.6 32.3 30.1 18.2 20.3 13.9 9.5 32.2 15.1 6.8 13.3 16.7 18.2 17.1 10.7 25.1 35.9 28.1 7.0 47.3 28.0 24.0 18.9 42.5 43.9 43.7 21.5 44.4 19.9 19.1 22.0 20.9 45.5 20.6 17.6 19.2 16.3 23.7 43.1 27.9 28.8 33.6 27.7 47.2 37.2 61.5 35.0 25.2 27.3 35.6 40.5 23.3 32.8 32.7 56.5 52.5 71.9 33.9 48.4 43.3 30.8 7.9 48.8 27.5 80.9 175.8 81.7 113.6 44.1 164.4 46.7 79.1 82.6 56.8 36.9 91.2 33.0 116.8 17.5 59.8 43.6 88.9 226.7 49.5 66.0 64.1 101.0 81.8 37.0 65.2 122.8 55.2 192.8 37.1 51.8 69.3 14.0 17.0 67.8 92.7 54.5 93.0 43.8 IFIT3 "CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G" ENSG00000119917 "Interferon induced protein with tetratricopeptide repeats 3" O14879 10 89327894-89340971 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 80.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 80.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 80.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.1;BJ hTERT+ SV40 Large T+: 82.1;BJ hTERT+ SV40 Large T+ RasG12V: 95.4" "Low region specificity" "Detected in all" HPA059914 Approved Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA059914: AB_2684159" "unprognostic (2.81e-1)" "unprognostic (5.62e-2)" "unprognostic (4.94e-2)" "unprognostic (5.25e-3)" "unprognostic (3.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (5.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.72e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (9.80e-3)" "unprognostic (5.09e-2)" 50.5 15.7 14.9 11.3 17.3 22.1 10.6 6.9 17.0 6.8 9.7 7.6 4.1 14.5 8.8 16.8 6.2 10.9 15.1 8.9 14.2 12.9 19.3 17.0 25.9 10.0 13.5 12.4 11.3 4.3 3.8 5.5 22.9 23.0 9.7 5.4 9.2 19.6 8.1 8.1 5.0 11.3 11.1 18.4 26.0 7.2 5.1 12.1 14.3 14.9 5.5 2.9 11.0 5.9 1.6 2.5 80.0 18.4 0.3 2.6 3.2 6.4 0.4 0.1 1.7 7.5 8.1 0.0 4.1 35.1 82.1 95.4 0.3 9.2 0.5 1.8 6.6 19.1 5.8 0.1 0.8 6.1 0.9 0.0 2.4 1.8 0.2 4.3 0.7 2.1 5.0 0.1 7.1 0.6 3.1 0.5 0.2 0.1 1.4 2.1 0.0 1.5 1.9 0.1 0.0 2.0 1.5 0.5 0.4 2.3 3.0 0.0 0.0 0.7 0.1 16.1 0.2 0.2 0.8 0.6 1.3 0.2 2.2 1.0 2.3 1.8 0.1 1.9 3.0 1.3 15.2 7.5 26.6 0.7 16.0 0.1 1.6 1.1 0.5 2.5 1.4 0.7 0.8 80.0 0.3 18.4 0.5 2.6 3.2 14.9 17.3 6.9 17.0 14.2 12.9 13.5 12.4 23.0 12.1 47.6 8.5 5.9 8.9 2.9 7.9 30.7 12.7 16.0 15.9 8.7 3.9 3.4 18.3 47.8 0.3 46.8 13.4 0.0 31.7 6.8 10.8 7.2 12.8 11.0 32.4 57.2 0.0 15.4 21.3 0.0 28.1 21.7 3.3 10.0 2.5 23.1 19.3 5.1 26.5 8.8 1.8 45.3 10.2 0.9 1.0 1.6 1.6 4.9 2.5 5.5 ILF3 "DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Enhanced Nucleoplasm,Nucleoli,Mitochondria No No 1100000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 31.0 39.0 29.6 45.5 26.8 88.2 34.5 48.3 35.2 34.2 30.2 30.8 35.2 30.3 45.4 31.7 40.5 41.9 32.5 34.0 25.5 20.0 28.1 25.6 34.1 44.9 24.7 27.8 52.8 36.8 34.9 34.9 31.8 32.3 34.9 27.3 35.5 35.1 46.2 50.1 37.7 37.2 33.2 33.3 44.5 32.6 54.3 28.0 58.6 43.4 32.4 41.1 38.5 32.1 18.7 18.7 11.5 14.3 15.4 19.4 8.0 45.7 37.3 60.4 55.2 13.1 18.0 35.2 29.3 24.9 49.2 38.6 42.7 26.6 57.2 29.1 26.3 30.1 41.0 65.2 39.6 44.4 36.5 58.0 74.2 32.9 39.8 18.8 53.4 37.1 17.0 17.7 39.0 43.8 18.8 42.0 33.4 63.3 45.0 28.6 37.7 88.5 85.8 72.5 24.2 41.0 65.2 57.5 39.5 19.6 48.6 66.7 48.5 37.7 30.0 21.8 28.6 25.4 34.3 33.7 40.4 38.4 41.8 57.7 38.6 52.8 69.4 22.6 57.1 43.5 11.5 13.4 7.1 19.4 10.4 16.1 14.7 15.9 17.3 16.8 18.7 15.7 16.0 2.1 15.4 14.3 18.7 15.0 8.0 29.6 26.8 48.3 35.2 25.5 20.0 24.7 27.8 32.3 28.0 92.3 128.4 63.8 84.3 76.5 92.4 59.0 50.9 96.4 131.9 40.1 80.5 65.6 23.2 66.6 12.8 60.9 40.0 46.7 69.0 90.4 57.8 80.9 92.6 46.1 63.0 89.0 109.3 33.7 53.5 14.4 70.8 66.0 37.1 46.9 68.0 70.5 72.3 56.1 58.7 38.2 92.6 32.3 67.0 108.6 117.8 67.2 59.3 68.2 82.6 87.0 IVD ACAD2 ENSG00000128928 "Isovaleryl-CoA dehydrogenase" P26440 15 40405795-40435947 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041391, HPA044250" Enhanced Supported Nucleoplasm,Mitochondria NA NA 66000 Mitochondria Nucleoplasm "HPA041391: AB_2677449, HPA044250: AB_2678875" "unprognostic (9.30e-2)" "unprognostic (3.31e-1)" "unprognostic (1.36e-2)" "unprognostic (4.24e-2)" "unprognostic (7.53e-2)" "unprognostic (1.74e-1)" "prognostic favorable (1.95e-5)" "unprognostic (1.50e-2)" "unprognostic (2.53e-1)" "unprognostic (2.84e-2)" "unprognostic (4.08e-2)" "unprognostic (2.31e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (1.14e-1)" "unprognostic (5.46e-3)" 12.3 32.0 15.4 13.2 20.6 6.7 24.3 14.4 18.0 12.7 13.7 20.5 23.3 12.3 11.8 16.6 8.9 17.2 22.7 30.4 13.8 16.1 28.9 71.9 14.2 10.4 16.1 15.9 19.4 18.9 19.5 23.9 7.4 16.3 21.0 13.0 14.4 11.8 31.9 30.6 3.5 9.8 13.7 14.7 11.0 14.4 11.2 15.7 8.6 55.7 12.2 9.0 11.2 7.9 11.6 34.1 14.3 29.8 14.7 13.5 8.6 8.7 5.3 9.7 17.4 15.4 13.5 0.4 13.5 13.2 17.3 10.8 19.8 7.6 0.3 25.8 17.0 14.9 10.3 18.4 19.9 10.7 12.6 14.8 22.7 15.4 19.0 27.1 9.2 22.6 20.6 6.9 9.6 20.2 20.0 17.1 24.4 1.0 1.1 15.5 13.8 11.4 14.3 8.2 0.5 16.9 16.7 13.3 10.4 20.5 23.7 16.6 9.2 18.6 40.5 8.2 9.4 34.9 40.7 14.5 14.4 9.4 10.1 10.8 21.8 14.9 0.3 13.5 9.2 14.1 5.8 10.2 14.3 13.5 16.1 12.6 11.6 7.5 11.4 22.3 9.9 8.4 11.7 1.3 14.7 29.8 34.1 9.7 8.6 15.4 20.6 14.4 18.0 13.8 16.1 16.1 15.9 16.3 15.7 26.8 46.2 14.3 16.6 2.1 24.6 72.6 45.9 42.8 40.9 41.8 13.7 16.5 81.2 15.9 4.4 18.0 17.7 23.3 13.0 4.8 15.4 16.0 32.5 123.8 25.1 15.9 18.9 17.2 20.2 4.9 19.0 13.9 5.0 31.5 22.5 25.1 14.1 3.5 23.3 60.9 18.9 19.4 13.9 19.0 4.3 0.5 8.2 12.2 33.1 11.2 KIAA0391 "MRPP3, PRORP" ENSG00000100890 KIAA0391 O15091 14 35121846-35277614 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA020459 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA020459: AB_2670449" "unprognostic (6.44e-3)" "unprognostic (8.10e-2)" "unprognostic (7.71e-3)" "unprognostic (4.90e-2)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" "unprognostic (8.67e-2)" "unprognostic (1.94e-2)" "unprognostic (3.25e-4)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (9.67e-5)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (6.65e-2)" 13.9 26.1 18.8 17.6 20.1 12.5 17.5 23.1 21.9 17.4 22.4 20.6 15.6 16.6 13.0 19.4 26.1 14.7 13.2 16.7 17.6 16.3 31.1 29.5 20.9 29.5 20.2 17.7 10.8 16.5 29.8 27.4 13.4 19.2 14.1 24.9 15.8 18.0 21.8 22.2 23.0 16.5 15.0 23.0 18.7 15.8 17.1 20.9 31.2 18.9 21.3 24.8 18.2 16.0 10.0 9.7 10.9 5.4 12.1 25.5 12.4 22.8 18.3 12.7 16.8 13.9 16.5 11.2 15.4 13.8 19.7 17.1 17.3 14.2 25.1 20.1 14.6 5.6 17.8 23.3 26.6 22.3 19.7 7.2 11.3 14.1 36.9 14.4 13.9 12.4 17.6 20.5 18.6 17.2 17.0 28.5 21.6 18.2 7.3 24.0 25.9 21.0 15.3 13.6 19.8 18.1 20.2 21.1 14.5 27.7 23.4 11.8 13.4 19.9 22.1 12.8 17.1 32.2 11.5 21.6 15.2 13.7 11.7 13.2 8.0 18.6 26.3 7.7 15.1 15.9 10.9 5.4 3.4 15.4 5.2 22.4 10.0 23.8 16.6 7.2 7.0 21.2 15.6 6.3 12.1 4.3 9.7 25.5 12.4 18.8 20.1 23.1 21.9 17.6 16.3 20.2 17.7 19.2 20.9 3.0 1.3 1.3 0.5 0.0 1.3 1.5 0.0 1.4 2.3 0.0 0.0 0.8 1.7 1.0 0.0 1.0 1.4 0.0 0.8 0.5 0.8 1.0 2.3 1.6 1.0 0.0 0.0 1.8 0.8 0.0 0.6 0.8 0.0 0.0 0.9 1.2 1.5 0.0 0.4 1.4 1.5 0.0 0.3 0.5 1.1 0.0 0.6 0.0 1.6 0.9 LACTB "FLJ14902, MRPL56" ENSG00000103642 "Lactamase beta" P83111 15 63121800-63142061 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protease" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 175.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036361, HPA036362" Supported Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA036361: AB_10672244, HPA036362: AB_10670798" "unprognostic (6.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.22e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.10e-2)" "unprognostic (8.08e-2)" "unprognostic (6.25e-2)" "unprognostic (8.98e-2)" "unprognostic (3.08e-1)" "unprognostic (6.22e-3)" "unprognostic (5.16e-3)" "unprognostic (6.28e-2)" "unprognostic (3.24e-1)" "unprognostic (8.64e-2)" "unprognostic (7.90e-2)" "unprognostic (3.88e-3)" 26.5 22.7 9.2 13.1 12.2 31.5 9.3 7.3 9.1 6.8 11.4 6.3 4.0 12.5 7.0 6.9 9.8 5.7 9.2 24.9 7.9 6.1 20.5 38.3 18.8 12.9 8.5 6.1 7.2 9.3 6.7 10.4 7.4 9.5 7.6 10.4 5.8 9.3 4.7 37.3 10.1 19.6 8.1 8.0 21.6 8.3 13.2 9.8 8.3 8.4 11.1 9.0 11.5 12.8 3.3 10.4 5.8 8.9 2.3 3.1 2.0 21.5 13.6 3.9 2.7 19.6 10.6 3.3 9.5 14.6 16.3 30.4 3.4 13.9 2.9 11.7 13.7 17.7 6.1 13.1 6.1 20.5 19.8 3.2 5.6 4.6 8.5 18.3 5.0 9.7 14.3 13.1 16.7 13.8 24.4 16.7 17.0 5.3 8.2 27.5 8.2 3.8 6.0 5.8 13.2 4.2 2.8 10.0 6.6 8.8 33.9 3.5 1.6 6.8 7.7 20.4 14.2 5.8 8.3 29.9 22.0 17.2 9.8 11.9 8.6 7.6 0.7 16.8 14.2 10.0 3.6 8.8 4.6 1.3 8.9 2.0 3.3 1.1 1.0 10.4 2.9 1.0 1.6 5.8 2.3 7.6 0.9 3.1 2.0 9.2 12.2 7.3 9.1 7.9 6.1 8.5 6.1 9.5 9.8 23.8 19.9 13.7 23.6 51.7 5.9 40.8 17.8 9.4 7.9 12.2 11.8 13.0 21.6 45.5 42.5 22.5 20.6 0.0 37.1 32.4 22.4 24.9 64.7 50.3 87.0 7.9 7.0 9.2 54.2 26.0 13.3 86.6 25.3 175.9 24.0 5.8 61.1 20.1 15.2 52.5 10.6 6.5 32.5 93.3 10.6 52.4 15.1 15.8 15.3 33.8 LARS2 "KIAA0028, LEURS, MGC26121, mtLeuRS" ENSG00000011376 "Leucyl-tRNA synthetase 2, mitochondrial" Q15031 3 45388506-45549421 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035951, HPA045450, HPA066085" Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612" "unprognostic (3.89e-1)" "unprognostic (3.89e-1)" "prognostic favorable (1.71e-4)" "unprognostic (3.02e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-3)" "unprognostic (9.19e-2)" "unprognostic (6.13e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-1)" "unprognostic (4.37e-2)" "prognostic favorable (1.32e-11)" "unprognostic (2.81e-1)" "unprognostic (5.74e-2)" "unprognostic (9.90e-2)" "unprognostic (9.07e-2)" 9.6 14.3 18.8 9.6 21.8 6.7 8.1 11.9 17.9 9.2 14.8 13.1 8.3 9.6 9.8 8.9 10.4 11.2 8.4 14.2 14.6 13.6 18.9 17.2 7.0 10.3 15.7 9.5 10.2 8.2 20.0 14.0 10.6 12.3 10.8 15.3 10.0 8.7 9.8 14.1 7.8 8.8 11.0 8.8 10.0 8.9 7.3 11.8 16.1 10.5 8.3 12.8 11.3 7.8 5.1 5.9 2.4 3.3 8.4 6.0 3.7 6.4 8.0 9.4 8.9 8.6 9.7 10.1 10.0 10.3 18.7 13.9 14.2 8.9 13.3 8.6 11.6 13.7 7.0 34.9 20.9 14.2 11.6 8.8 14.4 13.0 13.8 9.0 20.8 5.3 12.5 12.9 17.8 9.4 9.7 11.6 16.1 22.3 7.5 11.6 7.0 14.9 7.6 23.5 10.8 14.9 8.5 9.3 14.8 16.6 15.5 7.4 9.3 15.9 9.0 8.3 11.2 14.3 12.2 10.2 11.4 8.5 9.5 12.0 6.0 10.8 14.2 13.5 14.1 10.1 0.6 2.8 2.4 6.0 3.3 5.8 5.1 4.4 5.4 5.9 4.0 4.8 5.4 1.2 8.4 3.0 4.5 3.9 3.7 18.8 21.8 11.9 17.9 14.6 13.6 15.7 9.5 12.3 11.8 0.0 1.3 2.7 1.1 1.0 5.0 7.8 2.5 2.7 1.2 5.2 3.9 4.1 5.0 2.5 0.6 3.8 2.3 0.0 2.4 4.2 1.6 2.2 1.1 6.7 4.4 1.6 4.6 2.5 3.7 1.1 1.1 1.6 1.7 2.8 4.3 3.6 2.8 6.6 2.1 2.1 4.4 0.0 1.2 0.7 2.4 1.1 2.4 1.8 6.3 1.6 LETM1 SLC55A1 ENSG00000168924 "Leucine zipper and EF-hand containing transmembrane protein 1" O95202 4 1811479-1856247 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011029, HPA011100" Supported Supported Mitochondria NA NA Mitochondria "HPA011029: AB_1852804, HPA011100: AB_1852802" "unprognostic (1.16e-1)" "unprognostic (1.80e-1)" "unprognostic (3.85e-2)" "unprognostic (5.04e-2)" "unprognostic (5.48e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.37e-3)" "unprognostic (1.87e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.77e-4)" "prognostic favorable (8.90e-4)" "unprognostic (8.06e-3)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (2.42e-1)" 16.9 15.3 11.9 11.2 13.1 9.9 16.8 17.3 19.9 6.7 23.7 10.0 7.5 20.3 8.5 6.9 22.0 8.1 15.0 18.9 10.2 10.2 16.2 20.4 9.4 10.7 10.6 10.5 9.5 19.7 13.0 8.7 7.6 10.7 8.2 16.3 9.2 9.7 7.2 17.2 18.5 19.4 8.0 7.7 10.6 15.6 12.6 9.0 50.7 10.9 19.9 16.6 8.0 9.7 5.0 14.7 3.8 5.6 6.7 7.1 2.1 12.0 20.6 6.4 19.8 9.9 6.9 11.5 12.0 5.9 12.1 9.5 19.0 13.5 20.0 8.6 12.5 18.9 12.3 16.3 16.9 7.4 13.2 17.0 20.4 16.7 13.6 12.8 20.7 16.8 11.3 12.2 13.8 12.2 5.6 10.4 12.3 26.8 12.6 8.3 13.3 29.9 23.7 16.8 13.2 23.7 17.2 9.0 11.7 9.4 16.9 16.4 14.4 13.7 17.3 7.1 5.8 16.3 10.8 15.6 13.9 8.3 11.7 19.9 11.0 16.8 15.9 12.3 18.1 11.1 3.8 4.5 2.1 7.1 5.6 7.0 5.0 6.0 6.1 4.7 4.6 4.0 5.9 0.7 6.7 5.3 14.7 4.6 2.1 11.9 13.1 17.3 19.9 10.2 10.2 10.6 10.5 10.7 9.0 14.9 7.8 27.6 25.3 35.5 17.1 18.2 7.6 1.4 9.1 26.2 31.4 14.6 26.6 22.9 25.3 14.3 78.7 23.3 27.0 18.4 16.4 20.8 10.3 24.1 19.6 14.3 15.0 16.5 15.3 31.9 18.7 15.0 18.6 10.0 27.0 11.6 31.9 43.2 15.6 38.2 26.2 12.9 19.8 34.8 40.1 44.7 12.7 20.2 29.9 41.9 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: AB_2686682" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favorable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.4 5.1 7.7 12.8 8.1 9.2 16.2 15.4 19.7 9.6 8.3 5.9 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 24.8 8.2 19.1 14.6 14.3 11.1 11.6 8.9 12.3 3.4 9.3 18.3 7.6 6.1 10.7 10.2 11.4 15.0 6.9 5.8 13.1 17.6 5.3 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 20.8 22.7 30.4 41.1 44.1 20.2 12.5 22.9 25.4 11.4 22.7 9.8 40.0 77.9 12.6 6.3 19.6 22.0 23.3 28.4 18.9 32.4 29.0 25.3 16.3 26.2 17.5 26.7 20.3 41.0 11.9 30.2 21.2 37.1 17.2 34.4 24.4 16.0 28.1 28.7 31.5 16.5 25.8 38.1 20.6 19.4 38.8 23.3 42.4 49.8 24.8 MARC1 "FLJ22390, MOSC1" ENSG00000186205 "Mitochondrial amidoxime reducing component 1" Q5VT66 1 220786759-220819657 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 71.3;breast: 81.3" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 94.8;Extravillous trophoblasts: 36.6;Syncytiotrophoblasts: 62.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5" "Group enriched" "Detected in many" 32 "granulocytes: 28.5;monocytes: 20.6" "Cell line enhanced" "Detected in many" "BEWO: 51.6;HeLa: 22.0;Hep G2: 25.3;NTERA-2: 21.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA028702 Approved Supported Mitochondria NA NA Mitochondria "HPA028702: AB_10601135" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (2.16e-2)" "unprognostic (5.04e-2)" "unprognostic (2.90e-1)" "unprognostic (2.31e-1)" "unprognostic (3.71e-3)" "unprognostic (1.39e-1)" "unprognostic (7.51e-2)" "unprognostic (7.71e-3)" "unprognostic (3.71e-1)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.51e-4)" "unprognostic (3.85e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-1)" 71.3 3.0 4.6 7.5 6.1 7.3 81.3 3.1 4.0 3.4 7.8 2.1 18.7 3.3 1.4 5.5 3.4 2.8 6.4 6.7 3.7 4.6 3.4 33.6 4.3 4.3 4.0 3.3 2.5 4.0 4.0 3.3 9.7 4.3 14.9 6.8 4.4 27.8 10.5 4.2 1.4 3.8 2.6 2.6 4.3 3.2 0.6 1.4 0.1 22.0 2.7 1.4 3.9 7.5 0.2 0.7 28.5 20.6 0.0 0.1 4.9 5.7 3.1 2.0 0.0 0.4 0.1 51.6 0.5 0.4 0.3 0.5 17.0 0.3 0.0 2.1 0.5 0.0 0.0 10.7 1.0 0.7 0.0 10.9 0.0 22.0 25.3 1.3 0.1 0.1 2.0 0.6 0.0 0.0 0.0 0.3 0.0 1.6 0.1 0.3 5.6 0.0 10.9 21.8 16.8 9.5 0.0 0.0 0.1 2.4 6.4 6.1 14.2 3.1 3.8 0.0 6.0 14.4 13.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.0 20.6 8.1 0.1 1.5 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 28.5 0.0 0.4 0.2 0.0 4.9 4.6 6.1 3.1 4.0 3.7 4.6 4.0 3.3 4.3 1.4 0.0 12.8 0.9 0.0 0.8 5.7 5.1 0.0 2.7 0.0 8.7 0.0 94.8 1.7 0.0 4.4 2.9 6.3 0.0 0.0 36.6 1.0 0.0 2.3 22.1 10.4 0.0 4.1 3.1 22.0 2.6 0.6 0.2 0.0 0.0 22.2 12.4 0.0 9.5 5.6 2.5 1.4 0.0 3.1 0.0 0.7 0.5 62.8 0.0 9.5 0.0 MARCH5 "FLJ20445, MARCH-V, MITOL, RNF153" ENSG00000198060 "Membrane associated ring-CH-type finger 5" Q9NX47 10 92291163-92353964 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056596 Supported Mitochondria NA NA Mitochondria "HPA056596: AB_2683181" "unprognostic (4.00e-2)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (4.10e-2)" "unprognostic (5.47e-3)" "unprognostic (2.33e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.24e-2)" "unprognostic (9.77e-2)" "unprognostic (5.50e-3)" "unprognostic (4.02e-3)" "unprognostic (6.14e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (4.53e-1)" "unprognostic (2.85e-2)" 18.2 21.7 17.5 17.7 18.3 20.7 27.1 16.8 25.7 15.5 15.4 12.7 20.7 15.8 19.3 18.8 28.0 14.8 15.4 18.4 15.8 15.1 21.7 27.6 16.5 16.6 16.3 17.9 20.9 16.7 16.3 12.3 16.3 14.8 22.2 14.8 14.5 19.4 19.3 42.6 13.7 16.0 18.1 14.0 12.1 14.4 20.1 13.5 25.0 24.5 21.5 17.3 14.7 21.0 7.3 9.4 16.8 10.2 6.5 8.7 6.6 16.2 8.8 17.5 20.0 11.9 12.4 9.0 14.6 16.1 18.2 18.7 5.9 11.7 9.5 10.1 14.2 8.0 13.4 12.1 12.2 26.2 7.1 14.3 7.6 8.3 13.8 14.5 12.1 7.6 12.7 16.5 12.0 25.2 24.3 16.0 10.2 8.3 11.9 14.5 10.3 10.7 14.0 4.1 10.6 13.3 11.6 17.9 5.6 18.6 10.5 8.1 15.0 12.6 9.4 15.4 8.7 16.4 9.5 15.5 8.6 9.4 9.3 19.9 12.1 9.2 8.4 7.8 16.9 5.7 5.2 8.3 9.0 7.6 10.2 7.6 7.3 8.4 8.0 9.4 6.7 8.7 8.3 16.8 6.5 8.5 6.2 7.8 6.6 17.5 18.3 16.8 25.7 15.8 15.1 16.3 17.9 14.8 13.5 20.8 22.1 26.1 0.0 78.5 12.2 22.9 20.4 9.4 9.1 19.2 7.9 35.2 72.9 0.0 116.8 22.5 30.7 0.0 0.0 36.8 29.4 0.0 28.8 32.6 30.8 9.5 28.6 20.3 24.8 37.2 27.3 19.9 37.1 0.0 22.9 18.6 0.0 23.0 17.3 56.2 10.9 19.4 24.5 37.4 28.3 68.3 54.6 25.5 24.7 0.0 MCAT "fabD, FASN2C, MCT, MCT1, MT, NET62" ENSG00000100294 "Malonyl-CoA-acyl carrier protein transacylase" Q8IVS2 22 43132206-43143394 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 67.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003122, HPA035471" Approved Supported Mitochondria NA NA Mitochondria "HPA003122: AB_2666795, HPA035471: AB_10670590" "unprognostic (1.05e-1)" "unprognostic (1.57e-2)" "unprognostic (1.39e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-3)" "unprognostic (4.71e-2)" "unprognostic (5.13e-2)" "unprognostic (2.94e-1)" "unprognostic (1.32e-1)" "unprognostic (9.86e-2)" "prognostic favorable (2.18e-4)" "prognostic favorable (3.89e-4)" "unprognostic (3.67e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-1)" 10.4 18.2 13.3 8.2 17.2 11.0 12.8 10.4 24.6 10.6 11.9 9.4 10.7 9.5 11.0 17.2 12.3 20.7 21.4 12.9 14.4 14.2 25.6 24.3 8.6 7.1 12.0 12.0 14.4 16.2 20.3 14.3 9.2 15.1 12.8 10.6 9.9 14.5 10.2 17.7 11.7 9.7 8.6 6.0 7.6 12.1 19.6 5.2 18.4 20.1 14.0 9.9 8.5 8.1 10.2 13.9 2.5 9.5 11.6 10.3 5.6 7.2 9.5 6.8 11.8 5.7 6.1 6.9 8.1 7.2 11.0 10.2 9.5 7.4 12.2 8.4 6.0 6.2 12.2 12.8 10.7 8.2 4.2 37.8 4.5 11.0 10.5 9.1 21.6 5.5 4.5 10.5 10.7 8.5 6.4 7.8 7.4 10.7 5.0 5.3 13.3 10.0 23.5 6.5 10.2 16.9 13.3 6.6 19.3 13.7 6.3 8.9 4.7 8.7 17.1 12.3 3.2 8.8 14.0 4.6 4.8 9.4 10.3 11.4 8.9 9.2 8.8 10.3 8.3 5.7 0.0 9.5 0.7 7.7 9.1 10.3 8.3 8.6 10.1 13.9 10.2 10.1 7.1 2.5 11.6 5.5 13.7 5.5 5.6 13.3 17.2 10.4 24.6 14.4 14.2 12.0 12.0 15.1 5.2 6.0 5.0 6.7 9.1 15.9 10.0 8.7 30.6 10.7 4.5 19.2 0.0 16.7 43.1 25.8 13.8 7.1 10.0 0.0 19.0 8.4 9.3 14.1 3.5 20.8 13.6 6.4 13.9 16.5 8.2 9.0 6.9 4.8 6.8 8.2 12.4 9.5 19.8 17.5 15.6 67.4 8.7 19.4 9.8 29.0 10.4 18.3 7.7 4.9 22.7 9.5 MCCC1 MCCA ENSG00000078070 "Methylcrotonoyl-CoA carboxylase 1" Q96RQ3 3 183015218-183116075 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008310 Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA008310: AB_1853620" "unprognostic (4.01e-2)" "unprognostic (1.83e-3)" "unprognostic (2.05e-2)" "unprognostic (2.59e-3)" "unprognostic (3.46e-2)" "unprognostic (4.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-3)" "unprognostic (2.57e-3)" "unprognostic (9.82e-2)" "unprognostic (9.74e-2)" "unprognostic (7.65e-2)" "prognostic favorable (3.68e-4)" "unprognostic (4.73e-1)" "unprognostic (2.21e-1)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" 25.1 26.0 14.1 10.4 16.4 9.0 24.6 23.1 20.6 9.0 12.6 15.1 10.1 12.6 11.0 11.4 15.8 9.5 11.6 24.4 12.2 10.1 42.4 41.1 13.8 8.0 17.0 14.4 12.8 32.3 10.2 15.8 5.5 13.4 11.4 13.7 9.9 14.2 15.6 19.4 11.5 10.1 11.3 10.5 8.3 17.7 8.9 16.4 8.9 14.0 8.5 13.2 23.2 9.5 13.1 19.4 17.1 11.3 18.9 11.6 7.6 14.2 5.4 3.4 3.6 15.1 6.9 7.0 6.6 9.2 7.2 8.2 7.5 5.7 15.8 10.7 5.8 12.6 7.4 5.2 4.3 9.3 5.3 5.8 13.4 6.2 7.9 10.0 8.9 7.7 7.8 5.0 3.4 7.8 4.9 9.7 13.9 7.4 8.3 8.1 11.7 8.7 4.5 3.9 22.4 6.0 7.2 7.8 20.2 10.6 22.7 7.7 5.6 25.2 34.7 7.1 3.7 53.1 12.7 4.7 5.6 4.5 4.4 9.7 8.5 15.5 16.0 6.1 12.9 5.2 8.5 9.7 17.1 8.3 11.3 9.4 13.1 10.8 9.0 19.4 11.1 11.6 10.4 1.6 18.9 11.2 12.7 6.8 7.6 14.1 16.4 23.1 20.6 12.2 10.1 17.0 14.4 13.4 16.4 8.9 42.2 11.0 15.2 6.3 10.8 27.0 33.1 25.4 13.6 26.2 9.8 24.8 28.2 16.0 4.4 5.2 9.2 0.0 14.9 3.5 6.7 11.8 7.0 30.1 14.2 7.9 5.8 5.5 9.7 4.1 8.1 11.7 6.8 10.0 11.7 12.1 18.1 19.5 9.9 36.0 11.4 6.5 8.1 6.4 3.2 5.1 23.7 10.1 22.9 19.4 MCU "C10orf42, CCDC109A, FLJ46135" ENSG00000156026 "Mitochondrial calcium uniporter" Q8NE86 10 72692131-72887694 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 41.0" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016480 Approved Supported Mitochondria No No 1400000 Mitochondria "HPA016480: AB_2071893" "unprognostic (2.42e-2)" "unprognostic (1.58e-2)" "unprognostic (3.01e-2)" "unprognostic (5.37e-2)" "unprognostic (7.84e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (6.06e-5)" "unprognostic (1.23e-1)" "unprognostic (2.28e-1)" "unprognostic (2.33e-1)" "unprognostic (5.12e-3)" "unprognostic (1.73e-1)" "prognostic favorable (5.07e-4)" "unprognostic (4.51e-2)" "unprognostic (3.79e-1)" "unprognostic (2.74e-2)" "unprognostic (2.48e-2)" 8.2 6.5 6.3 9.4 6.1 12.3 9.8 41.0 6.8 7.0 19.8 4.1 8.5 19.1 10.9 7.4 13.4 7.8 11.5 6.9 4.8 4.3 11.1 7.2 10.1 7.4 3.4 4.1 5.8 12.1 8.2 5.5 8.8 5.5 4.6 21.9 5.1 9.5 5.8 41.4 9.0 23.0 11.0 3.8 4.9 29.4 4.7 3.5 4.9 5.4 14.9 7.3 10.1 15.0 3.4 5.4 16.6 7.6 1.9 4.6 3.6 19.7 32.0 8.3 6.0 12.7 14.3 8.5 12.2 17.4 12.2 13.1 19.0 18.9 8.4 9.8 14.9 6.6 18.1 10.9 14.5 16.4 9.2 10.2 10.5 12.0 10.5 9.9 26.3 8.9 14.5 12.4 10.9 23.4 19.2 14.6 9.0 6.5 6.3 11.3 11.5 7.1 5.7 9.2 21.6 6.7 7.4 17.8 2.2 16.5 10.8 8.9 3.9 15.0 16.8 3.6 10.5 3.3 6.9 11.8 5.9 10.2 12.7 8.1 4.7 5.9 5.9 7.9 13.2 4.5 1.7 6.1 16.6 2.9 6.7 3.1 3.4 3.0 3.5 5.4 1.7 2.3 2.6 8.2 1.9 7.6 1.9 4.6 3.6 6.3 6.1 41.0 6.8 4.8 4.3 3.4 4.1 5.5 3.5 32.8 13.4 2.7 10.4 10.4 3.0 5.9 10.2 18.7 26.1 17.4 2.0 6.4 1.7 7.2 10.7 7.4 22.6 0.0 22.1 8.3 6.7 8.1 8.1 5.0 6.3 0.0 8.1 8.6 6.3 4.7 4.9 3.7 8.5 2.8 24.0 4.8 27.5 8.6 3.9 6.1 3.3 12.9 8.9 3.9 4.9 10.8 7.8 2.5 20.4 20.7 ME2 ENSG00000082212 "Malic enzyme 2" P23368 18 50878734-50954257 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008247, HPA008880" Enhanced Supported Mitochondria NA NA 3400000 Mitochondria "HPA008247: AB_1853704, HPA008880: AB_1853702" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (9.57e-3)" "unprognostic (2.22e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.29e-8)" "unprognostic (1.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-2)" "unprognostic (4.75e-2)" "unprognostic (1.43e-2)" "unprognostic (4.27e-3)" "unprognostic (2.30e-1)" "unprognostic (2.47e-1)" "unprognostic (4.09e-1)" 12.6 18.1 17.1 18.4 16.2 11.6 10.7 13.2 16.0 9.4 26.4 14.3 16.8 30.2 10.5 7.7 10.6 9.3 10.5 34.6 15.8 17.8 12.1 12.1 10.3 24.1 18.7 14.0 11.1 16.7 20.6 20.2 10.5 47.7 11.8 26.6 9.4 8.8 23.1 29.5 7.1 44.8 16.9 18.9 36.6 20.3 15.3 8.7 24.3 9.0 7.8 17.3 14.2 15.7 4.9 9.6 14.3 17.4 6.7 6.0 4.5 13.0 13.1 17.5 20.4 8.0 8.9 8.1 10.9 8.2 14.3 12.1 6.0 7.2 46.7 4.3 9.7 13.1 10.9 26.1 11.1 16.5 19.3 4.0 11.9 8.3 7.0 23.6 39.6 14.3 5.5 13.6 18.0 29.3 9.4 18.3 27.8 12.6 11.4 9.7 2.7 28.6 3.9 11.7 9.4 5.4 18.8 8.7 13.5 15.6 2.8 21.7 11.5 10.2 6.3 10.9 11.0 4.8 19.3 11.3 10.2 11.4 5.3 14.5 21.3 8.6 22.9 10.3 28.3 10.8 5.0 11.6 14.3 5.0 13.1 4.1 4.9 3.3 6.0 9.6 4.9 2.9 3.5 13.3 6.7 17.4 3.2 3.1 4.5 17.1 16.2 13.2 16.0 15.8 17.8 18.7 14.0 47.7 8.7 8.9 11.0 34.0 15.3 13.5 17.4 93.2 7.6 5.3 26.1 14.0 13.7 14.6 33.2 28.0 13.4 14.8 44.5 0.0 34.2 14.5 10.8 15.2 15.1 7.4 87.2 7.9 11.5 30.7 83.1 4.7 10.6 39.2 11.8 27.9 24.3 13.0 27.5 20.1 15.6 14.0 55.9 6.5 15.4 50.9 20.4 9.4 7.2 26.1 35.2 14.8 MECR "CGI-63, ETR1, FASN2B, NRBF1" ENSG00000116353 "Mitochondrial trans-2-enoyl-CoA reductase" Q9BV79 1 29192873-29230942 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022018, HPA022030, HPA028740" Enhanced Supported Mitochondria NA NA Mitochondria "HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133" "unprognostic (2.53e-1)" "unprognostic (1.09e-2)" "unprognostic (1.52e-1)" "unprognostic (1.84e-1)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.06e-2)" "unprognostic (8.66e-2)" "prognostic favorable (5.81e-6)" "unprognostic (7.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.59e-1)" "prognostic unfavorable (5.29e-4)" 16.4 11.9 16.0 6.6 17.0 6.0 12.3 7.8 17.7 13.0 9.7 8.6 7.1 7.8 10.5 8.4 9.4 10.9 8.5 24.8 15.7 11.5 11.0 13.7 8.3 10.0 14.7 16.3 11.7 14.3 8.1 10.0 10.8 12.8 7.5 8.9 10.8 12.6 10.0 45.5 11.3 5.9 10.2 10.7 5.4 8.1 8.2 10.5 4.4 8.3 12.8 7.6 8.0 7.2 8.3 14.7 0.3 11.5 11.6 13.1 6.5 10.2 9.8 4.8 22.2 4.9 8.7 17.6 7.8 8.8 10.2 9.9 7.4 21.0 13.5 15.6 7.6 3.2 12.8 6.0 15.8 6.3 9.2 12.4 11.7 6.3 9.4 15.2 12.9 6.0 8.6 14.1 5.4 19.9 8.5 11.2 17.3 10.0 14.0 12.7 11.5 10.9 7.1 12.9 19.5 12.5 6.7 8.1 23.7 10.8 5.9 7.3 11.3 11.5 16.4 14.4 9.8 6.0 12.5 11.3 7.4 8.0 11.5 11.4 13.4 5.5 10.0 20.0 17.2 14.0 0.1 7.0 0.0 8.3 11.5 13.1 8.3 7.8 6.7 14.7 7.4 8.4 8.5 0.3 11.6 7.0 8.6 6.3 6.5 16.0 17.0 7.8 17.7 15.7 11.5 14.7 16.3 12.8 10.5 11.9 3.8 8.2 13.8 4.9 12.0 17.1 15.3 2.7 11.4 19.2 9.8 41.0 34.9 18.9 31.2 8.0 7.8 0.0 17.2 32.6 12.7 8.1 5.7 18.3 18.3 7.9 7.5 4.9 4.9 60.9 12.7 6.0 15.1 12.6 9.8 10.9 14.2 7.0 10.3 32.7 62.2 12.9 8.9 6.7 15.0 6.5 23.3 4.9 19.9 15.6 MFF "C2orf33, GL004" ENSG00000168958 "Mitochondrial fission factor" Q9GZY8 2 227325151-227357836 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 827.2;Late spermatids: 1262.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010968, HPA074625" Enhanced Supported Mitochondria No No Mitochondria "HPA010968: AB_1845714, HPA074625: AB_2686704" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.20e-4)" "unprognostic (3.07e-2)" "unprognostic (1.32e-1)" "unprognostic (6.07e-2)" "unprognostic (3.00e-2)" "unprognostic (6.24e-3)" "unprognostic (5.50e-2)" "unprognostic (1.00e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" "unprognostic (3.22e-1)" 20.2 23.9 31.6 18.0 27.6 22.3 21.3 25.7 38.4 19.6 22.5 26.5 14.7 22.1 21.9 20.9 21.5 18.0 17.1 40.5 27.8 28.4 33.7 24.4 16.6 27.1 30.2 20.2 25.7 27.6 25.0 19.3 17.7 28.0 20.6 22.5 25.6 20.6 27.6 37.4 16.7 18.6 22.9 33.4 16.9 18.8 97.0 20.6 25.9 19.8 22.2 23.3 20.7 17.8 40.2 34.9 59.9 33.8 29.3 44.1 33.1 23.2 20.0 24.6 33.8 31.9 30.7 32.7 23.2 31.4 28.3 30.3 21.7 16.6 13.3 27.8 25.3 29.8 19.3 40.4 29.5 38.5 28.1 32.5 28.1 51.6 54.4 42.1 27.1 25.2 27.5 38.9 26.8 28.7 37.1 24.4 30.7 24.4 40.0 25.0 23.4 28.6 41.8 33.3 25.0 21.2 26.0 31.1 25.7 41.3 22.0 26.1 24.5 50.9 23.7 33.8 21.2 15.2 26.9 16.4 27.6 23.3 40.8 25.7 32.6 22.1 26.7 36.5 24.2 37.5 42.4 32.9 59.9 32.8 33.8 35.3 40.2 34.5 32.0 34.5 38.2 36.6 31.0 31.0 29.3 30.6 34.9 44.1 33.1 31.6 27.6 25.7 38.4 27.8 28.4 30.2 20.2 28.0 20.6 29.8 37.7 68.1 54.7 42.8 34.0 71.6 35.7 26.8 52.4 57.6 29.5 82.2 107.8 83.0 827.2 38.3 47.7 93.5 82.7 82.5 63.5 55.3 20.9 54.0 67.9 38.1 31.0 41.1 54.0 1262.3 81.4 51.9 77.6 56.9 59.6 185.4 78.7 66.6 80.6 97.9 56.3 58.2 52.6 274.7 48.3 41.4 76.9 53.7 69.3 60.3 MFN1 FLJ20693 ENSG00000171109 "Mitofusin 1" 3 179347692-179394931 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033437, HPA059230" Approved Supported Mitochondria NA NA Mitochondria "CAB033437: AB_2250540, HPA059230: AB_2683952" "unprognostic (2.94e-2)" "unprognostic (5.56e-2)" "unprognostic (5.44e-3)" "prognostic unfavorable (6.70e-4)" "prognostic favorable (6.11e-4)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.08e-5)" "unprognostic (6.37e-2)" "unprognostic (1.86e-2)" "unprognostic (3.70e-2)" "unprognostic (3.76e-3)" "unprognostic (7.91e-2)" "unprognostic (7.90e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-1)" "unprognostic (6.24e-2)" "unprognostic (9.79e-2)" 13.7 16.5 12.2 12.1 17.2 9.9 15.4 24.3 22.4 18.4 16.5 15.9 19.4 12.0 19.6 21.3 19.6 18.5 13.4 31.1 12.0 11.4 17.9 14.9 12.3 16.0 16.9 14.5 16.6 29.9 18.2 22.3 12.4 21.5 17.7 14.6 12.8 17.4 17.4 21.7 19.6 16.6 15.7 16.0 18.2 17.8 11.8 17.0 16.9 14.5 20.1 19.6 17.6 15.1 10.5 4.1 8.9 4.5 4.1 7.3 2.1 16.7 5.0 9.7 15.8 14.0 13.0 12.9 10.5 10.8 11.1 13.2 12.5 7.0 5.7 11.0 15.4 22.4 9.9 13.6 10.3 19.5 9.0 10.5 9.3 11.6 6.8 11.5 4.9 9.0 9.0 9.1 11.9 8.5 9.2 14.0 9.6 6.8 7.6 15.4 8.9 7.2 3.7 11.5 16.9 9.3 5.1 15.3 21.1 10.6 17.8 9.2 13.1 9.8 26.3 14.2 10.4 36.0 3.6 11.7 9.7 10.8 15.0 15.3 10.2 11.0 9.5 10.8 8.3 10.5 5.5 3.8 8.5 4.3 4.5 7.3 7.8 4.9 4.4 3.4 10.5 4.6 5.1 8.9 4.1 3.6 4.1 4.4 2.1 12.2 17.2 24.3 22.4 12.0 11.4 16.9 14.5 21.5 17.0 23.8 33.7 14.5 9.5 14.8 16.0 28.0 10.2 33.5 27.3 17.4 37.3 9.7 8.3 11.0 2.3 9.4 11.7 23.3 15.0 8.4 13.8 17.9 8.1 16.6 7.2 11.1 9.8 17.2 10.7 2.5 12.4 11.3 11.8 6.4 16.0 11.5 14.1 8.6 16.6 10.3 16.6 6.5 13.9 25.4 11.5 23.6 11.0 7.4 13.3 20.1 MFN2 "CMT2A2, CPRP1, KIAA0214, MARF" ENSG00000116688 "Mitofusin 2" O95140 1 11980181-12013514 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy, Unfolded protein response" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.9;skeletal muscle: 111.1" "Cell type enriched" "Detected in all" 8 "Cardiomyocytes: 308.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030554, CAB079902" Uncertain Supported Mitochondria NA NA Mitochondria "CAB079902: AB_2724683, HPA030554: AB_10603018" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.38e-2)" "unprognostic (8.36e-2)" "unprognostic (9.71e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (3.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.43e-1)" "unprognostic (3.55e-1)" "prognostic favorable (2.36e-8)" "unprognostic (4.69e-2)" "unprognostic (2.76e-1)" "unprognostic (8.84e-3)" "unprognostic (2.12e-1)" 12.8 10.1 16.4 8.9 20.3 17.2 10.1 15.9 32.1 8.7 17.0 17.0 11.2 16.5 12.1 8.7 20.1 9.0 9.0 100.9 17.9 16.0 14.8 20.4 10.6 8.0 18.8 19.3 10.2 9.0 22.0 9.3 12.9 20.8 14.1 13.2 16.5 10.7 23.7 111.1 18.8 25.7 22.9 15.7 10.2 14.0 11.3 10.9 7.3 18.7 28.5 12.1 16.3 10.6 7.3 8.9 18.5 16.9 5.8 10.2 13.4 26.0 15.9 18.1 23.8 18.3 13.8 21.0 20.6 19.1 28.3 22.1 26.3 17.4 19.1 22.4 24.9 18.6 27.9 29.9 47.8 25.4 69.2 22.7 27.3 25.6 20.4 19.0 27.7 17.2 17.4 36.9 39.8 36.9 12.2 19.9 10.3 28.2 16.8 20.9 13.1 16.8 12.7 12.5 17.5 23.5 19.7 26.4 17.8 17.0 17.4 21.1 13.8 24.2 25.8 23.9 14.2 13.9 16.7 19.9 19.0 19.0 28.8 21.5 20.1 21.1 31.3 22.5 31.2 20.5 8.5 10.3 7.1 9.6 13.5 10.2 7.3 7.2 8.6 8.9 6.6 6.3 8.0 18.5 5.8 16.9 4.6 8.0 13.4 16.4 20.3 15.9 32.1 17.9 16.0 18.8 19.3 20.8 10.9 20.8 18.6 11.5 8.2 20.3 24.8 308.6 12.7 12.0 14.8 14.0 11.8 12.2 18.3 12.7 3.6 12.0 31.1 23.3 17.3 13.2 9.3 12.5 10.4 39.2 14.2 28.6 17.3 13.5 18.1 4.4 6.6 11.8 16.9 10.0 20.9 11.6 13.9 14.0 14.2 13.3 18.6 12.9 14.4 27.7 16.8 26.3 21.1 9.6 22.1 12.9 MGARP "C4orf49, CESP-1, HUMMR, OSAP" ENSG00000137463 "Mitochondria localized glutamic acid rich protein" Q8TDB4 4 139266163-139280338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 88.9;retina: 30.7" "Group enriched" "Detected in some" 9 "Bipolar cells: 140.5;Horizontal cells: 197.0;Muller glia cells: 424.1" "Cancer enhanced" "Detected in some" "renal cancer: 4.1" "Group enriched" "Detected in many" 4 "basal ganglia: 4.5;cerebellum: 8.0" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 10.7;fHDF/TERT166: 15.9;HHSteC: 12.9;HUVEC TERT2: 32.4" "Low region specificity" "Detected in some" "HPA015994, HPA070835" Enhanced Supported Mitochondria NA NA Mitochondria "HPA015994: AB_2630370, HPA070835: " "unprognostic (2.68e-1)" "unprognostic (1.73e-1)" "unprognostic (8.18e-2)" "unprognostic (4.25e-2)" "unprognostic (3.54e-2)" "unprognostic (3.11e-2)" "unprognostic (3.42e-2)" "unprognostic (1.02e-3)" "unprognostic (2.90e-2)" "unprognostic (4.96e-2)" "unprognostic (1.50e-2)" "unprognostic (1.31e-1)" "unprognostic (4.08e-2)" "unprognostic (1.47e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-2)" "unprognostic (2.36e-1)" 3.2 88.9 1.0 0.5 4.5 0.4 1.2 8.0 1.2 3.6 1.0 2.1 1.1 0.4 2.6 3.0 0.5 0.8 1.3 6.1 0.8 1.4 1.0 0.4 0.5 0.6 1.0 0.0 20.1 0.5 0.4 15.3 0.5 1.5 2.0 0.5 30.7 0.4 2.0 0.6 0.5 0.4 2.3 0.7 0.6 0.4 5.9 0.5 0.0 0.5 0.0 0.5 2.1 1.0 0.5 0.0 0.0 0.3 0.5 1.7 0.3 0.0 0.5 0.3 0.2 0.8 0.4 0.0 10.7 0.0 1.6 0.0 0.0 0.1 0.0 0.1 15.9 4.6 0.2 2.3 0.0 0.9 0.0 1.0 0.0 0.0 0.1 12.9 0.1 0.1 3.9 0.3 1.7 0.1 3.8 32.4 0.1 0.2 0.2 2.6 0.0 0.4 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.3 4.5 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.7 0.4 0.0 0.3 1.6 0.7 0.0 0.5 0.2 0.0 0.3 0.3 1.0 4.5 8.0 1.2 0.8 1.4 1.0 0.0 1.5 0.5 0.0 0.0 0.0 0.7 1.4 140.5 2.5 0.0 0.0 0.0 0.0 7.9 0.2 1.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 2.4 0.3 0.0 0.0 0.5 197.0 0.0 0.6 0.0 0.0 15.8 0.0 0.0 0.0 0.0 424.1 0.1 0.0 23.3 7.6 28.7 0.0 0.4 0.7 0.3 0.6 0.2 0.0 0.0 0.3 MGME1 "bA504H3.4, C20orf72, DDK1" ENSG00000125871 "Mitochondrial genome maintenance exonuclease 1" Q9BQP7 20 17968913-17991122 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040913 Approved Supported Mitochondria NA Yes Mitochondria "HPA040913: AB_10962835" "unprognostic (5.81e-3)" "unprognostic (5.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-3)" "unprognostic (5.42e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (6.98e-8)" "unprognostic (5.31e-2)" "unprognostic (7.05e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.13e-7)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (8.70e-2)" "unprognostic (6.89e-2)" 8.7 14.2 6.4 12.0 7.6 10.9 14.9 7.0 6.7 8.4 10.5 11.7 8.2 10.2 7.3 8.6 14.3 5.4 6.5 10.5 7.3 4.8 10.5 11.3 6.5 13.9 11.5 7.2 5.8 9.6 7.1 14.1 19.9 8.4 8.5 10.7 10.4 11.0 7.8 17.8 26.9 10.9 5.2 9.8 19.5 7.6 12.9 8.3 31.8 15.5 7.6 16.9 10.6 9.6 13.2 10.9 24.1 8.5 8.8 9.2 4.5 17.1 20.0 16.4 15.4 6.7 12.0 22.0 14.5 10.7 14.0 19.2 24.6 17.5 20.4 8.2 6.4 15.9 25.8 16.9 21.6 21.3 7.5 13.9 13.3 11.1 37.1 5.0 8.6 22.8 7.2 15.1 20.8 11.0 6.6 11.1 10.4 18.0 13.4 28.1 12.8 15.4 11.8 14.4 10.3 17.7 11.7 36.8 19.4 12.1 12.6 12.7 10.6 10.2 25.1 21.9 13.9 23.9 6.1 8.9 24.3 19.7 12.0 15.6 10.1 22.3 17.5 6.2 6.7 17.7 24.0 8.5 24.1 4.9 8.1 6.4 11.4 6.3 6.4 6.8 13.2 4.5 4.3 8.2 8.8 7.5 10.9 9.2 4.5 6.4 7.6 7.0 6.7 7.3 4.8 11.5 7.2 8.4 8.3 0.0 11.4 23.1 13.1 41.2 6.4 10.5 20.4 5.3 12.5 7.0 7.9 18.8 33.2 9.6 4.5 11.3 18.3 0.0 8.9 21.7 7.5 9.0 45.2 8.9 26.4 7.9 6.9 17.8 29.3 4.2 7.8 16.2 20.3 6.4 12.9 10.8 8.6 7.0 5.3 20.9 9.6 12.9 5.7 31.1 51.2 40.9 15.1 15.3 19.0 10.2 MICU1 "CALC, CBARA1, EFHA3, FLJ12684" ENSG00000107745 "Mitochondrial calcium uptake 1" Q9BPX6 10 72367327-72626191 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037479, HPA037480" Approved Supported Mitochondria NA NA Mitochondria "HPA037479: AB_2675495, HPA037480: AB_10696934" "unprognostic (8.18e-2)" "unprognostic (6.98e-3)" "unprognostic (6.71e-2)" "unprognostic (8.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.91e-2)" "unprognostic (3.60e-2)" "unprognostic (2.96e-3)" "unprognostic (3.38e-2)" "unprognostic (7.43e-2)" "unprognostic (2.23e-2)" "prognostic favorable (4.66e-7)" "unprognostic (1.70e-1)" "unprognostic (1.55e-1)" "unprognostic (5.35e-2)" "unprognostic (6.70e-2)" 16.8 36.4 22.9 14.4 25.3 17.0 15.4 56.3 30.7 18.2 16.9 18.9 11.6 20.9 29.7 14.3 13.3 20.5 18.6 24.0 23.3 21.7 58.9 64.7 16.7 11.2 20.9 22.7 25.0 11.6 21.1 23.4 16.3 25.2 14.9 19.2 15.1 15.5 13.8 36.9 16.3 21.5 22.2 17.5 18.1 24.1 11.8 15.0 15.1 13.8 14.6 11.9 20.0 15.2 6.5 9.5 39.0 21.7 5.6 6.5 11.5 15.8 28.1 17.9 21.0 29.0 27.3 8.1 17.5 39.9 26.3 36.3 16.5 30.2 21.5 14.9 24.6 21.5 19.1 22.5 15.8 31.1 19.2 18.4 14.5 15.7 23.8 23.0 19.9 16.1 27.2 14.4 28.8 26.9 36.2 22.6 20.8 22.4 25.5 30.5 14.5 17.5 18.9 7.5 17.2 6.9 19.2 24.1 14.2 32.2 11.9 13.8 19.9 20.8 26.0 16.1 18.8 15.5 19.4 13.9 13.1 20.3 25.8 14.5 13.5 22.5 15.1 26.1 26.7 8.8 7.3 21.7 39.0 6.5 18.3 5.7 5.8 5.8 6.0 9.5 6.5 5.7 4.8 18.3 5.6 18.4 6.1 5.5 11.5 22.9 25.3 56.3 30.7 23.3 21.7 20.9 22.7 25.2 15.0 50.6 25.2 26.6 13.0 8.9 30.3 31.7 30.6 44.2 53.4 33.2 19.6 16.4 68.0 29.8 7.7 21.6 24.5 0.0 23.4 16.0 19.5 12.8 17.4 51.2 30.8 15.9 13.8 19.0 33.9 7.9 24.7 24.0 11.8 20.8 23.9 57.0 39.7 23.0 24.4 60.0 30.6 6.5 15.5 61.4 40.5 12.4 18.0 14.9 22.1 12.3 MICU2 EFHA1 ENSG00000165487 "Mitochondrial calcium uptake 2" Q8IYU8 13 21492691-21604214 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045511, HPA058790" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA045511: AB_10959894, HPA058790: AB_2683821" "unprognostic (4.32e-3)" "unprognostic (1.50e-2)" "unprognostic (2.00e-1)" "unprognostic (7.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.11e-2)" "unprognostic (1.47e-2)" "unprognostic (8.01e-2)" "unprognostic (4.79e-3)" "unprognostic (1.63e-3)" "unprognostic (1.58e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.40e-7)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (5.15e-2)" "unprognostic (3.50e-1)" 14.8 32.4 23.9 23.5 23.2 20.9 22.9 28.6 25.4 19.5 25.4 17.3 16.1 18.0 16.7 21.1 19.9 17.8 16.3 41.7 22.9 24.1 52.8 24.5 15.6 16.8 23.4 25.6 17.0 16.9 19.5 30.3 31.2 20.6 20.3 23.9 14.5 16.9 23.6 39.6 15.5 21.0 14.7 28.1 19.4 20.1 17.5 22.6 25.2 26.3 25.6 19.4 15.6 15.4 33.2 21.8 26.5 23.5 22.8 30.7 17.2 11.8 6.8 16.2 10.3 14.5 19.5 14.0 20.1 16.5 21.5 15.0 9.9 19.2 18.5 13.1 19.1 11.1 15.9 15.9 16.9 29.7 18.7 16.5 31.9 7.4 11.4 17.5 23.9 18.6 16.8 16.8 12.1 8.6 19.3 14.3 17.5 11.2 8.3 35.0 10.2 15.9 22.8 11.0 41.9 10.8 17.5 41.4 12.3 42.3 9.7 13.1 10.1 13.7 16.2 13.0 14.8 15.8 22.6 17.6 9.4 8.4 19.0 16.5 6.2 8.2 13.5 9.2 20.0 23.2 22.1 20.1 26.5 26.1 23.5 24.1 33.2 23.0 26.0 21.8 20.8 20.9 26.0 18.7 22.8 19.3 20.1 30.7 17.2 23.9 23.2 28.6 25.4 22.9 24.1 23.4 25.6 20.6 22.6 35.7 23.2 29.6 35.2 26.7 24.7 68.6 30.6 50.9 37.5 48.8 21.6 50.6 122.7 36.4 20.1 21.0 30.6 23.3 23.9 37.2 35.7 25.7 24.3 21.3 32.4 39.7 29.2 19.6 34.1 10.0 31.4 30.0 45.5 39.7 26.0 60.5 29.6 54.7 33.9 82.6 49.4 58.2 27.8 59.5 48.0 22.3 58.8 35.4 29.2 26.8 MIEF1 "FLJ20232, MiD51, SMCR7L" ENSG00000100335 "Mitochondrial elongation factor 1" Q9NQG6 22 39499432-39518132 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 232.6;Late spermatids: 280.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061059 Approved "Intermediate filaments,Mitochondria" NA NA "Intermediate filaments, Mitochondria" "HPA061059: " "unprognostic (5.35e-2)" "unprognostic (2.66e-2)" "unprognostic (2.86e-3)" "unprognostic (1.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (1.95e-3)" "unprognostic (1.85e-2)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (6.65e-2)" "prognostic favorable (3.96e-5)" "unprognostic (1.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.30e-1)" 14.9 12.6 14.5 15.1 14.9 16.2 12.3 17.3 21.3 10.0 15.1 12.3 12.9 17.5 12.1 12.9 13.9 10.9 14.2 11.6 13.0 12.9 19.6 26.2 10.8 15.5 13.6 15.9 12.1 14.3 16.6 8.3 12.6 12.1 10.6 14.2 12.5 15.6 14.1 16.7 11.5 16.6 10.3 10.8 18.0 11.7 43.1 10.7 15.9 12.6 11.1 16.6 11.5 13.8 7.1 8.1 5.9 8.3 8.7 9.2 7.6 8.0 8.1 9.0 14.2 8.5 9.3 10.3 7.7 9.2 8.9 8.2 13.3 4.2 22.4 6.5 8.3 5.9 10.3 20.2 10.7 11.1 9.5 18.7 9.2 11.4 13.4 16.4 32.5 12.3 12.2 13.1 7.9 16.9 8.6 9.4 7.6 16.2 12.4 8.8 5.4 10.2 9.0 8.3 16.7 8.9 14.1 12.7 22.8 10.2 9.8 8.2 6.8 8.6 14.9 22.0 9.8 6.6 11.8 9.2 8.4 11.9 7.4 9.4 22.7 23.6 22.8 9.7 14.2 12.9 0.6 7.4 5.9 7.6 8.3 9.2 7.0 7.3 7.2 8.1 7.1 8.1 7.5 0.7 8.7 7.8 4.5 6.3 7.6 14.5 14.9 17.3 21.3 13.0 12.9 13.6 15.9 12.1 10.7 11.9 16.0 5.2 10.4 17.3 18.5 15.7 12.7 8.1 5.7 15.7 23.6 16.0 21.6 10.9 232.6 9.8 16.0 0.0 11.7 16.5 10.1 14.5 9.2 34.2 14.0 6.4 9.4 20.3 15.4 280.8 14.4 13.6 15.1 8.2 10.7 19.8 14.0 3.5 13.1 20.3 13.5 0.0 8.5 17.2 27.1 20.1 10.9 7.7 18.9 14.7 MIGA1 "FAM73A, FLJ35093" ENSG00000180488 "Mitoguardin 1" Q8NAN2 1 77779624-77879539 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 27.0;Collecting duct cells: 22.7;Proximal tubular cells: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017589 Approved Supported Mitochondria NA NA Mitochondria "HPA017589: AB_1848409" "unprognostic (3.27e-1)" "unprognostic (1.19e-2)" "unprognostic (7.31e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (3.48e-2)" "unprognostic (2.70e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (6.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.89e-1)" "unprognostic (1.68e-1)" "unprognostic (4.71e-2)" "unprognostic (4.75e-2)" 11.7 11.0 12.2 6.9 23.7 8.1 19.2 18.1 25.4 10.5 8.2 20.3 7.2 9.7 12.0 7.5 8.7 9.1 10.3 8.6 15.7 16.1 20.2 11.2 8.3 6.6 19.2 19.7 12.7 8.9 28.0 13.9 10.1 26.4 13.3 8.0 7.6 12.1 9.6 15.7 7.6 10.6 10.1 29.9 7.5 9.8 7.6 18.8 5.9 21.8 5.1 5.9 10.5 8.1 6.2 3.7 7.3 6.8 5.8 6.7 3.2 8.6 5.6 3.5 4.5 8.7 11.4 9.3 12.5 5.9 7.4 7.6 6.2 6.0 3.8 13.9 8.6 8.9 6.0 4.7 7.4 14.1 5.5 4.8 4.4 6.9 2.9 8.9 4.1 3.4 8.1 8.1 15.1 11.0 10.6 7.4 3.4 2.4 5.2 11.2 1.4 3.9 2.3 3.0 4.3 7.0 2.1 8.6 1.9 9.0 9.4 7.1 5.8 5.8 8.8 16.0 6.1 3.3 2.7 11.8 10.6 4.9 16.0 13.1 3.1 4.3 2.4 9.4 3.6 4.6 7.3 5.5 6.6 5.9 6.8 6.2 4.6 4.7 4.7 3.7 6.2 6.7 5.9 3.5 5.8 4.3 3.0 4.3 3.2 12.2 23.7 18.1 25.4 15.7 16.1 19.2 19.7 26.4 18.8 32.8 27.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 19.4 22.7 0.0 13.4 5.0 13.8 0.0 0.0 0.0 0.0 12.6 10.5 0.0 0.0 11.6 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 4.6 0.0 0.0 15.3 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 MINOS1 "C1orf151, FLJ36999, Mic10, MIO10, RP5-1056L3.2" ENSG00000173436 "Mitochondrial inner membrane organizing system 1" Q5TGZ0 1 19596977-19629821 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059930 Enhanced Supported Mitochondria NA NA Mitochondria "HPA059930: AB_2684167" "unprognostic (3.84e-2)" "unprognostic (8.74e-3)" "unprognostic (2.66e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.88e-1)" "unprognostic (8.74e-2)" "unprognostic (3.96e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.24e-3)" "unprognostic (7.13e-2)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "prognostic favorable (8.11e-4)" 10.1 9.7 22.0 8.1 21.3 5.4 12.6 20.4 22.2 17.7 16.3 7.2 7.5 10.6 14.5 13.7 15.1 15.2 13.7 25.4 18.3 21.4 19.8 12.5 9.7 8.3 20.6 15.5 14.0 13.3 14.5 16.6 8.3 17.0 17.2 18.3 9.3 13.8 17.8 25.2 10.1 17.4 18.2 12.1 8.9 11.4 5.0 11.8 7.7 13.7 20.3 11.8 13.9 10.9 7.0 8.4 9.0 10.5 3.7 11.3 8.9 7.6 10.6 6.0 6.6 11.6 11.1 3.7 6.7 7.6 7.9 8.0 7.4 7.1 6.5 5.6 8.8 6.4 5.6 10.5 8.8 12.8 9.8 7.3 5.7 17.0 10.2 5.1 8.8 4.3 9.0 14.5 7.9 9.7 6.0 11.5 4.9 12.1 4.9 11.8 13.6 4.5 11.5 5.1 10.0 13.5 4.5 7.3 8.6 19.3 4.7 12.5 5.6 7.4 6.0 5.8 5.0 5.9 4.9 7.6 6.2 4.8 7.8 6.6 3.1 5.2 6.7 4.8 16.9 5.8 5.6 8.1 9.0 6.4 10.5 5.8 7.0 8.7 7.0 8.2 6.7 11.3 8.1 5.5 3.7 10.5 8.4 7.8 8.9 22.0 21.3 20.4 22.2 18.3 21.4 20.6 15.5 17.0 11.8 157.8 125.9 175.7 110.6 149.9 78.1 411.9 318.5 207.5 112.6 347.2 43.2 260.0 704.6 351.8 112.1 128.1 424.9 46.7 394.4 215.9 199.3 157.4 195.4 297.4 460.5 85.8 231.3 133.8 238.8 184.5 222.6 223.0 214.2 236.3 403.3 76.4 343.8 474.2 207.9 655.8 74.3 64.7 206.0 163.1 143.3 192.6 153.4 121.5 528.4 124.4 MPDU1 "CDGIf, Lec35, PQLC5, SL15" ENSG00000129255 "Mannose-P-dolichol utilization defect 1" O75352 17 7583529-7592789 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transport "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014845 Uncertain Supported "Endoplasmic reticulum,Mitochondria" NA NA "Endoplasmic reticulum" Mitochondria "HPA014845: AB_1854072" "unprognostic (1.96e-1)" "unprognostic (8.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-2)" "unprognostic (5.00e-2)" "unprognostic (5.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" "unprognostic (4.70e-2)" "unprognostic (3.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (2.34e-3)" "unprognostic (9.00e-2)" "unprognostic (2.60e-1)" "unprognostic (2.48e-3)" "unprognostic (2.93e-1)" 15.4 24.6 12.6 10.3 16.5 16.6 16.7 9.1 26.2 16.0 27.3 22.8 4.6 18.5 8.2 15.3 20.5 14.2 16.4 9.1 11.6 10.3 36.0 80.1 15.4 12.3 12.9 8.4 10.8 24.3 21.0 9.3 27.4 15.7 15.1 30.0 17.3 17.2 9.6 11.0 14.7 39.0 11.8 13.3 23.8 20.3 9.1 10.9 17.6 21.4 12.5 17.5 15.5 11.3 7.5 19.7 5.5 26.8 6.4 10.0 8.7 12.5 26.3 19.2 12.6 24.3 22.4 11.6 20.8 30.6 39.5 29.0 13.7 21.2 7.5 15.1 36.0 17.0 24.4 29.1 35.7 33.7 15.6 26.6 13.6 17.4 23.4 30.4 11.3 21.2 22.8 29.5 36.8 21.8 18.3 29.8 21.0 22.2 9.7 42.7 18.0 7.4 7.0 20.7 29.3 12.5 17.2 14.8 12.7 39.6 12.3 12.1 22.0 27.1 18.9 7.2 17.9 22.1 9.2 20.0 16.3 8.4 9.5 25.9 4.9 9.0 6.2 23.3 14.7 23.2 5.5 16.2 4.8 6.7 26.8 5.5 7.5 6.5 9.0 19.7 7.5 6.7 7.6 2.6 6.4 24.2 18.5 10.0 8.7 12.6 16.5 9.1 26.2 11.6 10.3 12.9 8.4 15.7 10.9 8.9 26.0 42.4 30.9 9.5 15.5 4.3 40.8 17.4 12.5 22.7 11.8 99.2 29.9 56.7 2.3 16.3 81.1 0.0 66.5 77.5 25.4 35.1 13.9 42.4 70.3 15.9 35.7 27.0 31.6 3.6 15.8 35.1 23.6 39.7 56.4 28.4 60.1 66.6 6.0 39.4 20.1 25.8 11.3 19.7 30.4 11.0 131.8 21.8 53.6 36.1 MRM1 FLJ22578 ENSG00000278619 "Mitochondrial rRNA methyltransferase 1" Q6IN84 17 36601572-36608971 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021598 Supported Supported Mitochondria NA NA Mitochondria "HPA021598: AB_1854097" "unprognostic (9.07e-3)" "unprognostic (1.50e-1)" "unprognostic (1.86e-1)" "unprognostic (1.19e-1)" "unprognostic (4.86e-2)" "unprognostic (1.43e-1)" "unprognostic (1.08e-2)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (4.90e-2)" "unprognostic (2.47e-2)" "unprognostic (8.56e-2)" "unprognostic (2.75e-1)" "unprognostic (5.67e-2)" "unprognostic (2.36e-1)" "unprognostic (3.95e-1)" "unprognostic (1.74e-2)" 2.2 6.8 2.9 3.9 6.4 2.9 3.5 1.9 4.9 1.2 4.2 5.2 3.2 5.9 3.2 3.4 3.6 4.0 3.4 3.8 3.7 2.4 4.0 2.2 4.6 6.5 3.0 4.2 4.1 0.9 0.9 1.0 2.8 2.1 5.6 2.4 2.9 4.7 5.9 2.2 4.5 1.2 3.4 5.2 2.5 1.5 3.5 0.9 3.2 1.8 3.8 3.4 0.0 6.7 3.3 0.0 4.4 7.3 7.6 3.7 0.9 6.1 0.0 3.6 3.2 3.8 11.8 0.2 0.0 0.0 0.0 0.4 0.1 0.4 7.1 0.0 3.0 15.1 0.1 0.2 0.0 4.7 2.1 10.5 3.5 6.4 1.9 5.2 5.5 3.0 0.3 7.5 0.0 1.1 3.7 4.7 6.2 4.0 4.3 0.1 10.5 3.2 0.1 14.7 0.1 8.4 0.0 13.5 3.1 7.1 2.8 1.8 0.0 4.4 4.6 4.5 4.6 1.8 1.8 3.6 6.0 4.1 0.0 9.3 10.8 4.5 0.0 5.9 2.6 0.0 2.9 0.0 4.3 4.4 7.6 6.7 3.6 4.1 2.9 6.1 5.5 5.8 0.0 7.3 1.8 3.3 2.8 3.7 0.0 1.0 2.9 2.8 1.0 0.7 7.3 0.0 0.0 1.2 3.5 3.9 6.2 8.3 3.1 0.0 2.9 4.3 0.0 1.6 4.9 2.3 2.6 0.0 1.6 5.5 6.4 1.7 1.3 1.5 0.0 3.1 1.3 1.7 2.8 4.6 1.5 2.7 7.0 1.4 4.1 1.2 0.0 1.4 0.9 2.7 0.4 1.5 0.8 9.7 1.7 MRM3 "FLJ10581, HC90, RMTL1, RNMTL1" ENSG00000171861 "Mitochondrial rRNA methyltransferase 3" Q9HC36 17 782273-792509 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 22.9;Distal tubular cells: 16.6;Ductal cells: 16.4;Exocrine glandular cells: 16.0;Extravillous trophoblasts: 19.4;monocytes: 18.0;Proximal tubular cells: 15.9;Syncytiotrophoblasts: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022534, HPA023031, HPA023292" Enhanced Supported Mitochondria NA NA Mitochondria "HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388" "unprognostic (1.66e-1)" "unprognostic (5.83e-3)" "unprognostic (6.72e-2)" "prognostic favorable (2.81e-4)" "unprognostic (2.67e-1)" "unprognostic (1.83e-1)" "unprognostic (2.48e-1)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (8.20e-2)" "unprognostic (3.72e-3)" "unprognostic (8.47e-2)" "prognostic favorable (3.00e-4)" "unprognostic (3.82e-2)" "unprognostic (9.98e-2)" "unprognostic (1.05e-2)" "unprognostic (1.42e-2)" 10.0 13.8 7.2 12.4 11.9 16.4 10.5 12.8 11.8 7.1 9.1 7.8 8.0 8.6 8.6 8.2 12.0 9.4 10.1 14.7 7.1 7.2 11.1 20.5 6.5 11.9 9.7 7.7 10.3 21.2 8.3 9.2 7.6 10.1 8.2 8.9 7.0 11.4 8.6 31.0 14.6 8.2 8.7 4.8 10.8 12.4 21.4 8.9 12.2 10.1 13.8 10.1 8.7 10.8 22.1 14.8 8.0 14.2 17.6 20.2 14.8 13.5 28.3 6.1 10.6 9.1 7.8 12.1 7.3 6.9 14.7 12.6 16.5 6.3 24.5 7.6 5.8 7.1 11.5 18.1 6.5 14.2 8.2 29.5 9.4 16.4 14.3 9.2 8.1 8.6 9.1 9.1 15.6 13.7 7.7 11.2 15.0 15.8 11.0 7.8 14.6 13.8 10.6 9.0 10.2 14.9 17.0 4.4 13.0 9.8 7.4 8.1 9.4 10.4 8.8 13.6 5.3 10.9 7.3 8.7 7.9 6.1 11.4 20.0 4.3 6.1 9.9 9.9 11.4 10.6 4.9 14.2 8.0 15.2 11.3 16.4 22.1 16.6 18.5 14.8 20.9 20.2 17.6 1.1 17.6 10.9 11.8 17.2 14.8 7.2 11.9 12.8 11.8 7.1 7.2 9.7 7.7 10.1 8.9 6.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 5.2 0.0 22.9 16.6 16.4 0.0 0.0 0.0 0.0 16.0 19.4 0.0 0.0 3.5 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 18.0 0.0 0.0 11.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 MRPL11 ENSG00000174547 "Mitochondrial ribosomal protein L11" Q9Y3B7 11 66435075-66466738 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057685 Approved Supported Mitochondria NA NA Mitochondria "HPA057685: AB_2683502" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.21e-2)" "unprognostic (1.79e-2)" "unprognostic (9.30e-2)" "unprognostic (1.12e-2)" "unprognostic (1.81e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-1)" "unprognostic (8.32e-3)" "unprognostic (2.85e-2)" "unprognostic (3.21e-1)" "unprognostic (1.31e-2)" "unprognostic (9.34e-2)" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" 13.9 12.9 10.1 18.9 10.6 18.2 25.6 10.6 12.5 13.7 20.7 7.0 13.5 15.7 16.5 16.2 22.3 16.3 17.5 32.0 8.5 8.7 19.4 33.1 15.7 27.5 9.0 7.5 20.2 36.6 15.1 9.5 14.8 7.7 15.2 23.2 10.8 21.5 17.7 41.4 13.5 21.8 18.5 7.5 18.5 18.5 14.0 6.7 23.3 19.8 29.7 19.0 16.4 17.7 23.4 25.5 3.4 20.2 16.3 20.9 19.2 18.9 15.1 14.4 13.8 7.2 8.1 20.6 11.1 12.7 21.2 16.3 42.3 23.6 23.9 19.3 10.5 23.6 16.6 21.0 21.7 15.0 11.0 14.0 15.0 13.0 22.3 8.7 24.8 10.1 9.6 13.0 13.0 16.2 10.2 15.7 23.1 21.8 10.5 9.1 32.3 28.5 39.6 26.3 51.3 22.2 18.2 28.7 29.9 9.2 13.1 15.1 13.1 12.2 18.5 38.1 12.8 21.0 13.1 8.8 12.8 17.2 12.0 13.0 7.7 12.1 27.0 13.2 16.0 8.6 0.8 16.3 3.4 17.7 20.2 18.9 23.4 19.7 17.4 25.5 19.3 20.9 19.1 1.1 16.3 17.7 15.4 19.8 19.2 10.1 10.6 10.6 12.5 8.5 8.7 9.0 7.5 7.7 6.7 11.9 27.0 69.2 72.1 44.3 19.7 56.0 53.5 49.5 43.3 31.4 7.9 118.1 104.5 54.8 29.3 52.4 58.7 23.3 74.3 168.1 46.4 55.6 30.1 63.8 111.5 19.1 49.0 46.6 43.8 7.0 46.9 58.8 64.1 89.2 93.5 22.6 57.8 56.1 43.2 94.3 17.9 25.8 49.5 69.9 31.1 42.9 64.8 67.3 153.6 64.7 MRPL12 "MRPL7, MRPL7/L12, RPML12" ENSG00000262814 "Mitochondrial ribosomal protein L12" P52815 17 81703357-81707526 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022853, HPA023043" Supported Supported Mitochondria NA NA Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100" "unprognostic (1.16e-1)" "unprognostic (1.65e-1)" "unprognostic (6.59e-2)" "unprognostic (1.66e-2)" "unprognostic (9.52e-2)" "unprognostic (5.97e-2)" "unprognostic (5.97e-3)" "prognostic unfavorable (2.35e-4)" "unprognostic (1.78e-1)" "unprognostic (6.47e-3)" "unprognostic (8.17e-2)" "unprognostic (3.07e-1)" "unprognostic (8.77e-3)" "unprognostic (3.41e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (9.26e-2)" 15.7 18.6 15.3 14.5 16.9 14.4 27.7 13.6 18.6 9.8 27.2 8.3 14.9 25.2 10.7 8.6 24.4 12.6 14.8 63.7 14.8 13.7 22.8 64.9 15.4 20.4 17.8 10.5 8.9 40.7 13.3 10.7 12.8 13.1 11.6 20.5 9.3 19.6 13.9 79.1 12.6 18.2 11.4 9.4 17.2 15.2 14.4 7.5 16.1 12.2 50.4 16.0 10.9 11.2 24.7 34.6 5.0 30.0 14.7 20.5 17.7 28.1 48.3 12.9 15.1 9.9 10.9 24.0 22.1 13.6 33.4 25.0 40.3 13.6 43.9 13.4 14.5 22.6 24.0 16.6 28.4 17.1 10.2 83.3 33.5 25.8 45.1 14.6 36.7 17.6 12.5 20.8 23.0 25.7 10.7 27.7 21.9 32.5 14.6 16.5 35.6 31.1 54.4 20.3 30.8 63.0 29.8 21.1 32.4 24.7 23.6 33.2 42.7 16.2 70.2 36.2 14.0 35.7 33.5 14.4 25.5 30.2 19.9 44.8 28.3 9.7 24.9 17.4 26.6 19.1 5.0 24.1 3.2 15.0 30.0 20.5 24.7 15.1 16.6 34.6 23.1 16.0 14.3 2.6 14.7 17.3 28.4 12.9 17.7 15.3 16.9 13.6 18.6 14.8 13.7 17.8 10.5 13.1 7.5 17.9 10.9 51.4 58.7 47.4 14.4 76.5 94.3 20.1 20.5 43.6 3.9 154.3 185.6 101.2 30.5 40.0 177.2 46.7 102.2 149.2 34.5 46.3 31.0 198.0 146.6 22.3 99.8 41.1 56.4 97.4 36.5 37.4 55.6 57.7 173.6 25.5 108.9 97.9 30.8 211.9 12.4 32.3 36.8 47.3 51.0 52.9 94.1 34.1 243.5 97.4 MRPL14 "MRP-L32, RPML32" ENSG00000180992 "Mitochondrial ribosomal protein L14" Q6P1L8 6 44113454-44127457 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 116.6" "Low region specificity" "Detected in all" "HPA038769, HPA076790" Uncertain Supported Mitochondria NA NA Mitochondria "HPA038769: AB_10673288, HPA076790: AB_2686815" "unprognostic (4.58e-1)" "unprognostic (8.39e-2)" "unprognostic (1.84e-1)" "unprognostic (7.25e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-2)" "unprognostic (3.21e-2)" "unprognostic (7.20e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.74e-2)" "unprognostic (3.75e-1)" "prognostic unfavorable (7.46e-5)" "unprognostic (7.13e-2)" "unprognostic (1.65e-1)" "prognostic favorable (1.08e-4)" "unprognostic (3.27e-2)" 10.1 16.1 12.5 9.6 12.8 7.9 11.7 10.5 12.7 10.5 16.4 9.6 8.4 16.2 12.1 12.3 15.7 10.4 14.8 18.5 10.0 8.4 12.4 35.5 25.9 10.4 10.9 11.5 7.1 17.5 4.9 9.6 11.8 10.6 9.7 16.3 13.7 14.0 9.4 61.4 16.0 14.0 12.7 7.9 10.2 12.7 19.0 10.4 13.1 26.3 27.8 12.4 12.3 10.0 33.2 36.4 9.0 36.1 46.7 32.5 30.3 39.8 17.1 12.1 16.7 10.5 10.3 15.5 14.9 14.9 19.9 20.0 35.6 14.1 17.4 16.9 12.7 19.2 16.3 13.6 24.3 15.9 20.6 37.1 17.9 15.1 43.5 13.0 17.0 12.6 9.5 13.2 18.8 11.2 15.4 16.4 15.0 37.6 11.2 17.6 40.3 20.3 26.8 10.6 116.6 16.4 14.6 13.6 23.6 32.8 19.8 27.1 10.5 9.6 18.8 18.5 11.0 17.2 17.5 13.1 17.8 26.6 12.7 25.8 14.0 12.3 40.8 20.1 16.9 12.9 9.0 36.1 7.5 25.4 32.7 29.9 33.2 32.5 28.6 32.4 30.2 25.8 26.5 2.0 46.7 21.9 36.4 21.9 30.3 12.5 12.8 10.5 12.7 10.0 8.4 10.9 11.5 10.6 10.4 348.4 202.5 87.1 148.9 205.3 26.8 126.7 117.2 72.3 125.1 54.1 29.5 154.6 172.5 198.2 197.3 76.8 185.2 23.3 191.9 163.1 85.4 198.8 43.8 284.0 228.8 31.8 89.7 48.5 40.9 90.3 69.0 86.6 65.8 216.4 126.1 48.1 252.2 194.7 50.2 212.2 55.1 45.3 85.8 91.7 125.6 245.9 133.9 72.7 153.8 317.1 MRPL15 "HSPC145, L15mt, MRP-L15, MRP-L7, RPML7" ENSG00000137547 "Mitochondrial ribosomal protein L15" Q9P015 8 54135210-54147901 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.5" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 210.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044425 Enhanced Supported Mitochondria NA NA Mitochondria "HPA044425: AB_10969629" "unprognostic (5.67e-3)" "unprognostic (8.89e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (9.30e-2)" "unprognostic (1.90e-2)" "unprognostic (2.57e-2)" "unprognostic (3.10e-3)" "unprognostic (1.39e-1)" "unprognostic (3.39e-2)" "unprognostic (1.94e-3)" "unprognostic (1.57e-2)" "unprognostic (2.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (1.06e-1)" "unprognostic (1.06e-2)" 13.7 15.2 16.2 10.2 17.7 6.7 16.1 10.7 28.0 11.6 21.8 8.7 7.4 18.4 11.3 10.2 16.9 11.8 10.9 54.2 14.4 16.3 31.2 32.3 9.1 14.5 17.5 15.4 10.1 14.9 16.8 9.0 20.9 18.7 9.9 22.1 12.3 15.2 10.8 77.5 16.2 16.5 13.9 10.2 12.7 14.2 5.4 8.1 11.3 12.4 25.0 16.7 15.8 10.9 28.2 38.5 8.2 32.2 13.6 21.2 21.9 30.3 25.4 19.2 22.2 15.2 22.6 24.6 25.7 18.1 32.6 28.8 27.2 35.0 46.3 32.9 20.1 30.7 30.5 37.5 30.5 38.7 21.7 28.1 32.6 13.6 35.0 22.3 17.1 32.4 21.4 33.6 30.1 32.0 15.7 66.2 18.7 37.6 14.9 47.5 32.8 44.5 38.8 38.9 59.0 16.1 31.2 12.3 24.1 42.7 28.7 11.1 17.2 13.0 36.7 29.9 20.5 36.0 17.3 24.7 17.5 22.5 27.3 27.3 18.9 23.5 38.0 17.3 26.5 27.3 8.2 25.9 7.4 15.4 32.2 18.6 28.2 19.4 20.1 38.5 21.6 18.4 17.2 1.0 13.6 28.9 24.1 21.2 21.9 16.2 17.7 10.7 28.0 14.4 16.3 17.5 15.4 18.7 8.1 23.8 11.8 46.2 33.1 20.9 28.0 114.6 56.0 24.1 19.4 34.9 27.5 128.1 210.5 90.3 14.2 23.7 36.5 23.3 61.2 122.6 25.7 20.9 25.3 57.8 93.7 23.8 17.3 29.4 48.6 3.2 23.0 37.9 32.1 61.3 48.9 22.6 78.0 35.1 21.2 95.0 46.9 12.9 17.9 7.9 32.5 30.1 166.4 20.2 75.9 40.0 MRPL19 "KIAA0104, MRP-L15, RLX1, RPML15" ENSG00000115364 "Mitochondrial ribosomal protein L19" P49406 2 75646783-75690851 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046805, HPA056622" Approved Supported Mitochondria NA NA Mitochondria "HPA046805: AB_2679816, HPA056622: AB_2683195" "unprognostic (9.24e-2)" "unprognostic (3.84e-2)" "prognostic favorable (7.39e-4)" "unprognostic (8.40e-2)" "unprognostic (1.59e-2)" "unprognostic (7.52e-3)" "unprognostic (5.75e-2)" "unprognostic (9.86e-2)" "unprognostic (6.21e-3)" "unprognostic (9.71e-3)" "prognostic unfavorable (1.97e-5)" "unprognostic (2.42e-1)" "unprognostic (3.67e-2)" "unprognostic (1.55e-1)" "unprognostic (3.30e-1)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" 21.3 33.9 22.5 13.0 25.2 8.8 21.1 15.9 26.7 23.0 19.5 24.1 12.1 16.8 19.1 19.6 25.7 13.9 15.6 24.4 21.3 20.4 40.8 44.9 13.0 13.5 26.0 21.2 17.3 17.8 30.9 20.6 18.4 26.6 16.4 23.0 13.2 17.7 19.6 47.3 17.2 16.3 21.1 27.7 18.1 16.3 12.0 24.4 19.2 27.3 22.0 17.3 15.1 15.9 18.5 23.7 9.6 17.1 15.5 18.0 11.1 36.3 21.2 20.1 18.1 22.1 26.6 28.6 23.5 21.2 29.8 23.8 32.7 15.1 20.6 23.7 25.6 27.9 25.8 31.3 35.5 45.0 22.8 26.9 28.0 16.6 41.3 23.6 29.8 16.9 17.6 27.4 30.2 27.7 19.0 31.3 22.6 30.8 12.1 29.4 22.2 27.0 23.5 26.3 37.5 23.7 34.2 44.0 27.1 50.5 22.8 22.3 19.3 23.0 26.7 26.1 21.2 22.8 12.0 21.0 26.1 28.9 23.1 34.6 12.6 18.9 17.0 20.6 29.6 22.7 9.6 14.1 9.2 16.0 17.1 18.0 18.5 16.5 16.9 19.9 16.1 14.7 18.0 0.9 15.5 15.4 23.7 17.4 11.1 22.5 25.2 15.9 26.7 21.3 20.4 26.0 21.2 26.6 24.4 17.9 23.5 28.2 24.4 25.8 35.5 37.0 20.4 25.4 29.6 47.1 49.1 79.0 106.1 76.8 15.8 17.3 26.5 23.3 53.4 71.7 27.2 28.3 18.5 62.2 42.7 46.1 26.6 25.2 15.1 7.8 32.8 25.7 32.1 33.3 32.5 38.9 50.8 31.6 34.3 130.8 48.5 19.4 25.3 60.1 14.7 24.7 48.3 20.8 41.3 30.5 MRPL2 "CGI-22, MRP-L14, RPML14" ENSG00000112651 "Mitochondrial ribosomal protein L2" Q5T653 6 43054029-43059806 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007455, HPA064814" Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA007455: AB_1079410, HPA064814: AB_2685358" "unprognostic (2.31e-1)" "unprognostic (1.49e-2)" "unprognostic (3.06e-1)" "unprognostic (1.48e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (3.17e-1)" "prognostic favorable (6.01e-4)" "unprognostic (3.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.24e-2)" "unprognostic (6.42e-2)" "unprognostic (2.33e-2)" "unprognostic (3.13e-1)" "unprognostic (2.78e-1)" 16.9 19.9 17.4 13.1 22.5 16.0 14.2 13.6 21.8 13.0 15.6 13.3 16.4 20.3 14.1 16.9 13.6 16.2 15.5 31.7 16.0 16.8 20.9 55.0 12.9 16.2 18.8 20.3 15.7 17.4 25.8 17.8 11.7 15.3 12.9 15.0 12.6 21.1 19.6 53.2 13.8 15.2 13.4 12.4 11.5 13.4 21.0 13.2 17.5 15.7 25.5 12.3 12.4 11.9 21.0 26.9 14.3 18.5 17.5 16.9 13.6 10.9 12.6 6.3 11.0 7.7 6.2 9.8 4.9 7.0 12.8 11.5 24.1 3.8 15.5 12.3 6.8 9.5 11.6 13.6 13.1 8.0 9.0 28.2 12.5 10.2 29.1 15.2 10.4 6.1 8.1 13.9 14.8 20.1 6.7 9.0 19.8 20.9 10.4 6.8 21.3 13.4 37.0 5.7 42.2 14.9 15.6 6.3 19.8 9.6 6.9 15.2 7.9 4.8 8.5 15.0 5.6 9.6 18.7 8.1 7.5 10.1 9.9 13.6 12.1 11.0 32.0 5.5 16.8 7.3 6.8 18.5 14.3 13.5 17.2 16.9 20.4 15.6 16.0 25.2 21.0 15.9 16.1 5.5 17.5 13.4 26.9 16.6 13.6 17.4 22.5 13.6 21.8 16.0 16.8 18.8 20.3 15.3 13.2 20.8 15.2 33.7 27.7 21.6 18.7 34.1 35.7 29.4 27.3 57.6 25.5 66.2 157.5 45.9 72.1 31.5 50.7 46.7 46.7 41.8 35.6 25.5 27.7 68.6 44.0 4.8 29.4 30.1 23.0 24.4 50.9 27.0 50.6 45.1 37.0 29.6 38.4 49.5 48.4 109.4 17.2 25.8 39.1 33.4 34.3 23.7 53.1 27.7 57.2 21.0 MRPL20 FLJ10024 ENSG00000242485 "Mitochondrial ribosomal protein L20" Q9BYC9 1 1401908-1407313 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047074 Supported Supported Mitochondria NA NA Mitochondria "HPA047074: AB_10964064" "unprognostic (4.04e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-2)" "unprognostic (5.79e-2)" "unprognostic (3.71e-1)" "unprognostic (2.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (2.80e-2)" "unprognostic (2.33e-1)" "unprognostic (4.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.25e-1)" "unprognostic (4.34e-2)" "unprognostic (1.64e-1)" 36.7 36.2 44.4 31.0 40.7 22.6 41.2 30.3 46.8 24.8 33.4 24.2 38.8 30.7 28.1 52.3 33.8 32.7 39.9 75.3 37.3 38.6 40.1 48.8 31.5 59.7 39.9 31.4 26.5 72.8 28.4 36.3 27.2 35.6 35.1 33.1 29.1 50.5 47.7 121.8 27.3 28.9 44.5 39.1 30.5 33.6 27.7 29.7 22.8 34.3 54.8 35.9 27.1 26.9 50.6 77.5 37.5 52.1 40.5 59.9 51.7 39.6 38.5 28.9 29.2 22.3 24.3 21.3 35.6 27.3 46.4 33.3 45.7 48.6 42.5 50.0 30.5 21.7 25.4 47.1 38.4 36.1 36.7 66.6 45.9 67.7 44.9 31.0 67.4 29.7 28.3 14.9 35.6 38.4 27.0 34.3 40.7 46.3 25.4 38.9 39.8 51.8 51.5 30.0 46.4 77.9 34.5 26.7 54.1 36.2 26.7 51.4 42.4 33.9 71.0 52.2 25.3 30.4 50.0 29.3 28.4 33.0 42.4 43.9 39.0 55.4 82.8 43.8 54.9 19.7 27.8 52.1 37.5 46.8 49.1 52.4 50.6 52.3 46.4 53.2 47.5 59.9 57.3 24.1 40.5 37.7 77.5 45.0 51.7 44.4 40.7 30.3 46.8 37.3 38.6 39.9 31.4 35.6 29.7 62.5 114.8 142.1 105.7 115.6 77.1 229.7 152.8 116.4 110.3 153.5 33.4 194.5 449.3 166.0 28.9 116.1 135.5 210.2 283.0 213.3 100.7 167.9 100.8 326.9 195.7 47.7 132.8 120.3 122.8 28.2 99.8 123.4 131.6 174.1 154.0 179.7 210.2 161.2 104.3 475.5 87.1 64.7 124.6 122.1 210.0 137.9 189.1 99.7 179.2 143.3 MRPL23 "L23MRP, RPL23L" ENSG00000214026 "Mitochondrial ribosomal protein L23" Q16540 11 1947278-1984522 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 117.7" HPA050406 Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA050406: AB_2681116" "unprognostic (5.74e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "prognostic favorable (3.97e-4)" "unprognostic (3.45e-2)" "unprognostic (2.08e-1)" "unprognostic (2.40e-1)" "unprognostic (2.56e-1)" "unprognostic (2.34e-2)" "unprognostic (8.32e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "unprognostic (8.43e-2)" "unprognostic (1.82e-1)" "unprognostic (6.33e-2)" "unprognostic (7.23e-3)" "unprognostic (4.08e-2)" 19.4 32.7 19.3 21.8 19.3 37.3 22.1 14.0 25.1 18.1 21.0 17.2 22.5 28.7 19.9 31.4 31.5 30.7 29.9 39.8 16.6 16.8 25.1 43.8 17.4 42.9 18.4 16.9 29.4 69.1 22.6 25.8 14.5 17.4 17.9 21.0 21.2 48.7 25.9 61.0 35.5 23.8 15.9 14.3 22.4 25.6 11.1 11.4 32.5 21.1 44.3 30.1 12.7 17.9 24.1 20.2 12.6 14.5 6.8 22.1 3.3 23.6 27.9 15.0 17.9 6.1 17.3 21.9 7.1 10.5 12.1 9.0 1.7 28.8 24.1 14.2 16.4 16.7 23.7 24.2 33.1 5.8 26.8 117.7 8.6 8.7 34.1 16.3 22.7 13.6 13.6 12.9 8.3 2.4 14.3 8.6 14.1 6.5 13.0 17.5 26.0 18.1 4.7 20.5 21.3 21.2 25.0 7.8 25.1 10.7 9.3 30.2 25.6 8.9 21.1 13.1 8.8 0.5 28.7 10.8 16.5 10.2 4.1 15.6 18.2 16.2 22.6 25.7 19.8 0.0 1.9 14.5 12.6 7.0 10.7 5.6 24.1 10.3 7.8 20.2 20.3 22.1 6.7 0.8 6.8 7.8 8.6 14.6 3.3 19.3 19.3 14.0 25.1 16.6 16.8 18.4 16.9 17.4 11.4 11.9 4.6 111.7 57.4 165.5 6.8 63.0 104.4 28.1 33.0 36.6 0.0 122.5 104.5 95.9 8.1 41.5 179.4 93.5 203.3 208.2 58.0 53.8 97.8 151.5 158.7 4.8 130.7 55.3 173.8 10.3 21.3 115.0 190.6 101.8 117.6 20.1 153.1 173.2 34.3 212.5 8.2 38.8 82.9 24.7 40.3 226.1 75.7 66.0 150.6 57.5 MRPL28 "MAAT1, p15" ENSG00000086504 "Mitochondrial ribosomal protein L28" Q13084 16 367384-370527 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030594, CAB033542, HPA055589" Supported Supported Mitochondria NA NA Mitochondria "CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855" "unprognostic (2.39e-1)" "unprognostic (7.39e-3)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.15e-2)" "unprognostic (9.92e-2)" "unprognostic (2.92e-1)" "unprognostic (3.45e-3)" "unprognostic (6.76e-2)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (4.36e-1)" "unprognostic (2.60e-1)" "unprognostic (6.56e-2)" 18.3 21.7 32.2 18.6 36.6 25.1 19.5 17.9 38.4 15.3 26.0 19.1 14.6 21.7 16.8 21.3 21.1 21.2 20.0 49.6 30.9 22.5 26.9 35.5 15.1 24.5 24.9 20.9 15.7 21.4 23.6 15.5 15.8 17.7 16.2 12.0 16.8 21.7 18.4 42.1 16.0 19.2 19.6 16.8 18.1 15.8 25.7 10.4 24.9 20.3 36.3 20.4 16.9 14.7 38.0 47.1 48.2 42.0 28.0 47.7 33.7 17.8 41.8 17.9 21.5 10.1 13.1 24.5 21.0 27.4 37.9 37.5 51.3 24.9 26.4 23.9 21.2 19.5 23.5 27.4 44.2 20.2 23.7 66.4 19.3 32.3 42.1 32.7 23.9 26.1 19.6 22.0 35.3 28.4 18.3 27.8 26.0 35.4 19.8 23.6 72.3 37.8 27.4 28.8 17.8 26.7 47.1 21.9 37.8 31.0 11.0 30.9 28.2 25.9 26.5 21.5 17.9 34.1 25.0 21.8 23.4 32.6 18.5 23.3 31.3 24.1 34.9 15.7 17.5 36.5 30.4 42.0 45.8 30.1 40.8 24.6 34.3 26.2 28.4 37.7 38.0 18.6 23.8 48.2 28.0 40.7 47.1 47.7 33.7 32.2 36.6 17.9 38.4 30.9 22.5 24.9 20.9 17.7 10.4 35.7 28.5 54.4 43.0 30.8 29.9 47.6 43.3 36.1 30.7 66.3 7.9 72.2 164.2 92.3 75.5 43.2 76.2 46.7 97.0 87.9 37.6 40.1 25.5 57.1 86.3 27.0 61.5 39.9 64.5 166.1 35.4 45.0 67.4 176.7 45.6 55.2 87.0 56.0 36.0 146.8 31.1 38.8 39.2 91.0 46.2 28.2 38.3 40.5 57.0 41.7 MRPL36 "BRIP1, L36mt, MRP-L36, PRPL36, RPMJ" ENSG00000171421 "Mitochondrial ribosomal protein L36" Q9P0J6 5 1798386-1801366 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 90.2" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 359.0;Late spermatids: 373.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047238 Approved Supported "Nuclear bodies,Mitochondria" No No "Nuclear bodies, Mitochondria" "HPA047238: AB_10965331" "unprognostic (2.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-2)" "unprognostic (7.83e-3)" "unprognostic (2.03e-2)" "unprognostic (2.01e-2)" "unprognostic (1.09e-3)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (5.39e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.53e-2)" "unprognostic (9.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" 16.8 20.7 14.3 12.9 14.8 8.2 17.9 9.3 15.4 12.3 15.9 9.0 13.7 14.1 13.5 15.1 20.8 12.7 19.0 32.4 13.5 13.0 22.4 44.6 11.6 13.6 14.2 8.6 16.5 28.9 9.0 10.1 13.9 12.3 17.0 10.5 9.6 27.3 12.3 52.5 11.7 16.2 16.1 11.9 11.5 14.4 46.0 11.1 14.1 18.1 35.8 15.3 16.3 14.4 24.5 90.2 12.9 20.3 18.4 25.8 24.1 23.2 34.6 16.1 30.4 29.8 24.7 21.2 20.4 18.0 24.4 23.4 25.0 19.0 31.4 37.1 21.8 35.9 25.5 36.2 33.6 17.7 34.1 40.3 15.2 76.9 39.6 38.2 19.7 12.0 21.7 26.0 27.2 35.3 21.4 23.6 18.6 23.1 20.3 34.6 42.7 23.0 44.5 15.6 25.8 42.6 18.5 12.0 37.8 22.0 19.1 18.0 12.3 44.4 34.7 21.2 15.5 20.3 21.4 14.2 21.2 23.0 14.3 22.5 19.5 24.3 41.3 26.6 36.5 28.8 12.9 20.3 12.5 18.6 19.4 22.1 24.5 21.0 22.4 24.3 17.9 18.6 22.1 5.8 18.4 16.5 90.2 25.8 24.1 14.3 14.8 9.3 15.4 13.5 13.0 14.2 8.6 12.3 11.1 29.8 25.3 33.5 68.7 94.2 19.7 152.3 53.5 38.8 42.1 55.8 5.9 78.6 260.2 71.7 359.0 51.5 50.4 0.0 65.2 52.4 60.6 90.8 27.6 108.3 76.3 14.3 25.3 34.4 38.0 373.3 69.3 34.3 57.3 73.9 47.9 48.5 78.1 49.2 56.3 144.3 22.1 64.7 83.4 78.8 62.6 109.2 73.1 35.2 55.9 94.5 MRPL37 "MRP-L2, RPML2" ENSG00000116221 "Mitochondrial ribosomal protein L37" Q9BZE1 1 54184041-54225464 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025767, HPA025826, HPA025951" Supported Supported Mitochondria NA NA Mitochondria "HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107" "unprognostic (2.00e-1)" "unprognostic (6.81e-2)" "prognostic favorable (6.99e-4)" "unprognostic (1.71e-3)" "unprognostic (8.24e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (2.49e-2)" "unprognostic (1.56e-1)" "unprognostic (1.64e-1)" "unprognostic (1.92e-2)" "unprognostic (1.84e-1)" "unprognostic (3.07e-1)" "prognostic favorable (9.25e-4)" "unprognostic (2.43e-1)" "unprognostic (2.62e-1)" "unprognostic (7.67e-3)" 21.3 35.0 16.2 15.8 24.0 26.0 18.0 16.9 34.8 15.8 22.9 18.0 13.9 23.5 17.6 13.7 29.0 18.2 18.6 32.0 15.4 14.0 25.1 65.2 13.8 20.6 16.0 14.6 21.2 30.8 15.4 10.9 19.4 23.0 16.2 25.2 20.1 33.5 15.3 68.0 24.0 25.0 19.3 11.9 17.9 20.9 20.0 9.0 31.4 18.1 39.9 28.1 16.2 17.5 39.0 40.8 14.8 35.3 29.1 37.4 38.5 39.4 22.8 20.8 28.0 21.1 28.3 37.2 26.9 25.3 48.1 41.9 45.6 18.3 53.8 24.4 30.1 45.9 31.9 40.9 39.8 37.7 26.2 51.6 46.2 48.3 46.0 36.2 54.6 21.6 31.1 34.2 49.8 39.1 27.0 42.9 42.3 51.0 16.2 34.2 29.1 37.6 53.3 42.6 32.0 50.9 41.4 42.4 45.3 27.4 29.6 41.2 19.2 37.2 64.1 49.4 28.7 27.7 62.0 21.3 30.9 28.1 38.8 53.9 20.6 28.9 41.9 40.2 55.8 29.2 14.8 35.3 14.6 24.1 29.9 28.2 39.0 29.8 27.2 40.8 32.8 30.3 27.0 1.9 29.1 27.9 34.1 37.4 38.5 16.2 24.0 16.9 34.8 15.4 14.0 16.0 14.6 23.0 9.0 20.8 18.9 20.8 36.7 30.8 8.2 68.7 48.4 18.7 17.0 17.4 2.0 102.8 68.0 71.3 25.7 28.2 48.4 46.7 83.7 118.7 37.0 38.0 13.9 148.6 76.9 6.4 31.9 38.1 35.8 43.5 24.2 28.1 21.9 58.7 48.4 9.1 62.0 31.6 26.9 83.4 6.9 12.9 26.2 21.7 38.3 32.6 61.8 25.9 80.6 43.8 MRPL38 "HSPC262, MGC4810, MRP-L3, RPML3" ENSG00000204316 "Mitochondrial ribosomal protein L38" Q96DV4 17 75898643-75905413 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023054, HPA023135" Approved Supported Mitochondria NA NA Mitochondria "HPA023054: AB_1854109, HPA023135: AB_1854110" "unprognostic (1.17e-1)" "unprognostic (3.77e-3)" "unprognostic (1.83e-1)" "unprognostic (3.68e-3)" "unprognostic (2.47e-2)" "unprognostic (1.50e-2)" "unprognostic (4.44e-2)" "unprognostic (1.61e-1)" "unprognostic (7.59e-2)" "unprognostic (5.24e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (5.58e-4)" "unprognostic (3.06e-2)" "unprognostic (2.40e-1)" "unprognostic (3.72e-1)" "prognostic favorable (9.21e-5)" 10.8 14.1 12.4 6.7 14.8 6.0 8.2 8.4 20.8 9.6 11.7 23.3 6.5 10.6 9.5 7.8 11.2 15.4 10.2 21.2 11.7 9.2 11.7 17.6 8.4 8.1 15.7 18.1 12.0 17.5 8.7 7.7 7.3 14.8 8.7 8.2 8.8 17.1 13.6 41.8 9.5 8.9 17.9 11.3 8.8 10.3 15.1 14.7 8.3 8.8 14.1 9.5 10.9 7.5 28.5 29.4 9.9 21.8 24.0 24.6 21.3 17.7 24.9 5.0 6.1 7.4 6.1 20.5 6.0 10.5 23.4 17.0 30.4 10.7 17.2 7.1 10.3 12.2 12.6 17.9 16.3 6.1 5.1 33.7 11.4 7.0 27.2 18.5 15.2 10.3 8.8 18.6 15.1 12.2 5.9 22.7 20.5 14.3 7.8 8.3 37.1 18.3 15.1 6.4 23.2 24.7 13.8 17.3 18.5 17.4 8.9 9.8 11.0 11.2 26.3 24.3 5.0 24.6 15.2 6.9 8.9 15.4 7.0 15.8 10.2 6.4 4.9 10.8 11.8 8.2 4.5 20.0 9.9 23.7 21.8 23.8 28.3 24.5 22.2 29.4 28.5 24.6 23.7 1.6 24.0 17.5 20.9 24.5 21.3 12.4 14.8 8.4 20.8 11.7 9.2 15.7 18.1 14.8 14.7 17.9 5.3 2.7 0.6 1.3 0.9 1.7 0.0 16.0 7.9 3.5 0.0 4.3 3.3 19.9 0.9 1.0 9.8 0.0 18.4 3.7 2.3 1.2 3.5 2.0 2.9 1.6 9.9 3.1 0.3 0.9 2.8 2.7 6.8 22.6 12.2 0.9 17.8 18.7 2.8 5.1 2.7 0.0 3.1 2.3 1.7 1.3 2.9 2.9 18.8 0.5 MRPL39 "C21orf92, FLJ20451, L39mt, MGC104174, MGC3400, MRP-L5, MSTP003, PRED22, PRED66, RPML5" ENSG00000154719 "Mitochondrial ribosomal protein L39" Q9NYK5 21 25585656-25607517 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018331 Approved Supported Mitochondria NA NA Mitochondria "HPA018331: AB_1854111" "unprognostic (3.81e-3)" "unprognostic (5.34e-2)" "unprognostic (8.55e-3)" "unprognostic (4.61e-1)" "unprognostic (2.61e-1)" "unprognostic (4.32e-2)" "unprognostic (6.75e-2)" "unprognostic (2.35e-1)" "unprognostic (4.74e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (5.84e-4)" "unprognostic (7.48e-2)" "unprognostic (7.32e-3)" "unprognostic (9.81e-2)" "unprognostic (1.66e-1)" "unprognostic (2.45e-2)" "unprognostic (6.89e-2)" 15.3 29.4 18.7 14.4 22.7 12.0 17.1 24.0 25.6 11.7 17.8 12.8 13.6 15.8 14.1 27.3 20.9 13.1 9.9 38.2 22.1 13.8 24.9 33.5 12.9 19.4 23.4 23.9 13.7 18.8 28.9 13.6 16.0 19.6 13.1 20.6 8.3 14.8 13.3 35.0 15.5 14.3 16.7 16.6 13.9 17.2 35.9 21.6 13.2 12.7 26.7 21.9 13.7 14.3 28.8 19.7 14.4 13.3 15.4 24.9 8.8 28.7 14.2 20.2 12.8 10.2 14.9 31.3 18.7 16.6 26.1 22.0 27.9 16.3 31.8 10.5 11.6 23.7 8.5 42.7 25.3 29.2 16.0 22.3 32.5 15.4 29.4 11.9 32.8 10.8 12.0 22.6 25.8 21.2 14.5 19.3 33.3 35.7 26.3 25.7 18.1 21.4 17.9 32.1 29.0 22.1 25.1 32.8 33.4 26.9 11.7 12.8 12.3 17.1 31.6 24.3 14.9 22.9 18.7 12.1 14.0 20.7 14.8 22.6 18.6 23.6 39.6 20.8 35.5 20.9 14.4 8.1 9.0 18.1 13.3 22.5 28.8 22.1 20.3 14.0 22.6 22.1 19.5 1.3 15.4 9.3 19.7 24.9 8.8 18.7 22.7 24.0 25.6 22.1 13.8 23.4 23.9 19.6 21.6 23.8 8.0 16.6 17.4 17.7 21.4 70.6 5.1 33.5 17.0 24.4 9.8 41.0 26.6 27.7 164.4 23.3 8.5 0.0 29.4 36.2 20.2 11.4 15.0 17.9 26.8 9.5 7.5 13.5 8.8 22.4 13.8 14.2 18.6 18.0 9.1 19.0 23.6 5.8 21.9 40.7 14.3 45.3 21.7 74.3 25.8 14.8 30.9 13.8 18.9 10.9 MRPL40 "MRP-L22, NLVCF" ENSG00000185608 "Mitochondrial ribosomal protein L40" Q9NQ50 22 19431902-19436075 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 28.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006181 Uncertain Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA006181: AB_1079411" "unprognostic (4.12e-2)" "prognostic favorable (7.57e-4)" "unprognostic (2.64e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (4.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (4.08e-2)" "unprognostic (1.19e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (2.67e-2)" "unprognostic (1.75e-1)" "unprognostic (8.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.14e-2)" 4.0 6.6 5.5 2.5 6.6 1.3 3.9 5.1 5.4 4.3 2.6 2.9 3.0 5.0 3.7 5.0 2.9 11.8 4.6 4.7 6.1 10.3 2.2 3.0 5.1 4.7 7.0 6.4 4.9 2.5 4.6 2.2 8.7 4.2 14.8 3.6 2.3 2.4 5.0 2.7 3.1 2.8 8.2 2.8 3.7 2.5 28.1 21.6 10.3 15.1 10.9 16.4 16.6 13.2 9.2 2.2 8.4 13.7 12.7 7.0 10.0 11.6 14.1 17.6 10.8 7.7 11.6 10.4 11.0 8.1 13.1 13.9 15.9 11.9 11.8 21.3 10.5 6.6 13.3 20.2 15.0 7.0 13.1 15.5 10.4 18.6 9.5 9.4 4.4 42.5 11.1 13.6 10.1 7.8 8.9 3.6 18.7 12.5 7.4 14.5 5.3 16.8 5.6 7.6 7.0 15.3 12.9 19.2 5.2 11.4 8.8 11.8 18.8 17.4 7.4 9.7 10.6 14.2 16.9 12.3 10.2 13.6 5.9 13.8 10.3 13.0 15.1 14.0 28.1 13.2 13.5 15.0 25.5 16.4 14.3 1.6 10.9 12.0 21.6 15.0 16.6 41.7 33.6 52.8 60.0 35.8 28.7 83.9 76.5 109.7 53.4 45.4 11.8 118.0 220.5 67.0 81.1 33.6 39.3 0.0 84.9 110.0 43.1 49.9 33.4 122.0 116.9 20.6 33.6 40.5 35.4 118.1 67.0 37.7 81.0 100.0 42.0 80.3 63.8 42.4 67.8 201.9 38.4 45.3 58.7 83.7 70.0 33.6 52.6 34.6 45.0 39.2 MRPL41 "BMRP, MRP-L27, MRPL27, PIG3, RPML27" ENSG00000182154 "Mitochondrial ribosomal protein L41" Q8IXM3 9 137551199-137552555 "Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 55.8;skeletal muscle: 60.6" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 826.6;Distal tubular cells: 824.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 49.0;PC-3: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024550, HPA027160" Supported Supported Mitochondria NA NA Mitochondria "HPA024550: AB_1854112, HPA027160: AB_1854113" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (6.92e-2)" "unprognostic (1.22e-3)" "unprognostic (5.86e-3)" "unprognostic (8.04e-2)" "unprognostic (2.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.47e-1)" "unprognostic (1.14e-1)" "unprognostic (4.83e-3)" "unprognostic (3.24e-2)" "unprognostic (2.06e-3)" "unprognostic (3.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" 15.3 8.0 12.8 3.5 14.4 3.1 2.8 4.1 10.7 2.4 8.3 7.1 2.3 1.0 1.7 2.1 1.5 16.4 10.3 7.7 6.8 10.7 2.6 3.3 8.5 4.2 6.3 1.8 2.9 1.6 9.5 2.2 10.8 3.8 60.6 5.3 6.2 1.5 4.0 6.2 10.5 2.1 2.0 1.5 2.7 2.1 38.3 55.8 43.7 42.5 21.8 42.2 42.8 10.0 17.0 2.9 6.8 4.3 3.6 13.2 12.9 3.3 5.9 4.8 11.8 5.7 7.4 16.9 3.1 8.9 21.4 3.8 6.1 0.6 10.8 21.1 6.8 9.3 18.4 9.9 11.0 31.4 7.1 8.4 5.3 1.9 2.6 5.4 6.5 14.8 3.2 3.1 49.0 3.7 35.8 10.9 12.8 48.0 4.6 4.9 10.3 5.0 6.7 9.4 10.2 8.5 15.8 20.9 1.7 15.0 10.0 10.6 10.3 14.3 18.5 16.7 9.6 13.3 13.1 11.9 10.9 7.8 43.7 42.5 31.5 31.2 34.1 29.5 38.3 33.8 35.9 34.6 28.5 32.2 30.2 5.1 21.8 31.1 55.8 42.2 42.8 26.8 28.1 87.8 111.7 124.4 47.8 826.6 188.5 41.5 37.5 249.5 9.8 105.5 824.0 135.5 238.0 93.7 424.6 0.0 166.2 127.5 105.3 182.0 54.1 733.3 213.4 27.0 257.8 98.2 123.7 565.6 112.8 114.0 212.6 190.2 235.6 66.7 187.8 270.0 98.3 497.0 34.2 109.9 97.6 90.9 72.6 145.2 68.8 110.7 282.5 152.7 MRPL42 "HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31" ENSG00000198015 "Mitochondrial ribosomal protein L42" Q9Y6G3 12 93467488-93516213 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 276.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039398 Approved Supported "Plasma membrane,Mitochondria" NA NA "Plasma membrane, Mitochondria" "HPA039398: AB_10673529" "unprognostic (9.32e-2)" "unprognostic (4.18e-2)" "unprognostic (4.50e-2)" "unprognostic (3.89e-2)" "unprognostic (1.27e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (7.49e-4)" "unprognostic (6.13e-2)" "unprognostic (3.66e-2)" "unprognostic (1.95e-1)" "unprognostic (2.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (4.92e-1)" "unprognostic (1.62e-1)" "prognostic favorable (8.12e-4)" 18.4 35.6 16.7 13.9 23.6 14.6 22.5 23.2 24.4 22.0 21.5 16.6 16.3 17.0 18.7 16.5 26.7 20.5 15.1 24.2 16.8 16.4 31.0 28.9 16.0 15.3 21.4 16.7 18.4 16.3 26.1 35.8 18.5 26.2 19.3 26.4 13.7 17.8 19.0 15.1 15.8 18.4 19.8 20.4 18.8 18.1 34.5 17.1 25.7 19.5 14.9 21.5 19.1 21.0 29.9 18.8 23.3 23.1 29.3 32.0 21.0 17.3 18.7 30.1 24.4 18.0 27.1 25.4 21.5 21.8 32.9 26.6 25.1 13.9 24.5 9.4 19.6 15.6 15.7 38.7 29.0 50.4 28.7 29.9 28.2 12.8 31.1 24.6 32.6 14.2 20.0 31.8 28.5 42.3 24.9 31.8 27.6 37.2 13.4 37.4 18.5 36.5 25.5 45.0 27.7 34.4 30.3 15.2 29.9 36.3 35.7 36.9 20.1 18.4 30.8 23.1 25.6 30.5 18.0 15.7 24.2 13.8 15.3 28.8 16.0 23.2 27.0 9.5 25.7 36.2 18.0 17.7 23.3 19.0 23.1 24.4 29.9 24.9 20.9 18.8 23.9 26.1 26.8 7.4 29.3 21.5 13.3 32.0 21.0 16.7 23.6 23.2 24.4 16.8 16.4 21.4 16.7 26.2 17.1 26.8 28.6 54.8 70.8 59.8 33.3 73.5 40.8 62.9 31.8 43.6 56.9 85.2 180.8 81.9 276.9 50.6 37.0 0.0 67.3 120.5 56.8 91.3 58.7 45.9 48.2 44.5 89.3 28.3 38.6 81.3 47.8 37.0 57.3 27.9 49.8 19.9 75.9 42.1 52.6 106.7 35.0 51.8 64.3 114.9 71.6 65.6 79.9 55.1 63.5 104.3 MRPL43 bMRP36a ENSG00000055950 "Mitochondrial ribosomal protein L43" Q8N983 10 100969458-100987515 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073022 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA073022: " "unprognostic (2.65e-1)" "unprognostic (1.10e-2)" "unprognostic (2.01e-2)" "unprognostic (4.11e-3)" "unprognostic (6.07e-2)" "unprognostic (3.74e-1)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.03e-1)" "unprognostic (6.04e-3)" "unprognostic (3.02e-1)" "unprognostic (3.53e-2)" "unprognostic (7.29e-2)" "unprognostic (2.53e-2)" 34.6 34.5 25.9 20.1 24.2 22.5 25.0 24.0 32.9 26.0 26.1 32.5 25.5 28.5 24.7 29.9 31.8 25.9 30.2 25.0 24.4 20.9 37.2 39.6 20.5 20.3 26.5 19.3 32.7 62.2 16.7 21.4 26.6 22.9 31.9 8.3 30.1 61.4 34.4 100.4 26.8 30.1 25.5 32.1 24.8 32.0 28.6 20.3 23.5 45.2 35.2 25.6 27.6 22.6 36.2 36.6 41.3 32.3 36.4 39.4 33.4 30.1 34.3 7.2 12.7 7.5 9.7 22.4 21.1 19.2 16.4 16.7 19.5 23.7 26.0 28.8 8.8 8.9 18.9 2.6 17.6 2.2 19.6 44.6 20.5 24.9 30.2 16.2 16.1 16.5 15.1 13.8 13.9 6.1 7.8 15.4 16.6 10.1 13.3 4.9 31.9 15.0 36.7 11.6 8.2 32.4 16.2 24.1 17.4 9.1 15.6 8.1 20.9 15.4 7.5 23.6 2.4 40.1 7.8 18.8 15.4 20.6 16.5 22.1 27.9 21.2 13.1 19.7 30.2 11.1 41.3 32.3 35.1 32.3 30.0 33.2 36.2 35.7 32.1 36.6 33.3 34.7 30.9 11.0 36.4 28.8 28.6 39.4 33.4 25.9 24.2 24.0 32.9 24.4 20.9 26.5 19.3 22.9 20.3 41.7 35.1 68.5 70.1 49.5 43.4 32.2 84.1 78.9 51.2 71.5 39.3 112.8 152.5 84.3 53.4 47.0 56.3 70.0 110.7 118.6 57.0 57.6 45.1 59.7 86.2 17.5 58.7 51.5 39.7 31.5 79.1 47.5 60.8 68.5 68.0 64.2 77.6 84.2 69.3 155.7 46.0 51.8 80.4 138.2 73.5 59.8 86.7 61.0 79.0 55.9 MRPL44 "FLJ12701, FLJ13990" ENSG00000135900 "Mitochondrial ribosomal protein L44" Q9H9J2 2 223957404-223967714 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038147, HPA038148" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Mitochondria" NA NA Mitochondria "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA038147: AB_10671521, HPA038148: AB_2675863" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (3.38e-2)" "unprognostic (3.00e-1)" "unprognostic (7.05e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.16e-2)" "unprognostic (3.32e-1)" "unprognostic (7.65e-2)" "unprognostic (8.33e-2)" "unprognostic (6.65e-2)" "prognostic favorable (2.02e-4)" "unprognostic (2.47e-2)" "unprognostic (1.14e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-1)" 16.4 29.2 15.3 16.8 16.4 32.7 26.7 15.1 24.2 11.7 17.9 12.8 9.2 16.0 13.9 12.6 18.3 14.1 14.8 29.0 14.6 16.9 31.0 38.9 13.0 24.1 15.2 17.0 13.5 26.1 11.0 12.7 17.3 13.8 13.3 19.6 11.8 14.1 13.9 35.3 14.7 15.5 12.3 15.6 18.8 14.9 18.4 12.8 23.6 16.2 22.9 21.0 14.1 11.3 31.5 28.2 39.8 30.1 21.2 26.9 23.3 12.1 10.3 15.4 17.7 14.5 17.3 24.4 13.7 15.4 22.3 23.6 36.5 15.3 18.4 14.9 11.7 20.5 16.2 25.0 18.9 20.7 17.3 17.7 20.0 11.9 28.6 21.4 22.1 15.5 20.2 23.7 13.5 18.2 18.9 21.8 18.9 19.1 14.6 17.9 14.1 16.5 28.1 23.0 24.5 10.8 19.5 18.9 11.3 29.7 10.3 21.0 12.1 10.1 22.7 33.0 23.7 19.1 32.0 14.3 14.9 11.6 12.7 11.0 16.1 11.2 26.3 15.1 21.2 16.3 31.5 30.1 22.6 20.5 29.1 25.9 31.5 22.1 24.4 28.2 27.0 26.9 23.5 39.8 21.2 25.6 22.6 22.2 23.3 15.3 16.4 15.1 24.2 14.6 16.9 15.2 17.0 13.8 12.8 6.0 12.5 45.0 23.7 15.9 18.2 9.7 28.1 22.7 12.5 26.2 0.0 79.5 69.6 38.7 3.8 18.8 20.4 23.3 30.7 52.2 18.6 18.3 18.4 47.4 42.1 11.1 12.6 20.3 28.6 5.9 16.7 21.2 32.1 33.3 21.1 13.5 34.8 17.5 17.0 71.1 10.4 19.4 10.3 34.2 56.9 14.4 40.7 18.4 24.3 31.4 MRPL46 "C15orf4, LIECG2, P2ECSL" ENSG00000259494 "Mitochondrial ribosomal protein L46" Q9H2W6 15 88459476-88467419 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050166 Uncertain Supported "Nucleoplasm,Cell Junctions,Mitochondria" NA NA Mitochondria "Nucleoplasm, Cell Junctions" "HPA050166: AB_2681039" "unprognostic (1.42e-1)" "unprognostic (6.94e-3)" "unprognostic (1.02e-1)" "unprognostic (1.21e-2)" "unprognostic (3.28e-2)" "unprognostic (5.16e-2)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.79e-1)" "unprognostic (4.64e-3)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "prognostic favorable (2.09e-6)" "unprognostic (7.73e-2)" "unprognostic (9.18e-2)" "unprognostic (6.96e-3)" "unprognostic (1.63e-1)" 11.0 28.3 14.2 11.9 14.7 5.4 13.2 15.8 15.6 7.3 12.4 8.5 10.0 11.1 9.6 11.5 13.3 10.5 8.3 40.8 11.8 11.3 19.3 38.7 7.4 10.4 13.2 13.0 11.4 8.9 8.1 9.2 13.7 13.8 9.0 13.8 7.8 9.3 9.5 57.0 8.2 9.3 11.1 11.4 9.7 12.0 13.7 11.7 12.2 10.0 17.9 11.0 11.1 13.4 31.8 24.6 13.2 24.5 24.3 31.9 25.1 10.0 32.2 10.6 11.3 15.2 11.1 19.6 14.4 13.5 21.8 19.5 39.6 22.2 23.9 14.8 13.0 19.5 24.6 40.7 17.7 17.6 9.7 32.4 19.9 23.2 41.3 9.5 19.4 15.5 12.8 21.6 16.4 11.4 11.0 18.8 23.7 21.8 10.2 15.8 21.5 16.3 24.6 16.4 18.6 19.6 18.8 14.6 18.1 16.9 32.3 16.1 10.5 13.7 21.6 29.5 18.6 24.3 24.2 11.6 17.0 16.1 9.0 20.7 9.5 19.6 19.4 18.7 21.4 12.8 9.9 19.6 13.2 26.8 24.5 30.5 31.8 28.7 26.1 24.6 28.4 31.9 28.4 3.5 24.3 17.6 20.9 26.9 25.1 14.2 14.7 15.8 15.6 11.8 11.3 13.2 13.0 13.8 11.7 0.0 6.4 19.3 18.4 12.2 20.3 64.9 30.6 16.0 10.3 34.9 25.5 77.8 101.2 30.3 48.5 15.4 23.1 0.0 32.9 37.0 13.4 13.1 21.9 82.5 31.2 14.3 27.2 17.2 12.6 6.8 13.3 9.2 6.8 63.1 17.9 17.8 28.5 17.5 17.7 80.1 22.7 25.8 10.5 30.3 24.5 20.5 67.5 22.7 28.6 26.5 MRPL47 "CGI-204, NCM1" ENSG00000136522 "Mitochondrial ribosomal protein L47" Q9HD33 3 179588285-179604654 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 290.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037553, HPA047779" Approved Supported Mitochondria NA NA Mitochondria "HPA037553: AB_10671375, HPA047779: AB_2680154" "unprognostic (6.37e-2)" "prognostic favorable (6.44e-4)" "unprognostic (7.21e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (1.53e-1)" "unprognostic (8.55e-3)" "unprognostic (1.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.58e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-2)" "unprognostic (1.29e-2)" "unprognostic (5.64e-2)" "unprognostic (3.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.71e-1)" "unprognostic (8.84e-2)" 17.4 23.5 22.3 16.4 21.7 29.6 20.2 23.9 25.0 14.2 22.5 12.8 13.0 16.7 16.8 17.3 21.3 13.3 13.4 35.5 21.1 21.8 34.0 31.8 14.8 19.3 25.6 19.4 15.2 12.1 18.1 23.8 17.8 28.5 15.9 23.6 11.2 14.5 14.7 31.7 13.5 20.3 17.8 20.1 20.2 17.4 32.8 22.0 25.3 20.1 27.8 20.7 16.3 13.9 21.0 28.2 24.6 29.0 22.7 28.1 18.9 32.1 12.5 21.9 20.1 13.9 14.6 25.0 18.9 16.9 29.8 24.9 50.8 13.5 26.4 37.5 16.1 36.4 24.4 26.8 19.8 32.1 30.3 23.5 25.3 12.6 28.4 27.1 45.4 14.4 13.4 17.3 22.0 22.6 14.2 20.0 24.8 14.8 21.3 23.0 25.0 24.3 42.5 37.9 29.3 30.0 26.0 21.4 44.3 31.3 20.4 19.0 22.1 20.8 33.7 37.2 17.2 52.0 34.9 15.9 16.2 23.2 20.3 51.5 27.0 44.1 57.8 18.9 37.4 19.6 15.9 19.3 24.6 20.0 24.8 19.9 21.0 22.2 21.5 28.2 17.4 19.9 20.2 5.1 22.7 29.0 24.4 28.1 18.9 22.3 21.7 23.9 25.0 21.1 21.8 25.6 19.4 28.5 22.0 20.8 17.1 55.1 67.4 66.5 17.4 73.3 66.2 62.9 26.1 54.1 9.8 90.1 218.8 97.2 290.3 43.8 39.9 46.7 100.3 89.9 50.5 55.2 55.4 55.9 88.0 9.5 52.6 46.1 44.3 51.4 39.7 53.0 45.5 92.0 41.1 32.9 97.8 52.6 46.3 153.7 21.7 58.2 63.4 159.6 42.8 61.6 87.1 52.9 59.0 80.8 MRPL48 CGI-118 ENSG00000175581 "Mitochondrial ribosomal protein L48" Q96GC5 11 73787316-73865133 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040241, HPA040864" Approved Supported Mitochondria NA NA Mitochondria "HPA040241: AB_2676899, HPA040864: AB_2677175" "unprognostic (2.41e-1)" "unprognostic (1.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-3)" "unprognostic (1.99e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (8.89e-2)" "unprognostic (4.41e-2)" "unprognostic (3.97e-2)" "unprognostic (1.14e-1)" "unprognostic (5.85e-2)" "unprognostic (4.61e-3)" "unprognostic (1.25e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-2)" "unprognostic (3.30e-1)" 9.3 15.5 20.8 13.3 31.0 12.4 25.2 21.5 22.6 18.3 19.9 17.9 14.0 15.8 10.8 17.9 13.2 16.3 7.1 14.6 23.1 19.5 21.2 17.0 10.8 13.8 25.5 17.0 15.7 23.0 18.9 9.4 11.9 32.4 12.7 18.9 8.6 15.7 13.9 29.0 9.5 13.3 9.7 31.7 11.9 13.6 5.2 24.0 14.8 14.5 16.7 15.9 10.8 13.3 18.9 22.3 18.9 19.0 16.9 22.5 19.0 10.0 11.7 13.1 7.3 7.7 6.0 5.6 6.3 7.0 9.5 8.1 22.2 9.3 24.4 12.9 8.6 6.7 12.4 12.8 13.1 8.6 9.7 14.7 12.5 13.1 15.6 8.8 20.7 9.0 5.0 14.2 8.5 11.8 8.8 13.6 14.2 15.7 13.5 9.6 16.0 24.9 20.2 9.9 33.0 12.6 11.0 15.9 27.9 10.7 12.3 10.3 10.2 5.0 17.4 50.9 6.4 11.1 13.2 4.8 7.9 10.2 5.5 8.3 6.5 12.9 35.2 3.4 13.5 6.3 18.9 14.7 7.7 17.8 19.0 18.6 18.9 20.8 21.5 21.7 17.3 22.5 21.9 2.9 16.9 16.9 22.3 21.8 19.0 20.8 31.0 21.5 22.6 23.1 19.5 25.5 17.0 32.4 24.0 8.9 15.6 36.3 30.6 17.1 8.9 30.8 35.7 34.8 14.8 24.4 3.9 80.3 74.6 33.4 4.8 17.5 30.2 23.3 34.6 61.0 20.6 25.6 20.7 20.3 37.7 14.3 23.2 20.9 28.1 13.7 17.0 20.0 42.2 23.4 34.8 17.4 30.1 42.1 17.0 57.3 7.1 0.0 20.2 9.8 24.9 17.2 50.0 32.8 45.5 29.4 MRPL51 "bMRP64, CDA09, HSPC241, MRP64" ENSG00000111639 "Mitochondrial ribosomal protein L51" Q4U2R6 12 6491886-6493841 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 738.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039923 Approved Supported Mitochondria NA NA Mitochondria "HPA039923: AB_10795373" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "unprognostic (2.97e-1)" "unprognostic (1.44e-2)" "unprognostic (1.75e-1)" "unprognostic (2.87e-1)" "unprognostic (3.81e-3)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (1.18e-2)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.62e-1)" "unprognostic (1.17e-1)" "unprognostic (8.33e-2)" 21.4 32.4 36.3 30.4 31.8 24.4 29.1 14.7 29.5 21.0 29.2 18.8 27.2 20.7 22.0 35.2 35.8 20.8 26.8 48.9 29.3 29.6 38.5 50.1 18.1 29.8 36.9 21.3 20.9 52.7 18.8 26.2 26.6 28.4 23.2 30.0 15.8 36.2 28.7 74.0 19.5 24.3 21.5 28.9 27.3 24.0 46.6 25.8 37.5 32.8 52.1 36.7 21.7 26.7 58.4 85.4 59.7 56.2 50.2 61.2 69.5 35.2 43.1 51.1 34.6 33.5 30.5 54.8 24.7 30.5 37.2 36.0 59.5 47.2 43.7 17.3 37.2 47.8 31.5 35.5 40.2 56.6 53.8 44.9 30.2 62.7 50.5 31.1 41.1 30.0 29.4 32.0 34.4 44.8 52.3 34.1 40.7 21.5 16.4 47.9 55.1 48.1 66.1 103.8 66.0 43.8 33.4 49.7 37.5 34.1 48.2 18.4 32.7 37.9 52.2 42.8 101.3 15.8 47.1 26.1 33.6 47.2 27.0 55.2 16.2 23.3 112.5 42.8 31.3 44.7 49.1 56.2 59.7 52.2 51.2 58.7 58.4 56.4 57.5 63.4 54.4 57.6 59.4 21.2 50.2 49.6 85.4 61.2 69.5 36.3 31.8 14.7 29.5 29.3 29.6 36.9 21.3 28.4 25.8 98.3 68.5 97.5 142.6 120.9 43.2 273.6 168.2 99.0 78.5 162.3 11.8 231.8 397.9 217.7 738.9 110.2 117.5 23.3 240.5 337.1 125.9 189.7 91.1 309.5 231.7 41.3 144.0 136.9 142.5 334.3 141.8 111.9 183.9 403.0 155.0 81.7 214.9 150.8 139.0 412.8 36.2 109.9 124.6 380.4 168.5 137.1 180.2 102.2 183.9 151.7 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 24.3 29.4 31.8 31.8 36.8 27.8 54.5 18.8 34.7 22.7 35.5 13.5 31.4 43.7 21.3 23.5 37.5 20.8 39.2 73.7 28.3 31.0 34.1 41.9 36.9 55.9 35.5 27.8 17.2 58.5 21.6 20.7 20.9 40.1 22.4 22.4 12.7 41.6 43.0 79.5 24.3 35.1 22.9 37.0 27.6 39.9 30.6 24.0 27.8 27.4 38.4 25.2 15.6 31.6 43.9 50.6 25.4 39.0 21.9 30.7 29.7 43.9 34.6 18.9 23.4 11.8 13.9 46.1 30.7 22.2 27.5 26.2 42.4 61.7 33.5 33.9 21.1 28.0 40.1 15.5 42.5 20.7 35.4 25.5 24.9 13.8 96.1 35.9 39.1 35.9 20.8 29.4 35.6 30.4 21.8 43.6 42.7 25.5 33.4 20.1 61.7 31.6 59.5 34.8 54.8 76.5 39.2 23.6 39.5 28.7 26.3 18.9 24.4 23.8 23.3 32.6 14.1 22.4 37.5 33.5 28.8 33.7 36.0 46.5 33.1 39.0 40.8 26.2 26.9 45.9 25.4 36.0 18.0 25.4 39.0 23.2 43.9 27.9 22.9 50.6 37.7 26.4 25.3 6.1 21.9 28.7 41.9 30.7 29.7 31.8 36.8 18.8 34.7 28.3 31.0 35.5 27.8 40.1 24.0 68.5 78.6 124.3 65.2 107.6 20.6 96.4 201.2 95.0 89.9 129.1 17.7 163.2 235.4 222.3 47.9 83.9 246.5 93.5 272.5 246.5 72.7 86.6 121.1 226.4 208.7 19.1 132.6 105.6 152.4 44.5 51.8 104.0 118.1 247.9 188.7 49.5 303.7 207.0 46.3 360.5 27.7 64.7 84.5 124.7 106.0 130.4 105.4 86.1 183.5 87.8 MRPL53 ENSG00000204822 "Mitochondrial ribosomal protein L53" Q96EL3 2 74471958-74473322 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 71.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034612, HPA056185" Uncertain Supported Mitochondria NA NA Mitochondria "HPA034612: , HPA056185: AB_2683060" "unprognostic (2.22e-2)" "unprognostic (1.94e-2)" "unprognostic (2.81e-2)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (7.36e-5)" "unprognostic (3.60e-2)" "unprognostic (1.24e-1)" "unprognostic (4.06e-2)" "prognostic favorable (1.37e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.16e-8)" "unprognostic (8.76e-2)" "unprognostic (2.79e-1)" "unprognostic (4.13e-1)" "unprognostic (2.45e-2)" 16.8 26.4 15.8 16.9 15.2 14.0 23.2 14.8 17.7 14.1 16.9 15.2 8.5 18.6 15.1 14.6 19.4 17.5 16.8 40.2 14.0 13.2 25.5 44.8 16.0 28.2 16.6 12.3 23.8 31.2 14.8 18.4 19.9 13.3 18.6 8.9 20.1 36.9 19.8 44.1 12.5 16.3 16.1 15.5 20.3 17.8 13.2 12.2 27.7 28.9 20.3 18.9 14.3 14.6 45.9 42.9 26.1 35.6 19.0 42.5 38.9 8.0 29.8 9.9 6.4 11.1 10.1 14.5 8.6 8.1 10.3 8.2 33.6 11.3 6.7 5.3 7.8 13.6 9.7 4.4 14.3 3.7 16.9 26.1 9.1 11.1 22.1 8.1 5.7 9.2 12.5 8.7 13.3 6.7 11.3 9.8 16.5 9.5 18.8 8.8 41.0 13.8 17.1 6.3 23.4 16.4 10.6 17.9 16.4 10.5 7.3 10.7 10.1 5.9 18.7 10.6 7.0 8.4 7.2 6.1 13.7 12.2 11.1 10.7 19.7 18.3 12.7 10.2 7.4 11.9 24.7 35.6 14.3 21.6 31.9 26.3 44.8 30.2 23.8 29.3 45.9 42.5 31.2 26.1 19.0 29.9 42.9 34.9 38.9 15.8 15.2 14.8 17.7 14.0 13.2 16.6 12.3 13.3 12.2 8.9 18.0 20.8 5.8 15.2 1.7 1.2 5.1 71.0 12.5 10.4 0.0 12.7 18.3 27.3 7.1 11.7 28.4 0.0 49.2 14.7 14.3 5.6 32.4 21.7 15.5 1.6 38.2 13.5 30.7 2.1 8.1 19.3 25.3 46.9 25.4 2.2 34.1 43.2 4.2 18.9 2.8 6.5 14.1 8.8 7.0 22.0 13.2 20.6 22.1 5.8 MRPL57 MRP63 ENSG00000173141 "Mitochondrial ribosomal protein L57" Q9BQC6 13 21176645-21179084 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039779, HPA059370" Supported Supported Mitochondria NA NA Mitochondria "HPA039779: AB_10673362, HPA059370: AB_2683993" "unprognostic (1.00e-1)" "unprognostic (1.92e-1)" "unprognostic (4.32e-2)" "unprognostic (9.57e-3)" "unprognostic (1.51e-1)" "unprognostic (5.54e-2)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.68e-2)" "prognostic favorable (8.35e-4)" "unprognostic (7.65e-2)" "unprognostic (2.01e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-1)" "unprognostic (1.10e-1)" "unprognostic (6.78e-2)" 14.0 28.8 23.2 13.8 21.4 16.2 16.5 16.1 22.6 14.6 15.3 12.6 12.9 18.4 13.4 21.0 16.1 17.3 18.7 29.3 20.5 24.7 24.8 40.9 15.0 16.5 21.3 17.9 19.6 30.2 12.3 26.8 12.5 17.1 21.6 12.3 15.1 23.2 18.8 48.0 15.3 17.5 16.4 17.8 16.6 18.1 20.2 13.0 26.4 25.1 24.7 13.8 13.4 12.8 26.1 43.9 23.0 31.5 21.8 32.8 28.8 7.9 14.6 10.3 9.3 7.9 6.5 10.8 9.6 6.0 9.2 6.9 19.1 14.8 4.6 11.3 6.0 7.2 13.8 9.0 9.2 6.9 12.1 15.0 21.0 10.4 21.3 11.7 11.5 10.5 6.6 10.2 7.3 6.9 5.6 8.7 19.0 9.1 6.1 6.4 27.9 25.0 30.4 7.5 26.0 17.1 15.2 15.5 8.1 11.2 9.8 20.6 9.6 7.8 9.8 14.1 7.2 9.9 10.8 6.0 4.8 8.9 10.1 8.5 8.5 6.8 8.2 4.2 13.6 11.9 17.8 31.5 23.0 22.8 24.4 25.8 26.1 29.0 24.3 27.5 25.8 32.8 26.1 4.8 21.8 20.1 43.9 28.8 28.8 23.2 21.4 16.1 22.2 20.5 24.7 21.3 17.9 17.1 13.0 74.5 108.6 101.9 96.1 0.0 88.1 472.9 142.7 148.5 103.5 167.5 43.2 199.3 431.0 129.5 227.3 87.5 174.6 233.6 212.5 168.5 71.9 127.0 69.4 399.2 201.5 73.1 143.6 104.3 112.5 263.9 106.7 94.5 0.0 186.7 167.4 115.5 147.0 171.7 93.0 484.9 81.9 51.8 53.6 92.6 52.4 0.0 186.6 94.7 179.9 93.6 MRPL58 "DS-1, ICT1" ENSG00000167862 "Mitochondrial ribosomal protein L58" Q14197 17 75012670-75021261 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "Protein biosynthesis" "Hydrolase, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 56.1;Distal tubular cells: 48.0;Exocrine glandular cells: 52.2;Proximal tubular cells: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003634 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003634: AB_1851388" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" "unprognostic (1.94e-3)" "unprognostic (7.12e-2)" "unprognostic (3.16e-2)" "unprognostic (4.35e-2)" "unprognostic (1.38e-3)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (3.79e-3)" "unprognostic (4.98e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.66e-2)" "unprognostic (1.71e-1)" 12.4 23.4 13.9 18.4 14.8 13.7 17.6 18.1 15.7 10.6 15.2 9.8 17.5 13.1 12.5 15.1 19.4 12.5 16.3 31.2 12.2 12.0 25.7 41.7 10.2 15.2 14.3 14.0 10.5 24.2 13.5 9.1 13.9 14.0 13.6 16.3 10.1 17.7 22.5 57.3 16.5 13.4 14.8 12.9 14.6 15.1 7.6 14.0 13.2 14.8 31.2 15.7 14.3 11.6 18.3 28.9 11.2 22.0 20.0 33.5 20.9 26.1 36.9 12.3 14.1 13.3 13.2 17.2 15.5 16.9 32.4 27.6 28.3 16.5 18.2 12.8 15.4 20.0 18.7 25.2 26.7 34.3 9.3 29.9 14.3 17.5 23.5 25.1 29.8 9.8 14.2 12.8 21.5 34.5 11.0 24.6 18.9 23.0 13.3 18.3 32.7 25.7 20.5 9.3 40.8 50.0 13.3 21.9 26.5 23.8 19.4 11.5 22.0 13.4 24.5 30.1 16.5 32.8 24.6 10.4 17.5 19.2 18.4 29.2 13.9 11.0 20.1 20.0 33.4 14.4 11.2 22.0 10.5 17.3 20.7 14.9 18.3 21.1 17.2 28.9 14.8 15.7 17.6 2.0 20.0 17.4 19.4 33.5 20.9 13.9 14.8 18.1 15.7 12.2 12.0 14.3 14.0 14.0 14.0 29.8 8.3 0.0 0.0 0.0 0.0 0.0 0.0 38.8 14.8 24.4 0.0 56.1 48.0 41.8 0.0 0.0 0.0 0.0 52.2 30.7 0.0 0.0 1.1 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 26.2 0.0 0.0 44.8 0.0 0.0 104.5 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 MRPL9 ENSG00000143436 "Mitochondrial ribosomal protein L9" Q9BYD2 1 151759643-151763564 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008579 Approved Supported Mitochondria NA NA Mitochondria "HPA008579: AB_1079412" "unprognostic (2.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.34e-1)" "unprognostic (7.43e-3)" "unprognostic (7.66e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.04e-7)" "unprognostic (1.47e-1)" "unprognostic (5.22e-2)" "unprognostic (9.51e-3)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.79e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (6.30e-2)" 28.5 22.3 23.3 26.3 25.3 23.0 26.4 27.3 30.9 22.1 26.7 22.2 19.8 21.7 26.8 25.4 28.4 22.5 24.3 24.5 21.7 24.6 29.9 35.1 19.5 28.7 24.0 19.4 33.2 31.9 35.1 18.4 29.0 27.6 29.0 22.3 19.7 40.6 25.3 50.7 25.7 23.1 23.7 21.2 28.5 23.0 24.0 18.3 41.2 38.2 34.2 29.3 25.3 23.5 30.6 31.5 15.0 16.5 24.4 37.6 21.6 29.4 24.2 15.9 18.7 11.5 12.9 26.1 16.4 15.7 25.6 20.6 36.9 27.6 19.3 33.3 16.5 16.6 26.1 27.8 20.6 20.4 26.3 26.8 15.2 20.5 23.4 18.7 42.2 14.4 14.1 19.1 22.8 28.7 17.0 24.7 29.6 31.6 25.4 19.7 68.7 26.1 30.2 34.5 33.6 35.0 23.1 19.1 37.3 15.5 23.3 26.3 26.9 19.5 28.1 22.9 22.7 42.5 51.1 18.3 20.3 20.6 17.4 36.3 28.5 40.4 61.4 25.4 27.9 22.6 15.0 13.6 8.8 27.8 16.5 31.8 30.6 32.1 32.3 31.5 27.8 30.9 28.8 1.6 24.4 14.2 26.5 37.6 21.6 23.3 25.3 27.3 30.9 21.7 24.6 24.0 19.4 27.6 18.3 26.8 17.9 43.1 41.8 27.8 17.4 3.8 28.1 38.8 33.0 31.4 5.9 85.5 54.7 60.9 60.3 38.8 18.1 0.0 55.8 100.4 33.3 38.4 39.4 26.1 56.9 17.5 27.5 39.9 21.1 21.0 36.2 30.2 33.7 78.5 26.7 30.6 59.8 24.6 44.2 67.2 17.1 71.1 34.0 37.2 31.7 27.7 62.4 44.9 45.9 35.0 MRPS11 "FLJ22512, FLJ23406, HCC-2" ENSG00000181991 "Mitochondrial ribosomal protein S11" P82912 15 88467453-88480773 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043752, HPA050345" Enhanced Supported Mitochondria NA NA Mitochondria "HPA043752: AB_2678653, HPA050345: AB_2681100" "unprognostic (2.66e-1)" "prognostic favorable (3.60e-4)" "unprognostic (6.51e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (3.21e-1)" "unprognostic (3.45e-1)" "unprognostic (1.44e-1)" "unprognostic (6.45e-2)" "prognostic favorable (4.75e-4)" "unprognostic (8.31e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.44e-2)" "unprognostic (7.26e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" 12.4 19.1 19.5 9.0 18.3 6.1 13.5 11.2 19.6 7.0 13.4 8.0 11.0 17.6 7.3 9.3 15.1 11.4 10.3 31.0 19.1 17.3 16.5 28.5 8.2 10.5 18.3 15.0 6.0 22.5 9.6 9.3 9.0 15.8 8.9 8.6 8.0 11.4 10.4 44.3 11.5 13.1 10.0 13.7 9.5 10.7 9.9 10.4 12.9 17.7 12.9 10.4 9.7 7.9 18.5 23.0 18.9 19.0 20.9 24.4 17.4 5.6 22.4 3.2 5.7 7.8 3.9 9.2 4.7 8.0 5.9 6.5 15.4 8.8 5.1 9.5 3.8 6.4 8.0 9.3 6.3 2.9 6.8 24.4 6.9 14.5 16.8 9.3 2.4 4.6 7.6 6.2 5.1 5.1 3.2 8.0 6.7 5.0 2.2 9.9 23.9 4.7 10.0 9.3 7.3 23.9 10.2 6.4 12.0 8.3 15.3 11.3 5.5 4.9 11.8 18.3 3.0 11.1 13.6 3.7 8.5 9.4 5.6 6.6 4.7 8.5 5.9 10.6 5.8 8.8 18.9 18.4 13.2 11.7 19.0 13.3 18.5 13.3 13.6 21.2 12.9 14.1 13.7 6.7 20.9 12.1 23.0 24.4 17.4 19.5 18.3 11.2 19.6 19.1 17.3 18.3 15.0 15.8 10.4 6.0 17.8 35.0 31.0 20.3 31.6 5.0 30.6 29.4 22.7 43.6 45.2 79.4 114.4 52.5 21.7 29.2 79.0 46.7 58.5 79.5 31.0 23.1 32.4 74.4 78.6 25.4 23.7 36.2 33.0 25.4 30.8 35.9 30.4 78.5 44.3 37.2 56.5 73.7 40.0 99.0 41.4 19.4 23.9 62.1 38.8 24.7 74.9 44.1 54.1 29.0 MRPS14 HSMRPS14 ENSG00000120333 "Mitochondrial ribosomal protein S14" O60783 1 175010789-175023425 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051087 Uncertain Supported "Nuclear membrane,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Nuclear membrane" "HPA051087: AB_2681339" "unprognostic (9.24e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.46e-1)" "unprognostic (3.44e-2)" "unprognostic (5.39e-2)" "unprognostic (1.61e-2)" "unprognostic (3.01e-2)" "unprognostic (7.32e-2)" "unprognostic (4.85e-2)" "unprognostic (7.67e-2)" "unprognostic (3.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.67e-1)" "unprognostic (8.04e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-2)" 17.7 23.6 31.8 11.8 27.6 4.5 23.7 19.6 26.3 19.5 14.9 22.9 18.3 13.8 20.1 25.6 15.4 18.0 15.8 16.6 26.9 26.5 23.4 29.7 14.7 16.0 32.7 14.5 21.8 19.1 28.3 26.1 17.1 22.5 23.6 18.1 15.4 18.4 20.4 13.7 12.7 14.7 17.2 33.5 17.4 15.3 15.8 24.5 22.6 26.5 14.5 16.2 14.3 11.7 14.5 13.6 6.5 12.9 14.3 19.2 11.6 11.0 8.9 21.2 7.5 24.0 17.3 6.8 9.7 11.9 16.6 17.3 11.6 9.8 14.1 11.9 13.0 7.3 9.9 13.1 11.3 17.7 15.5 18.0 11.6 17.5 13.2 10.2 12.8 10.4 18.8 14.0 9.7 6.8 14.7 13.7 12.3 14.0 12.5 11.5 6.1 14.0 9.3 11.6 20.8 4.7 12.2 11.2 16.7 11.4 9.0 17.9 12.6 14.1 13.1 9.3 17.4 15.5 13.7 11.2 5.6 6.3 11.8 8.7 13.8 11.7 17.6 8.1 12.2 11.8 6.5 12.9 6.2 13.4 12.7 18.8 14.5 14.2 14.1 13.6 13.5 19.2 16.2 4.5 14.3 9.7 11.8 15.1 11.6 31.8 27.6 19.6 22.6 26.9 26.5 32.7 14.5 22.5 24.5 26.8 23.2 38.7 45.3 19.6 13.8 73.8 40.8 34.8 34.2 52.4 13.7 85.5 116.0 57.8 11.2 35.8 23.6 46.7 38.9 90.2 43.7 47.0 17.4 59.4 70.3 1.6 30.5 34.4 33.2 8.5 43.1 29.4 47.2 88.4 32.3 32.0 49.2 49.1 40.3 89.3 18.4 38.8 36.4 71.7 37.5 25.6 46.9 31.0 46.9 40.3 MRPS15 FLJ11564 ENSG00000116898 "Mitochondrial ribosomal protein S15" P82914 1 36455718-36464437 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 621.9;Late spermatids: 1487.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028100, HPA028134, HPA067137" Supported Supported Mitochondria NA NA Mitochondria "HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: AB_2685787" "unprognostic (2.05e-2)" "unprognostic (6.98e-2)" "unprognostic (7.57e-2)" "unprognostic (4.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (2.20e-2)" "unprognostic (3.28e-2)" "prognostic favorable (7.83e-4)" "unprognostic (8.48e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (2.31e-1)" "unprognostic (1.44e-1)" "unprognostic (8.94e-2)" "unprognostic (1.39e-1)" 22.6 20.7 17.8 16.9 17.3 24.0 23.8 9.5 16.0 13.2 19.9 9.3 13.7 14.3 13.3 23.0 23.0 10.4 16.6 43.2 15.0 15.2 30.6 61.7 16.6 23.3 17.5 10.6 13.8 23.3 14.3 14.3 23.7 18.3 15.0 18.2 13.8 24.0 14.7 89.5 14.1 18.4 15.7 12.3 17.3 18.8 65.5 10.6 20.3 19.1 41.3 19.3 16.0 12.9 24.5 40.7 7.0 28.7 20.3 28.1 28.6 40.5 22.6 24.7 30.1 24.6 35.7 61.5 22.7 32.6 56.3 51.8 39.9 43.8 37.6 37.1 29.8 33.9 35.8 36.0 57.3 50.8 24.4 45.7 38.4 29.3 43.6 46.1 47.5 27.2 32.9 51.2 50.1 40.6 21.8 45.9 28.3 41.5 29.7 34.7 27.9 45.7 50.9 44.4 34.8 39.9 35.4 43.5 55.0 49.7 34.2 36.7 20.3 31.4 40.2 58.2 38.5 24.8 32.7 21.6 31.7 33.7 39.1 47.8 29.9 41.0 52.5 36.1 32.3 44.2 4.9 26.7 7.0 22.0 28.7 27.2 24.5 25.2 25.0 40.7 21.6 23.9 23.2 1.8 20.3 18.9 27.7 28.1 28.6 17.8 17.3 9.5 16.0 15.0 15.2 17.5 10.6 18.3 10.6 35.7 41.7 43.3 52.5 58.2 23.2 120.0 53.5 38.8 28.4 68.0 13.7 219.1 273.5 113.2 621.9 59.7 89.2 116.8 140.3 210.6 61.7 96.5 41.5 122.3 137.3 12.7 63.4 52.8 79.0 1487.0 58.1 81.5 54.0 95.6 78.7 16.2 134.3 66.6 70.0 248.1 19.2 64.7 69.1 202.9 79.7 70.3 235.5 61.8 99.8 87.6 MRPS16 CGI-132 ENSG00000182180 "Mitochondrial ribosomal protein S16" Q9Y3D3 10 73248843-73252693 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050081, HPA054538" Supported Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA050081: AB_2681007, HPA054538: AB_2682519" "unprognostic (9.19e-2)" "unprognostic (5.19e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.23e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (1.68e-2)" "unprognostic (6.44e-2)" "unprognostic (2.98e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.20e-1)" "unprognostic (5.84e-2)" 16.6 28.4 16.4 16.9 15.8 15.8 28.6 12.6 26.6 13.3 22.1 12.4 18.0 20.8 16.3 16.8 22.7 16.5 20.8 42.2 17.6 15.7 23.4 35.1 17.7 30.0 16.2 16.0 16.5 37.0 15.7 15.5 17.0 15.9 15.4 21.1 14.4 18.4 19.0 53.2 16.8 18.4 18.0 14.7 18.4 18.3 13.7 9.8 32.7 16.9 26.1 20.1 15.5 13.9 30.0 28.3 17.0 24.2 17.7 22.3 24.3 22.8 33.1 12.8 16.9 10.3 8.4 18.8 10.6 18.5 14.8 15.4 39.2 22.5 27.7 11.8 11.1 13.4 21.4 14.7 21.1 9.3 15.6 14.4 17.4 17.9 29.6 17.4 22.5 15.6 12.7 16.1 15.1 36.3 12.9 16.1 24.5 25.5 15.6 15.3 25.4 24.2 20.8 15.5 15.1 62.2 22.0 17.2 20.0 15.5 13.7 8.6 15.9 12.1 50.0 23.2 8.2 35.2 12.0 12.7 14.1 24.6 15.2 20.5 23.4 24.8 21.6 15.4 26.2 9.5 16.7 22.7 17.0 19.0 24.2 20.5 28.7 20.8 17.8 18.5 30.0 22.3 19.6 10.4 17.7 19.1 28.3 20.6 24.3 16.4 15.8 12.6 26.6 17.6 15.7 16.2 16.0 15.9 9.8 6.0 25.9 52.8 58.4 31.1 26.8 89.2 63.7 37.5 47.8 45.4 29.5 103.9 210.5 89.2 46.6 48.4 69.2 23.3 103.5 134.8 44.9 77.2 30.0 123.8 134.2 19.1 52.3 41.7 57.2 29.0 57.5 59.6 62.4 83.0 89.7 45.0 115.2 38.6 39.3 179.3 33.2 0.0 45.3 128.1 75.4 38.6 89.4 44.9 103.6 86.7 MRPS18B "C6orf14, HSPC183, MRPS18-2, PTD017" ENSG00000204568 "Mitochondrial ribosomal protein S18B" Q9Y676 6 30617709-30626395 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043485, HPA050334" Supported Supported "Cell Junctions,Mitochondria" NA NA Mitochondria "Cell Junctions" "HPA043485: AB_2678506, HPA050334: AB_2681091" "unprognostic (8.18e-3)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (2.51e-2)" "unprognostic (4.20e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (2.98e-2)" "unprognostic (1.76e-1)" "unprognostic (1.40e-2)" "prognostic favorable (3.99e-5)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.39e-2)" 17.1 18.9 9.9 10.3 10.7 5.4 16.0 8.5 13.1 11.6 13.4 12.8 11.9 12.8 9.3 15.5 15.5 16.5 12.3 26.6 9.0 8.0 22.4 49.1 10.5 17.3 13.1 9.3 16.4 21.8 17.4 10.2 11.8 9.1 10.9 16.4 10.1 17.1 18.0 55.4 13.7 14.0 10.4 12.4 14.4 13.5 10.2 11.2 13.5 21.5 31.1 15.6 11.2 9.3 15.7 8.9 6.3 10.2 12.4 15.2 11.2 9.7 5.9 4.7 6.7 7.2 9.7 8.7 3.6 8.4 11.5 7.1 9.2 4.6 10.0 8.4 5.7 8.6 7.8 10.9 10.2 11.3 6.0 11.6 9.7 4.6 10.7 6.3 9.1 4.2 8.4 12.8 9.4 26.1 7.8 6.4 9.5 14.7 9.6 10.4 7.4 6.0 5.6 3.4 7.8 7.6 8.0 6.4 19.1 10.7 4.1 10.3 3.3 3.2 13.6 13.7 4.6 17.6 4.8 3.7 7.5 7.3 4.3 6.2 8.2 9.8 8.5 3.6 13.8 11.0 6.3 8.0 4.0 9.1 10.1 12.3 15.7 12.1 9.8 8.9 14.7 15.2 12.2 0.6 12.4 10.2 8.1 11.4 11.2 9.9 10.7 8.5 13.1 9.0 8.0 13.1 9.3 9.1 11.2 56.6 44.3 53.6 61.6 32.6 43.2 135.7 101.9 53.5 46.6 45.4 60.9 106.9 164.2 89.2 46.6 63.4 48.4 23.3 80.0 101.6 52.1 46.2 36.9 95.6 72.2 41.3 30.1 49.1 44.0 26.6 65.0 42.1 57.3 93.8 55.1 39.2 65.0 59.6 42.1 161.2 51.1 51.8 67.0 22.6 60.7 39.3 80.7 41.7 80.3 30.1 MRPS2 CGI-91 ENSG00000122140 "Mitochondrial ribosomal protein S2" Q9Y399 9 135499984-135504673 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029487, HPA057261" Approved Supported Mitochondria NA NA Mitochondria "HPA029487: , HPA057261: AB_2683385" "unprognostic (3.18e-3)" "unprognostic (9.42e-3)" "unprognostic (1.46e-1)" "unprognostic (7.81e-2)" "unprognostic (3.55e-1)" "unprognostic (8.45e-2)" "unprognostic (1.63e-1)" "unprognostic (5.63e-3)" "unprognostic (3.83e-1)" "unprognostic (2.90e-2)" "unprognostic (4.81e-2)" "unprognostic (7.58e-2)" "prognostic favorable (6.96e-9)" "unprognostic (2.74e-2)" "unprognostic (1.06e-1)" "unprognostic (8.29e-2)" "unprognostic (2.24e-1)" 18.5 31.7 15.6 14.8 18.4 17.7 32.1 17.9 28.9 15.2 19.6 12.6 31.3 20.9 19.7 15.7 20.7 33.3 20.6 43.6 15.0 15.5 24.5 48.6 17.8 32.7 15.4 15.1 25.6 37.1 21.7 15.5 16.5 14.1 18.3 16.2 15.0 25.7 29.3 43.0 19.7 16.0 22.0 12.8 18.4 20.6 12.3 10.6 18.5 22.5 28.4 18.2 18.5 15.7 20.6 16.2 7.3 15.8 14.5 22.3 13.7 16.4 27.3 10.0 13.6 11.4 12.8 17.3 12.1 11.0 20.5 15.3 41.0 15.6 20.9 16.6 11.1 21.8 37.3 25.1 28.3 8.0 12.8 39.4 10.3 27.6 27.4 20.0 20.9 12.7 17.1 22.1 22.3 16.0 13.2 19.1 21.0 34.0 15.4 11.9 50.6 20.4 36.5 22.9 30.5 44.1 22.4 16.4 43.9 17.0 14.0 30.3 16.0 16.4 31.6 17.4 7.0 26.2 16.6 11.8 15.1 16.9 25.9 21.7 17.0 33.3 23.1 15.5 19.1 13.8 4.8 15.8 7.3 18.0 14.9 20.4 20.6 18.1 19.2 16.2 20.3 19.7 19.6 1.3 14.5 12.2 13.9 22.3 13.7 15.6 18.4 17.9 28.9 15.0 15.5 15.4 15.1 14.1 10.6 11.9 16.0 41.4 32.0 39.8 20.6 28.6 30.6 12.0 28.4 12.2 5.9 59.6 61.3 46.7 11.0 25.6 22.5 0.0 33.5 47.9 22.6 23.0 8.1 40.9 37.4 23.8 20.8 19.0 15.9 24.2 22.5 14.8 18.6 40.5 34.8 16.9 37.7 28.1 21.5 65.5 14.5 32.3 24.7 7.2 19.4 40.0 31.2 29.7 51.6 29.8 MRPS21 ENSG00000266472 "Mitochondrial ribosomal protein S21" 1 150293720-150308979 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078289 Supported Mitochondria NA NA Mitochondria "HPA078289: AB_2686881" "unprognostic (3.48e-2)" "unprognostic (1.94e-2)" "unprognostic (5.46e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (1.15e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (9.71e-2)" "unprognostic (7.59e-2)" "unprognostic (2.12e-2)" "unprognostic (4.02e-2)" "unprognostic (3.97e-2)" "unprognostic (1.46e-1)" 10.5 17.7 10.8 8.6 16.5 8.6 14.2 8.7 18.8 9.7 8.5 8.1 9.7 10.1 10.4 15.1 9.5 12.1 9.3 15.0 8.9 13.3 12.2 8.1 10.3 8.4 16.7 16.4 11.5 10.9 13.6 8.3 15.9 9.3 7.5 10.0 9.9 12.2 16.9 9.0 8.6 10.3 7.9 9.6 9.9 10.3 9.3 6.2 13.8 11.7 11.7 8.7 9.4 37.8 43.7 15.7 25.8 21.2 36.9 30.3 25.9 21.8 28.2 14.3 27.0 26.8 23.3 19.2 16.4 19.1 18.5 4.5 24.8 26.6 13.3 21.0 5.6 24.9 24.1 20.5 17.1 17.9 31.0 15.4 32.3 31.7 21.4 23.0 13.5 29.6 21.9 23.0 26.2 11.4 24.1 23.4 25.4 35.2 25.4 59.7 19.5 21.1 48.0 50.2 38.2 17.8 14.6 45.2 22.0 19.2 21.8 45.9 16.2 32.9 31.2 32.2 17.9 33.7 17.0 7.4 14.1 19.8 21.1 30.5 32.1 26.5 9.6 12.8 14.1 11.8 25.8 15.7 24.8 24.5 29.7 37.8 32.2 28.3 28.6 33.1 36.9 31.3 6.0 21.2 21.9 43.7 30.1 30.3 104.2 104.0 163.5 169.4 106.9 66.9 259.0 229.3 202.1 128.5 249.5 31.4 245.7 446.0 195.9 694.8 155.8 149.1 70.0 269.9 209.7 167.2 161.3 128.3 304.8 248.0 46.1 133.1 141.8 166.8 412.5 213.2 158.3 172.1 281.3 121.3 85.2 275.1 103.0 219.2 414.9 47.8 97.0 163.5 202.6 93.1 128.6 196.7 126.4 148.9 171.7 MRPS22 "C3orf5, GIBT, GK002, MRP-S22" ENSG00000175110 "Mitochondrial ribosomal protein S22" P82650 3 139005806-139357223 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006083, HPA007830" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA006083: AB_1854122, HPA007830: AB_1854123" "unprognostic (8.38e-2)" "unprognostic (1.52e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (5.22e-3)" "unprognostic (5.45e-3)" "unprognostic (4.85e-2)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" "unprognostic (4.49e-3)" "prognostic unfavorable (1.55e-5)" "prognostic unfavorable (1.85e-4)" "unprognostic (3.22e-3)" "unprognostic (2.56e-2)" "unprognostic (1.49e-1)" "unprognostic (1.77e-1)" "unprognostic (3.40e-1)" 17.6 45.3 16.9 14.5 24.9 22.1 18.3 15.5 26.7 16.3 22.7 14.6 12.2 24.0 17.0 14.7 26.7 14.5 13.8 39.2 23.4 15.0 24.9 43.3 12.9 20.2 18.2 19.7 15.7 22.4 13.6 15.2 16.9 22.6 11.6 22.0 8.8 15.3 15.8 50.8 17.2 21.1 16.8 18.1 14.0 19.0 21.9 19.9 15.3 15.1 31.0 16.0 16.5 16.9 24.9 27.9 21.7 31.6 21.1 27.8 20.9 30.7 13.3 11.3 13.7 17.0 14.4 26.1 18.1 23.4 32.5 26.7 42.3 22.2 21.2 34.1 22.0 32.1 35.0 20.4 24.7 31.3 12.0 19.0 33.9 11.5 29.3 19.0 31.7 18.5 15.4 19.4 19.5 20.4 14.5 19.8 24.5 46.8 13.4 19.6 22.7 15.8 24.9 20.2 30.3 23.4 20.1 19.3 29.7 23.5 18.3 13.5 12.1 29.3 43.2 45.9 11.7 30.2 28.7 14.1 13.0 13.8 25.8 17.0 20.8 11.4 38.0 16.1 22.6 12.6 21.7 24.0 21.2 22.9 31.6 27.6 24.9 24.7 25.7 27.9 21.6 27.3 25.3 5.4 21.1 30.3 17.8 27.8 20.9 16.9 24.9 15.5 26.7 23.4 15.0 18.2 19.7 22.6 19.9 17.9 11.2 18.2 23.5 20.3 19.9 43.4 25.5 37.5 14.8 17.4 13.7 54.0 58.0 36.5 37.3 20.4 26.9 0.0 52.8 37.9 24.4 15.6 26.5 34.2 42.5 19.1 15.0 18.4 17.7 5.6 21.6 21.0 15.1 38.7 25.1 18.5 38.5 20.1 22.3 37.0 25.3 38.8 24.2 73.7 46.5 17.9 63.0 22.4 39.6 26.5 MRPS23 "CGI-138, HSPC329, MRP-S23" ENSG00000181610 "Mitochondrial ribosomal protein S23" Q9Y3D9 17 57834781-57850056 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023453 Supported Supported "Nuclear membrane,Mitochondria" No No Mitochondria "Nuclear membrane" "HPA023453: AB_1854125" "unprognostic (3.84e-3)" "unprognostic (3.36e-1)" "unprognostic (1.75e-2)" "unprognostic (2.00e-2)" "unprognostic (7.96e-2)" "unprognostic (3.06e-3)" "prognostic unfavorable (9.52e-4)" "unprognostic (3.71e-1)" "unprognostic (7.92e-2)" "unprognostic (2.63e-3)" "unprognostic (1.39e-2)" "unprognostic (8.74e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (2.83e-1)" 15.1 28.5 23.0 19.0 27.5 16.0 19.9 16.4 32.0 13.4 16.4 17.6 28.3 18.1 18.0 23.1 18.1 19.3 17.2 53.5 22.5 22.1 36.6 19.9 16.5 21.3 23.6 26.2 16.3 29.9 17.3 16.7 15.5 23.7 28.3 16.0 15.3 16.9 24.7 39.2 14.1 15.5 17.0 19.4 17.4 25.7 21.9 17.2 14.8 28.4 19.8 19.7 15.3 16.5 25.1 30.8 33.4 26.7 23.5 24.3 22.8 32.4 32.8 17.8 18.6 10.8 12.6 20.5 21.1 15.9 29.5 22.8 24.7 19.6 41.2 62.9 16.2 27.3 16.1 28.0 24.9 24.7 32.7 32.5 29.8 13.7 42.6 20.7 39.0 28.9 11.5 22.5 21.8 22.8 13.5 18.5 22.2 44.1 14.9 23.1 27.8 36.1 22.5 21.5 36.9 34.3 26.3 29.7 34.4 22.8 15.6 23.9 37.2 15.9 13.4 42.0 13.6 41.8 29.1 15.7 25.1 32.0 25.0 44.6 32.8 69.1 45.9 23.9 24.5 23.0 24.9 21.8 33.4 22.4 26.7 23.4 23.6 22.4 22.6 30.8 25.1 24.3 24.0 3.5 23.5 18.8 29.0 21.4 22.8 23.0 27.5 16.4 32.0 22.5 22.1 23.6 26.2 23.7 17.2 44.7 28.1 29.0 30.7 29.8 41.5 148.1 33.1 41.5 36.4 45.4 11.8 68.7 126.0 75.4 4.7 33.0 13.5 0.0 86.9 68.6 37.0 43.2 22.0 38.1 75.9 47.7 21.2 24.5 28.2 7.0 30.2 38.1 38.8 71.3 27.2 49.9 70.7 17.5 37.1 149.9 53.1 25.8 28.4 27.1 87.3 28.4 35.6 32.4 38.2 27.8 MRPS25 "DKFZp313H0817, FLJ00023, MRP-S25, RPMS25" ENSG00000131368 "Mitochondrial ribosomal protein S25" P82663 3 15042460-15065335 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Late spermatids: 1039.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043490 Approved Supported Mitochondria NA NA Mitochondria "HPA043490: AB_10794888" "unprognostic (3.98e-2)" "unprognostic (5.36e-2)" "unprognostic (4.58e-3)" "unprognostic (1.24e-2)" "unprognostic (4.66e-2)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.93e-3)" "unprognostic (2.23e-1)" "unprognostic (2.10e-1)" "unprognostic (6.29e-2)" "unprognostic (2.68e-3)" "prognostic favorable (3.60e-7)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.91e-3)" 14.8 18.5 18.7 18.4 28.3 12.0 14.3 24.9 21.9 11.7 20.9 13.1 15.2 31.6 16.8 15.8 15.6 15.4 15.0 41.7 15.2 16.5 18.4 27.5 14.4 17.7 16.3 24.0 18.1 24.1 18.1 21.4 11.4 16.8 14.9 23.3 20.3 14.9 17.4 47.6 18.8 26.4 24.5 13.2 17.4 17.3 33.3 15.0 10.2 28.5 15.7 18.6 14.8 13.5 21.1 16.1 3.6 18.6 6.8 15.3 9.4 8.4 12.6 10.3 14.3 10.9 9.4 32.9 11.6 4.5 9.4 8.1 14.3 9.2 22.3 6.2 5.1 6.3 11.0 14.9 11.0 8.1 8.9 20.9 18.4 25.9 17.8 7.7 16.3 14.1 11.3 10.5 14.8 4.5 6.4 8.7 15.1 19.5 13.4 7.0 27.0 12.6 15.8 10.7 19.8 19.8 17.2 8.9 23.0 11.7 14.7 8.2 12.3 8.5 16.2 16.7 6.6 21.9 14.2 10.7 8.5 12.5 11.6 14.5 13.0 13.9 16.0 8.6 21.0 7.9 1.1 15.4 3.6 10.1 18.4 11.8 21.1 9.6 10.4 16.1 18.2 15.3 12.5 1.0 6.8 18.6 13.3 7.4 9.4 18.7 28.3 24.9 21.9 15.2 16.5 16.3 24.0 16.8 15.0 47.6 31.7 62.5 44.0 34.2 56.6 264.1 53.5 44.2 52.4 34.9 155.1 83.6 189.0 44.3 290.5 31.6 105.8 0.0 29.4 55.3 41.2 30.5 25.4 89.4 82.4 63.5 51.9 19.6 22.7 1039.4 42.6 38.5 35.4 39.7 65.2 21.4 40.9 52.6 28.3 157.3 98.1 71.1 42.0 60.3 28.0 42.4 60.8 27.3 108.1 58.0 MRPS26 "C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13" ENSG00000125901 "Mitochondrial ribosomal protein S26" Q9BYN8 20 3045945-3048254 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045472, HPA054610" Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA045472: AB_10962052, HPA054610: AB_2682541" "unprognostic (1.53e-1)" "unprognostic (2.18e-1)" "unprognostic (3.71e-1)" "unprognostic (4.41e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (8.13e-3)" "unprognostic (3.14e-1)" "unprognostic (6.83e-2)" "unprognostic (8.21e-2)" "unprognostic (9.65e-3)" "unprognostic (2.14e-1)" "unprognostic (1.14e-2)" "unprognostic (3.77e-1)" "unprognostic (4.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.93e-3)" 20.2 30.4 27.1 14.4 29.2 13.4 20.9 25.9 31.7 19.2 19.8 15.3 32.3 22.5 18.1 30.6 19.6 24.4 21.2 25.8 24.4 28.2 28.8 39.6 14.7 15.4 24.6 27.0 28.9 43.4 21.0 28.1 16.4 20.0 31.0 16.4 15.2 32.3 27.9 37.1 22.3 20.1 27.8 19.0 16.2 22.1 13.3 20.7 12.3 28.9 23.0 16.9 18.4 19.2 36.5 28.4 10.3 24.4 29.2 30.8 23.0 26.8 36.2 8.2 14.9 9.0 6.8 21.5 10.5 7.1 12.1 9.3 31.6 12.4 26.7 13.4 5.4 16.0 25.5 16.2 21.7 7.1 6.8 34.6 12.2 13.1 52.4 12.5 19.2 6.0 7.7 16.9 10.0 15.2 8.5 8.9 16.1 19.6 6.3 7.2 23.2 19.8 33.8 40.5 20.5 35.8 22.0 14.2 28.5 11.8 18.0 25.8 33.5 12.1 40.5 24.3 8.5 18.2 10.9 8.4 7.9 12.6 14.2 19.4 28.7 36.9 16.2 5.1 16.1 8.8 7.6 21.4 10.3 24.0 24.4 30.0 36.5 26.6 25.6 28.4 34.9 30.8 26.4 1.7 29.2 19.0 17.2 20.6 23.0 27.1 29.2 25.9 31.7 24.4 28.2 24.6 27.0 20.0 20.7 14.9 23.2 55.8 62.3 72.8 37.0 58.1 63.7 30.8 29.6 52.4 33.4 157.2 177.4 69.1 3.0 39.5 65.6 46.7 47.8 88.9 56.4 71.2 13.9 99.1 71.1 44.5 52.9 30.7 23.5 7.5 63.9 31.3 64.1 32.5 77.7 64.3 51.7 49.1 58.0 189.5 37.6 58.2 67.0 32.2 73.4 80.7 65.7 38.5 105.3 45.7 MRPS27 KIAA0264 ENSG00000113048 "Mitochondrial ribosomal protein S27" Q92552 5 72219409-72320646 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 88.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071751 Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA071751: AB_2686442" "unprognostic (3.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.14e-3)" "unprognostic (3.60e-2)" "unprognostic (2.23e-2)" "unprognostic (1.63e-1)" "unprognostic (1.79e-2)" "unprognostic (7.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.22e-3)" "unprognostic (5.07e-2)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (1.33e-1)" "unprognostic (5.27e-2)" "unprognostic (7.73e-2)" "unprognostic (3.95e-2)" 26.9 32.3 19.0 20.9 26.8 13.6 26.1 24.6 31.8 25.1 21.0 20.1 21.8 16.5 28.6 23.7 33.6 26.3 18.0 43.6 18.9 17.5 25.1 30.9 14.9 27.4 18.1 21.7 33.9 25.1 24.5 23.7 17.5 23.5 26.2 26.4 25.5 31.0 26.5 43.7 23.9 17.5 25.0 17.5 22.2 20.9 12.1 12.6 34.2 32.1 26.7 32.4 25.9 21.0 19.6 23.3 6.1 14.1 21.5 21.5 16.1 16.4 22.1 19.7 32.5 25.9 33.5 25.4 15.9 22.8 30.3 24.5 27.5 23.4 42.7 22.3 18.5 33.1 18.4 38.2 56.4 32.9 16.0 23.6 21.9 26.6 30.2 25.9 19.2 17.1 31.3 23.9 31.7 35.6 27.7 32.2 31.5 21.9 12.9 25.0 19.8 28.7 23.3 22.7 12.0 13.9 30.6 32.7 43.8 27.9 17.7 30.5 16.3 26.6 22.0 19.7 19.0 33.7 23.4 18.2 12.4 18.3 17.4 28.5 13.1 19.7 30.1 21.3 31.7 19.5 6.1 12.1 4.1 14.0 14.1 20.6 19.6 17.4 17.0 23.3 16.5 20.3 21.5 1.8 21.5 11.3 8.9 17.8 16.1 19.0 26.8 24.6 31.8 18.9 17.5 18.1 21.7 23.5 12.6 8.9 9.4 25.3 22.2 18.1 10.8 88.0 7.6 10.7 13.6 10.4 15.7 35.7 21.6 16.5 1.7 15.7 8.5 0.0 14.9 37.9 17.7 10.8 7.0 28.9 21.9 9.5 15.5 16.5 33.5 3.0 17.5 13.4 10.1 34.3 21.2 15.6 15.4 17.5 23.7 18.8 12.2 12.9 17.5 8.0 17.4 15.4 24.1 22.3 29.1 12.1 MRPS28 "HSPC007, MRP-S28, MRPS35" ENSG00000147586 "Mitochondrial ribosomal protein S28" Q9Y2Q9 8 79918717-80030289 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 88.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027202 Approved Supported Mitochondria NA NA Mitochondria "HPA027202: AB_1854126" "unprognostic (3.63e-3)" "unprognostic (6.41e-2)" "unprognostic (9.61e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-3)" "unprognostic (2.17e-1)" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (4.55e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "prognostic favorable (1.20e-6)" "unprognostic (4.48e-2)" "unprognostic (3.13e-1)" "unprognostic (1.18e-1)" "unprognostic (7.18e-2)" 18.1 36.9 27.4 13.2 26.7 10.9 19.9 16.7 23.3 14.1 20.9 20.5 10.9 13.4 11.5 16.5 18.1 14.7 12.0 40.4 24.0 24.7 32.5 44.2 12.2 13.7 32.2 17.9 13.4 19.1 20.6 20.2 18.7 21.9 13.1 17.2 16.7 14.2 14.8 56.9 11.8 12.7 13.4 27.8 12.6 14.0 9.7 19.0 18.1 22.4 27.8 15.7 14.0 11.7 19.6 41.7 26.0 28.1 25.4 26.7 18.0 20.1 20.1 18.2 4.3 15.5 20.2 20.0 22.6 21.1 30.9 26.2 17.5 16.4 25.4 26.3 18.3 30.9 16.7 25.2 25.8 24.9 20.1 22.1 30.9 18.4 27.2 17.4 13.7 13.9 17.0 22.1 18.0 24.7 17.0 20.0 20.8 21.8 10.7 30.5 19.3 31.4 22.3 7.4 52.4 34.3 21.5 14.6 14.7 38.8 19.5 8.6 14.6 10.0 88.9 21.0 22.1 21.4 16.6 14.3 11.6 29.1 20.2 19.8 11.6 18.5 22.6 19.7 15.9 8.9 26.0 20.7 10.9 19.0 28.1 20.7 18.7 21.4 23.8 36.7 19.6 25.9 24.9 4.5 25.4 24.9 41.7 26.7 18.0 27.4 26.7 16.7 23.3 24.0 24.7 32.2 17.9 21.9 19.0 20.8 14.5 24.1 17.8 31.3 11.9 51.2 35.7 61.6 34.2 31.4 3.9 66.8 86.2 58.9 11.1 30.8 18.0 0.0 40.7 64.7 23.7 12.0 48.5 58.0 43.9 4.8 35.9 25.8 28.4 7.6 16.4 35.7 42.2 47.7 21.5 17.5 34.1 14.0 20.8 78.1 13.9 32.3 25.0 16.5 34.1 33.1 49.7 23.5 36.8 15.4 MRPS31 IMOGN38 ENSG00000102738 "Mitochondrial ribosomal protein S31" Q92665 13 40729135-40771173 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Ciliated cells: 350.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039083, HPA046344" Uncertain Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA039083: AB_2676340, HPA046344: AB_2679629" "unprognostic (9.62e-3)" "unprognostic (2.62e-1)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (1.04e-1)" "unprognostic (2.15e-2)" "unprognostic (5.96e-3)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.72e-3)" "unprognostic (3.92e-2)" "unprognostic (3.13e-3)" "unprognostic (2.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.86e-2)" "unprognostic (2.54e-2)" 14.2 20.1 19.3 17.9 21.2 13.2 18.2 27.7 22.9 14.4 16.4 16.9 10.7 15.4 18.0 15.4 18.9 16.6 10.9 24.3 18.4 16.9 26.7 29.9 12.1 22.5 17.9 17.1 21.5 15.0 10.7 35.3 13.1 22.1 12.6 17.0 12.4 14.7 12.5 32.5 14.2 16.3 16.3 16.0 16.0 15.3 17.9 23.3 22.9 21.1 17.2 25.1 18.0 15.9 22.2 11.8 17.2 10.4 15.9 25.7 10.9 8.0 7.7 13.1 8.6 9.0 10.6 13.1 10.3 7.2 13.7 9.2 19.8 12.0 47.3 10.1 5.9 18.4 21.3 16.4 12.9 16.3 12.4 12.4 19.6 5.8 12.6 7.5 20.0 9.5 8.5 9.5 11.2 9.5 9.1 10.4 13.6 13.1 5.0 8.7 9.1 15.5 19.6 12.7 27.5 9.2 14.9 10.8 8.8 17.9 9.3 5.7 8.4 7.1 11.9 16.2 16.4 10.4 17.7 6.3 4.3 7.2 9.9 10.7 3.9 7.2 23.8 8.7 14.3 8.1 17.2 9.6 14.4 19.1 9.7 18.6 22.2 21.4 19.2 11.8 18.9 25.7 22.6 7.0 15.9 10.4 11.6 21.4 10.9 19.3 21.2 27.7 22.9 18.4 16.9 17.9 17.1 22.1 23.3 44.7 16.3 16.4 28.7 8.7 32.3 61.3 30.6 350.7 67.1 21.0 17.7 53.8 92.9 37.0 42.6 34.6 21.2 23.3 29.4 40.9 23.6 14.3 22.0 64.5 22.6 39.7 22.4 35.6 18.6 4.9 32.8 19.5 18.6 45.9 31.0 30.1 28.6 21.0 28.7 51.9 47.6 45.3 25.8 51.0 45.1 11.7 56.9 27.4 31.5 26.5 MRPS34 "MGC2616, MRP-S12" ENSG00000074071 "Mitochondrial ribosomal protein S34" P82930 16 1771890-1773155 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 75.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042112 Supported Supported Mitochondria NA NA Mitochondria "HPA042112: AB_10796899" "unprognostic (2.02e-1)" "unprognostic (4.83e-2)" "unprognostic (6.79e-2)" "unprognostic (3.42e-2)" "unprognostic (2.27e-1)" "unprognostic (9.59e-2)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (3.52e-1)" "unprognostic (1.37e-2)" "unprognostic (6.60e-2)" "unprognostic (3.18e-1)" "unprognostic (5.44e-2)" 26.8 30.5 15.6 14.1 18.3 21.1 17.8 20.2 26.8 11.5 28.0 14.7 19.2 28.4 15.1 13.6 24.7 13.7 17.9 21.9 14.0 13.1 22.5 27.7 12.9 14.8 14.0 13.1 12.6 42.0 13.0 15.5 12.6 16.3 21.2 7.0 12.5 46.6 19.4 89.8 21.9 23.6 10.8 13.6 25.8 36.5 8.8 15.1 21.5 21.0 28.1 21.1 14.7 15.7 55.5 54.6 27.2 50.8 41.0 51.9 45.5 14.1 15.8 2.2 5.5 1.9 2.2 18.2 15.6 3.0 5.4 4.1 10.7 8.3 17.9 25.1 1.9 3.0 16.7 3.2 7.5 0.8 12.6 75.4 12.5 14.0 11.3 4.1 22.9 13.4 2.0 3.6 3.3 1.4 2.4 4.1 9.3 20.9 3.8 1.5 22.9 12.4 40.9 21.1 3.7 48.5 28.1 10.7 39.1 2.0 4.0 28.0 20.9 17.5 8.7 15.0 0.6 11.2 9.3 10.4 5.8 18.7 7.8 12.7 32.5 22.4 28.5 4.5 13.0 7.3 15.7 50.8 27.2 41.0 44.0 43.4 50.5 45.8 43.5 54.6 55.5 43.7 39.2 11.0 41.0 37.4 51.0 51.9 45.5 15.6 18.3 20.2 26.8 14.0 13.1 14.0 13.1 16.3 15.1 35.7 27.7 77.0 57.3 89.2 43.8 53.0 94.3 24.1 39.8 92.5 9.8 160.1 212.2 101.1 4.7 53.7 189.8 23.3 157.7 146.2 58.0 69.5 34.7 145.9 153.3 52.4 87.5 63.8 98.1 8.9 67.3 58.7 77.6 88.4 128.4 65.1 127.2 138.9 65.7 174.9 30.5 19.4 65.7 20.0 41.9 105.5 57.2 77.3 177.0 60.1 MRPS5 "MRP-S5, S5mt" ENSG00000144029 "Mitochondrial ribosomal protein S5" P82675 2 95087207-95149434 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055765 Approved Supported Mitochondria No No Mitochondria "HPA055765: AB_2682911" "unprognostic (1.18e-1)" "unprognostic (7.79e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (7.98e-7)" "unprognostic (7.51e-3)" "unprognostic (6.30e-3)" "prognostic unfavorable (7.73e-5)" "unprognostic (8.59e-2)" "unprognostic (1.87e-1)" "unprognostic (2.76e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-2)" "unprognostic (1.29e-1)" "prognostic favorable (6.36e-4)" "unprognostic (1.25e-1)" 17.7 25.0 17.6 16.2 24.1 24.0 15.3 31.7 22.7 14.8 24.7 22.6 15.0 27.2 17.6 14.9 23.8 17.3 12.7 36.7 17.9 17.7 30.9 40.4 16.8 17.2 23.4 15.9 18.5 21.2 20.7 30.1 14.7 20.0 14.6 27.8 14.3 19.1 18.0 45.6 12.8 22.0 18.6 19.3 18.2 19.6 13.3 24.5 20.8 19.9 20.4 20.6 17.2 22.8 24.9 29.3 17.5 38.4 19.3 30.5 20.7 36.5 23.1 16.9 14.5 14.8 19.2 31.6 19.6 9.0 17.3 18.0 45.9 21.6 29.0 16.1 16.1 38.1 24.0 24.6 20.4 24.5 24.4 30.5 20.4 21.0 41.9 24.0 27.3 16.3 18.9 16.7 23.7 25.4 19.9 21.4 23.1 28.6 14.7 17.6 22.5 38.6 31.1 15.9 34.1 36.5 22.8 16.6 37.3 28.6 30.6 23.0 14.8 15.5 29.1 32.8 26.5 13.7 25.2 18.3 21.1 26.2 28.1 29.0 18.1 15.8 26.3 16.4 29.2 18.0 13.4 33.7 17.5 21.9 38.4 21.3 24.9 27.1 23.0 27.5 23.6 24.2 24.1 6.3 19.3 34.7 29.3 30.5 20.7 17.6 24.1 31.7 22.7 17.9 17.7 23.4 15.9 20.0 24.5 74.5 72.9 43.9 46.5 30.9 51.5 113.0 66.2 72.3 66.0 62.8 47.1 71.4 157.5 66.7 42.9 42.6 68.4 0.0 47.7 68.6 45.1 45.4 38.3 122.2 65.2 44.5 57.1 46.6 47.9 32.4 47.5 57.4 42.2 44.1 58.4 32.1 45.5 45.6 50.2 80.6 66.4 38.8 60.9 57.2 78.4 28.0 33.0 50.3 84.0 42.3 MRPS6 "C21orf101, MRP-S6, RPMS6" ENSG00000243927 "Mitochondrial ribosomal protein S6" P82932 21 34073224-34143034 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 633.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007861, HPA008163, HPA049676" Supported Supported Mitochondria NA NA Mitochondria "HPA007861: AB_2667920, HPA008163: AB_2667998, HPA049676: AB_2680846" "unprognostic (2.71e-2)" "unprognostic (4.85e-2)" "unprognostic (5.16e-3)" "unprognostic (4.01e-2)" "unprognostic (9.84e-3)" "unprognostic (3.72e-2)" "unprognostic (7.58e-3)" "unprognostic (1.80e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.87e-2)" "unprognostic (2.52e-1)" "unprognostic (1.02e-3)" "unprognostic (9.37e-2)" "unprognostic (5.13e-2)" "unprognostic (5.51e-2)" "prognostic favorable (1.06e-5)" 25.3 29.3 26.1 17.5 27.3 8.5 62.4 20.6 25.3 12.6 28.7 12.9 23.6 14.1 21.8 24.5 14.8 22.7 14.0 23.3 28.6 25.6 67.4 24.2 14.4 23.7 28.9 13.0 18.8 9.9 9.6 17.4 28.3 33.2 15.7 18.8 28.0 12.1 25.7 41.7 20.2 16.1 20.1 35.6 12.4 21.0 26.4 22.8 15.8 98.7 12.4 25.3 19.6 52.1 30.9 42.8 22.2 21.1 41.7 40.5 29.9 15.7 12.4 47.7 17.3 16.8 16.8 16.3 17.8 38.8 14.7 15.4 40.3 29.5 24.0 12.1 21.1 20.8 6.3 27.7 23.3 14.1 42.4 15.7 20.5 7.7 9.5 8.3 9.4 6.8 7.3 23.7 28.1 25.3 22.1 10.0 10.7 25.7 5.9 28.2 13.4 16.2 23.7 30.9 27.2 28.9 22.7 8.8 22.6 61.8 11.1 43.2 11.4 18.9 9.2 22.1 24.0 19.7 11.6 5.7 14.5 8.5 24.7 9.7 30.3 26.3 20.9 47.2 25.7 14.1 22.0 21.1 22.2 38.8 20.2 30.2 30.9 30.9 36.3 22.0 19.4 40.5 39.9 17.5 41.7 20.1 42.8 29.9 29.9 26.1 27.3 20.6 25.3 28.6 25.6 28.9 13.0 33.2 22.8 20.8 33.4 82.3 175.5 237.0 30.2 47.6 20.4 73.6 45.5 239.0 9.8 167.8 633.3 35.0 75.6 32.3 45.3 0.0 31.5 200.0 124.7 236.7 137.1 83.4 108.6 7.9 87.8 28.8 34.4 54.0 25.9 104.8 96.2 214.6 155.9 23.0 44.7 112.2 96.5 119.4 20.4 116.4 46.4 94.2 130.9 289.3 152.5 90.0 91.6 157.8 MRPS9 "MRP-S9, RPMS9, S9mt" ENSG00000135972 "Mitochondrial ribosomal protein S9" P82933 2 105037983-105099960 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043476, HPA048479" Supported Supported Mitochondria No No Mitochondria "HPA043476: AB_2678498, HPA048479: AB_2680412" "unprognostic (8.10e-3)" "unprognostic (4.75e-3)" "unprognostic (3.69e-1)" "unprognostic (3.80e-3)" "unprognostic (5.25e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (3.78e-1)" "unprognostic (2.62e-3)" "unprognostic (4.62e-2)" "unprognostic (5.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" 13.9 25.0 14.1 16.9 18.5 13.3 15.4 13.2 20.6 13.7 18.9 15.9 14.3 19.0 17.6 13.2 16.7 16.2 8.9 39.1 14.4 15.3 24.5 23.5 10.0 14.5 18.1 15.7 21.0 17.3 22.0 23.9 8.4 25.2 15.8 22.0 10.9 15.3 16.4 56.8 14.0 17.0 16.6 15.0 14.0 17.4 20.6 16.6 20.7 15.6 28.7 16.8 15.2 12.4 22.1 20.4 7.1 17.2 20.0 22.8 14.5 22.3 9.7 20.4 18.8 10.8 11.2 23.9 14.4 13.8 22.8 20.6 51.5 15.7 23.4 14.3 11.3 23.9 20.3 40.0 20.9 24.3 14.4 26.3 23.1 14.3 31.1 18.0 17.0 10.3 13.3 14.3 18.8 15.8 13.3 17.5 28.8 32.9 12.2 15.5 17.9 22.9 22.4 32.3 19.1 21.3 29.3 17.5 32.4 28.6 15.7 17.7 10.7 16.6 24.5 19.4 21.0 20.1 17.3 11.4 13.5 27.3 13.4 15.4 11.3 13.3 18.7 11.7 26.2 11.3 7.1 11.6 4.6 19.9 14.6 22.0 22.1 22.0 20.9 20.4 16.5 22.3 21.9 1.3 20.0 17.2 15.2 22.8 14.5 14.1 18.5 13.2 20.6 14.4 15.3 18.1 15.7 25.2 16.6 20.8 23.3 15.2 20.5 17.3 23.1 95.6 17.8 37.5 18.2 21.0 11.8 34.7 91.2 34.3 24.9 25.9 18.2 46.7 36.9 32.2 14.4 14.6 22.0 28.2 25.1 7.9 18.9 15.4 11.5 6.6 22.2 16.4 28.7 28.9 24.6 17.9 21.3 14.0 25.5 53.7 28.2 38.8 20.6 54.8 38.2 11.5 17.0 24.5 35.4 15.6 MT-CO1 "COI, COX1, MTCO1" ENSG00000198804 "Mitochondrially encoded cytochrome c oxidase I" P00395 MT 5904-7445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Translocase "Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 81405.0;Enterocytes: 59874.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 872.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016241, HPA069328" Enhanced Supported Mitochondria NA NA Mitochondria "CAB016241: AB_2229888, HPA069328: AB_2686122" "unprognostic (4.39e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (1.59e-1)" "unprognostic (3.31e-1)" "prognostic favorable (2.29e-4)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (1.20e-2)" "unprognostic (6.60e-2)" "unprognostic (2.83e-2)" "unprognostic (5.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.15e-2)" "unprognostic (2.44e-2)" 57.6 82.5 184.1 22.2 164.2 26.4 37.4 40.6 117.1 31.5 80.8 78.1 25.7 42.7 43.5 24.8 32.4 345.0 161.8 111.7 151.0 150.5 20.9 22.6 126.3 23.7 42.5 62.3 10.1 29.0 35.8 84.4 65.6 54.2 380.7 68.9 60.0 38.2 61.2 28.1 65.5 27.8 23.8 21.9 31.6 15.3 292.2 232.9 177.4 396.5 182.8 192.4 130.5 114.5 173.2 235.7 256.3 540.3 247.5 249.9 261.4 87.1 66.0 110.6 208.4 373.6 302.7 125.7 198.6 65.0 435.2 26.9 231.6 94.6 143.0 165.0 181.7 872.7 389.9 74.8 104.9 230.2 288.6 241.1 65.3 145.0 306.7 79.4 172.7 115.3 217.3 195.5 277.4 85.7 469.5 59.9 156.0 141.8 112.3 70.4 181.6 334.7 303.0 112.7 150.2 90.6 351.3 163.0 296.6 201.5 352.9 316.5 264.7 180.2 259.8 131.1 103.0 98.6 68.6 130.7 276.7 128.6 177.4 396.5 169.3 156.6 236.0 176.4 255.6 154.9 171.8 163.0 292.2 159.7 192.4 93.5 182.8 260.1 232.9 138.6 130.5 2694.8 3022.9 23660.6 9171.4 8678.3 0.0 81405.0 28094.1 4463.5 5243.5 18590.0 0.0 0.0 3606.0 6482.3 1224.4 4243.1 59874.1 34807.7 4485.9 0.0 3116.3 8181.6 3594.1 45857.2 0.0 0.0 7240.0 18002.1 27410.8 6497.0 10830.0 8032.7 6539.1 13021.9 32338.6 0.0 5722.6 29051.7 7980.9 24852.9 0.0 13394.3 6634.5 9840.4 12887.5 10030.7 0.0 18830.6 25753.2 17251.8 MT-CYB "COB, CYTB, MTCYB, UQCR3" ENSG00000198727 "Mitochondrially encoded cytochrome b" P00156 MT 14747-15887 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 324.2;skeletal muscle: 302.1" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 61379.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 490.3;HeLa: 493.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032215, HPA068400, HPA074796" Approved Supported Mitochondria NA NA Mitochondria "CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: " "unprognostic (4.50e-1)" "unprognostic (2.56e-1)" "unprognostic (9.12e-2)" "unprognostic (3.88e-2)" "unprognostic (9.22e-2)" "unprognostic (3.50e-1)" "prognostic favorable (5.96e-4)" "unprognostic (1.63e-2)" "unprognostic (8.53e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.40e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (4.09e-2)" "unprognostic (1.54e-2)" 78.0 52.4 98.5 14.7 143.5 14.4 32.3 38.4 59.6 30.9 54.0 55.6 25.0 43.6 28.0 25.0 21.2 222.5 93.9 68.0 128.7 144.7 19.6 13.7 83.6 25.3 51.4 33.6 23.7 32.6 32.9 57.7 59.2 49.5 302.1 63.5 37.2 37.4 44.3 15.7 55.2 20.2 20.9 20.6 23.6 14.7 183.7 78.7 324.2 155.7 90.0 146.7 57.6 73.4 99.2 123.0 131.3 490.3 78.9 99.1 84.7 35.1 22.2 38.5 97.6 162.5 188.2 41.5 100.3 26.6 231.5 18.2 104.1 54.5 91.9 81.5 105.1 493.3 174.0 92.4 59.0 128.5 170.3 155.3 42.0 90.5 150.2 56.2 76.8 53.7 118.5 113.1 202.8 54.8 121.7 27.3 71.8 67.4 64.8 48.4 117.8 176.2 171.6 43.9 77.6 59.0 111.5 83.4 192.8 162.6 203.7 176.1 77.9 101.9 141.8 65.0 32.5 43.6 80.6 46.8 92.0 48.9 324.2 155.7 235.1 102.8 94.4 135.3 150.5 118.7 132.0 78.0 183.7 128.3 146.7 148.0 90.0 96.8 78.7 79.8 57.6 1101.8 1182.9 10535.1 6605.8 2949.0 0.0 61379.6 10280.2 2941.7 2205.5 7087.1 0.0 0.0 1833.6 2297.4 679.0 1928.7 15168.1 14904.3 3076.0 0.0 1463.9 4337.7 1777.7 14746.0 0.0 0.0 2756.0 7288.5 8580.4 3048.7 7355.0 2431.1 2478.3 3811.6 11241.0 0.0 2672.3 10113.2 5078.0 11513.5 0.0 5704.4 3210.7 4468.4 3767.8 2992.1 0.0 6827.7 9828.0 8723.5 MT-ND4 "LHON, MTND4, NAD4, ND4" ENSG00000198886 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4" P03905 MT 10760-12137 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 392.9" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 130137.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 821.0" "Low region specificity" "Detected in all" HPA053928 Approved Supported Mitochondria NA NA Mitochondria "HPA053928: AB_2682313" "unprognostic (8.39e-2)" "unprognostic (1.83e-1)" "unprognostic (7.29e-2)" "unprognostic (9.54e-2)" "unprognostic (5.41e-2)" "unprognostic (3.78e-2)" "unprognostic (2.50e-3)" "unprognostic (8.16e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.01e-2)" "unprognostic (7.23e-2)" "unprognostic (2.79e-2)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (3.14e-2)" "unprognostic (4.24e-2)" 82.5 72.4 124.2 19.8 138.2 14.9 34.5 43.8 78.5 34.1 68.7 56.5 27.8 37.1 32.9 25.2 23.7 292.7 122.4 90.3 129.8 178.5 20.8 17.4 101.6 25.5 58.3 37.8 19.7 39.1 37.3 82.1 61.7 65.6 288.4 61.1 41.0 37.8 63.6 21.7 67.7 29.6 24.3 23.4 26.0 15.3 164.7 87.6 392.9 119.5 87.1 129.7 53.0 102.6 106.9 138.9 205.1 326.5 82.3 97.3 104.6 40.0 24.3 47.5 162.1 117.7 182.9 92.3 89.1 35.8 192.5 12.4 169.4 43.6 105.5 67.2 112.6 821.0 271.8 49.3 113.1 134.0 139.2 179.5 35.8 128.4 229.8 58.7 92.3 93.8 226.5 87.5 231.7 44.5 257.0 39.3 89.7 72.7 60.6 43.6 110.2 177.8 222.1 51.2 69.3 60.8 202.4 104.6 257.3 141.7 267.4 162.8 99.5 96.8 133.1 81.0 135.9 55.1 81.4 64.9 196.6 52.9 392.9 119.5 268.8 82.9 91.3 115.5 148.0 93.0 98.9 65.9 164.7 109.6 129.7 105.7 87.1 89.0 87.6 67.6 53.0 1179.2 1324.7 15760.8 7514.4 3912.5 0.0 130137.0 15452.1 2295.3 2103.1 12148.5 0.0 0.0 2064.1 2636.7 917.0 2449.9 17720.8 23127.3 3538.6 0.0 2017.3 5309.0 2067.8 31565.1 0.0 0.0 4902.7 11944.3 15339.0 4282.8 8180.5 3605.2 3603.6 4879.3 17860.7 0.0 3353.9 12846.0 5441.2 13683.6 0.0 6208.8 3859.5 7259.5 5529.7 4316.1 0.0 9799.9 18174.2 10097.1 MTERF1 MTERF ENSG00000127989 "Mitochondrial transcription termination factor 1" Q99551 7 91692008-91880720 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044894, HPA069560" Uncertain Supported Mitochondria NA NA Mitochondria "HPA044894: AB_10966284, HPA069560: AB_2686154" "unprognostic (5.57e-2)" "unprognostic (7.31e-2)" "unprognostic (2.15e-2)" "unprognostic (1.50e-2)" "unprognostic (2.55e-1)" "unprognostic (1.81e-1)" "unprognostic (3.15e-3)" "unprognostic (1.25e-2)" "unprognostic (1.46e-3)" "unprognostic (7.62e-2)" "unprognostic (2.67e-1)" "unprognostic (5.19e-2)" "unprognostic (3.21e-2)" "unprognostic (1.14e-1)" "unprognostic (3.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.22e-3)" 8.9 11.5 16.1 10.9 18.1 13.9 14.4 23.2 18.9 10.4 11.8 12.1 10.0 11.5 11.6 11.0 13.4 9.8 8.3 8.7 15.2 10.5 13.2 17.6 8.3 19.4 20.3 13.1 14.7 11.4 10.0 18.0 10.6 18.8 11.6 12.1 8.5 12.5 9.2 9.3 9.9 13.6 9.7 22.7 17.6 12.5 10.0 18.5 11.9 12.2 10.3 19.0 12.0 11.4 15.0 9.4 24.8 8.8 9.8 19.0 10.0 10.4 9.1 8.8 5.9 8.5 9.0 7.7 8.9 9.0 9.6 11.9 11.0 10.0 21.5 7.4 7.0 14.1 9.2 13.1 7.9 13.7 1.2 9.5 9.7 9.8 8.5 7.6 17.1 10.8 10.7 10.5 10.5 11.2 7.6 8.3 5.4 17.7 8.9 11.1 13.3 17.9 19.6 13.2 12.9 10.2 5.1 11.7 14.7 9.9 11.4 8.1 15.6 9.0 19.0 17.9 16.8 6.6 12.3 5.3 11.4 14.0 15.4 9.0 12.8 12.9 29.1 8.2 5.6 15.9 24.8 8.8 11.9 10.6 7.5 12.7 14.6 13.8 15.2 9.4 15.0 19.0 15.1 4.2 9.8 8.2 7.4 13.2 10.0 16.1 18.1 23.2 18.9 15.2 10.5 20.3 13.1 18.8 18.5 8.9 11.7 3.4 3.4 0.0 0.0 4.5 5.1 2.7 4.5 3.5 0.0 8.2 5.0 5.1 0.9 2.9 3.8 0.0 4.5 6.1 1.9 2.9 4.7 8.9 4.5 0.0 1.2 6.7 7.6 1.1 6.4 5.3 0.0 7.2 3.2 0.0 3.2 3.5 6.7 6.2 0.0 12.9 1.4 11.2 9.8 0.0 3.8 8.6 4.6 1.8 MTERF3 "CGI-12, FLJ10939, MTERFD1" ENSG00000156469 "Mitochondrial transcription termination factor 3" Q96E29 8 96239398-96261610 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007355 Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA007355: " "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (4.68e-2)" "unprognostic (2.31e-2)" "unprognostic (3.86e-2)" "unprognostic (6.66e-2)" "unprognostic (2.75e-3)" "unprognostic (3.11e-3)" "unprognostic (6.43e-2)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (8.56e-2)" "prognostic unfavorable (5.88e-5)" "unprognostic (8.67e-3)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (1.74e-3)" 13.8 16.4 14.2 15.9 20.1 9.9 22.9 17.8 18.0 14.8 13.8 12.3 17.4 11.9 15.4 23.8 12.6 13.2 12.9 21.9 17.3 15.3 15.9 22.2 18.5 18.3 18.1 16.0 13.7 14.8 18.9 14.1 16.1 23.7 15.5 14.5 9.8 12.1 17.9 28.8 16.1 11.6 21.9 13.2 16.9 12.8 10.9 13.5 16.0 15.0 14.1 18.1 13.9 12.3 15.3 18.0 18.6 11.6 16.7 17.8 7.8 18.9 12.2 18.4 14.5 13.1 13.6 8.4 14.6 12.0 21.5 21.7 8.7 14.1 17.1 30.9 8.5 10.9 10.7 19.0 11.4 26.2 16.4 13.9 24.4 9.4 10.5 18.5 8.2 10.0 13.6 17.1 17.4 16.4 11.1 17.5 18.4 20.5 9.0 21.5 12.3 34.9 24.3 9.6 33.5 19.1 21.2 15.1 13.3 15.7 10.1 12.6 9.9 10.9 3.2 15.5 12.4 16.5 11.6 7.8 15.1 10.2 17.4 12.9 10.3 12.9 19.9 16.4 22.1 19.7 18.6 10.3 4.3 12.4 11.6 17.8 15.3 14.1 14.0 14.8 13.2 16.1 16.1 1.8 16.7 11.0 18.0 13.3 7.8 14.2 20.1 17.8 18.0 17.3 15.3 18.1 16.0 23.7 13.5 3.0 5.8 10.9 13.1 0.0 0.0 27.8 10.2 9.4 10.3 5.2 0.0 26.6 11.6 10.9 4.4 8.2 0.8 23.3 8.6 17.4 15.8 7.5 5.8 7.3 14.3 0.0 0.0 6.2 4.9 3.1 12.7 6.3 0.0 21.6 3.8 0.0 7.5 3.5 13.1 8.7 0.0 12.9 10.0 24.4 18.8 0.0 14.5 4.4 6.2 9.1 MTERF4 "MGC61716, MTERFD2" ENSG00000122085 "Mitochondrial transcription termination factor 4" Q7Z6M4 2 241072169-241102332 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027097 Uncertain Supported Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" "HPA027097: AB_10603879" "unprognostic (4.58e-2)" "unprognostic (3.66e-1)" "unprognostic (2.82e-1)" "unprognostic (5.95e-2)" "unprognostic (1.50e-1)" "unprognostic (6.70e-2)" "unprognostic (1.17e-3)" "unprognostic (2.99e-2)" "unprognostic (2.68e-2)" "unprognostic (1.20e-2)" "prognostic favorable (3.48e-4)" "unprognostic (2.28e-2)" "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-1)" 14.2 15.5 14.4 17.6 22.1 17.2 18.6 42.2 21.7 16.2 14.6 25.3 12.5 13.4 23.2 14.1 17.6 17.7 12.1 13.4 14.4 12.1 13.4 16.5 14.2 29.8 19.2 19.4 25.7 20.9 11.7 25.7 11.6 20.4 28.9 17.2 16.3 19.5 18.1 38.8 15.5 19.6 17.3 17.8 20.3 14.7 12.7 22.3 23.7 29.4 20.5 29.7 14.3 15.2 16.6 6.2 11.4 5.4 8.0 24.9 10.2 8.7 8.3 16.5 9.5 22.5 10.1 12.3 14.9 16.6 14.5 20.7 5.7 13.2 13.6 5.4 17.3 16.5 9.9 22.5 21.3 19.7 18.4 16.3 17.4 15.9 25.1 14.8 20.7 13.3 17.2 20.9 17.0 19.7 18.9 16.5 18.6 15.5 6.0 17.4 12.4 15.1 14.3 18.9 18.1 14.3 14.8 18.8 7.7 13.8 17.6 15.2 13.2 12.2 15.2 11.3 11.7 11.2 10.7 22.8 13.4 13.1 15.7 13.3 16.1 4.1 33.2 11.3 13.2 12.3 4.2 5.4 11.4 10.0 5.2 12.5 16.6 15.5 13.7 6.2 15.4 24.9 19.5 1.9 8.0 4.4 4.7 15.8 10.2 14.4 22.1 42.2 21.7 14.4 12.1 19.2 19.4 20.4 22.3 11.9 23.0 29.4 17.6 0.0 0.0 17.5 25.5 32.1 23.9 19.2 0.0 24.9 34.9 21.1 40.5 13.6 19.2 23.3 21.3 22.9 13.5 15.6 10.5 27.2 22.0 0.0 10.5 14.7 21.8 48.5 21.6 18.0 0.0 19.8 26.7 0.0 20.5 25.8 24.8 32.1 0.0 38.8 15.9 42.6 38.1 0.0 19.8 30.5 22.5 14.8 MTG1 GTPBP7 ENSG00000148824 "Mitochondrial ribosome associated GTPase 1" Q9BT17 10 133394094-133421307 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037826, HPA037827" Approved Supported Mitochondria NA NA Mitochondria "HPA037826: AB_2675692, HPA037827: AB_10670959" "unprognostic (2.94e-2)" "unprognostic (8.08e-2)" "unprognostic (5.90e-3)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-2)" "unprognostic (5.85e-2)" "unprognostic (6.20e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-1)" "prognostic favorable (5.08e-4)" "unprognostic (4.63e-3)" "prognostic unfavorable (6.79e-7)" "unprognostic (3.88e-2)" "unprognostic (5.96e-2)" "unprognostic (5.19e-2)" "prognostic favorable (1.03e-5)" 14.5 29.4 16.5 20.2 19.0 14.8 17.9 23.9 19.2 16.1 19.7 23.0 16.7 26.6 19.9 13.5 21.7 20.5 17.9 14.1 14.4 13.1 26.6 47.0 14.4 19.3 17.3 14.5 20.0 27.9 18.1 22.3 16.6 16.4 19.8 16.4 16.9 23.8 24.4 26.4 18.2 22.5 17.7 14.1 27.3 21.3 29.1 20.8 21.3 19.5 12.3 21.2 15.1 15.8 22.9 20.2 10.4 18.2 21.0 14.2 9.9 16.7 20.5 12.9 27.9 7.8 6.1 18.5 9.9 10.6 18.6 15.7 25.9 12.1 12.5 15.1 10.1 7.7 14.5 14.1 19.7 8.8 11.6 18.7 12.0 10.6 23.3 19.9 8.8 13.2 15.7 11.1 17.6 28.2 13.0 26.7 12.8 10.5 2.2 14.2 21.4 8.6 12.3 17.4 21.4 7.1 12.1 12.4 2.9 16.3 13.7 4.9 16.0 14.1 14.6 21.7 7.7 13.3 13.2 15.1 6.5 12.4 6.7 11.2 4.0 2.8 17.7 11.8 8.0 9.2 0.2 10.6 10.4 13.9 16.1 14.2 18.7 12.4 11.6 9.7 22.9 9.7 10.2 1.5 21.0 18.2 20.2 12.5 9.9 16.5 19.0 23.9 19.2 14.4 13.1 17.3 14.5 16.4 20.8 8.9 2.2 13.7 5.3 3.8 0.0 1.4 2.5 6.7 4.5 3.5 0.0 7.7 5.0 11.3 2.0 6.2 9.7 0.0 8.5 6.5 4.3 5.7 5.8 4.3 4.7 0.0 12.1 7.4 4.6 3.8 8.3 4.1 5.0 10.0 6.7 0.0 9.0 8.6 4.6 5.4 0.0 12.9 5.2 8.6 7.9 3.0 5.6 10.0 9.2 6.5 MTHFD2 ENSG00000065911 "Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase" P13995 2 74198562-74217565 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 263.3;Smooth muscle cells: 264.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003684, HPA049657" Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB003684: AB_425867, HPA049657: AB_2680842" "unprognostic (1.82e-3)" "unprognostic (4.60e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (2.07e-5)" "prognostic favorable (1.01e-4)" "unprognostic (3.10e-3)" "unprognostic (2.24e-3)" "unprognostic (4.75e-3)" "unprognostic (2.64e-2)" "unprognostic (3.96e-2)" "unprognostic (3.76e-3)" "unprognostic (3.57e-3)" "prognostic unfavorable (1.11e-16)" "unprognostic (3.66e-2)" "unprognostic (6.52e-2)" "unprognostic (9.07e-2)" "unprognostic (2.34e-3)" 26.2 5.7 5.8 21.6 14.1 12.1 21.9 3.0 8.0 15.1 12.4 5.9 12.6 10.1 15.8 8.7 14.1 17.5 10.5 12.1 10.0 8.2 12.0 3.4 15.9 21.0 19.0 1.5 20.6 39.7 1.5 15.6 8.2 16.1 12.7 15.3 3.0 32.9 12.0 39.4 8.6 9.2 21.0 25.6 26.3 15.3 11.9 11.8 8.4 11.4 16.7 23.5 20.3 41.8 4.8 11.4 13.6 19.7 10.7 12.7 6.3 18.6 6.9 7.8 26.6 8.6 9.7 20.6 23.5 15.9 13.8 19.6 15.9 7.9 39.4 6.3 12.7 15.4 6.6 25.9 13.8 26.1 21.2 10.8 38.0 3.9 15.4 35.2 27.6 25.4 20.0 44.1 17.2 74.8 7.1 9.2 63.6 17.5 57.4 13.5 11.7 17.3 34.2 17.0 27.2 11.5 19.3 21.9 34.7 7.9 5.5 20.4 14.9 8.1 24.4 55.1 5.9 20.9 38.4 4.0 4.3 34.7 9.8 26.3 47.5 21.0 32.0 11.9 33.9 12.2 13.6 8.1 9.6 3.3 19.7 4.8 4.8 6.0 3.6 11.4 3.0 4.3 3.3 1.1 10.7 19.1 5.0 12.7 6.3 5.8 14.1 3.0 8.0 10.0 8.2 19.0 1.5 16.1 11.8 14.9 26.5 62.1 28.1 79.3 0.0 8.2 7.6 2.7 13.6 1.8 0.0 20.5 3.3 54.8 3.2 18.0 6.9 93.5 92.6 49.1 52.6 48.5 53.0 0.6 64.6 0.0 18.3 13.5 55.9 2.9 21.0 92.7 67.4 263.3 33.2 0.0 75.9 5.8 19.8 1.4 0.0 135.8 264.7 30.1 55.8 65.2 11.7 30.5 21.6 55.0 MTIF3 "IF-3mt, IF3(mt)" ENSG00000122033 "Mitochondrial translational initiation factor 3" Q9H2K0 13 27435643-27450591 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 461.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039791 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA039791: AB_10795296" "unprognostic (1.82e-1)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (3.26e-3)" "unprognostic (1.49e-2)" "unprognostic (8.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (1.64e-2)" "unprognostic (1.62e-1)" "unprognostic (2.40e-1)" "unprognostic (3.24e-2)" "unprognostic (1.13e-1)" "unprognostic (9.27e-2)" "prognostic favorable (8.41e-4)" 36.9 30.4 29.8 21.9 26.3 8.5 28.4 22.8 26.7 21.5 24.8 16.9 25.9 23.7 15.1 38.5 25.5 16.5 20.5 55.7 27.5 22.8 41.5 38.7 15.1 22.2 28.9 19.7 23.1 28.3 14.5 40.3 20.2 28.3 22.7 24.8 17.4 43.3 28.1 46.1 21.6 29.7 18.2 28.7 24.9 22.7 28.3 26.2 29.7 22.9 38.5 24.0 27.8 16.4 25.3 44.3 35.9 26.5 18.5 24.1 19.4 12.6 8.8 19.9 10.0 22.3 33.5 10.1 18.7 20.5 13.8 14.0 11.7 15.7 13.8 12.7 20.3 9.6 10.9 10.7 14.7 19.0 14.5 13.2 17.5 8.1 14.5 21.8 18.1 16.7 18.8 27.1 11.3 14.4 31.2 23.9 13.7 10.0 5.6 20.8 22.3 15.8 22.1 10.3 40.0 10.0 9.3 10.8 15.8 28.4 13.0 14.6 8.9 11.3 16.7 21.2 22.5 13.0 27.3 16.3 9.3 5.5 24.0 12.7 4.3 6.0 8.0 9.7 18.2 13.3 34.2 26.5 35.9 17.1 25.5 18.4 25.3 21.8 17.2 27.9 21.7 19.3 19.6 17.7 18.5 22.1 44.3 24.1 19.4 29.8 26.3 22.8 26.7 27.5 22.8 28.9 19.7 28.3 26.2 26.8 39.6 74.4 31.9 30.2 0.0 153.3 114.7 80.3 53.4 109.9 0.0 82.5 276.8 69.3 461.6 70.4 109.5 70.0 91.1 54.9 56.4 44.1 70.4 186.6 88.5 0.0 61.7 75.5 115.6 139.9 129.5 86.8 101.3 78.5 97.0 0.0 94.2 104.0 117.4 273.1 0.0 122.9 55.6 149.2 77.3 37.1 47.5 55.4 92.5 39.3 MTPAP "FLJ10486, mtPAP, PAPD1, SPAX4" ENSG00000107951 "Mitochondrial poly(A) polymerase" Q9NVV4 10 30309801-30374448 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transcription" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "Early spermatids: 194.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038620, HPA058232" Approved Supported Mitochondria NA NA Mitochondria "HPA038620: AB_10673015, HPA058232: AB_2683646" "unprognostic (2.76e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (3.05e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.20e-6)" "unprognostic (1.16e-1)" "unprognostic (2.04e-1)" "unprognostic (4.78e-2)" "unprognostic (1.77e-1)" "unprognostic (3.56e-2)" "unprognostic (9.02e-2)" "unprognostic (6.28e-3)" "unprognostic (3.77e-1)" "unprognostic (1.14e-2)" "unprognostic (4.39e-2)" 10.9 12.7 9.9 10.2 12.4 32.8 11.1 12.4 16.1 9.6 9.9 7.3 6.5 11.0 10.4 7.0 12.6 9.5 7.6 11.5 7.8 7.2 10.6 11.1 9.4 10.5 11.9 13.0 11.4 18.9 9.5 7.2 10.0 11.4 8.0 12.0 8.2 10.7 10.2 22.3 13.1 10.0 14.3 9.0 9.3 9.7 10.6 8.3 6.7 11.0 12.4 10.5 11.7 9.1 15.6 22.9 18.4 24.4 16.9 17.1 8.3 14.2 14.3 9.1 13.1 9.0 8.5 11.8 10.0 3.5 10.2 10.7 15.1 20.1 20.4 7.1 6.5 9.4 16.9 17.5 11.6 12.5 10.3 13.7 20.7 13.5 15.2 9.4 13.5 16.3 8.3 10.8 11.4 6.8 5.7 11.0 19.2 22.3 16.1 7.6 11.9 16.2 12.0 6.1 10.8 7.7 16.4 16.1 19.0 9.4 9.5 15.0 12.1 9.0 9.4 13.9 8.9 9.1 8.7 10.6 10.8 13.9 15.0 11.0 3.6 8.7 27.9 9.2 24.8 3.8 16.4 18.5 18.4 16.2 24.4 17.1 15.6 15.4 15.6 22.9 13.1 16.7 16.8 3.0 16.9 18.1 12.0 15.5 8.3 9.9 12.4 12.4 16.1 7.8 7.2 11.9 13.0 11.4 8.3 8.9 6.1 9.7 10.8 22.3 0.0 15.3 5.1 10.7 11.4 3.5 0.0 12.2 16.6 7.7 194.2 12.0 7.8 0.0 7.9 9.8 11.5 8.6 4.7 12.1 12.7 0.0 4.1 10.4 12.3 17.1 11.2 11.5 8.5 10.8 13.7 0.0 8.4 0.0 15.6 11.0 0.0 12.9 11.4 21.9 17.2 21.8 9.6 9.6 16.6 14.0 MTX2 ENSG00000128654 "Metaxin 2" O75431 2 176269395-176338025 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 170.8;Spermatocytes: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031550, HPA031551, HPA031552" Approved Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoli "HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616" "unprognostic (2.61e-1)" "unprognostic (9.86e-2)" "unprognostic (6.54e-2)" "prognostic unfavorable (5.06e-4)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "unprognostic (2.87e-2)" "unprognostic (3.97e-2)" "unprognostic (1.80e-2)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (9.92e-2)" "unprognostic (3.15e-2)" "unprognostic (1.33e-2)" 13.2 26.4 21.3 12.0 22.3 5.5 18.8 15.0 44.9 13.0 20.7 18.5 16.6 15.4 15.5 27.9 22.2 20.0 12.0 33.6 23.6 26.3 31.5 20.2 10.6 8.9 21.5 16.5 13.2 16.4 23.7 25.7 17.3 21.8 18.9 24.6 16.3 24.7 16.5 45.0 12.5 14.8 17.6 25.7 9.4 14.6 40.6 14.0 10.2 14.7 19.8 13.6 14.4 13.6 16.2 12.1 4.7 12.6 15.1 13.4 7.9 17.5 10.4 21.2 13.0 14.3 16.5 20.4 18.9 17.7 17.4 20.3 17.9 19.2 22.5 32.1 16.7 28.1 11.8 23.1 23.3 24.0 22.3 16.6 21.4 13.1 31.5 22.6 33.1 7.2 18.4 29.1 18.2 31.4 21.3 24.7 22.0 28.4 17.5 20.4 16.0 11.6 33.7 20.2 34.4 16.5 0.0 15.4 20.0 49.2 31.9 30.3 26.0 15.8 21.1 39.0 42.7 11.7 21.6 21.7 17.4 15.4 18.2 19.7 19.6 20.4 26.9 21.6 16.7 21.0 4.7 7.7 3.2 8.5 12.6 11.5 16.2 10.9 9.6 12.1 11.4 13.2 13.4 0.0 15.1 10.9 9.8 13.4 7.9 21.3 22.3 15.0 44.9 23.6 26.3 21.5 16.5 21.8 14.0 17.9 16.9 20.4 33.1 27.6 0.0 60.5 28.1 33.5 20.5 54.1 0.0 65.7 170.8 45.6 18.6 25.5 29.0 0.0 34.6 53.9 27.4 37.9 42.7 32.0 41.3 0.0 39.9 12.3 17.8 12.3 32.8 24.8 33.7 34.3 41.6 0.0 41.1 17.5 30.8 83.3 0.0 38.8 36.0 167.0 118.7 36.6 54.3 16.2 51.9 46.0 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508161 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favorable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 13.3 15.9 10.3 12.9 12.3 20.6 20.4 9.2 22.2 13.1 15.8 19.0 8.0 11.6 18.2 10.7 17.2 17.0 18.5 26.2 11.7 12.5 20.5 20.1 16.3 12.1 16.8 9.5 17.5 26.8 21.9 13.0 21.6 17.6 13.9 13.3 14.3 15.3 18.1 26.7 17.4 19.5 17.0 11.7 13.6 15.2 14.1 11.6 18.5 15.1 14.6 14.0 16.3 13.6 23.2 26.0 31.9 30.4 25.2 32.1 27.5 17.1 16.6 9.6 19.8 20.8 11.7 10.4 17.0 20.4 21.2 20.5 10.2 28.5 12.9 19.1 24.0 16.1 26.1 17.2 24.6 15.5 12.8 13.6 9.9 11.2 14.8 24.5 13.5 17.0 19.1 32.5 21.7 22.6 12.5 13.8 11.7 12.9 15.8 23.0 8.7 8.1 9.1 9.8 14.3 15.9 8.0 12.1 16.7 25.0 9.6 9.8 14.5 15.3 16.4 20.9 8.1 11.5 13.0 15.6 20.7 11.9 18.0 15.2 18.5 16.1 13.9 16.2 18.4 19.1 26.3 26.5 31.9 30.9 30.4 32.1 23.2 23.6 31.4 26.0 21.5 27.1 26.3 24.0 25.2 25.4 20.1 32.1 27.5 10.3 12.3 9.2 22.2 11.7 12.5 16.8 9.5 17.6 11.6 20.8 9.3 11.7 7.8 4.6 12.5 14.6 12.7 9.4 6.8 17.4 5.9 33.7 10.0 21.4 1.6 9.7 12.0 0.0 20.3 20.8 12.1 8.1 3.5 11.9 19.7 12.7 8.2 10.4 11.4 2.8 12.0 7.7 18.6 21.6 11.8 15.6 19.7 11.5 14.5 8.7 10.5 19.4 8.5 10.6 13.4 6.1 31.5 10.8 10.1 9.0 NADK2 "C5orf33, FLJ30596, MNADK, NADKD1" ENSG00000152620 "NAD kinase 2, mitochondrial" Q4G0N4 5 36192592-36242279 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 128.6" "Group enriched" "Detected in many" 7 "Early spermatids: 231.1;Hepatocytes: 160.3;Late spermatids: 119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038366, HPA038367, HPA061492" Enhanced Supported Mitochondria NA NA 28000 Mitochondria "HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538" "unprognostic (1.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.01e-2)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (1.97e-2)" "unprognostic (4.06e-3)" "unprognostic (8.84e-2)" "unprognostic (3.32e-2)" "unprognostic (1.93e-3)" "unprognostic (1.09e-1)" "unprognostic (1.76e-1)" "unprognostic (9.73e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.54e-2)" "unprognostic (1.75e-2)" 5.7 10.2 13.7 4.1 12.5 4.4 6.8 6.7 13.4 6.6 6.0 13.3 5.9 7.0 5.9 4.1 4.9 6.0 5.5 8.3 14.3 8.5 10.0 128.6 4.0 4.2 11.6 12.0 8.8 12.2 4.8 3.1 7.2 11.6 9.5 6.2 3.9 5.6 7.7 11.1 3.3 5.5 24.8 20.3 3.8 7.6 7.3 11.4 2.5 7.6 3.5 5.1 15.2 5.9 5.1 3.3 9.1 4.2 9.5 3.2 1.7 9.1 6.0 9.2 10.5 14.1 12.0 12.6 8.6 5.7 7.9 5.9 16.8 11.5 32.9 6.4 9.8 9.8 6.4 8.6 6.3 11.1 9.1 7.6 8.8 17.8 9.8 10.4 19.1 3.5 13.2 9.7 8.7 13.2 9.8 8.3 12.8 23.2 11.8 7.9 3.6 17.8 7.3 5.1 7.4 8.7 17.3 22.8 7.0 10.1 7.8 4.1 9.3 44.4 14.1 4.6 7.6 10.0 16.8 6.2 15.4 8.4 11.6 10.2 10.8 13.0 9.7 6.5 24.9 6.0 9.1 2.0 1.9 2.1 2.0 2.7 2.2 3.2 2.5 3.3 5.1 2.7 2.2 0.1 9.5 4.2 1.5 2.9 1.7 13.7 12.5 6.7 11.4 14.3 8.5 11.6 12.0 11.6 11.4 3.0 5.8 6.7 5.9 6.1 5.5 25.5 22.9 8.1 7.9 5.2 7.9 6.8 21.6 3.9 231.1 6.8 5.2 0.0 8.0 6.9 11.2 12.7 1.1 160.3 7.5 3.2 6.9 13.5 8.9 119.7 18.4 4.9 13.5 2.8 11.7 15.3 8.4 7.0 21.5 19.6 5.0 0.0 13.0 16.7 10.5 5.0 6.1 5.7 12.3 8.1 NAGS "AGAS, ARGA, NAT7" ENSG00000161653 "N-acetylglutamate synthase" Q8N159 17 44004546-44009063 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Urea cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 16.4;liver: 30.2" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 12.2;Hepatocytes: 18.8;Proximal tubular cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.4;HHSteC: 6.6;TIME: 8.1;U-87 MG: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA027300 Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA027300: AB_2672207" "unprognostic (1.51e-3)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (8.67e-2)" "unprognostic (1.44e-2)" "unprognostic (1.30e-3)" "unprognostic (2.38e-2)" "unprognostic (1.98e-1)" "unprognostic (3.14e-2)" "unprognostic (2.73e-2)" "unprognostic (2.53e-3)" "unprognostic (1.46e-1)" "unprognostic (5.19e-2)" "unprognostic (6.99e-2)" "unprognostic (1.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" 0.6 0.6 0.5 0.4 2.4 0.0 1.0 0.7 1.5 0.3 7.2 0.5 5.6 16.4 0.5 2.6 0.9 0.3 0.3 0.9 0.7 1.5 4.4 30.2 2.5 0.2 1.8 0.6 0.5 0.3 3.6 0.4 0.4 1.2 0.8 0.4 0.1 0.9 6.5 0.1 0.6 13.4 0.3 2.0 0.5 0.3 0.4 1.1 0.2 2.9 0.0 0.1 0.8 0.8 1.5 2.0 2.3 2.7 1.0 3.5 1.3 3.4 0.2 0.0 0.5 0.0 6.4 0.1 0.6 0.0 0.2 0.0 2.2 0.8 0.0 1.4 0.0 0.1 1.5 0.0 1.2 0.1 0.3 0.8 0.1 0.2 2.7 6.6 0.0 0.0 2.8 0.1 0.2 0.0 0.6 1.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 1.7 2.7 0.1 0.2 0.0 0.0 0.0 2.6 0.0 1.2 0.0 0.0 0.1 0.2 0.1 8.1 3.0 0.8 0.2 0.7 0.2 0.2 0.2 12.1 0.1 0.4 1.8 1.4 2.3 3.5 1.5 2.8 1.2 2.2 2.9 2.0 1.5 1.1 1.7 0.8 1.0 2.7 0.3 1.7 1.3 0.5 2.4 0.7 1.5 0.7 1.5 1.8 0.6 1.2 1.1 3.0 3.4 0.5 0.8 1.3 0.4 2.4 5.1 1.4 4.5 12.2 0.0 0.9 6.6 1.6 4.4 0.9 10.4 0.0 3.6 1.6 0.6 0.4 0.0 18.8 1.0 0.0 6.9 1.3 2.6 2.2 1.4 4.2 0.0 9.0 2.6 0.9 3.7 3.2 0.7 14.6 0.5 0.0 1.0 5.5 1.5 0.6 0.3 1.5 3.3 0.6 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435961-78574874 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol No No "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favorable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 10.9 16.0 11.8 9.3 11.2 6.4 13.4 19.4 11.8 11.6 13.0 13.1 13.5 12.0 17.6 13.9 10.8 12.0 9.9 12.7 11.3 12.2 22.3 26.8 9.0 10.2 13.4 8.4 15.9 20.0 14.0 17.3 9.4 13.8 13.3 13.3 23.2 12.7 13.2 24.4 9.1 11.1 10.6 10.8 12.6 11.3 11.8 10.3 17.3 16.0 7.7 14.1 9.7 10.7 14.6 13.5 6.7 9.4 16.2 16.6 8.7 7.3 10.3 10.8 7.1 7.6 6.4 9.0 6.1 6.0 9.5 7.9 17.7 7.9 18.2 15.9 3.9 9.2 9.7 18.2 11.9 13.3 11.9 9.8 12.8 8.0 15.0 6.3 13.7 4.8 4.5 7.7 8.4 15.0 8.6 8.1 15.4 19.3 5.0 10.6 8.6 14.2 22.2 11.8 30.0 12.5 14.9 17.7 24.6 12.7 10.4 12.9 8.1 9.1 11.7 15.7 12.2 11.0 5.5 4.9 13.0 15.3 14.8 10.3 8.4 14.1 40.1 2.5 12.4 8.8 6.7 7.9 3.5 9.8 8.3 12.0 14.6 11.3 10.8 13.5 12.6 16.6 14.8 1.7 16.2 9.4 10.3 8.2 8.7 11.8 11.2 19.4 11.8 11.3 12.2 13.4 8.4 13.8 10.3 17.9 17.1 9.0 12.7 11.9 5.3 8.3 2.5 10.7 7.9 5.2 2.0 17.3 24.9 8.2 11.0 6.3 5.0 0.0 6.5 20.2 10.4 14.0 8.1 16.3 10.6 0.0 11.5 2.5 6.5 3.9 7.2 6.1 16.9 1.0 7.7 5.7 6.1 13.3 4.6 22.1 8.7 6.5 8.3 7.4 18.1 12.0 12.8 5.1 13.7 7.5 NDUFA10 CI-42k ENSG00000130414 "NADH:ubiquinone oxidoreductase subunit A10" O95299 2 239892450-240025402 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059529, HPA067045, CAB070846" Approved Supported Mitochondria "Intracellular and membrane" NA NA 12000 Mitochondria "CAB070846: AB_11152346, HPA059529: AB_2684051, HPA067045: AB_2732756" "unprognostic (2.12e-2)" "unprognostic (8.94e-3)" "unprognostic (8.73e-2)" "unprognostic (2.02e-2)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (5.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.05e-1)" "prognostic favorable (2.09e-7)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.98e-1)" "unprognostic (2.95e-1)" 19.0 37.5 19.7 18.2 30.4 20.3 19.5 26.2 31.5 14.5 31.0 24.5 18.6 30.4 14.8 18.4 28.5 18.8 17.1 66.0 28.6 18.7 36.3 40.6 13.1 13.8 21.4 27.7 19.8 23.5 25.1 15.5 15.9 33.4 13.7 34.7 16.2 20.6 26.7 67.0 26.1 24.3 18.6 27.0 13.8 24.9 15.4 19.8 13.2 16.9 34.1 20.2 19.3 17.7 24.6 35.7 11.0 27.7 21.2 24.6 24.5 16.9 16.6 12.4 20.8 15.0 25.0 20.3 14.4 18.6 20.8 20.9 16.6 21.2 12.6 6.7 16.0 15.5 22.8 27.9 25.8 26.7 16.7 18.5 16.5 15.7 35.5 22.6 22.5 13.4 24.2 21.1 16.6 22.7 18.1 26.3 20.4 25.0 8.9 22.2 25.9 21.3 23.2 14.6 26.3 18.1 21.8 27.6 22.0 29.5 33.3 19.6 12.9 14.2 32.2 22.5 9.4 29.9 22.9 16.4 14.8 15.1 18.8 16.0 15.3 6.8 20.1 16.1 20.6 17.7 6.3 26.1 11.0 18.9 27.7 24.6 24.6 19.1 20.5 35.7 18.3 19.0 19.0 5.8 21.2 23.4 12.7 22.0 24.5 19.7 30.4 26.2 31.5 28.6 18.7 21.4 27.7 33.4 19.8 71.5 71.5 70.9 81.5 93.2 72.1 304.5 79.0 77.6 80.8 73.3 58.9 175.7 263.6 95.5 40.3 66.1 150.4 0.0 68.2 97.5 68.1 53.9 64.6 119.2 111.3 47.7 89.3 62.6 83.6 48.6 46.3 74.1 106.3 115.4 134.7 70.1 74.8 106.6 46.3 181.4 103.3 64.7 75.1 53.2 69.0 104.0 182.4 62.3 201.1 84.3 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003770 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Group enriched" "Detected in all" 5 "Cardiomyocytes: 2083.1;Distal tubular cells: 525.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 24.0 24.8 36.0 17.9 36.8 19.7 19.7 27.2 36.5 17.9 35.5 12.5 20.0 27.4 17.0 21.9 23.3 19.4 14.4 82.8 31.2 32.0 33.2 34.6 18.1 20.1 37.0 29.9 17.0 18.4 22.3 22.4 21.1 31.3 19.1 35.7 13.1 18.7 20.7 129.0 17.4 26.7 24.0 24.2 23.9 20.9 14.2 23.5 21.0 27.9 40.0 28.1 21.9 21.4 60.8 78.4 69.7 67.9 59.1 93.8 100.6 41.6 45.3 37.9 26.9 31.1 29.0 28.2 19.9 29.3 43.5 39.5 55.9 21.5 47.9 11.8 30.4 24.1 31.5 38.9 45.9 49.4 41.3 46.7 40.1 37.8 56.3 32.0 56.8 49.0 31.1 58.0 36.4 44.7 45.5 35.6 41.7 37.4 22.3 42.1 60.4 39.3 87.8 28.7 51.2 78.9 30.1 32.8 54.6 42.6 62.6 36.1 21.9 33.7 49.2 25.8 34.2 48.6 37.4 40.6 23.1 23.5 33.5 33.8 36.4 54.0 73.1 13.9 47.6 35.2 69.7 59.5 29.8 52.1 67.9 48.2 60.8 71.6 62.5 78.4 50.7 93.8 68.6 8.6 59.1 63.3 48.0 74.8 100.6 36.0 36.8 27.2 36.5 31.2 32.0 37.0 29.9 31.3 23.5 68.5 58.6 79.6 121.2 96.5 65.8 2083.1 160.5 77.6 45.5 102.9 60.9 215.5 525.6 141.2 192.8 157.8 177.2 46.7 143.2 214.5 94.4 120.9 56.6 123.1 168.7 35.0 81.9 98.8 95.5 70.6 90.3 125.9 151.8 218.2 146.8 79.4 169.8 188.7 125.5 242.6 113.4 103.5 149.9 130.8 119.2 111.7 175.3 96.5 189.4 182.6 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.3;testis: 140.2" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 2344.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria NA NA Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 17.9 16.9 20.0 11.7 23.9 15.4 14.4 20.7 25.2 11.0 19.2 8.7 16.5 16.5 9.7 19.6 12.2 11.7 12.9 68.0 16.4 13.9 18.9 20.8 8.4 11.9 19.9 22.3 10.6 17.8 10.6 12.1 12.1 20.0 12.9 11.9 9.8 15.2 15.5 79.7 9.5 14.9 12.1 13.4 10.1 15.0 140.2 16.2 7.6 11.3 28.1 8.4 9.6 10.2 73.7 74.9 61.4 76.8 44.8 72.7 116.3 33.1 24.5 45.3 45.0 46.2 37.5 42.5 39.5 43.8 44.6 43.5 39.7 49.8 44.1 93.0 47.6 27.8 27.0 32.0 42.9 18.4 26.9 72.4 33.7 39.1 48.6 41.3 63.3 47.6 50.3 39.0 31.2 36.0 31.5 32.0 51.6 37.2 63.2 35.4 65.9 75.1 62.9 46.1 85.3 68.2 43.1 29.4 67.4 65.0 47.6 43.0 54.4 40.2 47.4 39.3 26.4 29.3 87.2 33.3 43.7 14.8 50.9 49.0 45.0 35.4 47.5 38.5 49.2 31.9 61.4 76.8 57.8 51.2 72.9 45.5 73.7 58.9 56.0 74.9 60.5 56.9 51.1 26.9 44.8 60.8 61.2 72.7 116.3 20.0 23.9 20.7 25.2 16.4 13.9 19.9 22.3 20.0 16.2 122.1 153.3 217.5 53.6 114.6 57.3 436.5 216.6 210.1 204.8 237.3 23.6 341.6 517.3 485.5 369.3 147.4 952.4 140.2 502.5 299.6 215.0 71.6 253.9 389.3 292.2 39.7 534.5 181.7 314.3 2344.2 142.1 234.7 249.7 531.2 516.2 105.2 438.1 641.8 121.3 667.2 59.7 90.5 183.3 59.7 92.9 111.0 416.8 195.8 508.5 65.7 NDUFA7 B14.5a ENSG00000267855 "NADH:ubiquinone oxidoreductase subunit A7" O95182 19 8308768-8321396 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 110.6" "Cell type enhanced" "Detected in many" 4 "monocytes: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA059251, HPA071866" Enhanced Supported Mitochondria NA NA Mitochondria "HPA059251: AB_2683960, HPA071866: AB_2686465" "unprognostic (6.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-1)" "unprognostic (3.85e-1)" "unprognostic (2.18e-1)" "unprognostic (5.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (3.40e-1)" "unprognostic (1.13e-3)" "unprognostic (1.81e-2)" "unprognostic (1.43e-1)" "unprognostic (1.09e-2)" "unprognostic (5.53e-2)" "unprognostic (1.29e-2)" "unprognostic (2.59e-2)" "unprognostic (9.35e-3)" 17.7 30.0 28.0 15.5 30.5 15.3 18.9 15.4 32.0 9.0 17.2 11.3 15.7 12.6 9.9 32.1 18.9 26.2 16.1 69.1 22.1 21.0 26.5 30.9 20.3 22.1 25.9 19.7 10.1 28.5 11.9 30.2 13.0 26.7 20.5 17.6 16.7 23.0 20.7 110.6 16.2 16.0 13.1 18.5 14.7 19.3 13.8 11.1 19.3 22.0 47.5 16.8 14.3 9.1 30.6 65.5 25.1 39.7 24.9 33.5 26.7 15.4 13.2 16.8 8.7 11.5 6.1 9.5 4.4 5.7 16.6 11.1 13.9 13.1 8.7 6.8 10.6 9.5 13.4 7.6 23.2 7.8 22.8 48.1 6.4 20.3 33.0 17.9 9.7 8.9 12.4 15.1 8.9 8.2 13.4 19.3 42.1 11.0 45.4 20.6 16.8 18.5 48.1 13.6 30.4 50.4 10.3 3.1 18.9 33.7 9.2 14.1 10.8 6.4 19.8 11.0 9.9 7.5 16.0 5.7 9.3 7.5 13.0 12.5 17.8 13.7 10.4 13.3 16.8 14.6 14.2 38.9 25.1 22.6 39.7 24.4 29.9 24.7 22.2 47.9 30.6 24.1 23.4 9.7 24.9 34.4 65.5 33.5 26.7 28.0 30.5 15.4 32.0 22.1 21.0 25.9 19.7 26.7 11.1 41.7 57.7 13.4 8.7 0.0 12.0 0.0 28.1 129.8 37.5 50.6 5.9 55.6 84.6 128.2 25.6 8.7 82.6 23.3 137.5 37.8 2.0 14.6 19.8 58.9 45.6 7.9 84.3 27.6 40.8 12.2 12.4 28.3 0.0 190.2 132.6 19.5 142.9 146.3 12.4 67.1 13.2 6.5 0.0 18.4 23.7 0.0 39.2 27.7 136.7 10.8 NDUFA8 "MGC793, PGIV" ENSG00000119421 "NADH:ubiquinone oxidoreductase subunit A8" P51970 9 122144058-122159819 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 105.4" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 528.1;Distal tubular cells: 520.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041510, HPA041600" Enhanced Supported Mitochondria NA NA 14000 Mitochondria "HPA041510: AB_10794379, HPA041600: AB_10796778" "unprognostic (2.90e-1)" "unprognostic (2.27e-3)" "unprognostic (3.58e-1)" "unprognostic (3.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-2)" "unprognostic (2.33e-2)" "unprognostic (6.98e-2)" "unprognostic (1.46e-2)" "unprognostic (4.12e-2)" "prognostic favorable (4.17e-6)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" 15.4 20.0 35.9 9.5 40.5 7.3 16.5 18.8 36.8 14.2 23.4 12.4 19.6 19.4 12.6 26.9 17.0 18.9 16.9 105.4 32.3 27.5 29.0 23.6 10.9 11.2 31.3 30.3 11.3 16.8 21.8 15.3 14.1 22.4 17.9 26.6 14.6 25.1 19.7 68.3 11.1 17.4 22.0 19.1 10.9 18.0 25.1 16.8 10.0 18.5 30.9 15.8 15.6 15.3 29.7 39.7 22.2 34.3 25.5 30.8 24.3 17.9 33.3 22.1 29.1 23.9 22.0 27.4 21.0 24.9 28.8 24.3 42.2 17.9 26.3 20.8 24.5 52.6 45.3 41.8 45.3 28.4 25.8 28.9 20.7 55.9 36.4 25.8 36.5 21.4 24.0 44.3 28.8 18.5 26.5 41.2 29.5 31.5 19.8 32.8 45.7 22.6 23.8 20.2 81.0 64.2 18.2 34.9 38.3 41.4 25.0 38.3 15.1 32.9 39.1 26.0 23.6 41.4 17.6 26.7 16.0 16.1 30.0 23.4 22.4 36.1 26.0 33.3 23.7 26.4 5.1 29.4 22.2 29.1 34.3 27.8 29.7 27.0 28.4 38.1 29.3 29.0 30.5 4.8 25.5 28.8 39.7 30.8 24.3 35.9 40.5 18.8 36.8 32.3 27.5 31.3 30.3 22.4 16.8 26.8 30.2 50.6 59.9 42.8 43.3 528.1 56.0 69.6 48.9 78.5 27.5 106.7 520.6 91.1 282.6 89.5 102.7 46.7 88.4 95.7 43.5 75.0 19.7 93.1 108.4 42.9 74.3 58.3 41.0 68.2 52.3 46.0 89.4 88.4 92.7 52.1 87.8 87.7 70.7 161.2 38.8 25.8 56.7 227.6 125.0 49.7 105.8 45.0 118.7 71.0 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 461.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA042268: AB_2677922, HPA073212: AB_2686581" "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favorable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.9 19.8 9.8 13.0 7.2 7.2 28.3 8.4 8.5 16.3 12.4 42.9 22.1 12.4 4.5 9.1 18.4 18.5 14.1 12.4 10.6 24.0 24.8 12.1 21.1 32.4 15.8 17.6 13.1 9.2 12.1 11.1 15.1 10.1 12.2 17.8 8.4 23.5 12.0 21.3 17.6 20.3 25.2 20.7 16.5 24.9 14.4 12.9 22.4 25.1 7.1 8.0 10.6 28.5 14.7 22.2 5.9 16.9 8.5 12.4 25.2 11.3 19.4 4.6 5.4 20.5 13.0 11.0 13.6 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 26.8 28.0 46.2 52.9 43.0 46.1 165.0 50.9 41.5 36.4 61.1 55.0 100.9 140.9 108.0 102.8 42.7 83.0 23.3 114.3 98.5 39.0 37.2 56.6 65.2 101.8 31.8 45.5 34.4 33.6 461.4 26.2 46.0 52.3 57.7 92.6 40.4 94.0 94.8 34.6 133.6 48.3 19.4 42.6 28.8 28.1 41.3 83.5 45.7 120.3 64.7 NDUFAB1 "ACP, ACP1, FASN2A, SDAP" ENSG00000004779 "NADH:ubiquinone oxidoreductase subunit AB1" O14561 16 23581002-23596356 "Predicted intracellular proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 118.2;skeletal muscle: 112.0" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 1253.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054364, HPA076020" Approved Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA054364: AB_2682463, HPA076020: " "unprognostic (3.33e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (1.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.97e-1)" "unprognostic (7.57e-2)" "unprognostic (3.89e-1)" "unprognostic (5.60e-2)" "prognostic favorable (1.94e-7)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (3.16e-1)" 21.6 25.5 29.4 14.8 28.0 15.1 20.4 21.2 37.7 13.4 31.2 11.4 16.2 30.2 13.7 15.5 19.4 16.2 17.4 118.2 24.1 25.6 32.5 38.8 12.0 15.2 27.0 21.6 10.9 29.1 21.9 18.6 15.2 23.3 16.0 26.5 15.3 24.3 19.2 112.0 12.4 25.7 18.1 15.5 14.0 20.1 11.4 11.5 14.5 15.8 54.3 16.7 13.4 12.7 39.3 61.8 17.4 49.3 25.0 39.5 43.1 28.2 20.9 26.2 23.3 18.7 20.2 36.4 21.8 16.2 22.0 18.1 18.1 23.0 46.8 35.8 15.7 27.4 23.4 45.5 25.9 17.5 26.5 52.6 25.1 37.5 88.9 19.6 46.6 20.9 18.8 36.0 16.2 17.5 20.7 27.9 42.3 52.6 23.8 23.8 42.8 36.0 70.9 68.0 42.2 48.6 49.6 29.5 63.7 20.2 25.4 36.0 28.1 24.4 44.7 40.7 30.1 36.1 39.0 21.9 20.2 21.2 19.5 29.9 30.4 44.2 52.5 22.6 37.7 22.8 15.1 43.1 17.4 31.7 49.3 34.6 39.3 37.7 35.0 55.2 34.6 35.2 36.5 8.9 25.0 38.0 61.8 39.5 43.1 29.4 28.0 21.2 37.7 24.1 25.6 27.0 21.6 23.3 11.5 92.3 83.8 96.1 105.6 108.4 80.0 1253.7 109.5 175.3 81.9 106.4 43.2 246.2 600.2 140.5 81.4 113.0 204.9 70.0 182.7 251.9 115.6 117.8 83.1 281.9 233.1 49.3 194.3 96.3 110.6 24.0 89.8 100.2 148.5 155.9 210.6 118.9 192.1 168.4 114.2 541.1 90.3 90.5 123.0 114.6 115.3 124.3 187.8 90.6 317.0 150.7 NDUFAF1 "CGI-65, CIA30" ENSG00000137806 "NADH:ubiquinone oxidoreductase complex assembly factor 1" Q9Y375 15 41387349-41402519 "Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039933, HPA040064" Supported Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA039933: AB_10795265, HPA040064: AB_10795687" "unprognostic (2.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.72e-1)" "unprognostic (2.10e-3)" "unprognostic (2.38e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.88e-5)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "prognostic favorable (3.34e-6)" "unprognostic (1.68e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-2)" "unprognostic (2.05e-1)" 11.1 22.0 15.0 6.4 14.0 3.0 9.8 13.3 17.8 7.8 7.7 12.4 5.3 8.4 8.3 10.7 9.6 7.9 7.1 29.7 13.2 13.4 21.9 27.5 7.0 8.5 14.7 14.4 7.0 7.7 11.9 9.7 7.0 13.1 8.5 8.1 8.4 8.5 9.8 38.6 6.2 7.7 10.3 13.5 7.5 8.5 14.1 12.0 6.5 9.6 15.8 9.1 8.8 5.8 14.5 19.1 25.2 16.2 13.9 15.9 8.7 9.2 6.6 8.7 9.0 20.0 20.4 9.6 17.7 14.5 15.6 13.0 12.2 5.1 10.6 24.6 15.5 11.0 15.3 11.8 11.9 14.1 19.9 13.7 15.0 13.9 7.2 17.1 16.0 10.6 22.7 11.4 12.9 13.0 13.6 11.1 19.2 22.8 11.5 22.8 8.5 12.8 13.3 7.0 16.1 11.1 10.0 11.7 21.9 23.8 15.0 10.5 8.3 9.0 20.1 6.7 11.6 16.5 30.9 11.5 12.7 5.9 19.0 14.6 9.4 20.3 16.0 14.2 25.4 12.1 25.2 13.7 16.4 9.6 16.2 9.9 14.5 11.5 12.3 12.1 12.6 13.0 10.3 12.8 13.9 12.4 19.1 15.9 8.7 15.0 14.0 13.3 17.8 13.2 13.4 14.7 14.4 13.1 12.0 11.9 8.5 15.6 13.8 4.1 14.0 56.8 12.7 16.0 5.7 21.0 11.8 32.1 54.7 26.4 36.4 11.3 11.9 0.0 27.1 30.5 15.5 11.6 6.9 25.2 26.1 6.4 6.4 6.7 14.8 5.4 15.3 14.8 10.1 26.2 6.8 19.5 18.8 2.9 15.2 56.4 17.6 25.8 9.9 67.2 17.8 6.8 42.1 10.2 8.1 13.6 NDUFAF4 "bA22L21.1, C6orf66, HRPAP20, HSPC125, My013" ENSG00000123545 "NADH:ubiquinone oxidoreductase complex assembly factor 4" Q9P032 6 96889313-96897881 "Disease related genes, Predicted intracellular proteins" Calmodulin-binding "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046560 Uncertain Supported Mitochondria NA Yes Mitochondria "HPA046560: AB_10966700" "prognostic unfavorable (1.31e-4)" "unprognostic (1.32e-1)" "unprognostic (1.09e-2)" "unprognostic (1.14e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (6.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (2.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (4.20e-3)" "unprognostic (6.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" 7.9 10.1 16.1 5.4 19.0 2.7 9.0 20.4 27.4 8.9 9.1 5.0 5.7 6.2 7.3 6.4 7.1 6.0 6.0 30.2 18.7 17.3 17.3 18.1 4.3 5.4 18.1 12.3 10.4 7.2 7.3 6.5 6.1 28.5 9.5 9.7 4.5 7.7 12.8 25.0 6.2 6.5 7.3 9.6 7.6 6.4 5.7 8.4 4.9 9.5 11.2 5.8 8.2 5.1 6.4 4.5 0.6 4.3 3.3 10.0 4.1 1.5 4.3 7.5 10.1 7.5 4.4 4.0 4.2 4.0 6.3 4.8 5.8 2.6 14.1 7.7 3.8 6.0 3.1 17.4 6.5 6.1 9.9 13.7 15.7 2.3 5.0 8.2 16.4 6.6 4.1 10.1 5.4 5.5 3.2 4.9 10.0 14.1 9.6 9.8 4.8 10.5 8.9 14.2 7.8 7.1 5.0 4.2 7.3 10.4 4.2 12.8 6.0 2.1 7.6 11.9 7.7 2.3 11.0 4.0 3.3 2.5 11.5 6.8 2.2 3.6 13.9 4.5 12.4 4.8 0.2 2.2 0.6 5.1 4.3 6.6 6.4 6.7 6.7 3.8 6.3 10.0 8.8 0.4 3.3 2.6 4.5 6.8 4.1 16.1 19.0 20.4 27.4 18.7 17.3 18.1 12.3 28.5 8.4 8.9 16.6 43.3 52.1 96.7 15.5 108.1 25.5 17.4 27.3 22.7 0.0 40.6 142.6 37.3 2.3 31.6 17.5 23.3 23.9 34.6 34.7 26.3 19.7 43.9 47.0 25.4 37.6 25.8 18.0 4.4 24.2 27.4 52.3 15.4 38.0 14.0 21.1 10.5 23.3 99.4 12.4 25.8 69.8 36.9 55.8 84.6 27.5 27.9 48.2 38.3 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 2033.2;Hepatocytes: 1436.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA063737: AB_2685109" "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favorable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.1 55.1 44.7 28.8 29.3 21.9 20.5 33.5 18.9 19.9 18.4 33.2 46.3 24.5 31.2 18.7 29.1 34.0 25.6 27.2 18.0 38.6 58.5 47.5 86.5 39.5 23.3 37.5 27.2 27.0 16.5 20.8 18.4 47.1 17.7 47.1 25.8 50.5 27.2 102.8 37.0 33.6 22.6 103.1 67.5 33.1 42.5 36.4 49.6 67.3 29.9 21.7 65.6 40.0 42.6 39.3 59.8 58.6 39.5 12.7 24.1 25.3 22.3 40.0 62.3 54.5 38.2 27.8 26.2 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 154.9 246.4 237.3 88.1 114.4 72.8 2033.2 565.6 282.4 178.6 369.9 37.3 225.4 988.2 197.4 98.7 145.0 655.0 280.4 371.9 86.0 164.5 117.3 207.1 1436.2 359.0 52.4 305.2 426.6 707.7 29.0 243.1 282.3 315.5 296.6 433.5 108.9 268.5 512.0 226.7 864.5 130.9 219.9 185.4 133.6 144.5 153.9 172.1 204.2 467.2 90.1 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051739, HPA064441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Mitochondria" No No Mitochondria "Nucleoplasm, Nuclear membrane" "HPA051739: AB_2681585, HPA064441: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favorable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.3 37.5 44.9 44.9 28.3 33.8 36.5 28.9 38.4 37.6 41.6 36.4 39.5 26.1 58.7 32.3 47.2 49.8 34.6 36.8 28.4 40.0 39.8 40.3 39.4 36.6 17.2 35.4 47.8 30.5 49.1 18.3 24.1 45.6 46.9 49.7 23.8 40.2 40.3 40.3 70.0 51.3 35.7 84.6 102.8 40.6 25.6 57.4 60.9 32.1 50.6 51.8 33.9 38.0 61.5 31.3 64.0 56.5 36.0 33.3 43.9 14.1 40.2 49.6 44.7 78.9 52.6 49.9 45.1 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 151.8 116.9 147.4 227.4 197.5 114.3 1416.5 333.7 208.8 175.1 303.6 55.0 310.4 1039.5 474.7 797.6 248.2 436.8 93.5 541.7 349.0 180.0 247.2 169.9 411.5 288.6 79.4 286.7 153.4 221.7 73.1 254.9 235.4 411.7 399.5 378.0 175.1 503.3 436.8 260.6 758.9 123.5 252.2 270.2 329.1 90.3 219.8 294.7 162.0 391.3 307.0 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favorable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 32.2 39.6 41.3 16.0 44.6 12.1 27.2 20.0 45.7 23.7 32.3 22.0 21.2 43.7 16.2 15.4 26.4 20.0 20.5 86.9 34.1 31.7 48.1 42.3 17.8 21.7 39.4 33.6 22.1 23.2 31.1 18.7 21.3 37.6 19.6 29.9 24.8 35.8 21.3 96.3 17.5 38.5 21.3 30.9 20.4 24.9 21.8 18.4 22.7 27.7 47.3 18.5 26.5 17.3 27.7 41.4 19.5 44.9 14.6 25.0 26.7 23.4 6.6 16.4 19.9 21.7 29.2 22.2 14.9 18.8 21.3 21.6 19.7 17.1 20.5 45.2 12.6 36.6 26.0 17.7 19.7 21.5 42.4 14.8 22.0 12.0 16.4 19.9 26.3 17.5 26.9 25.5 12.0 20.0 22.1 24.4 20.0 18.6 29.9 22.8 16.7 15.1 20.4 23.7 45.5 26.7 16.8 19.0 63.6 38.6 18.1 11.7 19.6 9.0 50.9 35.1 15.4 77.6 42.9 15.7 14.1 13.4 19.2 35.4 39.8 41.2 30.3 22.8 28.2 20.0 19.5 29.9 14.4 13.9 37.6 22.1 27.7 20.0 17.0 41.4 19.5 20.8 21.0 6.7 14.6 44.9 24.0 25.0 26.7 41.3 44.6 20.0 45.7 34.1 31.7 39.4 33.6 37.6 18.4 44.7 44.0 87.9 92.8 75.7 45.3 340.1 112.1 52.2 53.4 83.7 31.4 192.8 431.0 110.3 85.8 85.1 125.2 0.0 92.5 115.9 83.1 75.7 92.3 108.0 222.8 38.1 112.9 97.6 229.9 13.7 75.1 156.2 128.2 124.4 173.7 74.4 86.7 189.4 65.7 379.0 54.1 71.1 81.4 233.1 125.2 77.5 192.3 81.2 242.9 137.2 NDUFB9 "B22, LYRM3, UQOR22" ENSG00000147684 "NADH:ubiquinone oxidoreductase subunit B9" Q9Y6M9 8 124539103-124568510 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 254.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042768 Approved Supported Mitochondria NA NA Mitochondria "HPA042768: AB_10797508" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-3)" "unprognostic (8.32e-2)" "unprognostic (9.71e-2)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (3.80e-2)" "unprognostic (1.51e-1)" "unprognostic (3.64e-1)" "prognostic favorable (3.42e-5)" "unprognostic (9.54e-2)" "unprognostic (9.64e-2)" "unprognostic (4.94e-2)" "unprognostic (2.74e-1)" 26.9 20.8 61.0 19.6 45.1 43.7 33.3 26.9 63.7 20.7 40.4 15.0 25.4 35.5 17.4 30.0 27.9 19.4 23.8 125.1 44.2 39.0 50.1 52.9 23.8 38.2 60.0 49.1 16.8 51.7 20.6 16.3 15.8 46.7 20.6 37.5 13.4 39.9 24.0 221.3 18.0 26.1 31.3 44.8 15.3 28.9 44.1 31.1 13.5 27.7 80.7 19.3 16.7 16.5 53.8 52.7 52.1 54.4 37.5 71.2 64.2 28.8 26.7 20.5 27.7 21.3 18.2 17.2 14.2 16.2 25.9 19.6 35.1 27.9 28.6 36.9 16.3 13.5 32.9 29.7 22.6 24.5 33.2 40.5 69.5 19.0 42.0 28.4 21.6 19.0 21.2 32.9 23.7 51.3 14.1 23.5 20.8 42.9 24.1 20.7 90.1 34.0 43.3 20.6 104.1 59.4 23.0 15.6 39.0 34.0 24.4 28.6 22.4 30.9 254.6 30.4 12.9 35.0 29.3 18.7 15.1 39.4 14.1 33.4 31.1 41.4 32.8 26.3 43.3 19.9 52.1 54.4 27.5 48.3 37.2 47.9 53.8 64.0 53.9 52.7 42.5 63.4 52.2 11.2 37.5 27.2 39.6 71.2 64.2 61.0 45.1 26.9 63.7 44.2 39.0 60.0 49.1 46.7 31.1 116.1 101.5 163.0 206.1 193.5 71.0 877.9 259.9 172.6 153.6 272.2 92.3 413.9 678.1 287.5 321.0 148.3 490.6 46.7 353.1 228.0 195.3 239.3 136.2 450.4 353.4 35.0 224.5 179.2 208.1 585.5 147.0 181.9 234.5 201.0 282.2 86.2 298.7 372.2 143.5 593.2 52.3 168.1 258.4 306.2 277.3 164.6 437.4 148.2 397.6 262.6 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068304-78080219 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favorable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 55.0 70.8 40.8 23.3 44.4 32.3 46.2 51.4 58.4 22.5 41.1 31.2 68.0 63.4 31.8 32.8 41.8 35.6 31.9 60.4 41.0 44.5 37.5 89.6 30.1 36.4 43.2 47.0 27.3 48.4 25.3 34.7 31.8 40.8 27.3 20.3 29.7 79.5 59.0 122.8 29.0 55.3 23.7 41.1 24.5 36.6 28.6 23.2 26.9 63.5 43.7 23.3 31.9 24.1 50.3 78.2 70.3 73.2 44.5 46.3 81.2 36.0 45.0 24.5 15.4 23.3 14.7 30.2 44.1 26.5 35.1 25.0 120.6 40.5 21.6 80.9 20.8 28.7 38.1 18.4 25.9 13.4 40.9 52.1 23.2 46.7 94.9 39.8 50.7 23.1 20.4 24.1 26.9 10.2 21.6 23.8 23.2 45.7 36.5 19.6 62.1 33.1 91.4 27.6 88.8 56.9 29.0 46.6 73.1 26.5 54.3 34.6 30.7 31.4 64.8 22.7 22.3 51.3 42.1 31.1 34.2 42.2 81.4 37.8 33.6 65.8 49.7 19.5 30.5 32.7 65.8 73.2 70.3 39.4 58.2 36.2 50.3 45.6 41.5 77.2 45.5 39.6 41.3 21.0 44.5 48.0 78.2 46.3 81.2 40.8 44.4 51.4 58.4 41.0 44.5 43.2 47.0 40.8 23.2 154.9 160.2 100.4 139.2 84.8 134.1 213.8 247.1 202.1 144.5 371.6 62.8 347.5 258.6 334.7 231.4 158.7 177.9 70.0 374.9 317.5 154.4 190.2 148.0 738.1 305.1 85.8 161.2 184.1 179.8 53.3 199.6 133.3 232.8 193.8 274.2 214.0 379.3 301.9 189.5 354.7 91.8 232.8 163.6 380.6 170.3 100.0 323.7 113.3 343.3 186.0 NDUFC2-KCTD14 ENSG00000259112 "NDUFC2-KCTD14 readthrough" E9PQ53 11 78016971-78079865 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Alveolar cells type 2: 1.3;Ciliated cells: 2.7;Club cells: 2.3;Melanocytes: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 10.4;EFO-21: 8.5;RPMI-8226: 7.5;U-2 OS: 13.0" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" 7.1 11.3 6.3 5.8 7.9 9.7 8.9 13.8 11.7 9.6 7.4 5.5 13.8 27.3 8.8 5.9 9.5 9.7 5.6 11.3 7.7 7.1 6.9 18.7 6.6 6.7 6.4 9.1 6.6 8.8 5.4 5.6 5.6 7.7 8.4 6.3 5.1 18.0 11.8 10.1 5.7 10.6 5.9 5.9 5.9 15.9 4.9 3.7 4.5 12.7 8.3 4.8 4.6 6.1 30.7 37.7 30.7 33.7 16.5 33.2 39.7 0.0 2.1 0.6 0.6 0.6 0.0 1.4 1.5 0.9 1.3 2.9 10.4 1.2 0.2 8.5 0.0 1.8 0.3 1.7 0.0 0.7 5.9 0.0 1.2 0.0 0.0 0.7 0.8 2.1 0.0 0.3 0.3 1.8 1.8 0.9 6.4 0.3 0.1 0.2 0.0 3.0 1.1 5.2 1.0 0.3 1.0 0.1 7.5 0.0 0.0 1.5 2.3 0.0 1.1 3.3 0.0 0.6 1.1 0.9 0.5 13.0 4.2 0.0 1.2 1.4 3.0 0.8 0.3 1.4 22.5 33.7 30.7 24.5 24.1 19.3 30.7 22.8 23.0 37.7 23.7 20.5 21.5 10.0 16.5 25.7 37.5 33.2 39.7 6.3 7.9 13.8 11.7 7.7 7.1 6.4 9.1 7.7 3.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 NDUFS1 CI-75k ENSG00000023228 "NADH:ubiquinone oxidoreductase core subunit S1" P28331 2 206114817-206159603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.5" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 534.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064605, CAB070844" Enhanced Supported Mitochondria NA NA Mitochondria "CAB070844: , HPA064605: AB_2685297" "prognostic unfavorable (3.85e-4)" "unprognostic (1.76e-1)" "unprognostic (9.22e-3)" "unprognostic (5.01e-2)" "unprognostic (8.63e-3)" "unprognostic (3.75e-1)" "unprognostic (3.72e-2)" "unprognostic (6.18e-2)" "unprognostic (2.30e-2)" "unprognostic (3.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.47e-12)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" "unprognostic (4.73e-2)" 13.9 29.0 12.1 8.3 22.1 7.6 10.3 11.6 26.4 9.1 17.4 16.4 9.2 18.3 9.1 7.7 15.7 7.7 7.3 62.6 11.3 11.7 29.5 30.7 8.3 7.7 13.3 13.8 8.2 9.3 22.1 11.6 10.8 24.2 10.7 18.9 13.5 12.8 10.9 99.5 11.0 19.9 11.1 10.8 8.4 14.9 8.8 11.1 11.2 10.8 34.7 10.5 11.6 9.4 10.7 15.3 15.7 21.4 12.5 16.1 8.9 12.9 12.9 18.8 13.6 17.6 14.3 21.9 19.1 20.6 31.9 23.2 33.5 15.2 14.7 16.9 23.8 31.7 18.2 25.1 18.5 28.4 6.7 11.8 29.3 32.1 30.0 18.3 21.1 13.3 17.4 10.9 25.0 19.7 14.3 24.8 18.6 31.7 14.9 20.7 16.2 17.4 14.0 17.4 21.9 23.1 17.6 26.3 25.4 26.4 23.7 18.4 14.4 22.0 21.6 31.2 26.9 19.0 20.5 18.9 17.6 15.7 17.2 18.1 14.4 17.3 21.9 17.6 17.5 17.9 12.0 13.3 15.7 13.6 15.4 10.8 10.7 12.2 13.0 15.3 9.5 10.9 12.4 9.6 12.5 21.4 8.2 16.1 8.9 12.1 22.1 11.6 26.4 11.3 11.7 13.3 13.8 24.2 11.1 56.6 24.1 13.7 19.6 14.3 94.7 534.9 63.7 60.2 35.2 36.6 113.9 40.2 79.6 36.7 9.9 33.7 63.8 0.0 24.5 26.7 24.7 17.4 35.9 83.9 29.8 111.2 49.0 33.7 34.6 5.2 31.1 25.2 28.7 27.1 47.3 60.7 29.2 35.1 42.1 80.9 78.2 32.3 27.8 28.6 37.3 14.4 43.8 18.7 52.8 23.9 NDUFS2 CI-49 ENSG00000158864 "NADH:ubiquinone oxidoreductase core subunit S2" O75306 1 161197104-161214395 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 104.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055140, HPA061953" Enhanced Supported Mitochondria NA NA 16000 Mitochondria "HPA055140: AB_2682713, HPA061953: AB_2684646" "unprognostic (2.13e-2)" "unprognostic (2.24e-2)" "unprognostic (8.47e-2)" "unprognostic (7.78e-2)" "unprognostic (9.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-2)" "unprognostic (1.51e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (3.17e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.32e-4)" "unprognostic (2.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (1.82e-1)" 14.6 30.7 16.6 8.0 25.4 10.2 15.5 23.4 25.4 13.0 25.6 17.9 11.7 23.6 12.3 11.2 16.7 14.5 10.6 75.4 17.6 14.8 37.4 52.6 12.8 9.2 28.0 25.0 14.1 14.3 25.6 10.7 11.5 24.1 12.7 27.2 11.4 14.6 14.5 104.9 14.0 22.1 15.7 16.1 13.0 19.4 8.8 25.3 10.4 12.3 37.1 15.1 13.2 10.5 18.9 47.3 26.6 42.2 20.3 29.2 32.4 17.2 27.8 17.6 20.4 25.9 23.0 15.2 15.7 23.1 31.1 24.5 30.5 18.0 22.0 29.6 24.2 17.1 23.2 28.1 28.1 27.5 14.6 23.6 21.4 20.9 26.6 26.9 23.2 19.9 33.1 24.8 25.1 28.7 20.6 35.5 23.0 27.4 12.0 29.2 19.9 14.7 12.4 32.1 60.6 25.7 12.7 18.2 30.9 36.9 20.7 18.7 27.8 19.0 46.9 26.8 26.3 42.1 60.8 22.7 15.1 12.9 10.6 21.2 16.9 26.7 18.4 23.1 19.6 19.4 26.6 35.9 18.9 20.5 42.2 19.9 18.9 20.9 20.7 47.3 15.7 21.6 21.8 20.2 20.3 37.0 31.8 29.2 32.4 16.6 25.4 23.4 25.4 17.6 14.8 28.0 25.0 24.1 25.3 32.8 43.7 52.8 39.4 34.6 72.7 193.6 76.5 68.3 35.2 73.3 29.5 125.8 281.8 158.0 7.1 61.2 199.4 23.3 126.2 94.3 73.7 24.9 68.1 177.0 131.6 87.4 69.2 58.9 83.7 4.7 40.3 64.2 79.2 127.2 94.1 51.2 124.2 89.2 31.5 226.7 49.8 45.3 68.0 36.7 32.1 37.9 132.5 50.1 138.8 41.7 NDUFS3 CI-30 ENSG00000213619 "NADH:ubiquinone oxidoreductase core subunit S3" O75489 11 47565336-47584562 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004484, CAB034894" Enhanced Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "CAB034894: AB_2151118, HPA004484: AB_1079464" "unprognostic (2.18e-1)" "unprognostic (7.42e-3)" "unprognostic (1.75e-1)" "unprognostic (5.01e-2)" "unprognostic (7.51e-2)" "unprognostic (3.13e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.41e-2)" "unprognostic (6.75e-3)" "unprognostic (7.73e-2)" "prognostic favorable (2.61e-6)" "unprognostic (2.77e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (3.17e-3)" 13.4 22.9 29.7 13.2 46.3 25.5 18.1 23.9 35.0 16.6 28.4 16.5 16.1 31.4 12.7 16.0 19.1 17.3 16.3 45.8 26.0 24.8 34.1 32.0 12.0 13.9 29.4 24.9 12.2 23.0 21.4 17.0 12.0 26.0 13.9 30.9 14.4 20.1 17.4 100.9 15.1 28.9 15.9 17.1 14.2 18.9 15.1 15.4 20.5 16.1 51.6 18.8 14.5 11.7 25.0 36.1 18.7 31.2 16.4 23.8 31.5 11.5 22.0 18.6 19.4 16.1 16.7 15.9 11.0 18.8 27.2 25.9 32.3 20.4 25.8 11.0 15.7 19.3 21.4 26.3 19.8 22.2 13.8 42.5 15.6 30.9 31.2 16.6 38.1 20.3 16.3 14.3 10.3 17.0 11.6 17.1 21.3 22.7 17.8 17.6 35.4 26.1 49.4 26.4 32.0 31.2 31.8 26.9 21.2 23.3 18.1 20.9 15.1 14.1 24.2 24.9 11.6 27.0 36.4 11.9 16.3 18.3 18.9 24.8 20.5 27.1 28.5 16.5 29.3 16.1 12.2 28.6 18.7 18.7 31.2 19.8 25.0 19.7 20.3 33.7 23.1 18.8 20.1 7.5 16.4 25.0 36.1 23.8 31.5 29.7 46.3 23.9 35.0 26.0 24.8 29.4 24.9 26.0 15.4 50.6 35.2 47.4 60.2 58.3 41.3 154.2 96.8 75.0 45.5 66.3 39.3 103.3 343.2 99.0 93.6 59.9 204.6 23.3 97.2 97.6 64.9 43.1 56.6 108.3 166.7 57.2 81.3 52.8 54.3 46.0 62.5 73.9 113.1 83.8 120.8 100.0 80.5 103.7 65.0 231.7 51.0 103.5 79.3 76.9 75.2 66.4 74.5 62.9 167.5 58.5 NDUFS4 "AQDQ, CI-18" ENSG00000164258 "NADH:ubiquinone oxidoreductase subunit S4" O43181 5 53560633-53683340 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 469.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003884 Supported Supported Mitochondria NA NA Mitochondria "HPA003884: AB_1079465" "unprognostic (1.25e-1)" "unprognostic (3.61e-3)" "unprognostic (3.44e-2)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (6.73e-3)" "unprognostic (6.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.93e-1)" "unprognostic (4.38e-1)" "unprognostic (1.72e-2)" "unprognostic (3.11e-1)" "prognostic favorable (3.85e-6)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" 27.5 26.5 29.8 15.7 35.7 14.3 34.0 23.3 35.3 20.8 30.0 12.9 21.3 27.6 24.0 24.2 27.0 22.9 20.9 65.1 24.4 23.2 45.3 48.1 18.7 14.9 28.5 34.4 35.7 19.5 22.2 24.9 20.7 26.7 22.9 30.5 16.4 24.4 26.3 105.5 23.0 25.5 34.3 27.0 13.6 24.1 20.9 24.6 12.9 25.1 67.3 19.3 21.7 22.4 24.3 41.0 6.7 32.8 24.5 25.2 21.9 30.0 26.7 53.2 31.4 36.3 52.8 44.7 36.6 35.7 40.7 49.9 32.5 39.6 21.4 48.2 31.2 39.1 22.2 18.8 43.6 47.1 19.7 35.9 14.7 26.5 29.2 38.7 35.3 25.5 43.7 50.5 28.0 49.5 45.0 35.3 24.3 12.5 23.4 37.1 28.1 26.6 29.7 16.1 11.5 30.2 32.1 30.0 42.1 43.3 29.0 24.5 26.6 25.1 24.4 43.0 29.7 39.1 37.2 27.0 25.0 26.7 18.1 47.7 18.0 22.4 25.8 26.7 51.9 36.0 6.7 28.9 2.4 17.5 32.8 19.5 24.3 22.2 20.2 41.0 16.5 25.1 25.2 2.4 24.5 32.4 31.0 23.5 21.9 29.8 35.7 23.3 35.3 24.4 23.2 28.5 34.4 26.7 24.6 35.7 44.6 76.7 128.0 111.7 41.6 329.5 76.5 76.3 71.7 80.3 39.3 136.6 469.2 144.1 42.2 91.5 124.0 0.0 145.6 142.3 128.2 89.3 73.9 126.2 125.7 28.6 86.8 73.6 66.4 51.2 145.9 104.9 111.3 170.5 117.4 77.9 141.9 140.3 143.5 309.1 67.6 122.9 122.6 70.4 45.1 88.7 150.5 58.9 149.5 126.8 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67606852-67612535 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 150.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Enhanced Supported Mitochondria,Cytosol No No Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: AB_2686732" "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favorable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 23.3 28.9 27.3 20.7 33.9 20.3 18.9 32.9 48.8 18.5 33.0 23.1 19.2 40.6 19.4 21.5 25.5 22.5 23.4 93.0 26.5 24.1 39.0 41.5 15.9 20.6 31.5 40.5 24.6 38.3 49.2 18.8 15.7 34.8 16.1 25.1 17.6 27.3 27.0 150.8 28.4 30.3 22.7 23.1 21.5 28.2 30.2 24.3 18.3 23.4 67.9 20.3 18.7 18.6 23.8 41.2 13.5 30.7 36.2 28.2 24.3 25.9 27.9 14.2 28.5 17.8 17.9 26.6 16.2 15.6 25.4 17.0 52.8 31.5 48.0 34.2 13.9 20.7 35.0 30.0 25.3 8.0 24.4 23.7 19.6 37.9 26.0 25.2 26.7 22.0 26.5 24.6 20.6 18.5 16.1 22.5 35.2 35.7 39.3 15.4 39.0 31.2 52.9 13.9 59.1 35.2 36.3 27.6 77.9 20.6 19.5 22.7 21.4 20.5 71.8 54.1 9.9 36.4 27.2 17.8 24.7 18.4 35.1 17.0 38.4 21.8 23.9 28.7 28.3 23.7 12.6 26.7 13.5 25.9 30.7 28.2 23.2 21.7 24.5 41.2 23.8 20.2 25.1 4.8 36.2 17.4 26.5 27.8 24.3 27.3 33.9 32.9 48.8 26.5 24.1 31.5 40.5 34.8 24.3 56.6 80.9 64.0 70.8 71.3 67.0 408.9 66.2 72.3 67.1 82.0 47.1 180.6 336.5 96.7 57.0 53.7 205.0 23.3 97.8 127.6 79.5 47.7 59.0 122.2 121.6 60.4 94.7 53.4 67.1 159.3 60.7 67.5 108.0 83.8 141.7 63.1 68.4 126.7 55.5 398.9 60.4 45.3 98.9 77.2 78.1 70.4 158.1 71.2 225.4 78.9 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "HPA003404: AB_1079466, HPA077896: AB_2686866" "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 20.0 34.5 25.2 18.0 23.7 31.1 25.6 20.6 37.3 15.6 26.1 13.1 20.3 23.1 14.7 21.5 27.5 13.9 17.6 82.6 22.7 23.8 40.7 89.1 17.2 29.9 26.7 19.4 11.2 36.3 14.9 14.9 21.6 26.2 20.8 27.8 17.8 20.1 20.2 122.6 17.4 24.4 23.5 20.8 19.3 25.2 19.0 12.7 20.5 20.5 59.5 22.7 20.4 14.1 55.6 74.7 49.3 45.1 27.0 53.5 48.1 18.6 19.6 22.7 21.1 16.8 24.0 19.2 23.5 37.4 31.1 29.6 36.6 15.4 28.8 21.6 22.0 28.7 9.5 22.0 24.4 29.8 14.5 19.4 18.4 20.2 49.3 19.4 51.2 22.9 20.1 20.5 19.2 20.8 22.5 33.5 26.0 29.3 91.0 28.5 23.4 35.7 44.9 18.9 103.3 24.4 17.0 16.8 109.2 49.6 30.3 23.8 17.7 23.2 26.5 29.5 16.9 24.8 39.0 20.5 39.7 28.2 28.4 30.5 26.3 39.0 32.2 28.3 22.7 25.6 49.3 39.9 44.1 30.2 45.1 37.6 55.6 45.5 35.7 56.6 43.6 40.0 36.9 18.0 27.0 41.6 74.7 53.5 48.1 25.2 23.7 20.6 37.3 22.7 23.8 26.7 19.4 26.2 12.7 74.5 120.4 122.8 254.8 131.4 96.8 61.3 175.8 207.5 127.4 143.1 82.5 309.8 742.8 337.2 214.8 108.5 232.3 46.7 461.4 265.4 107.6 372.3 115.7 324.6 267.7 89.0 102.4 92.7 98.1 135.7 113.1 187.8 219.4 393.1 177.0 104.6 465.3 175.4 95.8 576.3 143.4 103.5 138.2 182.6 170.4 129.0 242.0 118.9 207.0 348.6 NIPSNAP2 GBAS ENSG00000146729 "Nipsnap homolog 2" O75323 7 55951793-56000181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 97.3;skeletal muscle: 144.4" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 161.9;Distal tubular cells: 192.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 80.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063084 Enhanced Supported Mitochondria NA NA Mitochondria "HPA063084: AB_2684938" "unprognostic (6.88e-2)" "unprognostic (6.53e-3)" "unprognostic (8.20e-3)" "unprognostic (4.95e-2)" "unprognostic (5.79e-2)" "unprognostic (1.53e-3)" "unprognostic (5.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (6.38e-3)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "prognostic favorable (3.02e-8)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (6.65e-3)" "unprognostic (3.59e-1)" 14.5 19.3 18.4 8.4 22.9 8.6 16.6 11.8 24.5 12.6 14.6 8.9 11.8 8.1 11.0 11.1 12.9 13.4 8.0 97.3 18.7 15.9 16.6 5.2 13.2 16.6 17.0 16.7 9.5 13.5 11.8 8.6 8.0 17.2 14.3 14.2 6.8 18.9 15.5 144.4 6.3 8.3 21.6 19.3 6.5 11.6 5.8 12.1 7.4 22.6 39.8 7.2 12.4 7.8 14.3 34.1 14.1 33.1 15.2 14.1 24.7 80.6 14.3 18.9 31.4 10.9 19.1 9.3 6.8 16.1 19.7 15.2 9.9 17.9 11.8 11.4 12.7 19.1 10.8 14.2 14.4 19.6 7.5 20.9 8.4 8.5 12.6 15.7 18.1 8.5 17.3 22.1 6.7 18.3 22.4 20.7 17.2 14.9 11.7 15.2 3.5 18.0 18.8 18.5 18.0 14.5 18.3 8.8 24.3 26.5 12.7 20.2 22.8 15.5 18.7 21.0 15.6 36.2 19.6 12.0 9.0 13.6 3.1 14.0 9.6 8.1 21.9 9.9 11.4 26.5 13.4 33.1 14.1 8.7 31.8 10.6 14.3 11.7 9.3 34.1 12.3 14.1 10.1 5.8 15.2 23.9 14.1 13.6 24.7 18.4 22.9 11.8 24.5 18.7 15.9 17.0 16.7 17.2 12.1 47.6 42.3 0.0 0.0 0.0 0.0 0.0 0.0 161.9 79.6 59.3 0.0 65.3 192.3 62.3 0.0 0.0 0.0 0.0 50.1 44.3 0.0 0.0 15.1 0.0 79.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 69.5 0.0 0.0 39.8 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 43.0 0.0 0.0 0.0 NLRX1 "CLR11.3, NOD9" ENSG00000160703 "NLR family member X1" Q86UT6 11 119166568-119184016 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 14.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061516 Supported Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA 35000 Mitochondria "Plasma membrane, Cell Junctions" "HPA061516: AB_2684548" "unprognostic (7.58e-2)" "unprognostic (3.71e-1)" "unprognostic (6.36e-2)" "prognostic favorable (2.47e-5)" "unprognostic (5.60e-3)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (8.80e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-1)" "unprognostic (3.29e-1)" "prognostic favorable (2.59e-6)" "unprognostic (3.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (4.22e-2)" 4.8 6.1 1.9 3.3 3.7 3.6 3.6 2.5 4.9 8.9 5.1 2.9 8.0 2.9 5.6 5.3 34.9 6.7 4.9 8.7 2.9 1.6 4.3 4.4 3.4 3.4 1.8 2.7 2.9 6.2 5.6 2.5 3.3 3.0 4.4 2.0 5.4 5.6 4.8 14.3 11.6 3.2 4.6 2.4 4.5 4.0 3.2 1.3 3.8 4.3 38.9 37.5 5.3 8.5 0.6 2.0 14.3 3.3 1.3 1.3 1.9 4.1 12.2 1.3 9.7 4.2 4.8 1.9 5.5 6.4 2.8 4.8 0.7 10.2 7.4 16.9 7.0 4.1 10.3 3.7 3.1 0.9 9.5 4.0 9.7 4.2 6.6 6.4 3.4 5.7 5.4 13.2 3.6 7.0 5.6 5.6 9.9 0.1 4.9 2.8 10.9 5.7 8.2 6.0 5.3 6.8 11.2 1.7 2.4 6.6 5.3 1.8 6.4 8.1 4.3 3.5 2.0 14.0 10.1 6.5 5.5 4.9 4.9 2.8 1.8 1.9 2.5 0.8 10.4 3.9 2.8 3.3 14.3 0.9 1.5 1.0 0.6 0.8 1.3 2.0 0.4 1.0 1.1 8.1 1.3 1.3 0.9 1.3 1.9 1.9 3.7 2.5 4.9 2.9 1.6 1.8 2.7 3.0 1.3 0.0 6.4 1.7 1.6 2.3 1.2 10.8 5.1 6.7 2.3 7.0 2.0 3.0 1.7 6.0 1.5 3.0 4.2 0.0 3.4 1.7 2.5 1.8 0.0 9.6 5.7 0.0 2.4 4.3 5.3 2.7 1.1 1.9 1.7 5.4 4.1 5.6 5.1 7.0 1.1 4.3 3.2 0.0 2.1 1.9 1.9 4.1 0.5 0.5 4.5 0.9 NME4 "NDPKD, nm23-H4, NM23H4" ENSG00000103202 "NME/NM23 nucleoside diphosphate kinase 4" O00746 16 396725-410367 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid transport, Nucleotide metabolism, Transport" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 212.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045997, HPA072588" Approved Supported Mitochondria Yes No Mitochondria "CAB045997: AB_11126630, HPA072588: AB_2686538" "unprognostic (3.27e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (3.70e-2)" "unprognostic (7.16e-3)" "unprognostic (1.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (4.46e-3)" "unprognostic (1.98e-1)" "unprognostic (3.12e-1)" "unprognostic (3.74e-2)" "unprognostic (7.79e-3)" "prognostic unfavorable (1.61e-7)" "unprognostic (3.78e-2)" "unprognostic (2.16e-1)" "unprognostic (6.04e-2)" "unprognostic (3.08e-1)" 34.5 34.4 21.5 13.9 17.6 46.8 34.6 10.4 13.6 25.6 44.6 12.8 40.7 9.7 21.7 33.7 25.1 20.0 39.9 26.9 16.6 16.5 20.2 61.2 13.5 27.5 16.9 11.3 31.9 19.2 22.0 17.3 19.4 11.7 46.9 10.6 32.2 44.4 44.0 13.7 7.5 15.3 83.9 12.4 17.8 27.1 13.3 10.9 19.6 21.0 14.2 14.5 64.1 27.5 13.1 28.6 18.2 6.3 1.2 13.7 5.2 0.1 50.4 44.8 61.6 18.0 31.6 10.0 23.7 28.6 35.9 30.9 33.6 29.3 0.5 17.9 37.8 13.0 0.6 24.2 25.5 10.6 20.3 36.2 24.4 6.9 44.9 34.0 17.8 9.0 40.6 13.4 22.0 2.1 25.9 23.0 35.1 25.3 4.3 26.7 41.3 15.5 22.4 45.7 12.3 11.2 78.4 10.0 12.7 24.9 0.2 13.1 71.0 6.0 0.4 22.1 17.2 30.0 41.8 28.7 25.7 37.4 17.1 5.9 0.5 0.3 13.3 11.2 3.2 29.6 4.1 6.3 18.2 7.5 5.6 6.5 12.3 7.7 8.3 8.7 13.1 13.7 7.1 2.2 1.2 4.8 28.6 0.4 5.2 21.5 17.6 10.4 13.6 16.6 16.5 16.9 11.3 11.7 10.9 0.0 11.5 29.0 48.4 28.6 13.9 34.0 35.7 4.0 4.5 55.8 2.0 59.9 212.2 109.2 3.5 43.9 11.0 186.9 35.0 20.4 74.3 109.3 29.9 119.9 107.7 7.9 43.4 47.9 41.0 14.6 82.6 23.2 59.1 66.7 34.5 18.6 75.4 17.3 89.1 59.0 5.4 51.8 95.1 1.4 43.5 21.5 18.2 14.9 56.3 48.5 NMNAT3 PNAT3 ENSG00000163864 "Nicotinamide nucleotide adenylyltransferase 3" Q96T66 3 139560180-139678017 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 527.0;Alveolar cells type 2: 437.0;Ciliated cells: 459.0;Club cells: 396.9;granulocytes: 256.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039077, HPA057402" Approved Supported Mitochondria NA NA Mitochondria "HPA039077: AB_2676336, HPA057402: AB_2683427" "unprognostic (9.45e-3)" "prognostic favorable (9.67e-4)" "unprognostic (2.29e-1)" "unprognostic (1.56e-3)" "unprognostic (2.33e-2)" "unprognostic (2.33e-1)" "unprognostic (2.77e-3)" "unprognostic (6.22e-2)" "unprognostic (9.69e-2)" "unprognostic (1.92e-1)" "prognostic favorable (7.29e-5)" "unprognostic (4.57e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.13e-2)" "unprognostic (1.63e-1)" "unprognostic (1.44e-1)" "unprognostic (3.07e-1)" 6.2 6.3 9.9 7.0 9.8 14.1 10.8 7.7 9.8 7.4 7.4 6.8 2.7 7.8 7.9 7.3 6.5 11.6 7.9 12.6 11.9 8.1 7.9 6.2 4.7 3.6 7.7 14.0 17.9 10.0 6.2 6.6 1.8 6.7 7.6 6.4 12.7 7.5 4.8 21.9 14.9 6.5 7.3 7.0 4.2 4.8 16.8 8.4 2.4 8.3 9.0 4.8 6.3 6.8 7.2 4.2 11.9 5.0 6.1 5.1 2.1 6.8 3.0 3.3 3.7 0.8 0.7 4.4 2.9 0.4 0.5 0.4 3.9 5.2 4.8 8.8 0.6 3.3 3.5 2.3 1.0 0.7 4.4 3.9 22.3 6.3 5.0 1.8 4.2 4.3 1.2 5.8 0.9 1.4 7.0 0.5 2.9 3.9 10.6 0.5 4.7 4.0 3.7 7.5 12.0 2.9 3.5 3.7 3.2 1.0 5.2 7.2 4.4 6.9 3.8 2.5 6.5 9.5 11.2 3.9 4.7 10.4 5.6 4.3 17.6 8.3 3.4 3.2 6.7 4.3 11.9 5.0 3.0 4.1 4.5 3.0 3.6 3.6 3.4 3.6 7.2 5.1 5.1 10.8 6.1 4.4 4.2 2.2 2.1 9.9 9.8 7.7 9.8 11.9 8.1 7.7 14.0 6.7 8.4 527.0 437.0 3.0 5.2 3.7 2.5 7.5 2.5 459.0 396.9 8.7 3.9 0.3 10.0 2.6 101.2 2.3 2.0 0.0 2.7 0.3 4.7 3.7 256.9 2.1 1.9 1.6 6.4 3.1 2.6 164.7 7.2 4.0 6.8 0.0 5.5 7.8 0.7 3.5 6.0 12.0 18.2 6.5 1.2 39.2 2.6 8.4 0.1 0.0 11.4 3.8 NOA1 "C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3" ENSG00000084092 "Nitric oxide associated 1" Q8NC60 4 56963370-56978823 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 22.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035838, HPA035839" Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA035838: AB_10669531, HPA035839: AB_10669658" "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (1.65e-3)" "unprognostic (5.19e-2)" "unprognostic (9.06e-2)" "unprognostic (1.49e-2)" "unprognostic (2.04e-2)" "unprognostic (1.29e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.33e-1)" "prognostic favorable (2.38e-4)" "unprognostic (8.97e-2)" "unprognostic (6.87e-2)" "unprognostic (1.79e-2)" "unprognostic (4.27e-2)" 4.5 4.7 2.6 3.0 3.2 5.4 5.3 4.3 2.8 4.3 5.3 7.0 5.9 3.8 6.1 6.0 2.9 3.5 2.5 2.1 3.6 2.8 3.3 5.1 2.1 5.6 13.9 3.6 2.1 2.3 3.8 4.9 5.9 3.7 10.5 6.8 4.9 3.2 2.6 3.8 6.0 1.7 4.0 5.8 6.7 4.5 20.2 16.5 7.0 14.1 20.3 22.3 14.3 7.5 7.0 5.2 9.2 9.6 17.2 14.3 6.0 10.8 6.9 7.0 12.0 14.2 27.1 10.4 5.0 5.7 8.1 9.8 10.6 6.6 5.0 12.7 6.8 6.2 13.0 7.5 12.3 7.4 15.9 12.9 6.4 11.2 14.7 11.5 11.9 11.4 9.8 9.3 10.9 17.6 16.5 6.8 14.5 10.8 12.3 5.6 10.2 9.9 11.3 12.0 10.2 6.1 25.0 8.9 6.9 11.2 8.8 7.5 5.6 13.4 6.7 11.1 12.6 5.2 14.1 5.7 7.9 7.1 6.2 14.1 7.0 12.2 13.0 18.3 20.2 18.2 15.2 16.5 17.0 22.3 18.4 4.8 20.3 11.2 13.3 21.1 14.3 3.0 4.3 15.3 14.0 22.6 6.3 12.0 12.7 18.7 10.3 7.0 3.9 27.0 16.6 15.6 19.3 11.3 11.0 0.0 19.7 29.3 15.0 12.7 8.1 4.3 16.0 1.6 16.8 6.7 17.8 9.1 15.0 14.6 11.8 19.0 19.9 8.0 18.7 21.0 21.9 11.2 8.0 12.9 16.5 7.5 10.5 21.7 23.3 19.1 38.8 19.5 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 27.7 8.6 13.5 26.1 14.9 29.6 23.5 30.1 19.2 14.9 14.2 17.0 10.5 13.0 14.7 12.9 18.2 13.7 14.7 17.4 13.4 14.1 13.5 27.3 22.0 16.1 18.3 12.8 15.5 12.5 21.9 18.9 31.9 13.6 14.3 10.3 14.2 12.0 15.2 40.4 18.3 14.8 16.8 17.2 17.5 13.4 7.3 18.2 37.1 18.0 15.1 18.2 14.8 32.2 11.1 13.6 33.7 11.8 10.9 9.6 7.3 10.1 20.7 1.5 0.0 13.6 15.2 1.8 15.9 19.1 13.8 15.9 1.5 13.6 9.0 7.3 23.3 16.1 9.6 0.1 12.5 17.1 5.0 7.1 2.3 28.0 4.5 12.8 9.3 7.2 11.0 16.2 22.6 22.1 17.2 5.1 4.1 3.3 34.3 12.1 3.6 5.4 6.6 4.1 1.7 4.4 1.9 14.4 19.1 4.0 0.7 2.7 2.1 27.8 4.0 6.6 1.8 1.8 13.4 12.2 33.4 6.6 15.9 12.0 6.9 6.3 14.1 17.5 9.6 11.6 25.4 9.8 17.9 9.3 11.8 7.7 7.6 9.6 8.9 13.6 11.1 9.2 8.9 33.7 10.9 10.5 12.4 5.8 7.3 13.5 14.9 30.1 19.2 13.4 14.1 18.3 12.8 13.6 18.2 62.5 66.3 52.2 35.5 52.2 11.3 38.3 43.3 45.5 46.6 24.4 15.7 34.4 14.9 27.4 129.9 67.3 15.8 0.0 28.6 30.5 63.9 36.5 86.6 160.0 47.2 35.0 27.0 55.3 56.4 113.7 58.4 78.4 50.6 53.3 2.3 41.2 29.3 21.0 67.1 50.1 55.0 148.8 81.5 18.0 35.6 49.2 30.6 85.5 12.0 12.3 NRDE2 "C14orf102, FLJ14051" ENSG00000119720 "NRDE-2, necessary for RNA interference, domain containing" Q9H7Z3 14 90267856-90332137 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047050, HPA050583" Uncertain Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA047050: AB_2679917, HPA050583: AB_2681182" "unprognostic (1.24e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-1)" "unprognostic (3.02e-1)" "unprognostic (4.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.60e-2)" "unprognostic (8.91e-3)" "unprognostic (1.10e-1)" "unprognostic (4.88e-3)" "unprognostic (3.26e-3)" "unprognostic (1.35e-2)" "unprognostic (2.31e-3)" "unprognostic (8.27e-2)" "unprognostic (6.56e-2)" "unprognostic (3.13e-2)" "unprognostic (3.49e-2)" 7.3 9.1 7.3 7.7 10.1 16.4 8.0 17.6 9.3 6.9 8.1 10.8 4.4 13.5 14.6 8.0 8.1 7.7 6.3 6.3 6.2 5.4 7.4 9.8 7.1 6.8 8.2 4.2 8.7 7.2 10.6 13.8 11.6 8.5 7.0 6.5 10.8 9.2 6.1 23.5 11.1 9.7 7.3 8.4 8.5 7.9 7.1 8.7 11.3 9.4 4.8 8.3 9.2 10.2 3.3 3.5 6.0 2.7 2.2 2.6 0.6 1.3 2.6 3.6 2.2 0.5 1.9 2.5 2.6 1.8 1.9 2.1 3.2 2.3 2.3 1.4 2.5 2.4 3.4 2.0 3.4 3.5 4.4 3.3 3.0 8.6 2.2 1.0 8.0 4.2 3.5 2.5 1.8 1.1 3.9 1.6 5.9 1.4 3.6 1.7 2.5 3.6 3.4 1.2 1.2 2.1 3.2 5.2 0.9 1.1 5.2 3.3 3.9 1.1 6.9 1.7 1.4 3.0 3.3 2.2 2.9 1.3 1.7 1.1 3.0 3.2 2.5 2.7 1.5 3.3 4.5 2.7 3.4 2.6 1.5 2.0 2.5 1.9 2.1 1.3 3.3 1.9 2.2 6.0 2.2 1.2 3.5 1.6 0.6 7.3 10.1 17.6 9.3 6.2 5.4 8.2 4.2 8.5 8.7 32.8 27.2 20.3 6.2 5.3 73.0 12.2 43.3 12.0 22.7 17.4 82.5 15.8 6.6 13.7 6.1 16.9 26.2 46.7 12.8 11.1 11.2 6.9 37.0 37.6 10.5 50.9 23.7 28.8 15.7 6.7 21.9 12.0 8.5 18.0 20.3 40.1 11.2 16.5 31.1 10.3 104.0 0.0 12.0 20.7 37.9 5.5 21.1 16.6 20.3 5.8 NUBPL "C14orf127, FLJ12660, huInd1, IND1" ENSG00000151413 "Nucleotide binding protein like" Q8TB37 14 31489956-31861224 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029203 Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA029203: AB_10602810" "unprognostic (1.49e-1)" "unprognostic (1.71e-2)" "unprognostic (5.21e-3)" "unprognostic (8.28e-2)" "unprognostic (8.25e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "unprognostic (1.93e-2)" "unprognostic (1.15e-1)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" "unprognostic (2.80e-1)" "prognostic favorable (3.64e-8)" "unprognostic (2.82e-2)" "unprognostic (6.60e-2)" "unprognostic (3.67e-3)" "unprognostic (1.56e-2)" 12.0 16.0 11.4 11.6 10.7 2.1 12.1 5.7 11.5 7.5 10.1 10.6 9.1 6.6 14.7 13.3 7.6 9.0 7.4 22.5 11.5 9.2 16.5 16.2 10.2 6.9 11.0 8.9 11.3 7.8 14.1 19.0 7.4 12.7 8.9 10.7 10.0 15.4 9.0 16.7 8.1 7.7 11.3 13.5 8.5 8.0 19.2 12.2 6.2 10.8 6.3 8.7 9.7 7.5 4.9 7.5 0.7 2.0 4.1 5.4 1.5 10.5 6.7 5.1 2.5 7.3 13.5 8.9 5.4 6.5 6.9 8.4 4.6 12.2 7.5 7.2 7.1 5.9 9.4 6.8 11.7 12.4 5.4 8.7 2.7 5.0 23.6 7.2 7.9 2.4 8.8 13.8 4.8 10.5 5.9 4.0 5.4 4.9 4.0 7.8 5.8 5.8 5.5 4.2 8.4 10.2 6.6 10.6 4.1 8.3 7.9 4.9 5.0 9.2 8.7 11.3 6.1 17.0 4.2 3.8 7.0 4.8 4.5 5.3 6.4 6.4 7.4 4.7 5.7 6.3 0.0 2.0 0.6 3.9 2.0 3.1 4.9 4.5 4.2 7.5 2.9 5.4 4.2 0.7 4.1 1.1 3.6 2.5 1.5 11.4 10.7 5.7 11.5 11.5 9.2 11.0 8.9 12.7 12.2 11.9 9.8 3.9 7.4 8.5 14.6 31.5 15.3 22.7 14.8 8.7 19.6 9.4 6.6 5.5 15.6 8.0 6.3 0.0 5.0 8.4 9.8 4.9 13.9 11.6 4.4 9.5 6.9 4.9 3.3 5.3 6.1 7.2 11.8 1.0 10.0 15.8 4.2 2.9 11.0 14.6 27.1 12.9 6.5 13.7 5.2 10.2 4.8 4.4 16.8 5.5 NUDT9 MGC3037 ENSG00000170502 "Nudix hydrolase 9" Q9BW91 4 87422582-87459454 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036917, HPA044866, HPA078535" Approved Approved "Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria" "Intracellular and membrane" NA NA 9000 "Nuclear bodies, Mitochondria" "Nuclear membrane, Cell Junctions" "HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885" "unprognostic (7.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.45e-2)" "prognostic favorable (7.43e-5)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (3.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.09e-2)" "unprognostic (4.23e-1)" "prognostic favorable (8.00e-11)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-3)" 14.2 25.6 19.5 10.0 22.7 4.0 31.1 22.5 22.3 17.9 19.6 11.8 18.0 27.0 17.3 24.5 12.8 16.2 11.4 18.0 21.8 19.4 28.1 30.9 15.8 12.2 22.9 16.5 18.4 64.1 35.4 33.1 17.5 20.0 22.5 18.3 11.3 20.2 18.7 23.8 10.2 30.0 16.0 17.0 9.9 14.1 14.1 22.6 7.6 22.7 16.0 9.7 13.6 35.9 13.9 13.8 3.7 13.9 9.3 18.3 10.6 10.6 11.6 12.9 6.5 25.6 16.2 10.4 20.7 13.5 8.0 8.0 8.1 18.5 15.7 21.2 16.7 14.6 7.4 11.9 14.5 12.8 11.7 9.1 5.1 13.5 14.3 16.1 9.4 8.5 15.5 19.3 9.5 9.0 16.5 15.9 5.1 14.4 10.6 15.0 14.1 13.1 10.2 10.4 25.1 4.7 15.4 11.5 9.2 60.2 9.9 15.7 10.7 13.3 23.6 10.5 17.5 13.5 13.6 16.3 12.9 12.5 9.4 10.1 8.1 6.3 12.8 18.5 8.9 16.3 0.9 11.7 3.7 13.4 13.8 12.4 13.9 13.4 13.2 13.8 12.0 15.9 18.3 1.3 9.3 13.9 13.0 12.3 10.6 19.5 22.7 22.5 22.3 21.8 19.4 22.9 16.5 20.0 22.6 62.5 31.4 15.2 36.7 8.9 13.8 35.3 43.3 45.5 60.3 22.7 25.5 27.4 34.9 42.5 19.0 27.0 24.4 0.0 31.7 28.2 26.6 34.7 19.7 42.0 28.9 6.4 16.1 17.8 11.6 7.6 23.6 17.1 10.1 22.6 15.4 21.8 28.5 25.8 25.1 47.3 15.3 25.8 26.7 29.8 21.7 8.3 31.5 7.2 22.2 26.3 OAT HOGA ENSG00000065154 "Ornithine aminotransferase" P04181 10 124397303-124418976 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 208.5" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033576, HPA040098, HPA064742" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343" "unprognostic (1.61e-2)" "unprognostic (1.70e-2)" "unprognostic (9.96e-2)" "unprognostic (1.02e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (4.43e-3)" "unprognostic (1.65e-1)" "unprognostic (2.37e-2)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.21e-1)" "unprognostic (2.19e-1)" "unprognostic (2.72e-2)" "unprognostic (2.00e-2)" 13.5 37.1 25.9 9.1 26.7 20.3 33.8 17.2 39.8 24.7 71.9 22.8 33.9 164.0 21.6 15.5 26.1 14.9 16.0 12.7 25.6 29.8 25.6 36.8 11.6 9.3 27.9 30.1 21.8 12.3 12.1 18.0 14.8 37.8 17.9 15.8 13.3 55.2 29.1 13.7 16.3 208.5 22.5 25.5 8.4 17.3 14.6 19.4 4.9 15.9 23.1 15.2 15.5 18.2 10.2 26.5 23.0 23.6 9.6 20.1 16.3 42.0 7.6 5.0 17.9 51.0 49.3 17.1 25.5 52.1 22.8 25.0 19.5 5.5 0.0 18.6 43.0 21.7 44.8 22.8 47.7 24.8 7.4 31.6 47.1 5.3 14.5 26.3 0.0 31.1 32.2 24.6 20.5 24.0 37.8 26.5 8.7 81.0 9.1 31.8 10.9 12.4 2.6 10.0 12.9 10.8 11.6 19.1 11.4 21.8 0.7 10.5 11.2 16.0 42.8 35.9 30.1 14.2 11.6 20.4 13.0 12.2 21.5 15.8 7.8 8.1 11.4 18.0 12.7 6.2 18.6 23.6 20.7 18.5 20.7 20.1 9.6 15.6 19.4 26.5 10.2 19.6 19.1 23.0 9.6 20.8 5.7 14.4 16.3 25.9 26.7 17.2 39.8 25.6 29.8 27.9 30.1 37.8 19.4 17.9 38.8 36.2 123.3 134.4 27.8 14.0 22.9 44.2 75.1 33.2 25.5 97.9 76.3 32.5 16.9 35.8 49.1 303.7 12.0 67.3 125.7 58.3 43.8 69.3 56.5 41.3 41.3 35.6 32.6 9.0 96.4 49.4 81.0 20.8 48.6 32.0 11.7 36.8 112.8 114.0 21.3 77.6 123.8 32.5 27.0 110.2 40.3 40.6 67.9 76.5 OPA1 "FLJ12460, KIAA0567, MGM1, NPG, NTG" ENSG00000198836 "OPA1, mitochondrial dynamin like GTPase" O60313 3 193593144-193697823 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Sensory transduction, Vision" Hydrolase "Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036926, HPA036927" Supported Supported Nucleoplasm,Mitochondria NA NA 13000 "Nucleoplasm, Mitochondria" "HPA036926: AB_10671247, HPA036927: AB_2675388" "unprognostic (2.10e-2)" "unprognostic (9.23e-3)" "unprognostic (7.98e-2)" "prognostic unfavorable (8.61e-4)" "unprognostic (1.62e-2)" "unprognostic (4.59e-2)" "unprognostic (2.24e-1)" "unprognostic (1.86e-2)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.44e-5)" "unprognostic (3.48e-2)" "prognostic favorable (1.84e-4)" "unprognostic (2.92e-1)" "unprognostic (4.75e-1)" "unprognostic (4.50e-3)" "unprognostic (3.21e-1)" 17.0 19.7 18.2 13.5 31.7 25.9 15.9 20.2 30.9 13.9 21.8 11.1 12.6 20.0 15.2 11.8 18.8 11.8 12.8 43.9 23.0 19.4 21.8 24.1 10.7 15.3 19.0 22.4 13.2 13.4 20.9 15.6 13.8 28.0 15.5 20.5 9.1 15.7 20.8 38.4 14.6 17.3 16.5 17.0 13.1 16.7 7.6 10.8 18.0 16.8 18.4 14.2 16.5 13.6 8.3 8.8 8.2 17.6 5.0 7.5 5.9 26.0 8.4 8.5 9.3 7.5 11.9 9.0 12.7 11.7 13.9 13.6 20.3 8.8 17.3 27.4 11.9 12.7 17.0 14.8 14.3 24.7 20.8 12.0 29.9 7.5 10.2 11.7 24.6 13.8 13.3 12.8 13.4 19.1 8.6 11.7 7.3 12.7 17.0 13.8 20.6 9.5 13.7 11.9 15.0 28.0 12.5 18.7 18.5 10.4 16.3 18.5 11.3 18.9 21.2 13.4 6.8 27.8 19.5 11.7 12.9 9.8 13.8 26.6 15.4 17.8 33.9 14.3 19.7 12.9 8.2 8.1 7.7 7.2 9.3 6.6 8.3 6.8 6.8 8.8 6.3 6.9 7.3 3.2 5.0 17.6 4.6 7.5 5.9 18.2 31.7 20.2 30.9 23.0 19.4 19.0 22.4 28.0 10.8 14.9 20.0 20.6 13.8 14.2 17.0 130.0 15.3 16.0 20.5 17.4 29.5 16.2 14.9 14.8 7.2 13.5 20.6 70.0 20.7 12.2 15.9 15.5 18.5 30.2 15.9 20.6 22.4 16.0 23.5 10.2 14.7 21.2 20.3 11.8 20.6 15.7 22.7 7.0 13.8 26.9 21.6 6.5 17.5 11.3 15.0 19.6 15.0 12.8 25.8 19.6 OSGEPL1 "OSGEPL, Qri7" ENSG00000128694 "O-sialoglycoprotein endopeptidase like 1" Q9H4B0 2 189746660-189763227 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030693 Uncertain Supported Mitochondria NA NA Mitochondria "HPA030693: AB_10601978" "unprognostic (1.10e-1)" "unprognostic (8.72e-2)" "unprognostic (8.19e-2)" "unprognostic (6.70e-2)" "unprognostic (6.07e-2)" "unprognostic (6.38e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (4.18e-3)" "unprognostic (1.06e-3)" "prognostic favorable (3.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.80e-2)" "unprognostic (3.34e-2)" "unprognostic (2.68e-1)" "unprognostic (1.51e-2)" "unprognostic (6.39e-2)" "unprognostic (1.55e-3)" 6.6 17.0 8.6 6.5 12.1 2.6 11.1 12.9 10.9 7.3 5.6 14.8 2.9 5.0 11.8 9.1 7.0 8.1 4.8 13.0 8.4 7.3 13.0 11.6 5.8 11.2 18.9 9.3 13.8 6.1 7.5 9.8 6.1 11.6 6.9 6.1 9.0 9.7 6.1 16.6 9.2 6.5 8.1 13.4 9.6 5.8 9.4 15.4 10.6 8.2 7.3 9.2 8.0 5.8 9.3 6.0 2.1 2.6 6.6 11.5 3.0 5.6 3.1 13.9 10.6 11.0 6.1 8.3 8.8 6.2 12.5 13.5 3.7 5.9 3.8 9.9 3.7 7.0 8.3 12.4 10.4 14.3 9.7 9.5 12.3 7.7 4.8 5.8 6.9 6.4 6.7 8.9 9.4 4.7 8.6 9.3 9.7 4.4 6.0 8.2 3.2 5.4 8.0 6.7 7.7 14.5 5.9 11.2 6.5 8.1 3.2 8.5 9.4 5.9 10.8 19.2 18.1 8.4 7.6 3.9 8.2 7.2 11.9 5.4 6.1 5.1 6.1 10.8 8.9 8.9 0.2 2.6 2.1 7.3 2.4 10.5 7.4 7.7 8.4 3.5 9.3 11.5 10.2 0.4 6.6 2.1 6.0 5.9 3.0 8.6 12.1 12.9 10.9 8.4 7.3 18.9 9.3 11.6 15.4 6.0 2.2 1.3 2.3 1.6 8.0 8.1 2.5 8.1 1.2 0.0 11.8 8.6 6.6 2.4 0.6 2.3 0.9 0.0 2.0 6.1 3.8 1.2 3.5 3.0 3.8 9.5 0.0 4.3 1.0 0.0 10.3 2.3 1.7 0.0 1.1 12.4 1.5 0.0 7.8 8.4 10.0 25.8 3.1 10.7 12.6 1.8 1.8 5.0 2.3 0.5 OTC ENSG00000036473 "Ornithine carbamoyltransferase" P00480 X 38352545-38421450 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "intestine: 59.1;liver: 90.3" "Group enriched" "Detected in some" 7 "Hepatocytes: 74.1;Ito cells: 20.3" "Cancer enriched" "Detected in some" 20 "liver cancer: 59.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;NB-4: 1.7;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8" "Not detected" "Not detected" "HPA000243, HPA000570" Enhanced Supported Mitochondria NA NA 1800000 Mitochondria "HPA000243: AB_1079535, HPA000570: AB_1079534" "unprognostic (6.93e-2)" "unprognostic (2.48e-1)" "unprognostic (1.89e-3)" "unprognostic (4.38e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-1)" "unprognostic (4.19e-2)" "unprognostic (7.70e-3)" "unprognostic (5.61e-2)" 0.4 0.1 0.1 0.4 0.2 0.0 0.2 0.1 0.1 0.8 16.5 0.0 0.2 26.9 1.1 0.2 0.2 0.3 5.3 0.2 0.1 0.2 0.1 90.3 0.7 2.3 0.2 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.1 0.1 59.1 0.8 0.3 0.1 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.6 1.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 1.7 0.0 0.2 0.0 0.0 0.0 0.0 74.1 0.0 0.0 1.2 20.3 1.9 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 1.5 0.0 OXA1L "MGC133129, OXA1" ENSG00000155463 "OXA1L, mitochondrial inner membrane protein" Q15070 14 22766522-22773041 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003531 Approved Supported Mitochondria NA NA Mitochondria "HPA003531: AB_1079539" "unprognostic (4.04e-3)" "unprognostic (2.41e-2)" "unprognostic (3.39e-1)" "unprognostic (2.24e-2)" "unprognostic (7.25e-2)" "unprognostic (1.42e-2)" "unprognostic (1.08e-2)" "unprognostic (1.06e-2)" "unprognostic (1.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "prognostic favorable (4.82e-4)" "unprognostic (8.35e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (1.15e-3)" 27.8 36.0 11.9 21.2 15.5 25.1 28.4 13.5 23.0 25.4 30.9 18.5 24.3 27.2 22.7 23.9 30.2 21.5 30.6 48.3 12.9 13.0 31.9 58.4 25.8 45.0 15.2 10.9 31.4 59.6 30.0 12.3 18.3 17.9 25.3 24.2 28.1 24.9 27.5 76.3 24.9 32.8 23.9 13.5 32.9 29.9 17.0 10.3 32.7 37.3 49.0 38.3 31.3 22.3 22.1 39.9 7.2 29.4 16.3 22.6 19.9 21.3 29.5 13.3 22.3 37.8 56.3 24.5 16.3 34.4 23.7 27.5 22.1 24.5 40.2 21.9 18.9 18.4 30.6 25.6 31.7 23.9 16.7 16.5 19.9 20.4 80.9 42.3 37.1 24.8 55.1 35.3 19.6 30.4 30.4 68.2 23.6 14.7 32.9 26.0 31.4 21.9 14.4 13.5 28.4 37.2 22.5 22.0 30.5 30.3 26.8 9.1 17.6 23.7 52.8 31.2 16.5 22.5 30.1 21.8 14.2 16.5 25.8 18.6 24.8 19.7 18.8 11.1 21.4 15.2 4.8 27.9 7.2 13.4 29.4 16.3 22.1 19.2 16.9 39.9 21.9 21.9 16.3 6.3 16.3 22.9 11.3 22.6 19.9 11.9 15.5 13.5 23.0 12.9 13.0 15.2 10.9 17.9 10.3 44.7 38.2 84.8 43.0 61.7 27.2 99.9 84.1 38.8 36.4 27.9 9.8 61.8 63.0 75.1 6.3 57.3 51.9 23.3 140.4 103.7 55.7 38.4 77.5 82.5 125.3 17.5 39.0 57.7 124.8 10.2 52.9 86.1 49.0 93.8 66.6 20.9 92.6 80.7 34.6 95.3 30.4 38.8 51.5 34.7 25.8 58.8 47.8 70.4 100.6 68.0 OXSM "CEM1, FASN2D, FLJ20604, KS" ENSG00000151093 "3-oxoacyl-ACP synthase, mitochondrial" Q9NWU1 3 25782917-25794534 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021293, HPA021300, HPA021337" Enhanced Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776" "unprognostic (2.20e-2)" "unprognostic (3.28e-1)" "prognostic favorable (1.35e-4)" "prognostic favorable (5.51e-4)" "unprognostic (1.01e-1)" "unprognostic (8.17e-2)" "unprognostic (2.15e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-1)" "unprognostic (2.83e-2)" "unprognostic (3.06e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.18e-9)" "unprognostic (1.79e-2)" "unprognostic (2.42e-1)" "unprognostic (3.10e-1)" "unprognostic (1.73e-2)" 6.2 13.7 6.7 9.8 10.5 3.7 10.3 8.3 11.9 6.0 11.8 6.2 13.7 10.1 6.4 16.2 10.3 7.7 7.9 13.5 6.6 6.4 14.9 26.1 10.0 7.7 6.6 6.5 6.4 18.7 8.3 13.0 7.3 7.0 8.0 13.8 10.4 15.5 15.6 19.4 8.3 8.9 5.8 6.7 9.6 8.9 19.9 8.0 8.1 11.7 12.3 11.3 7.9 6.4 8.4 9.0 3.7 6.5 10.3 11.8 6.6 7.7 12.9 2.7 7.6 8.0 8.8 8.0 6.2 9.0 11.7 8.3 9.8 9.3 14.3 8.4 5.7 6.8 8.2 11.4 11.9 11.0 8.6 11.5 15.8 10.9 11.8 9.8 12.7 10.1 8.2 14.8 9.3 9.8 7.6 10.0 13.6 16.2 11.6 9.9 11.5 9.3 9.8 0.5 6.2 14.9 12.4 7.2 23.4 17.1 4.8 3.9 7.2 9.9 17.0 12.6 4.6 18.6 11.9 6.1 7.3 8.8 9.6 8.9 11.1 12.8 4.5 10.3 11.2 7.5 2.1 5.4 3.7 9.4 6.0 10.8 8.4 9.7 11.6 8.6 8.2 11.4 11.8 0.9 10.3 6.5 9.0 6.0 6.6 6.7 10.5 8.3 11.9 6.6 6.4 6.6 6.5 7.0 8.0 0.0 10.3 2.9 5.0 2.7 6.2 9.8 7.6 5.3 4.5 10.4 3.9 17.5 10.0 11.3 38.3 4.9 6.3 0.0 5.9 13.9 6.5 5.4 9.3 13.9 7.7 4.8 2.4 6.7 2.7 11.5 6.6 3.7 5.0 6.4 9.8 8.3 7.4 7.6 3.9 16.1 6.5 0.0 3.1 26.1 12.0 3.9 11.8 5.0 9.6 2.4 PAM16 "Magmas, Tim16, TIMM16" ENSG00000217930 "Presequence translocase associated motor 16" Q9Y3D7 16 4331549-4355607 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 36.3" HPA062721 Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA062721: AB_2684849" "unprognostic (2.69e-2)" "unprognostic (1.64e-1)" "unprognostic (4.06e-1)" "unprognostic (6.81e-2)" "unprognostic (6.98e-2)" "unprognostic (9.68e-2)" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-1)" "unprognostic (4.79e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.73e-5)" "unprognostic (7.25e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "prognostic favorable (1.33e-4)" 10.9 15.2 12.9 8.4 14.1 17.0 10.0 9.3 15.1 7.0 9.5 5.6 8.2 14.0 7.8 11.8 11.2 7.5 7.5 19.9 11.1 10.7 9.2 33.7 9.8 10.9 9.8 11.3 8.5 26.1 7.1 10.3 8.0 9.2 8.8 8.0 7.8 13.2 11.0 54.5 12.6 10.1 8.2 8.3 9.5 10.1 16.2 7.3 7.3 12.0 17.8 9.6 8.4 9.9 16.0 19.8 11.2 15.3 11.5 14.3 12.3 3.9 7.7 4.2 10.3 2.8 3.9 10.9 9.5 2.3 3.6 2.9 5.4 5.8 11.5 10.6 2.8 3.7 8.1 3.9 4.2 1.7 11.2 25.4 12.0 7.2 3.8 4.6 8.4 9.0 5.8 5.4 4.3 4.7 3.2 2.8 8.1 14.1 5.5 3.0 10.6 7.6 14.7 6.8 2.5 17.2 14.5 3.5 11.1 3.7 3.8 16.0 12.4 8.2 7.0 9.7 3.3 9.2 10.2 3.5 7.2 9.3 36.3 10.4 8.2 8.8 14.3 2.6 8.2 6.8 0.2 15.3 2.3 12.3 9.5 10.5 16.0 11.2 11.3 10.7 15.5 14.3 13.7 11.2 11.5 10.2 19.8 12.7 12.3 12.9 14.1 9.3 15.1 11.1 10.7 9.8 11.3 9.2 7.3 3.0 4.5 2.2 0.9 3.5 0.5 0.4 10.2 6.7 5.7 0.0 0.0 1.9 6.6 3.1 2.6 0.7 2.1 0.0 2.6 2.3 2.7 1.0 1.1 10.9 1.5 1.6 0.0 4.3 7.8 0.8 4.6 1.1 1.7 7.2 2.1 0.3 5.2 3.4 3.5 3.0 0.6 6.5 1.4 8.9 12.9 5.1 1.0 1.7 3.4 1.0 PCCA ENSG00000175198 "Propionyl-CoA carboxylase alpha subunit" P05165 13 100089015-100530437 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 106.7" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 84.6;Proximal tubular cells: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 54.3;SCLC-21H: 30.1;U-937: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041716, HPA047792" Enhanced Supported Mitochondria NA NA 120000 Mitochondria "HPA041716: AB_2677635, HPA047792: AB_2680156" "unprognostic (1.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (4.71e-2)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.55e-1)" "unprognostic (5.90e-3)" "unprognostic (2.41e-1)" "unprognostic (1.55e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "prognostic favorable (0.00e+0)" "unprognostic (7.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.32e-2)" 15.6 26.2 9.7 11.3 11.1 3.2 12.0 24.0 10.7 12.0 17.5 12.0 14.3 6.7 16.4 106.7 8.8 8.4 7.6 12.4 9.5 7.5 51.3 44.3 8.1 4.0 11.2 8.2 9.7 12.7 5.5 12.4 10.5 12.6 13.1 13.7 11.7 12.2 10.4 10.7 7.7 7.8 17.0 12.0 8.2 16.1 4.7 10.9 4.2 11.9 5.0 6.9 10.8 8.8 3.7 13.0 1.6 10.8 7.3 6.1 4.7 3.3 5.9 9.8 3.2 9.4 8.2 5.5 3.3 5.0 3.1 2.9 7.3 4.5 0.2 5.1 3.2 4.0 3.8 2.9 4.6 5.1 5.5 3.2 7.7 4.2 15.8 5.2 0.3 3.7 7.5 5.0 2.9 4.8 7.6 6.4 4.2 3.0 4.4 5.6 3.6 0.8 17.3 6.1 11.8 2.6 6.7 4.2 5.4 54.3 6.6 30.1 3.6 2.2 12.6 5.5 11.1 9.1 13.7 4.6 3.2 2.7 2.2 2.3 4.3 3.9 0.1 6.1 41.9 2.2 1.5 8.5 1.6 4.6 10.3 6.1 3.7 3.0 4.3 13.0 2.6 4.1 5.1 1.3 7.3 10.8 1.1 6.0 4.7 9.7 11.1 24.0 10.7 9.5 7.5 11.2 8.2 12.6 10.9 3.0 8.3 7.3 25.7 1.6 15.4 8.7 38.2 10.7 10.3 19.2 27.5 21.2 84.6 13.8 14.8 9.9 14.0 0.0 7.3 5.4 7.1 14.3 13.9 41.9 10.3 27.0 3.5 11.6 10.2 7.9 8.1 7.2 5.0 2.8 10.1 10.4 6.2 14.0 12.7 63.9 32.3 12.9 8.9 4.8 4.3 3.3 25.3 4.9 26.5 19.5 PDHA1 PDHA ENSG00000131828 "Pyruvate dehydrogenase E1 alpha 1 subunit" P08559 X 19343893-19361705 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.3" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 422.4;Distal tubular cells: 300.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria "Intracellular and membrane" NA NA 15000 Mitochondria "HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931" "unprognostic (5.71e-3)" "unprognostic (2.46e-3)" "unprognostic (5.71e-2)" "unprognostic (3.36e-3)" "unprognostic (3.12e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-2)" "unprognostic (4.28e-1)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (6.90e-2)" "unprognostic (8.68e-2)" "prognostic favorable (1.13e-7)" "unprognostic (3.72e-2)" "unprognostic (3.03e-1)" "unprognostic (1.92e-2)" "unprognostic (9.06e-2)" 22.5 16.1 14.7 11.7 24.3 20.4 14.7 18.6 25.0 12.3 28.6 13.0 27.7 22.7 13.0 21.6 17.2 12.4 11.8 89.3 15.5 12.2 36.6 26.6 10.5 8.9 14.8 19.9 12.2 28.7 25.0 11.6 14.9 19.0 10.8 28.2 12.7 41.8 18.3 107.3 12.7 21.1 21.2 12.7 11.5 24.9 6.3 12.0 11.3 15.0 44.9 14.9 13.1 12.4 39.4 45.1 34.8 46.1 35.5 36.6 31.9 25.6 31.9 23.1 24.3 22.4 17.2 28.4 17.7 15.8 36.7 28.4 45.4 16.5 43.8 13.2 21.3 49.1 33.5 70.9 30.7 38.7 14.5 39.5 21.7 54.9 39.9 23.8 34.7 17.8 22.1 28.6 33.8 33.6 18.6 22.3 27.4 19.1 18.6 25.6 33.9 28.9 35.6 23.5 47.1 55.8 29.9 38.8 53.6 63.2 26.2 12.8 13.6 28.2 35.8 32.0 52.0 37.7 24.4 13.8 19.0 17.1 51.6 22.4 15.8 16.2 29.0 17.9 24.3 16.4 34.8 35.0 24.2 30.3 46.1 36.6 39.4 29.4 32.8 45.1 29.3 29.0 30.6 6.1 35.5 39.1 29.8 31.1 31.9 14.7 24.3 18.6 25.0 15.5 12.2 14.8 19.9 19.0 12.0 41.7 37.7 36.5 48.9 26.6 58.2 422.4 79.0 26.8 50.0 144.8 31.4 91.3 300.1 74.7 2.0 28.6 76.1 23.3 52.1 102.6 45.2 31.9 42.6 65.5 65.3 23.8 40.3 16.0 21.0 2.9 32.8 35.5 54.0 51.3 52.9 37.8 43.3 57.5 38.2 164.1 60.9 32.3 48.4 17.4 13.0 29.2 111.6 30.9 97.8 51.0 PDHA2 PDHAL ENSG00000163114 "Pyruvate dehydrogenase E1 alpha 2 subunit" P29803 4 95840019-95841474 "Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 146 "testis: 60.5" "Group enriched" "Detected in some" 6 "Early spermatids: 311.1;Late spermatids: 202.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria NA NA Mitochondria "HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 311.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 202.7 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 45.9 1.6 0.0 0.0 0.0 0.0 0.0 PDHB PDHE1B ENSG00000168291 "Pyruvate dehydrogenase E1 beta subunit" P11177 3 58427630-58433857 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 245.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033794, HPA036744, HPA036745" Enhanced Supported Nucleoplasm,Mitochondria No No 6500000 Mitochondria Nucleoplasm "CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285" "unprognostic (2.06e-2)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (7.22e-2)" "unprognostic (1.42e-1)" "unprognostic (3.20e-2)" "unprognostic (6.13e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (3.98e-1)" "unprognostic (2.35e-1)" "prognostic favorable (2.79e-8)" "unprognostic (2.67e-1)" "unprognostic (8.37e-2)" "unprognostic (1.06e-2)" "unprognostic (9.85e-2)" 21.8 34.3 22.5 19.5 28.4 8.6 17.1 15.1 26.2 18.0 21.6 18.4 19.2 16.2 17.2 18.2 22.8 15.0 16.5 64.2 24.1 20.8 38.7 41.8 13.9 18.2 23.7 23.3 11.0 17.2 26.0 20.0 21.6 26.4 19.5 23.9 16.1 17.6 22.1 92.2 14.3 17.3 24.5 22.8 23.2 21.4 21.8 17.5 20.9 16.1 33.8 20.6 17.9 14.4 37.0 50.1 33.6 39.8 43.4 38.6 38.3 19.0 26.7 27.7 20.8 28.2 34.7 33.3 24.1 30.2 35.7 36.8 48.2 18.5 40.8 13.6 30.5 33.1 11.1 33.7 22.1 27.3 23.6 24.8 36.4 50.5 36.3 28.6 29.5 20.5 30.3 20.5 28.7 16.9 41.9 30.7 34.1 18.7 18.4 38.7 18.2 27.9 31.0 38.2 20.2 30.4 13.3 21.6 39.3 56.3 26.2 19.3 21.2 22.3 32.2 24.0 41.8 47.6 31.7 22.5 19.1 25.5 20.0 27.2 25.8 36.6 28.7 29.3 35.1 18.0 16.4 35.4 33.6 31.5 39.8 33.2 37.0 31.2 30.0 50.1 33.3 35.1 31.4 7.0 43.4 35.9 33.7 38.6 38.3 22.5 28.4 15.1 26.2 24.1 20.8 23.7 23.3 26.4 17.5 56.6 28.0 47.4 32.8 24.7 30.0 245.7 48.4 69.6 48.9 33.2 23.6 144.4 195.6 84.1 43.2 62.9 34.8 23.3 63.6 85.4 31.9 17.8 38.1 61.1 74.4 54.0 55.7 43.6 38.0 10.4 55.8 41.0 54.0 89.2 44.3 51.8 51.0 41.3 48.1 105.9 44.7 64.7 61.8 85.0 80.3 26.1 131.5 46.0 47.8 28.8 PDK2 PDHK2 ENSG00000005882 "Pyruvate dehydrogenase kinase 2" Q15119 17 50094737-50112152 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.0" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008287 Supported Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA008287: AB_1079589" "unprognostic (2.74e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.16e-1)" "unprognostic (2.43e-3)" "unprognostic (1.22e-1)" "unprognostic (9.63e-3)" "unprognostic (9.80e-3)" "unprognostic (8.39e-3)" "unprognostic (3.19e-2)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "prognostic favorable (9.59e-5)" "unprognostic (3.81e-1)" "unprognostic (2.54e-1)" "unprognostic (5.33e-1)" "unprognostic (1.55e-1)" 20.6 26.1 17.2 5.2 27.5 3.2 10.8 53.7 34.4 10.1 16.1 16.1 10.1 15.5 13.1 69.8 12.5 14.4 11.5 51.7 18.2 13.0 33.7 27.8 9.0 5.7 14.6 20.9 27.7 24.1 16.9 7.5 8.6 14.2 12.7 12.4 19.5 14.0 16.5 101.0 10.6 16.5 15.1 9.9 7.8 13.6 7.2 11.4 6.2 15.6 31.4 7.4 13.8 9.4 11.3 20.1 8.9 12.9 16.5 17.4 12.2 6.4 9.2 11.1 10.0 11.8 8.9 1.2 7.0 10.4 10.5 10.2 0.8 7.0 8.1 11.7 19.5 7.1 3.1 7.4 2.8 10.3 16.3 10.3 7.2 9.1 6.8 6.3 0.0 7.8 18.7 10.8 6.8 0.5 18.5 9.1 10.4 2.9 8.1 5.9 8.2 6.0 0.0 2.4 19.5 9.0 9.1 24.9 10.9 5.7 5.5 7.4 11.2 9.9 3.1 4.7 14.2 18.3 7.2 4.7 12.3 10.1 8.4 5.1 16.0 15.1 4.4 18.0 2.6 7.9 8.9 12.9 6.8 14.0 9.8 11.1 11.1 12.5 14.8 14.2 11.3 14.6 15.0 2.2 16.5 10.5 20.1 17.4 12.2 17.2 27.5 53.7 34.4 18.2 13.0 14.6 20.9 14.2 11.4 8.9 9.3 13.6 13.9 13.5 20.8 5.0 10.2 1.4 11.4 19.2 5.9 15.1 49.7 8.0 7.3 8.3 46.6 0.0 7.9 3.4 19.5 7.6 1.1 39.8 16.7 41.3 13.3 13.5 13.7 15.0 22.5 7.9 23.6 15.4 45.3 33.6 7.9 43.6 49.5 118.5 9.2 19.4 12.1 3.3 4.4 16.4 6.6 15.8 37.1 8.4 PDK3 ENSG00000067992 "Pyruvate dehydrogenase kinase 3" Q15120 X 24465221-24539837 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046583, HPA072492" Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA046583: AB_2679707, HPA072492: AB_2686526" "unprognostic (5.41e-3)" "unprognostic (5.43e-3)" "unprognostic (5.35e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-3)" "unprognostic (5.38e-2)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.51e-1)" "unprognostic (5.57e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "unprognostic (1.02e-1)" "unprognostic (2.92e-1)" "unprognostic (2.28e-2)" "unprognostic (9.43e-3)" 9.6 5.6 5.7 9.8 17.3 16.3 12.8 3.3 23.6 8.0 14.7 5.5 5.6 13.6 7.3 15.7 9.5 13.2 7.0 16.9 12.5 6.8 13.7 11.1 11.2 13.4 6.2 13.7 11.0 7.3 12.8 14.1 7.7 14.9 8.3 10.1 9.9 19.3 5.2 3.9 14.2 15.6 8.6 6.1 17.9 12.7 23.1 4.8 12.5 6.2 4.1 14.9 10.3 9.2 4.5 7.2 36.4 10.9 7.1 11.0 6.7 9.0 4.6 3.9 6.6 0.1 0.0 4.1 2.7 2.4 3.7 6.5 0.4 11.1 9.2 1.9 0.7 10.5 2.1 11.3 6.9 10.0 7.8 5.4 4.9 5.3 2.6 1.3 4.2 4.8 0.7 3.1 0.9 0.9 0.4 5.5 9.6 0.9 14.0 0.5 17.0 7.8 5.4 7.0 9.7 5.4 4.0 7.0 13.5 3.2 17.7 2.5 3.2 14.7 6.0 4.6 6.2 8.3 1.6 0.2 2.6 3.8 4.8 3.2 9.0 6.9 11.0 7.1 6.4 5.4 9.4 8.9 21.3 7.6 10.9 11.0 4.5 6.2 6.2 7.2 4.1 4.9 5.7 36.4 7.1 10.4 2.3 5.1 6.7 5.7 17.3 3.3 23.6 12.5 6.8 6.2 13.7 14.9 4.8 3.0 1.3 2.9 8.6 4.0 3.4 6.3 0.0 1.4 2.3 1.8 0.0 4.0 3.3 3.6 53.4 2.8 4.5 0.0 4.5 26.4 3.2 5.2 5.7 4.2 13.2 7.9 4.1 4.3 18.9 22.4 3.4 9.6 15.1 8.2 2.4 3.2 2.8 0.0 5.3 11.3 3.9 0.0 9.2 6.4 6.3 3.9 14.9 14.9 3.3 7.1 PGAM5 "BXLBv68, MGC5352" ENSG00000247077 "PGAM family member 5, mitochondrial serine/threonine protein phosphatase" Q96HS1 12 132710819-132722734 "Enzymes, Predicted intracellular proteins" Necrosis Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036978, HPA036979, CAB068215" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559" "unprognostic (9.57e-2)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (3.11e-2)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.13e-6)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (5.67e-2)" "unprognostic (1.23e-1)" "unprognostic (6.92e-2)" "unprognostic (6.42e-3)" "unprognostic (1.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (5.53e-2)" 12.2 16.5 11.7 14.3 14.0 12.5 18.6 14.6 22.1 8.4 13.9 8.3 9.9 13.6 10.4 9.9 22.0 11.5 13.4 22.6 14.2 12.1 13.9 26.3 8.5 17.6 9.9 11.8 11.9 30.2 8.1 9.6 10.3 10.4 10.1 10.4 8.5 16.0 11.4 27.4 15.2 12.0 10.2 7.5 13.0 11.7 13.6 5.1 17.6 16.3 17.4 14.5 11.6 12.9 4.0 6.7 7.7 3.1 3.3 3.7 1.4 19.2 37.1 7.9 22.3 5.6 4.5 18.6 9.9 6.2 16.7 9.4 46.2 11.2 24.9 18.4 8.6 8.6 16.9 37.2 18.7 6.9 12.2 29.3 29.9 17.4 24.1 12.7 28.3 17.5 5.6 13.8 19.5 21.1 5.5 12.2 20.4 37.4 10.3 6.5 34.9 38.3 28.3 30.1 16.9 26.3 29.4 8.8 19.9 10.8 26.8 29.1 16.4 17.2 24.2 10.7 6.6 30.6 15.7 10.5 8.5 18.6 17.1 24.1 21.6 31.7 35.8 11.1 23.2 14.2 7.7 2.4 0.7 2.5 2.5 3.7 3.6 2.9 2.8 2.0 4.0 2.9 3.6 2.0 3.3 3.1 6.7 2.0 1.4 11.7 14.0 14.6 22.1 14.2 12.1 9.9 11.8 10.4 5.1 3.0 6.7 6.7 10.3 10.2 9.2 12.6 20.4 4.0 0.0 5.2 13.7 5.6 5.0 4.0 12.9 5.3 6.3 0.0 6.7 12.5 3.3 9.0 0.0 21.9 6.4 6.4 12.6 4.3 6.9 15.9 5.5 4.8 3.3 2.8 8.9 3.9 6.9 5.8 6.3 9.0 12.2 6.5 5.5 9.8 9.4 15.2 5.1 4.4 14.0 11.6 PHB PHB1 ENSG00000167085 Prohibitin P35232 17 49404049-49414905 "Plasma proteins, Predicted intracellular proteins" "DNA synthesis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 190.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003280 Supported Supported Mitochondria "Intracellular and membrane" NA NA 3800000 Mitochondria "HPA003280: AB_1855732" "unprognostic (2.31e-2)" "unprognostic (5.70e-2)" "unprognostic (1.19e-2)" "unprognostic (7.88e-3)" "unprognostic (8.33e-2)" "prognostic unfavorable (1.58e-4)" "prognostic unfavorable (9.91e-4)" "unprognostic (5.81e-2)" "unprognostic (4.40e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (7.36e-2)" "prognostic favorable (3.77e-4)" "unprognostic (5.10e-2)" "unprognostic (1.77e-1)" "unprognostic (2.71e-2)" "unprognostic (3.09e-3)" 27.4 31.6 21.8 19.9 24.9 19.0 30.6 12.9 25.9 21.6 38.9 24.0 17.0 26.9 24.1 17.7 28.6 24.3 18.6 41.6 21.9 20.9 54.0 53.7 19.2 18.5 27.6 21.4 27.1 24.1 27.8 18.8 24.1 22.0 25.3 40.7 24.7 41.8 20.2 41.7 19.5 32.7 26.6 20.5 22.7 25.0 16.6 18.2 23.3 42.5 35.6 22.3 22.4 24.0 33.4 84.6 6.3 28.0 28.4 34.7 40.2 36.2 67.8 16.3 31.9 21.9 17.3 45.3 26.9 17.9 43.6 28.6 190.5 32.7 67.3 49.2 24.7 40.2 23.7 44.2 38.8 45.2 29.2 58.1 33.9 44.0 86.1 16.2 67.0 21.0 19.2 26.9 47.1 17.4 16.1 31.8 33.3 60.5 18.2 28.3 61.8 46.4 41.9 30.2 90.0 64.8 37.1 61.8 55.2 29.6 38.5 33.0 28.1 20.3 23.8 37.7 31.7 40.4 31.2 27.7 41.4 32.0 32.3 57.6 23.3 63.7 65.1 27.1 44.6 35.8 6.3 25.3 6.2 32.3 28.0 34.7 33.4 28.7 31.0 38.1 29.9 30.4 30.9 2.5 28.4 21.0 84.6 28.1 40.2 21.8 24.9 12.9 25.9 21.9 20.9 27.6 21.4 22.0 18.2 44.7 38.5 91.0 108.8 104.4 37.8 5.0 99.3 58.9 45.5 80.3 35.3 200.2 344.8 205.1 11.2 83.1 152.0 0.0 137.6 226.4 92.2 139.6 72.6 90.4 199.3 20.6 126.7 58.9 47.1 19.5 82.8 74.2 150.1 170.5 170.0 63.9 145.3 121.0 108.2 332.8 35.0 51.8 84.4 14.9 52.8 108.4 127.5 73.5 226.1 142.5 PHYHIP "DYRK1AP3, KIAA0273, PAHX-AP" ENSG00000168490 "Phytanoyl-CoA 2-hydroxylase interacting protein" Q92561 8 22219704-22232341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.4;skin 1: 37.9" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 16.8;Smooth muscle cells: 7.8;Suprabasal keratinocytes: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.9;SH-SY5Y: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "amygdala: 111.3;basal ganglia: 281.7;cerebellum: 369.4;cerebral cortex: 248.5;hippocampal formation: 314.4" "HPA068030, HPA069318" Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068030: AB_2685944, HPA069318: AB_2686117" "unprognostic (1.19e-2)" "unprognostic (2.33e-2)" "unprognostic (3.06e-2)" "unprognostic (9.22e-3)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (2.80e-1)" "unprognostic (3.01e-2)" "unprognostic (7.44e-3)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (4.44e-5)" "unprognostic (8.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (4.09e-3)" 5.4 18.6 25.0 2.3 71.8 1.3 3.5 58.9 89.4 3.2 2.1 3.0 0.0 2.2 6.0 3.4 7.1 9.8 6.2 2.9 31.2 12.3 2.2 1.4 1.8 1.4 7.3 40.3 2.3 2.2 1.3 5.5 3.0 21.1 3.6 1.7 0.0 1.4 5.9 1.7 37.9 2.4 7.2 3.5 3.6 1.6 5.8 10.4 0.0 2.0 0.0 1.4 7.8 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 0.5 0.0 0.3 0.8 1.1 0.3 1.3 0.4 0.4 0.1 2.0 0.0 2.2 0.6 1.4 3.8 0.0 0.7 0.1 0.0 0.2 0.0 4.0 1.5 1.7 0.0 0.0 0.9 0.0 0.8 0.0 3.6 2.5 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.9 0.7 0.3 0.0 0.2 12.9 0.0 0.0 4.3 5.0 2.9 0.0 3.4 0.3 0.0 0.3 1.1 0.0 2.1 1.6 0.7 1.0 0.2 0.0 2.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 71.8 58.9 82.9 31.2 12.3 7.3 40.3 21.1 10.4 0.0 0.0 0.0 5.1 16.8 0.7 1.2 0.0 0.0 2.3 3.5 0.0 0.1 0.0 0.2 0.6 1.3 0.5 0.0 1.8 0.2 2.3 0.5 0.0 0.9 0.2 0.0 0.0 1.3 0.0 1.3 2.8 0.0 1.7 0.0 0.3 0.4 0.4 0.0 3.5 2.2 0.9 0.0 7.8 0.2 0.0 9.5 1.8 0.0 0.0 3.9 PITRM1 "hMP1, KIAA1104, MP1, PreP" ENSG00000107959 "Pitrilysin metallopeptidase 1" Q5JRX3 10 3137728-3172841 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 149.7;Late spermatids: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006753, HPA006754" Enhanced Supported Mitochondria NA NA Mitochondria "HPA006753: AB_1079624, HPA006754: AB_1079623" "unprognostic (1.83e-3)" "unprognostic (7.01e-3)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (3.20e-2)" "unprognostic (6.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (6.31e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-2)" "unprognostic (3.32e-1)" "unprognostic (7.10e-2)" "unprognostic (3.99e-1)" "unprognostic (5.80e-2)" "unprognostic (4.76e-3)" "unprognostic (2.08e-2)" 26.7 39.4 22.7 20.4 34.4 31.0 21.5 29.7 47.8 21.6 23.4 29.8 19.1 19.1 27.6 27.2 25.0 21.3 23.7 41.0 22.1 19.3 28.8 47.1 23.6 21.2 22.9 25.6 35.3 25.7 31.2 26.0 17.8 38.8 27.2 22.4 29.2 25.1 23.8 62.0 28.0 25.3 26.3 19.1 18.9 21.6 41.6 20.4 48.6 28.7 33.0 26.8 26.0 22.4 11.5 13.7 6.0 13.9 12.4 13.9 9.1 25.7 20.9 8.3 11.2 23.6 25.6 9.5 38.2 17.9 30.6 16.7 18.8 15.8 13.0 13.3 23.9 11.8 19.9 13.3 29.5 23.1 22.4 18.9 18.3 17.1 14.1 13.4 7.1 21.9 21.1 22.0 33.4 19.1 20.9 31.7 20.2 18.5 17.1 40.3 22.3 17.8 7.3 5.7 33.1 25.4 8.8 11.5 18.4 24.3 19.8 10.6 6.5 29.0 21.2 16.1 12.2 24.7 8.5 39.0 24.2 6.8 59.1 18.3 13.7 14.4 13.4 36.9 13.0 11.8 6.0 9.4 4.9 13.1 12.0 12.9 11.5 11.3 12.2 13.7 6.8 12.1 13.9 1.4 12.4 13.9 7.6 13.8 9.1 22.7 34.4 29.7 47.8 22.1 19.3 22.9 25.6 38.8 20.4 26.8 22.3 6.5 17.3 6.1 13.1 36.4 10.2 22.7 29.6 3.5 19.6 10.5 6.6 14.9 149.7 11.3 11.1 0.0 25.0 16.4 10.8 18.9 13.9 13.0 12.9 6.4 17.3 7.4 9.4 75.9 15.8 9.4 18.6 13.6 10.9 5.8 26.9 8.6 13.8 7.5 19.1 6.5 14.2 25.1 19.3 5.0 11.3 8.7 12.4 15.7 PLA2G16 "AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754." ENSG00000176485 "Phospholipase A2 group XVI" P53816 11 63573195-63616883 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 113.6" "Cell type enhanced" "Detected in many" 9 "monocytes: 759.2;Proximal tubular cells: 471.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 52.4" "Group enriched" "Detected in many" 5 "dendritic cells: 52.4;T-cells: 16.0" "Cell line enhanced" "Detected in many" "A549: 32.7;ASC diff: 37.1;CAPAN-2: 59.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011749, HPA058997" Uncertain Supported Mitochondria NA NA Mitochondria "HPA011749: , HPA058997: AB_2683874" "unprognostic (5.18e-2)" "unprognostic (3.67e-2)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.13e-1)" "unprognostic (3.06e-2)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (6.38e-2)" "unprognostic (1.93e-3)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "prognostic favorable (2.54e-5)" "unprognostic (2.35e-1)" 113.6 15.2 32.0 4.4 39.4 1.6 33.9 4.8 30.2 6.1 7.2 46.6 6.1 4.0 5.0 11.5 5.9 13.9 12.9 39.0 37.6 25.2 24.7 28.9 13.5 4.5 58.4 22.2 30.9 13.2 15.1 8.1 16.2 30.5 5.9 3.7 8.8 10.1 13.2 37.8 2.4 7.5 8.0 70.4 6.4 10.2 17.8 48.9 0.1 17.1 11.1 2.3 8.0 4.7 2.1 52.4 0.4 6.2 5.3 16.0 6.4 20.6 32.7 0.9 0.0 37.1 6.4 6.0 0.7 6.6 5.5 2.7 7.4 59.7 0.0 13.8 1.6 18.0 1.0 30.9 1.6 4.2 25.5 1.2 0.3 7.8 1.2 22.1 0.0 0.3 3.8 0.1 13.6 0.5 22.0 8.6 0.0 0.3 2.3 5.8 3.6 0.0 0.1 2.6 13.0 10.6 0.0 0.0 2.0 17.3 2.9 0.4 2.4 4.4 12.5 6.8 14.0 27.1 1.0 12.6 2.4 0.1 8.3 1.8 9.8 6.4 0.0 9.9 0.0 0.2 0.0 6.2 0.0 16.0 2.4 8.8 2.1 3.7 11.6 1.7 0.3 1.2 9.4 0.4 5.3 0.1 52.4 2.4 6.4 32.0 39.4 4.8 21.9 37.6 25.2 58.4 22.2 30.5 48.9 95.3 77.4 17.6 17.3 10.3 10.6 128.7 96.8 113.8 45.5 109.9 3.9 112.1 96.2 54.1 56.9 116.5 22.2 0.0 99.5 300.4 35.3 29.0 56.6 210.7 56.9 38.1 3.4 165.7 48.0 16.0 28.7 51.4 25.3 759.2 4.5 120.3 123.3 14.4 20.5 471.4 17.2 12.9 42.8 135.2 4.9 8.2 243.0 69.8 1.7 59.6 PLEKHO1 "CKIP-1, OC120" ENSG00000023902 "Pleckstrin homology domain containing O1" Q53GL0 1 150149183-150164720 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 60.7" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 188.6;Late spermatids: 315.7;monocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061018 Supported Mitochondria NA NA Mitochondria "HPA061018: AB_2684416" "unprognostic (1.41e-2)" "unprognostic (7.04e-3)" "unprognostic (2.01e-2)" "unprognostic (1.78e-2)" "unprognostic (3.23e-2)" "unprognostic (4.77e-2)" "unprognostic (1.62e-2)" "unprognostic (8.33e-2)" "unprognostic (3.84e-2)" "unprognostic (3.18e-2)" "unprognostic (8.71e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.47e-11)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (1.87e-1)" "unprognostic (6.52e-2)" 10.9 17.0 14.2 34.4 22.1 10.2 10.5 17.0 14.4 9.6 44.5 5.4 6.4 11.8 16.9 7.7 16.8 11.9 14.1 17.8 10.2 6.9 5.8 5.8 12.9 29.0 8.2 13.1 13.5 2.5 1.4 3.5 10.1 8.0 18.2 8.3 7.9 4.7 12.1 15.8 3.6 17.4 60.7 6.5 29.4 22.3 24.8 7.3 15.0 3.8 3.1 17.4 29.3 17.7 11.0 16.0 18.7 15.8 2.1 5.1 5.4 5.1 1.2 17.5 13.6 5.6 5.0 1.4 9.0 12.5 12.3 10.9 0.3 0.1 0.1 1.8 10.6 9.1 0.4 8.7 0.4 4.0 31.1 4.4 1.0 0.7 3.2 10.7 7.1 29.6 7.4 0.4 15.3 2.3 11.7 11.6 14.5 1.9 13.7 16.7 2.4 27.1 14.2 16.4 0.0 2.4 24.7 9.5 5.9 2.0 1.5 11.0 17.9 0.7 0.0 6.8 8.8 0.9 7.1 16.2 8.1 9.2 8.4 10.8 5.2 0.1 3.2 32.3 0.0 3.1 1.5 15.8 0.3 3.5 14.1 3.8 11.0 5.1 3.7 11.7 10.5 3.5 3.0 18.7 2.1 12.8 16.0 3.7 5.4 14.2 22.1 17.0 14.4 10.2 6.9 8.2 13.1 8.0 7.3 32.8 12.8 62.7 62.8 19.2 5.4 33.9 5.1 0.0 2.3 0.0 0.0 1.4 1.7 6.5 188.6 39.6 0.0 0.0 6.7 2.5 27.6 51.8 5.7 0.9 96.3 7.9 17.0 51.5 68.8 315.7 16.1 106.5 23.6 146.1 0.1 32.6 10.1 0.0 23.0 0.0 6.1 71.1 83.4 126.2 12.1 12.4 1.3 24.5 0.3 24.4 PLSCR3 ENSG00000187838 "Phospholipid scramblase 3" Q9NRY6 17 7389727-7394843 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.0;Ductal cells: 5.1;Exocrine glandular cells: 3.2;monocytes: 3.6;Pancreatic endocrine cells: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048387, HPA068609" Supported Supported Mitochondria NA NA Mitochondria "HPA048387: AB_2680381, HPA068609: AB_2686011" "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (2.29e-2)" "unprognostic (1.56e-2)" "unprognostic (4.36e-2)" "unprognostic (5.02e-2)" "unprognostic (2.27e-2)" "unprognostic (9.71e-2)" "unprognostic (1.75e-3)" "unprognostic (1.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.77e-2)" "unprognostic (2.11e-5)" "unprognostic (1.24e-2)" "unprognostic (1.48e-1)" "unprognostic (1.97e-1)" "unprognostic (2.55e-2)" 21.9 11.5 6.2 17.8 6.1 5.2 31.0 4.4 7.9 24.0 12.7 7.4 16.3 5.6 29.2 22.0 21.6 15.6 17.7 25.3 5.6 5.7 15.3 12.9 25.0 67.2 5.8 7.6 19.9 10.0 10.1 9.0 17.3 8.4 15.4 6.3 10.2 12.5 17.8 16.1 17.8 10.5 21.4 13.1 29.0 11.6 8.6 6.4 12.1 12.2 26.0 21.0 21.5 20.1 12.9 9.5 1.9 13.3 6.6 30.8 12.1 14.3 3.2 2.7 8.4 10.4 18.3 3.7 13.0 12.0 11.1 10.5 4.9 3.3 3.6 10.7 18.8 4.8 19.6 3.5 21.3 5.7 9.8 1.9 3.4 4.4 3.4 14.0 1.2 4.5 13.2 14.5 11.2 16.8 17.8 17.3 7.7 2.0 2.8 14.5 7.3 3.8 1.0 2.5 4.0 9.2 7.9 2.3 3.8 10.5 9.3 2.4 8.1 6.6 4.8 3.1 2.7 8.3 0.6 28.0 7.7 7.8 8.8 5.4 3.2 3.6 1.4 12.0 4.3 8.9 1.9 10.0 1.1 16.8 13.3 17.1 12.9 30.5 17.1 9.5 12.0 25.2 15.0 1.0 6.6 10.9 1.1 30.8 12.1 6.2 6.1 4.4 7.9 5.6 5.7 5.8 7.6 8.4 6.4 3.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PNPT1 "DFNB70, old-35, OLD35, PNPase" ENSG00000138035 "Polyribonucleotide nucleotidyltransferase 1" Q8TCS8 2 55634265-55693910 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transport" "Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase" "Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033424, HPA034602, HPA034603" Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130" "unprognostic (9.09e-2)" "unprognostic (7.40e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (3.40e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (1.95e-7)" "unprognostic (1.88e-1)" "unprognostic (5.93e-3)" "unprognostic (5.23e-2)" "prognostic unfavorable (5.44e-5)" "unprognostic (2.19e-2)" "unprognostic (2.11e-2)" "unprognostic (6.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 11.1 11.7 13.3 6.5 21.7 11.7 10.8 13.3 18.8 5.7 8.2 12.8 5.4 5.7 8.3 8.8 9.5 7.9 5.8 11.0 12.4 10.9 9.8 11.4 9.1 7.1 24.1 7.4 6.9 9.1 7.4 14.3 5.1 15.2 7.7 10.1 4.2 9.0 6.3 23.5 10.1 7.0 7.9 17.6 10.4 7.6 13.5 22.5 9.6 10.0 7.8 5.9 5.3 7.4 9.8 7.4 6.1 6.5 3.8 8.6 4.7 6.8 3.7 5.1 2.3 3.6 6.4 6.8 10.2 6.2 16.2 10.9 10.7 3.2 14.3 4.3 4.7 5.2 5.5 6.5 7.9 7.5 5.1 14.4 8.3 4.7 5.4 9.7 18.6 5.6 7.1 5.5 6.7 5.8 3.9 4.9 6.0 8.7 3.2 6.4 3.9 11.3 13.1 12.3 7.2 6.2 11.3 8.5 12.6 6.8 4.3 12.4 7.4 3.6 11.3 12.4 4.7 3.0 8.3 5.1 3.8 3.2 3.4 10.4 14.5 1.1 3.1 7.4 16.3 6.5 4.2 6.5 6.1 8.1 5.7 4.8 5.4 3.7 8.6 2.8 9.8 6.9 7.9 6.1 3.8 5.1 7.4 2.4 4.7 13.3 21.7 13.3 18.8 12.4 10.9 24.1 7.4 15.2 22.5 44.7 72.6 7.5 15.0 21.5 40.4 23.8 12.7 46.8 69.4 19.2 55.0 17.7 8.3 14.2 15.0 19.3 7.4 0.0 13.8 18.9 14.2 10.3 54.6 14.7 13.8 28.6 9.8 12.9 11.1 1.9 16.1 15.2 15.1 9.0 12.3 27.5 11.7 14.1 17.3 16.7 61.4 25.8 18.4 39.0 20.0 17.7 10.3 17.3 16.4 14.2 POLG "POLG1, POLGA" ENSG00000140521 "DNA polymerase gamma, catalytic subunit" P54098 15 89305198-89334861 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease mutation, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056821, HPA078482" Approved Supported Mitochondria NA NA Mitochondria "HPA056821: AB_2683247, HPA078482: " "unprognostic (1.87e-1)" "unprognostic (4.71e-2)" "unprognostic (2.61e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (3.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.63e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.65e-3)" "unprognostic (1.58e-2)" "unprognostic (4.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.45e-1)" 17.8 15.2 19.8 19.0 19.2 16.8 24.6 23.2 20.9 14.1 16.0 14.6 13.6 20.0 17.6 9.0 20.7 14.3 14.0 17.4 16.7 8.8 14.9 19.5 17.8 21.8 17.3 15.3 16.6 17.9 17.7 12.9 16.2 16.0 15.4 13.2 10.5 15.9 12.0 35.9 19.8 18.5 14.1 12.7 22.9 16.2 12.4 17.3 29.0 15.4 12.1 19.2 16.5 18.9 6.0 9.0 9.0 6.5 9.2 10.9 6.7 6.7 12.8 8.8 11.5 14.4 9.2 11.2 13.4 7.2 13.8 10.9 18.6 16.8 10.6 20.7 10.5 16.5 14.6 23.5 11.4 4.7 22.8 20.2 16.0 13.4 6.7 12.2 14.9 26.5 8.3 16.7 9.5 8.2 12.3 16.4 30.2 14.1 11.9 11.1 11.8 16.9 15.2 8.0 13.4 5.7 17.4 10.8 15.0 7.9 16.5 19.6 7.2 19.1 14.0 15.6 10.9 11.6 16.7 12.3 18.7 12.9 27.4 12.8 12.8 7.5 14.7 12.0 17.1 14.9 4.9 6.3 9.0 9.2 6.5 8.0 3.3 7.6 10.9 9.0 6.0 6.6 6.9 2.3 9.2 5.2 6.0 4.3 6.7 19.8 19.2 23.2 20.9 16.7 8.8 17.3 15.3 16.0 17.3 11.9 11.0 15.5 9.7 10.9 6.8 15.7 10.2 1.4 6.8 10.4 2.0 12.0 8.3 9.0 0.9 12.1 12.3 0.0 9.3 13.6 11.4 12.5 8.1 14.0 11.4 3.2 5.2 17.2 19.0 1.1 13.3 12.7 18.6 20.8 23.4 6.0 10.2 17.0 9.9 6.2 6.2 6.5 15.1 7.4 12.9 10.5 18.2 16.6 15.7 12.0 POLG2 "HP55, MTPOLB" ENSG00000256525 "DNA polymerase gamma 2, accessory subunit" Q9UHN1 17 64477785-64497036 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017030, HPA023202" Approved Approved "Nuclear bodies,Mitochondria" NA NA "Nuclear bodies" Mitochondria "CAB017030: , HPA023202: AB_1855523" "unprognostic (1.76e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.02e-2)" "unprognostic (6.01e-2)" "unprognostic (2.91e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (4.38e-2)" "unprognostic (8.46e-2)" "unprognostic (3.14e-1)" "unprognostic (5.17e-3)" "prognostic unfavorable (6.59e-4)" "prognostic unfavorable (1.17e-5)" "unprognostic (5.17e-2)" "unprognostic (1.58e-1)" "unprognostic (2.88e-2)" "unprognostic (4.82e-2)" 6.7 9.3 5.4 17.5 10.0 8.1 8.2 10.9 8.7 7.7 7.8 7.0 11.1 7.9 10.2 6.8 6.4 7.5 7.9 7.3 5.6 4.4 7.8 7.8 10.4 12.2 10.8 5.2 13.0 9.4 5.0 9.9 6.9 8.7 8.0 5.7 5.8 8.6 11.9 10.7 10.5 8.4 9.3 5.6 11.5 6.9 24.2 7.9 9.8 9.6 5.4 13.3 6.6 11.5 12.2 10.5 6.5 8.2 6.0 12.2 4.4 6.9 8.5 6.1 7.5 5.8 4.7 7.4 4.1 3.9 6.3 5.4 8.8 5.5 12.7 5.0 2.2 6.5 5.7 8.3 3.9 7.9 3.5 9.7 8.6 10.3 8.7 6.5 12.1 9.6 4.7 4.5 5.0 7.5 8.7 4.5 7.7 15.1 4.9 6.1 9.2 12.9 16.1 6.4 7.6 9.5 12.0 20.1 13.4 5.7 2.0 8.6 9.6 3.3 7.4 7.6 9.9 7.3 10.2 5.0 6.8 9.0 5.8 10.7 8.7 5.9 9.6 5.3 11.4 4.7 6.5 5.9 6.5 7.9 3.5 7.5 12.2 8.8 7.6 10.5 12.1 12.2 11.6 1.2 6.0 8.2 4.8 8.4 4.4 5.4 10.0 10.9 8.7 5.6 4.4 10.8 5.2 8.7 7.9 11.9 23.4 11.1 7.7 7.2 4.0 15.7 17.8 5.3 14.8 3.5 0.0 10.9 0.0 4.3 9.2 12.4 11.2 0.0 3.2 12.2 9.9 9.7 12.7 3.8 8.2 6.4 10.5 18.4 7.8 5.0 6.1 6.9 6.8 3.6 13.9 3.0 2.7 16.7 2.8 4.3 8.4 6.5 8.6 52.0 8.2 7.5 3.3 10.2 18.2 4.7 POLRMT "APOLMT, h-mtRPOL, MTRNAP, MTRPOL" ENSG00000099821 "RNA polymerase mitochondrial" O00411 19 617224-633604 "Enzymes, Predicted intracellular proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 63.9;Spermatogonia: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006366 Uncertain Supported Mitochondria NA NA Mitochondria "HPA006366: AB_1079654" "unprognostic (3.24e-1)" "unprognostic (4.31e-2)" "unprognostic (7.96e-2)" "prognostic favorable (4.50e-4)" "unprognostic (9.46e-2)" "unprognostic (2.94e-2)" "unprognostic (3.04e-2)" "unprognostic (9.41e-2)" "unprognostic (1.45e-1)" "unprognostic (3.48e-1)" "unprognostic (7.64e-3)" "unprognostic (1.81e-2)" "unprognostic (1.62e-1)" "unprognostic (1.28e-3)" "unprognostic (1.66e-1)" "unprognostic (2.92e-1)" "unprognostic (1.01e-1)" 10.2 10.7 10.1 16.3 11.9 6.9 8.1 12.1 20.7 9.5 11.6 12.3 4.4 16.7 9.8 12.2 14.4 8.7 12.7 24.7 11.5 8.9 12.9 21.4 7.3 11.8 9.4 15.1 10.1 15.9 9.5 10.7 6.2 9.7 10.2 8.8 8.5 9.6 11.7 42.2 16.7 12.8 10.8 8.4 12.8 11.2 32.1 6.3 11.6 11.1 8.6 10.4 10.1 7.8 8.2 7.3 3.1 5.5 7.5 9.0 5.3 10.5 19.1 4.4 19.2 9.2 5.2 16.1 4.9 5.9 7.4 6.7 19.2 7.3 10.8 10.1 4.5 3.7 10.9 16.2 9.4 5.5 12.1 38.5 8.4 11.9 24.6 9.6 14.2 16.1 5.0 13.3 7.5 9.1 5.3 10.3 15.2 15.8 10.9 6.7 14.9 18.8 19.5 17.4 13.8 13.4 18.2 6.0 18.5 9.7 9.0 14.0 10.0 4.5 12.2 12.3 4.9 6.9 13.0 6.1 8.0 10.2 12.5 14.5 25.9 21.3 16.5 17.1 11.9 9.7 0.0 3.7 3.1 9.0 5.2 7.1 7.8 6.7 6.6 7.3 8.2 5.7 6.3 0.6 7.5 5.5 7.2 4.1 5.3 10.1 11.9 12.1 20.7 11.5 8.9 9.4 15.1 9.7 6.3 11.9 14.4 8.8 5.0 7.1 17.9 15.6 10.2 4.0 9.1 15.7 17.7 13.3 6.6 5.3 31.3 7.1 22.6 0.0 6.7 7.0 6.0 5.1 12.7 22.5 9.2 11.1 12.5 8.6 7.9 63.9 11.5 9.2 10.1 3.6 12.0 7.8 5.6 11.5 12.4 14.6 15.8 6.5 9.9 30.7 84.7 6.4 6.4 8.7 19.1 5.4 PPIF "Cyp-D, hCyP3" ENSG00000108179 "Peptidylprolyl isomerase F" P30405 10 79347469-79355337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Necrosis" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 32.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077416 Supported Mitochondria NA NA 27000000 Mitochondria "HPA077416: AB_2686840" "unprognostic (2.21e-1)" "unprognostic (5.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.72e-3)" "unprognostic (1.69e-1)" "unprognostic (3.16e-3)" "unprognostic (3.45e-1)" "unprognostic (4.33e-3)" "unprognostic (1.66e-1)" "unprognostic (1.97e-1)" "unprognostic (2.82e-1)" "unprognostic (9.37e-3)" "unprognostic (1.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.88e-2)" 16.5 76.2 12.1 15.7 18.8 52.0 16.9 7.1 21.3 8.3 18.1 27.1 13.2 13.3 5.2 7.6 21.0 8.8 10.0 36.5 13.0 14.5 21.0 73.1 9.4 19.4 23.3 16.6 7.2 42.0 12.0 6.2 11.3 25.2 6.6 19.9 7.5 12.7 21.9 44.4 22.5 11.1 9.9 28.0 19.6 34.0 20.8 18.0 8.8 10.0 73.9 19.8 12.5 11.0 8.0 18.6 32.8 14.9 3.6 5.0 6.5 35.6 15.2 10.7 21.0 10.0 13.0 13.7 20.8 27.3 45.8 43.4 35.5 17.3 37.1 11.6 14.6 32.6 21.4 33.1 19.4 71.5 11.7 31.2 58.1 14.9 62.4 17.0 40.0 13.8 30.4 13.9 45.4 45.5 14.9 8.0 14.6 56.5 45.8 15.5 18.3 10.3 33.5 9.0 16.4 84.5 17.8 16.5 19.0 17.8 33.3 21.3 15.8 10.7 43.3 16.0 7.3 18.9 30.9 7.2 20.1 18.3 23.6 40.0 21.3 21.6 30.0 19.9 52.1 5.4 5.1 14.9 7.3 4.7 11.4 5.0 8.0 4.2 4.3 18.6 3.9 3.8 3.7 32.8 3.6 4.1 2.3 4.2 6.5 12.1 18.8 7.1 21.3 13.0 14.5 23.3 16.6 25.2 18.0 6.0 5.0 34.4 26.4 37.8 4.4 106.2 15.3 12.0 9.1 12.2 5.9 70.1 77.9 37.7 11.0 13.8 22.2 46.7 24.2 113.4 24.0 17.4 13.8 70.1 83.0 7.9 20.7 8.6 32.4 11.1 5.8 60.2 33.7 33.3 62.3 9.9 40.0 17.5 5.6 31.1 4.9 19.4 24.1 7.0 22.2 33.0 119.0 17.5 63.7 28.5 PPM1K "BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm" ENSG00000163644 "Protein phosphatase, Mg2+/Mn2+ dependent 1K" Q8N3J5 4 88257620-88284769 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 59.1" "Cell type enhanced" "Detected in all" 12 "Cardiomyocytes: 417.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 27.5;Karpas-707: 24.0;U-698: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020066, HPA020862, HPA023891" Approved Supported Mitochondria No No Mitochondria "HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630" "unprognostic (2.38e-2)" "unprognostic (5.86e-2)" "unprognostic (7.42e-3)" "unprognostic (6.70e-3)" "unprognostic (1.18e-1)" "unprognostic (1.17e-3)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (5.50e-2)" "unprognostic (1.41e-2)" "unprognostic (9.25e-3)" "unprognostic (6.56e-2)" "unprognostic (9.82e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "unprognostic (2.28e-1)" 3.6 6.1 19.2 8.8 17.2 5.9 9.3 21.1 26.8 12.9 3.8 12.5 2.5 3.0 21.8 5.5 7.6 14.1 6.0 59.1 23.1 14.6 11.8 5.1 6.5 14.5 21.6 15.9 22.0 7.3 10.4 8.4 6.4 17.0 11.1 4.3 4.7 7.1 5.3 8.3 1.9 6.7 18.2 15.0 10.9 5.4 12.3 19.4 7.3 5.4 1.9 15.8 6.5 8.1 31.8 38.8 5.5 3.4 7.9 16.1 7.1 2.2 0.7 2.8 5.0 4.3 5.6 1.1 3.5 6.4 11.8 14.0 5.7 0.5 27.5 3.9 2.2 5.7 0.2 8.4 2.7 4.7 21.2 3.5 4.9 2.2 5.1 3.3 6.7 2.6 3.7 1.3 7.2 6.3 2.4 1.9 11.9 7.3 24.0 3.4 3.1 8.8 3.7 1.7 1.6 1.1 5.0 4.7 10.5 4.1 0.9 2.2 1.9 2.2 0.2 2.6 4.9 11.4 1.9 0.4 4.1 2.1 1.3 2.0 7.6 6.9 23.0 4.5 5.5 6.8 5.5 2.9 2.3 12.4 3.4 16.1 30.4 11.8 12.4 5.5 31.8 11.7 14.1 0.9 7.9 0.9 38.8 13.3 7.1 19.2 17.2 21.1 26.8 23.1 14.6 21.6 15.9 17.0 19.4 44.7 11.3 104.3 16.5 8.8 97.4 417.4 7.6 24.1 17.0 47.1 17.7 9.4 132.6 5.9 6.1 17.6 2.0 46.7 5.4 2.6 28.3 31.2 18.5 22.1 23.1 81.0 9.2 20.3 11.1 6.2 22.2 13.9 20.3 111.0 15.6 19.2 6.3 4.9 29.7 39.1 14.1 25.8 38.7 35.6 21.3 4.6 2.4 54.8 2.9 5.7 PRDX3 "AOP-1, AOP1, MER5, SP-22" ENSG00000165672 "Peroxiredoxin 3" P30048 10 119167703-119178833 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 898.6;Proximal tubular cells: 684.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008656, HPA041488, CAB079909" Enhanced Supported Mitochondria NA NA 14000000 Mitochondria "CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508" "unprognostic (8.29e-2)" "unprognostic (1.02e-1)" "unprognostic (1.26e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (1.72e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (2.06e-1)" "unprognostic (3.65e-2)" "unprognostic (1.29e-2)" "unprognostic (9.48e-2)" "unprognostic (6.03e-3)" "unprognostic (2.77e-1)" "unprognostic (2.77e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" 34.0 100.7 28.8 18.8 28.3 14.4 29.1 16.1 28.9 23.0 27.1 20.7 25.1 28.1 25.5 26.3 30.6 24.8 21.8 55.8 26.7 28.2 78.8 114.8 16.3 20.0 29.9 23.2 19.2 34.1 25.2 24.6 29.9 33.6 27.4 29.6 21.2 40.5 29.3 80.9 10.3 34.6 26.8 24.1 27.4 24.6 14.0 24.6 24.3 48.9 46.1 20.5 25.9 17.9 30.9 65.7 41.4 74.9 20.9 34.2 73.0 54.1 62.1 37.9 43.0 40.1 43.5 23.7 38.9 66.4 59.4 62.5 47.6 54.3 63.6 34.1 45.8 28.3 24.8 62.6 47.0 67.1 62.2 65.9 28.6 27.0 84.2 42.0 53.5 34.7 50.9 30.3 47.4 44.2 42.7 42.9 39.1 35.1 13.3 54.3 21.7 40.4 45.3 35.4 41.3 36.8 43.0 55.1 43.9 100.3 26.0 16.7 24.3 41.3 55.8 51.0 34.2 28.9 64.5 30.2 19.4 29.3 27.7 50.4 20.8 30.3 51.0 30.5 79.5 17.2 19.5 74.9 40.8 20.3 61.8 25.9 30.9 27.1 24.5 65.7 24.3 28.3 25.2 41.4 20.9 53.2 36.8 34.2 73.0 28.8 28.3 16.1 28.9 26.7 28.2 29.9 23.2 33.6 24.6 44.7 64.4 72.5 95.3 62.0 25.6 212.3 122.3 104.4 39.8 139.6 9.8 296.9 898.6 109.2 4.2 70.9 99.7 70.0 65.9 187.6 95.6 106.7 51.9 340.4 218.6 38.1 106.5 71.2 159.0 8.6 71.7 113.7 126.5 146.1 117.2 58.7 65.7 98.2 95.1 684.3 19.1 71.1 104.2 10.0 22.8 45.9 129.6 54.3 181.8 109.3 PRDX5 "ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10" ENSG00000126432 "Peroxiredoxin 5" P30044 11 64318088-64321811 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008661, HPA037915, HPA037916" Enhanced Supported Mitochondria NA NA 19000000 Mitochondria "CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736" "unprognostic (2.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (9.43e-2)" "unprognostic (6.71e-3)" "unprognostic (1.08e-3)" "unprognostic (3.11e-1)" "unprognostic (9.30e-2)" "unprognostic (1.07e-3)" "unprognostic (1.57e-2)" "unprognostic (2.20e-1)" "prognostic favorable (1.24e-5)" "unprognostic (8.19e-2)" "unprognostic (2.30e-1)" "unprognostic (9.63e-2)" "unprognostic (5.03e-2)" 28.7 69.7 70.3 38.6 60.3 57.0 35.5 69.3 73.9 47.2 79.3 31.9 49.0 49.5 26.6 54.8 69.6 94.9 44.8 102.4 56.7 74.2 57.3 54.2 50.3 25.0 68.6 70.2 42.2 72.0 36.0 53.7 49.1 71.4 30.7 71.2 33.9 77.5 62.6 104.7 27.0 51.2 30.9 44.1 27.3 64.5 35.0 29.3 25.1 82.0 64.8 33.5 34.4 50.4 55.2 69.2 115.0 66.9 48.4 40.5 75.3 26.3 53.8 32.6 53.9 35.1 52.9 37.7 33.0 52.9 24.3 30.3 39.1 54.1 38.6 57.8 52.7 87.4 60.3 30.4 70.1 15.4 53.6 24.0 39.0 84.6 44.5 72.1 14.7 33.3 53.6 91.6 40.7 41.3 47.5 36.8 45.9 21.9 91.9 34.1 66.8 25.7 64.1 49.3 41.7 68.8 24.8 33.5 136.5 90.8 52.3 27.6 52.6 27.6 61.3 94.1 32.6 44.9 33.6 35.5 34.7 32.3 40.1 14.5 47.0 56.0 45.5 42.0 29.8 27.0 79.8 66.9 85.4 37.7 59.6 32.7 53.8 35.0 30.8 52.4 55.2 34.8 35.0 115.0 48.4 52.5 69.2 40.5 75.3 70.3 60.3 69.3 73.9 56.7 74.2 68.6 70.2 71.4 29.3 247.1 407.2 232.2 603.5 290.1 156.4 523.8 356.7 1310.3 342.4 427.5 66.8 1002.3 1366.1 644.2 57.6 187.4 757.5 163.5 919.1 972.3 308.0 330.5 103.7 331.1 418.0 87.4 770.7 194.0 207.8 207.7 258.3 234.8 413.3 423.8 875.2 180.0 1093.8 547.1 213.2 1094.9 109.1 194.1 199.4 113.7 345.0 225.2 818.7 191.8 959.8 988.5 PRELID1 "CGI-106, PRELI, PX19" ENSG00000169230 "PRELI domain containing 1" Q9Y255 5 177303774-177306959 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005701 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA005701: AB_1079721" "unprognostic (1.27e-1)" "unprognostic (8.99e-2)" "unprognostic (3.18e-2)" "unprognostic (2.09e-3)" "unprognostic (2.19e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (7.63e-3)" "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (1.71e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.89e-7)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" 18.9 25.0 21.9 33.9 20.3 30.3 21.6 12.0 31.1 16.9 44.6 14.8 15.4 43.5 18.3 15.5 35.6 17.4 20.6 16.8 19.3 18.6 46.1 62.3 18.9 43.0 20.2 14.7 20.3 91.6 12.3 17.7 29.4 21.0 19.8 35.0 18.9 40.1 16.4 11.9 26.2 70.6 19.0 14.8 43.5 24.6 12.9 13.5 25.2 29.3 27.2 33.7 18.0 18.9 27.1 77.4 111.7 94.2 30.4 26.4 49.2 32.3 30.4 18.5 49.4 16.6 18.0 61.7 23.1 16.2 33.8 32.7 68.1 37.1 27.5 27.3 21.7 36.8 18.4 33.0 61.8 23.1 117.7 45.7 23.8 31.5 45.3 17.5 37.3 33.4 16.2 22.3 26.6 22.8 14.0 41.8 19.8 26.1 39.9 32.8 84.0 23.9 54.6 37.7 37.8 50.4 7.7 37.4 49.4 22.0 27.1 29.6 37.2 21.6 43.1 40.1 24.1 27.8 46.0 23.0 31.0 27.1 25.4 55.3 22.4 38.2 40.0 26.7 50.4 32.1 31.5 75.7 111.7 26.4 94.2 25.8 27.1 21.9 26.2 77.4 21.1 19.3 21.1 55.2 30.4 90.3 28.3 23.3 49.2 21.9 20.3 12.0 31.1 19.3 18.6 20.2 14.7 21.0 13.5 20.8 22.6 181.8 227.7 309.4 61.7 0.3 145.2 13.4 28.4 99.5 21.6 650.2 257.0 407.3 4.8 123.4 610.0 116.8 488.9 446.5 187.8 329.7 110.3 191.7 318.8 57.2 151.0 114.8 245.1 15.2 105.6 182.1 243.0 153.3 210.5 81.8 553.8 343.7 102.6 293.8 49.9 45.3 167.5 80.1 183.7 367.9 738.9 173.0 351.5 462.0 PTRH2 "BIT1, CFAP37, CGI-147, PTH2" ENSG00000141378 "Peptidyl-tRNA hydrolase 2" Q9Y3E5 17 59674636-59707626 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Apoptosis Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012897 Supported Supported Mitochondria NA NA Mitochondria "HPA012897: AB_1855949" "unprognostic (2.26e-1)" "unprognostic (2.80e-2)" "unprognostic (1.02e-2)" "unprognostic (3.89e-2)" "unprognostic (1.31e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.38e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (2.72e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.01e-8)" "unprognostic (5.43e-3)" "unprognostic (6.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.49e-2)" 15.9 22.9 17.1 12.4 17.1 9.9 20.7 12.5 22.1 15.6 17.2 11.8 16.3 11.6 14.3 36.7 16.4 13.8 13.1 12.6 19.3 17.8 14.8 34.7 12.1 12.5 16.7 15.2 14.2 19.9 10.3 18.3 13.6 21.0 15.9 20.7 8.1 13.7 18.7 23.3 11.4 11.0 16.8 17.1 15.5 14.3 15.7 18.1 9.0 11.8 13.5 16.9 13.0 10.5 15.6 21.6 12.6 29.3 13.1 15.5 13.0 18.9 36.2 11.7 10.6 22.2 19.1 12.5 18.3 16.1 15.7 23.0 23.4 14.9 13.8 27.8 15.3 26.9 18.9 25.1 23.6 22.9 26.5 34.1 24.6 18.8 42.8 34.3 21.7 14.0 21.5 30.7 24.3 28.3 11.2 26.1 9.7 27.4 15.4 23.3 45.8 18.5 17.7 10.0 49.3 28.7 10.1 19.6 20.1 26.1 27.3 15.1 19.6 9.4 10.3 22.4 14.0 24.1 15.5 17.1 20.5 20.7 12.2 19.8 20.0 22.2 20.4 13.5 13.6 15.6 1.9 25.8 1.1 9.2 24.4 12.4 15.6 10.8 10.4 18.5 13.1 15.5 11.1 12.6 13.1 29.3 21.6 12.3 13.0 17.1 17.1 12.5 22.1 19.3 17.8 16.7 15.2 21.0 18.1 14.9 12.8 13.4 31.9 32.5 3.3 14.8 7.6 30.8 50.0 10.4 3.9 22.1 10.0 25.9 17.7 18.3 9.1 0.0 22.0 20.6 19.7 23.3 22.0 27.3 15.2 7.9 6.4 11.6 7.3 7.9 16.1 18.7 13.5 10.0 9.7 6.6 25.9 13.9 9.2 13.2 3.2 12.9 21.7 16.7 11.4 31.1 26.5 8.3 13.2 31.5 PUS1 ENSG00000177192 "Pseudouridylate synthase 1" Q9Y606 12 131929200-131945896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051636, HPA057593" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051636: AB_2681560, HPA057593: AB_2683479" "unprognostic (2.72e-1)" "unprognostic (9.13e-2)" "unprognostic (1.81e-1)" "unprognostic (2.69e-2)" "unprognostic (8.12e-3)" "unprognostic (8.07e-2)" "unprognostic (4.57e-3)" "unprognostic (7.34e-2)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (2.06e-1)" "unprognostic (5.30e-2)" "prognostic unfavorable (3.49e-8)" "unprognostic (1.80e-3)" "unprognostic (8.06e-2)" "unprognostic (8.59e-2)" "unprognostic (1.56e-2)" 12.7 15.8 18.8 19.5 23.3 26.2 11.2 8.8 16.9 8.7 11.9 9.4 11.0 12.4 13.6 18.7 16.5 12.9 25.1 8.6 15.6 8.3 10.7 22.8 11.0 21.4 11.7 15.8 10.1 19.8 7.2 9.5 8.3 11.7 11.7 10.5 7.6 11.4 15.7 13.5 15.4 13.9 9.7 6.2 17.4 13.6 11.9 16.4 11.6 10.3 11.6 15.8 10.8 12.8 5.9 4.6 1.9 2.0 9.1 4.0 1.3 15.4 20.2 4.8 8.5 4.6 7.9 29.5 11.9 5.0 9.1 5.9 22.3 10.1 18.4 13.8 6.5 7.1 19.6 15.8 11.3 5.9 8.1 31.9 18.5 9.8 19.4 12.5 31.7 17.1 8.0 9.2 10.4 8.9 4.4 8.9 12.9 22.9 5.7 5.2 26.8 20.8 28.5 25.3 12.6 30.8 19.9 6.8 19.1 7.4 21.5 13.4 7.5 10.0 13.7 11.0 4.9 15.0 34.3 7.7 7.3 15.6 15.4 17.2 15.6 11.7 21.9 7.5 25.4 10.0 1.2 2.0 0.4 3.2 1.4 2.2 5.9 2.7 3.3 1.6 5.5 4.0 2.1 1.9 9.1 1.3 4.6 2.4 1.3 18.8 23.3 8.8 16.9 15.6 8.3 11.7 15.8 11.7 16.4 0.0 6.7 10.0 16.1 26.3 5.2 4.5 12.7 4.0 3.4 5.2 21.6 12.0 5.0 9.3 0.6 9.0 4.5 0.0 8.2 14.4 9.6 13.4 16.1 11.3 13.6 0.0 13.8 8.0 7.3 2.0 7.2 8.9 6.8 8.2 17.2 4.6 12.7 7.0 8.9 10.4 9.6 6.5 11.8 16.5 22.1 19.8 7.2 7.5 15.5 13.7 RAD51C "FANCO, RAD51L2" ENSG00000108384 "RAD51 paralog C" O43502 17 58692573-58735611 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 79.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045198 Supported "Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol" NA NA "Nucleoplasm, Mitochondria, Cytosol" "Vesicles, Cell Junctions" "HPA045198: AB_2679250" "unprognostic (5.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (6.20e-2)" "unprognostic (1.83e-1)" "unprognostic (4.59e-2)" "prognostic unfavorable (8.68e-5)" "unprognostic (3.65e-2)" "unprognostic (2.91e-2)" "unprognostic (1.03e-2)" "prognostic favorable (5.33e-4)" "unprognostic (2.55e-1)" "unprognostic (2.62e-2)" "unprognostic (7.62e-2)" "unprognostic (2.41e-1)" "unprognostic (9.52e-2)" "unprognostic (2.42e-2)" 11.1 22.7 22.1 10.1 20.8 19.4 15.4 20.8 31.0 12.3 13.7 16.0 11.1 7.3 14.3 23.1 13.2 11.8 10.9 24.9 20.2 17.4 13.7 13.9 8.9 19.6 17.2 21.4 13.4 11.2 20.0 18.3 15.1 28.9 18.3 15.0 13.2 10.6 12.7 15.5 10.3 9.6 14.4 14.0 14.4 13.2 18.9 12.7 23.8 12.6 11.7 18.6 12.6 11.8 14.4 13.0 18.8 11.3 11.2 21.7 9.2 15.7 18.3 11.3 12.4 6.2 5.3 25.8 8.6 4.0 11.6 14.8 7.8 10.2 9.3 12.8 5.9 15.3 6.0 15.1 12.2 21.6 22.6 31.3 13.1 20.6 29.4 6.1 16.8 11.7 3.2 11.0 12.9 10.5 6.2 12.9 15.6 20.3 12.8 9.9 79.0 23.8 23.4 3.0 10.5 17.0 15.3 17.9 17.5 7.0 9.9 14.0 13.0 6.9 3.4 13.0 3.0 10.2 17.8 4.1 9.8 26.0 8.8 10.5 12.0 44.5 27.2 9.9 16.6 11.2 18.8 7.5 9.8 13.7 11.3 13.3 14.1 15.0 14.9 13.0 14.4 16.4 15.4 4.6 11.2 9.8 11.7 21.7 9.2 22.1 20.8 20.8 31.0 20.2 17.4 17.2 21.4 28.9 12.7 17.9 11.5 15.2 17.6 10.5 14.6 54.1 10.2 10.7 13.6 15.7 5.9 46.3 49.7 22.6 78.9 14.9 4.2 70.0 16.3 78.6 13.4 14.4 23.0 12.5 29.2 15.9 6.4 14.1 13.4 51.1 16.1 22.9 23.6 22.6 13.1 21.7 12.0 10.5 14.5 19.5 23.0 32.3 22.1 113.9 80.6 9.4 30.3 21.3 12.5 8.4 RDH13 SDR7C3 ENSG00000160439 "Retinol dehydrogenase 13" Q8NBN7 19 55039108-55071291 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Syncytiotrophoblasts: 175.4;Urothelial cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042006 Approved Supported Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA042006: AB_10960270" "unprognostic (9.26e-2)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.15e-2)" "unprognostic (8.74e-2)" "unprognostic (1.08e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-1)" "unprognostic (9.42e-3)" "unprognostic (1.61e-1)" "unprognostic (2.45e-3)" "prognostic favorable (2.09e-4)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.12e-2)" "unprognostic (1.66e-3)" 4.4 6.8 4.0 6.0 6.6 5.5 4.2 8.7 9.4 7.5 8.3 3.5 9.0 5.1 5.0 5.0 17.6 4.2 7.1 11.4 3.0 5.4 8.8 7.5 5.6 5.1 4.7 5.2 3.8 10.7 8.8 6.1 34.0 10.0 5.7 4.0 6.4 11.6 13.1 9.4 18.0 6.9 5.2 2.2 6.8 9.5 4.4 3.0 2.1 7.2 8.6 8.9 8.5 10.2 7.4 6.0 5.4 6.7 6.1 8.5 3.5 3.1 3.6 0.6 1.9 0.4 0.4 5.8 2.9 0.3 2.1 1.5 5.4 3.6 1.8 2.4 0.7 0.4 3.2 3.8 2.3 0.2 1.6 10.1 2.0 4.7 3.7 0.9 4.8 1.4 1.3 0.9 1.9 1.4 0.7 2.8 1.6 4.0 1.0 0.7 5.2 0.8 3.1 0.8 6.9 4.7 2.5 1.0 10.0 1.3 5.5 2.2 2.7 2.8 8.0 3.6 0.6 3.9 4.7 2.9 0.3 1.1 0.2 3.9 2.0 3.6 2.2 1.5 3.4 2.0 4.1 4.1 5.4 8.5 6.7 7.7 6.1 7.0 7.7 4.5 7.4 8.4 6.8 2.6 6.1 5.9 6.0 5.7 3.5 4.0 6.6 8.7 9.4 3.0 5.4 4.7 5.2 10.0 3.0 14.9 16.2 5.1 19.9 9.5 17.3 22.2 28.1 6.7 11.4 14.0 39.3 30.2 10.0 12.3 18.5 6.5 27.1 0.0 5.7 26.9 6.0 23.1 8.1 6.0 9.9 23.8 11.5 16.5 4.1 11.2 3.4 5.0 6.8 1.8 19.8 10.0 11.4 26.2 3.2 3.4 27.0 6.5 5.1 1.4 9.6 15.3 175.4 8.7 21.9 72.9 REXO2 "CGI-114, DKFZP566E144, SFN" ENSG00000076043 "RNA exonuclease 2" Q9Y3B8 11 114439386-114450279 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038450, HPA038451" Enhanced Supported "Nucleoli,Focal adhesion sites,Mitochondria" NA NA 390000 Mitochondria "Nucleoli, Focal adhesion sites" "HPA038450: AB_10672516, HPA038451: AB_10697391" "unprognostic (3.26e-3)" "unprognostic (2.36e-2)" "prognostic favorable (6.51e-4)" "unprognostic (6.84e-3)" "unprognostic (5.80e-3)" "unprognostic (1.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.78e-1)" "unprognostic (8.18e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-3)" "unprognostic (1.02e-1)" "unprognostic (1.73e-2)" "unprognostic (6.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.69e-2)" "prognostic unfavorable (6.70e-4)" 21.8 31.1 13.5 15.8 14.2 16.2 30.0 14.9 12.6 31.4 36.0 11.2 24.0 8.4 38.4 24.8 33.5 17.7 23.9 64.3 13.3 10.5 35.7 28.6 20.1 13.9 17.0 13.1 28.5 27.7 61.2 24.9 45.0 15.3 32.0 17.7 11.6 61.6 22.8 27.8 22.7 15.8 44.6 15.7 18.6 31.5 29.6 14.5 9.9 20.0 25.2 15.2 34.9 40.6 15.5 28.6 19.0 7.9 18.1 30.5 12.2 27.8 16.2 6.3 16.9 50.7 53.8 15.0 47.3 37.0 23.9 30.5 42.6 47.7 15.3 47.7 41.7 36.3 17.8 14.1 41.8 39.5 14.9 10.9 16.9 22.4 26.5 66.7 12.3 5.4 37.2 40.1 30.2 32.1 42.0 42.7 15.9 31.2 9.4 53.5 6.6 8.9 15.5 19.4 22.3 28.7 7.9 20.6 55.8 34.2 22.7 11.2 7.0 21.7 16.8 19.9 27.5 34.1 6.5 40.4 30.8 36.8 23.7 28.9 7.4 8.8 25.9 21.2 29.1 16.4 19.0 6.0 8.8 14.3 7.9 16.5 15.5 21.6 17.9 7.8 11.7 19.9 16.1 1.5 18.1 7.9 28.6 30.5 12.2 13.5 14.2 14.9 12.6 13.3 10.5 17.0 13.1 15.3 14.5 98.3 49.6 36.3 126.2 123.4 12.0 342.7 43.3 89.7 68.2 90.7 2.0 149.0 235.4 121.0 59.3 101.2 22.2 93.5 62.0 153.2 153.3 156.6 32.2 67.6 83.4 4.8 77.7 89.6 17.6 35.4 195.1 39.5 229.5 53.3 64.2 27.2 110.2 31.6 166.2 264.0 6.7 51.8 115.4 227.9 71.1 142.2 225.1 37.4 70.7 116.6 RHOT2 "ARHT2, C16orf39, MIRO-2" ENSG00000140983 "Ras homolog family member T2" Q8IXI1 16 668086-674174 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 288.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012624, HPA012895" Approved Supported Mitochondria NA NA Mitochondria "HPA012624: AB_1856272, HPA012895: AB_1856271" "unprognostic (1.59e-1)" "unprognostic (8.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.50e-2)" "unprognostic (1.09e-1)" "prognostic favorable (5.01e-4)" "unprognostic (4.68e-3)" "unprognostic (4.66e-2)" "unprognostic (3.41e-2)" "unprognostic (7.55e-2)" "unprognostic (7.87e-3)" "unprognostic (3.25e-1)" "prognostic favorable (5.43e-4)" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-2)" 15.2 22.8 19.9 26.4 22.3 25.8 16.4 33.3 22.6 14.6 27.2 14.7 19.5 29.5 16.4 27.6 17.3 17.3 28.5 26.5 18.4 11.5 21.8 23.0 15.7 23.4 20.1 20.5 17.3 25.1 18.1 25.3 17.7 19.9 23.3 8.9 30.5 31.7 20.2 21.9 25.3 25.1 13.8 10.4 27.0 24.5 15.8 15.3 20.2 22.1 14.6 20.8 16.6 16.3 11.0 16.4 16.9 18.6 8.7 20.1 13.2 9.4 18.2 10.6 16.4 5.3 5.6 18.9 15.8 7.4 13.5 10.3 25.3 14.5 10.6 11.3 6.4 4.7 17.8 7.5 15.0 3.5 15.1 31.1 12.6 22.5 18.1 9.8 11.6 17.3 9.0 12.9 10.0 5.9 7.9 9.6 14.6 22.9 8.9 7.1 38.6 12.2 12.8 26.2 8.2 12.6 28.3 11.9 22.1 8.6 18.0 23.0 27.2 14.9 19.7 8.6 6.3 20.3 18.2 15.4 10.6 17.0 8.9 11.4 23.9 15.1 14.8 6.9 11.0 15.0 4.5 16.1 16.9 20.1 18.6 12.2 10.1 16.0 15.9 15.9 11.0 12.2 10.3 13.8 8.7 14.3 16.4 18.0 13.2 19.9 22.3 33.3 22.6 18.4 11.5 20.1 20.5 19.9 15.3 29.8 28.0 27.6 25.8 30.0 90.3 21.7 30.6 17.4 15.9 27.9 249.4 51.8 18.3 35.5 4.3 24.8 52.3 0.0 31.1 43.7 26.8 20.0 50.7 31.0 31.5 81.0 41.2 21.5 34.9 4.0 25.0 26.4 27.0 56.9 37.2 36.1 33.9 37.1 24.1 19.5 288.4 51.8 33.5 28.6 51.3 27.7 56.1 51.2 38.3 20.5 RMND1 "bA351K16.3, C6orf96, FLJ20627, RMD1" ENSG00000155906 "Required for meiotic nuclear division 1 homolog" Q9NWS8 6 151404762-151452181 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031397, HPA031398, HPA031399" Approved Supported Mitochondria NA NA Mitochondria "HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156" "unprognostic (1.12e-1)" "unprognostic (4.45e-2)" "unprognostic (9.70e-3)" "unprognostic (6.67e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.50e-3)" "unprognostic (6.56e-2)" "unprognostic (1.02e-1)" "unprognostic (1.73e-1)" "unprognostic (2.03e-1)" "unprognostic (3.57e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (9.74e-2)" "unprognostic (1.04e-1)" 12.9 15.7 9.0 6.8 12.1 4.0 17.0 14.5 15.6 10.5 12.8 7.7 6.4 13.2 10.9 11.7 8.3 12.2 8.0 11.4 9.9 11.7 34.0 29.1 7.8 8.2 10.1 13.5 15.7 9.9 6.9 11.2 14.4 14.0 8.0 11.5 10.5 7.3 8.0 10.9 7.9 14.9 11.2 8.9 6.9 8.0 8.6 7.0 11.2 18.9 6.0 9.5 10.6 11.9 11.3 7.2 6.8 12.2 13.2 11.3 5.0 8.2 3.8 8.5 17.6 11.5 26.1 11.6 12.9 12.6 10.1 13.9 10.8 6.2 7.9 9.3 8.2 12.4 7.1 15.5 8.1 17.5 9.0 12.4 12.4 6.1 22.2 23.4 27.7 4.0 18.2 10.4 14.3 21.9 12.1 13.0 11.8 13.5 6.4 15.2 26.9 9.4 8.9 6.3 9.3 7.6 10.7 10.5 9.7 14.2 3.7 14.2 13.7 9.2 11.7 15.4 10.7 19.5 17.9 7.4 7.9 10.3 16.3 10.1 6.5 8.6 9.0 19.7 21.7 9.1 2.1 5.9 6.8 7.1 8.2 11.2 11.3 8.5 9.9 7.2 9.0 11.2 10.2 2.9 13.2 12.2 3.3 11.3 5.0 9.0 12.1 14.5 15.6 9.9 11.7 10.1 13.5 14.0 7.0 0.0 12.8 7.3 6.0 3.4 8.7 9.8 2.5 13.4 14.8 12.2 11.8 23.3 14.9 13.6 7.0 4.5 7.3 0.0 9.2 18.4 4.8 2.6 9.2 13.5 12.0 4.8 2.9 8.6 8.6 3.3 6.4 11.6 3.3 13.6 9.9 6.4 9.4 13.9 6.0 30.5 6.7 0.0 9.5 10.4 15.6 2.4 14.1 5.0 12.6 3.1 RNF144B "bA528A10.3, IBRDC2, P53RFP" ENSG00000137393 "Ring finger protein 144B" Q7Z419 6 18387350-18468874 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Basal keratinocytes: 563.5;Suprabasal keratinocytes: 1312.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 28.8" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8" "Cell line enhanced" "Detected in many" "Daudi: 55.9;EFO-21: 15.4;hTCEpi: 17.8;HUVEC TERT2: 16.5;TIME: 16.5;U-698: 47.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046013, HPA054127, HPA072469" Uncertain Approved Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: " "unprognostic (2.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.48e-3)" "unprognostic (5.89e-2)" "unprognostic (1.18e-2)" "unprognostic (6.55e-2)" "unprognostic (2.87e-3)" "unprognostic (2.44e-2)" "unprognostic (2.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" 16.3 2.0 4.6 11.1 6.8 15.7 21.1 5.1 7.5 8.0 4.2 2.8 4.6 1.5 6.8 7.5 9.4 9.0 6.8 8.7 5.3 4.3 13.8 11.4 39.0 11.1 8.3 2.3 4.2 3.7 3.0 2.3 11.1 8.8 12.8 2.3 8.3 16.9 6.2 36.8 19.2 3.7 4.9 9.2 37.1 4.3 3.3 6.9 5.8 32.9 11.4 12.2 7.3 6.6 2.0 7.9 15.6 28.8 0.2 0.7 2.6 1.3 0.2 0.1 0.0 0.0 0.6 2.9 1.5 1.7 3.3 3.6 0.0 0.1 55.9 15.4 0.6 0.2 4.8 0.0 4.7 4.7 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.8 17.8 1.3 4.0 1.5 16.5 1.2 0.0 0.0 0.8 0.5 0.4 0.0 0.5 0.1 0.3 0.2 0.5 3.3 10.0 3.1 0.5 0.0 0.3 7.1 5.3 0.4 8.4 0.1 16.5 2.6 0.5 0.2 0.3 0.0 0.0 47.0 0.3 0.1 0.2 0.1 9.1 5.1 0.2 16.4 0.7 2.0 0.3 0.3 5.6 1.6 0.7 0.4 15.6 0.2 28.8 7.9 0.2 2.6 4.6 6.8 5.1 7.5 5.3 4.3 8.3 2.3 8.8 6.9 41.7 12.9 4.2 36.0 563.5 0.9 10.4 10.2 21.4 36.4 36.6 2.0 9.7 16.6 8.2 1.6 32.1 1.0 0.0 7.7 2.9 12.4 85.1 3.5 17.4 13.8 0.0 1.2 28.8 98.2 1.6 1.1 68.0 57.3 44.1 1.3 16.0 6.0 2.9 2.8 16.3 1.0 0.0 10.1 1.7 2.6 1312.2 1.3 3.2 2.4 20.3 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridylate synthase domain containing 4" Q96CM3 11 126202094-126211692 "Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favorable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 7.5 6.8 5.1 7.7 7.8 6.0 7.8 8.2 9.6 6.3 6.0 4.8 7.6 6.4 7.0 6.8 7.8 7.2 5.2 13.2 5.1 4.9 6.3 10.2 5.0 7.7 6.5 8.1 10.1 16.1 5.7 5.1 4.5 7.2 6.9 6.9 5.2 9.5 8.2 72.0 8.9 5.9 8.3 4.8 7.6 9.3 7.0 7.1 6.2 7.7 18.2 9.3 6.2 12.0 9.8 11.0 1.0 8.5 8.4 15.2 8.7 6.6 6.7 8.0 9.6 12.6 16.5 5.7 7.5 10.5 8.2 7.3 20.5 13.2 15.7 7.4 6.7 11.4 11.7 18.3 11.5 8.7 13.1 10.1 36.6 7.1 19.2 8.3 19.2 8.4 15.1 17.4 8.9 11.2 12.3 16.4 12.9 22.8 11.6 9.6 6.5 12.0 22.2 8.8 22.7 11.8 14.1 12.2 14.5 12.5 9.7 13.9 9.5 9.6 14.3 7.0 8.7 21.4 10.2 9.9 9.2 6.4 6.9 8.8 4.9 5.2 13.5 4.2 21.9 9.4 1.0 8.5 0.8 10.8 7.7 14.0 9.8 13.3 10.3 11.0 9.5 15.2 12.2 0.7 8.4 8.3 4.7 12.2 8.7 5.1 7.8 8.2 9.6 5.1 4.9 6.5 8.1 7.2 7.1 3.0 6.7 16.7 17.9 24.5 8.9 30.7 12.7 8.1 5.7 7.0 7.9 11.7 8.3 10.7 1.1 11.3 9.7 0.0 16.9 13.7 10.1 10.5 5.7 11.1 11.8 11.1 14.9 8.6 10.2 1.4 8.9 8.5 10.1 21.6 9.3 4.5 13.0 7.0 8.1 11.8 7.6 6.5 10.8 7.7 15.4 21.0 11.1 15.9 15.7 13.3 S1PR4 EDG6 ENSG00000125910 "Sphingosine-1-phosphate receptor 4" O95977 19 3172346-3180332 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.2;bone marrow: 14.9;lymphoid tissue: 35.9" "Cell type enhanced" "Detected in many" 15 "B-cells: 50.4;Hofbauer cells: 26.6;Kupffer cells: 27.5;T-cells: 64.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 11.0;HL-60: 14.7;NB-4: 14.5;REH: 41.0;U-937: 14.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA060601, HPA067232" Supported Mitochondria NA NA Mitochondria "HPA060601: AB_2797261, HPA067232: AB_2797271" "prognostic favorable (3.13e-4)" "prognostic favorable (1.33e-4)" "unprognostic (2.58e-2)" "prognostic favorable (2.22e-4)" "unprognostic (2.98e-2)" "prognostic favorable (1.45e-6)" "unprognostic (1.27e-2)" "unprognostic (8.73e-2)" "unprognostic (1.21e-3)" "unprognostic (6.64e-3)" "unprognostic (3.59e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (2.06e-1)" "unprognostic (6.15e-3)" 2.0 0.5 0.7 8.3 0.3 14.9 1.3 0.6 0.7 0.5 0.9 0.4 0.2 0.8 0.7 0.7 1.2 1.4 0.7 2.1 0.3 0.2 1.2 1.4 6.4 35.9 0.3 0.4 0.7 0.3 0.0 0.2 1.7 0.6 0.7 0.0 1.0 1.3 0.2 1.1 0.4 7.1 0.2 0.5 34.2 3.9 0.3 0.3 10.2 1.5 0.2 10.7 1.9 0.6 14.1 7.3 44.2 15.3 5.4 23.1 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 4.7 0.1 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.1 0.0 41.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 14.0 0.0 16.4 10.4 27.4 11.8 11.6 10.5 11.3 14.7 11.4 7.3 14.1 12.4 11.9 44.2 5.4 15.3 6.6 23.1 7.2 0.7 0.3 0.6 0.7 0.3 0.2 0.3 0.4 0.6 0.3 3.0 5.8 50.4 0.2 1.1 0.0 0.4 0.0 0.0 2.3 1.8 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.1 0.1 0.2 5.7 0.0 26.6 0.0 0.0 3.1 27.5 0.0 0.0 13.2 1.7 1.8 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.3 0.0 64.7 0.0 0.3 SAMM50 "CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W" ENSG00000100347 "SAMM50 sorting and assembly machinery component" Q9Y512 22 43955421-44010531 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034537 Enhanced Supported Mitochondria NA NA 3700000 Mitochondria "HPA034537: AB_10602794" "unprognostic (2.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.95e-3)" "prognostic favorable (2.63e-7)" "unprognostic (2.43e-3)" "unprognostic (2.28e-1)" "unprognostic (5.28e-3)" "unprognostic (1.70e-3)" "unprognostic (3.37e-2)" "unprognostic (1.95e-1)" "unprognostic (2.42e-1)" "unprognostic (3.52e-1)" "prognostic favorable (4.43e-8)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (2.41e-1)" "unprognostic (1.60e-1)" 21.7 25.1 12.4 13.9 13.6 10.2 16.0 10.5 20.1 17.4 15.6 11.2 17.2 18.9 12.6 13.5 14.6 16.3 18.2 34.3 11.3 11.9 18.5 18.8 8.9 18.6 12.7 14.7 16.0 16.7 60.6 12.2 7.6 16.4 10.4 13.7 14.3 19.3 13.6 79.5 15.8 21.2 14.2 12.3 12.2 18.5 11.5 8.6 17.4 10.8 34.6 15.1 11.5 11.0 27.7 34.0 22.4 19.6 18.2 29.3 18.5 22.3 21.2 20.7 25.1 26.8 28.5 29.0 22.0 23.6 32.5 28.1 30.3 16.5 37.1 16.2 25.0 18.8 27.0 30.6 29.4 29.3 10.2 37.8 20.1 27.9 35.7 18.8 63.6 30.3 32.8 23.6 28.0 13.0 22.9 33.4 17.8 17.1 12.3 29.1 31.9 24.8 25.0 20.2 27.1 25.5 29.2 22.4 30.0 27.1 28.7 12.4 20.2 24.3 26.1 35.9 23.1 24.4 21.0 20.5 21.1 25.4 19.4 17.9 18.3 25.2 28.6 26.4 23.2 21.0 19.2 19.6 22.4 21.2 19.2 29.3 27.7 19.8 21.5 34.0 24.5 20.8 19.5 3.2 18.2 14.7 13.4 22.7 18.5 12.4 13.6 10.5 20.1 11.3 11.9 12.7 14.7 16.4 8.6 32.8 17.6 39.3 18.4 18.3 20.2 60.5 22.9 37.5 22.7 8.7 7.9 36.5 51.4 35.6 27.0 31.5 56.1 23.3 48.0 43.0 24.4 14.5 26.5 35.8 45.7 30.2 17.9 21.5 29.2 33.7 24.2 25.7 15.1 39.7 29.6 27.1 37.2 38.6 28.7 78.9 23.3 19.4 21.1 41.3 20.6 19.7 17.2 32.0 51.0 12.9 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61447529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 23.7 33.0 22.2 22.4 27.2 34.1 24.8 19.9 33.8 20.5 22.1 23.4 21.0 22.3 23.3 33.5 25.3 25.8 21.1 32.5 20.8 26.9 26.8 39.1 19.9 36.7 24.3 25.0 25.7 22.7 23.3 38.4 26.7 25.2 26.1 24.9 32.0 28.1 21.5 31.4 22.9 27.9 26.6 20.8 32.2 24.3 19.2 21.1 36.1 27.0 20.2 30.9 24.0 19.2 31.3 23.2 44.6 25.4 32.7 43.7 26.7 15.4 22.3 13.2 9.2 19.2 15.7 10.3 12.0 17.4 16.3 12.5 20.8 16.7 15.6 22.1 17.4 22.2 16.8 17.2 17.1 17.5 23.1 16.3 13.4 18.3 30.0 20.0 15.8 18.8 19.4 20.9 17.7 17.3 11.6 26.2 16.8 15.4 20.1 19.6 34.2 16.1 35.9 20.4 15.9 32.8 17.4 17.1 28.8 23.2 23.0 14.2 17.7 16.5 19.3 33.4 14.1 30.1 18.9 16.3 16.6 13.5 19.7 14.2 12.4 19.3 19.9 16.1 14.1 17.4 41.9 25.4 44.6 32.4 22.8 38.4 31.3 35.9 34.7 20.3 29.9 39.5 38.4 37.0 32.7 17.9 23.2 43.7 26.7 22.2 27.2 19.9 33.8 20.8 26.9 24.3 25.0 25.2 21.1 32.8 38.1 35.3 31.0 18.3 14.0 20.5 12.7 32.1 21.6 27.9 5.9 61.5 46.4 50.2 11.4 29.8 27.1 23.3 52.7 47.1 28.8 26.8 31.2 37.0 45.9 14.3 32.8 36.8 33.7 13.8 29.1 32.1 42.2 81.2 28.5 36.7 49.4 31.7 29.0 38.3 14.1 32.3 24.7 15.8 23.5 19.6 83.3 44.5 23.9 29.9 SDHB "SDH, SDH1" ENSG00000117118 "Succinate dehydrogenase complex iron sulfur subunit B" P21912 1 17018722-17054170 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 395.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002868, CAB009822, CAB068233, CAB068234, CAB068235" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Plasma membrane" "CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889" "unprognostic (1.06e-1)" "unprognostic (2.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (8.45e-2)" "unprognostic (5.51e-2)" "unprognostic (3.93e-2)" "prognostic favorable (2.93e-7)" "unprognostic (1.46e-1)" "unprognostic (2.75e-1)" "unprognostic (7.82e-2)" "unprognostic (3.82e-2)" 17.8 25.6 19.8 16.6 21.7 17.0 26.4 18.0 29.1 13.9 30.8 12.3 15.1 34.0 14.2 15.7 19.8 13.6 15.1 86.9 18.2 16.4 51.0 75.1 16.8 24.6 20.1 18.9 10.5 30.7 20.0 11.3 15.6 16.7 13.0 31.5 11.7 15.9 19.5 96.2 13.2 31.4 21.3 16.5 17.2 21.7 18.7 15.7 14.2 15.5 52.2 18.0 15.4 17.1 22.2 45.9 48.5 48.7 18.9 26.7 25.0 26.0 25.8 14.7 18.8 28.7 28.5 16.8 22.8 29.3 52.3 47.2 36.3 31.3 35.7 28.5 30.7 33.8 30.7 58.7 45.4 59.0 20.9 48.1 32.1 26.9 27.8 35.1 50.2 23.9 29.3 30.0 45.2 76.6 27.8 36.9 31.4 26.8 41.4 36.3 21.5 33.3 28.7 12.2 41.9 51.9 24.0 28.4 44.2 48.1 14.8 27.8 15.2 30.9 38.7 64.9 16.3 22.7 28.4 18.3 20.1 22.7 36.9 30.0 17.3 21.3 36.5 30.8 76.6 22.2 16.6 38.4 37.4 18.3 48.7 18.3 22.2 21.2 19.5 45.9 18.3 19.3 19.5 48.5 18.9 42.2 21.5 26.7 25.0 19.8 21.7 18.0 29.1 18.2 16.4 20.1 18.9 16.7 15.7 59.6 39.6 77.3 79.1 46.2 28.1 395.8 109.5 78.9 40.9 45.4 13.7 93.2 300.1 104.4 146.0 54.0 212.4 116.8 130.5 121.6 58.6 70.1 65.7 198.8 162.9 35.0 46.7 41.7 81.2 13.8 53.5 90.6 60.8 125.4 89.5 52.1 97.2 192.9 63.6 355.3 35.5 38.8 60.4 85.9 68.4 47.7 101.8 52.3 135.8 97.0 SELENOO SELO ENSG00000073169 "Selenoprotein O" Q9BVL4 22 50200979-50217616 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 22.6;Club cells: 10.3;Distal tubular cells: 13.3;Proximal tubular cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071795, HPA079100" Approved Supported "Mitotic chromosome,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Mitotic chromosome" "HPA071795: , HPA079100: " "unprognostic (1.79e-1)" "unprognostic (2.07e-3)" "unprognostic (1.60e-1)" "unprognostic (2.50e-3)" "unprognostic (3.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.85e-2)" "unprognostic (5.91e-2)" "unprognostic (1.51e-1)" "unprognostic (5.62e-2)" "unprognostic (8.20e-3)" "unprognostic (8.91e-2)" "unprognostic (1.81e-2)" "unprognostic (7.31e-2)" "unprognostic (1.98e-1)" "unprognostic (2.52e-1)" "prognostic favorable (8.32e-4)" 8.5 8.7 8.0 5.7 10.5 16.3 10.5 24.5 9.4 5.9 8.0 8.8 8.2 10.6 7.6 4.2 9.6 7.0 5.8 6.3 6.6 3.5 7.7 31.0 5.7 8.2 8.4 5.5 6.9 17.6 3.6 5.8 4.2 7.9 6.9 2.9 6.0 10.0 6.0 13.0 10.7 8.4 3.5 7.5 8.1 8.2 4.9 8.1 5.3 6.4 5.6 7.6 6.9 7.3 0.8 3.4 3.5 3.5 0.3 1.6 0.9 8.3 5.5 3.0 3.4 4.2 3.1 6.3 8.4 4.0 5.1 4.0 7.4 5.3 5.6 6.8 3.3 2.8 18.6 4.7 7.6 1.0 1.6 21.6 4.0 10.9 4.5 2.1 7.3 5.0 4.0 5.3 3.2 2.6 3.3 4.1 3.8 5.4 4.1 2.1 12.9 3.9 11.4 2.6 2.0 11.2 12.3 4.3 8.2 3.2 10.8 6.1 6.8 9.1 8.2 5.1 1.6 6.2 5.2 6.8 4.5 6.2 4.8 5.0 10.2 2.5 3.3 4.9 4.8 2.5 0.0 3.5 3.5 0.6 1.2 1.6 0.1 0.8 1.5 3.4 0.8 0.4 1.4 1.4 0.3 1.1 1.4 0.7 0.9 8.0 10.5 24.5 9.4 6.6 3.5 8.4 5.5 7.9 8.1 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 6.7 10.3 8.7 0.0 2.7 13.3 3.2 0.0 0.0 0.0 0.0 4.0 2.0 0.0 0.0 3.5 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 3.6 0.0 0.0 4.9 0.0 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 SHMT2 SHMT ENSG00000182199 "Serine hydroxymethyltransferase 2" P34897 12 57229327-57234935 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 103.1" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 158.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 212.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020543, HPA020549" Enhanced Supported Microtubules,Mitochondria NA NA 160000 Mitochondria Microtubules "HPA020543: AB_1856833, HPA020549: AB_1856834" "prognostic unfavorable (8.37e-5)" "unprognostic (1.24e-1)" "unprognostic (1.90e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (9.83e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.00e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.84e-8)" "unprognostic (3.05e-1)" "unprognostic (2.30e-1)" "unprognostic (2.72e-1)" "unprognostic (4.74e-2)" 13.0 13.5 5.9 15.0 7.1 12.6 9.5 9.6 9.5 10.5 11.5 6.1 5.0 13.4 10.2 8.5 22.1 8.6 10.3 11.0 6.5 5.4 15.5 103.1 11.8 18.7 8.7 4.6 17.9 38.9 4.5 8.1 16.8 6.5 10.3 9.4 7.1 44.6 5.7 16.5 13.7 11.5 9.9 7.6 23.5 13.4 5.4 6.3 26.1 13.2 19.0 25.6 11.2 13.8 33.6 14.5 6.5 11.7 9.7 48.7 12.3 25.1 11.7 11.8 31.2 9.3 14.3 23.4 13.6 22.2 18.3 16.8 16.7 12.2 46.6 22.6 16.8 7.6 16.1 21.3 22.2 9.9 26.0 19.0 19.2 7.2 11.8 68.7 31.7 17.0 18.3 32.2 14.7 49.2 16.6 18.1 24.8 20.0 44.3 13.8 16.5 25.2 17.4 10.1 10.1 19.0 17.0 212.4 43.1 9.1 11.6 25.3 12.1 7.1 16.8 49.3 4.5 22.8 39.0 11.4 7.4 15.1 9.6 18.5 59.5 32.5 39.5 16.0 29.6 13.3 6.5 9.8 5.9 6.9 11.7 8.0 33.6 12.1 7.4 14.5 32.4 5.3 5.4 0.5 9.7 7.5 4.8 48.7 12.3 5.9 7.1 9.6 9.5 6.5 5.4 8.7 4.6 6.5 6.3 8.9 13.1 58.9 19.1 30.8 6.2 7.5 20.4 9.4 12.5 3.5 0.0 53.0 11.6 41.7 0.4 13.5 11.0 46.7 41.3 42.8 21.6 14.9 28.8 158.5 43.3 7.9 9.2 20.3 38.1 0.2 16.7 22.7 37.1 27.1 21.6 42.4 40.1 21.0 15.2 48.7 4.9 6.5 22.6 2.1 7.2 28.4 31.2 26.2 37.7 17.6 SIAH3 FLJ39203 ENSG00000215475 "Siah E3 ubiquitin protein ligase family member 3" Q8IW03 13 45777243-45851736 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.2;fallopian tube: 11.8" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.0;Ciliated cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 6 "EFO-21: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060576 Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA060576: AB_2684325" "unprognostic (1.07e-3)" "unprognostic (1.26e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (4.96e-2)" "unprognostic (1.00e-2)" "unprognostic (1.05e-1)" "unprognostic (7.53e-2)" "unprognostic (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (4.77e-3)" "unprognostic (3.24e-3)" "unprognostic (9.03e-4)" "unprognostic (2.03e-1)" "unprognostic (2.18e-1)" 0.6 1.3 5.1 0.9 8.3 0.9 0.6 5.6 10.2 4.1 0.6 0.0 0.1 0.8 1.7 2.0 0.6 11.8 0.7 0.6 4.0 2.8 1.7 0.6 0.8 0.8 3.4 6.6 0.7 0.6 0.5 0.4 0.5 8.9 0.6 0.7 2.8 1.7 3.6 0.6 0.8 0.8 0.8 1.3 0.8 0.7 0.8 0.7 0.4 0.6 0.0 0.9 0.7 0.4 0.1 0.1 0.5 0.1 0.2 1.5 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 5.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.5 0.7 0.5 0.2 0.0 0.1 0.0 0.0 5.1 8.3 5.6 10.2 4.0 2.8 3.4 6.6 8.9 0.7 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 4.0 0.0 1.8 2.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIRT1 SIR2L1 ENSG00000096717 "Sirtuin 1" Q96EB6 10 67884669-67918390 "Predicted intracellular proteins" "Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 171.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003855, HPA006295, HPA052351" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Mitochondria, Cytosol" "CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796" "unprognostic (1.55e-1)" "unprognostic (2.78e-1)" "unprognostic (9.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-2)" "unprognostic (2.48e-1)" "unprognostic (4.95e-2)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (2.18e-2)" "unprognostic (2.83e-2)" "unprognostic (9.67e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" 17.2 32.3 12.6 21.1 17.8 17.0 18.1 22.6 14.5 24.2 20.5 15.7 14.0 9.2 19.0 12.7 12.7 15.1 15.2 14.7 14.1 10.4 13.9 17.3 12.6 16.1 17.0 10.1 26.6 14.4 16.4 13.3 14.7 12.1 21.7 12.5 12.1 12.3 16.1 19.9 12.9 15.0 21.0 17.7 13.5 13.2 25.4 16.3 28.1 15.2 9.3 14.7 21.6 37.5 4.9 3.9 3.8 3.5 3.6 7.1 1.8 8.3 9.6 15.2 16.9 14.5 11.2 9.5 11.6 12.0 16.0 14.3 10.5 7.2 17.6 6.3 7.7 10.0 6.7 18.8 3.9 17.2 9.4 10.9 9.3 7.2 8.2 13.3 10.0 7.2 10.3 9.4 9.6 16.6 17.2 6.4 10.1 11.8 9.6 11.6 6.7 9.3 13.9 18.8 5.4 15.3 16.9 12.0 6.9 7.5 5.2 9.8 13.5 21.3 14.1 14.7 13.7 10.2 9.3 5.3 12.5 11.6 11.0 11.2 8.1 9.6 34.9 6.4 15.2 5.1 3.8 2.4 3.2 3.4 3.0 4.9 4.9 3.7 4.7 3.9 3.3 7.1 4.2 3.1 3.6 3.5 3.5 2.9 1.8 12.6 17.8 22.6 14.5 14.1 10.4 17.0 10.1 12.1 16.3 17.9 6.1 10.4 16.4 34.8 11.7 27.0 15.3 1.4 9.1 5.2 25.5 5.7 5.0 3.9 171.4 12.8 17.4 23.3 4.7 4.3 17.6 23.9 11.5 14.8 7.8 11.1 41.1 14.1 20.9 29.0 16.4 13.5 15.1 1.8 16.9 7.0 6.4 10.5 18.4 6.3 13.4 0.0 38.2 20.6 15.4 41.5 10.4 13.8 12.4 14.9 SIRT5 ENSG00000124523 "Sirtuin 5" Q9NXA8 6 13574529-13615158 "FDA approved drug targets, Predicted intracellular proteins" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 47.2;Distal tubular cells: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021798, HPA022002, HPA022992" Approved Supported Mitochondria NA NA Mitochondria "HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915" "unprognostic (8.53e-2)" "unprognostic (7.79e-2)" "unprognostic (4.71e-2)" "unprognostic (5.26e-3)" "unprognostic (6.19e-2)" "unprognostic (1.63e-1)" "unprognostic (8.72e-2)" "unprognostic (1.38e-1)" "unprognostic (8.54e-3)" "unprognostic (2.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.65e-1)" "prognostic favorable (8.76e-10)" "unprognostic (2.39e-1)" "unprognostic (6.88e-2)" "unprognostic (6.86e-2)" "unprognostic (2.36e-3)" 5.9 6.2 8.8 6.8 10.4 5.9 9.2 11.1 13.5 4.9 7.2 6.4 12.5 8.1 6.8 6.7 5.7 8.0 6.6 22.9 8.5 8.3 9.9 29.9 9.8 6.9 9.5 6.9 8.8 10.5 12.9 7.6 5.3 8.3 6.5 8.3 6.2 8.6 8.7 25.8 8.8 8.5 6.2 6.9 9.5 7.6 6.6 6.1 7.5 8.5 7.0 6.5 6.8 6.0 9.2 4.6 10.9 9.3 7.3 10.0 5.6 5.8 4.6 5.9 7.6 3.7 4.8 4.4 3.0 3.2 3.3 5.0 7.3 7.0 8.4 18.3 2.4 7.3 9.5 4.1 5.9 5.0 3.8 6.8 5.3 4.2 11.8 6.1 4.3 4.6 5.2 12.1 2.9 10.4 7.2 6.0 11.9 7.5 3.2 3.9 7.1 4.7 8.5 4.9 9.1 7.3 8.4 3.8 15.3 6.8 6.4 9.7 3.5 3.4 5.9 13.4 16.7 6.8 2.8 5.3 5.1 2.9 3.1 3.3 7.8 8.8 5.7 2.9 4.3 4.8 0.5 4.5 10.9 8.1 6.1 8.2 9.2 10.0 7.9 4.6 9.1 9.5 8.5 1.5 7.3 9.3 4.6 7.2 5.6 8.8 10.4 11.1 13.5 8.5 8.3 9.5 6.9 8.3 6.1 26.8 2.7 9.1 9.2 3.7 6.4 47.2 10.2 21.4 17.0 10.4 0.0 17.1 44.7 10.5 2.2 8.7 9.6 23.3 6.0 9.0 4.9 5.7 0.0 22.2 8.5 1.6 5.8 10.4 10.4 0.5 7.5 6.1 5.0 5.4 12.6 8.4 6.7 13.9 5.3 24.0 6.2 0.0 5.0 6.5 7.8 4.0 8.9 6.9 16.5 7.3 SLC11A2 "DCT1, DMT1, NRAMP2" ENSG00000110911 "Solute carrier family 11 member 2" P49281 12 50979401-51028566 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032139, HPA032140" Uncertain Supported Mitochondria No No Mitochondria "HPA032139: AB_10964213, HPA032140: AB_10962932" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.92e-1)" "unprognostic (2.09e-1)" "prognostic favorable (3.07e-6)" "unprognostic (1.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.15e-1)" "unprognostic (7.28e-2)" "unprognostic (2.29e-1)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (2.32e-2)" "unprognostic (2.24e-1)" 11.3 15.1 12.8 9.6 26.2 9.6 20.8 14.7 22.1 20.8 11.3 38.2 8.4 35.3 12.3 12.7 17.3 15.4 12.1 12.9 14.5 14.2 16.1 18.0 18.6 7.9 40.0 15.4 10.4 20.6 29.8 21.7 16.4 29.7 18.0 11.8 18.7 26.9 14.8 17.6 15.6 11.6 11.0 33.1 9.5 12.5 8.7 31.0 15.8 29.9 8.7 16.5 12.9 13.9 4.1 9.8 3.0 9.5 8.3 7.1 4.6 7.7 10.0 13.2 12.1 14.7 12.5 44.4 8.4 30.5 8.0 9.4 12.6 14.6 4.8 16.6 9.4 15.3 10.7 11.9 7.9 9.4 6.9 7.2 11.4 12.1 14.3 15.6 7.7 23.0 13.7 9.9 14.9 15.2 19.6 9.5 9.8 9.8 2.4 9.3 8.9 9.1 5.2 19.6 8.2 6.9 5.9 12.1 8.5 9.7 11.6 9.1 8.1 6.4 19.5 8.5 16.0 21.9 5.1 11.4 8.2 6.9 9.2 4.4 6.0 8.1 2.0 23.1 4.2 3.4 0.7 6.6 2.4 6.4 9.5 5.8 3.6 5.0 6.3 9.8 4.1 7.1 6.6 3.0 8.3 6.0 4.1 3.8 4.6 12.8 26.2 14.7 22.1 14.5 14.2 40.0 15.4 29.7 31.0 35.7 40.3 11.5 22.2 13.7 23.8 12.0 28.1 45.5 43.3 54.1 17.7 20.6 3.3 25.3 0.8 14.3 8.6 70.0 24.8 18.3 17.5 32.8 67.2 38.4 29.8 27.0 15.7 9.8 13.3 1.5 8.9 25.8 25.3 9.0 13.5 27.5 20.6 14.7 8.1 8.8 16.5 6.5 12.4 5.5 12.8 11.7 16.2 7.9 16.1 19.0 SLC25A10 DIC ENSG00000183048 "Solute carrier family 25 member 10" Q9UBX3 17 81712236-81721016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.8" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 50.4;SK-BR-3: 38.8" HPA023048 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA023048: AB_2301950" "unprognostic (7.17e-2)" "unprognostic (2.38e-2)" "unprognostic (2.36e-2)" "unprognostic (1.36e-1)" "unprognostic (9.50e-2)" "prognostic favorable (2.56e-4)" "unprognostic (5.66e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-2)" "prognostic favorable (8.14e-4)" "unprognostic (6.73e-2)" "unprognostic (1.33e-1)" "unprognostic (6.02e-2)" "unprognostic (6.32e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.31e-4)" 10.2 4.9 2.7 5.9 3.2 5.2 6.3 3.3 5.2 4.2 9.5 3.9 7.5 13.9 1.3 3.8 12.2 5.4 8.2 4.3 2.1 2.5 21.0 51.8 3.3 4.6 3.7 4.6 2.4 17.4 10.7 2.1 2.1 3.5 5.6 4.4 4.7 16.8 6.6 2.0 5.9 11.2 1.8 4.7 1.6 7.4 21.8 2.5 7.8 3.3 7.7 8.7 4.3 3.4 0.9 0.7 0.0 1.2 3.6 1.9 0.7 14.2 26.4 2.5 12.6 0.9 0.7 5.0 6.0 2.0 7.8 5.9 16.0 6.1 6.4 4.7 1.4 3.8 9.2 3.6 6.3 1.4 4.7 20.4 5.2 16.1 50.4 1.1 11.7 6.4 0.5 3.3 5.5 1.1 1.5 4.5 9.1 8.7 8.1 2.6 26.8 17.1 12.4 2.6 6.0 19.9 13.0 5.4 20.2 6.9 12.9 16.7 11.3 5.7 38.8 1.3 0.7 16.6 6.5 1.9 6.0 19.8 8.7 11.0 5.0 2.5 3.7 2.6 12.4 5.2 0.0 0.9 0.0 0.8 1.2 1.5 0.1 0.5 1.9 0.7 0.9 0.5 0.4 0.0 3.6 0.2 0.4 1.0 0.7 2.7 3.2 3.3 5.2 2.1 2.5 3.7 4.6 3.5 2.5 0.0 2.1 0.0 5.5 0.0 2.9 3.3 17.8 13.4 5.7 14.0 0.0 11.3 21.6 15.4 23.8 0.5 9.3 0.0 20.3 4.7 0.9 3.9 0.0 37.7 6.8 0.0 4.7 3.1 0.3 65.6 2.0 0.3 0.0 1.0 15.4 1.5 9.6 24.6 1.8 75.1 3.8 0.0 0.2 8.4 2.3 0.0 3.5 1.5 28.8 4.3 SLC25A13 "ARALAR2, CITRIN, CTLN2" ENSG00000004864 "Solute carrier family 25 member 13" Q9UJS0 7 96120220-96322147 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 79.1" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 124.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018997 Enhanced Supported Mitochondria NA NA Mitochondria "HPA018997: AB_1857023" "unprognostic (3.61e-2)" "unprognostic (7.99e-2)" "unprognostic (6.99e-2)" "unprognostic (7.19e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (1.42e-2)" "unprognostic (6.67e-2)" "unprognostic (2.31e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-1)" "unprognostic (6.99e-2)" "prognostic favorable (9.14e-4)" "unprognostic (1.15e-1)" "unprognostic (1.05e-1)" "unprognostic (3.32e-1)" "unprognostic (7.09e-2)" 7.7 10.3 4.2 4.9 11.8 4.1 6.7 3.0 7.5 5.4 12.5 21.1 15.6 8.9 5.1 8.0 6.9 5.9 6.7 4.5 5.6 5.3 17.7 79.1 5.5 4.9 14.5 4.8 5.9 7.3 8.2 8.8 8.9 12.4 5.9 10.2 12.6 5.7 17.3 4.6 8.2 9.7 5.0 13.1 7.2 7.9 4.3 12.6 1.8 7.9 3.0 4.8 5.0 5.3 3.7 8.9 3.1 6.7 2.8 2.4 2.1 16.1 14.3 16.5 5.7 2.8 2.3 23.2 4.1 3.1 10.0 10.1 25.6 15.2 7.3 19.6 2.6 21.8 9.7 18.5 5.9 11.8 2.8 12.2 8.3 13.5 19.9 6.7 10.5 6.5 6.1 6.3 8.5 7.7 3.8 11.4 1.1 23.3 2.8 4.8 17.8 0.0 9.8 29.1 17.3 8.9 4.1 9.8 16.8 23.8 15.3 7.9 26.0 14.2 30.2 24.3 28.7 9.0 8.1 6.6 7.4 16.6 17.5 12.4 5.7 14.3 4.6 9.1 10.1 12.2 0.6 4.6 3.1 2.2 6.3 2.4 3.7 1.8 2.0 8.9 2.0 1.2 1.5 0.8 2.8 6.7 4.7 1.8 2.1 4.2 11.8 3.0 7.5 5.6 5.3 14.5 4.8 12.4 12.6 8.9 9.3 10.5 6.9 6.5 34.3 7.1 38.2 14.7 6.8 17.4 51.1 25.9 23.2 17.3 9.5 16.9 23.5 0.0 16.5 20.5 14.8 9.8 13.9 124.1 20.1 9.5 36.2 12.3 22.7 6.7 12.0 19.6 20.3 2.8 19.4 22.1 18.9 24.6 14.9 50.8 47.6 12.9 8.3 5.4 9.1 6.9 16.7 5.7 23.3 12.2 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856931-48898993 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.8;liver: 58.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 35.4;RPMI-8226: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Approved Mitochondria,Cytosol NA NA 13000 "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 11.9 13.7 6.7 5.6 7.3 3.4 10.2 3.0 5.6 3.3 19.7 4.7 5.2 25.0 4.7 3.1 3.3 5.0 9.9 37.1 7.3 4.6 16.8 58.3 6.6 4.9 8.5 5.1 2.7 16.8 5.9 5.1 3.3 5.8 5.0 9.1 5.4 7.4 3.7 27.4 4.0 32.2 5.7 5.5 8.8 7.5 4.4 6.6 9.1 5.5 5.5 5.9 4.5 9.8 9.4 33.3 57.8 29.0 17.3 28.4 24.7 1.4 4.5 3.6 5.0 11.5 4.4 0.7 8.0 4.3 5.6 5.8 5.6 6.9 6.6 5.7 12.6 6.8 1.4 8.8 3.5 4.2 16.8 4.2 9.2 7.0 7.1 5.2 9.6 17.8 5.6 4.0 7.5 1.2 2.2 7.2 10.1 8.2 35.4 7.3 3.7 10.5 4.8 1.8 8.1 10.2 3.8 2.1 48.7 6.0 3.5 1.4 5.1 7.4 0.0 4.0 5.2 11.3 4.5 5.8 6.4 1.1 9.3 5.8 13.1 9.1 7.7 9.1 6.8 8.4 13.8 29.0 57.8 28.4 21.0 18.1 9.4 16.1 20.8 27.0 7.8 12.7 21.3 13.5 17.3 21.4 33.3 16.1 24.7 6.7 7.3 3.0 5.6 7.3 4.6 8.5 5.1 5.8 6.6 6.0 2.4 7.5 2.3 1.5 1.1 31.1 7.6 5.3 2.3 0.0 5.9 1.7 3.3 3.2 1.1 3.1 38.0 0.0 3.7 1.9 4.1 2.4 1.1 55.2 15.8 0.0 7.0 9.2 13.2 1.0 9.8 7.5 1.7 40.5 10.8 2.8 4.0 13.5 11.7 12.5 1.1 0.0 2.2 7.1 7.0 1.1 1.0 13.8 12.8 2.0 SLC25A23 "APC2, FLJ30339, MGC2615" ENSG00000125648 "Solute carrier family 25 member 23" Q9BV35 19 6436079-6465203 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009675, HPA050883" Approved Supported Mitochondria NA NA Mitochondria "HPA009675: AB_2668252, HPA050883: AB_2681260" "unprognostic (3.51e-1)" "unprognostic (1.53e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.05e-2)" "unprognostic (3.65e-3)" "unprognostic (3.43e-2)" "unprognostic (1.31e-3)" "unprognostic (1.27e-1)" "unprognostic (3.82e-1)" "unprognostic (1.30e-1)" "unprognostic (3.25e-1)" "prognostic favorable (1.10e-12)" "unprognostic (8.95e-2)" "unprognostic (3.20e-1)" "unprognostic (5.44e-2)" "unprognostic (4.22e-1)" 12.1 13.0 68.2 5.2 97.6 0.4 6.3 21.5 51.7 12.5 22.3 17.6 10.3 18.2 13.0 11.9 31.2 16.1 10.1 36.2 66.2 25.1 17.9 13.0 11.3 4.0 25.6 33.1 15.8 10.0 24.5 5.5 2.2 28.0 14.3 23.5 12.2 32.1 20.3 37.0 11.9 18.6 30.7 16.9 4.3 9.9 3.7 25.9 1.2 29.2 9.7 14.1 16.8 9.3 2.5 0.9 0.8 0.0 0.7 4.5 0.9 20.0 8.1 11.8 37.1 15.9 7.0 5.4 5.8 9.6 11.4 13.8 20.4 13.4 11.2 14.3 14.7 12.5 17.1 24.0 14.0 9.1 0.0 20.2 8.1 17.2 16.2 14.8 0.5 19.2 20.0 12.3 10.1 4.4 23.3 11.9 12.5 23.3 14.3 2.2 14.6 7.0 11.5 8.5 21.6 25.0 3.4 3.2 17.2 30.5 3.6 0.8 11.6 4.2 25.8 10.7 13.4 13.5 17.8 4.1 3.6 15.4 0.9 3.8 2.6 3.5 9.9 1.6 19.1 5.6 0.8 0.0 0.0 4.5 0.0 1.1 2.5 2.7 2.3 0.4 1.0 4.0 3.4 0.0 0.7 0.0 0.9 2.6 0.9 68.2 97.6 21.5 51.7 66.2 25.1 25.6 33.1 28.0 25.9 8.9 18.1 7.0 8.3 9.3 9.8 34.8 48.4 1.4 4.5 43.6 7.9 1.2 16.6 52.9 16.5 5.5 100.4 0.0 24.8 1.5 5.8 13.9 6.9 27.0 2.1 7.9 13.3 12.9 2.1 45.5 17.5 2.2 16.9 1.8 35.6 14.6 40.3 35.4 27.6 22.6 16.4 12.9 6.2 0.3 3.2 20.5 0.7 4.3 23.9 24.3 SLC25A25 "KIAA1896, MCSC, PCSCL" ENSG00000148339 "Solute carrier family 25 member 25" Q6KCM7 9 128068201-128109245 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020381 Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA "Vesicles, Mitochondria" "HPA020381: AB_1857037" "unprognostic (4.62e-2)" "unprognostic (2.66e-2)" "unprognostic (2.56e-2)" "unprognostic (1.59e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.01e-4)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (4.96e-2)" "unprognostic (3.70e-2)" "prognostic favorable (4.65e-6)" "unprognostic (1.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.66e-3)" "unprognostic (1.42e-2)" 29.2 15.8 7.3 8.1 12.8 5.5 10.6 8.8 20.0 14.4 7.2 6.3 20.0 7.9 14.6 8.2 22.7 17.5 31.6 5.6 7.6 9.0 9.5 48.4 12.4 6.7 7.5 8.0 13.6 52.6 12.1 19.0 7.6 15.0 8.5 5.5 13.6 7.6 63.5 31.3 9.5 10.0 17.3 8.7 7.8 10.5 7.3 5.3 5.4 10.8 20.2 9.7 8.6 9.6 2.9 4.6 3.8 8.4 1.5 7.6 3.9 5.7 6.1 8.6 12.4 6.5 5.6 5.7 12.0 11.2 10.1 6.7 10.9 6.1 7.5 3.7 5.5 5.6 10.3 6.8 3.9 3.8 8.7 5.6 4.3 12.2 6.5 10.4 5.0 10.0 7.2 3.8 9.9 7.3 3.3 6.8 12.6 15.6 16.2 6.3 13.9 8.7 5.1 8.7 18.7 9.5 8.7 7.4 15.7 3.9 6.0 21.4 9.2 12.6 8.1 16.7 3.5 8.9 2.9 4.3 11.5 6.8 8.6 11.8 14.2 24.8 8.0 7.8 2.7 9.4 3.8 2.3 1.2 4.8 7.3 2.4 1.7 5.3 4.8 4.6 2.9 4.5 7.6 0.4 1.5 8.4 1.5 3.9 3.9 7.3 12.8 8.8 20.0 7.6 9.0 7.5 8.0 15.0 5.3 20.8 41.7 5.2 37.8 23.2 18.1 2.0 33.1 21.4 9.1 19.2 119.8 8.5 10.0 10.3 0.3 33.7 36.7 23.3 10.0 10.4 16.9 26.9 8.1 58.9 8.4 17.5 49.5 19.0 13.3 0.6 8.6 18.9 20.3 18.0 17.3 12.8 10.0 28.1 7.8 8.6 65.5 19.4 63.4 4.1 8.6 37.6 19.2 8.7 15.3 47.7 SLC25A26 ENSG00000144741 "Solute carrier family 25 member 26" Q70HW3 3 66133610-66388116 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026887 Supported Supported Mitochondria NA NA Mitochondria "HPA026887: AB_2189921" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (7.83e-2)" "unprognostic (7.94e-2)" "unprognostic (5.38e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (9.21e-2)" "unprognostic (8.43e-2)" "prognostic favorable (1.73e-5)" "unprognostic (4.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-1)" 11.8 12.9 20.2 8.5 14.8 13.3 16.5 7.9 27.2 10.3 12.6 15.8 9.2 9.7 11.1 12.9 14.3 13.1 10.1 19.5 16.9 12.8 15.7 22.7 10.0 15.2 17.6 11.8 20.0 21.2 16.2 11.6 11.9 14.6 10.8 13.4 12.6 16.1 12.6 29.8 16.5 11.0 16.8 14.3 11.4 12.7 18.3 12.6 12.0 19.0 14.2 12.9 13.4 10.8 12.0 12.2 3.6 7.1 10.5 14.4 9.1 6.3 6.2 3.8 7.7 8.5 8.8 8.0 5.3 10.2 7.2 6.8 8.1 8.5 6.5 3.2 9.7 8.8 4.7 4.4 9.9 7.4 6.8 10.3 9.9 4.9 11.7 10.2 13.8 8.4 12.0 19.7 5.7 13.8 6.9 5.3 13.2 4.4 8.7 8.6 7.9 5.8 15.9 11.1 14.4 3.6 6.0 6.9 11.0 5.9 4.7 2.9 8.9 7.7 6.7 12.6 7.0 5.6 10.9 6.0 7.6 7.2 9.5 9.3 12.9 16.8 8.4 10.5 13.2 8.2 1.3 6.8 3.6 10.9 7.1 9.9 12.0 12.1 11.1 12.2 10.2 14.4 12.3 0.4 10.5 4.1 11.6 11.1 9.1 20.2 14.8 7.9 27.2 16.9 12.8 17.6 11.8 14.6 12.6 29.8 20.3 23.3 31.4 31.8 17.7 96.8 20.4 13.4 12.5 17.4 11.8 29.9 29.9 25.2 20.6 19.7 19.1 0.0 38.7 36.6 33.9 31.6 18.5 34.2 26.5 11.1 17.9 9.2 19.0 19.2 15.0 17.8 35.4 20.8 25.5 22.4 26.4 14.0 20.5 46.3 21.5 19.4 29.5 21.4 30.2 32.1 27.3 46.5 33.0 33.6 SLC25A27 "FLJ33552, UCP4" ENSG00000153291 "Solute carrier family 25 member 27" O95847 6 46652915-46678193 "Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 20.5;Cone photoreceptor cells: 27.5;Early spermatids: 23.2;Horizontal cells: 19.1;Rod photoreceptor cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 26.3;hTCEpi: 14.8;U-698: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069732 Supported Mitochondria NA NA Mitochondria "HPA069732: AB_2686185" "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (9.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.87e-1)" "unprognostic (2.03e-1)" "unprognostic (2.81e-1)" "unprognostic (1.24e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "prognostic favorable (6.16e-4)" "unprognostic (3.82e-3)" "unprognostic (1.01e-1)" "unprognostic (7.53e-2)" "unprognostic (1.18e-1)" "unprognostic (1.74e-1)" "unprognostic (7.47e-3)" 13.3 15.0 18.5 6.6 28.8 1.5 18.7 63.8 30.2 11.8 13.2 20.2 11.3 5.0 28.4 50.9 7.6 13.9 14.2 11.9 17.6 10.5 12.6 12.2 10.1 4.2 24.7 28.9 39.4 9.7 25.8 37.8 2.6 19.6 31.0 11.5 23.6 14.3 17.9 11.2 28.1 6.8 17.0 18.0 6.3 9.1 12.6 26.9 0.4 21.7 7.7 3.8 11.4 17.6 0.0 0.4 0.3 0.0 0.0 0.3 0.0 2.0 1.4 2.4 8.0 9.1 6.3 0.1 1.1 3.7 1.1 0.2 0.0 2.9 0.8 5.5 2.0 2.6 4.1 1.1 3.5 0.7 0.0 11.8 0.0 26.3 2.9 4.8 0.1 0.3 9.8 14.8 0.0 9.4 5.8 0.2 8.0 0.1 0.0 0.9 0.8 0.0 0.1 1.2 2.0 3.1 0.0 3.1 0.1 6.0 7.5 7.3 0.8 5.5 0.3 2.9 3.6 5.9 0.0 0.8 5.0 3.3 0.5 1.0 3.2 0.0 16.2 0.8 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 18.5 28.8 63.8 30.2 17.6 10.5 24.7 28.9 19.6 26.9 3.0 2.9 0.0 3.6 0.8 20.5 7.0 0.0 6.7 2.3 5.2 27.5 0.0 0.0 0.6 23.2 3.1 0.3 0.0 0.6 0.0 2.5 5.8 1.1 1.7 0.2 19.1 5.8 2.5 0.3 16.0 2.8 0.1 1.7 0.0 1.3 8.3 0.3 0.0 4.9 0.5 38.2 0.0 2.3 0.5 0.7 2.0 0.0 0.0 1.5 2.1 SLC25A3 PHC ENSG00000075415 "Solute carrier family 25 member 3" Q00325 12 98593591-98606379 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 233.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045709 Supported Mitochondria NA NA 5500000 Mitochondria "HPA045709: AB_10965843" "unprognostic (1.16e-2)" "unprognostic (4.68e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (1.56e-2)" "unprognostic (6.38e-2)" "unprognostic (3.25e-3)" "unprognostic (9.41e-2)" "unprognostic (4.98e-2)" "unprognostic (6.43e-2)" "unprognostic (5.65e-2)" "unprognostic (7.40e-2)" "prognostic favorable (8.11e-7)" "unprognostic (3.45e-1)" "unprognostic (2.99e-1)" "unprognostic (8.66e-3)" "unprognostic (4.72e-2)" 35.7 71.2 23.6 38.3 27.2 24.6 48.9 25.1 50.2 29.8 69.6 22.4 33.8 53.9 38.5 35.9 54.6 30.1 55.1 233.5 22.9 25.3 60.2 72.6 47.0 75.5 27.8 26.0 39.6 59.7 55.5 29.1 34.2 31.6 33.8 53.3 30.9 53.5 33.5 190.6 33.8 76.0 46.7 19.6 35.6 51.4 16.9 15.1 42.0 41.5 125.8 44.4 38.5 31.9 46.8 82.3 33.4 78.5 43.3 56.6 76.3 74.7 58.4 77.5 64.2 70.6 117.4 99.9 65.6 87.5 85.1 71.2 104.8 39.3 102.2 39.0 79.5 38.5 64.4 78.6 88.7 89.8 38.4 62.7 60.9 43.1 69.5 86.9 71.3 48.4 111.0 79.4 61.8 88.9 128.1 120.1 53.0 65.6 30.3 101.4 55.8 66.1 79.6 71.7 64.7 96.0 75.6 80.8 113.4 110.0 75.1 39.8 53.4 78.5 70.7 108.3 68.5 95.5 78.0 80.7 47.4 44.8 52.0 65.6 51.4 60.4 71.5 37.4 42.1 61.0 24.4 59.5 33.4 40.1 77.2 47.4 46.8 45.7 44.3 82.3 33.3 47.9 45.3 26.4 43.3 78.5 50.3 56.6 76.3 23.6 27.2 25.1 50.2 22.9 25.3 27.8 26.0 31.6 15.1 199.5 265.4 295.0 454.5 334.1 211.9 1401.5 384.7 145.9 192.2 204.1 74.6 677.0 741.1 434.4 31.9 273.0 744.3 163.5 762.2 755.9 400.5 371.4 205.5 373.5 527.3 276.5 300.1 249.2 430.8 19.5 236.2 288.2 415.0 543.8 392.0 226.4 536.4 501.2 241.1 802.3 176.2 297.5 387.5 94.1 178.4 316.8 681.4 269.7 620.6 559.0 SLC25A32 MFTC ENSG00000164933 "Solute carrier family 25 member 32" Q9H2D1 8 103398635-103415189 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024763, HPA047402" Uncertain Supported Mitochondria NA NA Mitochondria "HPA024763: , HPA047402: AB_2680032" "unprognostic (2.45e-3)" "unprognostic (8.19e-2)" "unprognostic (3.87e-3)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.06e-2)" "unprognostic (6.50e-3)" "unprognostic (1.22e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (9.47e-2)" "unprognostic (8.43e-2)" "unprognostic (2.08e-1)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.53e-6)" "unprognostic (7.82e-2)" "unprognostic (2.12e-1)" "unprognostic (1.62e-1)" "unprognostic (4.49e-2)" 24.1 14.9 11.1 19.6 17.0 21.6 21.6 22.1 21.9 16.3 14.7 15.4 8.8 11.0 19.4 13.0 13.1 18.8 19.6 16.4 12.6 16.5 15.2 29.6 16.1 23.9 16.4 11.6 21.0 13.4 17.3 30.1 16.5 24.2 14.9 14.2 15.7 13.0 13.1 17.8 13.9 14.1 18.5 14.1 25.1 14.4 15.3 13.6 17.2 14.9 11.7 19.8 18.3 14.2 8.9 5.0 1.8 4.6 5.7 9.3 6.5 15.0 5.4 7.4 9.0 10.1 11.8 4.9 12.8 18.1 14.4 15.0 6.6 9.3 32.8 12.2 13.8 8.6 9.7 10.6 10.8 22.4 20.0 7.5 24.2 4.6 8.4 17.6 11.8 11.0 11.6 9.0 16.2 24.2 5.8 14.9 9.6 14.9 12.9 14.3 6.0 20.1 9.7 8.9 17.7 10.9 15.1 7.9 22.6 9.8 6.9 20.7 9.0 6.2 10.3 21.4 6.2 9.1 8.5 10.3 17.9 11.9 20.6 16.5 9.2 8.6 34.2 15.2 17.3 13.2 0.7 3.9 1.8 7.7 4.4 9.3 8.9 8.3 8.8 5.0 6.5 8.6 8.7 1.1 5.7 4.6 4.3 6.5 6.5 11.1 17.0 22.1 21.9 12.6 16.5 16.4 11.6 24.2 13.6 3.0 3.5 26.5 13.0 20.5 8.9 9.9 10.2 1.4 3.4 5.2 5.9 10.3 6.6 7.8 3.0 19.4 3.2 0.0 8.2 11.5 13.8 8.2 9.2 13.0 9.3 7.9 10.9 16.5 5.0 2.8 8.6 7.4 10.1 10.0 6.3 7.1 8.1 3.5 8.1 7.4 7.4 19.4 12.6 20.0 17.9 22.6 11.7 13.1 6.2 14.0 SLC25A4 "ANT1, PEO2, PEO3, T1" ENSG00000151729 "Solute carrier family 25 member 4" P12235 4 185143241-185150382 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Transport" "Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 4236.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (4.19e-2)" "unprognostic (1.06e-2)" "unprognostic (3.11e-1)" "unprognostic (8.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.90e-3)" "unprognostic (8.25e-2)" "unprognostic (1.26e-2)" "unprognostic (7.87e-2)" "unprognostic (1.60e-1)" "prognostic favorable (3.41e-4)" "unprognostic (2.05e-1)" "prognostic favorable (0.00e+0)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (8.28e-3)" 3.0 4.2 6.9 2.0 10.8 1.4 3.1 19.4 14.4 2.6 6.6 3.7 2.9 2.8 3.0 3.4 6.7 3.7 3.5 163.7 7.4 7.3 8.3 4.3 3.0 2.0 6.3 6.1 3.6 3.0 4.6 4.6 2.2 12.8 6.2 3.4 7.9 4.4 8.5 92.5 2.3 4.1 5.5 4.5 2.1 5.3 3.1 2.3 0.0 4.6 62.4 3.4 4.4 2.1 3.5 3.0 0.4 0.0 0.7 4.1 1.5 0.7 3.3 2.7 5.5 3.0 0.3 5.0 2.7 0.9 3.3 3.3 7.1 1.8 2.4 2.0 3.3 2.6 2.6 10.4 2.9 2.2 4.0 8.9 1.6 4.9 8.3 6.1 1.4 1.6 2.2 7.1 5.1 1.4 7.8 2.4 4.2 3.8 1.9 2.0 5.1 1.6 3.2 4.4 2.3 7.1 2.6 1.4 3.3 7.5 5.1 8.8 6.7 3.2 1.4 12.6 5.1 2.6 1.2 1.8 0.2 1.5 1.7 3.5 7.9 3.6 3.1 2.4 0.3 3.0 0.0 0.0 0.0 4.1 0.0 3.1 3.5 1.4 3.5 0.1 2.2 1.2 3.0 0.4 0.7 0.0 3.0 1.2 1.5 6.9 10.8 19.4 14.1 7.4 7.3 6.3 6.1 12.8 2.3 80.4 55.4 33.5 125.8 39.2 174.4 4236.1 140.1 112.4 42.1 68.0 98.2 59.7 837.3 68.4 15.8 25.9 41.2 0.0 65.1 47.9 24.6 55.0 11.5 83.9 50.1 151.0 51.6 24.5 7.6 7.7 43.1 7.9 180.5 15.4 35.7 473.2 51.1 24.6 106.1 140.9 178.4 103.5 194.8 24.0 35.3 15.8 33.9 10.7 48.8 46.9 SLC25A42 MGC26694 ENSG00000181035 "Solute carrier family 25 member 42" Q86VD7 19 19063999-19112888 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 68.0;Hepatocytes: 44.5;Rod photoreceptor cells: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9" "Group enriched" "Detected in many" 6 "B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1" "Cell line enhanced" "Detected in many" "K-562: 17.5" "Low region specificity" "Detected in all" HPA049449 Approved Supported Mitochondria Yes No Mitochondria "HPA049449: AB_2680772" "unprognostic (2.27e-1)" "prognostic favorable (5.04e-4)" "unprognostic (5.79e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (3.42e-3)" "unprognostic (1.27e-3)" "prognostic favorable (4.11e-4)" "unprognostic (6.89e-2)" "unprognostic (2.73e-1)" "unprognostic (1.37e-3)" "unprognostic (3.04e-2)" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (4.17e-2)" "unprognostic (2.03e-2)" 4.8 5.7 13.8 4.5 12.2 7.5 4.9 22.5 15.4 7.0 4.8 5.9 4.5 5.7 6.8 4.4 4.5 7.4 4.7 8.9 9.7 7.8 26.7 42.3 5.4 8.5 5.9 7.8 13.8 7.4 6.5 9.6 3.2 7.9 7.6 3.0 12.2 11.0 6.3 26.7 5.2 5.6 5.7 6.1 7.3 4.6 4.5 8.1 6.6 17.1 7.3 12.2 5.5 5.4 6.2 0.7 0.2 0.6 2.8 5.1 1.5 6.2 0.8 1.6 2.8 6.1 5.1 2.5 3.0 4.6 4.7 5.4 1.2 12.5 4.5 7.1 2.8 4.7 1.1 3.2 2.5 2.7 1.1 6.2 1.5 1.7 10.0 4.9 0.7 3.2 5.1 1.8 3.6 2.2 3.8 2.1 14.7 17.5 8.1 2.5 5.6 7.5 7.1 0.9 1.7 6.5 5.8 2.8 8.6 1.8 1.1 1.8 1.3 3.2 0.1 1.3 2.2 5.7 3.5 1.9 3.5 2.0 7.3 2.9 9.4 5.1 3.5 3.7 9.6 1.8 0.0 0.2 0.2 5.1 0.5 2.8 6.2 2.9 4.3 0.3 5.1 1.9 2.8 0.0 2.8 0.6 0.7 2.9 1.5 13.8 12.2 22.5 15.4 9.7 7.8 5.9 7.8 7.9 8.1 0.0 9.6 8.9 2.4 2.9 68.0 8.9 2.5 1.4 3.4 8.7 17.7 5.7 11.6 1.4 1.2 3.5 5.4 0.0 2.7 2.7 3.6 2.6 3.5 44.5 1.5 3.2 8.1 4.3 0.3 0.6 4.6 1.1 3.3 0.0 4.0 11.9 1.9 2.9 6.0 27.0 42.5 6.5 5.7 7.9 6.4 2.5 3.9 11.4 2.9 1.3 SLC25A46 ENSG00000164209 "Solute carrier family 25 member 46" Q96AG3 5 110738136-110765161 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 176.3;Late spermatids: 325.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039601, HPA071582" Approved Supported Mitochondria NA NA Mitochondria "HPA039601: AB_2676592, HPA071582: AB_2686422" "unprognostic (1.86e-1)" "unprognostic (3.29e-1)" "prognostic favorable (8.41e-4)" "unprognostic (4.91e-2)" "unprognostic (2.27e-2)" "unprognostic (2.25e-1)" "unprognostic (2.34e-1)" "unprognostic (1.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.97e-2)" "unprognostic (1.67e-1)" "unprognostic (2.40e-1)" "unprognostic (2.25e-2)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (2.52e-4)" "unprognostic (1.98e-1)" 16.9 15.6 11.9 12.7 19.3 11.3 13.6 17.6 25.7 12.5 14.0 12.2 8.5 15.7 13.4 9.5 16.4 9.5 10.0 20.8 10.4 10.0 18.7 22.0 11.4 13.7 14.5 14.8 10.2 12.4 12.7 20.2 11.5 27.7 10.2 14.7 8.3 14.2 10.7 55.6 13.0 15.4 13.9 15.0 12.1 12.9 15.8 12.3 20.4 12.5 14.3 17.5 13.1 10.9 14.6 15.1 20.2 17.3 17.7 16.3 14.9 12.5 9.7 9.2 7.4 21.3 20.2 3.7 15.7 20.4 18.0 22.5 13.2 10.7 33.8 16.1 18.3 23.9 10.4 14.5 26.0 20.4 21.7 8.3 14.5 14.1 9.5 19.0 12.6 14.6 17.0 7.7 21.2 15.0 9.4 11.2 12.9 10.9 21.3 18.6 10.0 18.4 5.4 6.9 8.2 9.7 9.0 20.6 25.1 11.4 14.7 16.2 12.0 13.6 10.5 16.5 9.1 11.4 10.5 14.7 15.9 8.0 14.4 18.8 40.9 25.6 25.4 16.5 14.8 8.5 20.2 14.7 11.5 12.3 17.3 12.4 14.1 13.7 12.6 15.1 14.6 14.8 14.8 6.2 17.7 15.2 10.6 16.3 14.9 11.9 19.3 17.6 25.7 10.4 10.0 14.5 14.8 27.7 12.3 20.8 22.7 11.9 7.5 20.4 16.0 56.7 5.1 12.0 7.9 19.2 21.6 18.8 16.6 15.0 176.3 20.2 27.2 23.3 22.2 16.5 20.2 7.3 18.5 39.4 23.8 17.5 22.5 30.1 24.3 325.8 19.5 18.9 28.7 22.6 25.4 21.5 14.4 25.7 20.8 30.4 13.6 19.4 20.6 20.0 10.2 23.5 17.2 25.4 19.0 5.5 SLC25A5 "2F1, ANT2, T2, T3" ENSG00000005022 "Solute carrier family 25 member 5" P05141 X 119468400-119471319 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Chromosome partition, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 2147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 7800000 Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.25e-2)" "prognostic favorable (7.35e-4)" "prognostic favorable (7.47e-4)" "unprognostic (1.48e-1)" "unprognostic (4.58e-2)" "unprognostic (1.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.47e-1)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.41e-1)" "unprognostic (2.65e-1)" "unprognostic (4.36e-2)" "unprognostic (3.03e-1)" 26.0 28.9 26.8 32.2 29.5 36.5 36.6 21.8 39.0 23.0 74.1 16.3 26.0 120.7 22.5 18.3 64.1 17.5 39.5 31.4 22.5 18.8 80.7 71.0 38.3 53.8 27.2 23.8 18.1 128.2 22.5 14.6 30.7 24.2 18.9 84.9 20.1 58.3 21.5 16.6 42.1 157.5 33.6 20.5 34.3 68.2 16.8 17.1 87.0 31.1 59.9 47.0 30.8 33.8 51.6 97.8 18.5 113.2 33.4 48.0 84.9 82.0 78.9 30.9 53.1 19.8 29.2 57.4 30.7 33.5 64.8 58.0 65.5 52.1 104.2 41.3 29.4 46.8 57.8 75.8 64.1 59.2 27.5 73.1 35.1 47.7 46.6 25.1 95.3 58.0 31.7 72.1 66.7 42.6 24.7 67.2 53.7 28.1 43.2 35.3 182.7 84.3 96.8 65.0 112.7 127.2 46.3 39.1 80.8 49.3 66.0 37.4 35.4 52.7 80.3 62.1 32.9 33.1 48.3 27.9 30.7 44.4 68.3 110.0 50.7 62.9 83.4 33.9 97.5 49.5 10.1 68.1 18.5 20.7 113.2 23.9 51.6 30.1 26.9 97.8 39.7 30.1 28.3 11.3 33.4 84.9 53.9 48.0 84.9 26.8 29.5 21.8 39.0 22.5 18.8 27.2 23.8 24.2 17.1 151.8 244.7 335.6 401.9 724.7 105.3 125.5 328.6 187.4 221.8 177.9 56.9 945.1 2147.0 467.3 2.7 209.6 1628.0 163.5 919.2 321.7 246.2 228.4 191.3 343.1 785.8 25.4 385.2 119.1 477.4 13.9 134.6 447.5 519.6 300.2 755.1 85.2 524.3 956.2 104.0 1138.1 131.4 129.4 460.4 8.9 116.7 839.4 1329.0 292.0 958.7 657.9 SLC25A6 "ANT3, ANT3Y, MGC17525" ENSG00000169100 "Solute carrier family 25 member 6" P12236 X 1386152-1392724 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 85.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 7200000 Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.13e-1)" "unprognostic (1.65e-2)" "unprognostic (4.79e-2)" "unprognostic (1.45e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.01e-3)" "unprognostic (1.34e-1)" "unprognostic (8.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.37e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (4.57e-3)" 18.5 19.7 12.1 12.2 14.0 23.7 14.4 8.2 12.2 9.8 16.5 28.9 14.3 4.8 16.4 10.4 7.0 9.4 10.3 8.2 18.4 5.4 11.1 14.4 9.4 25.6 38.7 10.1 14.0 8.6 12.4 8.8 45.0 12.5 6.1 14.9 23.3 7.7 5.8 15.4 19.2 2.4 16.3 9.5 14.2 11.2 62.2 85.7 3.7 69.0 30.1 43.6 71.2 22.2 48.7 34.6 35.3 24.0 46.8 37.5 34.1 32.7 25.2 25.1 64.4 27.2 82.8 27.6 22.4 38.0 14.5 23.2 40.7 7.9 20.7 73.8 45.2 33.4 73.5 56.3 32.5 55.2 77.2 75.0 19.7 29.0 32.7 37.3 26.1 31.5 19.5 24.6 47.4 60.1 62.3 43.9 8.8 65.7 30.4 28.6 64.2 30.7 56.0 56.6 88.9 23.1 70.1 97.0 21.0 38.9 67.0 42.7 25.7 14.4 50.2 34.0 50.6 8.1 55.8 3.8 31.4 13.9 2.4 58.1 3.7 29.4 69.0 43.6 62.2 40.4 34.8 85.7 47.5 38.1 37.2 3.0 30.1 67.9 41.0 38.7 71.2 137.0 195.3 871.5 1042.4 1022.6 282.9 87.0 257.4 128.5 280.9 300.1 92.3 1322.2 1405.9 633.0 8.9 418.0 863.0 303.7 1275.3 963.9 807.0 855.9 337.0 132.8 1090.5 228.8 892.0 411.9 1235.3 26.5 618.4 976.3 715.3 1354.4 1107.0 100.8 835.0 866.6 344.4 1021.3 199.6 336.3 860.1 13.3 52.8 1155.2 1458.6 553.5 1380.0 1328.6 SLC44A1 "CD92, CDw92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 111.6" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 73.5;ASC TERT1: 58.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064714, HPA074007" Enhanced Supported Nucleoplasm,Mitochondria NA NA 270000 Mitochondria Nucleoplasm "HPA064714: AB_2685334, HPA074007: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favorable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 8.7 7.4 40.0 6.4 48.8 5.3 14.6 7.2 37.0 9.9 26.7 69.5 10.2 12.0 8.8 18.4 10.1 8.5 11.0 6.9 50.0 29.6 12.0 20.3 9.8 4.6 64.3 21.3 8.0 8.0 20.5 3.9 12.3 38.2 6.6 26.9 4.6 6.0 14.8 4.8 11.4 14.0 9.5 111.6 4.8 18.9 2.3 59.4 2.3 24.0 5.1 7.9 12.4 7.9 2.4 3.7 2.5 5.4 8.7 1.8 1.6 6.9 5.8 1.6 1.9 73.5 58.1 5.0 5.8 15.3 3.8 5.1 6.2 18.5 9.2 3.0 22.0 4.3 13.8 4.7 8.4 6.5 8.0 3.8 11.5 4.1 7.7 4.9 2.2 5.9 32.2 6.9 7.3 6.6 9.8 12.0 4.8 0.3 19.2 4.3 9.8 9.1 2.6 8.9 12.3 5.6 1.9 6.1 6.9 5.2 16.3 7.7 3.0 8.2 9.1 8.2 9.9 9.0 6.9 10.2 3.8 3.4 4.1 4.2 14.8 9.8 6.9 7.4 5.0 5.0 2.5 5.4 1.1 1.1 2.1 0.8 2.0 1.2 0.8 3.7 2.4 1.8 0.6 1.0 8.7 1.2 1.3 1.1 1.6 40.0 48.8 7.2 29.8 50.0 29.6 64.3 21.3 38.2 59.4 32.8 21.6 15.9 31.4 62.7 7.6 9.3 56.0 14.7 9.1 101.2 221.9 44.4 3.3 16.4 2.4 38.4 140.4 0.0 31.4 7.9 49.9 25.3 98.1 132.6 20.0 6.4 151.0 54.0 50.8 2.9 101.8 39.6 70.9 122.6 158.5 6.7 33.4 123.8 75.0 23.3 44.8 38.8 27.0 1.4 1.7 65.0 59.0 15.3 134.8 29.5 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 261.2" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 10.0;SuSa: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: AB_2675130, HPA052726: AB_2681927" "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 10.0 0.1 0.1 0.0 0.1 0.0 0.9 3.7 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 0.0 1.1 0.5 0.0 0.0 0.2 1.3 0.0 1.4 0.0 17.4 2.0 0.0 41.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.7 0.0 0.0 0.0 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.2 0.8 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.0 0.0 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 43.1" "Group enriched" "Detected in many" 7 "Early spermatids: 118.1;Late spermatids: 86.8;Spermatocytes: 121.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" NA NA Mitochondria "Centriolar satellite" "HPA058971: AB_2683865, HPA065520: AB_2685502" "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.1 1.1 1.1 1.1 3.1 0.9 0.9 1.4 2.0 0.9 0.8 3.7 0.0 0.8 2.6 2.3 0.7 0.9 1.6 0.9 1.6 1.0 0.8 0.7 1.1 2.4 2.4 1.1 1.5 1.3 1.2 2.4 0.9 3.1 1.1 0.8 2.8 0.7 0.9 0.7 1.9 0.8 0.7 4.4 1.0 0.8 43.1 2.3 4.2 1.1 0.0 1.7 1.2 0.9 2.0 1.9 0.6 0.6 0.4 4.9 0.6 0.4 0.0 2.2 3.3 4.4 3.3 0.7 0.8 1.1 0.0 0.2 0.0 0.2 1.7 0.6 1.7 0.7 0.0 1.7 0.9 1.5 3.2 2.3 2.5 2.0 0.0 0.0 0.7 0.5 0.5 1.0 0.0 1.8 0.9 1.3 4.5 1.2 1.7 1.7 1.3 1.0 2.2 0.8 0.5 0.0 2.7 1.8 0.5 0.9 0.5 2.1 5.0 0.6 0.8 2.5 1.5 0.4 1.7 0.7 0.9 0.3 1.0 1.1 5.5 4.0 1.4 1.2 1.0 2.4 0.6 0.6 0.1 1.5 0.4 1.7 1.8 1.2 1.8 0.7 2.0 4.9 2.8 0.3 0.4 0.3 1.9 1.7 0.6 1.1 3.1 1.4 2.0 1.6 1.0 2.4 1.1 3.1 2.3 3.0 1.0 1.9 0.5 1.1 1.9 0.8 0.0 0.0 0.0 0.0 15.7 0.4 1.7 0.3 118.1 0.7 0.0 0.0 0.4 0.2 1.5 0.8 0.0 0.0 1.1 3.2 0.0 0.6 4.1 86.8 4.9 0.8 1.7 1.8 0.0 2.7 0.7 0.0 2.8 0.6 5.0 0.0 1.4 121.2 8.1 0.5 0.5 1.0 0.0 0.5 SLIRP "C14orf156, DC50" ENSG00000119705 "SRA stem-loop interacting RNA binding protein" Q9GZT3 14 77708071-77761104 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1046.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020291 Approved Supported Mitochondria No No 38000 Mitochondria "HPA020291: AB_1845563" "unprognostic (9.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.18e-1)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (1.14e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" "unprognostic (9.95e-3)" "unprognostic (1.52e-1)" "unprognostic (2.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.37e-1)" 31.9 36.0 65.2 25.0 55.1 33.6 49.9 24.3 54.7 29.2 49.8 30.6 23.2 37.2 23.7 65.1 38.1 24.4 26.5 63.6 47.5 50.5 57.5 69.8 19.1 24.3 53.7 40.6 26.1 49.3 19.3 34.8 30.0 44.9 25.2 46.7 27.8 36.9 30.6 105.7 20.5 42.1 31.9 46.3 26.3 32.0 31.7 34.4 16.5 27.4 72.9 34.6 27.9 23.5 35.2 52.2 20.9 59.6 18.3 33.0 40.5 41.5 82.6 33.9 33.0 22.4 22.5 45.7 23.6 22.3 46.9 41.0 111.7 38.1 30.2 24.9 26.8 29.7 41.1 61.8 48.1 62.3 16.5 69.4 30.5 78.1 111.0 34.3 20.2 22.0 24.1 31.7 37.6 41.9 23.3 38.5 39.3 29.8 17.3 40.8 134.5 30.9 55.3 52.6 89.7 116.8 28.4 28.4 33.7 48.1 79.3 43.4 28.4 25.0 53.2 34.0 38.8 55.7 35.9 22.4 24.0 43.1 25.9 41.1 18.7 34.0 56.5 32.9 39.7 30.7 17.4 59.6 20.9 23.8 56.5 25.0 35.2 31.7 23.3 50.8 31.2 33.0 27.3 19.1 18.3 56.9 52.2 31.7 40.5 65.2 55.1 24.3 54.7 47.5 50.5 53.7 40.6 44.9 34.4 101.3 132.2 131.6 134.2 158.9 62.3 1046.2 321.0 215.5 236.6 251.2 45.2 353.2 653.2 329.0 411.9 162.1 390.6 186.9 458.2 301.6 205.6 130.6 164.3 649.5 274.7 41.3 237.0 176.8 193.5 63.4 155.6 186.2 237.8 215.6 299.7 100.1 358.6 298.1 159.8 577.8 85.2 168.1 217.8 171.1 196.1 187.3 201.2 82.8 331.8 147.8 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: AB_2684257" "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favorable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favorable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favorable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 8.7 12.3 20.3 14.6 18.0 15.3 19.9 19.5 17.9 15.2 12.9 10.2 14.7 11.0 13.0 20.2 16.4 15.7 10.7 21.3 15.8 16.2 14.1 18.4 10.1 14.4 16.3 12.4 23.2 21.6 11.3 12.9 9.8 9.9 16.4 12.1 15.5 37.0 15.9 26.4 10.4 18.0 9.8 13.3 10.6 12.9 10.9 7.9 15.2 23.4 18.7 16.1 14.9 16.9 5.4 5.0 2.3 3.5 2.9 5.9 3.0 2.2 1.5 3.1 3.7 5.7 4.1 2.4 0.8 4.1 5.1 4.4 2.9 2.2 5.8 1.0 4.3 1.4 2.6 4.0 4.3 3.3 1.5 6.6 1.9 3.2 4.1 7.1 3.5 2.5 3.2 7.3 2.0 4.3 2.9 5.0 2.1 3.1 5.1 3.5 5.9 4.9 5.3 1.1 5.7 3.3 4.3 2.7 8.4 6.4 2.6 3.8 2.5 2.0 4.6 5.0 1.6 3.9 3.8 2.0 2.2 2.4 1.9 1.5 3.5 3.8 6.9 3.3 3.4 1.6 2.3 3.5 1.6 2.7 1.7 3.7 3.7 5.4 2.8 5.0 5.4 5.9 3.9 0.3 2.9 2.5 3.8 3.0 3.0 20.3 18.0 19.5 17.9 15.8 16.2 16.3 12.4 9.9 7.9 77.4 85.3 270.8 168.6 148.1 59.5 296.6 234.4 179.3 92.1 193.7 19.6 251.6 485.7 138.8 92.3 121.8 346.2 0.0 174.6 167.3 105.2 269.9 91.0 309.5 220.1 52.4 331.5 110.5 164.5 80.6 175.2 186.8 200.8 116.4 276.7 86.2 148.7 295.1 140.0 446.7 82.0 122.9 137.7 196.7 54.5 239.6 258.2 167.5 271.3 230.0 SPATA18 FLJ32906 ENSG00000163071 "Spermatogenesis associated 18" Q8TC71 4 52051331-52097292 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 41.7;testis: 65.7" "Group enriched" "Detected in many" 10 "Early spermatids: 536.7;Late spermatids: 1836.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 12.5" "Cell type enriched" "Detected in single" 23 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 23 "B-cells: 2.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 20.1;BEWO: 15.1;BJ hTERT+: 9.7;HSkMC: 18.5;hTCEpi: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036854, HPA036855" Enhanced Supported Mitochondria NA NA Mitochondria "HPA036854: AB_10670927, HPA036855: AB_2675352" "unprognostic (6.54e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.32e-5)" "unprognostic (1.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.27e-2)" "unprognostic (4.49e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-1)" "unprognostic (3.13e-1)" "unprognostic (3.13e-2)" "prognostic favorable (3.73e-9)" "unprognostic (4.38e-1)" "unprognostic (1.39e-1)" "unprognostic (1.01e-2)" "unprognostic (4.00e-2)" 2.1 4.2 2.6 1.2 3.3 0.0 3.7 0.1 1.1 6.8 2.3 3.6 5.3 1.2 2.5 9.9 4.9 41.7 11.5 1.5 3.1 2.8 3.7 4.4 12.0 0.3 0.6 0.6 7.6 1.6 4.2 6.1 1.8 12.5 3.5 3.5 1.4 13.2 6.0 1.1 4.3 2.8 1.8 0.8 0.5 2.9 65.7 0.8 1.3 1.6 4.1 3.1 2.3 2.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.1 0.0 8.0 20.1 15.1 5.6 9.7 0.3 0.4 0.0 0.9 0.0 0.0 7.4 0.1 0.1 0.0 4.3 0.2 0.0 0.6 0.0 0.0 4.7 7.1 0.0 0.0 18.5 17.8 0.6 2.8 3.2 4.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 1.2 0.6 0.0 0.0 6.3 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.3 0.1 1.1 3.1 2.8 0.6 0.6 12.5 0.8 8.9 4.0 0.0 6.6 4.6 0.0 2.4 7.6 115.1 18.2 0.0 0.0 1.4 1.7 0.9 536.7 0.4 1.1 0.0 2.4 1.1 2.3 5.1 2.3 1.7 0.3 0.0 1.7 2.5 1.2 1836.3 10.0 1.2 0.0 0.0 1.6 0.0 1.2 2.9 10.3 5.4 0.0 0.0 1.8 11.7 6.8 6.6 0.7 0.0 3.8 6.4 SQOR "CGI-44, SQR, SQRDL" ENSG00000137767 "Sulfide quinone oxidoreductase" Q9Y6N5 15 45631148-45691294 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 14 "Ductal cells: 93.9;Exocrine glandular cells: 153.6;Hofbauer cells: 133.1;monocytes: 269.7;Pancreatic endocrine cells: 118.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 64.9;RPTEC TERT1: 41.1" "HPA017079, HPA041589" Enhanced Supported Mitochondria NA NA 30000 Mitochondria "HPA017079: AB_1857467, HPA041589: AB_2677565" "unprognostic (6.15e-2)" "unprognostic (3.28e-2)" "unprognostic (2.15e-1)" "prognostic favorable (2.57e-4)" "unprognostic (2.75e-2)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "prognostic unfavorable (8.80e-4)" "unprognostic (1.81e-1)" "unprognostic (3.77e-1)" "unprognostic (6.65e-3)" "unprognostic (2.37e-1)" "unprognostic (3.14e-3)" "unprognostic (2.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.44e-2)" "unprognostic (4.38e-1)" 23.6 8.6 4.4 33.5 5.7 12.0 16.7 1.6 3.8 11.9 54.7 3.0 12.1 14.2 11.7 11.4 38.7 8.4 15.2 12.2 2.8 2.3 16.9 34.2 27.1 22.4 6.8 2.3 8.7 27.7 7.4 7.5 7.0 4.8 18.0 48.5 11.2 21.5 15.2 66.9 14.3 31.5 21.5 4.9 21.4 19.7 4.6 3.1 11.7 19.0 36.6 30.3 24.6 20.7 11.0 27.8 62.3 43.5 10.0 29.2 29.2 7.7 13.9 0.0 0.8 28.7 34.5 0.0 8.4 28.5 5.1 7.8 0.5 12.2 7.2 8.2 6.4 16.1 7.0 0.4 64.9 3.1 24.4 0.2 0.6 3.1 9.7 8.3 3.9 1.1 10.1 19.2 11.9 27.3 13.4 14.1 6.4 0.0 8.9 5.5 6.1 2.4 9.2 0.0 31.7 8.3 0.3 1.4 9.7 41.1 11.4 0.2 0.2 2.1 5.6 2.7 0.1 12.0 12.6 15.7 2.1 0.5 30.2 1.8 11.3 11.8 0.4 20.7 21.3 2.2 18.4 43.5 16.2 16.3 32.9 22.8 11.0 21.6 18.3 27.8 9.5 11.3 12.2 62.3 10.0 29.0 8.1 29.2 29.2 4.4 5.7 1.6 3.8 2.8 2.3 6.8 2.3 4.8 3.1 29.8 54.4 0.0 0.0 0.0 0.0 0.0 0.0 44.2 27.3 14.0 0.0 0.6 10.0 93.9 0.0 0.0 0.0 0.0 153.6 0.6 0.0 0.0 10.5 0.0 133.1 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 269.7 0.0 0.0 118.9 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 SSBP1 "mtSSB, SSBP" ENSG00000106028 "Single stranded DNA binding protein 1" Q04837 7 141738321-141787922 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002866 Supported Supported Mitochondria NA NA 250000 Mitochondria "HPA002866: AB_1080092" "unprognostic (2.95e-1)" "unprognostic (2.99e-1)" "unprognostic (2.49e-2)" "unprognostic (3.62e-2)" "unprognostic (7.36e-3)" "unprognostic (2.86e-2)" "prognostic unfavorable (4.42e-4)" "unprognostic (3.68e-2)" "unprognostic (6.03e-2)" "prognostic favorable (3.40e-4)" "unprognostic (9.23e-3)" "unprognostic (4.02e-1)" "unprognostic (9.65e-3)" "unprognostic (1.62e-1)" "unprognostic (9.38e-2)" "unprognostic (1.25e-2)" "unprognostic (9.58e-2)" 41.1 52.5 45.4 40.9 52.6 41.7 51.6 26.8 44.3 41.7 42.4 33.9 38.7 36.9 45.2 58.9 61.0 37.1 36.8 57.8 38.6 38.6 55.2 83.4 31.0 56.0 42.7 41.0 45.2 49.6 40.7 44.4 47.2 44.4 38.8 44.8 34.1 41.2 39.0 62.9 42.4 40.8 45.5 36.7 50.7 44.6 38.3 33.3 62.9 45.6 67.4 54.7 42.8 38.6 42.6 41.2 31.3 35.9 36.3 48.7 40.8 39.6 46.0 41.1 51.7 18.3 29.8 37.8 28.6 27.6 36.6 41.2 48.5 45.5 62.0 40.6 24.0 60.0 29.9 47.6 50.0 52.1 29.8 49.7 30.4 34.6 42.8 36.2 89.1 24.2 28.0 34.1 38.3 54.0 26.0 44.6 39.0 76.6 26.3 50.0 58.2 63.1 116.4 90.6 64.7 57.6 36.6 37.4 80.7 47.9 39.1 37.0 50.9 33.5 44.5 44.4 32.2 30.1 39.3 32.1 26.1 25.2 40.2 75.9 47.4 62.7 111.0 53.5 80.3 56.9 31.3 29.1 26.6 30.1 35.5 44.0 42.6 48.7 40.2 36.8 37.0 45.1 48.1 7.5 36.3 35.9 41.2 46.4 40.8 45.4 52.6 26.8 44.3 38.6 38.6 42.7 41.0 44.4 33.3 95.3 94.9 115.3 144.9 103.0 51.8 257.7 158.0 105.7 114.9 143.1 39.3 266.1 296.8 270.0 118.1 112.7 85.6 46.7 306.8 254.8 138.8 122.4 145.8 187.5 221.5 41.3 92.5 95.8 119.0 35.7 127.1 153.1 99.5 206.4 126.8 92.4 270.9 108.7 116.3 344.0 71.9 97.0 135.8 228.3 170.8 113.2 218.9 139.5 153.1 201.9 SUPV3L1 SUV3 ENSG00000156502 "Suv3 like RNA helicase" Q8IYB8 10 69180232-69209099 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038380, HPA038405" Supported Supported Mitochondria NA NA Mitochondria "HPA038380: AB_2675983, HPA038405: AB_10675797" "unprognostic (4.70e-2)" "unprognostic (1.85e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.74e-2)" "unprognostic (3.32e-2)" "unprognostic (1.44e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (9.47e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (5.48e-3)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (5.27e-2)" "unprognostic (1.33e-1)" 12.8 17.0 11.1 12.6 17.3 26.1 17.7 21.9 19.9 10.8 14.4 12.6 7.8 11.2 13.5 12.4 13.2 11.9 12.6 19.2 12.0 11.3 16.4 22.2 9.6 15.2 9.9 13.1 15.8 18.2 15.4 14.7 10.9 16.1 11.4 16.7 12.4 11.8 13.9 31.1 15.6 12.5 13.9 9.9 15.5 13.0 26.6 9.9 12.7 14.1 13.4 14.8 12.4 11.6 10.1 7.3 5.6 7.7 7.4 13.7 6.2 11.5 8.1 7.3 22.3 8.2 7.0 9.6 7.2 11.2 14.6 13.8 20.8 9.8 20.8 5.9 7.2 10.4 13.3 17.4 11.2 14.1 8.7 13.7 9.1 6.4 10.9 20.7 21.6 6.9 8.8 14.2 13.4 30.8 10.0 8.4 13.3 23.7 10.9 8.0 7.5 13.1 13.4 8.7 11.0 44.4 12.1 10.3 9.1 6.6 5.6 10.4 7.9 9.9 20.8 18.9 8.4 6.4 9.5 5.2 5.8 10.5 8.8 13.9 8.6 10.0 19.5 9.6 22.9 3.6 5.6 5.2 4.3 12.3 7.7 13.7 10.1 8.9 10.5 7.3 8.3 9.9 10.6 0.9 7.4 5.2 4.0 8.7 6.2 11.1 17.3 21.9 19.9 12.0 11.3 9.9 13.1 16.1 9.9 6.0 9.0 10.0 9.6 21.2 21.5 19.6 10.2 14.7 13.6 7.0 3.9 15.0 10.0 10.0 8.2 8.5 7.8 0.0 7.4 9.9 9.7 6.9 7.0 10.9 8.7 11.1 8.6 6.7 3.1 3.4 6.4 5.6 5.0 5.4 8.6 10.8 8.0 9.0 8.5 12.2 11.3 6.5 13.4 28.6 24.5 19.4 18.8 15.8 11.8 9.5 TBC1D15 "DKFZp761D0223, FLJ12085" ENSG00000121749 "TBC1 domain family member 15" Q8TC07 12 71839707-71927248 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013388, HPA015592" Supported Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA013388: AB_2199233, HPA015592: AB_1857789" "unprognostic (3.87e-2)" "prognostic favorable (7.06e-4)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (4.63e-2)" "unprognostic (6.13e-3)" "unprognostic (2.96e-2)" "unprognostic (3.10e-1)" "unprognostic (2.61e-1)" "unprognostic (1.02e-2)" "unprognostic (4.07e-2)" "unprognostic (2.18e-1)" "prognostic favorable (5.34e-4)" "unprognostic (5.73e-2)" "unprognostic (4.34e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" 37.4 27.4 20.2 14.3 22.5 35.2 26.4 19.6 23.7 21.8 20.2 17.0 19.8 15.1 22.9 15.4 20.2 15.1 20.4 15.4 16.9 16.4 22.3 32.9 24.5 19.0 28.9 18.7 22.7 26.3 19.1 38.0 25.4 23.8 18.0 14.8 12.0 20.6 14.4 44.0 19.2 20.8 19.5 26.3 21.4 17.8 19.4 27.5 22.2 25.9 14.5 18.6 27.5 16.3 5.9 6.3 13.9 8.8 7.2 13.5 6.7 13.9 13.9 11.7 12.0 23.5 23.5 17.8 15.1 34.2 18.8 23.8 9.8 11.8 17.7 10.1 13.8 14.4 8.8 14.4 10.5 20.6 15.6 12.2 16.8 13.4 9.9 19.8 21.4 12.3 22.8 13.3 14.4 27.3 26.8 15.6 16.5 16.2 9.9 16.0 10.3 14.2 13.3 24.3 13.4 12.0 11.3 13.4 19.7 14.1 13.5 12.9 11.1 19.9 17.6 16.8 17.5 18.0 15.6 15.7 16.2 7.3 18.4 8.9 25.6 23.5 22.7 9.7 14.1 14.6 2.0 6.8 8.6 8.1 7.0 9.3 5.7 10.1 7.9 6.3 5.9 12.9 11.1 13.9 7.2 8.8 3.8 13.5 6.7 20.2 22.5 19.6 23.7 16.9 16.4 28.9 18.7 23.8 27.5 44.7 61.3 35.0 26.8 52.1 32.3 22.6 17.8 62.9 40.9 17.4 9.8 16.5 11.6 22.6 88.2 47.2 16.6 0.0 22.2 13.1 33.3 37.8 31.4 33.4 20.8 49.3 13.2 81.0 48.0 11.5 32.2 32.3 30.4 19.8 19.1 26.9 22.6 11.5 30.8 28.6 24.5 19.4 30.7 44.0 22.1 59.8 32.0 28.8 14.5 29.8 TIMM13 "Tim13, TIMM13B" ENSG00000099800 "Translocase of inner mitochondrial membrane 13" Q9Y5L4 19 2425624-2427894 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048985 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA048985: AB_2680589" "unprognostic (5.47e-2)" "unprognostic (6.63e-2)" "unprognostic (7.15e-2)" "prognostic favorable (4.68e-5)" "unprognostic (8.67e-2)" "unprognostic (4.43e-2)" "unprognostic (1.37e-3)" "unprognostic (1.14e-1)" "unprognostic (3.50e-1)" "unprognostic (1.53e-1)" "prognostic favorable (9.77e-4)" "unprognostic (4.91e-2)" "prognostic favorable (3.88e-5)" "unprognostic (4.00e-2)" "unprognostic (3.35e-2)" "unprognostic (4.33e-1)" "unprognostic (2.47e-2)" 18.5 38.2 21.7 21.3 19.9 25.0 15.7 15.9 28.6 14.6 26.4 18.5 19.8 43.0 14.2 20.4 32.5 17.1 22.9 28.1 20.6 19.1 29.4 49.8 13.6 20.7 23.1 19.3 22.5 57.0 9.7 16.9 21.5 21.1 20.6 14.7 16.7 32.7 26.1 56.6 22.3 34.5 13.7 17.3 21.7 25.6 33.3 17.4 23.6 20.0 44.6 18.5 15.7 17.4 21.1 72.7 10.5 36.1 19.6 21.0 24.5 29.0 30.5 11.1 21.9 6.3 6.3 15.3 17.0 6.0 12.5 9.2 43.9 14.8 17.5 6.1 5.6 9.2 21.5 17.2 23.1 3.5 16.1 60.4 14.6 29.6 33.4 18.0 28.2 16.0 14.8 12.5 13.7 9.4 8.6 15.0 23.2 29.5 26.3 4.9 12.1 33.2 38.8 31.0 23.7 44.8 25.1 8.9 47.1 12.1 25.0 41.3 38.0 7.7 31.4 19.5 5.2 20.9 31.4 14.0 14.8 16.4 27.6 33.8 41.5 21.3 18.3 15.2 38.7 22.4 6.3 36.1 10.5 14.5 33.2 17.8 21.1 16.6 15.2 32.6 19.9 21.0 17.9 2.3 19.6 19.5 72.7 16.3 24.5 21.7 19.9 15.9 28.6 20.6 19.1 23.1 19.3 21.1 17.4 47.6 68.0 116.2 113.2 207.0 40.2 121.0 165.6 61.6 52.4 123.9 3.9 298.1 356.4 234.7 53.8 96.6 287.7 46.7 331.2 342.2 152.2 160.2 61.1 358.4 276.3 25.4 184.3 95.2 160.0 96.5 119.0 123.6 214.2 119.0 243.4 60.1 263.5 192.9 93.0 418.3 36.8 51.8 100.2 95.0 119.4 241.4 237.7 84.3 327.1 151.1 TIMM23 TIM23 ENSG00000265354 "Translocase of inner mitochondrial membrane 23" O14925 10 45972449-46003734 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA031408 Approved Supported Mitochondria NA NA Mitochondria "HPA031408: AB_10600828" "unprognostic (4.09e-2)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "prognostic favorable (6.79e-4)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (3.24e-1)" "unprognostic (7.78e-2)" "unprognostic (5.54e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" 5.7 4.6 1.2 6.8 3.8 6.0 13.6 4.1 8.6 2.6 4.2 1.5 5.8 6.1 2.9 7.3 4.2 2.4 3.2 11.5 5.3 6.6 8.3 4.8 9.9 1.6 2.5 2.2 2.8 3.0 3.4 8.1 5.5 3.4 4.1 2.6 7.5 5.2 16.2 2.4 3.5 3.6 2.2 2.5 2.8 17.2 1.4 4.5 4.5 4.0 4.4 3.3 1.7 29.5 39.7 18.5 45.3 26.7 29.8 39.6 40.7 43.0 28.6 28.8 23.8 22.3 27.9 33.7 40.5 41.1 43.7 54.2 32.5 36.5 28.0 35.4 29.5 35.2 43.6 36.0 40.8 27.0 43.0 23.3 32.3 58.2 38.4 43.2 26.1 26.7 32.2 35.1 50.0 17.1 37.9 31.9 41.1 20.6 36.0 40.8 38.5 60.1 34.5 30.2 13.4 29.9 27.6 26.7 46.1 28.6 33.6 30.9 18.7 41.7 33.7 23.1 44.1 25.9 27.8 19.9 34.7 25.4 47.9 22.1 36.4 51.3 37.0 62.6 16.5 15.7 35.6 18.5 28.0 45.3 28.7 29.5 27.1 29.8 39.7 27.9 24.6 27.2 8.2 26.7 39.3 32.8 29.6 39.6 8.9 17.4 24.2 12.4 19.5 13.0 86.5 30.6 28.1 19.4 12.2 7.9 39.3 38.1 39.5 62.9 13.7 15.7 23.3 26.2 38.0 14.2 16.2 26.6 23.3 30.2 0.0 9.8 17.8 17.5 15.7 16.4 18.4 21.9 33.3 15.8 22.1 29.8 14.0 11.0 47.3 9.2 6.5 16.5 85.7 48.5 18.9 29.7 13.8 23.3 16.0 TIMM29 C19orf52 ENSG00000142444 "Translocase of inner mitochondrial membrane 29" Q9BSF4 19 10928733-10933535 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 31.3;Extravillous trophoblasts: 25.5;Hofbauer cells: 19.8;monocytes: 26.2;Syncytiotrophoblasts: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041858 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA041858: AB_10963429" "unprognostic (8.45e-2)" "prognostic favorable (9.93e-5)" "unprognostic (8.99e-2)" "unprognostic (5.21e-2)" "unprognostic (9.31e-2)" "unprognostic (8.10e-2)" "unprognostic (2.82e-3)" "unprognostic (1.42e-2)" "unprognostic (1.81e-1)" "unprognostic (5.92e-2)" "unprognostic (5.26e-3)" "unprognostic (1.80e-1)" "unprognostic (3.79e-3)" "prognostic favorable (7.03e-7)" "unprognostic (1.10e-1)" "unprognostic (2.35e-1)" "unprognostic (7.26e-3)" 13.4 11.4 13.8 11.0 18.0 18.4 8.0 19.9 16.4 8.5 9.9 10.3 7.6 17.5 11.3 7.1 13.8 8.6 9.4 12.5 15.1 8.9 10.5 13.5 8.1 11.6 13.5 9.3 8.3 17.1 7.0 10.8 12.2 11.9 9.9 5.1 11.3 16.8 9.5 30.9 12.1 12.4 10.3 8.3 11.7 15.0 11.3 13.2 12.0 9.2 8.9 9.7 10.1 10.6 13.6 10.3 8.7 8.7 10.9 12.0 3.2 10.7 3.9 3.1 5.2 2.7 2.6 8.9 7.5 3.8 5.4 5.0 7.0 3.5 9.1 13.3 3.4 2.9 10.0 1.6 4.4 0.9 10.9 13.1 10.5 4.0 4.7 4.3 7.5 8.0 2.2 4.3 3.7 1.5 2.1 3.2 7.8 11.4 7.7 2.0 8.8 8.5 14.6 11.3 3.2 17.4 11.6 4.5 11.0 2.2 4.1 8.1 8.4 8.6 4.5 8.8 1.2 6.5 8.2 5.4 8.7 5.3 11.1 11.4 26.7 26.0 9.7 5.4 9.6 7.2 3.5 7.9 8.7 5.6 8.7 8.8 13.6 10.8 12.0 5.6 10.6 10.1 8.5 1.7 10.9 6.7 10.3 11.0 3.2 13.8 18.0 19.9 16.4 15.1 8.9 13.5 9.3 11.9 13.2 3.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 15.7 0.0 31.3 16.6 17.6 0.0 0.0 0.0 0.0 9.2 25.5 0.0 0.0 1.1 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 26.2 0.0 0.0 13.2 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 TIMM50 TIM50L ENSG00000105197 "Translocase of inner mitochondrial membrane 50" Q3ZCQ8 19 39480412-39493785 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" RNA-binding "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Late spermatids: 445.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048843, HPA056448" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA048843: , HPA056448: AB_2683137" "unprognostic (1.49e-1)" "unprognostic (6.97e-2)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" "unprognostic (4.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.11e-2)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-2)" "unprognostic (9.43e-2)" "unprognostic (2.01e-2)" "unprognostic (4.14e-3)" "unprognostic (3.04e-2)" "unprognostic (9.87e-2)" "unprognostic (3.82e-2)" "unprognostic (4.04e-2)" 21.3 20.2 17.9 17.0 25.8 23.0 15.7 14.3 38.2 13.4 18.4 18.0 14.4 18.0 19.0 11.7 22.6 15.8 12.5 42.2 17.6 17.4 23.9 28.0 14.2 16.6 17.8 20.2 16.4 19.8 16.4 13.4 20.0 22.0 15.3 12.0 18.1 18.3 14.6 58.1 14.0 16.1 16.5 12.7 15.1 16.9 40.4 14.7 18.5 24.0 25.5 16.9 16.9 18.2 19.3 27.4 10.3 25.3 17.0 19.9 27.8 26.5 63.9 11.9 29.6 10.5 9.5 21.6 21.0 10.8 25.0 20.4 45.7 18.8 30.1 22.4 14.2 14.0 15.3 23.8 21.7 13.3 26.2 34.6 27.9 18.7 31.6 15.9 54.3 19.3 12.2 15.5 18.7 17.1 7.1 16.2 35.8 44.6 18.1 15.7 35.2 33.2 20.9 20.7 31.3 24.4 33.9 23.7 23.2 17.2 36.7 31.5 17.7 25.3 36.8 43.2 8.6 17.2 29.6 16.2 31.0 28.9 25.5 48.9 17.1 31.4 45.4 23.3 27.3 34.4 10.3 25.3 6.1 16.9 24.0 17.3 19.3 16.2 18.5 27.4 18.1 18.4 17.0 2.1 17.0 22.4 20.6 19.9 27.8 17.9 25.8 14.3 38.2 17.6 17.4 17.8 20.2 22.0 14.7 20.8 24.2 14.2 35.2 23.1 10.0 41.2 22.9 12.0 23.9 24.4 11.8 72.5 56.3 52.0 155.0 24.1 24.2 0.0 44.6 67.0 29.8 28.0 39.2 29.6 59.4 27.0 22.4 19.6 11.8 445.2 21.6 26.0 28.7 22.6 20.3 12.8 42.9 14.4 19.8 53.1 10.4 6.5 34.0 92.9 48.7 23.3 79.1 17.5 42.6 40.9 TIMM8A "DDP, DFN1, MTS" ENSG00000126953 "Translocase of inner mitochondrial membrane 8A" O60220 X 101345659-101349196 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Deafness, Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 90.8;Suprabasal keratinocytes: 77.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 76.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003628 Supported Supported Mitochondria NA NA Mitochondria "HPA003628: AB_1080284" "prognostic unfavorable (7.89e-5)" "unprognostic (1.36e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (8.87e-5)" "unprognostic (2.06e-1)" "unprognostic (9.28e-3)" "unprognostic (5.14e-3)" "unprognostic (8.32e-2)" "unprognostic (1.90e-2)" "unprognostic (1.86e-3)" "unprognostic (6.41e-2)" "unprognostic (8.57e-3)" "prognostic favorable (1.69e-4)" "unprognostic (1.14e-2)" "unprognostic (7.75e-2)" "unprognostic (1.70e-1)" "unprognostic (3.86e-2)" 6.8 6.9 7.6 7.5 12.2 7.0 8.0 5.2 13.3 5.6 7.8 6.1 3.1 6.9 6.5 5.7 10.4 6.2 4.1 11.8 7.6 7.2 12.1 27.7 4.9 8.4 8.6 8.2 7.2 17.0 5.5 4.5 6.9 11.9 7.5 8.6 5.7 6.7 4.2 10.1 8.1 7.4 5.4 6.1 6.3 5.6 4.0 6.5 6.5 7.1 16.4 9.4 4.9 6.5 14.1 11.6 1.9 5.3 5.8 11.1 4.8 10.8 9.5 5.4 10.1 4.2 4.6 7.1 7.6 3.7 6.8 13.6 8.5 6.8 11.2 10.3 5.8 11.4 8.5 14.3 8.3 10.0 5.2 9.6 21.8 12.5 14.1 4.0 12.4 76.4 4.3 6.7 9.7 6.0 3.1 6.8 4.8 15.6 12.8 8.7 16.1 6.0 12.2 18.3 14.4 15.9 9.7 9.9 15.8 5.9 7.4 7.2 6.3 9.5 7.3 6.8 6.3 6.1 6.2 5.1 8.9 10.9 12.4 8.5 6.2 14.2 14.9 4.8 16.6 6.7 1.9 4.4 0.2 6.7 5.3 7.8 12.2 7.3 7.7 5.1 14.1 11.1 9.3 0.6 5.8 3.0 11.6 3.8 4.8 7.6 12.2 5.2 13.3 7.6 7.2 8.6 8.2 11.9 6.5 3.0 4.1 13.7 25.8 90.8 6.5 25.4 2.5 8.1 11.4 10.4 5.9 30.9 33.2 12.5 0.4 9.0 6.3 0.0 9.3 35.1 15.4 10.7 16.1 57.6 18.6 3.2 8.1 4.9 6.7 0.0 6.1 7.0 13.5 2.8 7.0 5.2 13.1 7.0 2.5 33.5 7.7 0.0 15.0 1.7 9.6 77.3 30.7 10.0 18.4 19.7 TIMM9 TIM9A ENSG00000100575 "Translocase of inner mitochondrial membrane 9" Q9Y5J7 14 58408494-58427614 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002932 Approved Supported Mitochondria NA NA Mitochondria "HPA002932: AB_1080287" "prognostic favorable (8.04e-4)" "unprognostic (8.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (9.89e-5)" "unprognostic (1.51e-1)" "unprognostic (1.84e-1)" "prognostic favorable (6.39e-5)" "unprognostic (3.41e-1)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (5.77e-2)" 22.2 20.8 23.0 14.6 33.9 14.6 25.0 18.7 25.2 18.2 22.5 16.4 19.5 19.7 20.3 29.7 23.3 18.8 19.7 18.7 20.8 19.1 23.7 21.4 14.5 25.9 20.2 20.6 31.8 42.8 11.9 18.9 17.5 22.1 19.5 15.0 15.4 29.1 20.3 33.5 17.8 13.9 25.9 20.9 18.5 20.2 21.4 22.3 20.1 25.2 24.8 19.3 26.6 17.9 17.6 14.3 4.0 10.6 16.5 19.2 7.6 25.2 21.6 17.2 16.5 19.8 36.0 23.5 24.6 13.0 18.6 16.4 21.9 27.3 33.8 26.5 14.3 17.0 17.7 22.7 23.8 27.2 22.7 12.9 17.6 14.6 24.9 49.7 28.2 16.9 28.5 30.4 18.1 36.9 30.2 19.1 17.4 28.3 21.0 18.7 42.8 26.2 35.2 14.7 37.9 38.1 22.2 26.1 21.3 24.7 22.5 22.0 13.2 15.6 40.5 42.8 20.8 28.8 16.6 19.0 23.6 32.4 15.6 26.6 14.4 14.3 31.0 18.5 27.5 27.6 4.0 9.0 2.2 9.4 10.1 17.4 17.6 15.0 13.9 13.1 14.4 19.2 17.7 0.9 16.5 10.6 14.3 15.1 7.6 23.0 33.9 18.7 25.2 20.8 19.1 20.2 20.6 22.1 22.3 29.8 18.3 54.9 38.9 31.4 13.2 16.9 22.9 17.4 21.6 14.0 21.6 67.7 61.3 33.7 21.8 22.4 19.6 0.0 46.4 80.4 30.9 38.4 35.8 26.1 53.0 4.8 24.2 33.7 38.6 24.7 68.7 33.3 32.1 26.2 36.7 19.3 38.9 24.6 48.4 88.0 21.4 19.4 36.3 66.9 15.8 34.6 61.4 30.6 54.6 36.6 TLR2 "CD282, TIL4" ENSG00000137462 "Toll like receptor 2" O60603 4 153684070-153705702 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 64.7;Kupffer cells: 106.5;Macrophages: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4" "Group enriched" "Detected in many" 46 "dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5" "Cell line enhanced" "Detected in some" "HL-60: 6.9;HSkMC: 7.5;hTCEpi: 7.5;RPTEC TERT1: 7.7;RT4: 9.5;THP-1: 36.3;U-937: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060231, HPA071546" Supported Nucleoplasm,Mitochondria No NA "Nucleoplasm, Mitochondria" "HPA060231: , HPA071546: " "unprognostic (4.15e-1)" "unprognostic (3.29e-2)" "unprognostic (5.32e-2)" "unprognostic (1.52e-2)" "unprognostic (3.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.39e-2)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-2)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.87e-2)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (5.93e-3)" 16.3 6.9 6.9 30.0 11.1 34.6 7.3 1.4 5.3 4.7 4.7 3.0 9.3 2.2 3.1 8.0 3.2 7.2 10.0 7.2 6.7 3.3 9.8 7.3 31.1 37.8 12.4 1.4 4.2 5.1 1.1 4.4 6.4 9.9 5.5 1.9 3.3 15.0 9.9 2.5 3.1 4.0 6.6 21.9 29.3 3.9 4.8 9.5 0.9 3.3 1.0 8.5 7.3 3.5 0.2 19.1 72.9 29.5 0.8 0.2 9.3 4.0 0.0 0.2 0.0 0.5 1.6 0.0 0.0 0.3 0.3 0.5 1.9 0.2 0.0 0.4 0.0 0.0 3.6 0.4 0.3 0.2 0.0 0.0 0.1 0.0 0.4 0.0 6.9 0.5 7.5 7.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.4 0.0 1.6 0.1 0.0 0.0 7.7 9.5 0.0 0.2 0.4 0.0 1.8 0.2 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.9 0.9 6.2 29.5 0.2 0.0 28.1 0.0 0.0 0.1 0.0 19.1 0.2 0.2 0.0 72.9 0.8 18.4 0.1 0.0 9.3 6.9 11.1 1.4 5.3 6.7 3.3 12.4 1.4 9.9 9.5 6.0 64.7 0.8 1.1 1.0 0.0 1.2 5.1 2.7 12.5 3.5 0.0 0.1 0.0 4.8 0.3 0.6 0.0 0.0 3.2 0.1 0.9 2.0 3.5 0.9 16.3 0.0 0.0 2.5 106.5 0.0 0.6 52.5 1.7 0.0 0.1 0.0 3.1 0.0 0.4 1.0 0.3 12.9 0.4 0.2 0.4 1.0 0.1 0.7 0.0 1.4 TMEM11 "C17orf35, PM1, PMI" ENSG00000178307 "Transmembrane protein 11" P17152 17 21197280-21214624 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051795, HPA062854" Uncertain Supported Mitochondria No No Mitochondria "HPA051795: AB_2681612, HPA062854: AB_2684882" "unprognostic (2.29e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (3.55e-1)" "unprognostic (3.36e-3)" "unprognostic (1.45e-2)" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (1.40e-1)" "unprognostic (1.19e-1)" "unprognostic (1.97e-1)" "unprognostic (2.17e-2)" "unprognostic (4.61e-2)" 9.7 6.5 5.5 6.2 5.8 13.2 9.7 6.2 8.7 6.1 6.1 6.3 4.3 5.4 6.8 7.6 8.5 5.1 5.2 8.3 5.1 5.1 8.0 9.0 5.9 5.0 5.6 4.5 6.2 10.7 4.5 5.1 10.6 6.5 7.4 4.1 6.4 11.0 6.2 30.2 8.2 7.2 6.3 5.3 6.0 6.5 8.4 4.5 7.3 8.8 12.8 7.9 5.9 5.7 8.0 7.0 11.7 12.2 5.5 6.5 7.6 3.9 2.9 4.1 2.9 6.0 3.3 5.1 8.1 2.2 7.1 5.0 9.3 1.7 3.8 4.4 6.2 6.0 5.1 5.8 5.9 1.6 4.0 5.8 2.7 2.6 1.6 6.6 3.1 3.8 4.5 4.7 8.0 3.7 2.8 3.5 4.3 3.4 1.4 3.3 2.4 5.0 4.8 4.4 11.6 2.4 3.5 7.7 2.3 3.2 1.1 2.4 4.0 3.2 3.8 3.9 15.4 2.4 2.8 2.9 4.0 6.0 5.7 7.5 2.0 1.9 9.0 3.2 4.1 2.3 4.7 12.2 11.7 5.4 8.7 4.9 6.1 5.5 4.9 7.0 8.0 6.5 4.9 9.8 5.5 10.9 6.1 4.9 7.6 5.5 5.8 6.2 8.7 5.1 5.1 5.6 4.5 6.5 4.5 44.7 17.9 37.9 46.1 75.4 30.4 45.2 22.9 26.8 25.0 34.9 17.7 67.7 43.1 50.5 14.5 32.3 46.6 23.3 35.6 65.2 47.1 49.3 26.5 27.3 48.0 22.3 30.7 35.0 22.9 14.1 33.1 25.2 38.8 55.1 46.9 25.0 41.8 51.8 54.1 42.6 36.5 32.3 48.9 36.2 38.5 80.9 76.0 34.4 42.0 71.1 TMEM126B HT007 ENSG00000171204 "Transmembrane protein 126B" Q8IUX1 11 85628573-85636539 "Predicted membrane proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014480, HPA019186" Uncertain Supported Mitochondria NA NA Mitochondria "HPA014480: AB_1858083, HPA019186: AB_1858084" "unprognostic (1.11e-1)" "unprognostic (4.97e-2)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (5.67e-1)" "unprognostic (1.44e-1)" "unprognostic (5.55e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (6.70e-3)" "unprognostic (4.42e-2)" "unprognostic (4.30e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (6.50e-2)" "unprognostic (5.86e-2)" "unprognostic (2.66e-2)" 15.5 17.0 28.9 13.5 28.0 6.4 22.1 26.7 33.2 19.7 21.2 12.2 15.5 21.7 21.9 35.4 16.5 15.9 19.1 26.2 27.2 31.7 27.5 19.9 16.5 18.9 28.7 25.7 15.9 15.3 13.9 28.0 14.6 28.8 19.8 20.0 14.2 16.8 16.6 15.7 15.1 20.8 24.2 24.9 19.3 18.9 11.7 27.0 15.1 22.6 17.5 18.8 20.8 14.3 14.0 14.9 12.5 13.2 15.8 19.6 11.5 13.8 11.4 13.0 6.1 24.5 19.6 4.1 12.3 13.5 9.8 15.0 31.7 14.1 14.7 27.2 10.4 11.0 16.8 20.7 12.7 9.3 20.4 18.7 11.2 20.2 13.9 13.9 27.3 13.8 14.3 16.2 14.9 18.2 15.8 15.0 18.5 26.5 12.2 24.3 17.8 10.8 33.8 14.0 47.8 18.9 9.4 9.7 12.4 19.3 15.6 11.8 7.3 11.6 9.5 12.0 17.4 19.2 16.9 7.8 15.0 10.6 37.9 12.9 5.7 31.9 17.9 7.6 22.2 7.9 12.5 11.7 5.7 15.4 13.2 19.6 14.0 19.1 18.4 14.9 12.9 19.1 18.9 4.5 15.8 9.6 13.4 18.3 11.5 28.9 28.0 26.7 33.2 27.2 31.7 28.7 25.7 28.8 27.0 20.8 31.8 41.0 29.3 23.2 28.2 69.0 56.0 48.2 33.0 38.4 13.7 35.1 142.6 63.7 3.8 48.7 36.2 0.0 43.2 44.9 49.7 26.1 41.5 37.6 71.4 22.3 33.3 35.0 32.1 5.6 61.5 48.5 69.2 48.7 36.7 41.5 48.0 50.1 83.1 128.5 25.6 38.8 51.5 30.7 40.3 32.2 21.1 60.8 44.7 37.9 TMEM141 MGC14141 ENSG00000244187 "Transmembrane protein 141" Q96I45 9 136791355-136793257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 530.6;Enterocytes: 541.1;Paneth cells: 627.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 64.4;T-47d: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014615, HPA050244" Approved Supported "Cell Junctions,Mitochondria" NA NA Mitochondria "Cell Junctions" "HPA014615: AB_2204756, HPA050244: AB_2681061" "unprognostic (2.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (2.00e-1)" "unprognostic (8.53e-3)" "unprognostic (1.52e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.24e-1)" "unprognostic (8.45e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.49e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" 10.0 15.5 15.7 23.4 15.3 15.5 22.9 11.6 28.3 17.2 54.4 21.0 22.4 21.9 9.4 31.1 35.5 22.6 27.9 22.8 15.2 12.2 38.5 43.4 14.4 23.0 19.9 19.3 13.8 46.3 20.6 23.1 31.7 22.0 49.0 51.4 12.5 32.5 27.5 13.5 22.0 25.6 10.5 19.1 14.1 23.3 16.5 13.8 16.3 28.6 26.0 15.2 16.4 16.3 11.1 42.7 9.0 19.4 12.4 11.3 12.2 15.0 11.0 9.8 6.1 12.4 10.0 21.2 8.5 13.4 10.6 8.5 14.5 13.7 14.5 13.3 9.2 9.6 22.6 4.2 25.0 3.4 10.5 7.6 8.1 6.1 16.1 18.1 8.4 10.1 9.6 42.9 8.1 23.0 12.1 15.7 19.3 8.0 7.8 13.8 30.8 11.5 6.5 4.7 64.4 12.4 9.6 10.3 42.7 24.0 8.5 16.5 7.4 9.2 35.1 9.6 8.8 62.6 8.2 10.7 7.6 6.0 13.8 5.5 5.1 7.9 7.7 11.4 12.2 10.8 6.5 13.8 9.0 11.3 19.4 10.2 8.7 7.9 8.1 11.2 11.1 10.9 10.0 3.3 12.4 16.0 42.7 7.5 12.2 15.7 15.3 11.6 28.3 15.2 12.2 19.9 19.3 22.0 13.8 53.6 66.5 48.0 79.9 36.1 13.8 38.7 140.1 40.2 47.8 111.7 7.9 153.9 530.6 139.6 35.4 42.8 541.1 0.0 69.3 125.8 30.6 159.7 40.5 149.9 127.7 4.8 198.8 60.2 56.6 92.7 34.8 37.5 81.0 99.2 409.6 43.5 87.4 627.8 28.0 354.2 22.0 45.3 28.3 48.3 42.6 54.8 229.4 48.4 378.9 92.2 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: AB_2671101" "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 9.5 12.3 7.6 7.4 8.0 7.0 9.4 7.1 12.8 6.0 7.4 3.6 3.9 4.8 6.1 9.0 6.2 9.1 7.4 13.3 9.3 7.9 9.7 38.8 6.2 9.6 6.8 7.3 7.3 17.0 5.1 6.3 8.1 10.0 6.3 8.0 3.8 7.1 5.3 81.1 4.8 6.9 7.7 6.3 9.9 10.6 10.9 5.1 8.5 6.5 13.4 7.9 6.7 5.9 18.4 12.3 7.5 11.0 6.2 12.7 12.7 11.2 9.0 7.2 7.5 8.5 7.3 7.4 9.6 8.7 10.7 8.7 8.4 6.5 15.2 8.3 6.4 9.1 10.2 13.8 9.2 12.1 9.8 9.4 15.2 5.9 11.2 8.5 8.2 8.1 6.8 8.6 6.8 3.6 4.1 9.0 7.7 11.4 7.5 11.4 8.3 18.8 15.6 6.7 14.4 11.2 13.3 7.1 12.9 11.3 10.6 16.4 7.3 5.9 43.0 12.1 6.0 8.9 7.6 5.7 6.3 7.6 11.4 9.0 11.2 9.6 14.9 9.1 6.4 6.9 6.3 10.8 7.0 9.5 11.0 10.9 18.4 10.9 10.8 10.5 10.8 12.7 11.8 7.5 6.2 8.1 12.3 8.6 12.7 7.6 8.0 7.1 12.8 9.3 7.9 6.8 7.3 10.0 5.1 14.9 36.2 37.2 32.5 59.8 24.1 39.1 15.3 42.8 23.9 21.0 7.9 61.6 56.3 28.4 11.2 35.3 22.8 0.0 55.5 44.6 47.0 32.0 38.2 44.2 119.9 9.5 13.3 28.3 89.0 5.6 27.6 68.1 38.8 36.1 27.6 19.7 38.3 37.1 27.3 55.5 15.9 38.8 44.8 32.9 28.3 52.1 58.8 34.8 29.0 23.3 TMLHE "BBOX2, FLJ10727, TMLH, XAP130" ENSG00000185973 "Trimethyllysine hydroxylase, epsilon" Q9NVH6 X 155490115-155669944 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034589, HPA040331" Approved Supported Mitochondria NA NA Mitochondria "HPA034589: AB_10670571, HPA040331: AB_2676929" "unprognostic (1.98e-1)" "unprognostic (9.15e-2)" "unprognostic (3.04e-1)" "unprognostic (5.41e-2)" "unprognostic (6.66e-3)" "unprognostic (1.10e-3)" "unprognostic (6.50e-2)" "unprognostic (1.00e-1)" "unprognostic (3.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.20e-3)" "unprognostic (6.97e-2)" "prognostic favorable (3.68e-6)" "unprognostic (1.69e-1)" "unprognostic (5.74e-2)" "unprognostic (2.73e-1)" "unprognostic (7.75e-2)" 10.1 15.0 8.5 6.7 10.5 6.7 10.4 17.1 13.5 11.3 10.5 10.0 9.1 10.7 10.9 10.1 9.5 9.5 7.4 22.3 10.3 7.5 15.8 16.9 6.9 14.6 12.5 7.4 12.4 10.7 18.4 17.5 7.6 11.5 7.7 11.6 10.6 16.2 9.6 28.1 7.8 10.0 13.8 13.7 9.2 9.8 3.1 11.2 12.2 10.5 5.3 8.7 10.2 9.1 9.1 10.3 14.7 15.7 4.3 5.6 4.5 15.2 7.5 6.2 18.1 7.7 11.9 0.0 6.2 9.1 7.8 20.4 5.3 8.6 0.0 25.0 10.8 18.0 8.3 13.2 6.0 8.9 6.2 9.0 6.8 12.2 6.2 10.8 6.4 4.9 12.6 12.7 8.7 13.2 11.7 12.3 9.8 9.5 5.6 12.9 5.7 7.7 7.2 1.9 13.2 0.1 7.7 9.9 5.8 9.4 5.2 5.9 8.9 5.8 0.3 6.7 7.0 6.7 7.3 10.3 6.6 6.3 13.0 7.6 7.0 7.5 5.8 8.0 10.0 6.0 1.9 10.1 11.3 3.9 11.4 2.9 6.2 4.3 3.3 10.3 9.1 5.6 4.9 14.7 4.3 15.7 4.7 4.2 4.5 8.5 10.5 17.1 13.5 10.3 7.5 12.5 7.4 11.5 11.2 0.0 2.9 10.0 9.7 4.6 3.6 6.5 7.6 9.4 4.5 8.7 0.0 7.2 19.9 8.9 0.0 5.6 8.6 0.0 6.6 5.8 7.5 2.7 9.3 11.3 10.9 0.0 5.8 5.5 14.6 0.0 7.8 11.4 11.8 10.8 6.9 7.2 8.0 7.0 5.3 11.3 5.2 0.0 8.2 0.4 1.7 3.6 5.6 6.9 7.6 8.7 TOMM34 "HTOM34P, TOM34" ENSG00000025772 "Translocase of outer mitochondrial membrane 34" Q15785 20 44942130-44960486 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.2;testis: 53.2" "Cell type enhanced" "Detected in many" 12 "monocytes: 303.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018845, HPA056875" Enhanced Supported Vesicles,Mitochondria,Cytosol NA NA Cytosol "Vesicles, Mitochondria" "HPA018845: AB_1858184, HPA056875: AB_2683264" "unprognostic (4.96e-2)" "unprognostic (6.88e-2)" "unprognostic (5.05e-2)" "unprognostic (1.36e-3)" "unprognostic (4.91e-2)" "prognostic unfavorable (4.47e-5)" "prognostic unfavorable (8.71e-6)" "unprognostic (2.55e-1)" "unprognostic (5.04e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.11e-2)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (1.02e-1)" "prognostic favorable (5.45e-4)" "unprognostic (5.79e-3)" 4.4 17.9 14.9 6.4 56.2 8.7 7.3 4.2 18.1 7.2 7.1 5.3 5.6 5.8 7.1 25.6 7.2 24.9 6.8 6.3 35.3 11.0 11.9 7.9 5.9 8.8 8.6 14.4 13.9 8.2 11.2 10.5 15.1 13.9 7.6 9.3 8.0 6.3 9.0 6.3 5.5 5.6 7.7 5.7 5.8 7.0 53.2 5.6 7.0 8.3 7.2 10.4 8.8 6.3 18.8 26.1 9.5 11.5 8.7 12.3 10.7 33.1 11.7 10.4 22.1 9.6 9.5 23.5 19.3 28.2 24.2 17.7 47.2 12.5 22.8 16.7 15.1 24.7 21.0 25.4 41.8 28.3 4.0 11.8 17.9 15.5 33.2 12.3 11.7 11.1 10.3 11.7 33.8 60.8 21.3 24.6 9.4 20.3 9.4 22.9 21.9 12.3 16.2 12.2 17.7 44.5 10.7 11.0 24.6 19.7 18.7 17.9 10.6 26.4 18.4 22.8 8.4 13.8 10.2 14.5 32.0 21.1 15.3 28.8 8.2 9.6 18.9 29.2 14.0 12.4 8.3 11.1 9.5 10.4 11.5 11.0 17.3 10.9 11.0 26.1 18.8 12.3 9.7 3.1 8.7 11.2 13.7 12.3 10.7 14.9 56.2 4.2 18.1 35.3 11.0 8.6 14.4 13.9 5.6 6.0 8.6 13.0 69.8 12.2 3.6 9.0 7.6 64.3 18.2 12.2 3.9 98.4 26.6 29.7 14.0 10.8 6.7 0.0 26.6 29.1 11.6 59.4 9.2 9.6 19.7 3.2 11.5 5.5 3.9 24.2 6.4 10.5 6.8 303.0 8.2 13.2 32.2 9.3 6.0 16.5 4.1 0.0 12.2 45.4 36.6 9.7 47.3 6.9 12.8 47.8 TOMM5 "bA613M10.3, C9orf105, Tom5" ENSG00000175768 "Translocase of outer mitochondrial membrane 5" Q8N4H5 9 37582646-37592642 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA048712 Approved Supported Mitochondria NA NA Mitochondria "HPA048712: AB_2680499" "unprognostic (1.81e-2)" "unprognostic (1.96e-1)" "unprognostic (3.37e-2)" "unprognostic (3.34e-2)" "unprognostic (2.02e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (9.89e-3)" "prognostic unfavorable (5.49e-4)" "prognostic favorable (2.37e-4)" "unprognostic (7.80e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-1)" "unprognostic (3.23e-2)" "unprognostic (3.07e-2)" "unprognostic (2.37e-1)" "unprognostic (9.09e-2)" 33.2 37.8 34.5 31.2 39.7 28.3 44.1 24.3 38.5 26.7 34.7 13.1 28.3 37.5 28.7 32.7 36.9 25.4 31.1 39.6 30.9 34.7 44.3 45.3 24.4 37.4 37.6 26.3 27.4 83.8 12.7 28.8 19.6 32.3 25.2 31.2 17.3 49.6 36.2 51.5 24.1 34.8 34.1 23.9 38.9 31.2 33.0 27.2 24.5 36.3 46.1 37.8 26.7 35.3 59.1 43.1 14.0 33.9 40.2 54.9 50.5 55.1 64.4 38.2 34.2 43.9 43.2 21.1 42.1 27.0 41.1 44.0 68.5 22.9 37.8 34.6 39.9 41.9 19.2 33.9 50.2 42.9 53.1 53.6 33.2 89.6 98.1 36.1 54.4 22.0 37.2 27.6 45.2 44.8 19.5 46.8 42.5 80.8 42.5 41.7 44.2 45.8 47.9 66.5 46.6 40.8 38.9 31.9 55.6 47.0 34.6 33.1 30.4 21.6 29.5 30.7 33.9 20.6 63.8 31.7 28.5 61.0 44.8 64.9 16.2 46.8 63.1 34.9 47.1 43.8 12.3 32.2 14.0 43.0 33.9 52.7 59.1 53.1 47.7 39.0 49.1 54.9 50.5 3.7 40.2 28.5 43.1 42.1 50.5 34.5 39.7 24.3 38.5 30.9 34.7 37.6 26.3 32.3 27.2 26.8 30.2 43.6 35.9 99.7 4.4 20.1 58.6 49.5 53.4 43.6 11.8 22.0 68.0 47.4 168.9 45.6 41.0 0.0 110.0 44.6 34.2 29.9 44.0 129.9 59.4 1.6 17.4 52.2 57.8 127.0 32.5 43.7 59.1 81.2 44.0 6.7 88.5 35.1 29.4 80.6 6.2 0.0 32.3 51.5 22.8 128.0 21.1 47.8 53.1 48.7 TOMM6 "OBTP, Tom6" ENSG00000214736 "Translocase of outer mitochondrial membrane 6" Q96B49 6 41787662-41789898 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Alveolar cells type 2: 16.0;Ciliated cells: 30.8;Club cells: 19.4;granulocytes: 8.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 201.9" "Low region specificity" "Detected in all" HPA004801 Approved Supported Mitochondria NA NA Mitochondria "HPA004801: AB_1859553" 44.1 68.7 54.2 47.4 51.9 55.4 66.4 26.0 52.6 44.0 44.7 43.6 37.1 29.1 38.9 83.4 62.1 49.0 32.1 64.6 45.3 43.8 80.9 92.6 37.7 60.4 45.1 36.3 56.9 84.5 31.6 39.7 49.9 42.3 47.1 53.1 48.4 83.1 43.8 80.2 47.2 48.7 39.4 41.5 58.7 42.0 53.1 37.2 56.7 65.9 78.3 71.9 44.7 38.7 66.2 75.2 39.0 70.5 33.8 56.9 89.2 56.8 28.4 34.4 34.8 32.4 39.2 36.6 28.6 30.3 37.0 35.7 49.3 26.6 26.1 35.0 34.1 41.8 18.2 54.8 47.4 47.7 36.6 57.8 46.8 36.4 80.1 25.6 62.3 30.5 35.1 49.8 40.5 34.8 26.4 44.4 36.9 116.5 32.0 45.3 67.2 44.7 98.9 30.2 201.9 29.0 32.8 21.6 76.7 49.7 29.3 30.5 42.5 19.5 33.8 47.5 38.2 41.1 126.6 31.0 25.4 31.5 25.2 42.6 29.7 63.3 114.8 14.4 53.0 32.7 15.1 69.1 39.0 49.1 68.7 47.7 66.2 50.2 48.7 72.0 61.8 56.9 55.4 9.0 33.8 70.5 75.2 46.5 89.2 54.2 51.9 26.0 52.6 45.3 43.8 45.1 36.3 42.3 37.2 3.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TOP1MT ENSG00000184428 "DNA topoisomerase I mitochondrial" Q969P6 8 143304384-143359979 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "MOLT-4: 58.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001915, HPA021542" Approved Supported Mitochondria NA NA Mitochondria "HPA001915: AB_1080331, HPA021542: AB_1858186" "unprognostic (5.02e-3)" "unprognostic (3.79e-2)" "unprognostic (6.57e-2)" "unprognostic (6.92e-3)" "unprognostic (2.32e-2)" "unprognostic (1.04e-2)" "unprognostic (3.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (1.52e-7)" "unprognostic (3.66e-2)" "unprognostic (3.62e-2)" "unprognostic (8.55e-3)" "unprognostic (5.66e-3)" 11.7 13.5 8.1 13.7 9.8 33.0 22.1 2.2 10.3 14.7 10.7 4.5 3.9 6.0 10.0 7.4 14.9 11.3 11.0 5.9 8.8 5.6 9.6 22.5 8.5 11.4 6.9 8.1 27.0 15.9 5.9 8.6 5.9 7.3 14.7 8.0 5.9 11.0 10.8 5.7 15.4 8.3 8.8 6.8 11.4 9.3 18.1 6.4 25.1 19.2 9.6 11.4 14.0 30.9 16.7 18.8 11.7 5.5 0.2 14.3 4.7 7.6 11.8 4.9 18.6 7.1 8.0 8.8 3.5 4.6 6.5 6.7 14.8 11.1 22.5 13.5 4.9 4.6 8.2 10.5 6.6 5.6 8.8 16.1 19.8 6.6 14.9 8.0 13.2 21.6 8.1 7.0 5.4 7.9 5.6 7.8 6.5 23.7 8.8 5.7 32.1 58.6 26.4 8.6 16.7 20.2 7.4 6.5 33.7 4.8 12.4 8.9 10.8 10.2 9.1 18.4 6.4 6.0 22.0 5.1 4.5 18.4 5.1 9.1 4.8 5.0 11.5 7.6 19.8 5.4 11.7 5.5 0.2 3.5 3.2 3.6 16.7 6.4 4.8 18.8 8.0 14.3 10.4 0.4 0.2 0.6 16.4 1.7 4.7 8.1 9.8 2.2 10.3 8.8 5.6 6.9 8.1 7.3 6.4 6.0 7.5 9.0 28.1 21.1 1.4 2.0 7.6 4.0 13.6 8.7 0.0 10.3 6.6 9.5 19.8 7.3 2.7 23.3 7.8 19.8 11.7 15.2 6.9 7.8 10.8 3.2 4.7 6.7 5.9 6.7 8.1 10.1 20.3 4.6 8.7 1.4 9.6 8.6 4.2 12.3 0.1 6.5 13.4 31.6 39.0 20.8 8.5 6.4 19.3 18.6 TRIT1 "FLJ20061, IPT" ENSG00000043514 "TRNA isopentenyltransferase 1" Q9H3H1 1 39841022-39883511 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024174, HPA027330" Approved Supported Mitochondria NA NA Mitochondria "HPA024174: AB_1858346, HPA027330: " "unprognostic (4.61e-2)" "unprognostic (1.77e-1)" "unprognostic (8.38e-3)" "prognostic unfavorable (8.80e-4)" "unprognostic (4.00e-2)" "unprognostic (8.55e-2)" "prognostic unfavorable (5.34e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-3)" "unprognostic (3.18e-2)" "unprognostic (3.54e-1)" "unprognostic (6.68e-3)" "prognostic unfavorable (7.08e-8)" "unprognostic (6.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (6.90e-2)" 9.5 10.3 12.9 10.4 19.1 8.0 19.8 25.8 18.4 15.1 13.4 15.9 22.7 11.4 19.3 21.3 19.8 18.4 9.1 15.9 12.5 12.0 14.6 13.2 11.9 14.8 13.9 10.4 16.7 27.7 14.1 26.7 17.6 14.4 21.4 15.8 13.5 15.1 23.9 10.1 22.9 11.7 18.0 9.8 14.0 12.9 17.3 17.9 15.4 19.2 9.4 14.7 17.2 17.5 3.9 13.4 0.9 6.6 2.4 5.2 2.8 14.7 6.8 14.8 15.1 7.4 11.2 22.4 9.8 13.2 15.8 17.8 13.1 19.5 8.6 13.0 8.4 9.5 15.1 21.3 16.9 22.2 10.4 10.8 18.3 15.8 8.1 17.1 17.7 10.0 9.4 15.3 19.8 19.6 16.2 12.7 18.9 24.7 10.3 9.9 7.2 13.5 19.1 19.9 11.2 6.2 14.4 18.6 19.6 15.0 19.0 16.8 11.2 14.1 9.6 10.8 16.4 10.7 30.4 9.1 10.6 13.0 18.2 16.2 14.0 11.0 17.3 13.4 18.1 9.1 0.0 6.6 0.9 2.7 4.9 5.2 3.9 2.6 2.9 13.4 3.2 3.4 3.5 0.1 2.4 5.8 11.6 2.7 2.8 12.9 19.1 25.8 18.4 12.5 12.0 13.9 10.4 14.4 17.9 20.8 5.6 4.4 14.1 13.2 3.1 8.9 7.6 20.1 10.3 7.0 2.0 27.7 6.6 9.5 3.6 5.1 3.2 0.0 8.1 30.0 8.3 6.6 2.3 5.8 7.2 14.3 9.8 8.6 6.2 2.0 8.9 6.8 5.0 7.2 8.2 5.2 9.2 7.0 10.6 7.0 7.3 0.0 5.2 18.6 16.7 14.9 13.8 3.5 8.9 9.0 TRMT10C "FLJ20432, MRPP1, RG9MTD1" ENSG00000174173 "TRNA methyltransferase 10C, mitochondrial RNase P subunit" Q7L0Y3 3 101561862-101566446 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036671 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036671: AB_10602085" "unprognostic (7.42e-2)" "unprognostic (2.68e-1)" "unprognostic (9.08e-3)" "unprognostic (4.47e-3)" "unprognostic (5.01e-2)" "unprognostic (5.55e-2)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (5.42e-2)" "unprognostic (4.70e-2)" "unprognostic (3.28e-2)" "prognostic favorable (3.32e-5)" "unprognostic (2.77e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" 18.0 21.2 13.1 13.6 14.1 14.4 19.7 16.4 19.1 16.1 15.3 5.5 12.9 11.6 14.6 13.1 20.9 15.0 10.7 20.4 13.0 13.4 26.6 34.6 10.0 19.3 12.5 16.7 18.8 12.1 9.9 19.9 18.2 18.5 16.2 14.2 5.5 14.5 13.0 35.2 15.2 16.5 15.3 14.3 19.6 15.6 14.7 10.6 23.0 16.6 30.5 18.5 15.6 11.3 21.6 15.4 27.4 14.8 12.2 23.1 11.8 21.0 10.3 13.7 13.8 12.6 10.8 12.8 12.6 12.3 16.4 18.4 15.6 14.3 43.8 16.4 7.8 13.3 21.3 26.4 19.2 22.7 15.6 13.0 29.4 8.2 11.3 9.7 25.8 12.5 12.6 20.0 14.3 13.4 8.8 15.9 16.8 24.9 9.8 17.6 14.4 20.6 18.9 25.5 27.4 22.4 15.4 11.2 19.5 21.0 17.9 34.2 19.5 9.8 20.9 27.6 12.6 27.6 28.4 10.5 9.0 17.0 5.9 13.2 11.4 20.8 42.0 15.2 18.6 13.4 27.4 11.2 7.3 13.6 14.4 18.8 21.6 16.8 15.8 13.5 20.4 23.1 21.1 4.9 12.2 14.8 15.4 15.0 11.8 13.1 14.1 16.4 19.1 13.0 13.4 12.5 16.7 18.5 10.6 20.8 20.0 45.2 114.9 83.8 27.3 45.1 15.3 44.2 47.8 27.9 13.7 57.1 44.7 44.7 22.0 33.0 12.7 0.0 29.3 34.7 35.1 33.3 46.1 46.1 28.0 20.6 34.3 28.8 19.4 6.3 34.5 28.4 13.5 36.9 26.7 27.5 31.9 14.0 35.3 55.3 29.1 32.3 41.5 61.4 51.3 91.8 54.8 41.7 40.3 115.3 TRMU "FLJ10140, MTO2, TRMT" ENSG00000100416 "TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase" O75648 22 46330875-46357340 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "RNA-binding, Transferase, tRNA-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000824, HPA035273, HPA043300" Uncertain Supported Mitochondria NA NA Mitochondria "HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415" "unprognostic (2.96e-1)" "unprognostic (1.09e-2)" "unprognostic (8.07e-2)" "unprognostic (4.27e-2)" "unprognostic (2.64e-1)" "unprognostic (3.52e-3)" "prognostic unfavorable (3.04e-5)" "unprognostic (4.72e-2)" "unprognostic (7.14e-2)" "unprognostic (7.89e-2)" "prognostic favorable (6.86e-4)" "unprognostic (4.74e-3)" "prognostic unfavorable (5.63e-6)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (3.56e-1)" "unprognostic (7.44e-3)" 8.5 16.1 11.5 9.9 16.0 6.4 7.5 17.8 16.0 9.7 8.7 11.5 10.2 10.9 12.1 18.0 10.9 6.2 7.3 16.8 11.3 11.9 20.5 18.8 7.1 10.2 15.7 11.8 8.0 22.7 20.0 13.6 9.7 11.2 8.7 10.2 9.0 12.5 15.5 17.8 9.8 7.6 9.4 11.4 8.7 9.2 8.3 13.9 6.5 9.6 8.3 9.8 7.1 9.1 6.2 7.6 3.9 9.6 7.5 11.3 6.3 10.8 10.0 4.3 9.7 8.1 5.7 10.8 11.3 8.0 16.1 12.6 14.1 2.8 7.1 8.1 10.1 7.0 9.7 18.2 10.1 13.8 4.6 24.5 8.5 15.3 16.6 6.9 16.2 5.8 5.4 11.4 16.7 5.3 6.7 10.3 3.7 11.7 1.7 9.8 11.4 6.3 13.2 16.1 6.6 17.6 7.4 9.2 13.2 8.0 7.6 10.2 12.3 10.0 11.8 19.0 5.6 6.7 6.7 7.5 7.2 12.9 10.2 12.6 4.2 4.5 7.6 10.2 11.8 14.5 0.0 6.8 3.9 11.1 9.4 9.4 5.7 9.4 10.0 7.6 6.2 8.6 8.0 1.4 7.5 9.6 6.0 11.3 6.3 11.5 16.0 17.8 16.0 11.3 11.9 15.7 11.8 11.2 13.9 8.9 6.7 12.6 9.5 5.6 25.1 12.4 5.1 9.4 5.7 10.4 15.7 20.8 23.2 18.2 0.8 11.9 11.4 23.3 16.7 17.5 10.3 9.9 9.2 16.6 13.8 12.7 12.0 15.4 11.8 1.7 14.1 8.3 8.5 17.2 9.8 11.0 16.7 10.5 15.9 22.8 26.2 6.5 11.7 18.2 13.2 8.4 12.8 10.1 15.3 8.2 TRNT1 "CCA1, CGI-47, MtCCA" ENSG00000072756 "TRNA nucleotidyl transferase 1" Q96Q11 3 3126916-3150879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036938 Uncertain Supported Mitochondria Yes No Mitochondria "HPA036938: AB_10670566" "unprognostic (6.39e-3)" "unprognostic (1.58e-1)" "unprognostic (2.38e-3)" "unprognostic (4.69e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (2.68e-1)" "unprognostic (6.22e-2)" "unprognostic (5.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-2)" "unprognostic (6.50e-2)" "unprognostic (1.09e-1)" "unprognostic (3.78e-1)" "unprognostic (1.02e-1)" 15.2 16.9 17.5 17.8 20.7 8.7 18.2 14.5 22.7 12.9 13.2 13.2 17.4 11.1 18.4 14.7 15.9 12.2 15.6 13.9 17.1 16.0 21.1 16.1 13.7 19.0 17.5 15.6 14.6 13.9 14.3 31.0 19.0 21.3 23.9 16.4 10.1 13.2 13.1 14.8 15.3 12.5 15.3 19.3 20.5 15.5 13.5 15.1 22.1 20.9 10.6 19.8 17.8 13.0 15.1 10.5 29.0 12.0 15.1 16.6 7.4 12.0 17.4 13.5 7.7 16.1 13.8 14.4 13.8 11.5 13.8 14.3 16.1 14.8 22.0 9.2 13.3 22.0 8.7 17.8 12.4 17.6 16.3 8.6 20.4 18.6 16.1 21.5 21.6 16.6 12.9 17.6 14.2 4.8 11.6 13.6 17.0 15.9 9.2 23.7 22.5 13.9 19.5 10.6 18.0 12.7 13.3 18.2 21.4 18.4 18.0 7.7 11.1 20.0 14.5 11.5 19.0 13.4 12.3 11.1 15.6 13.6 16.1 17.7 9.5 18.9 27.7 11.7 19.4 17.4 29.0 8.8 22.5 12.1 11.8 11.9 15.1 15.0 12.7 10.5 9.5 16.6 14.3 11.7 15.1 12.0 9.6 11.1 7.4 17.5 20.7 14.5 22.7 17.1 16.0 17.5 15.6 21.3 15.1 14.9 8.3 13.9 18.6 13.2 12.9 12.1 2.5 10.7 13.6 17.4 13.7 21.8 38.1 16.1 1.5 22.5 9.6 0.0 8.7 14.3 13.9 19.8 22.0 7.8 11.6 9.5 8.1 10.4 12.9 1.9 10.0 11.3 6.8 18.0 9.7 15.8 10.1 8.6 8.1 25.6 16.8 0.0 17.7 20.0 16.9 11.4 23.7 13.8 11.5 18.2 TSFM "EF-TS, EF-Tsmt" ENSG00000123297 "Ts translation elongation factor, mitochondrial" P43897 12 57782589-57808071 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "RH-30: 157.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006204 Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA006204: AB_1080405" "unprognostic (1.17e-1)" "unprognostic (6.84e-3)" "unprognostic (1.93e-2)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (2.56e-3)" "unprognostic (2.49e-2)" "unprognostic (1.53e-1)" "unprognostic (8.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.49e-1)" "unprognostic (1.49e-3)" "prognostic favorable (8.82e-4)" "unprognostic (3.05e-1)" "unprognostic (6.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" 14.5 46.2 16.6 14.7 21.5 15.3 18.5 18.2 24.3 12.7 18.8 13.3 17.6 17.8 11.6 13.7 16.1 12.4 10.3 27.7 14.6 15.6 27.0 30.2 10.1 14.6 15.4 20.8 10.3 19.6 17.0 13.1 11.6 17.8 11.7 18.3 11.1 13.5 14.1 33.5 14.7 13.4 17.7 11.6 12.5 14.0 23.2 13.6 11.3 15.4 26.9 13.4 14.4 13.0 18.5 18.7 9.0 16.8 20.0 23.5 16.0 8.4 9.8 5.9 8.8 5.5 5.5 8.6 7.1 6.3 11.6 8.1 11.4 11.2 21.2 13.6 6.2 6.5 10.0 9.9 10.2 8.8 8.6 12.0 12.9 8.3 10.0 8.4 16.4 7.8 6.4 10.5 8.8 5.0 8.9 7.1 12.0 16.6 11.5 8.7 9.8 9.7 17.9 9.1 12.3 13.1 11.8 157.2 19.0 11.0 9.6 12.8 7.9 7.6 13.4 12.9 5.5 23.2 12.0 5.2 6.3 8.9 9.2 7.6 8.5 17.4 16.5 8.9 9.9 7.5 3.7 14.8 9.0 18.6 13.8 23.5 18.5 20.9 18.4 18.7 16.4 21.2 21.7 4.2 20.0 16.8 14.7 18.1 16.0 16.6 21.5 18.2 24.3 14.6 15.6 15.4 20.8 17.8 13.6 17.9 9.6 15.6 12.7 23.0 19.8 29.9 35.7 20.1 13.6 43.6 13.7 59.0 81.2 56.0 69.4 9.6 12.7 23.3 75.2 41.0 20.6 14.1 21.9 32.5 31.6 14.3 13.3 17.8 7.3 33.2 21.0 18.6 25.3 102.8 18.4 20.6 51.6 17.5 22.6 110.7 16.3 58.2 17.6 36.4 60.1 31.7 39.8 15.0 32.8 9.2 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151514-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 139.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011232, HPA046260, HPA072304" Uncertain Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB011232: , HPA046260: , HPA072304: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 33.9 21.2 9.8 17.8 11.0 117.3 48.7 2.7 8.1 24.9 23.9 12.3 10.3 20.5 12.3 13.6 83.2 14.3 36.8 32.1 8.0 5.4 18.0 22.0 39.8 40.0 15.4 5.2 13.3 13.2 4.0 6.7 15.5 9.7 23.1 9.7 16.4 34.6 9.2 13.2 46.6 23.0 12.7 11.4 27.2 39.0 10.5 10.0 9.4 17.9 44.3 50.0 19.1 41.3 22.9 99.9 91.4 139.5 28.5 43.8 104.8 47.6 23.6 1.6 22.4 9.0 29.9 1.8 35.6 17.4 17.9 19.1 4.6 36.5 0.0 24.7 27.6 8.8 39.5 4.5 27.6 2.3 7.9 18.6 4.8 25.9 1.6 32.7 10.8 24.4 23.2 45.5 10.6 9.5 21.1 42.4 0.0 3.9 9.0 18.3 39.9 0.1 30.2 1.9 24.6 59.0 10.7 0.0 81.4 22.9 28.8 2.3 11.0 16.9 33.8 41.5 0.0 12.7 42.0 43.7 22.3 16.7 22.7 14.9 3.6 0.6 0.4 28.9 35.1 28.5 43.8 139.5 75.3 28.4 86.3 22.2 16.3 39.5 27.8 99.9 22.9 30.4 24.5 91.4 28.5 57.1 17.7 43.8 104.8 9.8 11.0 2.7 8.1 8.0 5.4 15.4 5.2 9.7 10.0 148.9 135.1 105.0 344.2 325.8 2.2 79.7 336.3 127.2 167.2 195.4 2.0 9.0 313.4 570.0 2.1 215.5 499.4 46.7 512.5 126.3 307.4 297.1 261.1 99.0 745.0 3.2 187.3 163.2 688.0 6.1 76.5 573.3 686.7 477.9 485.1 116.9 963.2 644.9 148.2 97.5 17.1 103.5 217.3 1.1 4.9 468.6 16.7 155.6 529.3 666.0 TST RDS ENSG00000128311 "Thiosulfate sulfurtransferase" Q16762 22 37010859-37020183 "Enzymes, Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.1" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 203.8;Enterocytes: 300.1;Hepatocytes: 350.5;Paneth cells: 284.5;Proximal tubular cells: 229.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 16.0" "Group enriched" "Detected in all" 6 "dendritic cells: 16.0;granulocytes: 14.3;monocytes: 11.5" "Cell line enhanced" "Detected in many" "OE19: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003044, HPA003643, CAB009546" Enhanced Supported Mitochondria NA NA 2800000 Mitochondria "CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411" "unprognostic (3.09e-2)" "unprognostic (2.70e-1)" "unprognostic (2.07e-1)" "unprognostic (1.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-1)" "unprognostic (7.96e-3)" "unprognostic (4.38e-2)" "unprognostic (1.78e-1)" "prognostic favorable (7.59e-6)" "unprognostic (6.08e-3)" "unprognostic (3.46e-1)" "unprognostic (1.16e-1)" "prognostic favorable (1.04e-4)" 8.5 29.7 6.0 13.5 7.6 5.7 6.1 5.0 10.5 9.5 38.4 12.9 10.9 37.4 5.9 4.0 16.6 6.8 38.4 14.1 5.1 4.9 19.7 102.1 6.2 3.2 8.2 7.0 7.2 23.9 1.8 2.3 5.0 5.9 8.1 21.6 6.2 13.6 6.9 8.3 5.4 39.5 3.8 4.7 3.5 22.8 3.3 6.7 1.8 8.5 12.8 10.5 7.2 9.2 1.6 16.0 14.3 11.5 2.2 1.2 5.2 11.1 24.9 3.1 10.6 7.7 3.0 5.9 6.2 5.3 3.6 5.4 7.2 7.3 3.0 5.2 4.9 3.5 9.6 2.3 6.2 0.8 8.7 13.9 3.1 4.7 14.0 19.2 4.3 7.4 5.9 7.0 2.7 2.3 5.1 8.8 1.6 3.6 5.2 1.7 25.6 0.1 13.9 5.4 73.6 10.9 10.0 3.4 5.2 10.2 10.5 1.8 4.8 6.5 11.8 8.4 3.2 12.2 10.9 6.6 4.1 7.7 6.8 1.9 3.9 3.9 0.9 1.5 12.4 2.4 5.3 11.5 4.9 0.6 3.0 1.1 1.6 0.5 0.4 16.0 0.8 0.3 0.2 14.3 2.2 0.8 1.1 1.2 5.2 6.0 7.6 5.0 10.5 5.1 4.9 8.2 7.0 5.9 6.7 26.8 66.9 14.5 10.5 1.1 0.8 32.5 203.8 21.4 19.4 19.2 0.0 9.5 39.7 35.3 1.4 5.0 300.1 0.0 38.8 6.0 15.5 9.3 13.9 350.5 13.2 1.6 33.0 36.2 24.7 2.7 12.0 8.3 1.7 17.2 154.8 25.4 33.8 284.5 7.4 229.1 0.6 0.0 3.6 0.7 0.1 2.0 9.5 10.9 155.4 15.2 TTC21B "FLJ11457, IFT139B, JBTS11, NPHP12, THM1" ENSG00000123607 "Tetratricopeptide repeat domain 21B" Q7Z4L5 2 165857475-165953843 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035494, HPA035495, HPA073293" Supported Supported Mitochondria Yes No Mitochondria "HPA035494: AB_2674650, HPA035495: AB_10672866, HPA073293: " "unprognostic (1.63e-2)" "unprognostic (1.17e-1)" "unprognostic (3.10e-1)" "unprognostic (1.60e-2)" "unprognostic (2.96e-1)" "unprognostic (2.51e-1)" "unprognostic (7.09e-3)" "unprognostic (2.81e-2)" "unprognostic (2.98e-2)" "unprognostic (7.57e-2)" "unprognostic (3.52e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (1.84e-2)" 10.4 9.0 11.3 7.0 18.3 8.6 11.7 39.6 19.8 12.3 9.2 7.1 5.3 6.5 13.8 10.0 6.7 15.3 7.5 10.4 10.1 8.1 12.5 8.9 9.4 8.9 12.3 11.9 17.5 10.1 10.4 17.6 9.8 15.7 14.9 8.9 6.3 9.1 10.2 16.4 10.7 8.2 9.7 12.2 8.4 8.5 9.7 13.8 16.2 9.4 7.1 8.0 9.8 11.8 3.8 3.1 8.7 2.7 3.7 4.7 1.8 5.0 3.9 17.7 7.2 12.0 11.7 4.7 10.1 8.2 8.1 8.0 5.5 3.3 11.7 6.1 7.1 7.7 5.3 11.9 6.3 9.7 8.2 5.9 9.6 6.8 13.4 7.0 9.0 0.0 6.3 4.1 9.4 6.8 10.3 8.8 9.1 12.7 8.9 10.3 2.7 11.0 7.1 7.3 5.6 9.6 12.2 14.3 4.0 6.3 10.8 12.7 7.5 7.9 1.9 8.8 9.0 3.0 6.4 6.4 14.4 6.5 8.0 7.4 5.1 7.1 10.8 6.0 5.6 9.0 8.7 1.9 3.3 2.9 2.3 4.2 3.8 3.4 2.9 3.1 3.2 4.4 4.7 0.8 3.7 2.7 1.6 4.2 1.8 11.3 18.3 39.6 19.8 10.1 8.1 12.3 11.9 15.7 13.8 3.0 9.8 4.1 7.8 8.1 21.3 11.8 0.0 38.8 13.6 5.2 31.4 2.6 0.0 2.9 2.1 6.3 3.9 0.0 1.6 3.0 6.1 7.1 5.8 7.4 10.3 14.3 6.9 11.1 9.2 2.3 9.8 4.2 10.1 1.0 5.4 11.5 1.0 7.0 12.0 6.9 22.2 6.5 6.1 6.5 11.9 3.3 2.4 8.7 6.0 4.3 TXNRD2 "TR, TR3, TRXR2" ENSG00000184470 "Thioredoxin reductase 2" Q9NNW7 22 19875517-19941992 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002007, HPA003323" Supported Approved Vesicles,Mitochondria,Cytosol NA NA 410000 "Vesicles, Mitochondria, Cytosol" "CAB002007: , HPA003323: AB_1080396" "unprognostic (3.17e-2)" "unprognostic (8.72e-2)" "unprognostic (4.30e-1)" "unprognostic (9.71e-3)" "unprognostic (7.25e-2)" "unprognostic (6.35e-2)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (2.83e-1)" "unprognostic (4.94e-3)" "unprognostic (2.49e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.47e-1)" "unprognostic (5.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" 9.8 30.2 8.5 8.3 10.1 11.6 7.4 19.0 15.0 8.3 10.3 9.0 7.6 9.2 11.9 12.3 8.8 8.4 13.0 22.6 8.3 7.5 13.9 40.9 10.8 8.4 7.8 9.7 11.9 13.0 9.9 9.9 14.0 7.1 17.9 4.5 10.0 15.2 8.8 16.5 6.0 10.2 5.4 5.6 11.2 14.6 10.5 6.8 4.9 12.6 9.2 10.5 7.5 7.9 4.8 9.1 5.8 12.1 4.8 4.9 4.9 6.4 13.3 1.2 5.2 2.4 3.4 3.0 6.2 7.3 11.2 8.3 12.4 6.7 3.6 15.1 6.5 11.6 11.4 6.2 8.5 4.3 6.8 15.3 6.0 10.6 7.3 4.6 6.7 2.9 3.3 6.5 5.7 4.9 4.6 31.8 0.7 33.2 6.1 8.7 15.6 2.3 10.0 6.1 15.9 9.5 3.4 29.6 3.3 6.8 7.0 6.6 5.8 10.7 13.9 7.1 2.1 11.4 9.1 17.7 8.2 49.4 6.8 13.0 6.1 4.4 2.2 7.9 5.1 10.3 3.2 12.1 5.8 4.3 9.2 3.3 4.8 3.8 3.9 9.1 3.6 4.9 4.0 1.3 4.8 8.7 3.4 2.4 4.9 8.5 10.1 19.0 15.0 8.3 7.5 7.8 9.7 7.1 6.8 14.9 27.1 5.2 19.2 3.8 20.0 13.6 17.8 13.4 10.3 19.2 9.8 51.6 49.7 18.7 21.0 11.3 13.5 0.0 27.8 19.6 12.5 19.5 1.1 47.4 23.3 9.5 1.2 10.4 20.5 14.1 14.4 12.1 5.0 25.2 12.1 19.0 19.9 14.0 8.5 44.0 9.5 6.5 9.1 8.6 12.8 4.5 35.1 11.7 14.7 12.7 UCP2 "BMIQ4, SLC25A8" ENSG00000175567 "Uncoupling protein 2" P55851 11 73974667-73983307 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 219.1;lymphoid tissue: 144.8" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 420.4;Hofbauer cells: 378.7;Intestinal endocrine cells: 285.5;monocytes: 710.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 68.0;SK-BR-3: 87.6;U-698: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025583, HPA075202" Approved Supported Mitochondria NA NA Mitochondria "CAB025583: , HPA075202: AB_2732284" "unprognostic (1.13e-1)" "prognostic favorable (4.65e-5)" "unprognostic (8.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-3)" "unprognostic (2.07e-1)" "unprognostic (4.59e-2)" "unprognostic (1.13e-3)" "unprognostic (1.37e-1)" "prognostic unfavorable (7.80e-6)" "unprognostic (3.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.77e-3)" "unprognostic (3.88e-3)" 19.8 9.8 5.3 40.4 9.5 24.5 15.9 1.1 4.9 8.1 7.7 10.2 20.3 11.4 4.2 12.0 4.5 37.9 13.1 11.5 4.4 5.5 12.8 10.6 20.2 85.6 7.8 2.4 7.2 4.7 1.2 6.2 8.7 6.5 6.5 8.9 14.2 17.4 17.2 45.3 4.3 24.7 6.4 9.0 91.1 12.3 5.5 5.9 144.8 17.9 19.3 55.7 19.4 2.9 141.6 219.1 101.8 135.3 119.8 180.2 172.1 0.1 14.3 3.3 9.8 1.9 0.0 2.5 2.4 1.6 9.8 2.8 25.1 12.2 68.0 34.0 3.7 0.8 0.6 2.3 0.0 4.6 17.2 0.8 39.7 6.0 5.2 5.9 20.8 16.7 2.2 0.0 9.3 0.0 1.9 1.3 26.2 18.2 27.8 1.9 24.5 21.5 11.2 2.6 1.5 2.9 19.9 22.7 38.5 27.4 40.6 5.0 6.1 12.8 87.6 4.8 9.9 25.8 18.6 1.8 0.0 12.6 2.9 4.7 9.5 4.5 56.6 1.7 8.3 0.1 45.7 81.5 101.8 112.6 135.3 69.9 141.6 92.3 95.0 88.4 134.2 86.9 91.1 11.4 119.8 111.3 219.1 180.2 172.1 5.3 9.5 1.1 4.9 4.4 5.5 7.8 2.4 6.5 5.9 3.0 35.4 250.6 2.3 3.1 0.9 3.6 2.5 93.7 23.9 87.2 7.9 6.6 6.6 1.2 16.1 5.0 4.2 420.4 6.5 10.3 6.7 15.6 84.3 0.6 378.7 0.0 285.5 11.6 244.1 37.5 0.9 160.3 25.3 710.6 23.4 2.9 2.5 37.6 0.4 1.9 6.3 6.5 5.3 14.4 13.4 4.0 9.4 172.7 24.7 21.6 UQCC2 "bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1" ENSG00000137288 "Ubiquinol-cytochrome c reductase complex assembly factor 2" Q9BRT2 6 33694293-33711727 "Disease related genes, Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 791.0;Late spermatids: 864.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039111 Uncertain Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA039111: AB_2676352" "unprognostic (3.58e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (1.93e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.50e-1)" "unprognostic (2.35e-3)" "unprognostic (2.43e-2)" "unprognostic (5.93e-2)" "unprognostic (2.33e-2)" "unprognostic (7.43e-2)" "unprognostic (5.77e-2)" "unprognostic (3.88e-1)" "unprognostic (1.07e-1)" 13.4 22.9 26.1 13.3 31.4 14.6 17.7 15.0 22.9 12.4 15.8 12.0 12.3 12.8 17.4 23.4 15.2 10.9 9.2 71.0 19.2 23.0 18.3 23.4 8.9 12.3 22.8 22.6 11.5 25.3 7.9 24.5 14.4 20.6 15.7 17.2 18.9 19.6 14.3 76.4 12.2 10.4 20.0 20.0 12.9 15.9 30.9 18.3 12.3 19.0 22.0 14.9 10.9 11.0 39.7 38.9 7.2 39.6 21.9 31.5 34.8 42.7 30.8 34.5 29.9 28.7 28.9 27.2 24.4 24.5 34.0 33.7 49.4 18.1 17.2 39.5 29.4 52.4 23.1 23.4 34.1 30.3 21.9 38.5 33.7 20.4 68.3 47.1 31.4 27.6 29.5 55.0 27.3 44.2 19.7 25.3 33.2 35.9 35.7 39.9 46.0 30.4 65.3 20.9 32.8 35.1 22.0 28.3 58.3 24.1 40.7 59.4 21.1 26.9 41.3 33.7 19.1 36.2 80.0 23.4 39.1 33.2 25.2 50.2 27.5 38.2 29.1 11.8 47.6 45.1 7.2 27.0 5.2 24.0 39.6 29.1 39.7 30.3 27.4 31.9 32.8 31.5 28.4 2.6 21.9 32.7 38.9 31.1 34.8 26.1 31.4 15.0 22.9 19.2 23.0 22.8 22.6 20.6 18.3 26.8 27.7 65.4 71.0 52.0 115.5 791.0 94.3 38.8 39.8 73.3 47.1 122.2 331.5 87.4 273.9 53.4 58.0 93.5 155.9 94.8 61.5 91.6 57.8 134.7 186.1 66.7 95.6 51.5 60.7 864.2 72.8 62.9 79.2 67.7 57.9 48.7 112.6 54.0 78.8 214.9 98.9 0.0 58.5 99.8 96.6 66.7 79.8 40.6 79.2 104.5 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673687 "Disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 10.0 13.4 8.9 11.4 8.5 10.6 14.7 8.7 9.9 7.3 15.4 4.7 19.7 16.5 7.3 8.5 14.5 6.5 12.4 13.2 8.0 8.7 10.7 13.4 5.6 8.3 8.5 8.7 9.5 15.4 5.3 7.6 6.2 7.7 12.3 4.9 7.1 22.9 14.1 27.8 8.6 14.8 6.0 6.2 9.6 12.2 5.7 5.4 6.4 13.5 12.3 9.1 8.0 18.1 23.7 21.2 15.2 20.8 14.0 19.4 15.5 12.0 24.5 3.6 5.6 2.2 2.2 3.0 4.8 1.6 3.6 3.6 14.3 10.5 7.8 10.0 1.6 4.9 12.0 3.4 5.6 1.1 3.9 12.7 4.4 12.8 9.1 3.0 7.1 3.6 2.1 4.8 3.2 3.6 2.3 2.8 3.8 9.4 5.7 2.0 36.8 6.9 17.5 4.0 4.8 13.9 8.1 5.5 13.9 2.7 6.0 7.3 7.4 5.3 19.4 7.1 1.1 18.4 6.7 3.6 7.9 9.3 8.2 10.6 8.8 4.8 8.1 6.5 6.2 5.7 9.1 20.8 15.2 18.1 14.4 17.1 23.5 18.0 15.9 15.8 23.7 16.6 13.3 8.9 14.0 12.7 21.2 19.4 15.5 8.9 8.5 8.7 9.9 8.0 8.7 8.5 8.7 7.7 5.4 41.7 23.5 61.4 42.6 0.0 20.8 31.7 66.2 22.7 29.6 61.1 15.7 44.7 119.3 51.7 1.4 26.8 115.3 46.7 67.1 41.2 21.0 70.4 4.7 99.1 47.7 17.5 33.9 39.9 38.4 2.3 44.8 22.9 0.0 43.3 98.1 39.6 57.0 91.2 33.9 137.3 26.2 38.8 31.1 2.7 33.7 0.0 24.3 25.9 101.8 45.4 UQCRC1 "D3S3191, QCR1, UQCR1" ENSG00000010256 "Ubiquinol-cytochrome c reductase core protein 1" P31930 3 48599002-48610976 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 172.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 576.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 65.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002815, HPA003525, CAB033782" Enhanced Supported Mitochondria NA NA 1300000 Mitochondria "CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484" "unprognostic (1.29e-1)" "unprognostic (3.15e-3)" "unprognostic (6.91e-3)" "unprognostic (1.06e-1)" "unprognostic (1.66e-1)" "unprognostic (9.91e-2)" "unprognostic (8.53e-2)" "unprognostic (1.99e-1)" "unprognostic (3.11e-2)" "unprognostic (9.14e-2)" "unprognostic (3.37e-1)" "unprognostic (7.20e-2)" "prognostic favorable (2.35e-10)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "unprognostic (1.02e-1)" "unprognostic (6.72e-2)" 18.1 13.7 11.1 9.8 12.5 9.4 11.8 12.5 20.5 11.0 33.7 6.9 10.4 20.0 9.1 9.7 15.8 12.4 10.8 66.7 10.8 11.2 23.0 30.5 7.7 9.3 13.3 13.5 6.3 14.4 20.4 7.8 11.5 13.3 12.5 12.3 7.8 19.5 21.9 172.7 14.0 20.9 12.0 8.7 8.4 23.0 18.4 7.4 9.4 9.1 39.9 9.8 10.3 9.1 23.3 52.7 28.1 57.8 15.1 22.0 74.3 10.1 16.5 6.0 3.6 8.8 8.1 27.1 18.8 15.2 15.6 14.2 25.6 3.0 26.3 11.9 8.4 18.3 9.8 7.5 21.8 2.9 15.6 35.9 27.0 14.3 27.7 17.5 16.9 11.7 11.1 24.8 10.6 17.5 7.4 15.5 17.4 14.5 1.8 9.4 17.7 12.2 19.3 15.0 15.0 65.5 8.3 16.0 21.5 16.1 11.1 6.4 11.4 25.4 3.1 15.0 1.7 6.5 2.7 15.5 4.3 16.5 13.6 19.3 16.0 14.1 15.2 9.6 19.5 13.9 17.6 57.8 28.1 18.9 56.9 17.9 23.3 18.9 19.0 52.7 18.6 17.1 16.4 14.1 15.1 48.5 21.0 22.0 74.3 11.1 12.5 12.5 20.5 10.8 11.2 13.3 13.5 13.3 7.4 53.6 50.3 63.6 133.4 104.5 38.0 576.9 142.7 78.9 46.6 115.1 27.5 292.1 310.0 150.4 116.4 44.8 496.0 46.7 145.4 266.4 68.1 72.4 80.8 173.2 214.8 38.1 138.8 44.2 110.4 218.8 54.1 87.6 113.1 113.6 228.6 55.4 138.8 252.6 66.4 309.3 39.8 58.2 92.9 102.7 76.4 92.1 281.6 56.5 307.7 117.4 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 20.1 38.8 18.6 28.9 30.9 30.9 22.1 48.2 27.5 19.9 18.4 25.6 15.4 17.6 21.3 17.6 19.0 17.4 20.5 17.8 16.9 15.8 15.5 18.3 18.3 26.2 26.6 22.5 27.0 19.8 24.6 35.4 23.1 26.8 21.6 22.0 22.1 24.5 16.3 17.0 23.9 22.2 22.2 19.7 29.1 26.2 15.8 23.6 25.8 23.9 14.0 29.0 19.8 21.0 13.7 10.5 33.7 9.6 5.6 11.2 5.6 14.9 7.1 16.8 12.1 14.6 18.0 16.6 18.8 12.8 12.7 16.8 6.5 15.3 16.8 12.7 17.0 9.9 13.8 20.6 15.2 19.3 16.3 14.1 35.9 26.5 11.8 13.0 18.0 19.2 14.6 13.1 12.8 14.3 17.4 37.2 12.8 28.2 47.5 15.5 7.4 14.9 23.4 10.5 15.3 12.8 21.0 16.9 19.6 14.5 12.6 20.5 12.8 17.7 16.3 42.5 23.5 8.3 21.8 26.4 13.7 11.2 16.7 10.9 38.2 27.1 16.7 13.2 22.3 20.0 33.7 9.6 16.7 6.4 4.6 7.6 13.7 9.5 9.5 10.5 12.8 11.2 7.0 8.9 5.6 5.0 7.7 10.1 5.6 18.6 30.9 48.2 27.5 16.9 15.8 26.6 22.5 26.8 23.6 50.6 38.5 34.3 22.6 19.7 74.8 58.2 22.9 32.1 20.5 19.2 58.9 51.8 21.6 25.0 51.8 24.5 18.7 70.0 17.5 50.1 30.9 20.6 47.5 21.2 26.0 47.7 20.8 28.3 22.2 33.0 32.2 24.7 55.6 47.7 26.9 29.1 20.0 17.5 48.4 16.5 69.2 32.3 25.0 42.9 48.2 22.5 27.2 35.5 30.2 17.1 VDAC2 ENSG00000165637 "Voltage dependent anion channel 2" P45880 10 75210154-75231448 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043475 Enhanced Supported Mitochondria NA NA 4000000 Mitochondria "HPA043475: AB_10795615" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (9.47e-2)" "unprognostic (9.00e-3)" "unprognostic (5.74e-2)" "prognostic unfavorable (4.51e-4)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.83e-3)" "unprognostic (5.89e-2)" "unprognostic (2.45e-1)" "unprognostic (2.02e-2)" "unprognostic (1.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.40e-1)" "unprognostic (1.65e-1)" "unprognostic (6.28e-2)" "unprognostic (1.34e-2)" 26.2 31.9 27.8 18.7 40.5 25.1 59.7 34.2 55.4 29.0 39.1 24.2 19.9 31.8 25.5 20.3 63.7 25.0 18.5 141.7 28.1 24.1 38.2 24.4 23.2 23.0 27.6 37.7 29.6 38.9 37.6 18.4 24.1 36.5 24.2 40.3 23.0 30.5 30.6 99.7 30.7 30.5 43.7 27.9 17.8 31.1 30.4 16.9 15.6 27.5 31.9 30.0 33.7 39.1 44.8 63.2 39.0 62.9 36.0 49.6 54.6 41.9 34.7 42.0 53.2 37.5 51.1 44.1 54.6 61.6 59.9 56.6 52.3 40.2 50.0 30.7 45.6 33.3 56.5 76.9 54.1 58.9 27.1 44.8 29.1 29.4 59.0 37.5 55.2 32.4 45.2 64.2 51.0 109.3 84.4 44.2 31.7 49.1 40.8 62.9 31.0 35.5 45.0 36.1 47.6 134.3 42.6 33.3 31.7 58.9 26.4 26.7 31.5 30.1 101.0 63.8 51.3 58.8 24.8 34.1 29.9 41.0 44.2 58.5 32.9 44.8 51.6 43.4 54.7 25.4 39.0 51.5 38.0 32.5 54.0 39.6 44.8 44.7 36.4 63.2 36.0 45.5 41.7 17.7 36.0 62.9 30.8 49.6 54.6 27.8 40.5 34.2 55.4 28.1 24.1 27.6 37.7 36.5 16.9 89.3 45.7 134.1 325.8 338.7 144.0 304.7 142.7 73.6 99.0 106.4 41.2 263.8 567.0 389.3 129.8 150.9 543.9 46.7 300.7 379.6 156.9 217.1 110.7 72.5 237.9 122.3 143.7 133.8 127.5 75.8 157.3 179.7 212.6 317.4 241.2 222.4 375.0 269.6 156.3 255.3 119.1 174.6 229.6 245.4 142.7 367.4 331.6 102.2 304.0 486.8 VDAC3 HD-VDAC3 ENSG00000078668 "Voltage dependent anion channel 3" Q9Y277 8 42391624-42405897 "Plasma proteins, Predicted intracellular proteins" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 187.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026864 Uncertain Supported Mitochondria NA NA 9300000 Mitochondria "HPA026864: AB_1858733" "unprognostic (2.55e-2)" "unprognostic (1.96e-2)" "unprognostic (9.88e-3)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-1)" "unprognostic (4.98e-2)" "unprognostic (2.25e-2)" "unprognostic (1.40e-2)" "unprognostic (5.76e-2)" "unprognostic (3.74e-1)" "unprognostic (1.19e-2)" "unprognostic (6.16e-3)" "unprognostic (2.96e-2)" "unprognostic (1.76e-1)" "unprognostic (8.78e-3)" "unprognostic (6.94e-3)" 19.9 18.8 26.0 13.7 29.8 18.6 17.3 38.3 39.1 16.0 23.7 14.5 12.3 19.1 19.1 17.7 26.8 21.5 13.9 85.8 28.2 35.3 27.9 22.1 12.5 14.6 32.5 24.6 18.1 15.0 17.5 16.5 15.4 44.3 17.6 26.2 16.0 22.2 20.8 187.5 13.0 22.7 22.1 19.6 17.3 16.6 27.4 13.0 20.5 21.6 39.7 18.4 23.1 13.3 34.4 59.4 47.5 44.4 31.4 52.4 81.9 48.6 49.1 38.6 41.1 32.6 28.4 19.2 39.0 33.3 50.2 46.0 37.8 41.7 50.0 37.5 33.0 45.3 31.2 52.1 41.8 55.3 25.4 43.0 76.1 32.8 53.8 23.3 36.6 42.5 22.1 31.8 38.0 17.7 33.5 60.9 44.5 59.6 35.0 51.0 27.0 78.2 42.1 45.9 62.4 32.0 41.4 71.1 35.4 53.9 43.4 34.1 29.3 24.7 29.3 24.5 29.8 61.9 28.0 32.5 19.5 34.1 48.6 37.7 32.6 54.2 57.1 26.2 51.8 32.9 31.1 44.4 47.5 42.1 43.8 42.4 34.4 45.1 41.7 59.4 24.2 45.1 43.3 22.0 31.4 38.5 43.8 52.4 81.9 26.0 29.8 38.3 39.1 28.2 35.3 32.5 24.6 44.3 13.0 41.7 19.5 49.6 71.1 57.4 83.7 294.5 58.6 89.7 33.0 62.8 33.4 118.8 260.2 101.6 108.7 64.1 58.2 46.7 78.4 84.2 75.7 46.5 54.3 48.2 122.7 130.3 45.9 60.2 53.6 110.3 64.2 66.6 69.2 161.5 75.4 54.5 76.5 66.6 91.6 145.2 76.0 64.7 82.1 279.8 154.0 61.9 48.7 63.7 98.4 64.8 WARS2 TrpRS ENSG00000116874 "Tryptophanyl tRNA synthetase 2, mitochondrial" Q9UGM6 1 119031216-119140671 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028007, HPA069692" Enhanced Supported Mitochondria NA NA Mitochondria "HPA028007: , HPA069692: AB_2686172" "unprognostic (1.00e-1)" "unprognostic (2.25e-1)" "unprognostic (2.03e-1)" "unprognostic (5.64e-2)" "unprognostic (3.42e-1)" "unprognostic (7.05e-2)" "unprognostic (7.73e-3)" "unprognostic (3.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.17e-2)" "unprognostic (3.96e-2)" "unprognostic (6.76e-3)" "prognostic favorable (1.45e-4)" "unprognostic (4.83e-2)" "unprognostic (1.83e-1)" "unprognostic (9.88e-3)" "unprognostic (4.71e-2)" 17.3 16.7 6.8 11.7 8.3 2.8 14.6 7.5 8.7 12.9 11.2 7.7 7.6 12.3 13.5 10.4 13.4 14.9 8.8 12.1 6.2 6.1 15.3 14.9 9.2 12.4 6.4 6.1 14.7 17.8 15.1 12.3 14.9 8.3 14.1 12.7 11.3 10.5 10.4 12.2 10.0 13.1 9.0 5.4 9.9 11.2 6.9 6.1 11.6 12.8 13.2 14.2 14.3 10.4 7.2 9.0 0.5 6.9 5.3 7.4 4.9 10.3 4.5 6.1 6.4 7.8 17.6 6.6 5.8 8.3 6.1 7.3 11.3 4.7 15.2 9.5 9.3 3.7 7.0 10.9 9.9 9.4 8.2 14.2 7.2 12.1 10.8 15.9 11.6 4.1 13.4 7.7 8.9 16.3 8.1 9.1 6.7 11.2 11.1 11.3 12.0 6.9 6.7 8.2 7.8 9.3 5.1 20.2 7.7 16.7 14.5 9.0 5.5 9.1 12.7 13.1 11.2 5.6 9.1 6.9 6.7 8.0 12.5 11.0 5.4 3.6 6.7 8.2 9.8 12.3 0.0 6.9 0.5 5.1 4.9 7.4 6.6 5.4 6.7 9.0 7.2 6.5 6.2 0.3 5.3 3.0 4.5 6.0 4.9 6.8 8.3 7.5 8.7 6.2 6.1 6.4 6.1 8.3 6.1 8.9 10.5 8.8 16.5 8.5 6.3 9.2 7.6 16.0 10.3 10.4 5.9 14.1 14.9 9.0 52.2 6.8 5.2 0.0 10.3 13.0 10.8 11.7 8.1 7.3 8.4 6.4 6.4 1.8 7.3 24.7 9.2 6.3 10.1 15.4 9.5 4.9 9.1 3.5 7.8 12.6 7.7 6.5 9.5 3.5 5.9 9.4 16.7 6.4 14.6 11.3 WISP3 CCN6 ENSG00000112761 "WNT1 inducible signaling pathway protein 3" O95389 6 112054072-112070969 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 9.5" "Cell type enriched" "Detected in some" 9 "Early spermatids: 82.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basal ganglia: 2.3;cerebellum: 5.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 11.2;THP-1: 3.6;U-2197: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA064196 Supported Mitochondria "Secreted to extracellular matrix" NA NA Mitochondria "HPA064196: AB_2685209" "unprognostic (2.13e-2)" "unprognostic (7.90e-3)" "unprognostic (5.00e-2)" "unprognostic (2.22e-2)" "unprognostic (3.76e-1)" "unprognostic (6.52e-2)" "unprognostic (1.98e-3)" "unprognostic (4.07e-3)" "unprognostic (1.82e-1)" "unprognostic (3.90e-1)" "unprognostic (1.02e-2)" "unprognostic (4.81e-2)" "unprognostic (1.80e-2)" "unprognostic (1.50e-2)" "unprognostic (3.11e-1)" "unprognostic (4.91e-2)" "unprognostic (2.93e-2)" 0.4 0.5 0.3 0.4 2.3 0.8 4.2 5.9 0.5 1.9 0.3 0.3 0.3 0.1 0.6 9.5 0.9 3.2 1.4 0.4 0.3 0.5 5.3 0.8 0.4 0.5 0.4 0.3 1.6 0.3 0.0 0.3 0.4 0.3 1.1 0.0 0.3 0.6 0.3 0.6 4.8 0.3 0.3 0.4 0.4 0.4 5.8 0.9 0.3 0.3 2.8 2.2 0.3 1.5 1.1 0.6 2.0 0.5 1.7 1.2 0.2 0.1 0.0 0.3 1.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.9 0.2 0.3 0.3 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.7 0.3 0.1 0.0 0.2 0.9 0.4 0.1 0.2 0.3 0.1 0.3 0.0 11.2 0.5 0.6 0.1 0.2 0.9 0.4 0.2 3.6 0.2 0.2 0.2 2.6 0.3 0.3 0.0 0.3 0.4 1.1 0.2 1.4 0.4 0.6 0.5 0.3 0.6 0.8 0.9 0.9 0.3 1.1 1.2 1.1 2.0 1.7 0.5 0.6 0.6 0.2 0.3 2.3 5.9 0.5 0.3 0.5 0.4 0.3 0.3 0.9 0.0 0.0 0.0 2.7 0.7 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 82.4 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.2 6.5 0.0 0.6 0.7 0.6 0.1 0.0 0.0 2.1 XAF1 "BIRC4BP, HSXIAPAF1, XIAPAF1" ENSG00000132530 "XIAP associated factor 1" Q6GPH4 17 6755447-6775647 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 56.6;Club cells: 50.0;granulocytes: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 34.2;HHSteC: 15.2" HPA057302 Approved Supported "Nucleoplasm,Mitochondria,Rods & Rings" Yes NA Mitochondria "Nucleoplasm, Rods & Rings" "HPA057302: AB_2683405" "unprognostic (6.28e-2)" "unprognostic (1.71e-1)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.09e-3)" "unprognostic (4.89e-2)" "unprognostic (1.39e-1)" "unprognostic (8.08e-3)" "unprognostic (3.34e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.73e-7)" "unprognostic (2.33e-1)" "unprognostic (1.74e-2)" "unprognostic (2.31e-1)" "unprognostic (6.15e-3)" 32.8 7.5 12.2 27.0 13.2 17.5 14.4 4.3 14.0 12.8 10.5 8.9 11.4 15.3 15.6 22.4 11.8 12.0 20.1 13.1 10.7 7.9 19.1 37.9 25.1 15.8 11.0 9.6 34.6 2.7 2.2 8.6 15.2 16.4 13.2 10.1 9.9 26.4 9.0 9.1 10.7 14.4 14.7 10.8 35.0 14.0 5.4 11.0 17.3 10.5 9.2 11.3 12.0 13.4 4.3 7.7 13.1 11.6 7.7 8.5 5.3 2.0 0.1 0.2 0.5 2.8 6.3 0.2 2.5 10.4 33.1 34.2 0.2 3.0 0.5 0.8 3.8 11.9 1.2 0.0 0.5 3.8 4.5 0.1 0.7 0.3 0.4 15.2 0.4 3.1 2.9 0.0 4.4 0.1 0.1 2.7 9.6 0.2 10.8 1.0 0.1 2.2 8.8 0.2 0.1 0.8 4.3 0.1 0.2 0.0 1.9 0.2 0.2 1.2 0.2 5.5 0.2 0.3 12.1 0.3 0.4 0.3 0.9 0.2 1.6 0.5 0.2 0.9 7.2 0.8 13.1 8.8 4.2 7.5 11.6 5.7 3.3 5.9 5.2 7.7 4.3 4.0 4.1 10.6 7.7 10.7 0.8 8.5 5.3 12.2 13.2 4.3 14.0 10.7 7.9 11.0 9.6 16.4 11.0 56.6 31.7 5.4 5.3 4.6 0.2 1.6 12.7 36.1 50.0 0.0 0.0 0.1 0.0 1.1 3.1 24.8 8.1 23.3 1.7 3.5 8.7 2.7 46.3 13.6 15.0 0.0 1.7 28.8 16.4 0.6 33.6 22.5 5.0 3.6 8.4 1.0 6.2 0.0 25.8 0.2 0.3 19.4 3.9 0.3 0.6 2.4 0.3 13.8 6.6 5.4 XPNPEP3 "APP3, ICP55, NPHPL1" ENSG00000196236 "X-prolyl aminopeptidase 3" Q9NQH7 22 40857077-40932815 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 196.2;Late spermatids: 233.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000527 Approved Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA000527: AB_1079266" "prognostic unfavorable (8.19e-4)" "unprognostic (6.77e-2)" "unprognostic (3.22e-3)" "unprognostic (5.03e-3)" "unprognostic (6.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (2.53e-1)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.24e-1)" 8.2 13.6 7.5 5.8 9.2 4.7 9.7 5.2 7.8 7.3 6.1 10.8 11.6 32.3 10.7 12.3 7.2 9.4 10.5 11.2 7.6 7.1 9.8 19.0 6.6 10.6 7.9 6.1 10.7 10.5 8.0 15.0 6.1 10.7 7.3 6.2 9.3 8.5 13.6 12.0 11.5 20.9 7.1 9.3 7.7 6.8 18.9 8.2 11.5 9.1 7.3 8.8 12.6 8.2 5.9 6.0 6.4 10.0 1.2 4.4 4.0 3.3 4.7 3.2 7.1 9.0 6.0 2.2 4.1 3.1 2.3 2.3 3.9 2.1 6.5 2.3 7.9 9.7 7.6 6.0 3.2 3.4 3.9 12.4 4.2 9.3 7.3 4.1 7.4 0.7 5.3 5.0 7.2 4.3 3.5 4.0 4.6 3.5 5.9 4.9 5.0 3.5 3.9 1.9 6.0 9.6 4.9 4.3 3.7 6.5 4.4 2.8 2.5 4.1 6.1 3.8 3.5 7.1 3.4 4.0 4.7 4.1 4.3 2.4 5.6 4.2 7.9 7.2 9.6 3.2 4.0 4.4 4.4 3.4 3.9 1.8 5.9 2.1 2.2 3.1 3.7 4.4 3.3 6.4 1.2 10.0 6.0 3.0 4.0 7.5 9.2 5.2 7.8 7.6 7.1 7.9 6.1 10.7 8.2 6.0 21.2 6.5 6.9 11.7 14.9 17.6 20.4 29.4 13.6 8.7 17.7 17.8 13.3 11.7 196.2 11.7 4.2 0.0 14.7 16.0 11.3 6.7 13.9 32.1 12.4 15.9 13.3 11.1 13.5 233.7 18.4 13.0 16.9 2.8 9.5 12.1 10.8 9.7 14.5 18.6 19.3 32.3 13.2 50.5 32.5 14.3 16.7 5.0 10.6 6.2 YARS2 "CGI-04, FLJ13995, mt-TyrRS" ENSG00000139131 "Tyrosyl-tRNA synthetase 2" Q9Y2Z4 12 32727490-32755902 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038721, HPA057610, HPA074097" Uncertain Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (2.30e-3)" "unprognostic (1.02e-2)" "unprognostic (2.12e-1)" "unprognostic (5.99e-3)" "prognostic unfavorable (3.19e-5)" "unprognostic (1.41e-2)" "unprognostic (4.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-2)" "unprognostic (8.39e-2)" "unprognostic (7.45e-2)" "unprognostic (1.99e-1)" "unprognostic (4.71e-1)" "unprognostic (4.07e-1)" "unprognostic (2.09e-1)" 12.6 15.8 11.0 12.6 15.3 13.9 13.8 11.6 14.9 13.1 11.8 11.5 18.4 9.8 13.3 12.9 17.5 11.3 9.1 12.1 11.9 9.7 12.4 16.3 9.2 15.5 10.8 11.7 13.3 21.0 11.0 16.6 15.9 13.5 12.9 13.7 11.3 17.4 10.0 15.9 12.0 10.8 11.1 12.6 13.3 12.3 12.5 12.6 17.5 12.3 16.0 16.4 13.3 11.8 11.8 9.5 9.4 9.9 12.9 12.7 5.2 9.4 11.4 6.7 7.9 7.3 8.6 21.0 7.2 7.4 9.0 8.8 28.5 12.1 17.1 11.9 7.3 13.0 12.3 13.2 19.1 10.2 7.4 20.7 11.3 8.6 15.8 10.6 12.0 6.6 8.0 12.2 8.5 15.5 11.6 14.2 9.1 15.9 7.9 9.4 7.7 8.9 14.5 36.6 6.3 14.0 10.1 14.2 10.1 11.4 13.6 10.3 5.0 11.1 9.7 7.1 27.1 18.1 10.9 9.5 8.5 9.0 13.8 12.2 4.7 5.0 17.8 7.9 9.0 7.0 9.4 7.0 4.1 10.1 8.9 10.6 8.8 10.7 10.4 9.5 11.8 11.2 12.7 1.4 12.9 9.9 9.3 9.3 5.2 11.0 15.3 11.6 14.9 11.9 9.7 10.8 11.7 13.5 12.6 6.0 4.1 13.7 17.3 9.0 16.5 6.9 2.5 5.3 7.9 10.4 19.6 29.4 6.6 17.0 4.4 5.7 5.2 23.3 14.2 29.0 10.7 7.9 6.9 4.5 17.9 14.3 6.9 5.5 7.0 2.8 9.8 5.5 5.0 19.0 6.6 11.6 12.2 10.4 8.1 9.3 18.8 12.9 6.2 4.9 14.7 7.3 15.0 12.1 11.5 11.4 YME1L1 ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110112-27155266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA066953: AB_2685753" "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 27.8 37.3 22.7 25.0 26.2 41.4 39.2 27.8 27.5 27.6 24.3 15.7 29.8 22.3 29.9 35.9 34.5 25.3 24.4 34.1 23.4 21.5 26.8 45.4 26.9 38.7 19.3 25.5 32.5 33.8 27.8 28.6 33.4 22.0 25.9 26.3 23.3 28.1 31.3 79.0 26.8 25.3 34.6 20.2 26.5 24.7 24.7 20.9 41.7 30.9 32.0 28.9 36.4 28.9 55.6 79.2 73.9 53.0 45.5 56.0 45.9 40.9 30.8 36.8 18.2 36.2 38.9 30.1 40.5 23.7 41.5 47.7 41.5 50.4 43.6 26.9 44.6 29.8 39.6 44.2 35.7 45.9 39.6 26.5 41.5 27.4 29.1 39.7 28.3 34.1 31.9 42.3 36.2 36.7 36.7 43.4 39.9 48.1 44.5 45.8 27.7 52.3 16.4 29.2 34.2 14.4 45.3 59.1 40.4 33.9 19.5 28.4 36.4 40.4 31.4 40.5 31.8 30.1 35.5 42.5 25.2 35.2 42.2 36.2 22.4 32.8 55.8 35.8 52.6 19.2 53.0 53.0 55.2 55.3 44.8 56.0 51.4 53.8 51.2 42.6 55.6 49.7 51.9 73.9 45.5 47.3 79.2 52.6 45.9 22.7 26.2 27.8 27.5 23.4 21.5 19.3 25.5 22.0 20.9 62.5 66.8 93.1 70.6 62.3 52.1 93.2 25.5 80.3 70.5 27.9 78.5 53.8 13.3 45.6 37.7 61.8 166.4 0.0 41.6 60.0 62.5 67.3 107.5 64.8 64.5 47.7 48.2 55.3 92.4 21.3 53.5 112.2 54.0 43.3 68.3 59.1 53.7 84.2 40.7 38.2 67.9 71.1 75.6 83.7 30.3 56.8 79.3 84.7 70.3 58.6